data_2ozw_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ozw _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.335 0 CA-C-O 121.98 0.895 . . . . 0.0 110.281 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -148.74 149.94 32.26 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 105.053 -2.202 . . . . 0.0 105.053 169.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 17.0 mt -60.23 -26.93 66.78 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -171.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.58 -28.06 65.64 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.888 0.767 . . . . 0.0 112.434 175.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.8 mt -79.3 -28.08 42.19 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 123.334 0.654 . . . . 0.0 111.149 -177.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 39.9 mt -64.85 128.0 93.22 Favored Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -47.16 130.31 16.56 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.41 2.74 . . . . 0.0 110.944 171.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -81.74 -37.63 26.97 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.357 0.599 . . . . 0.0 110.922 -173.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 43.8 t -134.73 135.13 53.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 170.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -152.93 123.54 7.27 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 169.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 20.2 pt . . . . . 0 CA--C 1.534 0.349 0 C-N-CA 125.601 1.56 . . . . 0.0 107.334 -171.768 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 32.2 p90 . . . . . 0 C--O 1.235 0.299 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -81.8 155.83 25.22 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 123.213 0.605 . . . . 0.0 110.772 -172.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -144.54 160.42 41.14 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.73 1.212 . . . . 0.0 108.174 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.1 m -132.85 152.34 35.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 C-N-CA 124.299 1.04 . . . . 0.0 109.169 173.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.36 123.65 47.22 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 103.654 -2.721 . . . . 0.0 103.654 173.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.7 mt -125.55 121.16 59.53 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 -177.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 23.1 ttp180 -76.64 143.47 40.12 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 169.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.2 t -133.66 142.45 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 C-N-CA 128.568 2.747 . . . . 0.0 104.593 -172.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -127.77 151.95 48.37 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.164 0.985 . . . . 0.0 108.806 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 39.1 m -63.7 90.74 0.06 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.997 0.919 . . . . 0.0 111.48 175.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.419 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -136.32 19.21 0.05 OUTLIER Pre-proline 0 CA--C 1.552 1.025 0 CA-C-O 116.473 -1.727 . . . . 0.0 113.201 168.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' A' ' 30' ' ' ALA . 77.0 Cg_exo . . . . . 0 C--N 1.362 1.284 0 CA-C-N 123.915 2.434 . . . . 0.0 113.064 172.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 . . . . . 0 CA--C 1.539 0.52 0 CA-C-O 121.358 0.599 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 12.5 m -140.28 158.55 43.85 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.503 1.121 . . . . 0.0 108.66 170.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -150.95 165.4 33.83 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 127.284 2.233 . . . . 0.0 105.822 -173.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.9 mp0 -128.72 147.87 50.8 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 176.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.3 pt -127.11 154.38 37.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 124.623 1.169 . . . . 0.0 109.456 176.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.0 t -117.66 119.28 61.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 178.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.9 mmp_? -129.49 145.28 51.46 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.007 1.323 . . . . 0.0 107.454 176.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.98 134.43 2.32 Favored Glycine 0 N--CA 1.452 -0.282 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 177.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -151.92 150.2 29.78 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -170.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -60.69 -27.57 67.96 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 118.88 -0.581 . . . . 0.0 112.407 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 11.3 p-90 -69.72 -26.16 64.2 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.259 0.936 . . . . 0.0 113.02 176.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.02 82.27 7.68 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 119.926 1.239 . . . . 0.0 109.667 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -66.34 -12.45 56.79 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.029 0.932 . . . . 0.0 111.884 176.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -142.06 152.01 42.92 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.522 1.929 . . . . 0.0 107.946 178.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -73.9 -32.88 63.78 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 121.692 -0.63 . . . . 0.0 110.308 -170.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.09 -28.39 52.13 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-O 118.561 -0.733 . . . . 0.0 112.265 172.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -66.43 -48.72 69.1 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 119.269 0.941 . . . . 0.0 110.731 -176.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.89 -42.85 86.12 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.675 177.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -61.51 -44.63 96.73 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 119.896 1.225 . . . . 0.0 110.098 -177.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -63.03 -48.55 78.25 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.888 0.767 . . . . 0.0 111.936 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 36.1 tttt -62.41 -52.89 61.77 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.387 0.675 . . . . 0.0 110.951 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 78.4 t -70.86 -49.61 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-O 118.231 -0.89 . . . . 0.0 109.125 -170.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 66.7 m -68.25 -23.4 64.78 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 119.721 1.146 . . . . 0.0 111.186 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.6 -48.82 78.77 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 169.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -62.27 -45.79 91.68 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 118.448 1.124 . . . . 0.0 111.816 176.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 39.0 mmt -55.99 -48.2 76.32 Favored 'General case' 0 C--O 1.227 -0.083 0 CA-C-N 118.17 0.441 . . . . 0.0 110.463 176.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -69.82 -27.56 64.97 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 118.779 0.718 . . . . 0.0 112.037 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -66.58 -36.48 82.73 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.37 0.986 . . . . 0.0 110.25 169.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -70.36 -30.91 67.97 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 120.0 1.273 . . . . 0.0 110.44 169.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 129.62 -26.63 4.29 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 127.618 2.532 . . . . 0.0 111.365 174.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 85.6 m -51.15 142.36 12.72 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 126.306 1.842 . . . . 0.0 111.861 -175.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -101.96 146.73 27.46 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 176.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 79.2 m -143.1 163.28 33.29 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -168.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -150.65 128.88 11.97 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 169.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 9.2 p -66.95 131.58 46.18 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 169.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 38.8 mt -74.83 -21.52 59.23 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 120.974 -1.079 . . . . 0.0 110.176 170.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 162.53 -168.35 37.42 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 108.66 -1.776 . . . . 0.0 108.66 175.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -133.34 172.83 21.36 Favored Glycine 0 CA--C 1.521 0.421 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 173.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -171.59 -163.99 26.47 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 108.084 -2.006 . . . . 0.0 108.084 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 29.2 ptt180 -135.47 154.81 51.3 Favored 'General case' 0 CA--C 1.512 -0.511 0 O-C-N 120.639 -1.506 . . . . 0.0 109.294 172.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.9 mt . . . . . 0 N--CA 1.445 -0.704 0 N-CA-C 104.331 -2.47 . . . . 0.0 104.331 178.399 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 22.3 t60 . . . . . 0 N--CA 1.451 -0.381 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.6 t -133.82 130.43 55.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -173.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -171.26 -175.48 1.68 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.474 0.579 . . . . 0.0 110.235 -169.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.47 -166.47 39.94 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 174.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -157.67 161.09 38.57 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.391 0.676 . . . . 0.0 111.629 175.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.9 t -87.74 154.46 20.55 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 168.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.4 ptm -92.34 -32.37 15.01 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 119.024 0.829 . . . . 0.0 110.422 173.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.19 -24.35 59.34 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.048 0.84 . . . . 0.0 111.836 175.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -133.92 -4.9 2.79 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -169.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.4 -177.21 52.92 Favored Glycine 0 CA--C 1.535 1.317 0 CA-C-N 119.412 1.006 . . . . 0.0 113.124 175.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.58 138.55 38.66 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.232 2.621 . . . . 0.0 110.41 176.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.45 169.56 18.01 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.694 0.798 . . . . 0.0 111.192 169.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -79.5 80.85 5.83 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 169.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 41.9 m80 -56.1 -20.13 16.03 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.843 0.857 . . . . 0.0 113.244 -178.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.23 -44.3 71.6 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.428 1.491 . . . . 0.0 112.352 169.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 70.7 mt -66.25 -44.7 91.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.43 -49.38 76.42 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.921 0.888 . . . . 0.0 110.78 -178.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.1 p -64.55 -46.71 81.68 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 118.362 -0.827 . . . . 0.0 110.708 -175.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -60.87 -40.1 91.69 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 119.295 0.952 . . . . 0.0 110.705 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 45.1 mttm -68.36 -46.97 68.68 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.807 -0.558 . . . . 0.0 111.509 177.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 68.8 mt -66.63 -38.51 81.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 119.469 1.031 . . . . 0.0 109.198 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 93.7 mttt . . . . . 0 N--CA 1.468 0.44 0 CA-C-N 119.696 1.134 . . . . 0.0 109.56 173.597 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.1 t . . . . . 0 C--O 1.234 0.289 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.6 p -136.83 170.18 16.52 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.496 1.119 . . . . 0.0 109.507 177.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 41.8 p-90 . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 172.452 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.366 0 CA-C-O 121.776 0.798 . . . . 0.0 111.631 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -146.29 143.72 29.35 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 105.558 -2.016 . . . . 0.0 105.558 169.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 76.6 mt -55.69 -33.03 63.8 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -171.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.82 -25.44 66.44 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.911 0.778 . . . . 0.0 112.318 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.1 mt -81.23 -24.39 37.43 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.481 0.712 . . . . 0.0 111.397 -176.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 52.3 mt -70.9 131.02 87.74 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-O 118.145 -0.931 . . . . 0.0 108.783 -169.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -47.27 120.38 4.32 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 124.26 3.307 . . . . 0.0 112.894 172.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -66.13 -35.76 81.35 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.475 1.51 . . . . 0.0 111.739 -178.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.9 t -143.41 138.23 26.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 176.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -153.19 113.82 4.06 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 169.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.2 pt . . . . . 0 CA--C 1.534 0.331 0 C-N-CA 123.145 0.578 . . . . 0.0 110.878 -169.685 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 . . . . . 0 C--O 1.237 0.433 0 CA-C-O 121.351 0.596 . . . . 0.0 109.782 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.4 mttm -70.48 156.2 39.69 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.63 1.172 . . . . 0.0 111.785 -172.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -144.54 161.59 38.72 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.614 1.966 . . . . 0.0 107.639 169.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.1 m -129.15 151.76 36.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 124.971 1.309 . . . . 0.0 109.537 173.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.97 120.34 39.66 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 104.202 -2.518 . . . . 0.0 104.202 171.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 46.1 mt -122.06 127.34 75.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 -177.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -81.36 148.0 29.56 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 169.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.1 t -133.03 144.25 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 -177.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -125.65 154.19 42.7 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.534 1.134 . . . . 0.0 109.396 -176.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 44.3 m -69.54 47.45 0.08 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.996 1.718 . . . . 0.0 114.157 177.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.13 -5.4 0.09 OUTLIER Pre-proline 0 CA--C 1.556 1.192 0 CA-C-O 114.775 -2.536 . . . . 0.0 117.334 169.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo . . . . . 0 C--N 1.363 1.292 0 C-N-CA 123.599 2.866 . . . . 0.0 115.543 178.026 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 . . . . . 0 C--O 1.24 0.589 0 CA-C-O 121.647 0.737 . . . . 0.0 109.903 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.5 m -140.71 160.38 40.17 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.862 1.265 . . . . 0.0 108.778 172.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -148.28 170.19 18.45 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 127.43 2.292 . . . . 0.0 106.291 -173.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.3 mp0 -133.15 154.08 50.94 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 121.084 -1.01 . . . . 0.0 108.294 178.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 34.2 pt -137.69 156.58 32.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 C-N-CA 125.712 1.605 . . . . 0.0 109.337 178.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 85.4 t -118.7 119.42 61.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.0 mmt85 -134.84 143.46 47.03 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -179.99 136.24 2.69 Favored Glycine 0 CA--C 1.509 -0.287 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -178.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -154.74 153.3 31.03 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -169.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -55.05 -29.67 57.96 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 178.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 8.7 p-90 -73.53 -22.54 60.07 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.969 0.804 . . . . 0.0 113.124 -179.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.86 83.5 7.17 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-N 120.056 1.298 . . . . 0.0 110.047 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -64.18 -18.41 64.46 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.976 0.91 . . . . 0.0 112.003 176.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -138.08 146.85 43.43 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.746 1.619 . . . . 0.0 108.398 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 29.2 m80 -65.03 -33.77 76.83 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.133 0.573 . . . . 0.0 110.832 -175.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.93 -25.82 45.03 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 118.382 -0.818 . . . . 0.0 112.987 173.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -67.75 -50.83 55.12 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 119.705 1.139 . . . . 0.0 110.569 -176.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.65 -37.17 78.2 Favored 'Isoleucine or valine' 0 C--N 1.339 0.147 0 CA-C-O 117.913 -1.041 . . . . 0.0 109.976 176.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -60.3 -49.47 77.46 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.651 1.114 . . . . 0.0 110.45 178.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -63.2 -47.1 84.01 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.345 0.52 . . . . 0.0 111.3 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.2 tttt -61.1 -53.7 53.76 Favored 'General case' 0 CA--C 1.522 -0.124 0 C-N-CA 123.126 0.571 . . . . 0.0 111.091 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 95.4 t -71.94 -44.91 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 117.937 -1.03 . . . . 0.0 109.294 -171.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.0 m -62.73 -33.77 75.82 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 120.292 1.406 . . . . 0.0 110.703 177.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.33 -47.6 89.93 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-N 118.946 0.794 . . . . 0.0 111.273 171.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -63.04 -46.29 88.23 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 118.625 1.213 . . . . 0.0 111.363 178.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 38.2 mmt -57.27 -45.93 83.57 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 123.488 0.715 . . . . 0.0 110.727 175.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -63.79 -36.42 83.82 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.786 0.835 . . . . 0.0 111.696 177.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -66.89 -37.21 83.96 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 119.232 0.923 . . . . 0.0 110.917 172.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -68.78 -23.65 64.33 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 119.283 0.947 . . . . 0.0 111.965 171.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 118.1 -12.93 12.76 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 126.248 1.88 . . . . 0.0 112.626 174.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 91.0 m -67.27 168.45 10.49 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.022 1.329 . . . . 0.0 111.55 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -125.44 152.11 45.33 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 170.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 65.4 m -143.44 163.69 32.41 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -168.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -148.71 137.59 21.49 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.042 1.737 . . . . 0.0 106.843 170.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.9 p -78.7 118.49 20.83 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 169.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 44.3 mt -70.85 -22.59 62.29 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 122.023 -0.423 . . . . 0.0 110.381 174.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 163.42 -166.76 37.34 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 172.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -151.68 175.66 30.39 Favored Glycine 0 CA--C 1.52 0.344 0 N-CA-C 111.807 -0.517 . . . . 0.0 111.807 171.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -166.6 -162.07 17.25 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 108.366 -1.894 . . . . 0.0 108.366 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.95 164.94 25.84 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 120.893 -1.357 . . . . 0.0 108.515 174.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 68.8 mt . . . . . 0 C--N 1.325 -0.474 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 -171.931 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 19.5 t60 . . . . . 0 N--CA 1.452 -0.336 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.0 t -141.84 137.11 31.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -163.03 -179.58 6.83 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.953 0.901 . . . . 0.0 109.247 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.9 -166.5 19.22 Favored Glycine 0 CA--C 1.523 0.553 0 O-C-N 121.695 -0.628 . . . . 0.0 112.592 169.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -159.07 157.85 31.87 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.903 1.281 . . . . 0.0 109.527 178.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.4 t -89.96 147.33 23.77 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 168.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.42 -42.46 62.02 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 171.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -80.72 -24.6 38.67 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 118.912 -0.566 . . . . 0.0 112.205 -171.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -132.49 -1.07 3.53 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -169.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.11 -179.72 49.81 Favored Glycine 0 CA--C 1.534 1.249 0 CA-C-N 118.964 0.802 . . . . 0.0 113.288 173.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.38 138.63 33.19 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.935 2.423 . . . . 0.0 109.981 175.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.07 168.1 20.65 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.254 0.55 . . . . 0.0 111.094 170.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -79.26 81.82 5.48 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 168.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 45.7 m80 -57.04 -18.38 13.85 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -174.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.82 -40.36 69.49 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.018 1.327 . . . . 0.0 112.151 170.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 61.2 mt -66.06 -47.28 85.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 178.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.42 -49.29 78.37 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.315 1.046 . . . . 0.0 110.798 -176.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 31.0 p -63.32 -49.12 75.2 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 118.642 -0.694 . . . . 0.0 109.568 -175.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -59.35 -40.72 87.34 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.11 0.868 . . . . 0.0 111.31 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 44.4 mttm -65.72 -47.15 76.31 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 118.507 0.594 . . . . 0.0 111.338 177.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 67.7 mt -64.01 -39.26 84.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 CA-C-N 119.202 0.91 . . . . 0.0 109.235 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.0 mtpt . . . . . 0 N--CA 1.469 0.502 0 CA-C-N 119.351 0.978 . . . . 0.0 109.999 177.348 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.2 t . . . . . 0 N--CA 1.448 -0.534 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 9.7 p -135.08 171.25 14.69 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.694 1.198 . . . . 0.0 108.764 176.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 55.7 p-90 . . . . . 0 C--O 1.235 0.326 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 172.393 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.435 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -146.21 153.06 40.18 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.675 1.99 . . . . 0.0 105.887 169.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 54.4 mt -53.15 -36.2 60.58 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.036 0.835 . . . . 0.0 112.077 -177.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.24 -25.72 68.19 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 118.801 0.728 . . . . 0.0 112.571 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.9 mt -83.73 -22.24 32.04 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.465 0.706 . . . . 0.0 111.489 -177.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 15.9 mt -66.48 131.71 94.2 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -50.39 128.9 24.49 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.842 2.361 . . . . 0.0 110.786 171.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -74.66 -41.69 59.86 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.378 0.671 . . . . 0.0 110.794 -176.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 53.5 t -136.29 129.18 46.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 177.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -152.12 111.94 4.0 Favored 'General case' 0 CA--C 1.521 -0.173 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 171.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 9.5 pt . . . . . 0 CA--C 1.535 0.386 0 C-N-CA 125.077 1.351 . . . . 0.0 109.067 -169.733 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 30.4 p90 . . . . . 0 CA--C 1.533 0.318 0 CA-C-O 121.248 0.547 . . . . 0.0 109.787 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.5 mttt -99.62 151.7 20.89 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.603 1.161 . . . . 0.0 108.83 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -142.91 162.8 34.5 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.232 1.013 . . . . 0.0 108.984 -174.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.0 m -133.6 155.25 40.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 C-N-CA 124.542 1.137 . . . . 0.0 109.718 173.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -106.96 116.73 32.44 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 178.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 80.3 mt -120.71 115.11 45.98 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -173.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -72.76 142.83 48.13 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 168.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.6 p -138.75 146.9 25.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -127.85 146.83 50.49 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.884 1.274 . . . . 0.0 108.484 -171.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 61.2 m -61.95 100.21 0.15 Allowed 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.598 0.759 . . . . 0.0 111.077 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.453 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -144.98 22.75 0.04 OUTLIER Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 126.029 1.732 . . . . 0.0 112.976 168.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.453 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 72.0 Cg_exo . . . . . 0 C--N 1.361 1.235 0 CA-C-N 123.872 2.419 . . . . 0.0 114.991 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 . . . . . 0 CA--C 1.542 0.653 0 CA-C-O 121.234 0.54 . . . . 0.0 109.891 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.9 m -143.27 159.94 41.4 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.964 1.306 . . . . 0.0 108.936 176.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.8 tttt -149.6 165.54 31.96 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 126.768 2.027 . . . . 0.0 107.246 -174.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -124.95 128.4 48.54 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 169.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 39.5 pt -108.89 155.07 10.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 124.84 1.256 . . . . 0.0 110.257 173.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 33.1 t -119.32 114.92 46.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 -175.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 12.7 mmp_? -128.38 146.84 50.66 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.084 1.353 . . . . 0.0 108.404 -177.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 174.98 137.55 2.52 Favored Glycine 0 C--N 1.332 0.306 0 CA-C-N 118.849 0.75 . . . . 0.0 111.303 176.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -153.33 154.16 34.02 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -169.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -56.92 -34.47 68.0 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 118.591 -0.719 . . . . 0.0 112.556 175.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 10.1 p-90 -65.5 -27.31 68.39 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.1 0.864 . . . . 0.0 112.294 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -87.29 73.22 9.72 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 119.033 0.833 . . . . 0.0 109.585 175.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -67.9 -5.05 14.89 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.458 0.703 . . . . 0.0 111.648 175.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -138.66 147.96 43.45 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 126.197 1.799 . . . . 0.0 107.142 173.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 59.9 m80 -73.89 -31.49 63.14 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 121.812 -0.555 . . . . 0.0 110.185 -169.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.76 -28.72 50.69 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 118.333 -0.842 . . . . 0.0 112.586 171.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -67.49 -49.31 64.06 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 119.624 1.102 . . . . 0.0 110.729 -177.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.35 -38.5 80.95 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 CA-C-O 117.732 -1.127 . . . . 0.0 110.045 177.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -64.43 -41.88 96.34 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 120.19 1.359 . . . . 0.0 110.669 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -63.43 -48.83 76.14 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.315 0.961 . . . . 0.0 111.304 176.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -56.79 -55.7 30.89 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.372 1.069 . . . . 0.0 110.628 178.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 81.1 t -77.08 -44.43 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-O 117.79 -1.1 . . . . 0.0 109.791 -169.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.1 t -62.73 -36.85 84.36 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 120.555 1.525 . . . . 0.0 109.266 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.51 -50.74 64.51 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 172.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -62.71 -45.95 90.36 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 118.728 1.264 . . . . 0.0 111.755 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 38.7 mmt -57.31 -47.86 80.42 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.377 0.671 . . . . 0.0 110.145 176.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -66.54 -30.92 71.33 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 118.698 -0.668 . . . . 0.0 111.805 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -67.48 -35.13 78.56 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.757 1.162 . . . . 0.0 110.724 170.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -72.8 -15.05 61.64 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 119.525 1.057 . . . . 0.0 111.208 169.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 110.04 -25.5 16.2 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 127.431 2.443 . . . . 0.0 112.247 177.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 93.3 m -55.8 149.28 14.95 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.957 1.703 . . . . 0.0 111.936 -175.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -108.87 143.36 38.18 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 177.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 96.1 m -141.3 164.91 28.98 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -168.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -151.41 128.37 11.04 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.794 1.637 . . . . 0.0 106.932 171.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.1 p -73.48 117.3 15.07 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 169.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 39.4 mt -70.76 -23.42 62.41 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.904 -0.497 . . . . 0.0 110.563 174.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.42 -170.97 42.46 Favored Glycine 0 C--N 1.337 0.626 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 171.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -132.23 169.91 22.02 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 174.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -174.34 -161.57 24.49 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -177.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 50.0 ttt180 -141.65 152.22 43.75 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 125.082 1.353 . . . . 0.0 107.816 -172.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 40.6 mt . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 173.752 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 22.9 t60 . . . . . 0 CA--C 1.517 -0.307 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.9 t -129.11 125.02 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -164.77 -167.98 1.36 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.694 0.798 . . . . 0.0 109.076 -171.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.71 -176.09 53.95 Favored Glycine 0 CA--C 1.527 0.793 0 O-C-N 121.633 -0.667 . . . . 0.0 111.473 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -158.97 149.84 20.01 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.01 0.924 . . . . 0.0 110.804 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.0 t -75.37 162.48 28.35 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 168.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.2 ptm -103.72 -31.27 9.93 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 118.629 -0.7 . . . . 0.0 110.783 170.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -73.71 -25.74 60.36 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 119.351 0.978 . . . . 0.0 111.6 174.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -132.49 -6.17 3.3 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.941 0.896 . . . . 0.0 113.351 -169.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.94 -176.1 54.1 Favored Glycine 0 CA--C 1.534 1.277 0 CA-C-N 118.945 0.793 . . . . 0.0 113.39 173.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -67.67 135.23 35.18 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.267 2.645 . . . . 0.0 110.471 175.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.69 168.23 20.44 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.11 0.564 . . . . 0.0 110.891 169.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -81.56 80.07 8.01 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 169.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -55.46 -20.5 12.77 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.09 -44.29 67.47 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.925 1.29 . . . . 0.0 112.196 170.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 71.7 mt -64.59 -48.35 85.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.46 -50.94 71.41 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.508 1.123 . . . . 0.0 110.443 -176.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.2 p -64.69 -46.25 83.19 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 119.347 0.976 . . . . 0.0 111.048 -175.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -60.7 -39.92 90.28 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.564 1.074 . . . . 0.0 110.625 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.3 mttt -72.55 -41.34 65.87 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 121.676 -0.64 . . . . 0.0 111.965 178.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 76.8 mt -65.76 -41.75 90.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 119.289 0.95 . . . . 0.0 108.662 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 91.6 mttt . . . . . 0 N--CA 1.467 0.385 0 CA-C-N 119.54 1.063 . . . . 0.0 109.882 173.184 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 C--O 1.234 0.249 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 21.6 p -136.18 168.17 19.89 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.778 1.231 . . . . 0.0 109.247 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 36.5 p-90 . . . . . 0 C--O 1.236 0.346 0 O-C-N 121.838 -0.539 . . . . 0.0 110.321 172.578 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.344 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -139.28 149.11 43.89 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 170.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.0 mt -54.75 -33.72 61.62 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.684 0.794 . . . . 0.0 112.343 -174.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.0 -25.22 68.03 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.077 0.853 . . . . 0.0 112.561 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 79.6 mt -78.28 -25.68 46.8 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.205 0.602 . . . . 0.0 111.369 -177.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.0 mt -69.63 130.43 90.48 Favored Pre-proline 0 CA--C 1.538 0.502 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -173.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -50.67 127.6 21.42 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.856 2.371 . . . . 0.0 109.884 169.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -82.39 -34.07 28.48 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 121.88 -0.512 . . . . 0.0 111.481 -171.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 52.5 t -133.92 131.86 56.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 171.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -152.99 126.86 8.93 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 174.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.3 pt . . . . . 0 CA--C 1.535 0.394 0 C-N-CA 124.097 0.959 . . . . 0.0 110.349 -169.758 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 21.2 p90 . . . . . 0 N--CA 1.466 0.355 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -72.61 156.19 39.25 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 122.952 0.501 . . . . 0.0 110.464 -176.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -147.64 164.86 32.2 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.472 1.109 . . . . 0.0 108.302 172.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.4 m -133.92 153.08 35.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 C-N-CA 124.725 1.21 . . . . 0.0 108.963 173.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.1 114.71 28.82 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 54.0 mt -119.38 117.92 55.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -170.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.7 ttp180 -73.63 147.13 44.06 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 169.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.0 t -135.2 150.3 29.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 127.097 2.159 . . . . 0.0 105.517 -176.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -131.8 153.86 49.69 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.691 1.196 . . . . 0.0 108.245 176.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.2 m -68.87 44.71 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.946 1.698 . . . . 0.0 114.111 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -73.96 -5.56 0.09 OUTLIER Pre-proline 0 CA--C 1.551 1.004 0 CA-C-O 115.159 -2.353 . . . . 0.0 116.824 172.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo . . . . . 0 C--N 1.359 1.118 0 CA-C-N 125.263 2.915 . . . . 0.0 112.068 169.543 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 . . . . . 0 CA--C 1.541 0.613 0 CA-C-O 121.512 0.672 . . . . 0.0 109.635 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.1 m -141.58 161.18 38.56 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.288 1.435 . . . . 0.0 108.969 174.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.5 tttt -149.63 162.19 40.69 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 126.203 1.801 . . . . 0.0 107.772 -172.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.5 mp0 -130.22 119.75 23.4 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 172.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 43.9 pt -104.99 159.24 5.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 C-N-CA 125.137 1.375 . . . . 0.0 110.705 178.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.4 t -118.14 120.59 64.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.4 mmp_? -126.55 141.09 51.98 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 176.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.04 131.81 1.83 Allowed Glycine 0 C--N 1.331 0.256 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 174.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -148.81 147.47 28.8 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -169.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -57.5 -27.31 62.43 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 177.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 12.2 p-90 -68.09 -27.97 66.94 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.221 0.918 . . . . 0.0 112.438 176.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.44 83.39 7.95 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 119.411 1.005 . . . . 0.0 109.054 175.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -66.85 -16.97 64.65 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 122.859 0.464 . . . . 0.0 111.65 176.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -134.3 152.69 51.95 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.028 1.731 . . . . 0.0 108.441 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 76.8 m-70 -73.3 -33.27 65.09 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -169.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.39 -28.75 56.02 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 118.408 -0.806 . . . . 0.0 112.71 173.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -67.63 -49.61 62.12 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 119.443 1.02 . . . . 0.0 110.46 -177.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.21 -42.79 91.7 Favored 'Isoleucine or valine' 0 C--N 1.341 0.209 0 CA-C-O 117.933 -1.032 . . . . 0.0 109.659 175.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -61.05 -45.13 96.03 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.687 1.131 . . . . 0.0 110.68 -177.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -63.32 -49.09 75.34 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.2 0.909 . . . . 0.0 111.655 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 31.5 tttt -59.13 -50.41 74.14 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.599 0.76 . . . . 0.0 110.883 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 91.9 t -72.73 -42.33 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-O 117.832 -1.08 . . . . 0.0 109.012 -172.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 63.0 m -60.15 -33.27 71.94 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-N 120.65 1.568 . . . . 0.0 111.087 173.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.03 -53.92 39.04 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-N 119.468 1.031 . . . . 0.0 110.54 172.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.424 ' HA ' ' HE3' ' A' ' 66' ' ' LYS . 19.0 t70 -60.32 -46.1 91.06 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.442 1.121 . . . . 0.0 111.828 -178.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.518 ' HG3' ' HG ' ' A' ' 71' ' ' CYS . 35.3 mmt -59.45 -50.21 74.83 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.963 0.905 . . . . 0.0 110.119 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -67.07 -29.73 69.59 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 118.461 0.573 . . . . 0.0 111.605 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.424 ' HE3' ' HA ' ' A' ' 63' ' ' ASP . 52.3 mtmt -66.06 -36.55 83.52 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.343 0.974 . . . . 0.0 110.861 170.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -72.44 -13.14 61.37 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.817 1.189 . . . . 0.0 112.069 169.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.76 -10.85 66.49 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 126.267 1.889 . . . . 0.0 112.346 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 85.1 m -56.38 153.0 10.4 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.815 1.308 . . . . 0.0 111.233 175.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -114.3 139.36 49.5 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 170.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.518 ' HG ' ' HG3' ' A' ' 64' ' ' MET . 35.4 m -141.56 161.24 38.41 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -168.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -153.35 126.84 8.68 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 176.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.7 p -70.59 121.27 17.55 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 169.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 36.6 mt -66.9 -24.5 66.11 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.864 -0.523 . . . . 0.0 109.82 170.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.91 -170.21 42.66 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 125.3 1.429 . . . . 0.0 109.612 169.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -124.15 169.29 16.23 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 173.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -175.83 -166.29 33.06 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -175.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -143.88 160.38 40.89 Favored 'General case' 0 CA--C 1.516 -0.344 0 O-C-N 120.906 -1.349 . . . . 0.0 109.561 178.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 95.2 mt . . . . . 0 N--CA 1.448 -0.546 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 -176.856 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 21.6 t60 . . . . . 0 CA--C 1.521 -0.166 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.3 t -133.36 135.22 56.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 -178.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -170.56 -171.18 1.02 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -170.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 109.65 -172.74 16.24 Favored Glycine 0 CA--C 1.523 0.55 0 CA-C-N 119.3 0.955 . . . . 0.0 113.32 169.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -157.4 154.02 28.17 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.923 1.689 . . . . 0.0 107.668 -169.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.5 t -126.27 140.25 52.68 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 169.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 21.7 ptp -80.62 -34.98 34.63 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 118.71 -0.662 . . . . 0.0 110.11 173.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.65 -25.03 49.32 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.068 0.849 . . . . 0.0 112.182 -177.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -133.13 -5.29 3.06 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -169.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.87 171.83 42.96 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-N 118.964 0.802 . . . . 0.0 112.044 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.78 137.24 34.92 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.299 2.0 . . . . 0.0 109.312 177.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.18 170.75 6.56 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.16 0.505 . . . . 0.0 111.114 171.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 21.6 mm100 -64.99 -32.82 74.73 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 119.255 -0.402 . . . . 0.0 111.955 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 35.8 m80 61.7 -30.99 0.07 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 128.316 2.646 . . . . 0.0 115.526 -174.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.56 -45.94 88.21 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.649 1.18 . . . . 0.0 111.179 173.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 73.5 mt -61.21 -46.16 97.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.43 -52.04 66.98 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.891 1.276 . . . . 0.0 110.522 -174.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.2 p -64.57 -44.13 91.7 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.418 -177.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -60.63 -41.53 95.08 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.811 1.187 . . . . 0.0 110.736 -179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 25.7 mmtp -65.93 -47.9 73.16 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 118.735 0.698 . . . . 0.0 111.102 176.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 56.6 mt -64.67 -41.87 93.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 119.194 0.906 . . . . 0.0 109.237 -176.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 92.4 mttt . . . . . 0 N--CA 1.467 0.416 0 CA-C-N 119.776 1.171 . . . . 0.0 109.619 175.059 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 CA--C 1.532 0.253 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 17.2 p -136.15 168.21 19.81 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.809 1.244 . . . . 0.0 109.501 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 31.6 p-90 . . . . . 0 C--O 1.235 0.331 0 O-C-N 121.762 -0.586 . . . . 0.0 110.411 171.797 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.548 0 CA-C-O 121.507 0.67 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -152.93 146.5 25.04 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 169.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 61.3 mt -55.18 -34.3 63.73 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -173.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.22 -26.24 65.61 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.845 0.748 . . . . 0.0 112.159 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.2 mt -81.47 -23.46 37.4 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.513 0.725 . . . . 0.0 111.22 -177.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.8 mt -66.31 129.29 94.17 Favored Pre-proline 0 CA--C 1.538 0.514 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 -175.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -46.65 116.22 1.53 Allowed 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 124.195 3.263 . . . . 0.0 111.777 170.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -72.63 -31.73 65.36 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.603 0.761 . . . . 0.0 111.577 -172.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 64.2 t -141.72 137.24 31.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 171.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -151.18 110.84 4.02 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 169.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 40.5 pt . . . . . 0 C--O 1.236 0.357 0 C-N-CA 124.211 1.005 . . . . 0.0 109.195 -170.111 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 16.5 p90 . . . . . 0 N--CA 1.469 0.494 0 CA-C-O 120.49 0.186 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.1 mmtm -72.46 152.65 41.81 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 173.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.477 ' HH ' ' CD2' ' A' ' 102' ' ' HIS . 0.2 OUTLIER -142.1 160.05 41.0 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 175.146 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.4 m -130.15 152.98 38.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 124.615 1.166 . . . . 0.0 109.433 173.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.2 114.92 29.17 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 104.201 -2.518 . . . . 0.0 104.201 177.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 54.5 mt -118.88 124.88 73.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -172.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -78.24 148.09 34.1 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 169.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.3 t -132.12 145.53 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -127.55 148.51 50.34 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.762 1.225 . . . . 0.0 108.218 178.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.4 m -62.35 99.13 0.13 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.759 0.824 . . . . 0.0 110.92 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.437 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -142.44 20.15 0.04 OUTLIER Pre-proline 0 CA--C 1.552 1.028 0 CA-C-O 116.491 -1.719 . . . . 0.0 113.502 169.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.437 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 76.3 Cg_exo . . . . . 0 C--N 1.363 1.301 0 CA-C-N 123.817 2.399 . . . . 0.0 114.174 177.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 . . . . . 0 CA--C 1.541 0.617 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.5 m -141.84 160.5 40.06 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.628 1.171 . . . . 0.0 109.403 174.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -152.0 171.56 17.64 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 127.393 2.277 . . . . 0.0 106.509 -172.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.8 mp0 -133.24 157.66 44.86 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 172.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 30.3 pt -137.13 156.03 33.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 C-N-CA 125.717 1.607 . . . . 0.0 109.114 177.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 52.9 t -118.54 120.87 65.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 178.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 25.6 mmt85 -135.63 144.89 46.34 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 176.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 178.44 134.72 2.15 Favored Glycine 0 N--CA 1.453 -0.202 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -178.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.405 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 9.7 m-85 -154.79 155.53 34.64 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -169.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -58.02 -34.13 69.71 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.714 0.806 . . . . 0.0 112.07 -178.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.405 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 13.9 p-90 -67.32 -27.55 67.24 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 118.707 -0.663 . . . . 0.0 112.613 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.36 80.5 9.19 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 119.635 1.107 . . . . 0.0 109.104 175.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -64.23 -18.13 64.23 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.062 0.545 . . . . 0.0 112.0 175.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -134.07 151.05 51.24 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 126.601 1.961 . . . . 0.0 108.023 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -74.1 -31.92 63.0 Favored 'General case' 0 C--O 1.234 0.254 0 O-C-N 121.847 -0.533 . . . . 0.0 110.064 -169.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.32 -29.76 48.96 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 118.564 -0.731 . . . . 0.0 112.48 172.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -67.75 -50.65 56.12 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 119.289 0.95 . . . . 0.0 110.796 -175.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.36 -38.26 80.5 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.157 0 CA-C-O 117.846 -1.073 . . . . 0.0 110.036 176.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -59.92 -48.35 82.06 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.76 1.163 . . . . 0.0 110.317 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -63.54 -47.68 80.61 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.347 0.521 . . . . 0.0 111.495 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 31.6 tttt -61.2 -52.81 63.24 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 123.198 0.599 . . . . 0.0 111.144 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 92.6 t -70.94 -46.1 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-O 118.024 -0.989 . . . . 0.0 108.975 -172.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.8 m -62.32 -31.95 72.64 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 120.283 1.402 . . . . 0.0 111.055 176.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.16 -49.78 74.39 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-N 119.038 0.835 . . . . 0.0 111.077 171.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -61.68 -44.19 97.41 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 118.654 1.227 . . . . 0.0 111.61 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.526 ' HG3' ' HG ' ' A' ' 71' ' ' CYS . 37.6 mmt -59.39 -47.82 84.0 Favored 'General case' 0 C--O 1.226 -0.159 0 C-N-CA 123.06 0.544 . . . . 0.0 110.053 176.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -67.49 -28.61 67.99 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.85 0.75 . . . . 0.0 112.025 179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -68.05 -36.98 80.79 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 119.585 1.084 . . . . 0.0 110.418 170.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -68.04 -29.74 68.79 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 119.625 1.102 . . . . 0.0 110.122 169.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 122.37 -23.17 7.26 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 128.13 2.776 . . . . 0.0 111.297 177.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 84.6 m -53.82 146.5 13.74 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 126.682 1.993 . . . . 0.0 111.321 -175.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -107.87 142.01 38.6 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.526 ' HG ' ' HG3' ' A' ' 64' ' ' MET . 72.7 m -142.44 163.86 31.71 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -168.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -151.81 133.79 15.0 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.552 1.541 . . . . 0.0 107.668 170.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.6 p -72.22 115.76 11.84 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 169.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 45.6 mt -67.04 -24.98 66.05 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.986 -0.446 . . . . 0.0 110.002 172.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.92 -164.32 37.74 Favored Glycine 0 C--N 1.336 0.536 0 N-CA-C 108.374 -1.89 . . . . 0.0 108.374 172.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -155.13 -176.41 27.31 Favored Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 111.004 -0.838 . . . . 0.0 111.004 171.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -171.44 -156.4 11.82 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 -175.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.1 ttp180 -135.66 147.0 48.41 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 -177.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.3 mt . . . . . 0 C--O 1.235 0.337 0 N-CA-C 106.484 -1.672 . . . . 0.0 106.484 -174.757 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 19.4 t60 . . . . . 0 CA--C 1.515 -0.367 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.6 t -133.22 132.57 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 -176.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -160.15 -167.93 2.07 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.937 1.295 . . . . 0.0 108.886 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.15 -171.34 42.96 Favored Glycine 0 CA--C 1.525 0.703 0 O-C-N 121.612 -0.68 . . . . 0.0 113.632 176.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -161.87 152.89 18.01 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.523 1.129 . . . . 0.0 110.123 -169.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.5 t -81.59 168.45 18.17 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 167.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 20.8 ptp -111.44 -29.68 7.69 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 121.215 -0.928 . . . . 0.0 111.39 170.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.19 -25.76 59.88 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.716 1.144 . . . . 0.0 111.434 171.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -131.76 -7.14 3.6 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.886 0.874 . . . . 0.0 113.015 -169.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.39 -179.11 48.94 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 123.735 0.683 . . . . 0.0 113.638 172.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -68.4 142.08 53.33 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.83 2.354 . . . . 0.0 110.743 173.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.68 178.19 6.26 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 168.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -63.61 -28.4 69.9 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 119.045 -0.503 . . . . 0.0 111.868 170.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.477 ' CD2' ' HH ' ' A' ' 22' ' ' TYR . 42.4 m80 59.08 -23.16 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 128.283 2.633 . . . . 0.0 116.63 -173.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.72 -39.04 93.31 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.688 1.195 . . . . 0.0 110.794 172.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 75.3 mt -63.33 -44.44 99.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 175.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.1 -44.62 94.71 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.135 0.974 . . . . 0.0 111.252 -177.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.54 -51.0 67.3 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 119.275 0.943 . . . . 0.0 110.611 176.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -57.6 -43.98 85.1 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.027 0.83 . . . . 0.0 110.62 -177.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -71.41 -40.27 70.57 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 118.102 -0.951 . . . . 0.0 111.832 -178.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 83.8 mt -69.3 -34.89 64.96 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-N 120.78 1.627 . . . . 0.0 108.957 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 94.4 mttt . . . . . 0 N--CA 1.47 0.559 0 CA-C-N 120.404 1.457 . . . . 0.0 110.385 171.083 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.7 p . . . . . 0 N--CA 1.45 -0.471 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 21.2 p -139.05 171.48 14.25 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.923 0.889 . . . . 0.0 109.399 171.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 19.6 p-90 . . . . . 0 C--O 1.235 0.338 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 169.471 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.504 0 CA-C-O 121.542 0.687 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -149.68 153.22 36.63 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 125.963 1.705 . . . . 0.0 106.486 171.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 44.2 mt -56.39 -33.18 65.5 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 118.697 0.681 . . . . 0.0 112.666 -176.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.52 -25.49 65.87 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.919 0.781 . . . . 0.0 112.167 177.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.1 mt -86.64 -21.91 26.47 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.87 0.868 . . . . 0.0 111.372 -176.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 56.7 mt -64.54 128.56 93.55 Favored Pre-proline 0 CA--C 1.54 0.559 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 178.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -46.3 114.94 0.97 Allowed 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 124.232 3.288 . . . . 0.0 111.58 172.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -72.08 -30.81 65.49 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.369 0.668 . . . . 0.0 112.071 -169.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 42.3 t -143.12 142.47 25.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 171.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -151.38 127.8 10.67 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 169.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 40.9 pt . . . . . 0 CA--C 1.54 0.581 0 C-N-CA 127.622 2.369 . . . . 0.0 106.219 -176.745 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 36.5 p90 . . . . . 0 N--CA 1.468 0.429 0 CA-C-O 120.997 0.427 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -77.86 154.12 32.07 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.019 0.928 . . . . 0.0 110.495 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -142.28 164.91 28.88 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.313 1.045 . . . . 0.0 108.891 175.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.9 m -132.14 152.91 37.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 C-N-CA 124.589 1.156 . . . . 0.0 109.287 172.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.2 tp -108.11 117.95 35.49 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 177.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 95.4 mt -122.7 123.04 67.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -171.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -79.57 147.8 31.98 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 169.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.5 p -138.38 146.99 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 175.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 -120.01 156.96 29.85 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.852 1.261 . . . . 0.0 108.78 -176.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.4 m -63.15 87.64 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.698 1.199 . . . . 0.0 111.922 177.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.415 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -138.55 19.39 0.05 OUTLIER Pre-proline 0 CA--C 1.551 1.019 0 CA-C-O 116.405 -1.759 . . . . 0.0 114.449 169.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 30' ' ' ALA . 80.1 Cg_exo . . . . . 0 C--N 1.36 1.157 0 CA-C-N 123.976 2.456 . . . . 0.0 113.681 172.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 . . . . . 0 CA--C 1.537 0.466 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.8 m -142.26 158.17 44.02 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.958 0.903 . . . . 0.0 110.334 -174.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -149.21 166.01 30.16 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 127.56 2.344 . . . . 0.0 105.947 -175.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.8 mp0 -125.33 151.6 45.83 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 174.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 21.2 pt -127.27 155.04 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 125.997 1.719 . . . . 0.0 108.594 173.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 85.1 t -127.87 115.96 41.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 -173.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 26.7 mmt85 -135.33 139.82 44.6 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -176.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -170.92 141.61 6.6 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 178.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -156.1 149.02 24.15 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -171.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -58.77 -32.83 69.65 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 118.839 -0.6 . . . . 0.0 111.61 174.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 9.7 p-90 -65.32 -26.83 68.22 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.018 0.826 . . . . 0.0 112.489 177.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.41 73.44 10.5 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 119.337 0.971 . . . . 0.0 109.524 175.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -65.67 -8.56 21.27 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.35 0.66 . . . . 0.0 112.104 176.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -138.17 144.91 40.94 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 126.896 2.079 . . . . 0.0 106.836 177.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 60.9 m80 -71.44 -31.13 66.84 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 121.885 -0.509 . . . . 0.0 109.979 -171.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.47 -27.27 47.31 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 118.258 -0.877 . . . . 0.0 112.676 171.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -68.33 -48.93 63.58 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 119.818 1.19 . . . . 0.0 110.763 -176.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.32 -40.26 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 CA-C-O 117.732 -1.127 . . . . 0.0 109.782 175.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -62.49 -44.66 95.85 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 120.047 1.294 . . . . 0.0 110.599 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -62.49 -47.34 84.42 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.818 0.735 . . . . 0.0 111.369 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 31.7 tttt -62.29 -53.59 52.92 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.245 0.618 . . . . 0.0 110.999 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 92.0 t -73.52 -48.35 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-O 118.539 -0.743 . . . . 0.0 109.179 -171.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.0 t -63.32 -34.74 78.35 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 119.568 1.076 . . . . 0.0 109.759 178.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.28 -48.59 85.24 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-N 118.978 0.808 . . . . 0.0 111.182 172.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -63.02 -43.6 98.29 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 118.69 1.245 . . . . 0.0 111.596 178.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 39.2 mmt -59.27 -47.31 85.85 Favored 'General case' 0 CA--C 1.527 0.077 0 C-N-CA 122.769 0.428 . . . . 0.0 110.111 176.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -64.92 -32.69 74.53 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.423 0.689 . . . . 0.0 111.274 179.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -67.4 -35.65 79.71 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.443 1.019 . . . . 0.0 111.052 170.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -69.03 -15.8 63.55 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 119.838 1.199 . . . . 0.0 111.286 169.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 109.17 -18.82 30.46 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 126.838 2.161 . . . . 0.0 111.94 177.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 73.1 m -57.05 162.91 2.27 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.654 1.982 . . . . 0.0 112.874 -175.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -123.25 137.35 54.89 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 176.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 80.4 m -142.69 166.17 25.4 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -168.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -151.09 131.65 13.88 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.797 1.239 . . . . 0.0 108.32 170.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.3 p -69.74 115.77 9.36 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 169.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 64.3 mt -66.97 -26.93 67.06 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.984 0.514 . . . . 0.0 109.95 173.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.08 -172.97 42.92 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 169.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -123.13 165.52 15.76 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 110.951 -0.859 . . . . 0.0 110.951 175.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -168.54 -163.56 22.74 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -178.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.7 ttp180 -146.45 158.37 43.88 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 121.141 -1.211 . . . . 0.0 107.763 -175.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 56.7 mt . . . . . 0 N--CA 1.449 -0.478 0 N-CA-C 104.851 -2.278 . . . . 0.0 104.851 -178.512 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 12.4 t60 . . . . . 0 N--CA 1.446 -0.671 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 54.5 t -131.82 106.0 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 -169.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -164.16 162.86 23.02 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.311 0.644 . . . . 0.0 109.517 -175.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 143.08 -169.08 25.85 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -155.85 151.66 27.41 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.101 0.56 . . . . 0.0 110.64 171.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.4 t -90.41 161.34 15.61 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 168.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 27.6 ptm -94.04 -33.91 13.22 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 118.995 0.816 . . . . 0.0 110.018 169.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.6 -25.38 56.94 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.905 0.775 . . . . 0.0 112.006 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -133.46 -4.13 2.98 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -169.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.83 -175.39 52.03 Favored Glycine 0 CA--C 1.535 1.326 0 CA-C-N 119.031 0.832 . . . . 0.0 113.344 173.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.99 138.8 37.93 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.385 2.724 . . . . 0.0 111.206 175.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.24 168.44 17.29 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 168.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 23.0 mm100 -68.55 -27.07 65.76 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.856 -0.528 . . . . 0.0 111.864 172.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 37.6 m80 60.48 -29.24 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 128.962 2.905 . . . . 0.0 115.895 -175.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.8 -40.66 93.5 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.536 1.134 . . . . 0.0 112.467 -179.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.3 mp -62.55 -46.33 96.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 177.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.3 m -59.47 -47.22 86.34 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 123.892 0.877 . . . . 0.0 110.621 -176.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.5 p -64.77 -41.12 96.1 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 118.097 -0.954 . . . . 0.0 111.065 -176.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -58.91 -45.51 90.13 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.951 1.25 . . . . 0.0 110.649 177.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 44.3 mttm -67.41 -46.24 73.79 Favored 'General case' 0 N--CA 1.462 0.158 0 O-C-N 122.128 -0.358 . . . . 0.0 111.037 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 55.7 mt -68.57 -38.05 78.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -176.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 96.1 mttt . . . . . 0 N--CA 1.471 0.592 0 CA-C-N 120.523 1.511 . . . . 0.0 110.031 174.26 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.4 t . . . . . 0 CA--C 1.534 0.36 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 6.3 p -139.66 170.23 16.28 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.335 1.054 . . . . 0.0 109.879 177.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 39.5 p-90 . . . . . 0 C--O 1.236 0.361 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 169.775 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.501 0 CA-C-O 121.246 0.545 . . . . 0.0 110.526 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -152.39 151.25 30.59 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 169.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 78.1 mt -56.08 -34.62 66.14 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.273 0.629 . . . . 0.0 112.549 -176.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.1 -25.21 65.21 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.691 0.678 . . . . 0.0 112.08 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.5 mt -83.41 -21.74 32.91 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.539 0.736 . . . . 0.0 111.328 -177.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.4 mt -65.34 127.48 92.96 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 177.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -47.76 125.38 11.15 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 123.649 2.899 . . . . 0.0 111.193 171.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -76.48 -36.44 57.84 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.097 0.475 . . . . 0.0 111.008 -173.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.6 t -140.67 133.07 31.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 177.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -154.56 119.76 5.02 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 105.072 -2.196 . . . . 0.0 105.072 169.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.7 pp . . . . . 0 C--O 1.235 0.34 0 C-N-CA 124.477 1.111 . . . . 0.0 109.53 -171.075 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.5 p90 . . . . . 0 N--CA 1.466 0.344 0 CA-C-O 120.937 0.399 . . . . 0.0 110.385 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -72.94 151.32 41.91 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.702 0.801 . . . . 0.0 110.758 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.462 ' HH ' ' CD2' ' A' ' 102' ' ' HIS . 0.2 OUTLIER -144.12 161.85 37.78 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.848 1.259 . . . . 0.0 107.845 177.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.5 m -130.34 151.45 35.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 C-N-CA 124.24 1.016 . . . . 0.0 109.349 174.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.74 114.58 28.88 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 103.643 -2.725 . . . . 0.0 103.643 176.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.8 mt -120.31 124.79 73.28 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -172.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.2 ttm180 -78.93 143.69 35.57 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 168.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.5 p -137.39 136.88 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 178.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -107.18 148.91 28.29 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.889 1.275 . . . . 0.0 109.006 -172.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.1 p -72.43 85.25 1.12 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.56 0.695 . . . . 0.0 111.138 178.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -131.52 33.07 0.23 Allowed Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 124.602 1.161 . . . . 0.0 112.368 169.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo . . . . . 0 C--N 1.354 0.824 0 CA-C-N 122.133 1.798 . . . . 0.0 109.961 -178.521 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 . . . . . 0 C--O 1.238 0.45 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.6 m -139.85 158.85 43.41 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.639 0.776 . . . . 0.0 110.256 175.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -142.07 166.41 24.78 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 127.973 2.509 . . . . 0.0 105.417 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 30.7 mp0 -126.69 149.75 49.38 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.1 pt -132.94 155.62 41.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 C-N-CA 125.059 1.344 . . . . 0.0 109.86 178.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 85.3 t -117.66 114.93 46.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.9 mmp_? -126.6 147.14 49.93 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 173.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 178.72 139.27 3.46 Favored Glycine 0 C--N 1.331 0.259 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 176.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.404 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 20.6 m-85 -154.59 150.22 27.49 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 123.397 0.679 . . . . 0.0 109.344 -171.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.4 tptt -62.31 -26.55 68.49 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 118.578 -0.725 . . . . 0.0 112.055 177.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.404 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 9.9 p-90 -63.86 -27.93 69.5 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.677 1.126 . . . . 0.0 112.28 176.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.63 76.05 10.04 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 119.242 0.928 . . . . 0.0 109.491 174.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -66.77 -5.79 13.49 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.219 0.607 . . . . 0.0 112.135 175.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -139.43 144.39 38.05 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 126.471 1.908 . . . . 0.0 107.026 175.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -70.62 -30.98 67.77 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 121.979 -0.451 . . . . 0.0 110.036 -171.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.55 -30.15 40.5 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 118.759 -0.639 . . . . 0.0 112.627 172.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -68.09 -50.52 54.4 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 119.134 0.879 . . . . 0.0 110.804 -175.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.08 -38.42 81.2 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.19 0 CA-C-O 117.761 -1.114 . . . . 0.0 109.935 174.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -60.16 -46.11 90.79 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 120.191 1.36 . . . . 0.0 110.91 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -65.35 -48.47 72.87 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 122.644 0.377 . . . . 0.0 111.275 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 44.3 tttt -62.29 -49.12 76.91 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 123.304 0.642 . . . . 0.0 111.479 -176.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 86.7 t -75.15 -45.5 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-O 118.423 -0.799 . . . . 0.0 109.33 -172.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.9 m -61.85 -35.82 79.42 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 119.423 1.01 . . . . 0.0 110.103 175.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.7 -48.02 87.15 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 173.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -63.35 -45.27 91.99 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 118.96 1.38 . . . . 0.0 111.429 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 39.1 mmt -59.57 -43.9 93.47 Favored 'General case' 0 C--O 1.227 -0.091 0 CA-C-N 118.202 0.456 . . . . 0.0 109.933 177.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -68.58 -27.92 66.48 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.716 0.807 . . . . 0.0 111.752 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -69.39 -36.86 77.18 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 119.455 1.025 . . . . 0.0 109.749 169.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -68.09 -25.79 65.5 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 119.928 1.24 . . . . 0.0 110.266 169.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 122.25 -27.63 6.04 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 128.237 2.827 . . . . 0.0 111.313 174.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 97.2 m -58.58 145.23 40.2 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 126.07 1.748 . . . . 0.0 110.691 -177.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -108.43 156.28 19.62 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 177.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 86.1 m -141.48 165.42 27.56 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 -168.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -150.92 132.7 14.98 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.546 1.538 . . . . 0.0 107.085 169.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.6 p -70.82 121.05 17.32 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 169.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 38.1 mt -70.34 -23.2 62.77 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.99 -0.444 . . . . 0.0 109.902 171.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.94 -166.27 39.04 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 170.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -146.86 173.12 27.17 Favored Glycine 0 CA--C 1.52 0.387 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 172.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -172.35 -156.13 12.07 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 107.356 -2.298 . . . . 0.0 107.356 -178.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 26.9 ptt-85 -142.31 160.25 40.62 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 120.614 -1.521 . . . . 0.0 109.403 176.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 93.7 mt . . . . . 0 C--N 1.321 -0.65 0 N-CA-C 104.404 -2.443 . . . . 0.0 104.404 -174.179 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 23.1 t60 . . . . . 0 C--O 1.233 0.199 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.0 t -137.49 130.89 43.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -162.28 -173.99 3.86 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.047 0.939 . . . . 0.0 109.869 -172.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.38 -172.33 50.4 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 123.659 0.647 . . . . 0.0 112.285 178.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -160.79 151.55 18.47 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.716 0.806 . . . . 0.0 111.05 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.0 t -72.43 164.86 25.67 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 168.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 23.0 ptp -111.69 -28.92 7.91 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 118.359 -0.829 . . . . 0.0 111.174 171.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.14 -26.5 60.36 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.737 1.153 . . . . 0.0 111.428 171.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -131.13 -6.04 3.88 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.777 0.831 . . . . 0.0 113.139 -169.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.18 -179.21 42.79 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 123.603 0.62 . . . . 0.0 113.504 173.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.17 135.62 40.99 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.067 2.512 . . . . 0.0 110.633 176.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.74 169.36 18.43 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 169.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -77.98 81.93 4.36 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 168.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.462 ' CD2' ' HH ' ' A' ' 22' ' ' TYR . 43.4 m80 -57.45 -14.94 5.57 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -175.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.58 -39.91 89.79 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.019 1.328 . . . . 0.0 111.47 170.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 63.0 mt -64.5 -47.18 90.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 176.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.9 -50.12 74.42 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.142 0.977 . . . . 0.0 110.526 -176.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 10.1 p -64.56 -47.48 78.58 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 119.243 0.929 . . . . 0.0 111.276 -176.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -60.21 -40.3 89.63 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.397 0.999 . . . . 0.0 110.475 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 49.2 mttm -65.45 -49.08 70.46 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 119.187 -0.435 . . . . 0.0 111.356 176.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 62.9 mt -64.54 -40.14 88.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-N 119.067 0.849 . . . . 0.0 109.16 -176.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 93.9 mttt . . . . . 0 N--CA 1.468 0.473 0 CA-C-N 119.605 1.093 . . . . 0.0 109.633 174.922 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.4 t . . . . . 0 N--CA 1.453 -0.302 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.3 p -134.55 173.67 11.39 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 169.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 37.6 p-90 . . . . . 0 N--CA 1.452 -0.373 0 CA-C-O 121.242 0.544 . . . . 0.0 109.905 174.556 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.572 0 CA-C-O 120.888 0.375 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -155.04 153.22 30.61 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.226 1.011 . . . . 0.0 108.399 177.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.0 mt -54.36 -32.83 57.82 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.771 0.828 . . . . 0.0 112.401 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.79 -23.61 67.43 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.76 0.709 . . . . 0.0 112.527 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 76.0 mt -74.83 -26.72 59.91 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 118.512 0.596 . . . . 0.0 110.944 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.2 mt -72.42 133.03 83.33 Favored Pre-proline 0 C--O 1.239 0.503 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 -177.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.23 135.0 48.21 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 121.067 1.178 . . . . 0.0 109.229 169.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -72.61 -33.48 66.7 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.325 0.583 . . . . 0.0 111.404 -175.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 51.0 t -135.25 138.89 47.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 105.221 -2.14 . . . . 0.0 105.221 172.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -149.92 129.4 13.03 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 169.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.5 pt . . . . . 0 CA--C 1.537 0.451 0 C-N-CA 126.676 1.99 . . . . 0.0 106.305 -179.801 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 23.5 p90 . . . . . 0 N--CA 1.467 0.389 0 CA-C-O 120.805 0.336 . . . . 0.0 110.594 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -79.53 158.11 27.26 Favored 'General case' 0 C--O 1.233 0.231 0 O-C-N 121.697 -0.627 . . . . 0.0 109.653 176.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.3 163.35 35.79 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.365 1.066 . . . . 0.0 108.805 176.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.2 m -136.65 157.0 36.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 124.655 1.182 . . . . 0.0 110.127 172.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.34 119.59 39.94 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 104.732 -2.322 . . . . 0.0 104.732 177.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 57.2 mt -121.29 114.51 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 CA-C-N 119.488 1.04 . . . . 0.0 108.48 -172.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 24.0 ttm-85 -71.54 138.12 48.61 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 104.967 -2.235 . . . . 0.0 104.967 168.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.4 p -136.31 116.49 17.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 178.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -81.7 142.83 32.33 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 169.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.1 t -67.72 117.01 9.06 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 169.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -143.57 43.11 0.42 Allowed Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 123.781 0.833 . . . . 0.0 108.921 168.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo . . . . . 0 C--N 1.351 0.679 0 C-N-CA 122.063 1.842 . . . . 0.0 111.731 -169.419 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 . . . . . 0 CA--C 1.536 0.44 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.0 m -141.86 157.49 44.93 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.941 0.896 . . . . 0.0 110.435 173.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -148.98 165.28 32.1 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 127.767 2.427 . . . . 0.0 106.651 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -125.93 126.89 45.12 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.341 -1.725 . . . . 0.0 106.341 170.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 30.4 pt -110.01 155.51 11.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 125.044 1.338 . . . . 0.0 110.267 175.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 24.5 t -120.43 125.89 74.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 -175.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.4 mmp_? -129.65 146.59 51.43 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.965 1.306 . . . . 0.0 107.739 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -172.98 133.99 2.81 Favored Glycine 0 N--CA 1.453 -0.208 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 169.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.405 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 10.7 m-85 -152.21 159.72 43.51 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -177.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -78.73 -26.13 44.7 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 121.793 -0.567 . . . . 0.0 109.894 -176.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.405 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 12.9 p-90 -61.33 -31.99 71.87 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 119.183 -0.437 . . . . 0.0 111.671 174.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -86.79 71.66 10.29 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 118.735 0.698 . . . . 0.0 109.524 173.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -63.42 -15.39 57.48 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 122.893 0.477 . . . . 0.0 111.775 177.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.41 144.24 51.09 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 126.548 1.939 . . . . 0.0 107.891 177.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 43.6 m80 -68.45 -34.6 76.25 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 119.148 -0.453 . . . . 0.0 112.134 -169.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.08 -28.89 55.85 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 118.311 -0.852 . . . . 0.0 112.645 174.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -68.29 -48.58 64.59 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 119.633 1.106 . . . . 0.0 111.323 -174.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.92 -41.28 89.61 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 CA-C-O 118.438 -0.791 . . . . 0.0 109.772 176.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -61.72 -53.34 57.42 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 118.317 -0.849 . . . . 0.0 109.722 -178.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -60.1 -42.85 95.56 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.16 0.891 . . . . 0.0 111.841 -176.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 31.6 tttt -60.52 -51.14 70.72 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 123.226 0.61 . . . . 0.0 110.796 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 63.9 t -84.74 -36.98 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-O 117.949 -1.024 . . . . 0.0 111.28 -169.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 71.7 p -64.43 -31.89 73.29 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 120.871 1.669 . . . . 0.0 109.684 171.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.66 -50.03 72.11 Favored Glycine 0 C--N 1.337 0.638 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 171.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -62.07 -43.34 99.04 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 118.68 1.24 . . . . 0.0 111.726 178.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 34.6 mmt -60.05 -46.08 90.71 Favored 'General case' 0 C--O 1.225 -0.191 0 N-CA-C 109.776 -0.454 . . . . 0.0 109.776 178.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -68.47 -27.91 66.57 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.606 0.762 . . . . 0.0 112.127 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -68.34 -37.22 80.32 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.34 0.973 . . . . 0.0 109.953 169.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -69.42 -25.37 64.09 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 119.631 1.105 . . . . 0.0 110.494 169.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 120.17 -26.35 7.1 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 127.996 2.713 . . . . 0.0 111.543 177.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 89.7 m -56.06 153.26 9.22 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 126.377 1.871 . . . . 0.0 111.51 -177.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -120.07 140.02 51.66 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -169.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 77.2 m -131.54 165.83 22.74 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 -167.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -153.13 122.48 6.67 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.72 2.008 . . . . 0.0 106.486 172.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.8 p -71.47 120.69 17.41 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 169.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 42.1 mt -68.53 -27.23 65.92 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.996 -0.44 . . . . 0.0 110.109 175.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 171.05 -171.38 43.87 Favored Glycine 0 C--N 1.337 0.592 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 175.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -138.09 164.37 25.56 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 176.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -168.54 -162.16 20.06 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -176.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 57.4 ttt180 -138.78 144.71 39.51 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 121.034 -1.274 . . . . 0.0 107.582 -172.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 99.6 mt . . . . . 0 N--CA 1.448 -0.535 0 N-CA-C 104.309 -2.478 . . . . 0.0 104.309 172.937 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 40.9 t60 . . . . . 0 N--CA 1.452 -0.361 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.9 t -125.08 129.56 73.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 -171.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -161.58 -169.1 2.16 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.673 1.189 . . . . 0.0 107.836 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 103.06 176.11 26.58 Favored Glycine 0 CA--C 1.522 0.53 0 CA-C-N 119.423 1.01 . . . . 0.0 112.113 169.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -151.85 143.85 23.82 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 122.953 0.501 . . . . 0.0 109.965 169.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.8 t -72.79 165.58 24.57 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 168.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 27.7 ptm -103.53 -30.5 10.48 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 118.558 -0.735 . . . . 0.0 110.486 169.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.42 -24.19 53.98 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.403 1.001 . . . . 0.0 111.874 174.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -134.76 -6.98 2.44 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -169.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.24 -173.5 54.91 Favored Glycine 0 CA--C 1.537 1.436 0 CA-C-N 119.325 0.966 . . . . 0.0 113.712 174.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -67.33 156.33 66.66 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.425 2.75 . . . . 0.0 111.116 176.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -104.88 166.16 10.57 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.68 1.192 . . . . 0.0 109.774 171.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -78.99 85.72 4.91 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 169.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -58.43 -16.47 15.06 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -178.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.82 -42.04 78.87 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.595 1.158 . . . . 0.0 111.473 170.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 59.1 mt -65.58 -46.95 88.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.98 -50.51 73.13 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.795 0.838 . . . . 0.0 110.802 -177.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.6 p -66.54 -44.26 82.88 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.891 -174.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -58.09 -43.63 87.18 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.754 1.161 . . . . 0.0 110.34 178.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -69.58 -44.58 70.51 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-O 118.976 -0.535 . . . . 0.0 111.407 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 62.9 mt -66.64 -38.35 81.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 119.674 1.124 . . . . 0.0 109.095 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 94.2 mttt . . . . . 0 N--CA 1.468 0.465 0 CA-C-N 119.805 1.184 . . . . 0.0 109.646 173.244 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 C--O 1.234 0.25 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 17.6 p -137.19 171.35 14.62 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.69 0.796 . . . . 0.0 109.534 177.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 24.8 p-90 . . . . . 0 C--O 1.235 0.328 0 O-C-N 121.558 -0.713 . . . . 0.0 111.919 178.194 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.5 0 CA-C-O 121.653 0.74 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -150.37 150.17 31.06 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 169.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 68.5 mt -56.83 -32.35 65.66 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -174.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.58 -25.87 66.0 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.039 0.836 . . . . 0.0 112.222 178.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.3 mt -85.24 -23.84 28.06 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 123.786 0.834 . . . . 0.0 111.389 -176.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 61.7 mt -64.64 129.05 94.11 Favored Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 -178.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -44.34 117.11 1.24 Allowed 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 124.494 3.463 . . . . 0.0 111.81 172.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -76.85 -34.93 57.81 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.17 0.51 . . . . 0.0 111.31 -169.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.9 t -137.83 135.78 45.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 174.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -154.16 107.99 2.97 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 169.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 15.6 pt . . . . . 0 CA--C 1.537 0.462 0 C-N-CA 124.46 1.104 . . . . 0.0 108.419 -172.756 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 23.7 p90 . . . . . 0 N--CA 1.465 0.31 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -79.76 151.73 30.2 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 169.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.415 ' HH ' ' HB2' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -142.14 158.84 43.29 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.619 1.168 . . . . 0.0 108.466 -178.009 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.9 m -128.37 154.11 38.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 124.662 1.185 . . . . 0.0 109.984 173.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.415 ' HB2' ' HH ' ' A' ' 22' ' ' TYR . 0.9 OUTLIER -110.53 114.46 27.88 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 104.546 -2.39 . . . . 0.0 104.546 178.259 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.2 mt -117.98 121.76 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -172.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -73.47 147.99 43.61 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 169.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.4 t -132.49 146.82 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 178.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -124.95 154.27 41.43 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.604 1.161 . . . . 0.0 108.568 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.3 m -64.26 88.36 0.05 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.034 0.934 . . . . 0.0 111.798 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -136.66 35.39 0.26 Allowed Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 125.295 1.438 . . . . 0.0 112.422 169.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo . . . . . 0 C--N 1.359 1.087 0 CA-C-N 123.009 2.11 . . . . 0.0 111.981 170.26 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.0 mm-40 . . . . . 0 CA--C 1.539 0.541 0 CA-C-O 121.367 0.604 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.3 m -140.57 159.26 42.6 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.653 1.181 . . . . 0.0 109.051 172.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -149.87 171.28 17.03 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 127.565 2.346 . . . . 0.0 106.185 -173.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.9 mp0 -134.77 152.58 51.87 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 174.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 38.4 pt -130.08 155.06 41.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 125.474 1.51 . . . . 0.0 109.37 176.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 45.4 t -118.42 120.14 63.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.2 mmp_? -128.66 145.01 51.28 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.312 1.445 . . . . 0.0 107.622 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.93 132.92 1.72 Allowed Glycine 0 C--N 1.331 0.282 0 CA-C-N 119.632 1.105 . . . . 0.0 111.142 174.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -154.46 157.87 39.09 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -172.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.3 mttp -58.78 -34.85 71.92 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 119.186 -0.435 . . . . 0.0 111.852 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 15.6 p-90 -65.4 -30.75 71.6 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 118.964 -0.541 . . . . 0.0 112.326 -177.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.53 74.57 10.38 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 119.161 0.891 . . . . 0.0 109.465 175.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.93 -17.36 63.16 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.221 0.608 . . . . 0.0 111.572 175.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.81 144.25 51.09 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 126.147 1.779 . . . . 0.0 108.025 178.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -67.95 -34.93 77.52 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 119.27 -0.395 . . . . 0.0 111.862 -169.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.77 -29.1 53.16 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 118.411 -0.804 . . . . 0.0 112.664 174.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -66.55 -49.88 65.0 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 119.437 1.017 . . . . 0.0 111.394 -172.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.08 -41.4 89.48 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 CA-C-O 118.987 -0.53 . . . . 0.0 110.271 176.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -62.3 -49.05 77.19 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 119.26 -0.4 . . . . 0.0 110.217 -177.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -63.94 -45.3 89.8 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 118.608 0.64 . . . . 0.0 111.149 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 28.7 tttt -57.36 -54.36 47.73 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.523 0.729 . . . . 0.0 110.826 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 91.7 t -80.91 -40.8 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-O 117.799 -1.096 . . . . 0.0 110.827 -169.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 58.2 m -62.94 -25.8 68.51 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 120.77 1.623 . . . . 0.0 110.911 173.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.06 -55.43 29.62 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 169.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -61.26 -39.03 88.84 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 118.645 1.222 . . . . 0.0 112.689 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.462 ' HG3' ' HG ' ' A' ' 71' ' ' CYS . 38.7 mmt -57.26 -47.38 81.56 Favored 'General case' 0 N--CA 1.461 0.077 0 CA-C-N 118.624 0.647 . . . . 0.0 109.515 174.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -67.79 -28.77 67.88 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.15 0.58 . . . . 0.0 112.542 178.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.9 mttm -63.24 -44.34 95.49 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.56 1.073 . . . . 0.0 109.445 169.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -65.93 -25.87 67.33 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 119.183 0.901 . . . . 0.0 110.89 171.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 122.82 -26.25 6.25 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 127.432 2.444 . . . . 0.0 111.64 175.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 97.2 m -53.9 148.46 10.41 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.649 1.98 . . . . 0.0 112.252 -173.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -108.79 138.78 44.56 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -177.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.462 ' HG ' ' HG3' ' A' ' 64' ' ' MET . 91.7 m -141.74 162.16 36.16 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 -168.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -153.01 131.58 12.24 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.595 1.558 . . . . 0.0 107.872 171.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.0 p -69.74 118.5 12.68 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 169.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 43.7 mt -68.49 -25.4 64.95 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.882 -0.511 . . . . 0.0 109.903 172.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.38 -164.29 37.51 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 108.317 -1.913 . . . . 0.0 108.317 173.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -150.88 -179.32 26.53 Favored Glycine 0 N--CA 1.451 -0.303 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 171.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -169.83 -157.19 11.81 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 -175.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -143.45 147.24 34.27 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 -173.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 12.2 mt . . . . . 0 C--N 1.33 -0.27 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 -172.555 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 20.7 t60 . . . . . 0 N--CA 1.451 -0.41 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.6 t -135.01 131.37 52.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 -178.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -160.19 -164.37 1.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 O-C-N 121.486 -0.759 . . . . 0.0 109.388 -177.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.04 -172.23 55.11 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 118.812 0.733 . . . . 0.0 112.457 173.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -162.45 150.07 13.96 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.989 0.915 . . . . 0.0 110.151 -174.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.0 t -78.74 165.59 23.43 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 167.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 21.8 ptp -108.45 -28.99 9.04 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 118.52 -0.752 . . . . 0.0 111.025 171.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.2 -25.16 57.99 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 119.49 1.041 . . . . 0.0 111.602 171.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -133.78 -5.95 2.82 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -169.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.77 -178.07 51.11 Favored Glycine 0 CA--C 1.535 1.335 0 CA-C-N 119.025 0.83 . . . . 0.0 113.575 173.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -68.13 142.31 55.52 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.806 2.337 . . . . 0.0 110.815 174.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.51 177.31 5.4 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 169.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 21.4 mm100 -62.91 -28.59 70.16 Favored 'General case' 0 CA--C 1.535 0.404 0 O-C-N 121.85 -0.532 . . . . 0.0 111.66 172.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . 0.263 38.3 m80 59.45 -27.64 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 128.556 2.742 . . . . 0.0 116.481 -174.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.26 -42.41 99.15 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 119.547 1.067 . . . . 0.0 110.251 173.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 62.2 mt -61.06 -47.26 94.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 176.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.4 -52.35 64.95 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.399 1.079 . . . . 0.0 110.599 -173.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 33.0 p -64.63 -48.47 74.74 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 118.781 -0.628 . . . . 0.0 109.636 -176.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -60.58 -40.24 91.01 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.958 0.799 . . . . 0.0 111.096 -177.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 48.9 mttm -64.78 -46.94 79.97 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 118.877 0.762 . . . . 0.0 111.19 176.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 63.2 mt -62.14 -44.39 98.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt . . . . . 0 N--CA 1.466 0.366 0 CA-C-N 118.782 0.719 . . . . 0.0 110.336 179.552 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.3 t . . . . . 0 N--CA 1.451 -0.408 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.0 p -135.71 170.97 15.13 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.55 1.14 . . . . 0.0 109.283 176.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 34.9 p-90 . . . . . 0 C--O 1.234 0.266 0 O-C-N 121.817 -0.552 . . . . 0.0 111.034 172.015 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.514 0 CA-C-O 121.619 0.723 . . . . 0.0 111.55 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -153.36 149.6 28.0 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 126.488 1.915 . . . . 0.0 106.309 169.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 68.9 mt -54.79 -34.61 62.9 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 123.395 0.678 . . . . 0.0 112.539 -175.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.29 -25.05 65.85 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.861 0.755 . . . . 0.0 112.42 -178.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.8 mt -78.72 -25.05 44.58 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.023 0.529 . . . . 0.0 111.195 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 21.1 mt -70.87 129.39 89.71 Favored Pre-proline 0 CA--C 1.538 0.504 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -176.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -52.87 128.14 27.54 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.703 2.269 . . . . 0.0 110.644 169.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -80.47 -23.71 40.0 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 121.909 -0.495 . . . . 0.0 111.854 176.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.1 t -136.22 131.55 48.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 173.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -163.38 116.04 1.51 Allowed 'General case' 0 C--O 1.233 0.205 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 169.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.536 0.44 0 C-N-CA 124.379 1.072 . . . . 0.0 109.127 -173.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 . . . . . 0 C--O 1.238 0.469 0 CA-C-O 121.33 0.586 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -71.17 157.1 38.74 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 124.082 0.953 . . . . 0.0 112.073 -171.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -145.31 164.74 30.5 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.066 1.747 . . . . 0.0 107.657 170.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.5 m -131.21 150.92 34.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 C-N-CA 124.28 1.032 . . . . 0.0 109.199 171.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.73 118.67 36.74 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 104.234 -2.506 . . . . 0.0 104.234 173.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 53.6 mt -120.31 124.84 73.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 -177.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -81.18 148.7 29.42 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 169.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.5 t -133.02 147.09 31.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 -175.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -132.49 147.33 52.36 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.815 1.246 . . . . 0.0 107.96 -178.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.8 m -62.25 103.18 0.36 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.524 0.73 . . . . 0.0 111.117 -178.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.462 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -144.45 19.18 0.04 OUTLIER Pre-proline 0 CA--C 1.555 1.146 0 CA-C-O 116.265 -1.826 . . . . 0.0 113.654 169.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.462 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 87.2 Cg_exo . . . . . 0 C--N 1.365 1.428 0 CA-C-N 123.538 2.299 . . . . 0.0 114.349 178.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 . . . . . 0 CA--C 1.54 0.567 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.3 m -141.52 159.24 42.63 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.616 1.166 . . . . 0.0 109.547 175.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -153.41 166.33 33.01 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 127.107 2.163 . . . . 0.0 106.727 -173.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -127.61 154.28 45.42 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 119.577 1.08 . . . . 0.0 108.968 177.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.6 pt -134.73 153.05 34.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 C-N-CA 125.185 1.394 . . . . 0.0 109.37 175.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 43.2 t -118.98 114.22 44.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.4 mmp_? -126.63 147.11 49.95 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 175.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -176.97 141.29 5.32 Favored Glycine 0 C--N 1.331 0.253 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 175.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -152.9 153.83 33.82 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -172.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -59.51 -28.8 67.38 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 8.0 p-90 -70.91 -24.56 62.49 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.115 0.871 . . . . 0.0 112.596 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.42 75.74 9.97 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.586 1.085 . . . . 0.0 110.587 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -63.81 -14.49 53.34 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.288 0.635 . . . . 0.0 112.142 173.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -131.04 136.98 48.96 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.723 1.609 . . . . 0.0 107.317 177.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 34.6 m80 -60.72 -32.5 71.75 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 123.102 0.561 . . . . 0.0 110.594 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.69 -27.85 52.42 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 118.326 -0.845 . . . . 0.0 112.986 172.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -68.43 -49.78 57.5 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 119.619 1.1 . . . . 0.0 110.395 -176.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.36 -40.38 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-O 117.63 -1.176 . . . . 0.0 109.839 175.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -59.88 -47.8 84.28 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 120.301 1.41 . . . . 0.0 110.628 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -64.67 -47.62 77.78 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.569 0.622 . . . . 0.0 111.576 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 46.8 tttt -62.81 -50.75 69.74 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.11 0.564 . . . . 0.0 111.151 -178.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 93.2 t -71.96 -48.41 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-O 118.255 -0.879 . . . . 0.0 108.808 -172.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.9 m -64.21 -26.76 68.65 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 120.098 1.317 . . . . 0.0 111.251 177.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.91 -51.19 57.4 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 170.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -61.01 -43.03 99.48 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 118.495 1.147 . . . . 0.0 111.667 177.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.52 ' HG3' ' HG ' ' A' ' 71' ' ' CYS . 37.3 mmt -59.72 -47.18 86.66 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 118.974 -0.536 . . . . 0.0 109.859 177.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -69.82 -27.54 64.96 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.959 0.8 . . . . 0.0 112.096 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -67.28 -38.29 84.83 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.309 0.959 . . . . 0.0 109.988 169.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -69.02 -26.7 65.13 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 119.655 1.116 . . . . 0.0 110.293 169.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 119.7 -22.73 8.61 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 128.059 2.742 . . . . 0.0 112.219 175.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 92.9 m -52.64 147.98 7.83 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 126.067 1.747 . . . . 0.0 111.791 -178.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -108.11 140.18 41.69 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.52 ' HG ' ' HG3' ' A' ' 64' ' ' MET . 66.7 m -140.71 163.04 33.96 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -168.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -151.78 128.23 10.68 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.515 1.526 . . . . 0.0 107.489 175.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.8 p -70.9 121.46 18.14 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 169.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 51.4 mt -70.17 -27.14 64.28 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.968 -0.457 . . . . 0.0 109.851 171.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.62 -170.34 41.09 Favored Glycine 0 C--N 1.337 0.63 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 173.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -131.98 165.05 23.6 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.399 -0.68 . . . . 0.0 111.399 176.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -166.05 -162.99 18.69 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 125.284 1.421 . . . . 0.0 109.666 177.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 33.8 ptt180 -138.22 159.72 41.31 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 121.067 -1.255 . . . . 0.0 109.2 176.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 84.6 mt . . . . . 0 N--CA 1.45 -0.464 0 N-CA-C 103.843 -2.651 . . . . 0.0 103.843 -174.459 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 20.0 t60 . . . . . 0 N--CA 1.451 -0.381 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.7 t -137.37 134.84 47.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -171.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -174.42 172.39 3.18 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.253 1.421 . . . . 0.0 107.858 -178.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 144.1 -169.89 26.1 Favored Glycine 0 C--N 1.334 0.441 0 CA-C-N 119.017 0.826 . . . . 0.0 112.249 169.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -160.46 114.11 2.12 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.582 1.553 . . . . 0.0 107.737 -176.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.3 t -72.62 142.65 48.35 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 168.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.0 ppp? -71.64 -39.91 70.07 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 171.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.79 -25.06 35.57 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 118.711 -0.662 . . . . 0.0 112.408 -172.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -134.58 0.47 3.01 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -169.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.94 -175.27 53.95 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-N 119.197 0.908 . . . . 0.0 112.881 176.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -76.16 138.57 20.47 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.975 2.45 . . . . 0.0 109.847 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.48 171.76 9.59 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.094 0.473 . . . . 0.0 110.625 169.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 58.2 mm-40 -64.25 -35.77 81.91 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 119.116 -0.469 . . . . 0.0 111.828 175.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 33.9 m80 59.96 -31.2 0.05 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 128.767 2.827 . . . . 0.0 115.479 -173.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.57 -37.96 85.76 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.132 1.373 . . . . 0.0 112.115 174.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 90.4 mt -63.41 -46.51 95.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 176.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.67 -47.37 84.72 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.193 0.997 . . . . 0.0 110.939 -177.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.9 p -64.23 -51.98 61.01 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 119.137 0.881 . . . . 0.0 110.694 -177.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -60.28 -39.82 88.26 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 118.726 0.694 . . . . 0.0 110.574 -175.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -64.59 -56.05 16.46 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-O 118.462 -0.78 . . . . 0.0 111.187 174.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 66.9 mt -63.36 -41.4 92.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.215 -172.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 94.0 mttt . . . . . 0 N--CA 1.472 0.652 0 CA-C-N 120.121 1.328 . . . . 0.0 110.194 175.517 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.2 t . . . . . 0 CA--C 1.533 0.323 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 16.8 p -137.0 170.79 15.52 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.664 1.12 . . . . 0.0 109.926 176.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 38.5 p-90 . . . . . 0 C--O 1.235 0.334 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 172.434 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.386 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -146.97 147.96 31.24 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 169.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 71.5 mt -57.94 -30.02 65.62 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -173.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.22 -26.71 63.99 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.979 0.809 . . . . 0.0 111.981 177.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.2 mt -83.88 -25.52 30.17 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.772 0.829 . . . . 0.0 111.215 -177.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 51.9 mt -63.34 127.83 91.66 Favored Pre-proline 0 CA--C 1.538 0.506 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -45.9 122.8 5.48 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.968 3.112 . . . . 0.0 111.409 172.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -79.45 -36.24 39.18 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 121.209 0.528 . . . . 0.0 110.768 -172.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 77.9 t -136.69 129.97 45.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 N-CA-C 105.658 -1.978 . . . . 0.0 105.658 175.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -154.69 125.7 7.19 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 170.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.9 pt . . . . . 0 C--O 1.237 0.399 0 C-N-CA 124.835 1.254 . . . . 0.0 108.451 -173.841 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 9.4 p90 . . . . . 0 C--O 1.234 0.258 0 CA-C-O 120.484 0.183 . . . . 0.0 111.317 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -71.95 156.55 39.13 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 175.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.1 163.74 32.02 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 172.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.2 m -133.29 149.59 31.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 C-N-CA 124.385 1.074 . . . . 0.0 109.15 172.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.53 121.59 41.39 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 104.055 -2.572 . . . . 0.0 104.055 173.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 85.5 mt -122.57 126.47 74.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -177.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -82.14 148.31 28.57 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 169.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.5 t -137.26 147.02 27.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 126.857 2.063 . . . . 0.0 105.606 -173.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -128.11 152.0 48.53 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.684 1.194 . . . . 0.0 108.889 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.8 m -62.86 93.26 0.06 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.31 1.044 . . . . 0.0 111.028 175.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.445 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -141.1 16.39 0.04 OUTLIER Pre-proline 0 CA--C 1.551 0.992 0 CA-C-O 116.245 -1.836 . . . . 0.0 114.115 169.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.445 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 76.8 Cg_exo . . . . . 0 C--N 1.363 1.298 0 CA-C-N 124.104 2.501 . . . . 0.0 114.226 175.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 . . . . . 0 CA--C 1.539 0.53 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.9 m -142.17 157.19 45.16 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.711 1.205 . . . . 0.0 109.088 176.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -151.64 167.51 27.9 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 127.146 2.178 . . . . 0.0 106.427 -173.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 -131.88 154.12 49.53 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 175.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 35.8 pt -132.38 155.68 41.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 125.168 1.387 . . . . 0.0 109.852 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 98.6 t -118.16 115.11 47.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 177.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 12.1 mmp_? -125.78 141.93 51.76 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.239 1.416 . . . . 0.0 107.518 176.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -177.9 137.32 3.33 Favored Glycine 0 C--N 1.333 0.363 0 CA-C-N 119.31 0.959 . . . . 0.0 111.113 174.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -153.19 153.3 32.47 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 117.097 0.449 . . . . 0.0 110.54 -169.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -57.26 -32.47 66.62 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.086 0.954 . . . . 0.0 112.274 177.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 13.0 p-90 -67.83 -27.64 66.88 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.853 0.752 . . . . 0.0 112.529 177.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.98 81.63 8.7 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 119.724 1.147 . . . . 0.0 109.438 174.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -64.11 -19.1 65.03 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.266 0.626 . . . . 0.0 112.017 174.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -135.22 152.56 51.67 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 126.327 1.851 . . . . 0.0 108.001 -179.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 44.8 m-70 -73.72 -32.85 64.08 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 121.84 -0.537 . . . . 0.0 109.575 -169.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.0 -28.9 55.64 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 118.481 -0.771 . . . . 0.0 112.597 172.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -66.73 -50.51 62.55 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 119.356 0.98 . . . . 0.0 110.637 -175.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.67 -40.21 85.61 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 CA-C-O 117.257 -1.354 . . . . 0.0 109.826 175.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -60.86 -47.83 84.6 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-N 120.214 1.37 . . . . 0.0 110.243 -178.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -61.73 -46.17 90.78 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.001 0.819 . . . . 0.0 111.886 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 34.4 tttt -61.21 -50.0 74.88 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 123.082 0.553 . . . . 0.0 110.671 178.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 86.6 t -77.54 -39.98 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-O 117.751 -1.119 . . . . 0.0 109.757 -170.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 80.8 p -63.08 -34.16 76.99 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 120.888 1.676 . . . . 0.0 109.617 175.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.65 -53.32 46.34 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 171.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -60.22 -46.26 90.36 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 118.547 1.174 . . . . 0.0 111.813 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.545 ' HG3' ' HG ' ' A' ' 71' ' ' CYS . 38.0 mmt -57.92 -48.96 78.36 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.366 0.666 . . . . 0.0 110.369 177.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -68.21 -28.48 67.28 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.66 0.664 . . . . 0.0 111.996 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -67.95 -38.0 82.28 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 119.243 0.928 . . . . 0.0 110.594 171.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -67.56 -29.86 69.34 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 119.67 1.123 . . . . 0.0 110.437 169.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 126.96 -21.87 5.79 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 127.458 2.456 . . . . 0.0 111.692 174.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 68.1 m -52.45 150.14 5.12 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 125.947 1.699 . . . . 0.0 112.438 -176.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -108.51 136.24 48.45 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 173.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.545 ' HG ' ' HG3' ' A' ' 64' ' ' MET . 99.5 m -144.13 164.96 29.17 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -168.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -149.83 136.17 19.0 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.007 1.723 . . . . 0.0 107.847 171.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.3 p -73.22 125.0 26.75 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 169.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 44.4 mt -75.26 -23.29 57.44 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.812 -0.555 . . . . 0.0 110.398 173.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.01 -174.02 43.52 Favored Glycine 0 C--N 1.337 0.604 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 171.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -123.48 168.07 15.7 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 175.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -172.32 -165.25 29.13 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -173.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -149.38 150.49 32.51 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -169.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 58.7 mt . . . . . 0 C--O 1.235 0.341 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 -172.161 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 36.2 t60 . . . . . 0 N--CA 1.451 -0.416 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.2 t -131.83 136.62 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -178.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -161.0 -161.09 0.79 Allowed 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 125.145 1.378 . . . . 0.0 107.424 -172.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.73 -177.81 45.21 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-O 122.539 1.077 . . . . 0.0 113.451 169.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -164.07 150.64 11.45 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 126.032 1.733 . . . . 0.0 106.793 -169.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.3 t -116.96 145.9 43.35 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.66 1.584 . . . . 0.0 106.813 171.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.0 ptm -87.35 -34.46 18.81 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 118.79 -0.624 . . . . 0.0 110.193 174.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.81 -26.09 56.94 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.117 0.871 . . . . 0.0 111.949 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -131.13 -5.09 3.89 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -169.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.44 173.8 40.27 Favored Glycine 0 CA--C 1.533 1.197 0 CA-C-N 118.858 0.754 . . . . 0.0 112.312 178.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.23 134.37 24.76 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.71 2.273 . . . . 0.0 109.527 177.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.28 166.57 19.86 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.674 0.75 . . . . 0.0 112.433 176.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -77.64 74.87 4.19 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.897 1.279 . . . . 0.0 108.973 169.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -54.15 -22.33 10.93 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -176.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.81 -40.64 89.07 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.955 0.902 . . . . 0.0 111.761 173.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 65.0 mt -63.28 -46.36 95.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.55 -50.86 72.25 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.451 1.1 . . . . 0.0 110.129 -176.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 20.9 p -65.39 -42.61 92.47 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 118.049 -0.977 . . . . 0.0 111.378 -174.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -61.35 -40.86 95.82 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.821 1.191 . . . . 0.0 110.742 178.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 43.4 mttm -66.51 -46.28 76.77 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 121.793 -0.567 . . . . 0.0 111.277 176.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 67.2 mt -64.8 -40.71 89.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -177.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 89.7 mttt . . . . . 0 N--CA 1.47 0.528 0 CA-C-N 119.88 1.218 . . . . 0.0 109.862 174.898 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.451 -0.418 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 26.0 p -136.21 172.0 13.65 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.075 0.95 . . . . 0.0 108.912 173.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 45.7 p-90 . . . . . 0 C--O 1.234 0.282 0 CA-C-O 121.076 0.465 . . . . 0.0 110.752 172.593 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.517 0 CA-C-O 121.287 0.565 . . . . 0.0 110.743 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -151.87 152.14 32.2 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.544 1.538 . . . . 0.0 106.864 170.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.2 mt -57.03 -31.66 65.38 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.568 0.622 . . . . 0.0 112.553 -176.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.84 -24.7 65.3 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 118.825 0.739 . . . . 0.0 112.376 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.2 mt -85.31 -18.68 33.15 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.549 0.74 . . . . 0.0 111.499 -176.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 50.1 mt -65.01 131.84 95.32 Favored Pre-proline 0 CA--C 1.54 0.577 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -50.4 115.79 2.13 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 123.503 2.802 . . . . 0.0 110.104 169.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -70.73 -39.18 73.5 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -169.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 45.5 t -140.83 138.5 34.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 176.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -152.51 112.49 3.99 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 169.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 40.0 pt . . . . . 0 CA--C 1.54 0.578 0 C-N-CA 124.693 1.197 . . . . 0.0 109.88 -169.95 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 25.1 p90 . . . . . 0 C--O 1.237 0.423 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.4 mmtp -74.68 154.57 38.4 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.045 0.938 . . . . 0.0 109.174 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.428 ' HH ' ' HB2' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -145.99 161.58 39.78 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.75 0.82 . . . . 0.0 108.985 176.369 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.6 m -133.79 152.09 34.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 C-N-CA 124.897 1.279 . . . . 0.0 109.331 173.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.428 ' HB2' ' HH ' ' A' ' 22' ' ' TYR . 28.2 tp -108.83 116.12 31.38 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 105.226 -2.138 . . . . 0.0 105.226 177.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 86.0 mt -120.15 119.12 59.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -169.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.3 ttp180 -78.13 145.36 35.75 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 168.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.3 p -139.25 148.85 23.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -130.71 145.95 52.06 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.084 1.353 . . . . 0.0 108.29 -169.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.0 m -61.38 108.23 0.9 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.644 0.778 . . . . 0.0 111.266 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.411 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -150.35 22.25 0.03 OUTLIER Pre-proline 0 CA--C 1.552 1.03 0 C-N-CA 125.185 1.394 . . . . 0.0 112.441 168.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 30' ' ' ALA . 45.5 Cg_endo . . . . . 0 C--N 1.359 1.087 0 CA-C-N 122.669 1.989 . . . . 0.0 110.998 -171.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 . . . . . 0 CA--C 1.537 0.475 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.4 m -140.71 157.85 44.83 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.393 1.077 . . . . 0.0 109.29 173.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -152.87 168.26 26.35 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 127.354 2.261 . . . . 0.0 106.23 -173.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -130.88 147.39 52.52 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.03 -1.044 . . . . 0.0 108.614 177.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 29.8 pt -130.75 156.0 42.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 125.881 1.672 . . . . 0.0 109.315 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.2 t -131.23 116.53 33.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 -169.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.5 mmt85 -137.22 148.9 46.82 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -176.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 177.69 137.43 2.75 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -154.85 154.09 32.18 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -170.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -59.71 -29.22 67.97 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.274 0.629 . . . . 0.0 112.651 178.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 11.2 p-90 -69.4 -28.21 65.96 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.014 0.825 . . . . 0.0 112.258 178.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.86 77.67 9.67 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 119.41 1.005 . . . . 0.0 109.022 175.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -63.13 -18.59 63.6 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 122.937 0.495 . . . . 0.0 111.303 173.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.65 146.3 51.44 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.64 1.576 . . . . 0.0 107.724 178.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -72.67 -30.22 64.08 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.131 0.572 . . . . 0.0 110.262 -169.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.41 -30.8 42.05 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 118.636 -0.697 . . . . 0.0 112.549 170.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -69.37 -47.61 63.75 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 119.34 0.973 . . . . 0.0 110.902 -175.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.73 -40.8 84.52 Favored 'Isoleucine or valine' 0 C--N 1.34 0.178 0 CA-C-O 117.891 -1.052 . . . . 0.0 110.117 175.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -61.21 -45.65 93.7 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.747 1.158 . . . . 0.0 110.288 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -62.53 -47.16 85.13 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.318 0.508 . . . . 0.0 111.583 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 26.1 tttp -63.62 -54.08 41.5 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 122.814 0.446 . . . . 0.0 110.995 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 97.3 t -71.07 -52.36 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -170.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 33.4 m -67.2 -27.96 67.69 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 119.206 0.912 . . . . 0.0 111.249 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.56 -46.92 93.3 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 170.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -63.23 -42.22 99.22 Favored 'General case' 0 CA--C 1.526 0.053 0 CA-C-N 118.568 1.184 . . . . 0.0 111.245 176.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.5 mmt -59.72 -45.1 93.18 Favored 'General case' 0 C--O 1.226 -0.18 0 CA-C-N 118.242 0.473 . . . . 0.0 110.14 176.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.7 mm-40 -66.72 -30.49 70.74 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.817 0.847 . . . . 0.0 111.912 178.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -68.61 -39.19 80.96 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.718 1.145 . . . . 0.0 110.301 170.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -65.4 -26.25 67.9 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.178 0.899 . . . . 0.0 110.431 169.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 119.09 -22.07 9.19 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 128.152 2.786 . . . . 0.0 111.82 175.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 91.3 m -58.69 150.58 23.04 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 126.452 1.901 . . . . 0.0 111.414 -176.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -108.78 146.03 34.24 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.481 1.113 . . . . 0.0 108.174 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 82.4 m -140.01 162.88 34.14 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -168.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -150.81 122.5 8.03 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 125.417 1.487 . . . . 0.0 107.66 173.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.5 p -69.88 120.0 14.95 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 169.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 45.1 mt -68.1 -25.64 65.41 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.987 -0.445 . . . . 0.0 109.893 172.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 165.55 -167.27 38.9 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 125.434 1.492 . . . . 0.0 109.432 170.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -132.76 170.89 21.88 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 123.977 0.799 . . . . 0.0 111.489 176.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -171.16 -161.31 21.59 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 125.471 1.51 . . . . 0.0 109.719 -177.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -142.29 165.95 26.04 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 121.372 -1.075 . . . . 0.0 108.909 174.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 60.1 mt . . . . . 0 CA--C 1.532 0.276 0 C-N-CA 123.12 0.568 . . . . 0.0 109.544 -169.61 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 24.3 t60 . . . . . 0 CA--C 1.521 -0.152 0 N-CA-C 109.506 -0.554 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.5 t -140.16 132.27 32.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -166.88 -173.69 2.47 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.18 0.992 . . . . 0.0 108.809 -172.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.92 -166.33 21.31 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-N 119.059 0.845 . . . . 0.0 112.263 171.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -155.64 178.22 10.5 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.424 1.09 . . . . 0.0 110.145 178.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.8 t -129.91 151.15 50.79 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 104.824 -2.288 . . . . 0.0 104.824 169.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.3 ptm -88.88 -34.05 17.11 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 118.787 -0.625 . . . . 0.0 110.281 175.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.34 -25.85 55.13 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.08 0.855 . . . . 0.0 111.981 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -130.84 -4.63 4.04 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -169.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.94 175.61 42.19 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-N 118.854 0.752 . . . . 0.0 112.353 177.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -66.7 138.43 49.18 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.428 2.085 . . . . 0.0 110.035 173.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.31 169.31 7.44 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.033 0.533 . . . . 0.0 110.953 171.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 21.2 mm100 -63.25 -30.26 71.43 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 118.975 -0.536 . . . . 0.0 111.428 170.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 40.2 m80 60.8 -31.56 0.07 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 129.017 2.927 . . . . 0.0 115.496 -175.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.09 -41.94 93.57 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.202 1.401 . . . . 0.0 112.318 178.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.8 mt -62.38 -49.15 85.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 177.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.4 m -54.68 -45.16 73.89 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.54 1.136 . . . . 0.0 112.172 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -61.3 -50.0 74.76 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 119.747 1.158 . . . . 0.0 110.315 178.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -61.26 -41.42 96.89 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.972 0.805 . . . . 0.0 110.889 -177.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 24.5 mmtp -68.23 -43.82 77.09 Favored 'General case' 0 C--N 1.338 0.086 0 CA-C-O 118.699 -0.667 . . . . 0.0 111.629 178.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 79.9 mt -67.23 -38.15 80.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 119.958 1.254 . . . . 0.0 109.01 -178.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 91.8 mttt . . . . . 0 N--CA 1.469 0.485 0 CA-C-N 119.64 1.109 . . . . 0.0 109.49 173.548 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.6 t . . . . . 0 N--CA 1.452 -0.34 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 16.9 p -135.06 171.09 14.92 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.137 0.975 . . . . 0.0 109.241 173.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 35.6 p-90 . . . . . 0 C--O 1.235 0.298 0 O-C-N 121.597 -0.69 . . . . 0.0 109.436 172.865 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.535 0 CA-C-O 121.263 0.554 . . . . 0.0 110.43 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -149.21 147.64 28.65 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 169.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 95.1 mt -55.51 -34.21 64.44 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.537 0.735 . . . . 0.0 112.407 -175.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.05 -25.54 66.31 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.834 0.743 . . . . 0.0 112.249 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.6 mt -79.25 -24.01 43.28 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.178 0.591 . . . . 0.0 111.183 -178.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 39.5 mt -68.31 128.78 93.1 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -176.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -47.42 123.05 7.41 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.939 3.093 . . . . 0.0 111.925 172.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -71.87 -37.52 70.19 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.499 0.72 . . . . 0.0 111.294 -177.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 63.9 t -137.52 134.32 46.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 176.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -152.66 119.96 5.92 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 171.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.5 pt . . . . . 0 CA--C 1.534 0.347 0 C-N-CA 124.28 1.032 . . . . 0.0 109.299 -169.937 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 23.2 p90 . . . . . 0 C--O 1.237 0.421 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -75.66 156.3 34.94 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.491 0.717 . . . . 0.0 110.003 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.44 163.34 35.97 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.004 1.322 . . . . 0.0 107.869 -178.151 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.3 m -135.95 156.04 36.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 C-N-CA 124.304 1.041 . . . . 0.0 109.7 172.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.81 122.23 45.97 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 104.225 -2.509 . . . . 0.0 104.225 173.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 73.9 mt -121.53 122.5 67.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 -176.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 37.6 ttp180 -80.74 146.82 30.84 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 169.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.6 t -132.13 143.77 39.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 -175.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -128.96 138.36 51.93 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 176.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.5 p -67.31 115.87 7.44 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.777 0.799 . . . . 0.0 110.641 -175.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.405 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -148.43 27.49 0.05 OUTLIER Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 125.833 1.653 . . . . 0.0 111.609 169.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.405 ' CD ' ' N ' ' A' ' 30' ' ' ALA . 35.2 Cg_endo . . . . . 0 C--N 1.358 1.064 0 CA-C-N 122.569 1.953 . . . . 0.0 111.985 -173.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 . . . . . 0 C--O 1.238 0.466 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.2 m -140.89 157.86 44.77 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.299 0.64 . . . . 0.0 110.589 -175.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -152.22 167.5 28.38 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 127.586 2.355 . . . . 0.0 106.008 -175.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.9 mp0 -133.21 156.49 47.42 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 120.713 -1.242 . . . . 0.0 108.443 176.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 32.2 pt -136.31 155.35 34.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 125.255 1.422 . . . . 0.0 109.807 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 48.1 t -118.14 122.36 69.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 -179.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.1 mmp_? -129.29 146.18 51.23 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.083 1.353 . . . . 0.0 107.832 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 177.32 131.36 1.5 Allowed Glycine 0 C--N 1.331 0.283 0 CA-C-N 119.173 0.897 . . . . 0.0 111.045 173.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -153.95 152.3 30.42 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -173.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.9 pttm -58.89 -29.4 66.99 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 11.1 p-90 -65.4 -27.52 68.6 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.231 0.923 . . . . 0.0 111.854 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.56 75.67 10.01 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 118.871 0.76 . . . . 0.0 109.052 172.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -67.22 -6.59 18.75 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.685 0.794 . . . . 0.0 111.574 175.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -137.28 146.14 44.34 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 126.63 1.972 . . . . 0.0 107.224 173.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 61.1 m-70 -68.97 -34.29 75.08 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -171.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.97 -26.49 48.47 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 118.355 -0.831 . . . . 0.0 112.766 174.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -69.11 -48.06 63.53 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 119.749 1.159 . . . . 0.0 111.111 -175.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.08 -38.02 81.09 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.024 176.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -62.23 -50.32 72.2 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.612 177.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -60.99 -44.12 97.85 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.798 1.181 . . . . 0.0 112.02 -178.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.6 tppt? -57.08 -54.64 44.45 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.169 0.988 . . . . 0.0 110.527 177.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.2 t -85.26 -34.41 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-O 117.619 -1.182 . . . . 0.0 111.974 -168.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 57.2 p -63.26 -33.18 74.94 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 121.345 1.884 . . . . 0.0 109.485 170.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.74 -52.85 50.5 Favored Glycine 0 C--N 1.338 0.64 0 N-CA-C 110.354 -1.099 . . . . 0.0 110.354 171.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -59.86 -44.6 94.04 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.717 1.258 . . . . 0.0 111.993 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.525 ' HG3' ' HG ' ' A' ' 71' ' ' CYS . 35.4 mmt -60.35 -47.98 83.72 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 123.238 0.615 . . . . 0.0 109.903 178.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -68.57 -28.62 67.11 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 118.501 0.591 . . . . 0.0 111.827 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -67.3 -37.7 83.8 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 118.119 -0.943 . . . . 0.0 110.393 170.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -68.82 -30.04 68.51 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.871 1.214 . . . . 0.0 110.31 169.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 126.2 -22.36 5.98 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 127.625 2.536 . . . . 0.0 111.872 175.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 82.5 m -55.52 152.09 9.49 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 126.188 1.795 . . . . 0.0 112.339 -177.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -110.68 140.86 44.66 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.525 ' HG ' ' HG3' ' A' ' 64' ' ' MET . 96.8 m -143.32 165.03 28.61 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -168.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -151.43 127.24 10.27 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.545 1.538 . . . . 0.0 107.542 175.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.2 p -70.56 120.15 15.77 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 169.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 58.3 mt -71.29 -22.96 61.88 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.932 -0.48 . . . . 0.0 110.424 174.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 165.96 -169.27 40.16 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 172.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -135.76 174.96 21.09 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 174.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -178.53 -168.16 37.4 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 -176.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -137.84 163.05 32.38 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 119.029 1.414 . . . . 0.0 109.73 173.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 75.0 mt . . . . . 0 C--N 1.33 -0.264 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 -169.698 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 28.1 t60 . . . . . 0 N--CA 1.46 0.068 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.4 t -141.01 135.65 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -166.26 -174.28 2.86 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.623 0.769 . . . . 0.0 109.664 -172.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.35 -170.48 39.05 Favored Glycine 0 CA--C 1.523 0.581 0 O-C-N 121.77 -0.581 . . . . 0.0 112.101 171.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -159.95 152.88 21.59 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.061 0.944 . . . . 0.0 109.845 -178.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.7 t -82.79 154.77 24.56 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 168.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.8 ppp? -82.29 -39.24 23.2 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 171.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.6 -25.59 45.22 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 119.152 -0.451 . . . . 0.0 111.971 -175.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -132.0 -2.32 3.64 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -169.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.88 -174.79 51.0 Favored Glycine 0 CA--C 1.534 1.281 0 CA-C-N 118.903 0.774 . . . . 0.0 113.101 174.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.98 138.34 43.82 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.963 2.442 . . . . 0.0 110.091 173.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.75 170.93 15.24 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.614 0.721 . . . . 0.0 111.488 170.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -78.86 76.02 5.36 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 169.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -57.62 -18.63 21.16 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -174.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.15 -35.77 76.05 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.194 0.998 . . . . 0.0 112.35 171.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 69.4 mt -65.81 -45.53 91.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 176.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.3 m -58.68 -46.85 86.33 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.998 0.919 . . . . 0.0 111.52 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 21.0 p -60.56 -53.26 59.63 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 119.184 0.902 . . . . 0.0 109.325 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -61.81 -40.96 97.07 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.795 0.725 . . . . 0.0 111.437 -175.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -66.53 -48.13 70.69 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 118.708 0.685 . . . . 0.0 111.481 178.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 73.4 mt -66.36 -37.45 79.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 119.229 0.922 . . . . 0.0 109.003 -178.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 46.7 mtpt . . . . . 0 N--CA 1.469 0.518 0 CA-C-N 119.615 1.098 . . . . 0.0 110.118 175.103 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.4 t . . . . . 0 N--CA 1.45 -0.447 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.3 p -132.51 172.0 13.05 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.084 0.953 . . . . 0.0 109.498 176.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 33.5 p-90 . . . . . 0 C--O 1.235 0.299 0 O-C-N 121.603 -0.686 . . . . 0.0 109.967 173.024 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.576 0 CA-C-O 121.339 0.59 . . . . 0.0 110.816 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -152.73 153.98 34.32 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.85 1.66 . . . . 0.0 106.635 170.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.4 mt -53.28 -36.58 61.33 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.038 0.835 . . . . 0.0 112.0 -179.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.02 -25.66 68.22 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.875 0.761 . . . . 0.0 112.506 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.1 mt -83.66 -20.27 33.89 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.38 0.672 . . . . 0.0 111.44 -178.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 32.0 mt -67.38 131.61 93.25 Favored Pre-proline 0 CA--C 1.539 0.52 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -49.76 119.54 4.88 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 123.066 2.511 . . . . 0.0 110.63 169.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -71.15 -39.65 71.82 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.791 0.836 . . . . 0.0 111.155 -175.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.9 t -134.89 139.45 47.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 172.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -152.02 122.87 7.5 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 170.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 45.1 pt . . . . . 0 CA--C 1.538 0.496 0 C-N-CA 127.366 2.266 . . . . 0.0 105.703 177.387 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.8 p90 . . . . . 0 N--CA 1.467 0.386 0 N-CA-C 110.767 -0.086 . . . . 0.0 110.767 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -66.35 155.31 37.68 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.331 0.586 . . . . 0.0 110.523 -178.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -141.48 163.56 32.6 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.309 1.444 . . . . 0.0 107.376 173.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.4 m -138.34 156.56 30.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 C-N-CA 123.905 0.882 . . . . 0.0 109.467 172.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.21 118.86 37.85 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 104.392 -2.448 . . . . 0.0 104.392 176.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 62.8 mt -121.72 115.71 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 119.809 1.186 . . . . 0.0 108.402 -173.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -74.54 140.88 44.77 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 168.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.9 p -134.85 148.01 29.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 178.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -127.52 143.47 51.18 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.184 1.393 . . . . 0.0 108.623 -169.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.8 m -62.49 105.08 0.58 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.574 0.75 . . . . 0.0 111.308 177.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.401 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -149.02 25.27 0.04 OUTLIER Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 125.568 1.547 . . . . 0.0 111.872 168.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 30' ' ' ALA . 43.6 Cg_endo . . . . . 0 C--N 1.356 0.964 0 CA-C-N 122.263 1.844 . . . . 0.0 111.115 -169.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 . . . . . 0 CA--C 1.541 0.6 0 CA-C-O 121.344 0.592 . . . . 0.0 109.986 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.6 m -140.59 161.26 38.17 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.841 1.256 . . . . 0.0 109.186 174.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 58.9 tttt -145.56 165.13 29.54 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 126.947 2.099 . . . . 0.0 107.074 -176.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.7 mp0 -125.31 119.49 28.53 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 173.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 35.5 pt -104.34 154.45 6.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 124.286 1.034 . . . . 0.0 110.078 174.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 45.9 t -121.33 124.28 71.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 -172.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.6 mmp_? -132.36 148.61 52.43 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.185 1.394 . . . . 0.0 108.585 -176.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.97 134.93 2.33 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 169.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -156.69 152.51 27.16 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 124.09 0.956 . . . . 0.0 108.471 -176.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -63.52 -26.83 68.89 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 8.1 p-90 -65.63 -25.52 67.41 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.021 0.828 . . . . 0.0 111.701 178.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.09 83.99 5.88 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 170.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -65.58 -16.21 63.47 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.346 0.658 . . . . 0.0 111.473 174.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -138.74 153.41 48.48 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 126.768 2.027 . . . . 0.0 107.896 178.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 37.8 m-70 -70.99 -34.06 71.02 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -171.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.44 -26.81 44.21 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 118.319 -0.848 . . . . 0.0 112.829 174.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -68.77 -49.75 56.05 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 119.653 1.115 . . . . 0.0 110.892 -175.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.42 -39.44 85.22 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.105 175.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -61.51 -52.52 64.15 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 118.106 -0.95 . . . . 0.0 109.503 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -60.34 -43.49 96.4 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 119.465 1.03 . . . . 0.0 112.002 -177.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.1 tppt? -57.37 -53.66 55.6 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 124.02 0.928 . . . . 0.0 110.596 176.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.2 t -85.42 -36.86 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-O 117.566 -1.207 . . . . 0.0 112.042 -168.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 83.4 p -63.19 -36.65 84.34 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 121.237 1.835 . . . . 0.0 109.432 171.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.45 -48.83 81.88 Favored Glycine 0 C--N 1.34 0.755 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 171.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -62.86 -43.7 98.09 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 118.848 1.324 . . . . 0.0 111.668 178.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 35.7 mmt -60.85 -44.0 97.59 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-N 118.225 0.466 . . . . 0.0 110.065 177.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -66.93 -29.9 69.89 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.048 0.939 . . . . 0.0 111.968 177.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -68.68 -38.71 80.55 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.67 1.123 . . . . 0.0 109.938 169.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -66.93 -24.71 66.11 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 119.269 0.941 . . . . 0.0 110.495 169.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.73 -21.97 12.11 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 128.412 2.911 . . . . 0.0 112.094 176.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 89.5 m -59.37 150.48 26.15 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 126.0 1.72 . . . . 0.0 110.832 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -108.82 153.07 24.03 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 89.9 m -144.59 162.99 35.25 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 -168.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -149.69 125.91 10.72 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 169.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.7 p -68.32 115.19 7.48 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 169.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 53.3 mt -67.45 -23.63 65.54 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 122.072 -0.393 . . . . 0.0 110.206 174.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 172.64 -174.6 45.71 Favored Glycine 0 C--N 1.338 0.674 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 170.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -133.08 166.81 23.59 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 172.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -173.86 -156.74 13.93 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -176.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -141.01 159.39 42.31 Favored 'General case' 0 CA--C 1.518 -0.288 0 O-C-N 120.93 -1.335 . . . . 0.0 110.416 175.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 78.3 mt . . . . . 0 N--CA 1.448 -0.549 0 N-CA-C 104.299 -2.482 . . . . 0.0 104.299 174.658 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 30.0 t60 . . . . . 0 N--CA 1.454 -0.243 0 N-CA-C 109.119 -0.696 . . . . 0.0 109.119 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.1 t -142.03 118.63 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -173.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -168.05 165.81 13.34 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.942 0.897 . . . . 0.0 108.994 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 136.52 -178.59 18.72 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-N 118.685 0.675 . . . . 0.0 111.511 170.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -141.99 146.38 35.52 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.226 0.61 . . . . 0.0 111.253 169.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.5 t -84.21 153.08 23.84 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 168.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 27.6 ptm -84.39 -35.4 23.16 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 119.128 0.876 . . . . 0.0 109.753 171.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.73 -26.21 57.28 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.68 0.673 . . . . 0.0 112.144 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -132.97 -3.58 3.17 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -169.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 78.42 -176.07 54.45 Favored Glycine 0 CA--C 1.535 1.29 0 CA-C-N 119.114 0.87 . . . . 0.0 113.121 174.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -70.47 167.61 24.87 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 123.765 2.977 . . . . 0.0 111.412 174.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -124.57 166.18 16.53 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.941 1.296 . . . . 0.0 111.003 -173.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 24.6 mm100 -78.85 74.57 5.38 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.81 0.844 . . . . 0.0 109.164 171.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -53.78 -23.63 12.63 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.15 0.98 . . . . 0.0 112.697 176.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -51.71 -42.37 62.18 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.168 1.387 . . . . 0.0 112.688 171.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 78.3 mt -65.42 -48.48 82.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 179.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.4 m -57.39 -48.05 80.1 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.468 1.107 . . . . 0.0 110.845 -177.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.7 p -66.44 -48.62 69.38 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 119.17 0.896 . . . . 0.0 110.713 -177.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -57.47 -42.98 83.67 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 119.332 0.969 . . . . 0.0 110.547 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -70.0 -50.52 40.69 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 118.522 -0.751 . . . . 0.0 111.074 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 76.6 mt -63.55 -38.48 82.33 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 120.097 1.317 . . . . 0.0 109.591 -175.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 94.9 mttt . . . . . 0 N--CA 1.469 0.501 0 CA-C-N 119.651 1.114 . . . . 0.0 109.99 174.47 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.4 p -136.5 167.85 20.59 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 123.828 0.851 . . . . 0.0 109.683 175.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 13.4 p-90 . . . . . 0 C--O 1.237 0.415 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 170.074 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.389 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -145.21 147.67 32.68 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 169.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.2 mt -56.18 -34.41 66.18 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -172.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.16 -22.71 63.91 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.748 0.703 . . . . 0.0 112.54 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.4 mt -81.85 -20.0 39.85 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.376 0.67 . . . . 0.0 111.287 -178.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 46.9 mt -66.52 133.01 94.25 Favored Pre-proline 0 CA--C 1.542 0.643 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -49.48 130.29 25.19 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.304 2.669 . . . . 0.0 111.259 170.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -80.46 -37.87 31.06 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.005 0.431 . . . . 0.0 111.508 -175.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.2 t -136.27 130.44 47.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 176.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -151.93 123.36 7.8 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 169.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.9 pt . . . . . 0 CA--C 1.535 0.376 0 C-N-CA 124.901 1.28 . . . . 0.0 109.732 -169.301 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 31.8 p90 . . . . . 0 C--O 1.232 0.153 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -76.22 153.08 36.35 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.015 0.526 . . . . 0.0 110.298 -178.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.539 ' HH ' ' CD2' ' A' ' 102' ' ' HIS . 0.4 OUTLIER -145.56 162.2 38.01 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.574 1.15 . . . . 0.0 108.125 176.601 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.0 m -130.31 153.58 39.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 C-N-CA 124.361 1.064 . . . . 0.0 109.493 173.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -108.09 114.79 28.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 103.864 -2.643 . . . . 0.0 103.864 178.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 49.7 mt -118.27 125.84 74.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -171.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 -81.75 149.38 28.45 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 169.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.7 t -132.93 147.77 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 127.325 2.25 . . . . 0.0 105.031 -176.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -132.15 147.93 52.45 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 177.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.3 m -61.0 101.53 0.15 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.649 0.78 . . . . 0.0 110.852 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.446 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -144.45 19.96 0.04 OUTLIER Pre-proline 0 CA--C 1.55 0.971 0 CA-C-O 116.319 -1.8 . . . . 0.0 113.872 169.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.446 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 75.3 Cg_exo . . . . . 0 C--N 1.362 1.288 0 CA-C-N 124.015 2.47 . . . . 0.0 113.316 172.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 . . . . . 0 CA--C 1.539 0.549 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.9 m -140.85 157.87 44.77 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.703 1.201 . . . . 0.0 109.068 173.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.7 tmtm? -156.1 165.92 34.99 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.275 1.83 . . . . 0.0 107.408 -169.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.5 mp0 -131.56 155.89 46.69 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.95 1.25 . . . . 0.0 109.334 175.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 41.7 pt -139.66 158.17 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 126.046 1.738 . . . . 0.0 110.084 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.2 t -118.44 118.83 59.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 12.2 mmp_? -127.43 141.36 51.69 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 175.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.87 137.25 2.96 Favored Glycine 0 C--N 1.332 0.329 0 CA-C-N 119.09 0.859 . . . . 0.0 111.493 174.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.405 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 12.9 m-85 -154.02 150.8 28.64 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -170.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -60.13 -29.08 68.4 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 118.681 -0.676 . . . . 0.0 112.197 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.405 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 11.8 p-90 -63.48 -29.18 70.5 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.257 0.935 . . . . 0.0 112.391 177.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.8 73.24 10.65 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 119.204 0.911 . . . . 0.0 109.349 174.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -68.87 -2.42 9.59 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.421 0.688 . . . . 0.0 111.869 177.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -138.93 145.19 39.52 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 126.588 1.955 . . . . 0.0 107.008 172.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -71.27 -32.0 68.17 Favored 'General case' 0 C--O 1.234 0.273 0 O-C-N 121.879 -0.513 . . . . 0.0 110.058 -171.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.61 -27.83 42.19 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 118.438 -0.791 . . . . 0.0 112.629 172.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -68.51 -49.64 58.15 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 119.647 1.112 . . . . 0.0 110.809 -176.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.43 -40.75 87.37 Favored 'Isoleucine or valine' 0 C--N 1.342 0.239 0 CA-C-O 117.837 -1.078 . . . . 0.0 109.619 175.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -61.13 -45.55 94.21 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.781 1.173 . . . . 0.0 110.446 -178.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -63.78 -49.01 74.63 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.864 0.756 . . . . 0.0 111.606 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.4 tttp -59.58 -49.0 79.47 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.422 0.689 . . . . 0.0 111.014 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 88.8 t -75.08 -42.86 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-O 117.686 -1.15 . . . . 0.0 109.244 -172.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 65.4 m -59.11 -36.28 74.89 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 120.572 1.533 . . . . 0.0 110.541 173.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.14 -53.94 41.6 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 172.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -61.61 -46.19 90.88 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 118.718 1.259 . . . . 0.0 111.679 -179.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.528 ' HG3' ' HG ' ' A' ' 71' ' ' CYS . 35.5 mmt -57.62 -51.14 70.7 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.509 0.724 . . . . 0.0 109.793 178.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.9 mm-40 -67.79 -27.19 66.53 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.717 0.69 . . . . 0.0 111.957 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -67.78 -38.14 82.98 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 119.518 1.054 . . . . 0.0 110.576 170.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -68.01 -30.92 70.28 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.808 1.186 . . . . 0.0 109.779 169.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 126.75 -26.24 5.16 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 128.253 2.835 . . . . 0.0 110.875 177.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 89.5 m -49.72 142.01 9.14 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 127.214 2.206 . . . . 0.0 111.799 -174.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -104.67 138.32 41.17 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 178.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.528 ' HG ' ' HG3' ' A' ' 64' ' ' MET . 59.3 m -142.06 160.36 40.37 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -168.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -146.49 134.76 21.77 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.419 1.488 . . . . 0.0 107.998 172.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.3 p -74.0 119.42 18.19 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 169.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 35.0 mt -71.58 -22.04 61.79 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 121.85 -0.531 . . . . 0.0 110.024 172.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.29 -163.78 37.12 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 170.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -149.67 -175.57 22.05 Favored Glycine 0 N--CA 1.451 -0.326 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 170.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -174.17 -161.41 24.1 Favored Glycine 0 CA--C 1.52 0.394 0 N-CA-C 107.598 -2.201 . . . . 0.0 107.598 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.2 ptt180 -134.22 154.27 51.36 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.102 -1.234 . . . . 0.0 108.612 172.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 66.8 mt . . . . . 0 N--CA 1.445 -0.687 0 N-CA-C 104.429 -2.434 . . . . 0.0 104.429 -177.092 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 27.2 t60 . . . . . 0 CA--C 1.522 -0.116 0 CA-C-O 119.691 -0.195 . . . . 0.0 110.566 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 22.0 t -138.31 130.46 38.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -168.97 -165.45 0.55 Allowed 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.796 0.839 . . . . 0.0 110.051 -176.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.33 -165.53 54.21 Favored Glycine 0 CA--C 1.524 0.595 0 O-C-N 121.755 -0.591 . . . . 0.0 112.434 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -164.85 157.12 15.98 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.015 0.926 . . . . 0.0 111.015 -173.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.6 t -81.94 159.86 23.5 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 167.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.0 ptm -95.84 -33.63 12.16 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 118.961 0.801 . . . . 0.0 110.424 169.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.95 -25.42 58.86 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.188 0.904 . . . . 0.0 112.039 176.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -131.91 -5.31 3.56 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -169.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.56 -177.49 49.21 Favored Glycine 0 CA--C 1.535 1.339 0 CA-C-N 119.022 0.828 . . . . 0.0 113.506 172.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -69.39 138.22 38.46 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.173 2.582 . . . . 0.0 110.363 173.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -78.42 171.8 14.56 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.035 0.445 . . . . 0.0 109.933 169.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 92.3 mm-40 -77.61 83.95 3.99 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 168.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.539 ' CD2' ' HH ' ' A' ' 22' ' ' TYR . 38.8 m80 -57.55 -13.92 4.47 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -176.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.0 -44.45 87.24 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.93 1.292 . . . . 0.0 110.788 169.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 61.1 mt -64.76 -47.21 89.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 179.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.76 -51.31 70.51 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.044 0.938 . . . . 0.0 110.43 -175.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.6 p -65.91 -46.12 79.43 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 117.862 -1.066 . . . . 0.0 110.313 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -58.71 -42.28 88.32 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 120.239 1.381 . . . . 0.0 110.938 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -65.48 -46.32 80.2 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 118.765 -0.636 . . . . 0.0 111.265 177.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 57.4 mt -64.93 -44.26 96.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 -178.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 26.9 mtpt . . . . . 0 N--CA 1.465 0.29 0 CA-C-N 119.396 0.998 . . . . 0.0 110.935 -178.773 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.4 t . . . . . 0 C--O 1.239 0.511 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 20.7 p -134.13 169.07 17.7 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.577 1.151 . . . . 0.0 110.293 -178.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 27.3 p-90 . . . . . 0 C--O 1.235 0.313 0 C-N-CA 123.143 0.577 . . . . 0.0 109.923 169.883 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.542 0 CA-C-O 121.164 0.507 . . . . 0.0 110.394 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -151.78 150.19 29.88 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 171.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 53.9 mt -57.87 -31.14 66.42 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.268 0.627 . . . . 0.0 112.617 -175.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.44 -25.09 65.73 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.674 0.67 . . . . 0.0 112.278 178.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.1 mt -79.82 -24.79 41.12 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.04 0.536 . . . . 0.0 111.024 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 7.3 mt -68.97 131.99 90.63 Favored Pre-proline 0 C--O 1.237 0.421 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 176.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.66 135.61 31.15 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 121.526 1.484 . . . . 0.0 110.571 176.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.67 -27.27 66.7 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.673 0.789 . . . . 0.0 111.578 -178.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.2 t -139.6 134.87 39.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -178.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -152.41 121.17 6.5 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 169.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.5 pt . . . . . 0 CA--C 1.534 0.361 0 C-N-CA 124.497 1.119 . . . . 0.0 110.192 -169.466 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 37.0 p90 . . . . . 0 C--O 1.234 0.237 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.95 152.87 41.2 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -178.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.16 162.14 38.65 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.477 1.111 . . . . 0.0 108.787 -177.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.6 m -134.95 155.38 38.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 C-N-CA 124.492 1.117 . . . . 0.0 110.178 171.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -108.28 117.8 35.1 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 176.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 53.9 mt -119.0 114.77 45.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -173.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -74.22 145.23 44.29 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 168.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.9 p -139.26 148.62 23.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -178.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -130.94 144.98 51.87 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.017 1.327 . . . . 0.0 108.074 -170.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.7 m -62.58 103.85 0.46 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.646 0.778 . . . . 0.0 111.653 -177.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.42 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -146.53 24.02 0.04 OUTLIER Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 125.487 1.515 . . . . 0.0 112.252 168.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.42 ' CD ' ' N ' ' A' ' 30' ' ' ALA . 56.8 Cg_endo . . . . . 0 C--N 1.357 0.985 0 CA-C-N 122.575 1.955 . . . . 0.0 110.93 -173.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 . . . . . 0 CA--C 1.538 0.518 0 CA-C-O 121.511 0.672 . . . . 0.0 109.745 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.7 m -138.95 158.22 44.59 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.464 1.106 . . . . 0.0 108.99 172.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -152.75 175.11 13.21 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 127.629 2.372 . . . . 0.0 105.894 -173.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -140.78 156.35 46.19 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 120.735 -1.228 . . . . 0.0 108.424 177.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 34.7 pt -136.47 155.15 33.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 124.92 1.288 . . . . 0.0 109.255 179.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.7 t -116.14 122.13 68.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 -178.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -126.05 145.28 50.39 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 177.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -179.69 129.77 1.4 Allowed Glycine 0 C--N 1.329 0.177 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 173.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -151.56 153.89 35.4 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -173.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.1 tptt -60.35 -32.93 71.73 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 119.175 -0.441 . . . . 0.0 111.761 -178.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 15.7 p-90 -64.35 -31.03 72.07 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.413 0.551 . . . . 0.0 112.395 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.48 74.86 10.26 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 119.15 0.886 . . . . 0.0 109.187 175.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -63.19 -18.75 63.83 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.195 0.598 . . . . 0.0 111.378 176.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -123.65 146.4 48.23 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.929 1.692 . . . . 0.0 107.99 176.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 39.8 m-70 -71.9 -33.9 68.69 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.327 0.651 . . . . 0.0 109.68 -169.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.73 -28.68 57.07 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 118.379 -0.819 . . . . 0.0 112.545 173.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -68.58 -48.58 63.82 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 119.626 1.103 . . . . 0.0 111.072 -174.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.72 -40.46 87.87 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-O 118.268 -0.873 . . . . 0.0 109.963 176.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -61.94 -50.96 70.05 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 119.401 -0.919 . . . . 0.0 109.74 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -60.76 -44.2 97.02 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 119.31 0.959 . . . . 0.0 111.807 -178.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 22.2 tttp -60.08 -51.56 69.12 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 123.159 0.584 . . . . 0.0 110.71 178.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.7 t -84.56 -33.53 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-O 117.923 -1.037 . . . . 0.0 111.506 -169.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 61.1 p -63.64 -34.69 78.39 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 121.071 1.759 . . . . 0.0 109.403 170.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.15 -51.06 60.7 Favored Glycine 0 C--N 1.338 0.667 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 171.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -60.71 -42.93 98.21 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 118.579 1.189 . . . . 0.0 112.137 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 38.0 mmt -62.67 -45.68 91.7 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 122.814 0.446 . . . . 0.0 110.249 176.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -68.19 -29.06 67.83 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 118.768 0.713 . . . . 0.0 111.843 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -67.57 -37.47 82.67 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 119.163 0.892 . . . . 0.0 110.365 170.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -68.71 -27.73 66.21 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.581 1.082 . . . . 0.0 110.77 169.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 125.69 -25.84 5.53 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 127.441 2.448 . . . . 0.0 111.788 175.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 88.4 m -57.35 151.56 15.92 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 126.389 1.876 . . . . 0.0 112.192 -175.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -109.77 145.31 36.87 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 86.9 m -140.63 165.16 28.22 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -168.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -153.11 126.29 8.54 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.448 1.499 . . . . 0.0 107.735 170.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.7 p -69.69 119.55 14.1 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 169.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 42.5 mt -70.9 -25.47 62.79 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.858 -0.526 . . . . 0.0 110.263 173.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.9 -172.01 43.09 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 109.769 -1.333 . . . . 0.0 109.769 172.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -132.26 177.17 18.94 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 176.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 179.15 -163.71 31.45 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 108.341 -1.904 . . . . 0.0 108.341 -176.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -136.55 152.85 50.95 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 121.005 -1.291 . . . . 0.0 108.506 171.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.7 mt . . . . . 0 C--N 1.322 -0.606 0 N-CA-C 103.897 -2.631 . . . . 0.0 103.897 178.821 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 35.7 t60 . . . . . 0 N--CA 1.45 -0.445 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.7 t -135.27 129.1 49.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 179.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -165.85 -164.99 0.76 Allowed 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.171 0.988 . . . . 0.0 108.512 -176.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.96 -172.26 55.18 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -160.38 154.33 22.9 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.326 0.65 . . . . 0.0 110.722 -176.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.4 t -82.26 163.54 21.77 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 168.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 20.3 ptp -102.06 -30.97 10.86 Favored 'General case' 0 C--O 1.232 0.156 0 O-C-N 121.524 -0.735 . . . . 0.0 110.444 169.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.92 -26.7 61.49 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.179 0.9 . . . . 0.0 111.737 173.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -133.25 -2.96 3.1 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -169.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.15 -174.68 46.7 Favored Glycine 0 CA--C 1.535 1.33 0 CA-C-N 119.088 0.858 . . . . 0.0 113.051 175.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.97 143.29 54.14 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.814 2.343 . . . . 0.0 110.424 172.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.51 176.94 5.65 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.138 0.575 . . . . 0.0 109.927 169.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 20.8 mm100 -63.34 -28.83 70.27 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.841 -0.537 . . . . 0.0 111.68 171.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 39.2 m80 60.54 -29.72 0.05 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 128.767 2.827 . . . . 0.0 116.311 -175.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.38 -43.08 99.67 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.21 1.004 . . . . 0.0 110.681 173.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 69.1 mt -60.79 -44.41 97.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 177.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.95 -53.46 56.99 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.328 1.051 . . . . 0.0 110.105 -177.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.3 p -63.86 -44.73 92.25 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 117.7 -1.143 . . . . 0.0 110.123 -173.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -58.1 -40.73 81.92 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 120.215 1.37 . . . . 0.0 111.163 -179.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 36.3 mttm -69.82 -44.47 69.92 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 121.782 -0.574 . . . . 0.0 111.061 178.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 58.7 mt -64.65 -43.23 96.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 118.79 0.723 . . . . 0.0 109.115 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 93.6 mttt . . . . . 0 N--CA 1.467 0.407 0 CA-C-N 119.605 1.093 . . . . 0.0 109.976 175.968 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.2 t . . . . . 0 CA--C 1.536 0.408 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 19.8 p -129.3 168.51 16.13 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.784 0.834 . . . . 0.0 110.219 175.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 43.9 p-90 . . . . . 0 C--O 1.235 0.322 0 O-C-N 121.742 -0.599 . . . . 0.0 109.728 169.879 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.508 0 CA-C-O 121.127 0.489 . . . . 0.0 110.389 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -149.84 146.16 26.97 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 169.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 80.9 mt -55.11 -33.32 62.74 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.83 0.852 . . . . 0.0 112.657 -175.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.74 -25.69 67.4 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.087 0.858 . . . . 0.0 112.341 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.2 mt -78.54 -25.51 45.51 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.189 0.596 . . . . 0.0 111.094 -178.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.8 mt -70.6 131.38 88.02 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -172.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -49.57 119.93 5.24 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 123.525 2.817 . . . . 0.0 111.359 169.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -74.04 -29.88 62.14 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.15 0.5 . . . . 0.0 111.49 -176.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.9 t -141.84 131.54 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 174.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -149.39 111.35 4.59 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 169.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.9 pt . . . . . 0 C--O 1.234 0.269 0 C-N-CA 124.01 0.924 . . . . 0.0 109.7 -169.651 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 . . . . . 0 C--O 1.235 0.319 0 CA-C-O 121.477 0.655 . . . . 0.0 111.892 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -65.55 156.18 33.42 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 124.834 1.254 . . . . 0.0 111.684 -169.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.473 ' HH ' ' CD2' ' A' ' 102' ' ' HIS . 0.2 OUTLIER -147.17 161.17 41.44 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.082 1.353 . . . . 0.0 108.257 171.573 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.5 m -130.0 154.62 40.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 C-N-CA 124.782 1.233 . . . . 0.0 109.803 174.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.05 115.65 30.52 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 104.212 -2.514 . . . . 0.0 104.212 176.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 73.3 mt -119.65 124.51 73.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -173.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -81.41 145.08 30.98 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 169.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.2 t -129.68 143.44 41.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 -175.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -130.96 132.97 45.39 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 -178.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.0 t -66.43 118.66 10.38 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -175.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.401 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -151.05 32.06 0.06 OUTLIER Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 126.163 1.785 . . . . 0.0 109.77 168.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 30' ' ' ALA . 44.8 Cg_endo . . . . . 0 C--N 1.357 1.012 0 CA-C-N 121.913 1.719 . . . . 0.0 111.458 -171.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 . . . . . 0 CA--C 1.541 0.62 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.4 m -137.55 161.88 35.23 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.303 1.041 . . . . 0.0 110.112 177.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.6 tttp -148.85 165.45 31.46 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.533 2.333 . . . . 0.0 106.137 -174.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -137.52 140.15 40.93 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 106.09 -1.818 . . . . 0.0 106.09 175.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 41.2 pt -134.3 156.83 41.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 124.218 1.007 . . . . 0.0 110.724 -172.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 95.7 t -121.55 118.75 56.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 -177.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 27.2 mmt85 -136.02 144.23 45.17 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 177.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.22 135.57 2.42 Favored Glycine 0 C--N 1.331 0.284 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 -178.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -153.58 160.94 42.59 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 117.356 0.578 . . . . 0.0 110.122 -169.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.5 mtmm -59.88 -33.86 72.39 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -179.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.433 ' CH2' ' HE2' ' A' ' 59' ' ' LYS . 9.5 p-90 -68.66 -24.23 64.5 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.835 0.743 . . . . 0.0 112.634 -179.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.47 82.13 8.54 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 119.588 1.085 . . . . 0.0 109.297 176.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -65.45 -19.38 65.91 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.44 171.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -133.89 148.68 51.27 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 126.048 1.739 . . . . 0.0 108.137 -178.058 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -72.56 -30.97 64.89 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 121.925 -0.485 . . . . 0.0 109.897 -171.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.01 -28.64 53.66 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 118.082 -0.961 . . . . 0.0 112.776 172.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -65.53 -55.85 15.53 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.669 1.122 . . . . 0.0 109.583 -179.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -66.07 -34.62 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-O 117.355 -1.307 . . . . 0.0 110.687 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -60.98 -53.59 55.38 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 120.104 1.32 . . . . 0.0 109.506 175.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -60.37 -42.91 96.77 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.983 0.81 . . . . 0.0 111.896 -178.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.433 ' HE2' ' CH2' ' A' ' 49' ' ' TRP . 0.0 OUTLIER -59.28 -55.54 33.51 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.221 1.008 . . . . 0.0 110.209 178.589 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 89.9 t -77.62 -43.77 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-O 117.801 -1.095 . . . . 0.0 109.881 -169.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.7 p -63.81 -31.26 72.39 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 120.709 1.595 . . . . 0.0 109.937 175.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.29 -51.31 59.57 Favored Glycine 0 C--N 1.337 0.636 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 171.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -61.71 -44.53 96.74 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 118.835 1.318 . . . . 0.0 111.68 178.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.451 ' HG3' ' HG ' ' A' ' 71' ' ' CYS . 38.4 mmt -59.12 -46.96 86.98 Favored 'General case' 0 C--O 1.227 -0.081 0 CA-C-O 119.231 -0.414 . . . . 0.0 110.045 177.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -69.27 -28.27 66.15 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.654 0.661 . . . . 0.0 112.152 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -67.59 -37.41 82.53 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.342 0.974 . . . . 0.0 110.255 170.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -68.25 -31.01 70.2 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.772 1.169 . . . . 0.0 110.106 169.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 127.5 -23.43 5.41 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 127.93 2.681 . . . . 0.0 111.662 174.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 95.8 m -55.92 154.42 7.36 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 126.404 1.882 . . . . 0.0 112.602 -177.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -112.49 145.47 40.18 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.909 1.284 . . . . 0.0 108.066 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.451 ' HG ' ' HG3' ' A' ' 64' ' ' MET . 74.9 m -144.64 164.33 31.29 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -168.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -149.02 130.57 14.88 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.289 1.435 . . . . 0.0 107.713 171.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.6 p -75.06 114.73 13.89 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 169.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 39.7 mt -68.65 -25.33 64.77 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.823 -0.548 . . . . 0.0 110.374 176.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.14 -164.88 37.83 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 175.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -154.32 -175.5 25.58 Favored Glycine 0 N--CA 1.452 -0.268 0 N-CA-C 111.509 -0.636 . . . . 0.0 111.509 171.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -171.49 -153.71 9.26 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 108.488 -1.845 . . . . 0.0 108.488 -176.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -143.25 142.96 31.55 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 -174.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 61.7 mt . . . . . 0 C--O 1.235 0.315 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -171.312 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 31.5 t60 . . . . . 0 C--O 1.232 0.184 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.9 t -141.41 133.62 28.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 173.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -157.17 -170.04 3.14 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.221 1.008 . . . . 0.0 108.726 -178.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.28 -175.46 45.89 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-N 118.619 0.645 . . . . 0.0 112.145 176.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -162.33 149.4 13.64 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.532 1.133 . . . . 0.0 110.546 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.6 t -71.63 166.2 22.38 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 168.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.5 ptm -111.5 -29.86 7.6 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 118.485 -0.769 . . . . 0.0 111.051 170.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -73.59 -25.55 60.4 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.574 1.079 . . . . 0.0 111.407 172.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -132.65 -9.47 3.18 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.05 0.94 . . . . 0.0 113.037 -169.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 78.68 -176.66 54.37 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-N 118.773 0.715 . . . . 0.0 113.71 171.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.43 137.2 42.31 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.059 2.506 . . . . 0.0 110.482 175.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -78.01 168.8 19.32 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 169.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -77.76 84.69 4.08 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 168.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.473 ' CD2' ' HH ' ' A' ' 22' ' ' TYR . 39.7 m80 -57.86 -13.86 5.09 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -175.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.03 -41.46 96.61 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.651 1.18 . . . . 0.0 110.978 170.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 56.2 mt -65.46 -47.43 86.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 177.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.97 -49.68 76.94 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.066 0.946 . . . . 0.0 110.703 -176.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.4 p -64.4 -47.53 78.82 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 118.182 -0.913 . . . . 0.0 110.989 -176.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -60.01 -40.38 89.07 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.52 1.055 . . . . 0.0 110.537 -178.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 52.9 mttm -67.29 -46.22 74.26 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-O 118.935 -0.555 . . . . 0.0 111.476 177.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 63.8 mt -64.61 -39.87 87.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-N 119.432 1.015 . . . . 0.0 109.006 -179.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 92.3 mttt . . . . . 0 N--CA 1.469 0.509 0 CA-C-N 119.855 1.207 . . . . 0.0 109.514 175.063 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.4 t . . . . . 0 N--CA 1.454 -0.262 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 16.6 p -134.69 174.42 10.59 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.478 1.111 . . . . 0.0 108.914 174.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 47.5 p-90 . . . . . 0 C--O 1.235 0.318 0 O-C-N 121.669 -0.644 . . . . 0.0 110.657 171.271 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.397 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -146.73 146.59 30.37 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 169.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 51.0 mt -58.99 -29.22 67.06 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -173.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.61 -26.41 66.24 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.113 0.87 . . . . 0.0 111.883 177.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.7 mt -82.69 -24.18 33.79 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.654 0.782 . . . . 0.0 111.191 -177.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 51.3 mt -65.46 129.01 94.27 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -178.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -44.82 120.72 3.0 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 124.141 3.227 . . . . 0.0 111.599 172.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -78.75 -32.94 46.86 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.283 0.563 . . . . 0.0 111.139 -170.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.2 t -136.85 140.26 43.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 105.091 -2.188 . . . . 0.0 105.091 172.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -151.77 130.15 12.1 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 170.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.9 pt . . . . . 0 CA--C 1.537 0.477 0 C-N-CA 126.873 2.069 . . . . 0.0 106.9 -178.355 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.4 p90 . . . . . 0 N--CA 1.464 0.24 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -77.1 154.98 32.74 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.521 0.728 . . . . 0.0 110.377 -177.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.31 162.51 37.97 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.0 1.32 . . . . 0.0 108.164 179.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.8 m -132.7 154.31 39.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 124.418 1.087 . . . . 0.0 109.488 172.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.35 119.22 38.88 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 104.293 -2.484 . . . . 0.0 104.293 176.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.2 mt -122.26 123.79 69.57 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -173.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.438 ' HE ' ' CE1' ' A' ' 28' ' ' HIS . 36.9 ttp-105 -77.36 147.59 36.03 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 169.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.8 t -133.29 143.72 38.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 -178.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.438 ' CE1' ' HE ' ' A' ' 26' ' ' ARG . 99.9 m-70 -123.68 145.06 49.25 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 125.021 1.329 . . . . 0.0 107.913 174.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.0 m -62.07 107.93 0.96 Allowed 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.439 0.696 . . . . 0.0 110.635 177.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -148.9 29.1 0.05 OUTLIER Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 124.823 1.249 . . . . 0.0 112.404 169.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo . . . . . 0 CA--C 1.545 1.075 0 C-N-CA 123.489 2.792 . . . . 0.0 115.84 -169.809 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 . . . . . 0 CA--C 1.54 0.563 0 CA-C-O 121.527 0.68 . . . . 0.0 109.812 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.6 m -140.92 158.54 43.79 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.822 1.249 . . . . 0.0 108.463 173.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -153.06 170.75 19.7 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 126.894 2.078 . . . . 0.0 106.296 -171.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.401 ' HB2' ' HE3' ' A' ' 108' ' ' LYS . 17.7 mp0 -134.08 157.16 46.85 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 169.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 32.6 pt -132.46 155.39 41.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 125.344 1.458 . . . . 0.0 109.508 178.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 56.7 t -116.9 121.35 67.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 177.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.8 mmp_? -127.52 141.1 51.74 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 177.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -171.64 136.6 3.94 Favored Glycine 0 C--N 1.329 0.192 0 CA-C-N 119.538 1.063 . . . . 0.0 110.609 170.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -153.85 148.55 26.39 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -173.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.5 pttm -54.99 -31.08 60.66 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.355 1.462 . . . . 0.0 113.236 173.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 11.8 p-90 -68.92 -28.71 66.91 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.29 0.95 . . . . 0.0 112.044 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.79 73.6 10.28 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 119.278 0.944 . . . . 0.0 109.235 174.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -65.94 -6.82 13.7 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.861 0.864 . . . . 0.0 111.457 174.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -137.14 144.09 42.8 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.621 1.968 . . . . 0.0 106.809 173.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 44.1 m-70 -70.34 -31.37 68.63 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -171.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.29 -29.84 35.45 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 118.529 -0.748 . . . . 0.0 112.652 172.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -68.85 -48.57 63.14 Favored 'General case' 0 C--N 1.341 0.199 0 CA-C-N 119.39 0.995 . . . . 0.0 111.097 -174.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.36 -41.68 91.82 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.018 176.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -61.83 -50.72 71.15 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 119.296 -0.962 . . . . 0.0 109.668 -178.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -61.13 -44.43 97.34 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.125 0.875 . . . . 0.0 111.91 -178.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 30.5 tttt -59.9 -50.32 74.23 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.315 0.646 . . . . 0.0 110.895 178.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.4 t -85.71 -33.6 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-O 117.572 -1.204 . . . . 0.0 111.401 -169.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 84.6 p -61.57 -36.71 81.41 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 121.306 1.866 . . . . 0.0 109.179 169.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -56.63 -52.47 50.27 Favored Glycine 0 C--N 1.34 0.753 0 C-N-CA 124.218 0.913 . . . . 0.0 111.141 170.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -60.73 -45.16 95.32 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 119.14 1.47 . . . . 0.0 111.854 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.501 ' HG3' ' HG ' ' A' ' 71' ' ' CYS . 35.2 mmt -59.46 -47.03 87.04 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.998 0.519 . . . . 0.0 109.787 178.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -68.17 -30.08 69.11 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.536 0.734 . . . . 0.0 111.937 178.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -66.59 -37.94 85.97 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 119.511 1.051 . . . . 0.0 110.278 171.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -64.62 -46.15 83.83 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.746 1.157 . . . . 0.0 108.486 169.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 142.17 -21.49 2.45 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 127.872 2.653 . . . . 0.0 111.204 174.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 80.8 m -54.65 148.36 12.75 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 126.891 2.076 . . . . 0.0 111.608 -176.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -108.56 141.47 40.42 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.501 ' HG ' ' HG3' ' A' ' 64' ' ' MET . 94.5 m -141.6 165.51 27.29 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -168.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -154.33 130.03 10.02 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.869 1.667 . . . . 0.0 107.431 171.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.1 p -69.82 123.77 22.3 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 169.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 33.9 mt -69.31 -28.3 66.14 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.933 -0.479 . . . . 0.0 109.969 172.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.98 -171.29 43.34 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 174.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -124.78 173.6 17.1 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 174.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -178.2 -164.96 32.2 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 108.254 -1.938 . . . . 0.0 108.254 -176.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 12.0 ptp180 -148.06 161.76 40.74 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 120.741 -1.447 . . . . 0.0 109.208 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 81.9 mt . . . . . 0 C--N 1.324 -0.538 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 -171.837 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 21.1 t60 . . . . . 0 C--O 1.233 0.187 0 N-CA-C 110.359 -0.237 . . . . 0.0 110.359 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.5 t -136.58 137.48 47.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 -177.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -164.96 -171.01 2.1 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.084 -1.01 . . . . 0.0 109.854 -174.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.69 -167.71 54.76 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-O 121.402 0.446 . . . . 0.0 112.278 169.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -158.36 173.2 17.02 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.315 1.046 . . . . 0.0 110.218 -172.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.0 t -107.17 164.0 12.53 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 127.033 2.133 . . . . 0.0 106.2 168.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 21.4 ptp -105.96 -29.89 9.67 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 118.547 -0.739 . . . . 0.0 110.881 172.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -73.12 -26.32 61.18 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.39 0.995 . . . . 0.0 111.563 172.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -132.0 -3.74 3.57 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -169.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 72.52 -177.14 41.01 Favored Glycine 0 CA--C 1.535 1.297 0 CA-C-N 118.908 0.776 . . . . 0.0 112.73 177.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.49 138.13 37.92 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.889 2.393 . . . . 0.0 110.916 175.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.96 176.47 5.69 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.297 0.639 . . . . 0.0 110.026 169.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 21.5 mm100 -65.7 -31.83 73.05 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 121.901 -0.499 . . . . 0.0 112.292 178.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 39.1 m80 61.63 -30.83 0.07 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 128.438 2.695 . . . . 0.0 115.972 -174.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.7 -44.46 96.18 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.224 1.01 . . . . 0.0 110.787 174.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 72.9 mt -60.47 -45.35 97.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 176.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.46 -52.24 66.07 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 124.61 1.164 . . . . 0.0 109.747 -174.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 22.6 p -67.09 -43.07 83.49 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 117.982 -1.009 . . . . 0.0 111.151 -174.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -59.38 -41.9 90.43 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.756 1.162 . . . . 0.0 110.386 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.401 ' HE3' ' HB2' ' A' ' 42' ' ' GLU . 42.1 mttm -66.77 -45.4 78.62 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 119.009 -0.519 . . . . 0.0 111.263 176.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 55.8 mt -63.44 -42.81 97.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 119.111 0.868 . . . . 0.0 108.992 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 92.3 mttt . . . . . 0 N--CA 1.47 0.53 0 CA-C-N 120.216 1.371 . . . . 0.0 109.455 176.26 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.454 -0.273 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 22.1 p -137.3 173.96 11.12 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.079 0.952 . . . . 0.0 108.848 172.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 52.1 p-90 . . . . . 0 C--O 1.235 0.297 0 O-C-N 121.988 -0.445 . . . . 0.0 110.6 173.727 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.541 0 CA-C-O 121.715 0.769 . . . . 0.0 111.454 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -151.27 151.59 32.04 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 126.677 1.991 . . . . 0.0 105.924 170.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 52.4 mt -55.44 -34.49 64.52 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.732 0.696 . . . . 0.0 112.656 -175.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.15 -25.86 64.59 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.744 0.702 . . . . 0.0 112.21 179.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.0 mt -81.83 -23.23 36.57 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.468 0.707 . . . . 0.0 111.178 -178.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.2 mt -64.84 128.03 93.23 Favored Pre-proline 0 CA--C 1.54 0.577 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 178.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -47.41 140.21 15.96 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.588 2.859 . . . . 0.0 111.249 170.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -89.78 -36.06 15.36 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 121.987 -0.446 . . . . 0.0 111.627 -170.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.4 t -140.99 138.96 34.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 124.866 1.266 . . . . 0.0 107.702 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 68.5 t0 -152.93 111.34 3.69 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 169.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 36.6 pt . . . . . 0 CA--C 1.537 0.459 0 C-N-CA 124.913 1.285 . . . . 0.0 109.439 -173.562 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 43.0 p90 . . . . . 0 C--O 1.235 0.328 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -80.05 155.88 27.36 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.91 163.61 32.92 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.997 1.319 . . . . 0.0 108.27 176.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.5 m -133.23 150.83 32.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 124.36 1.064 . . . . 0.0 109.589 172.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.05 117.0 33.6 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 104.139 -2.541 . . . . 0.0 104.139 175.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 76.5 mt -118.93 122.82 70.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 -175.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 36.2 ttp180 -79.46 147.49 32.25 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 169.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.8 t -133.73 145.01 34.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 104.762 -2.31 . . . . 0.0 104.762 -175.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -130.42 150.14 51.77 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.596 1.158 . . . . 0.0 108.129 -179.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.9 m -60.81 100.73 0.12 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.122 0.969 . . . . 0.0 111.773 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.456 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -144.59 17.78 0.04 OUTLIER Pre-proline 0 CA--C 1.554 1.111 0 CA-C-O 116.188 -1.863 . . . . 0.0 113.898 169.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.456 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 66.9 Cg_exo . . . . . 0 C--N 1.365 1.444 0 CA-C-N 123.702 2.358 . . . . 0.0 114.41 177.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 . . . . . 0 CA--C 1.536 0.416 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.1 m -142.76 159.23 42.64 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.786 0.834 . . . . 0.0 110.596 -173.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -151.07 165.95 32.24 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 127.625 2.37 . . . . 0.0 106.168 -174.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.5 mp0 -131.26 154.23 48.69 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 121.039 -1.038 . . . . 0.0 108.494 177.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 39.3 pt -135.26 156.18 38.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 125.277 1.431 . . . . 0.0 109.686 178.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 54.2 t -118.65 120.34 63.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 105.434 -2.062 . . . . 0.0 105.434 177.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.0 mmp_? -130.28 146.23 51.86 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 172.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -179.55 140.51 4.33 Favored Glycine 0 N--CA 1.454 -0.139 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 174.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -154.88 156.06 35.46 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -170.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.5 mmtm -53.05 -39.45 63.26 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.407 1.083 . . . . 0.0 112.026 174.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 12.8 p-90 -67.2 -27.72 67.49 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.519 0.6 . . . . 0.0 112.503 -176.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.96 80.32 9.05 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 119.295 0.952 . . . . 0.0 108.964 173.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -63.73 -18.52 64.11 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.254 0.621 . . . . 0.0 111.488 174.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -132.1 148.87 52.51 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 126.47 1.908 . . . . 0.0 108.043 178.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 37.3 m-70 -72.52 -32.26 65.99 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -170.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.85 -29.08 54.29 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 118.561 -0.733 . . . . 0.0 112.663 172.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -67.14 -49.66 64.04 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 119.338 0.972 . . . . 0.0 110.84 -175.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.8 -38.88 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 CA-C-O 117.557 -1.211 . . . . 0.0 109.995 174.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -60.36 -47.33 86.52 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 120.191 1.36 . . . . 0.0 110.404 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -63.67 -47.91 79.31 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.265 0.484 . . . . 0.0 111.507 179.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 40.9 tttt -62.63 -51.19 68.24 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 123.239 0.616 . . . . 0.0 111.315 -178.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 94.6 t -72.56 -46.33 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-O 118.189 -0.91 . . . . 0.0 108.967 -172.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 56.6 m -64.11 -27.26 68.97 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 120.157 1.344 . . . . 0.0 111.162 175.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.84 -51.28 56.88 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 170.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -60.73 -43.37 98.0 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.418 1.109 . . . . 0.0 111.638 178.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.52 ' HG3' ' HG ' ' A' ' 71' ' ' CYS . 37.5 mmt -59.62 -47.25 86.32 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 123.131 0.573 . . . . 0.0 110.011 177.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -69.48 -28.26 65.92 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.892 0.769 . . . . 0.0 112.066 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -66.92 -38.24 85.84 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 119.179 0.9 . . . . 0.0 110.112 169.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -69.48 -25.66 64.18 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 119.668 1.122 . . . . 0.0 110.496 169.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 118.84 -21.42 9.62 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 127.919 2.676 . . . . 0.0 112.456 175.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 92.2 m -53.08 149.59 6.61 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 126.112 1.765 . . . . 0.0 112.1 -178.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -108.48 138.65 44.43 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 177.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.52 ' HG ' ' HG3' ' A' ' 64' ' ' MET . 97.3 m -141.41 164.18 30.92 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -168.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -153.79 130.26 10.61 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.499 1.52 . . . . 0.0 107.49 174.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 5.9 p -70.92 122.1 19.34 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 169.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 41.9 mt -70.12 -25.67 63.6 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.861 -0.525 . . . . 0.0 109.941 170.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.93 -171.78 43.03 Favored Glycine 0 C--N 1.337 0.608 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 170.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -128.84 171.87 19.68 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 175.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -176.81 -162.71 27.84 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 108.6 -1.8 . . . . 0.0 108.6 -176.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -146.0 163.67 34.47 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 121.055 -1.262 . . . . 0.0 108.547 -178.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 81.4 mt . . . . . 0 C--N 1.324 -0.5 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 -170.596 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 54.2 t60 . . . . . 0 C--O 1.234 0.28 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 18.7 t -127.81 128.95 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.114 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -160.81 -172.4 3.48 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.236 -0.915 . . . . 0.0 111.132 -169.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 66.29 -166.21 38.14 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-O 121.425 0.459 . . . . 0.0 112.616 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -162.08 157.2 23.04 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.083 0.953 . . . . 0.0 110.502 -170.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.9 t -85.24 164.38 18.09 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 168.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.0 ptm -104.83 -31.8 9.12 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 118.625 -0.702 . . . . 0.0 110.646 169.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.8 -26.41 61.5 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.324 0.965 . . . . 0.0 111.556 174.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -132.46 -3.56 3.39 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.925 0.89 . . . . 0.0 113.089 -169.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.46 -177.3 43.74 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-N 118.779 0.718 . . . . 0.0 112.997 175.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -67.89 142.07 55.92 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.652 2.234 . . . . 0.0 110.41 172.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.19 173.89 9.5 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 122.369 1.08 . . . . 0.0 110.322 169.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -81.47 79.48 8.06 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 103.828 -2.656 . . . . 0.0 103.828 167.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 51.6 m80 -60.95 -13.74 18.04 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -169.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.86 -35.91 77.8 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.554 0.742 . . . . 0.0 111.622 172.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 83.8 mt -65.15 -44.16 95.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 177.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.87 -48.44 81.37 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.158 0.983 . . . . 0.0 110.684 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.4 p -66.38 -42.46 87.91 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 117.813 -1.089 . . . . 0.0 110.661 -177.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -58.22 -44.11 88.02 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 120.226 1.376 . . . . 0.0 110.772 177.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -69.13 -44.21 72.84 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.873 -0.517 . . . . 0.0 111.635 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 81.5 mt -71.55 -34.19 51.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 O-C-N 121.257 -0.902 . . . . 0.0 109.478 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 91.6 mttt . . . . . 0 N--CA 1.469 0.477 0 CA-C-N 119.684 1.129 . . . . 0.0 109.483 170.707 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.6 t . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 19.3 p -133.05 168.8 17.83 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.198 0.999 . . . . 0.0 108.676 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 57.9 p-90 . . . . . 0 C--O 1.234 0.268 0 CA-C-O 121.178 0.513 . . . . 0.0 111.802 173.733 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.451 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -141.95 142.41 33.0 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 169.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 81.5 mt -57.46 -32.36 66.87 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.734 0.814 . . . . 0.0 112.713 -171.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.84 -25.52 64.69 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.895 0.77 . . . . 0.0 112.1 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.5 mt -80.53 -24.92 38.99 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.37 0.668 . . . . 0.0 111.186 -177.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 41.0 mt -67.24 128.49 93.75 Favored Pre-proline 0 C--O 1.24 0.558 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -175.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -46.9 127.05 11.8 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.885 3.057 . . . . 0.0 111.341 171.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -81.4 -34.1 31.83 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 121.051 0.453 . . . . 0.0 111.311 -170.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.0 t -138.77 133.7 41.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 174.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -147.95 133.49 18.73 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 170.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 38.6 pt . . . . . 0 CA--C 1.537 0.461 0 C-N-CA 127.113 2.165 . . . . 0.0 106.102 -177.458 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 37.2 p90 . . . . . 0 N--CA 1.463 0.204 0 CA-C-O 120.777 0.322 . . . . 0.0 110.444 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.25 152.03 39.79 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.62 0.768 . . . . 0.0 109.35 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.98 161.15 41.94 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.296 1.038 . . . . 0.0 109.082 -178.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.4 m -131.21 153.69 39.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 C-N-CA 124.4 1.08 . . . . 0.0 110.097 173.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -108.39 115.02 29.34 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 104.345 -2.465 . . . . 0.0 104.345 177.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 54.4 mt -119.37 124.53 73.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 -172.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -78.55 148.97 33.16 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 169.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.5 t -133.56 148.17 30.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 105.55 -2.019 . . . . 0.0 105.55 -179.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -129.59 156.2 44.58 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.806 1.243 . . . . 0.0 109.357 -178.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.1 m -68.75 44.41 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.1 1.76 . . . . 0.0 114.626 178.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -72.7 -9.41 0.15 Allowed Pre-proline 0 CA--C 1.557 1.234 0 N-CA-C 117.846 2.535 . . . . 0.0 117.846 170.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo . . . . . 0 C--N 1.362 1.262 0 C-N-CA 123.82 3.013 . . . . 0.0 116.67 -177.612 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 . . . . . 0 CA--C 1.539 0.53 0 CA-C-O 121.453 0.644 . . . . 0.0 109.34 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.5 m -141.16 160.36 40.26 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.61 1.164 . . . . 0.0 108.984 171.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -149.59 169.83 20.07 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 127.338 2.255 . . . . 0.0 106.457 -173.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.1 mp0 -133.27 152.79 51.94 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 176.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 38.9 pt -133.96 155.73 40.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 125.551 1.54 . . . . 0.0 109.589 178.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 89.1 t -117.08 120.09 63.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 105.696 -1.965 . . . . 0.0 105.696 177.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 10.4 mmp_? -127.69 142.17 51.41 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 174.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -172.63 139.84 5.42 Favored Glycine 0 C--N 1.332 0.321 0 CA-C-N 119.429 1.013 . . . . 0.0 111.412 172.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.423 ' CD2' ' CZ2' ' A' ' 49' ' ' TRP . 30.1 m-85 -154.81 156.61 36.54 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.673 0.789 . . . . 0.0 109.893 -171.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.3 mttp -67.68 -32.02 72.39 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 118.793 -0.622 . . . . 0.0 111.007 175.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.423 ' CZ2' ' CD2' ' A' ' 47' ' ' TYR . 14.5 p-90 -62.57 -30.86 71.63 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.723 0.692 . . . . 0.0 111.575 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.73 71.04 6.68 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.357 0.663 . . . . 0.0 109.47 171.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -61.33 -18.3 57.94 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.502 0.721 . . . . 0.0 111.454 176.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -125.02 146.97 49.18 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 126.466 1.906 . . . . 0.0 107.764 176.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 60.9 m80 -73.12 -31.35 64.26 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 122.887 0.475 . . . . 0.0 110.441 -169.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.02 -30.83 49.21 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 118.612 -0.709 . . . . 0.0 112.4 172.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -69.67 -49.13 56.49 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 119.321 0.964 . . . . 0.0 111.084 -176.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.79 -40.18 86.94 Favored 'Isoleucine or valine' 0 C--N 1.342 0.274 0 CA-C-O 117.518 -1.23 . . . . 0.0 109.699 175.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -59.98 -50.55 73.29 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 119.726 1.148 . . . . 0.0 109.96 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -61.14 -45.35 95.02 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 119.059 0.845 . . . . 0.0 112.028 -178.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 30.7 tttt -61.4 -49.09 78.28 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 122.912 0.485 . . . . 0.0 110.574 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 85.0 t -78.91 -39.42 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 117.692 -1.146 . . . . 0.0 109.954 -170.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 91.5 p -61.42 -39.23 90.02 Favored 'General case' 0 C--N 1.339 0.122 0 CA-C-N 120.757 1.617 . . . . 0.0 109.13 174.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -57.28 -51.66 56.23 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 123.948 0.785 . . . . 0.0 111.363 172.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -61.73 -46.31 90.19 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 118.943 1.372 . . . . 0.0 111.68 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.5 ' HG3' ' HG ' ' A' ' 71' ' ' CYS . 36.0 mmt -59.41 -47.52 85.14 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.349 0.66 . . . . 0.0 110.456 177.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -62.84 -35.82 81.21 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.788 0.835 . . . . 0.0 111.279 177.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -66.38 -35.5 80.5 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 118.043 -0.98 . . . . 0.0 111.302 172.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -71.73 -17.51 62.2 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 119.972 1.26 . . . . 0.0 112.159 170.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.37 -8.57 41.19 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.696 1.617 . . . . 0.0 112.543 178.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 90.4 m -65.96 165.44 13.2 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.636 1.218 . . . . 0.0 110.863 176.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -125.33 148.3 48.79 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 170.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.5 ' HG ' ' HG3' ' A' ' 64' ' ' MET . 65.9 m -145.31 165.34 28.73 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -168.307 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -149.22 137.64 20.9 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.811 1.645 . . . . 0.0 106.921 169.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.4 p -77.69 115.48 17.47 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 169.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 36.9 mt -67.99 -24.43 65.13 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 121.981 -0.449 . . . . 0.0 110.149 174.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.92 -165.73 38.69 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 170.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -147.7 178.84 25.04 Favored Glycine 0 CA--C 1.519 0.318 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 172.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -176.29 -157.84 18.41 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 107.546 -2.221 . . . . 0.0 107.546 -176.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 31.0 ptt-85 -137.02 157.78 45.95 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 120.616 -1.52 . . . . 0.0 108.811 173.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 97.4 mt . . . . . 0 C--N 1.322 -0.597 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 -177.517 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 24.5 t60 . . . . . 0 N--CA 1.455 -0.199 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.6 t -137.37 124.89 30.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -164.48 -178.3 5.33 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 121.468 -0.77 . . . . 0.0 109.909 -172.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.49 -174.04 55.19 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -178.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -157.3 155.79 31.31 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.05 0.54 . . . . 0.0 111.958 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.1 t -75.81 164.67 26.0 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 168.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.3 ptm -108.53 -30.5 8.22 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 118.492 -0.766 . . . . 0.0 111.122 170.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.06 -26.06 60.18 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.551 1.069 . . . . 0.0 111.431 173.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -131.91 -7.42 3.53 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.915 0.886 . . . . 0.0 113.015 -169.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.92 -177.13 52.49 Favored Glycine 0 CA--C 1.535 1.293 0 CA-C-N 118.673 0.669 . . . . 0.0 113.607 171.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.08 135.65 38.16 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.092 2.528 . . . . 0.0 110.404 176.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.04 167.94 20.95 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.131 0.491 . . . . 0.0 110.128 169.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 -78.92 82.63 5.1 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 168.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -57.57 -15.09 6.34 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -176.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.55 -43.96 80.42 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.22 1.408 . . . . 0.0 111.215 169.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 64.1 mt -64.58 -47.12 90.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.91 -50.94 71.63 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.777 0.831 . . . . 0.0 110.923 -176.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.6 p -65.05 -46.95 79.13 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.593 -174.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -60.04 -40.2 88.56 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.311 0.959 . . . . 0.0 110.592 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -66.39 -47.52 73.06 Favored 'General case' 0 CA--C 1.528 0.12 0 O-C-N 121.86 -0.525 . . . . 0.0 111.457 176.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 61.7 mt -64.82 -40.25 88.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 119.369 0.986 . . . . 0.0 109.128 -177.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 92.8 mttt . . . . . 0 N--CA 1.469 0.475 0 CA-C-N 119.449 1.022 . . . . 0.0 109.551 174.852 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.5 t . . . . . 0 N--CA 1.454 -0.275 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.3 p -134.53 171.59 14.1 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.481 1.112 . . . . 0.0 109.4 176.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 27.6 p-90 . . . . . 0 C--O 1.234 0.276 0 O-C-N 121.674 -0.641 . . . . 0.0 110.709 173.984 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.442 0 CA-C-O 121.499 0.666 . . . . 0.0 110.785 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -152.93 152.12 31.11 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 170.235 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 57.0 mt -53.54 -36.88 62.29 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 118.627 0.649 . . . . 0.0 112.12 -178.165 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.56 -25.21 68.13 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.871 0.759 . . . . 0.0 112.509 -179.09 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.4 mt -83.57 -20.81 33.11 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.316 0.646 . . . . 0.0 111.561 -176.961 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 24.0 mt -68.07 128.94 93.26 Favored Pre-proline 0 CA--C 1.539 0.527 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -177.085 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -50.81 117.94 3.76 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 123.337 2.691 . . . . 0.0 110.705 169.705 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -73.01 -34.37 66.34 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 122.65 0.38 . . . . 0.0 111.532 -171.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.7 t -141.64 123.06 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 177.847 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -143.58 107.68 4.74 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 106.86 -1.534 . . . . 0.0 106.86 171.35 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.6 pt . . . . . 0 CA--C 1.532 0.256 0 C-N-CA 123.599 0.76 . . . . 0.0 110.49 -169.794 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 . . . . . 0 C--O 1.238 0.465 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -73.76 162.91 28.64 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.219 1.008 . . . . 0.0 112.548 -170.277 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -151.3 163.41 38.97 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.514 1.926 . . . . 0.0 108.006 169.813 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.3 m -131.07 155.9 42.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 124.756 1.222 . . . . 0.0 109.816 172.125 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.1 117.67 34.75 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 178.233 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 69.1 mt -121.49 113.85 40.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -171.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.5 ttm-85 -69.88 142.41 53.01 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 168.699 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.8 p -140.86 147.81 22.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -122.13 151.77 40.6 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.929 1.292 . . . . 0.0 109.347 -174.61 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 56.0 m -62.51 93.28 0.05 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.094 0.958 . . . . 0.0 110.955 172.376 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.404 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -138.87 24.3 0.07 OUTLIER Pre-proline 0 CA--C 1.552 1.027 0 CA-C-O 116.767 -1.587 . . . . 0.0 114.015 169.442 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.404 ' CD ' ' N ' ' A' ' 30' ' ' ALA . 83.5 Cg_exo . . . . . 0 C--N 1.359 1.091 0 CA-C-N 123.774 2.383 . . . . 0.0 113.606 172.409 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 . . . . . 0 CA--C 1.541 0.633 0 CA-C-O 121.455 0.645 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.4 m -141.89 160.98 39.09 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.097 1.359 . . . . 0.0 109.004 176.659 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.8 tttt -148.24 165.77 29.96 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 126.963 2.105 . . . . 0.0 107.117 -174.462 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -125.64 131.38 52.65 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 169.782 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 44.2 pt -112.85 159.59 12.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 125.414 1.486 . . . . 0.0 110.569 174.068 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 25.0 t -126.24 121.77 59.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 -173.63 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 26.4 mmt85 -139.34 147.02 40.98 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.382 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.53 135.71 2.49 Favored Glycine 0 C--N 1.331 0.305 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 -179.656 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -153.57 155.71 36.65 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -171.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -59.36 -29.98 68.07 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -179.049 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 8.9 p-90 -68.46 -23.75 64.62 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.78 0.718 . . . . 0.0 112.4 -179.481 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.03 78.61 8.7 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 119.346 0.975 . . . . 0.0 110.085 177.064 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -62.3 -18.39 61.2 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.943 0.897 . . . . 0.0 111.468 172.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -128.1 143.15 51.05 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.771 1.629 . . . . 0.0 106.888 178.829 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -65.08 -30.92 71.92 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 118.478 0.581 . . . . 0.0 109.828 176.623 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.54 -29.35 58.78 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 118.484 -0.77 . . . . 0.0 112.788 171.445 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -68.71 -49.5 58.4 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.559 1.072 . . . . 0.0 110.476 -175.255 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.93 -38.08 80.68 Favored 'Isoleucine or valine' 0 C--N 1.34 0.18 0 CA-C-O 117.859 -1.067 . . . . 0.0 110.157 175.8 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -61.95 -47.67 83.82 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 119.776 1.171 . . . . 0.0 110.275 179.036 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -61.96 -46.71 88.09 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.319 0.509 . . . . 0.0 111.362 179.163 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 32.6 tttt -62.92 -54.8 32.9 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 123.027 0.531 . . . . 0.0 111.078 -179.451 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 86.2 t -72.3 -49.3 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-O 118.183 -0.913 . . . . 0.0 109.161 -170.549 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.8 m -65.45 -28.27 69.11 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 120.048 1.294 . . . . 0.0 110.992 178.866 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.13 -49.29 76.4 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 170.219 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -62.45 -44.3 96.73 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 118.734 1.267 . . . . 0.0 111.304 177.458 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 39.2 mmt -55.99 -49.34 73.88 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-O 119.133 -0.461 . . . . 0.0 110.032 175.183 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -66.75 -29.11 69.0 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.965 0.802 . . . . 0.0 112.281 179.598 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -67.59 -37.33 82.43 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.718 1.144 . . . . 0.0 110.511 171.014 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -69.1 -27.5 65.65 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 119.546 1.066 . . . . 0.0 110.479 169.549 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 122.37 -25.72 6.55 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 127.914 2.673 . . . . 0.0 111.215 177.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 95.9 m -54.16 142.92 24.14 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 126.732 2.013 . . . . 0.0 110.792 -175.538 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -108.84 142.0 40.06 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -176.219 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 85.7 m -137.57 165.55 26.05 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 -167.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -153.03 125.74 8.31 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.864 2.066 . . . . 0.0 107.124 173.748 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.8 p -73.55 124.71 26.42 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 169.435 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 35.1 mt -71.41 -25.74 62.46 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.796 -0.565 . . . . 0.0 110.257 172.38 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 162.69 -165.34 36.22 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 108.477 -1.849 . . . . 0.0 108.477 177.89 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -148.04 173.35 28.11 Favored Glycine 0 CA--C 1.519 0.329 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 173.624 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -168.36 -160.23 15.7 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 108.501 -1.84 . . . . 0.0 108.501 -178.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 35.6 ptt-85 -136.4 160.16 39.58 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 121.084 -1.245 . . . . 0.0 108.057 177.357 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 86.5 mt . . . . . 0 C--N 1.325 -0.487 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 -170.803 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 23.7 t60 . . . . . 0 C--O 1.232 0.132 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.1 t -145.45 133.94 16.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 176.274 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -169.74 -176.97 2.54 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.07 0.948 . . . . 0.0 109.302 -179.416 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 102.71 -170.06 19.77 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.407 -0.677 . . . . 0.0 111.407 173.824 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -157.92 151.51 23.67 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.858 0.863 . . . . 0.0 109.833 179.48 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.8 t -84.36 148.24 26.73 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 168.678 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 4.5 ptt? -76.27 -41.06 50.15 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 169.795 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.26 -25.14 54.66 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 118.881 -0.581 . . . . 0.0 112.246 -173.19 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -135.05 -1.83 2.62 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -169.619 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.04 -178.08 49.46 Favored Glycine 0 CA--C 1.535 1.297 0 CA-C-N 119.141 0.882 . . . . 0.0 113.089 176.415 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.86 139.57 33.59 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.999 2.466 . . . . 0.0 110.129 175.181 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.49 170.49 16.46 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.045 0.538 . . . . 0.0 110.58 169.758 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -78.4 84.0 4.59 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 168.605 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 48.5 m80 -57.95 -14.14 5.82 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -175.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.78 -41.1 85.86 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.429 1.492 . . . . 0.0 111.937 169.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 67.7 mt -65.8 -45.07 92.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.856 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.61 -49.38 76.62 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.354 1.061 . . . . 0.0 110.917 -179.006 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.4 p -63.19 -48.58 77.77 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 118.295 -0.86 . . . . 0.0 110.763 -176.438 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -60.08 -39.3 85.59 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.248 0.931 . . . . 0.0 110.764 -177.33 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 52.9 mttm -71.24 -45.05 64.11 Favored 'General case' 0 CA--C 1.528 0.112 0 O-C-N 121.839 -0.538 . . . . 0.0 111.817 178.652 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 73.9 mt -65.73 -38.29 81.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-N 119.363 0.983 . . . . 0.0 108.943 -179.444 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 92.7 mttt . . . . . 0 N--CA 1.468 0.431 0 CA-C-N 119.471 1.032 . . . . 0.0 109.115 171.905 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 C--O 1.235 0.293 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.7 p -133.01 169.9 16.16 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.353 1.061 . . . . 0.0 109.76 177.606 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 41.6 p-90 . . . . . 0 C--O 1.235 0.339 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 171.231 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.3 mmt . . . . . 0 N--CA 1.482 1.164 0 CA-C-O 121.74 0.781 . . . . 0.0 111.037 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.52 164.57 31.21 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 126.665 1.986 . . . . 0.0 105.958 169.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.6 p -138.69 120.46 17.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 175.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.54 174.57 4.06 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.98 0.895 . . . . 0.0 110.281 175.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -148.74 149.94 32.26 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 105.053 -2.202 . . . . 0.0 105.053 169.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 17.0 mt -60.23 -26.93 66.78 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -171.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.58 -28.06 65.64 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.888 0.767 . . . . 0.0 112.434 175.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.8 mt -79.3 -28.08 42.19 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 123.334 0.654 . . . . 0.0 111.149 -177.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 39.9 mt -64.85 128.0 93.22 Favored Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -47.16 130.31 16.56 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.41 2.74 . . . . 0.0 110.944 171.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -81.74 -37.63 26.97 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.357 0.599 . . . . 0.0 110.922 -173.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 43.8 t -134.73 135.13 53.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 170.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -152.93 123.54 7.27 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 169.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 20.2 pt -148.57 159.33 6.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 125.601 1.56 . . . . 0.0 107.334 -171.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -126.42 102.13 7.01 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 170.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.6 m -116.83 131.94 56.82 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.499 1.12 . . . . 0.0 111.354 -168.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -159.05 40.15 0.22 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.02 0.928 . . . . 0.0 110.775 171.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 155.48 -119.53 0.93 Allowed Glycine 0 C--N 1.339 0.746 0 O-C-N 120.91 -1.119 . . . . 0.0 111.333 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 91.1 t -123.98 122.77 65.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 126.836 2.054 . . . . 0.0 106.275 -177.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -161.1 156.17 24.11 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.281 1.032 . . . . 0.0 108.786 -175.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -81.8 155.83 25.22 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 123.213 0.605 . . . . 0.0 110.772 -172.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -144.54 160.42 41.14 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.73 1.212 . . . . 0.0 108.174 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.1 m -132.85 152.34 35.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 C-N-CA 124.299 1.04 . . . . 0.0 109.169 173.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.36 123.65 47.22 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 103.654 -2.721 . . . . 0.0 103.654 173.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.7 mt -125.55 121.16 59.53 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 -177.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 23.1 ttp180 -76.64 143.47 40.12 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 169.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.2 t -133.66 142.45 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 C-N-CA 128.568 2.747 . . . . 0.0 104.593 -172.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -127.77 151.95 48.37 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.164 0.985 . . . . 0.0 108.806 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 39.1 m -63.7 90.74 0.06 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.997 0.919 . . . . 0.0 111.48 175.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.419 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -136.32 19.21 0.05 OUTLIER Pre-proline 0 CA--C 1.552 1.025 0 CA-C-O 116.473 -1.727 . . . . 0.0 113.201 168.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' A' ' 30' ' ' ALA . 77.0 Cg_exo -46.67 147.26 4.63 Favored 'Trans proline' 0 C--N 1.362 1.284 0 CA-C-N 123.915 2.434 . . . . 0.0 113.064 172.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.9 mmm180 52.1 10.26 0.12 Allowed 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -173.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.8 m 52.1 29.09 5.99 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.291 1.036 . . . . 0.0 110.957 -169.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -164.17 3.03 0.06 OUTLIER Glycine 0 C--N 1.344 0.973 0 CA-C-O 118.445 -1.197 . . . . 0.0 114.984 -169.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.08 137.4 73.63 Favored Pre-proline 0 CA--C 1.544 0.731 0 CA-C-N 119.617 1.708 . . . . 0.0 109.586 169.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.23 -19.91 14.97 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.708 2.272 . . . . 0.0 112.967 -175.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.44 159.41 18.44 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.725 0.81 . . . . 0.0 110.762 176.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -142.88 35.39 1.4 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.338 1.455 . . . . 0.0 109.295 177.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -79.65 177.16 9.08 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.672 0.789 . . . . 0.0 109.437 176.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 12.5 m -140.28 158.55 43.85 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.503 1.121 . . . . 0.0 108.66 170.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -150.95 165.4 33.83 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 127.284 2.233 . . . . 0.0 105.822 -173.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.9 mp0 -128.72 147.87 50.8 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 176.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.3 pt -127.11 154.38 37.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 124.623 1.169 . . . . 0.0 109.456 176.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.0 t -117.66 119.28 61.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 178.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.9 mmp_? -129.49 145.28 51.46 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.007 1.323 . . . . 0.0 107.454 176.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.98 134.43 2.32 Favored Glycine 0 N--CA 1.452 -0.282 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 177.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -151.92 150.2 29.78 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -170.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -60.69 -27.57 67.96 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 118.88 -0.581 . . . . 0.0 112.407 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 11.3 p-90 -69.72 -26.16 64.2 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.259 0.936 . . . . 0.0 113.02 176.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.02 82.27 7.68 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 119.926 1.239 . . . . 0.0 109.667 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -66.34 -12.45 56.79 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.029 0.932 . . . . 0.0 111.884 176.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -142.06 152.01 42.92 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.522 1.929 . . . . 0.0 107.946 178.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -73.9 -32.88 63.78 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 121.692 -0.63 . . . . 0.0 110.308 -170.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.09 -28.39 52.13 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-O 118.561 -0.733 . . . . 0.0 112.265 172.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -66.43 -48.72 69.1 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 119.269 0.941 . . . . 0.0 110.731 -176.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.89 -42.85 86.12 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.675 177.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -61.51 -44.63 96.73 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 119.896 1.225 . . . . 0.0 110.098 -177.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -63.03 -48.55 78.25 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.888 0.767 . . . . 0.0 111.936 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 36.1 tttt -62.41 -52.89 61.77 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.387 0.675 . . . . 0.0 110.951 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 78.4 t -70.86 -49.61 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-O 118.231 -0.89 . . . . 0.0 109.125 -170.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 66.7 m -68.25 -23.4 64.78 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 119.721 1.146 . . . . 0.0 111.186 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.6 -48.82 78.77 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 169.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -62.27 -45.79 91.68 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 118.448 1.124 . . . . 0.0 111.816 176.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 39.0 mmt -55.99 -48.2 76.32 Favored 'General case' 0 C--O 1.227 -0.083 0 CA-C-N 118.17 0.441 . . . . 0.0 110.463 176.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -69.82 -27.56 64.97 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 118.779 0.718 . . . . 0.0 112.037 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -66.58 -36.48 82.73 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.37 0.986 . . . . 0.0 110.25 169.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -70.36 -30.91 67.97 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 120.0 1.273 . . . . 0.0 110.44 169.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 129.62 -26.63 4.29 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 127.618 2.532 . . . . 0.0 111.365 174.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 85.6 m -51.15 142.36 12.72 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 126.306 1.842 . . . . 0.0 111.861 -175.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -101.96 146.73 27.46 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 176.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 79.2 m -143.1 163.28 33.29 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -168.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -150.65 128.88 11.97 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 169.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 9.2 p -66.95 131.58 46.18 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 169.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 38.8 mt -74.83 -21.52 59.23 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 120.974 -1.079 . . . . 0.0 110.176 170.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 162.53 -168.35 37.42 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 108.66 -1.776 . . . . 0.0 108.66 175.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -133.34 172.83 21.36 Favored Glycine 0 CA--C 1.521 0.421 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 173.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -171.59 -163.99 26.47 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 108.084 -2.006 . . . . 0.0 108.084 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 29.2 ptt180 -135.47 154.81 51.3 Favored 'General case' 0 CA--C 1.512 -0.511 0 O-C-N 120.639 -1.506 . . . . 0.0 109.294 172.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.9 mt -110.41 134.96 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 104.331 -2.47 . . . . 0.0 104.331 178.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 18.9 m -139.58 158.87 43.39 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 173.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -148.54 26.43 0.94 Allowed 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.702 -0.624 . . . . 0.0 111.125 176.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -73.1 -96.67 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.42 1.488 . . . . 0.0 108.698 -176.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.2 m 42.44 -150.99 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.202 1.801 . . . . 0.0 112.675 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 -127.07 21.14 6.84 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.621 1.568 . . . . 0.0 108.232 169.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -143.23 118.44 10.16 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 102.792 -3.04 . . . . 0.0 102.792 -177.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.404 ' HD2' ' H ' ' A' ' 86' ' ' LYS . 2.5 mptt -74.28 -0.3 16.55 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 123.887 0.875 . . . . 0.0 113.052 -169.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.1 ttmt -50.55 121.53 5.88 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.409 1.084 . . . . 0.0 108.315 171.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 93.3 mt -66.22 149.29 11.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 175.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 22.3 t60 -136.18 144.88 45.2 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 121.162 -0.961 . . . . 0.0 109.811 -173.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.6 t -133.82 130.43 55.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -173.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -171.26 -175.48 1.68 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.474 0.579 . . . . 0.0 110.235 -169.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.47 -166.47 39.94 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 174.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -157.67 161.09 38.57 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.391 0.676 . . . . 0.0 111.629 175.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.9 t -87.74 154.46 20.55 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 168.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.4 ptm -92.34 -32.37 15.01 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 119.024 0.829 . . . . 0.0 110.422 173.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.19 -24.35 59.34 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.048 0.84 . . . . 0.0 111.836 175.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -133.92 -4.9 2.79 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -169.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.4 -177.21 52.92 Favored Glycine 0 CA--C 1.535 1.317 0 CA-C-N 119.412 1.006 . . . . 0.0 113.124 175.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.58 138.55 38.66 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.232 2.621 . . . . 0.0 110.41 176.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.45 169.56 18.01 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.694 0.798 . . . . 0.0 111.192 169.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -79.5 80.85 5.83 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 169.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 41.9 m80 -56.1 -20.13 16.03 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.843 0.857 . . . . 0.0 113.244 -178.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.23 -44.3 71.6 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.428 1.491 . . . . 0.0 112.352 169.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 70.7 mt -66.25 -44.7 91.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.43 -49.38 76.42 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.921 0.888 . . . . 0.0 110.78 -178.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.1 p -64.55 -46.71 81.68 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 118.362 -0.827 . . . . 0.0 110.708 -175.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -60.87 -40.1 91.69 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 119.295 0.952 . . . . 0.0 110.705 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 45.1 mttm -68.36 -46.97 68.68 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.807 -0.558 . . . . 0.0 111.509 177.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 68.8 mt -66.63 -38.51 81.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 119.469 1.031 . . . . 0.0 109.198 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -57.68 -47.82 81.25 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 119.696 1.134 . . . . 0.0 109.56 173.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.56 -35.79 81.66 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.051 0.387 . . . . 0.0 111.54 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 21.3 tptt -69.97 -36.27 75.08 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.277 0.631 . . . . 0.0 111.287 178.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -128.37 70.0 78.99 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 124.867 1.267 . . . . 0.0 110.026 -175.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -68.32 -14.77 41.07 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.835 2.357 . . . . 0.0 112.859 -176.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -67.69 -20.93 65.34 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.895 0.878 . . . . 0.0 112.017 172.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -116.18 -175.65 2.79 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.729 2.011 . . . . 0.0 108.331 -178.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -136.68 161.81 34.91 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 171.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.1 t -140.75 144.78 26.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 -172.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.6 p -136.83 170.18 16.52 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.496 1.119 . . . . 0.0 109.507 177.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 41.8 p-90 -143.75 155.63 44.24 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 172.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.39 120.4 4.41 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 171.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -77.61 1.01 20.98 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 120.341 -0.544 . . . . 0.0 112.277 -171.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -61.32 -33.05 72.95 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.68 1.592 . . . . 0.0 113.007 -176.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -82.86 -171.03 46.7 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 123.561 0.6 . . . . 0.0 112.815 -173.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 2.1 t80 . . . . . 0 C--O 1.236 0.369 0 C-N-CA 124.513 1.125 . . . . 0.0 110.545 -169.582 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptp . . . . . 0 N--CA 1.484 1.23 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.14 165.61 33.35 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.988 1.315 . . . . 0.0 108.914 174.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.9 m -67.67 169.28 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 C-N-CA 123.979 0.912 . . . . 0.0 110.665 173.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -74.15 173.87 9.5 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.776 0.798 . . . . 0.0 111.631 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -146.29 143.72 29.35 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 105.558 -2.016 . . . . 0.0 105.558 169.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 76.6 mt -55.69 -33.03 63.8 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -171.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.82 -25.44 66.44 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.911 0.778 . . . . 0.0 112.318 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.1 mt -81.23 -24.39 37.43 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.481 0.712 . . . . 0.0 111.397 -176.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 52.3 mt -70.9 131.02 87.74 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-O 118.145 -0.931 . . . . 0.0 108.783 -169.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -47.27 120.38 4.32 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 124.26 3.307 . . . . 0.0 112.894 172.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -66.13 -35.76 81.35 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.475 1.51 . . . . 0.0 111.739 -178.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.9 t -143.41 138.23 26.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 176.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -153.19 113.82 4.06 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 169.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.2 pt -141.64 158.48 21.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 123.145 0.578 . . . . 0.0 110.878 -169.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -147.41 43.1 1.1 Allowed 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.427 1.491 . . . . 0.0 109.336 169.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.6 m -72.92 70.24 1.0 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.433 1.093 . . . . 0.0 108.753 170.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -74.96 36.27 0.11 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.352 1.861 . . . . 0.0 112.151 -177.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 159.69 -174.38 36.53 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 127.237 2.351 . . . . 0.0 107.858 -170.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.0 t -70.25 98.95 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 174.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -142.58 158.01 44.12 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.676 1.19 . . . . 0.0 109.782 -177.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.4 mttm -70.48 156.2 39.69 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.63 1.172 . . . . 0.0 111.785 -172.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -144.54 161.59 38.72 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.614 1.966 . . . . 0.0 107.639 169.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.1 m -129.15 151.76 36.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 124.971 1.309 . . . . 0.0 109.537 173.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.97 120.34 39.66 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 104.202 -2.518 . . . . 0.0 104.202 171.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 46.1 mt -122.06 127.34 75.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 -177.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -81.36 148.0 29.56 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 169.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.1 t -133.03 144.25 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 -177.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -125.65 154.19 42.7 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.534 1.134 . . . . 0.0 109.396 -176.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 44.3 m -69.54 47.45 0.08 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.996 1.718 . . . . 0.0 114.157 177.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.13 -5.4 0.09 OUTLIER Pre-proline 0 CA--C 1.556 1.192 0 CA-C-O 114.775 -2.536 . . . . 0.0 117.334 169.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -43.43 153.65 0.22 Allowed 'Trans proline' 0 C--N 1.363 1.292 0 C-N-CA 123.599 2.866 . . . . 0.0 115.543 178.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 42.6 ttt180 55.15 14.51 1.02 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.232 1.413 . . . . 0.0 112.707 -169.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.1 m 51.36 25.59 2.66 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.212 1.405 . . . . 0.0 112.099 -169.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 170.69 25.72 0.02 OUTLIER Glycine 0 C--N 1.343 0.96 0 CA-C-O 118.569 -1.128 . . . . 0.0 115.29 -172.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.84 149.41 23.05 Favored Pre-proline 0 CA--C 1.544 0.741 0 CA-C-N 119.446 1.623 . . . . 0.0 110.245 170.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.41 -24.47 19.27 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 122.536 2.158 . . . . 0.0 113.152 -174.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.92 155.03 39.56 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.45 0.7 . . . . 0.0 110.376 175.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -141.11 30.59 1.79 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.827 1.251 . . . . 0.0 110.109 176.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 -74.15 173.77 9.65 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-O 121.647 0.737 . . . . 0.0 109.903 174.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.5 m -140.71 160.38 40.17 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.862 1.265 . . . . 0.0 108.778 172.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -148.28 170.19 18.45 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 127.43 2.292 . . . . 0.0 106.291 -173.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.3 mp0 -133.15 154.08 50.94 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 121.084 -1.01 . . . . 0.0 108.294 178.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 34.2 pt -137.69 156.58 32.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 C-N-CA 125.712 1.605 . . . . 0.0 109.337 178.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 85.4 t -118.7 119.42 61.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.0 mmt85 -134.84 143.46 47.03 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -179.99 136.24 2.69 Favored Glycine 0 CA--C 1.509 -0.287 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -178.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -154.74 153.3 31.03 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -169.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -55.05 -29.67 57.96 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 178.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 8.7 p-90 -73.53 -22.54 60.07 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.969 0.804 . . . . 0.0 113.124 -179.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.86 83.5 7.17 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-N 120.056 1.298 . . . . 0.0 110.047 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -64.18 -18.41 64.46 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.976 0.91 . . . . 0.0 112.003 176.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -138.08 146.85 43.43 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.746 1.619 . . . . 0.0 108.398 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 29.2 m80 -65.03 -33.77 76.83 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.133 0.573 . . . . 0.0 110.832 -175.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.93 -25.82 45.03 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 118.382 -0.818 . . . . 0.0 112.987 173.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -67.75 -50.83 55.12 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 119.705 1.139 . . . . 0.0 110.569 -176.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.65 -37.17 78.2 Favored 'Isoleucine or valine' 0 C--N 1.339 0.147 0 CA-C-O 117.913 -1.041 . . . . 0.0 109.976 176.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -60.3 -49.47 77.46 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.651 1.114 . . . . 0.0 110.45 178.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -63.2 -47.1 84.01 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.345 0.52 . . . . 0.0 111.3 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.2 tttt -61.1 -53.7 53.76 Favored 'General case' 0 CA--C 1.522 -0.124 0 C-N-CA 123.126 0.571 . . . . 0.0 111.091 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 95.4 t -71.94 -44.91 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 117.937 -1.03 . . . . 0.0 109.294 -171.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.0 m -62.73 -33.77 75.82 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 120.292 1.406 . . . . 0.0 110.703 177.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.33 -47.6 89.93 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-N 118.946 0.794 . . . . 0.0 111.273 171.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -63.04 -46.29 88.23 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 118.625 1.213 . . . . 0.0 111.363 178.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 38.2 mmt -57.27 -45.93 83.57 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 123.488 0.715 . . . . 0.0 110.727 175.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -63.79 -36.42 83.82 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.786 0.835 . . . . 0.0 111.696 177.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -66.89 -37.21 83.96 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 119.232 0.923 . . . . 0.0 110.917 172.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -68.78 -23.65 64.33 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 119.283 0.947 . . . . 0.0 111.965 171.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 118.1 -12.93 12.76 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 126.248 1.88 . . . . 0.0 112.626 174.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 91.0 m -67.27 168.45 10.49 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.022 1.329 . . . . 0.0 111.55 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -125.44 152.11 45.33 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 170.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 65.4 m -143.44 163.69 32.41 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -168.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -148.71 137.59 21.49 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.042 1.737 . . . . 0.0 106.843 170.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.9 p -78.7 118.49 20.83 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 169.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 44.3 mt -70.85 -22.59 62.29 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 122.023 -0.423 . . . . 0.0 110.381 174.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 163.42 -166.76 37.34 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 172.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -151.68 175.66 30.39 Favored Glycine 0 CA--C 1.52 0.344 0 N-CA-C 111.807 -0.517 . . . . 0.0 111.807 171.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -166.6 -162.07 17.25 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 108.366 -1.894 . . . . 0.0 108.366 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.95 164.94 25.84 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 120.893 -1.357 . . . . 0.0 108.515 174.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 68.8 mt -114.53 144.1 22.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 -171.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 39.0 p -155.88 -152.55 0.39 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.855 1.662 . . . . 0.0 108.345 -175.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.41 160.01 41.78 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.139 1.376 . . . . 0.0 109.009 173.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -124.89 77.79 1.64 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.13 0.972 . . . . 0.0 109.765 -170.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.5 m 58.66 12.93 2.38 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 169.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -142.13 138.55 31.7 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 174.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -58.77 -26.99 64.56 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -169.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 35.9 mtmt -118.91 11.39 12.55 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 118.103 -0.951 . . . . 0.0 113.032 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -95.68 86.04 4.31 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 169.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 78.8 mt -60.72 158.75 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 172.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -141.1 160.09 40.83 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 120.611 -1.305 . . . . 0.0 110.124 -177.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.0 t -141.84 137.11 31.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -163.03 -179.58 6.83 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.953 0.901 . . . . 0.0 109.247 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.9 -166.5 19.22 Favored Glycine 0 CA--C 1.523 0.553 0 O-C-N 121.695 -0.628 . . . . 0.0 112.592 169.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -159.07 157.85 31.87 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.903 1.281 . . . . 0.0 109.527 178.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.4 t -89.96 147.33 23.77 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 168.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.42 -42.46 62.02 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 171.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -80.72 -24.6 38.67 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 118.912 -0.566 . . . . 0.0 112.205 -171.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -132.49 -1.07 3.53 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -169.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.11 -179.72 49.81 Favored Glycine 0 CA--C 1.534 1.249 0 CA-C-N 118.964 0.802 . . . . 0.0 113.288 173.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.38 138.63 33.19 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.935 2.423 . . . . 0.0 109.981 175.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.07 168.1 20.65 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.254 0.55 . . . . 0.0 111.094 170.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -79.26 81.82 5.48 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 168.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 45.7 m80 -57.04 -18.38 13.85 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -174.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.82 -40.36 69.49 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.018 1.327 . . . . 0.0 112.151 170.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 61.2 mt -66.06 -47.28 85.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 178.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.42 -49.29 78.37 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.315 1.046 . . . . 0.0 110.798 -176.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 31.0 p -63.32 -49.12 75.2 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 118.642 -0.694 . . . . 0.0 109.568 -175.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -59.35 -40.72 87.34 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.11 0.868 . . . . 0.0 111.31 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 44.4 mttm -65.72 -47.15 76.31 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 118.507 0.594 . . . . 0.0 111.338 177.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 67.7 mt -64.01 -39.26 84.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 CA-C-N 119.202 0.91 . . . . 0.0 109.235 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.0 mtpt -61.91 -44.23 97.22 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.351 0.978 . . . . 0.0 109.999 177.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.13 -40.19 96.87 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.156 0.434 . . . . 0.0 111.15 176.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.432 ' HE2' ' HA ' ' A' ' 112' ' ' LYS . 0.7 OUTLIER -66.16 -32.27 73.62 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 118.056 -0.973 . . . . 0.0 111.835 178.939 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -133.36 73.28 73.94 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 119.208 0.913 . . . . 0.0 110.213 -173.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.31 -26.08 50.62 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 123.446 2.764 . . . . 0.0 115.141 -176.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -72.63 -11.82 60.8 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.493 0.717 . . . . 0.0 112.642 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -112.87 174.85 5.7 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.865 1.666 . . . . 0.0 109.039 -178.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -133.62 160.57 37.1 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 169.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.2 t -144.14 142.73 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 -174.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 9.7 p -135.08 171.25 14.69 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.694 1.198 . . . . 0.0 108.764 176.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 55.7 p-90 -142.81 156.54 44.98 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 172.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -154.57 102.76 2.42 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 174.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.07 -0.6 22.39 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -169.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -58.1 -30.12 66.02 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.373 1.069 . . . . 0.0 112.201 178.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -73.84 131.8 14.65 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 170.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 . . . . . 0 C--O 1.239 0.535 0 C-N-CA 125.614 1.566 . . . . 0.0 108.747 178.302 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.7 mmm . . . . . 0 N--CA 1.483 1.215 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.52 -174.07 3.94 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.456 1.502 . . . . 0.0 108.827 175.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.0 p -145.55 153.91 13.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 124.848 1.259 . . . . 0.0 107.861 177.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -162.95 -162.85 0.8 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.798 2.039 . . . . 0.0 107.463 -175.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -146.21 153.06 40.18 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.675 1.99 . . . . 0.0 105.887 169.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 54.4 mt -53.15 -36.2 60.58 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.036 0.835 . . . . 0.0 112.077 -177.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.24 -25.72 68.19 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 118.801 0.728 . . . . 0.0 112.571 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.9 mt -83.73 -22.24 32.04 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.465 0.706 . . . . 0.0 111.489 -177.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 15.9 mt -66.48 131.71 94.2 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -50.39 128.9 24.49 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.842 2.361 . . . . 0.0 110.786 171.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -74.66 -41.69 59.86 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.378 0.671 . . . . 0.0 110.794 -176.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 53.5 t -136.29 129.18 46.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 177.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -152.12 111.94 4.0 Favored 'General case' 0 CA--C 1.521 -0.173 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 171.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 9.5 pt -147.86 157.97 8.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 125.077 1.351 . . . . 0.0 109.067 -169.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -59.23 -51.12 71.33 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.837 0.855 . . . . 0.0 112.697 -176.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.8 m 41.97 43.77 2.77 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.977 1.711 . . . . 0.0 114.65 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -132.02 11.25 4.66 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.289 1.035 . . . . 0.0 111.187 173.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.33 -161.84 35.41 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 94.5 t -71.48 140.69 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 123.679 0.792 . . . . 0.0 108.946 169.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -163.85 167.42 20.78 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.844 1.257 . . . . 0.0 109.787 169.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.5 mttt -99.62 151.7 20.89 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.603 1.161 . . . . 0.0 108.83 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -142.91 162.8 34.5 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.232 1.013 . . . . 0.0 108.984 -174.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.0 m -133.6 155.25 40.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 C-N-CA 124.542 1.137 . . . . 0.0 109.718 173.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -106.96 116.73 32.44 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 178.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 80.3 mt -120.71 115.11 45.98 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -173.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -72.76 142.83 48.13 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 168.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.6 p -138.75 146.9 25.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -127.85 146.83 50.49 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.884 1.274 . . . . 0.0 108.484 -171.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 61.2 m -61.95 100.21 0.15 Allowed 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.598 0.759 . . . . 0.0 111.077 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.453 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -144.98 22.75 0.04 OUTLIER Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 126.029 1.732 . . . . 0.0 112.976 168.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.453 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 72.0 Cg_exo -46.36 150.77 2.02 Favored 'Trans proline' 0 C--N 1.361 1.235 0 CA-C-N 123.872 2.419 . . . . 0.0 114.991 178.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.9 14.19 0.3 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.562 1.545 . . . . 0.0 113.282 -171.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.6 m 53.68 31.34 12.57 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.664 1.185 . . . . 0.0 111.69 -169.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -163.99 0.85 0.05 OUTLIER Glycine 0 CA--C 1.533 1.169 0 CA-C-O 118.326 -1.263 . . . . 0.0 115.982 -174.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.28 142.07 76.37 Favored Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 119.842 1.821 . . . . 0.0 110.911 176.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -79.22 -20.36 9.9 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.015 2.477 . . . . 0.0 113.743 -174.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.96 159.53 22.72 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.612 0.765 . . . . 0.0 110.838 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -143.43 30.05 1.4 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.563 1.145 . . . . 0.0 111.214 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -76.36 176.25 8.36 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.234 0.54 . . . . 0.0 109.891 171.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.9 m -143.27 159.94 41.4 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.964 1.306 . . . . 0.0 108.936 176.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.8 tttt -149.6 165.54 31.96 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 126.768 2.027 . . . . 0.0 107.246 -174.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -124.95 128.4 48.54 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 169.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 39.5 pt -108.89 155.07 10.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 124.84 1.256 . . . . 0.0 110.257 173.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 33.1 t -119.32 114.92 46.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 -175.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 12.7 mmp_? -128.38 146.84 50.66 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.084 1.353 . . . . 0.0 108.404 -177.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 174.98 137.55 2.52 Favored Glycine 0 C--N 1.332 0.306 0 CA-C-N 118.849 0.75 . . . . 0.0 111.303 176.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -153.33 154.16 34.02 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -169.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -56.92 -34.47 68.0 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 118.591 -0.719 . . . . 0.0 112.556 175.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 10.1 p-90 -65.5 -27.31 68.39 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.1 0.864 . . . . 0.0 112.294 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -87.29 73.22 9.72 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 119.033 0.833 . . . . 0.0 109.585 175.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -67.9 -5.05 14.89 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.458 0.703 . . . . 0.0 111.648 175.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -138.66 147.96 43.45 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 126.197 1.799 . . . . 0.0 107.142 173.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 59.9 m80 -73.89 -31.49 63.14 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 121.812 -0.555 . . . . 0.0 110.185 -169.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.76 -28.72 50.69 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 118.333 -0.842 . . . . 0.0 112.586 171.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -67.49 -49.31 64.06 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 119.624 1.102 . . . . 0.0 110.729 -177.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.35 -38.5 80.95 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 CA-C-O 117.732 -1.127 . . . . 0.0 110.045 177.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -64.43 -41.88 96.34 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 120.19 1.359 . . . . 0.0 110.669 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -63.43 -48.83 76.14 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.315 0.961 . . . . 0.0 111.304 176.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -56.79 -55.7 30.89 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.372 1.069 . . . . 0.0 110.628 178.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 81.1 t -77.08 -44.43 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-O 117.79 -1.1 . . . . 0.0 109.791 -169.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.1 t -62.73 -36.85 84.36 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 120.555 1.525 . . . . 0.0 109.266 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.51 -50.74 64.51 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 172.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -62.71 -45.95 90.36 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 118.728 1.264 . . . . 0.0 111.755 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 38.7 mmt -57.31 -47.86 80.42 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.377 0.671 . . . . 0.0 110.145 176.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -66.54 -30.92 71.33 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 118.698 -0.668 . . . . 0.0 111.805 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -67.48 -35.13 78.56 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.757 1.162 . . . . 0.0 110.724 170.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -72.8 -15.05 61.64 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 119.525 1.057 . . . . 0.0 111.208 169.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 110.04 -25.5 16.2 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 127.431 2.443 . . . . 0.0 112.247 177.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 93.3 m -55.8 149.28 14.95 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.957 1.703 . . . . 0.0 111.936 -175.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -108.87 143.36 38.18 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 177.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 96.1 m -141.3 164.91 28.98 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -168.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -151.41 128.37 11.04 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.794 1.637 . . . . 0.0 106.932 171.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.1 p -73.48 117.3 15.07 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 169.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 39.4 mt -70.76 -23.42 62.41 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.904 -0.497 . . . . 0.0 110.563 174.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.42 -170.97 42.46 Favored Glycine 0 C--N 1.337 0.626 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 171.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -132.23 169.91 22.02 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 174.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -174.34 -161.57 24.49 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -177.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 50.0 ttt180 -141.65 152.22 43.75 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 125.082 1.353 . . . . 0.0 107.816 -172.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 40.6 mt -123.79 139.89 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 173.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 18.6 m -140.47 151.5 44.9 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 172.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 72.0 m-70 -76.27 -17.09 59.63 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 118.737 -0.649 . . . . 0.0 112.173 178.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 38.1 mm-40 -145.61 143.52 29.92 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.5 1.92 . . . . 0.0 106.949 171.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 65.1 m -148.36 -149.71 0.31 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.326 1.45 . . . . 0.0 108.222 174.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -60.25 -8.38 2.51 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.839 1.256 . . . . 0.0 113.415 171.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -127.4 150.74 49.49 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.429 1.492 . . . . 0.0 107.919 169.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -84.05 -2.36 56.55 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -169.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.43 174.74 9.3 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 120.503 1.502 . . . . 0.0 109.097 169.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 77.3 mt -60.5 130.45 24.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 102.478 -3.156 . . . . 0.0 102.478 167.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 22.9 t60 -121.86 150.44 41.93 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 118.868 0.758 . . . . 0.0 110.378 -169.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.9 t -129.11 125.02 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -164.77 -167.98 1.36 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.694 0.798 . . . . 0.0 109.076 -171.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.71 -176.09 53.95 Favored Glycine 0 CA--C 1.527 0.793 0 O-C-N 121.633 -0.667 . . . . 0.0 111.473 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -158.97 149.84 20.01 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.01 0.924 . . . . 0.0 110.804 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.0 t -75.37 162.48 28.35 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 168.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.2 ptm -103.72 -31.27 9.93 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 118.629 -0.7 . . . . 0.0 110.783 170.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -73.71 -25.74 60.36 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 119.351 0.978 . . . . 0.0 111.6 174.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -132.49 -6.17 3.3 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.941 0.896 . . . . 0.0 113.351 -169.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.94 -176.1 54.1 Favored Glycine 0 CA--C 1.534 1.277 0 CA-C-N 118.945 0.793 . . . . 0.0 113.39 173.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -67.67 135.23 35.18 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.267 2.645 . . . . 0.0 110.471 175.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.69 168.23 20.44 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.11 0.564 . . . . 0.0 110.891 169.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -81.56 80.07 8.01 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 169.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -55.46 -20.5 12.77 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.09 -44.29 67.47 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.925 1.29 . . . . 0.0 112.196 170.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 71.7 mt -64.59 -48.35 85.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.46 -50.94 71.41 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.508 1.123 . . . . 0.0 110.443 -176.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.2 p -64.69 -46.25 83.19 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 119.347 0.976 . . . . 0.0 111.048 -175.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -60.7 -39.92 90.28 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.564 1.074 . . . . 0.0 110.625 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.3 mttt -72.55 -41.34 65.87 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 121.676 -0.64 . . . . 0.0 111.965 178.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 76.8 mt -65.76 -41.75 90.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 119.289 0.95 . . . . 0.0 108.662 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -55.88 -47.42 77.41 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.54 1.063 . . . . 0.0 109.882 173.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.43 -41.82 98.99 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 119.2 -0.428 . . . . 0.0 111.646 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -72.19 -33.6 67.78 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.787 0.721 . . . . 0.0 111.591 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -126.1 63.89 50.98 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 124.092 0.957 . . . . 0.0 110.502 -170.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.68 -10.64 29.13 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.154 2.569 . . . . 0.0 113.309 -174.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -67.77 -10.24 50.99 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.981 0.912 . . . . 0.0 112.231 170.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -129.2 179.64 5.65 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.288 1.835 . . . . 0.0 109.099 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -135.56 155.88 49.76 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 172.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.1 t -137.99 146.74 26.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 -169.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 21.6 p -136.18 168.17 19.89 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.778 1.231 . . . . 0.0 109.247 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 36.5 p-90 -146.1 162.41 38.0 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.838 -0.539 . . . . 0.0 110.321 172.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -152.27 139.05 18.88 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 169.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -81.12 78.58 7.91 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 172.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -141.23 -175.09 4.21 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.043 1.737 . . . . 0.0 106.334 170.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 103.53 -153.41 17.95 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-N 119.526 1.057 . . . . 0.0 111.038 -175.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 87.4 t80 . . . . . 0 C--O 1.238 0.47 0 C-N-CA 125.167 1.387 . . . . 0.0 109.558 176.18 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.7 ttp . . . . . 0 N--CA 1.482 1.139 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.34 -173.3 3.61 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.627 0.771 . . . . 0.0 110.184 172.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 49.9 t -132.83 148.55 31.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 169.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -153.31 -174.35 4.91 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.174 1.79 . . . . 0.0 107.916 -177.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -139.28 149.11 43.89 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 170.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.0 mt -54.75 -33.72 61.62 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.684 0.794 . . . . 0.0 112.343 -174.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.0 -25.22 68.03 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.077 0.853 . . . . 0.0 112.561 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 79.6 mt -78.28 -25.68 46.8 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.205 0.602 . . . . 0.0 111.369 -177.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.0 mt -69.63 130.43 90.48 Favored Pre-proline 0 CA--C 1.538 0.502 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -173.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -50.67 127.6 21.42 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.856 2.371 . . . . 0.0 109.884 169.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -82.39 -34.07 28.48 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 121.88 -0.512 . . . . 0.0 111.481 -171.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 52.5 t -133.92 131.86 56.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 171.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -152.99 126.86 8.93 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 174.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.3 pt -147.93 167.18 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.097 0.959 . . . . 0.0 110.349 -169.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -144.08 89.66 2.05 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.553 1.141 . . . . 0.0 108.588 169.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.1 m -65.11 170.87 4.08 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.901 1.68 . . . . 0.0 113.125 -173.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -146.65 -43.85 0.19 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.669 1.188 . . . . 0.0 110.572 169.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.98 -40.28 0.25 Allowed Glycine 0 CA--C 1.525 0.693 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 177.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 96.6 t -143.26 120.83 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 103.874 -2.639 . . . . 0.0 103.874 169.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -153.9 148.3 26.05 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.055 0.843 . . . . 0.0 110.382 -175.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -72.61 156.19 39.25 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 122.952 0.501 . . . . 0.0 110.464 -176.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -147.64 164.86 32.2 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.472 1.109 . . . . 0.0 108.302 172.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.4 m -133.92 153.08 35.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 C-N-CA 124.725 1.21 . . . . 0.0 108.963 173.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.1 114.71 28.82 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 54.0 mt -119.38 117.92 55.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -170.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.7 ttp180 -73.63 147.13 44.06 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 169.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.0 t -135.2 150.3 29.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 127.097 2.159 . . . . 0.0 105.517 -176.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -131.8 153.86 49.69 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.691 1.196 . . . . 0.0 108.245 176.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.2 m -68.87 44.71 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.946 1.698 . . . . 0.0 114.111 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -73.96 -5.56 0.09 OUTLIER Pre-proline 0 CA--C 1.551 1.004 0 CA-C-O 115.159 -2.353 . . . . 0.0 116.824 172.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -50.18 158.0 2.66 Favored 'Trans proline' 0 C--N 1.359 1.118 0 CA-C-N 125.263 2.915 . . . . 0.0 112.068 169.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 21.8 ttp180 54.32 26.58 7.04 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 121.518 -0.739 . . . . 0.0 110.606 -169.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.6 m 49.87 24.21 1.24 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.169 1.788 . . . . 0.0 113.672 -170.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 143.39 77.88 0.04 OUTLIER Glycine 0 C--N 1.34 0.79 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -176.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -72.43 148.93 91.02 Favored Pre-proline 0 CA--C 1.541 0.618 0 CA-C-N 117.997 0.898 . . . . 0.0 108.932 178.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -54.9 -27.63 54.61 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.418 2.745 . . . . 0.0 115.797 -172.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.15 -40.92 97.58 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.758 0.823 . . . . 0.0 112.339 -175.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 44.82 35.03 1.33 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.631 1.572 . . . . 0.0 113.267 -170.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -83.35 -179.86 7.49 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.278 1.031 . . . . 0.0 109.635 175.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.1 m -141.58 161.18 38.56 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.288 1.435 . . . . 0.0 108.969 174.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.5 tttt -149.63 162.19 40.69 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 126.203 1.801 . . . . 0.0 107.772 -172.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.5 mp0 -130.22 119.75 23.4 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 172.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 43.9 pt -104.99 159.24 5.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 C-N-CA 125.137 1.375 . . . . 0.0 110.705 178.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.4 t -118.14 120.59 64.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.4 mmp_? -126.55 141.09 51.98 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 176.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.04 131.81 1.83 Allowed Glycine 0 C--N 1.331 0.256 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 174.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -148.81 147.47 28.8 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -169.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -57.5 -27.31 62.43 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 177.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 12.2 p-90 -68.09 -27.97 66.94 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.221 0.918 . . . . 0.0 112.438 176.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.44 83.39 7.95 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 119.411 1.005 . . . . 0.0 109.054 175.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -66.85 -16.97 64.65 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 122.859 0.464 . . . . 0.0 111.65 176.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -134.3 152.69 51.95 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.028 1.731 . . . . 0.0 108.441 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 76.8 m-70 -73.3 -33.27 65.09 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -169.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.39 -28.75 56.02 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 118.408 -0.806 . . . . 0.0 112.71 173.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -67.63 -49.61 62.12 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 119.443 1.02 . . . . 0.0 110.46 -177.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.21 -42.79 91.7 Favored 'Isoleucine or valine' 0 C--N 1.341 0.209 0 CA-C-O 117.933 -1.032 . . . . 0.0 109.659 175.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -61.05 -45.13 96.03 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.687 1.131 . . . . 0.0 110.68 -177.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -63.32 -49.09 75.34 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.2 0.909 . . . . 0.0 111.655 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 31.5 tttt -59.13 -50.41 74.14 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.599 0.76 . . . . 0.0 110.883 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 91.9 t -72.73 -42.33 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-O 117.832 -1.08 . . . . 0.0 109.012 -172.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 63.0 m -60.15 -33.27 71.94 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-N 120.65 1.568 . . . . 0.0 111.087 173.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.03 -53.92 39.04 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-N 119.468 1.031 . . . . 0.0 110.54 172.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.424 ' HA ' ' HE3' ' A' ' 66' ' ' LYS . 19.0 t70 -60.32 -46.1 91.06 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.442 1.121 . . . . 0.0 111.828 -178.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.518 ' HG3' ' HG ' ' A' ' 71' ' ' CYS . 35.3 mmt -59.45 -50.21 74.83 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.963 0.905 . . . . 0.0 110.119 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -67.07 -29.73 69.59 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 118.461 0.573 . . . . 0.0 111.605 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.424 ' HE3' ' HA ' ' A' ' 63' ' ' ASP . 52.3 mtmt -66.06 -36.55 83.52 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.343 0.974 . . . . 0.0 110.861 170.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -72.44 -13.14 61.37 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.817 1.189 . . . . 0.0 112.069 169.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.76 -10.85 66.49 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 126.267 1.889 . . . . 0.0 112.346 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 85.1 m -56.38 153.0 10.4 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.815 1.308 . . . . 0.0 111.233 175.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -114.3 139.36 49.5 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 170.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.518 ' HG ' ' HG3' ' A' ' 64' ' ' MET . 35.4 m -141.56 161.24 38.41 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -168.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -153.35 126.84 8.68 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 176.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.7 p -70.59 121.27 17.55 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 169.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 36.6 mt -66.9 -24.5 66.11 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.864 -0.523 . . . . 0.0 109.82 170.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.91 -170.21 42.66 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 125.3 1.429 . . . . 0.0 109.612 169.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -124.15 169.29 16.23 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 173.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -175.83 -166.29 33.06 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -175.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -143.88 160.38 40.89 Favored 'General case' 0 CA--C 1.516 -0.344 0 O-C-N 120.906 -1.349 . . . . 0.0 109.561 178.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 95.2 mt -123.26 141.48 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 -176.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 18.8 m -139.4 146.4 40.11 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 123.579 0.549 . . . . 0.0 111.237 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.85 171.02 9.95 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.369 1.868 . . . . 0.0 112.988 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -63.8 6.56 0.15 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 127.6 2.36 . . . . 0.0 114.51 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.0 m -113.27 11.61 18.72 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.852 1.261 . . . . 0.0 111.11 174.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 19.9 tp60 -124.19 -19.09 5.66 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.491 1.516 . . . . 0.0 110.358 172.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -150.26 163.48 38.18 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.66 1.984 . . . . 0.0 106.707 171.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -57.19 -28.04 62.49 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.938 0.79 . . . . 0.0 112.831 178.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -127.34 176.45 7.42 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.3 1.44 . . . . 0.0 108.617 179.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 77.9 mt -64.41 132.15 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 N-CA-C 104.255 -2.498 . . . . 0.0 104.255 169.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 21.6 t60 -129.4 150.84 50.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 118.73 0.695 . . . . 0.0 110.308 -169.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.3 t -133.36 135.22 56.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 -178.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -170.56 -171.18 1.02 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -170.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 109.65 -172.74 16.24 Favored Glycine 0 CA--C 1.523 0.55 0 CA-C-N 119.3 0.955 . . . . 0.0 113.32 169.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -157.4 154.02 28.17 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.923 1.689 . . . . 0.0 107.668 -169.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.5 t -126.27 140.25 52.68 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 169.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 21.7 ptp -80.62 -34.98 34.63 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 118.71 -0.662 . . . . 0.0 110.11 173.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.65 -25.03 49.32 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.068 0.849 . . . . 0.0 112.182 -177.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -133.13 -5.29 3.06 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -169.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.87 171.83 42.96 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-N 118.964 0.802 . . . . 0.0 112.044 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.78 137.24 34.92 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.299 2.0 . . . . 0.0 109.312 177.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.18 170.75 6.56 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.16 0.505 . . . . 0.0 111.114 171.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 21.6 mm100 -64.99 -32.82 74.73 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 119.255 -0.402 . . . . 0.0 111.955 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 35.8 m80 61.7 -30.99 0.07 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 128.316 2.646 . . . . 0.0 115.526 -174.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.56 -45.94 88.21 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.649 1.18 . . . . 0.0 111.179 173.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 73.5 mt -61.21 -46.16 97.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.43 -52.04 66.98 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.891 1.276 . . . . 0.0 110.522 -174.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.2 p -64.57 -44.13 91.7 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.418 -177.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -60.63 -41.53 95.08 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.811 1.187 . . . . 0.0 110.736 -179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 25.7 mmtp -65.93 -47.9 73.16 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 118.735 0.698 . . . . 0.0 111.102 176.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 56.6 mt -64.67 -41.87 93.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 119.194 0.906 . . . . 0.0 109.237 -176.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -56.59 -49.48 74.77 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 119.776 1.171 . . . . 0.0 109.619 175.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.76 -36.5 83.28 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 122.478 0.311 . . . . 0.0 111.765 -176.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -90.18 -15.29 31.78 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 118.674 -0.679 . . . . 0.0 112.452 -175.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -132.91 63.94 69.07 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 124.883 1.273 . . . . 0.0 109.369 176.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -71.05 -7.07 20.6 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.133 2.555 . . . . 0.0 112.835 -175.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -61.9 -20.27 63.57 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.382 1.073 . . . . 0.0 112.255 174.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -143.6 -165.97 2.22 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.48 1.112 . . . . 0.0 109.508 176.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -131.76 158.77 40.35 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.116 1.367 . . . . 0.0 108.988 -174.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.2 t -137.25 146.46 27.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 -172.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 17.2 p -136.15 168.21 19.81 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.809 1.244 . . . . 0.0 109.501 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 31.6 p-90 -146.62 156.07 42.94 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 121.762 -0.586 . . . . 0.0 110.411 171.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -159.27 117.96 2.89 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 169.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.76 -1.36 21.67 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 118.458 0.572 . . . . 0.0 112.297 -171.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -58.68 -31.36 68.14 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.441 1.096 . . . . 0.0 112.248 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -78.51 135.3 15.52 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 175.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 52.1 p90 . . . . . 0 C--O 1.239 0.519 0 C-N-CA 125.593 1.557 . . . . 0.0 109.397 171.625 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.9 tpp . . . . . 0 N--CA 1.482 1.135 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.08 168.3 20.63 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.427 1.091 . . . . 0.0 109.661 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.7 t -136.39 119.92 23.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 -178.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.67 -177.63 3.8 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.783 0.833 . . . . 0.0 111.111 177.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -152.93 146.5 25.04 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 169.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 61.3 mt -55.18 -34.3 63.73 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -173.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.22 -26.24 65.61 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.845 0.748 . . . . 0.0 112.159 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.2 mt -81.47 -23.46 37.4 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.513 0.725 . . . . 0.0 111.22 -177.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.8 mt -66.31 129.29 94.17 Favored Pre-proline 0 CA--C 1.538 0.514 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 -175.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -46.65 116.22 1.53 Allowed 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 124.195 3.263 . . . . 0.0 111.777 170.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -72.63 -31.73 65.36 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.603 0.761 . . . . 0.0 111.577 -172.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 64.2 t -141.72 137.24 31.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 171.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -151.18 110.84 4.02 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 169.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 40.5 pt -141.37 158.05 22.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 C-N-CA 124.211 1.005 . . . . 0.0 109.195 -170.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -75.21 -178.54 3.96 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.507 0.723 . . . . 0.0 110.308 172.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.2 m -147.91 0.09 0.63 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.963 1.305 . . . . 0.0 113.114 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -67.15 -25.36 66.13 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 120.159 1.345 . . . . 0.0 113.39 -171.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 176.79 -160.8 28.31 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -174.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.4 t -64.17 143.3 15.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 123.618 0.767 . . . . 0.0 109.243 172.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -156.58 157.84 36.03 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.179 0.991 . . . . 0.0 111.145 173.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.1 mmtm -72.46 152.65 41.81 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 173.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.477 ' HH ' ' CD2' ' A' ' 102' ' ' HIS . 0.2 OUTLIER -142.1 160.05 41.0 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 175.146 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.4 m -130.15 152.98 38.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 124.615 1.166 . . . . 0.0 109.433 173.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.2 114.92 29.17 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 104.201 -2.518 . . . . 0.0 104.201 177.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 54.5 mt -118.88 124.88 73.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -172.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -78.24 148.09 34.1 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 169.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.3 t -132.12 145.53 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -127.55 148.51 50.34 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.762 1.225 . . . . 0.0 108.218 178.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.4 m -62.35 99.13 0.13 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.759 0.824 . . . . 0.0 110.92 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.437 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -142.44 20.15 0.04 OUTLIER Pre-proline 0 CA--C 1.552 1.028 0 CA-C-O 116.491 -1.719 . . . . 0.0 113.502 169.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.437 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 76.3 Cg_exo -45.29 140.53 7.97 Favored 'Trans proline' 0 C--N 1.363 1.301 0 CA-C-N 123.817 2.399 . . . . 0.0 114.174 177.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.3 tpp180 43.23 24.65 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.509 2.323 . . . . 0.0 114.325 -172.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.9 m 50.85 30.33 5.06 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.2 1.4 . . . . 0.0 112.353 -173.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -155.52 -2.04 0.12 Allowed Glycine 0 CA--C 1.53 0.998 0 CA-C-O 118.504 -1.164 . . . . 0.0 114.895 -171.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.09 137.86 80.08 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-N 119.517 1.658 . . . . 0.0 110.283 172.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -77.62 -20.86 11.84 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.866 2.377 . . . . 0.0 113.089 -178.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.93 159.63 22.43 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.598 0.759 . . . . 0.0 110.823 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -143.55 35.48 1.3 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.247 1.419 . . . . 0.0 109.624 178.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -84.29 -179.67 7.25 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.027 0.931 . . . . 0.0 109.448 177.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.5 m -141.84 160.5 40.06 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.628 1.171 . . . . 0.0 109.403 174.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -152.0 171.56 17.64 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 127.393 2.277 . . . . 0.0 106.509 -172.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.8 mp0 -133.24 157.66 44.86 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 172.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 30.3 pt -137.13 156.03 33.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 C-N-CA 125.717 1.607 . . . . 0.0 109.114 177.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 52.9 t -118.54 120.87 65.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 178.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 25.6 mmt85 -135.63 144.89 46.34 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 176.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 178.44 134.72 2.15 Favored Glycine 0 N--CA 1.453 -0.202 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -178.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.405 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 9.7 m-85 -154.79 155.53 34.64 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -169.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -58.02 -34.13 69.71 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.714 0.806 . . . . 0.0 112.07 -178.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.405 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 13.9 p-90 -67.32 -27.55 67.24 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 118.707 -0.663 . . . . 0.0 112.613 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.36 80.5 9.19 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 119.635 1.107 . . . . 0.0 109.104 175.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -64.23 -18.13 64.23 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.062 0.545 . . . . 0.0 112.0 175.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -134.07 151.05 51.24 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 126.601 1.961 . . . . 0.0 108.023 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -74.1 -31.92 63.0 Favored 'General case' 0 C--O 1.234 0.254 0 O-C-N 121.847 -0.533 . . . . 0.0 110.064 -169.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.32 -29.76 48.96 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 118.564 -0.731 . . . . 0.0 112.48 172.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -67.75 -50.65 56.12 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 119.289 0.95 . . . . 0.0 110.796 -175.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.36 -38.26 80.5 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.157 0 CA-C-O 117.846 -1.073 . . . . 0.0 110.036 176.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -59.92 -48.35 82.06 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.76 1.163 . . . . 0.0 110.317 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -63.54 -47.68 80.61 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.347 0.521 . . . . 0.0 111.495 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 31.6 tttt -61.2 -52.81 63.24 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 123.198 0.599 . . . . 0.0 111.144 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 92.6 t -70.94 -46.1 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-O 118.024 -0.989 . . . . 0.0 108.975 -172.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.8 m -62.32 -31.95 72.64 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 120.283 1.402 . . . . 0.0 111.055 176.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.16 -49.78 74.39 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-N 119.038 0.835 . . . . 0.0 111.077 171.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -61.68 -44.19 97.41 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 118.654 1.227 . . . . 0.0 111.61 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.526 ' HG3' ' HG ' ' A' ' 71' ' ' CYS . 37.6 mmt -59.39 -47.82 84.0 Favored 'General case' 0 C--O 1.226 -0.159 0 C-N-CA 123.06 0.544 . . . . 0.0 110.053 176.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -67.49 -28.61 67.99 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.85 0.75 . . . . 0.0 112.025 179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -68.05 -36.98 80.79 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 119.585 1.084 . . . . 0.0 110.418 170.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -68.04 -29.74 68.79 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 119.625 1.102 . . . . 0.0 110.122 169.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 122.37 -23.17 7.26 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 128.13 2.776 . . . . 0.0 111.297 177.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 84.6 m -53.82 146.5 13.74 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 126.682 1.993 . . . . 0.0 111.321 -175.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -107.87 142.01 38.6 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.526 ' HG ' ' HG3' ' A' ' 64' ' ' MET . 72.7 m -142.44 163.86 31.71 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -168.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -151.81 133.79 15.0 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.552 1.541 . . . . 0.0 107.668 170.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.6 p -72.22 115.76 11.84 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 169.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 45.6 mt -67.04 -24.98 66.05 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.986 -0.446 . . . . 0.0 110.002 172.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.92 -164.32 37.74 Favored Glycine 0 C--N 1.336 0.536 0 N-CA-C 108.374 -1.89 . . . . 0.0 108.374 172.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -155.13 -176.41 27.31 Favored Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 111.004 -0.838 . . . . 0.0 111.004 171.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -171.44 -156.4 11.82 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 -175.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.1 ttp180 -135.66 147.0 48.41 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 -177.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.3 mt -121.79 141.2 43.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 106.484 -1.672 . . . . 0.0 106.484 -174.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.2 m -141.43 170.06 16.44 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.018 1.327 . . . . 0.0 110.657 -171.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 7.0 m170 65.17 179.9 0.19 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.948 2.099 . . . . 0.0 111.546 -170.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -142.62 152.92 42.99 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.558 1.143 . . . . 0.0 108.799 -172.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.7 m -66.66 7.99 0.3 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.144 2.178 . . . . 0.0 115.163 -171.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -139.04 18.03 2.63 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.75 1.62 . . . . 0.0 110.04 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -137.05 -52.56 0.68 Allowed 'General case' 0 N--CA 1.467 0.384 0 O-C-N 121.581 -0.699 . . . . 0.0 112.291 -170.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -159.39 159.63 33.98 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.709 1.204 . . . . 0.0 107.768 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 42.0 pttt -48.34 137.01 11.7 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 172.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 41.7 mm -59.21 149.04 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 176.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 19.4 t60 -131.15 152.32 50.56 Favored 'General case' 0 CA--C 1.515 -0.367 0 O-C-N 121.554 -0.716 . . . . 0.0 109.699 176.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.6 t -133.22 132.57 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 -176.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -160.15 -167.93 2.07 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.937 1.295 . . . . 0.0 108.886 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.15 -171.34 42.96 Favored Glycine 0 CA--C 1.525 0.703 0 O-C-N 121.612 -0.68 . . . . 0.0 113.632 176.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -161.87 152.89 18.01 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.523 1.129 . . . . 0.0 110.123 -169.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.5 t -81.59 168.45 18.17 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 167.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 20.8 ptp -111.44 -29.68 7.69 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 121.215 -0.928 . . . . 0.0 111.39 170.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.19 -25.76 59.88 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.716 1.144 . . . . 0.0 111.434 171.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -131.76 -7.14 3.6 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.886 0.874 . . . . 0.0 113.015 -169.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.39 -179.11 48.94 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 123.735 0.683 . . . . 0.0 113.638 172.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -68.4 142.08 53.33 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.83 2.354 . . . . 0.0 110.743 173.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.68 178.19 6.26 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 168.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -63.61 -28.4 69.9 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 119.045 -0.503 . . . . 0.0 111.868 170.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.477 ' CD2' ' HH ' ' A' ' 22' ' ' TYR . 42.4 m80 59.08 -23.16 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 128.283 2.633 . . . . 0.0 116.63 -173.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.72 -39.04 93.31 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.688 1.195 . . . . 0.0 110.794 172.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 75.3 mt -63.33 -44.44 99.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 175.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.1 -44.62 94.71 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.135 0.974 . . . . 0.0 111.252 -177.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.54 -51.0 67.3 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 119.275 0.943 . . . . 0.0 110.611 176.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -57.6 -43.98 85.1 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.027 0.83 . . . . 0.0 110.62 -177.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -71.41 -40.27 70.57 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 118.102 -0.951 . . . . 0.0 111.832 -178.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 83.8 mt -69.3 -34.89 64.96 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-N 120.78 1.627 . . . . 0.0 108.957 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -61.84 -43.72 98.29 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 120.404 1.457 . . . . 0.0 110.385 171.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.86 -37.67 87.78 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.922 0.783 . . . . 0.0 111.615 178.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 41.6 tptt -66.61 -38.2 86.49 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.804 0.842 . . . . 0.0 111.142 176.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -130.7 68.97 82.24 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 124.208 1.003 . . . . 0.0 110.048 -171.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -68.47 -19.4 42.99 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.536 2.158 . . . . 0.0 112.519 -175.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -73.53 -5.37 39.71 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.706 1.202 . . . . 0.0 112.258 172.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -136.64 -168.43 2.26 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.824 1.65 . . . . 0.0 109.396 -173.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -147.62 164.01 34.83 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.774 0.797 . . . . 0.0 110.138 -178.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.7 p -145.99 154.26 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 126.163 1.785 . . . . 0.0 106.755 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 21.2 p -139.05 171.48 14.25 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.923 0.889 . . . . 0.0 109.399 171.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 19.6 p-90 -141.56 151.95 43.65 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 169.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.46 137.05 12.13 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 103.933 -2.617 . . . . 0.0 103.933 169.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -80.7 46.49 0.88 Allowed 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 119.395 0.998 . . . . 0.0 109.708 178.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -67.28 -28.47 68.04 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 125.584 1.554 . . . . 0.0 112.442 -169.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -170.49 -175.37 39.19 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 125.194 1.378 . . . . 0.0 109.737 -178.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 73.8 t80 . . . . . 0 C--O 1.234 0.272 0 CA-C-O 121.267 0.556 . . . . 0.0 109.926 -178.719 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtt . . . . . 0 N--CA 1.482 1.163 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.09 169.5 22.23 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.223 1.409 . . . . 0.0 108.693 176.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.52 140.6 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 177.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -76.65 179.91 5.72 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.472 0.709 . . . . 0.0 110.895 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -149.68 153.22 36.63 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 125.963 1.705 . . . . 0.0 106.486 171.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 44.2 mt -56.39 -33.18 65.5 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 118.697 0.681 . . . . 0.0 112.666 -176.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.52 -25.49 65.87 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.919 0.781 . . . . 0.0 112.167 177.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.1 mt -86.64 -21.91 26.47 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.87 0.868 . . . . 0.0 111.372 -176.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 56.7 mt -64.54 128.56 93.55 Favored Pre-proline 0 CA--C 1.54 0.559 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 178.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -46.3 114.94 0.97 Allowed 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 124.232 3.288 . . . . 0.0 111.58 172.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -72.08 -30.81 65.49 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.369 0.668 . . . . 0.0 112.071 -169.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 42.3 t -143.12 142.47 25.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 171.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -151.38 127.8 10.67 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 169.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 40.9 pt -147.53 163.98 6.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 127.622 2.369 . . . . 0.0 106.219 -176.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -143.82 -37.55 0.33 Allowed 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.01 165.69 12.87 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.27 0.628 . . . . 0.0 111.069 172.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -143.97 84.78 1.79 Allowed 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.844 1.258 . . . . 0.0 108.089 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.3 -166.05 39.38 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 -173.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 66.6 t -66.45 126.75 26.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 169.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -160.05 158.37 30.34 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.782 0.833 . . . . 0.0 110.815 169.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -77.86 154.12 32.07 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.019 0.928 . . . . 0.0 110.495 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -142.28 164.91 28.88 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.313 1.045 . . . . 0.0 108.891 175.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.9 m -132.14 152.91 37.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 C-N-CA 124.589 1.156 . . . . 0.0 109.287 172.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.2 tp -108.11 117.95 35.49 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 177.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 95.4 mt -122.7 123.04 67.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -171.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -79.57 147.8 31.98 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 169.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.5 p -138.38 146.99 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 175.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 -120.01 156.96 29.85 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.852 1.261 . . . . 0.0 108.78 -176.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.4 m -63.15 87.64 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.698 1.199 . . . . 0.0 111.922 177.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.415 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -138.55 19.39 0.05 OUTLIER Pre-proline 0 CA--C 1.551 1.019 0 CA-C-O 116.405 -1.759 . . . . 0.0 114.449 169.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 30' ' ' ALA . 80.1 Cg_exo -43.96 137.33 6.98 Favored 'Trans proline' 0 C--N 1.36 1.157 0 CA-C-N 123.976 2.456 . . . . 0.0 113.681 172.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.4 mmp_? 42.38 25.45 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 127.497 2.319 . . . . 0.0 114.339 -172.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.2 m 50.4 30.57 4.66 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.028 1.331 . . . . 0.0 112.236 -173.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -153.47 -1.61 0.17 Allowed Glycine 0 CA--C 1.53 0.992 0 CA-C-O 118.508 -1.162 . . . . 0.0 114.684 -169.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.29 135.25 75.66 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 119.462 1.631 . . . . 0.0 109.846 170.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -77.99 -21.31 10.96 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.764 2.309 . . . . 0.0 113.201 -176.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.16 162.95 18.69 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.696 0.799 . . . . 0.0 110.851 177.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.24 66.9 0.96 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.996 1.319 . . . . 0.0 108.42 177.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -133.38 -172.26 2.91 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.739 1.616 . . . . 0.0 108.514 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.8 m -142.26 158.17 44.02 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.958 0.903 . . . . 0.0 110.334 -174.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -149.21 166.01 30.16 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 127.56 2.344 . . . . 0.0 105.947 -175.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.8 mp0 -125.33 151.6 45.83 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 174.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 21.2 pt -127.27 155.04 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 125.997 1.719 . . . . 0.0 108.594 173.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 85.1 t -127.87 115.96 41.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 -173.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 26.7 mmt85 -135.33 139.82 44.6 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -176.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -170.92 141.61 6.6 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 178.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -156.1 149.02 24.15 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -171.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -58.77 -32.83 69.65 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 118.839 -0.6 . . . . 0.0 111.61 174.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 9.7 p-90 -65.32 -26.83 68.22 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.018 0.826 . . . . 0.0 112.489 177.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.41 73.44 10.5 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 119.337 0.971 . . . . 0.0 109.524 175.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -65.67 -8.56 21.27 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.35 0.66 . . . . 0.0 112.104 176.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -138.17 144.91 40.94 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 126.896 2.079 . . . . 0.0 106.836 177.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 60.9 m80 -71.44 -31.13 66.84 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 121.885 -0.509 . . . . 0.0 109.979 -171.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.47 -27.27 47.31 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 118.258 -0.877 . . . . 0.0 112.676 171.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -68.33 -48.93 63.58 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 119.818 1.19 . . . . 0.0 110.763 -176.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.32 -40.26 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 CA-C-O 117.732 -1.127 . . . . 0.0 109.782 175.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -62.49 -44.66 95.85 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 120.047 1.294 . . . . 0.0 110.599 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -62.49 -47.34 84.42 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.818 0.735 . . . . 0.0 111.369 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 31.7 tttt -62.29 -53.59 52.92 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.245 0.618 . . . . 0.0 110.999 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 92.0 t -73.52 -48.35 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-O 118.539 -0.743 . . . . 0.0 109.179 -171.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.0 t -63.32 -34.74 78.35 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 119.568 1.076 . . . . 0.0 109.759 178.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.28 -48.59 85.24 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-N 118.978 0.808 . . . . 0.0 111.182 172.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -63.02 -43.6 98.29 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 118.69 1.245 . . . . 0.0 111.596 178.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 39.2 mmt -59.27 -47.31 85.85 Favored 'General case' 0 CA--C 1.527 0.077 0 C-N-CA 122.769 0.428 . . . . 0.0 110.111 176.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -64.92 -32.69 74.53 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.423 0.689 . . . . 0.0 111.274 179.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -67.4 -35.65 79.71 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.443 1.019 . . . . 0.0 111.052 170.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -69.03 -15.8 63.55 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 119.838 1.199 . . . . 0.0 111.286 169.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 109.17 -18.82 30.46 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 126.838 2.161 . . . . 0.0 111.94 177.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 73.1 m -57.05 162.91 2.27 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.654 1.982 . . . . 0.0 112.874 -175.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -123.25 137.35 54.89 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 176.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 80.4 m -142.69 166.17 25.4 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -168.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -151.09 131.65 13.88 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.797 1.239 . . . . 0.0 108.32 170.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.3 p -69.74 115.77 9.36 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 169.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 64.3 mt -66.97 -26.93 67.06 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.984 0.514 . . . . 0.0 109.95 173.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.08 -172.97 42.92 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 169.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -123.13 165.52 15.76 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 110.951 -0.859 . . . . 0.0 110.951 175.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -168.54 -163.56 22.74 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -178.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.7 ttp180 -146.45 158.37 43.88 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 121.141 -1.211 . . . . 0.0 107.763 -175.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 56.7 mt -120.98 130.79 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 104.851 -2.278 . . . . 0.0 104.851 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 30.1 m -152.33 176.49 11.56 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.478 1.911 . . . . 0.0 108.237 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -81.24 150.57 28.53 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 168.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -62.29 -35.46 79.1 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.888 0.767 . . . . 0.0 112.876 -174.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 77.7 p -170.73 -147.9 0.06 Allowed 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 -172.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -64.54 -20.36 66.18 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.486 0.585 . . . . 0.0 110.52 168.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -76.24 136.16 39.68 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 123.538 0.735 . . . . 0.0 109.161 169.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -80.92 -6.59 58.87 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 117.405 -1.283 . . . . 0.0 113.909 -169.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -50.37 129.25 21.45 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 120.052 1.296 . . . . 0.0 108.587 177.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 49.6 mm -69.12 146.0 12.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -176.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 12.4 t60 -130.29 143.11 50.58 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 54.5 t -131.82 106.0 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 -169.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -164.16 162.86 23.02 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.311 0.644 . . . . 0.0 109.517 -175.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 143.08 -169.08 25.85 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -155.85 151.66 27.41 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.101 0.56 . . . . 0.0 110.64 171.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.4 t -90.41 161.34 15.61 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 168.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 27.6 ptm -94.04 -33.91 13.22 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 118.995 0.816 . . . . 0.0 110.018 169.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.6 -25.38 56.94 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.905 0.775 . . . . 0.0 112.006 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -133.46 -4.13 2.98 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -169.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.83 -175.39 52.03 Favored Glycine 0 CA--C 1.535 1.326 0 CA-C-N 119.031 0.832 . . . . 0.0 113.344 173.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.99 138.8 37.93 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.385 2.724 . . . . 0.0 111.206 175.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.24 168.44 17.29 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 168.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 23.0 mm100 -68.55 -27.07 65.76 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.856 -0.528 . . . . 0.0 111.864 172.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 37.6 m80 60.48 -29.24 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 128.962 2.905 . . . . 0.0 115.895 -175.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.8 -40.66 93.5 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.536 1.134 . . . . 0.0 112.467 -179.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.3 mp -62.55 -46.33 96.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 177.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.3 m -59.47 -47.22 86.34 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 123.892 0.877 . . . . 0.0 110.621 -176.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.5 p -64.77 -41.12 96.1 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 118.097 -0.954 . . . . 0.0 111.065 -176.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -58.91 -45.51 90.13 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.951 1.25 . . . . 0.0 110.649 177.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 44.3 mttm -67.41 -46.24 73.79 Favored 'General case' 0 N--CA 1.462 0.158 0 O-C-N 122.128 -0.358 . . . . 0.0 111.037 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 55.7 mt -68.57 -38.05 78.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -176.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -58.62 -42.15 87.56 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 120.523 1.511 . . . . 0.0 110.031 174.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.0 -40.41 96.3 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.646 0.657 . . . . 0.0 111.369 177.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -66.89 -23.06 65.95 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.197 0.599 . . . . 0.0 112.205 174.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 9.9 t80 50.19 53.19 13.78 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 126.327 1.851 . . . . 0.0 113.244 174.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -71.19 -16.08 31.76 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 122.193 1.928 . . . . 0.0 111.78 173.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -148.5 166.66 27.53 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 127.481 2.312 . . . . 0.0 106.861 177.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -49.58 -40.73 39.7 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.938 1.295 . . . . 0.0 112.695 178.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -157.64 165.87 34.35 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 119.197 0.908 . . . . 0.0 110.757 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.4 t -140.12 143.94 28.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 126.389 1.876 . . . . 0.0 106.04 -175.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 6.3 p -139.66 170.23 16.28 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.335 1.054 . . . . 0.0 109.879 177.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 39.5 p-90 -140.96 161.28 38.21 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 169.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -158.47 141.92 15.11 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 103.915 -2.624 . . . . 0.0 103.915 169.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -80.84 48.83 1.13 Allowed 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 119.216 0.917 . . . . 0.0 109.269 176.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -66.7 -33.68 76.17 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 125.018 1.327 . . . . 0.0 113.476 -169.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 162.75 -159.94 32.31 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -171.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 86.1 t80 . . . . . 0 C--O 1.237 0.443 0 CA-C-O 121.46 0.647 . . . . 0.0 109.899 173.911 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 N--CA 1.484 1.261 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.25 168.73 23.17 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.329 1.452 . . . . 0.0 108.627 176.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.2 p -147.35 143.33 19.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 178.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -81.0 -176.42 5.92 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.205 0.602 . . . . 0.0 110.526 178.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -152.39 151.25 30.59 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 169.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 78.1 mt -56.08 -34.62 66.14 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.273 0.629 . . . . 0.0 112.549 -176.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.1 -25.21 65.21 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.691 0.678 . . . . 0.0 112.08 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.5 mt -83.41 -21.74 32.91 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.539 0.736 . . . . 0.0 111.328 -177.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.4 mt -65.34 127.48 92.96 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 177.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -47.76 125.38 11.15 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 123.649 2.899 . . . . 0.0 111.193 171.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -76.48 -36.44 57.84 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.097 0.475 . . . . 0.0 111.008 -173.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.6 t -140.67 133.07 31.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 177.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -154.56 119.76 5.02 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 105.072 -2.196 . . . . 0.0 105.072 169.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.7 pp -145.6 158.9 12.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 C-N-CA 124.477 1.111 . . . . 0.0 109.53 -171.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -74.11 -179.61 3.91 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.963 1.705 . . . . 0.0 110.455 171.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.9 m -142.92 22.3 1.93 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.978 1.311 . . . . 0.0 111.227 -177.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -57.48 -39.99 77.63 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -169.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 152.95 -50.35 0.51 Allowed Glycine 0 C--N 1.336 0.534 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 177.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.3 t -146.32 130.62 10.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 105.642 -1.985 . . . . 0.0 105.642 170.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -159.34 152.85 22.64 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.931 0.787 . . . . 0.0 110.385 178.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -72.94 151.32 41.91 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.702 0.801 . . . . 0.0 110.758 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.462 ' HH ' ' CD2' ' A' ' 102' ' ' HIS . 0.2 OUTLIER -144.12 161.85 37.78 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.848 1.259 . . . . 0.0 107.845 177.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.5 m -130.34 151.45 35.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 C-N-CA 124.24 1.016 . . . . 0.0 109.349 174.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.74 114.58 28.88 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 103.643 -2.725 . . . . 0.0 103.643 176.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.8 mt -120.31 124.79 73.28 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -172.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.2 ttm180 -78.93 143.69 35.57 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 168.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.5 p -137.39 136.88 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 178.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -107.18 148.91 28.29 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.889 1.275 . . . . 0.0 109.006 -172.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.1 p -72.43 85.25 1.12 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.56 0.695 . . . . 0.0 111.138 178.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -131.52 33.07 0.23 Allowed Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 124.602 1.161 . . . . 0.0 112.368 169.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -60.61 141.94 96.54 Favored 'Trans proline' 0 C--N 1.354 0.824 0 CA-C-N 122.133 1.798 . . . . 0.0 109.961 -178.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.0 mmp_? 44.37 21.86 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.86 2.064 . . . . 0.0 113.953 -169.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.5 m 48.2 30.89 2.34 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.362 1.465 . . . . 0.0 112.428 -171.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -125.03 -18.81 2.53 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-O 118.751 -1.027 . . . . 0.0 114.068 -169.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.29 133.37 95.44 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 119.124 1.462 . . . . 0.0 110.013 176.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -79.36 -14.94 12.86 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.087 2.524 . . . . 0.0 112.599 176.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.4 164.57 8.94 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.117 0.967 . . . . 0.0 111.089 176.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -148.86 48.91 1.0 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.968 1.307 . . . . 0.0 108.573 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -102.4 175.89 5.36 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 125.963 1.705 . . . . 0.0 108.692 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.6 m -139.85 158.85 43.41 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.639 0.776 . . . . 0.0 110.256 175.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -142.07 166.41 24.78 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 127.973 2.509 . . . . 0.0 105.417 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 30.7 mp0 -126.69 149.75 49.38 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.1 pt -132.94 155.62 41.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 C-N-CA 125.059 1.344 . . . . 0.0 109.86 178.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 85.3 t -117.66 114.93 46.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.9 mmp_? -126.6 147.14 49.93 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 173.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 178.72 139.27 3.46 Favored Glycine 0 C--N 1.331 0.259 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 176.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.404 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 20.6 m-85 -154.59 150.22 27.49 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 123.397 0.679 . . . . 0.0 109.344 -171.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.4 tptt -62.31 -26.55 68.49 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 118.578 -0.725 . . . . 0.0 112.055 177.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.404 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 9.9 p-90 -63.86 -27.93 69.5 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.677 1.126 . . . . 0.0 112.28 176.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.63 76.05 10.04 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 119.242 0.928 . . . . 0.0 109.491 174.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -66.77 -5.79 13.49 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.219 0.607 . . . . 0.0 112.135 175.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -139.43 144.39 38.05 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 126.471 1.908 . . . . 0.0 107.026 175.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -70.62 -30.98 67.77 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 121.979 -0.451 . . . . 0.0 110.036 -171.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.55 -30.15 40.5 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 118.759 -0.639 . . . . 0.0 112.627 172.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -68.09 -50.52 54.4 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 119.134 0.879 . . . . 0.0 110.804 -175.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.08 -38.42 81.2 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.19 0 CA-C-O 117.761 -1.114 . . . . 0.0 109.935 174.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -60.16 -46.11 90.79 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 120.191 1.36 . . . . 0.0 110.91 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -65.35 -48.47 72.87 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 122.644 0.377 . . . . 0.0 111.275 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 44.3 tttt -62.29 -49.12 76.91 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 123.304 0.642 . . . . 0.0 111.479 -176.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 86.7 t -75.15 -45.5 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-O 118.423 -0.799 . . . . 0.0 109.33 -172.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.9 m -61.85 -35.82 79.42 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 119.423 1.01 . . . . 0.0 110.103 175.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.7 -48.02 87.15 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 173.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -63.35 -45.27 91.99 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 118.96 1.38 . . . . 0.0 111.429 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 39.1 mmt -59.57 -43.9 93.47 Favored 'General case' 0 C--O 1.227 -0.091 0 CA-C-N 118.202 0.456 . . . . 0.0 109.933 177.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -68.58 -27.92 66.48 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.716 0.807 . . . . 0.0 111.752 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -69.39 -36.86 77.18 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 119.455 1.025 . . . . 0.0 109.749 169.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -68.09 -25.79 65.5 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 119.928 1.24 . . . . 0.0 110.266 169.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 122.25 -27.63 6.04 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 128.237 2.827 . . . . 0.0 111.313 174.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 97.2 m -58.58 145.23 40.2 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 126.07 1.748 . . . . 0.0 110.691 -177.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -108.43 156.28 19.62 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 177.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 86.1 m -141.48 165.42 27.56 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 -168.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -150.92 132.7 14.98 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.546 1.538 . . . . 0.0 107.085 169.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.6 p -70.82 121.05 17.32 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 169.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 38.1 mt -70.34 -23.2 62.77 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.99 -0.444 . . . . 0.0 109.902 171.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.94 -166.27 39.04 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 170.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -146.86 173.12 27.17 Favored Glycine 0 CA--C 1.52 0.387 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 172.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -172.35 -156.13 12.07 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 107.356 -2.298 . . . . 0.0 107.356 -178.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 26.9 ptt-85 -142.31 160.25 40.62 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 120.614 -1.521 . . . . 0.0 109.403 176.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 93.7 mt -118.09 145.03 24.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 104.404 -2.443 . . . . 0.0 104.404 -174.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.8 p -144.5 163.07 34.94 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 123.424 0.69 . . . . 0.0 110.393 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -112.08 31.36 6.3 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.089 1.356 . . . . 0.0 109.723 176.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 51.74 -164.8 0.06 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 127.368 2.267 . . . . 0.0 112.677 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.4 p -67.01 -46.92 73.03 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.875 1.27 . . . . 0.0 111.043 176.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -158.36 -39.47 0.06 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.829 0.851 . . . . 0.0 111.522 -177.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -60.09 140.28 56.96 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 118.422 0.556 . . . . 0.0 110.696 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -70.78 -12.94 61.85 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -169.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -58.68 127.53 32.66 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 120.783 1.628 . . . . 0.0 108.167 177.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 71.6 mt -75.18 154.34 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 105.642 -1.984 . . . . 0.0 105.642 174.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 23.1 t60 -138.36 159.08 42.97 Favored 'General case' 0 C--N 1.331 -0.221 0 O-C-N 120.836 -1.165 . . . . 0.0 109.98 177.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.0 t -137.49 130.89 43.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -162.28 -173.99 3.86 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.047 0.939 . . . . 0.0 109.869 -172.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.38 -172.33 50.4 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 123.659 0.647 . . . . 0.0 112.285 178.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -160.79 151.55 18.47 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.716 0.806 . . . . 0.0 111.05 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.0 t -72.43 164.86 25.67 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 168.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 23.0 ptp -111.69 -28.92 7.91 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 118.359 -0.829 . . . . 0.0 111.174 171.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.14 -26.5 60.36 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.737 1.153 . . . . 0.0 111.428 171.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -131.13 -6.04 3.88 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.777 0.831 . . . . 0.0 113.139 -169.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.18 -179.21 42.79 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 123.603 0.62 . . . . 0.0 113.504 173.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.17 135.62 40.99 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.067 2.512 . . . . 0.0 110.633 176.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.74 169.36 18.43 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 169.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -77.98 81.93 4.36 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 168.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.462 ' CD2' ' HH ' ' A' ' 22' ' ' TYR . 43.4 m80 -57.45 -14.94 5.57 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -175.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.58 -39.91 89.79 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.019 1.328 . . . . 0.0 111.47 170.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 63.0 mt -64.5 -47.18 90.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 176.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.9 -50.12 74.42 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.142 0.977 . . . . 0.0 110.526 -176.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 10.1 p -64.56 -47.48 78.58 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 119.243 0.929 . . . . 0.0 111.276 -176.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -60.21 -40.3 89.63 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.397 0.999 . . . . 0.0 110.475 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 49.2 mttm -65.45 -49.08 70.46 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 119.187 -0.435 . . . . 0.0 111.356 176.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 62.9 mt -64.54 -40.14 88.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-N 119.067 0.849 . . . . 0.0 109.16 -176.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -58.62 -48.13 82.04 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.605 1.093 . . . . 0.0 109.633 174.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.86 -39.06 93.27 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.56 0.344 . . . . 0.0 111.328 -178.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 21.7 tptm -67.19 -38.99 86.32 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 118.758 -0.639 . . . . 0.0 110.987 177.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -128.32 69.13 78.08 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 123.808 0.843 . . . . 0.0 110.605 -169.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.34 -12.63 35.5 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 122.857 2.372 . . . . 0.0 112.991 -177.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.45 -9.73 54.93 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.209 1.003 . . . . 0.0 112.274 170.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -126.84 -178.37 4.37 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.613 1.965 . . . . 0.0 108.647 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -136.91 159.17 42.66 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 171.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.4 t -141.01 140.19 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 -171.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.3 p -134.55 173.67 11.39 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 169.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 37.6 p-90 -142.27 156.17 45.27 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.242 0.544 . . . . 0.0 109.905 174.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.71 123.89 5.28 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 103.161 -2.903 . . . . 0.0 103.161 173.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -80.28 27.5 0.33 Allowed 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.484 1.038 . . . . 0.0 113.171 -169.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -67.24 -178.0 0.76 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.783 0.833 . . . . 0.0 109.486 169.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 91.53 -143.2 16.45 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.044 -1.223 . . . . 0.0 110.044 -176.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 86.5 t80 . . . . . 0 C--O 1.239 0.523 0 C-N-CA 124.827 1.251 . . . . 0.0 109.523 -176.628 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 N--CA 1.483 1.178 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.79 172.09 14.18 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 125.23 1.412 . . . . 0.0 108.421 174.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.2 p -152.36 166.17 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 174.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.56 176.03 3.14 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 118.454 0.57 . . . . 0.0 110.933 178.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -155.04 153.22 30.61 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.226 1.011 . . . . 0.0 108.399 177.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.0 mt -54.36 -32.83 57.82 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.771 0.828 . . . . 0.0 112.401 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.79 -23.61 67.43 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.76 0.709 . . . . 0.0 112.527 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 76.0 mt -74.83 -26.72 59.91 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 118.512 0.596 . . . . 0.0 110.944 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.2 mt -72.42 133.03 83.33 Favored Pre-proline 0 C--O 1.239 0.503 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 -177.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.23 135.0 48.21 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 121.067 1.178 . . . . 0.0 109.229 169.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -72.61 -33.48 66.7 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.325 0.583 . . . . 0.0 111.404 -175.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 51.0 t -135.25 138.89 47.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 105.221 -2.14 . . . . 0.0 105.221 172.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -149.92 129.4 13.03 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 169.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.5 pt -146.3 158.9 11.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 126.676 1.99 . . . . 0.0 106.305 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -151.39 44.89 0.79 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 122.004 0.907 . . . . 0.0 110.047 177.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.5 m -145.71 172.39 13.36 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.549 1.54 . . . . 0.0 110.045 -177.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -155.48 167.09 31.52 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.515 1.526 . . . . 0.0 108.232 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.15 -72.14 2.89 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 124.781 1.181 . . . . 0.0 111.194 175.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 70.7 t -154.39 130.4 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 126.511 1.924 . . . . 0.0 106.871 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -163.88 158.31 19.74 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.097 0.959 . . . . 0.0 110.594 169.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -79.53 158.11 27.26 Favored 'General case' 0 C--O 1.233 0.231 0 O-C-N 121.697 -0.627 . . . . 0.0 109.653 176.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.3 163.35 35.79 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.365 1.066 . . . . 0.0 108.805 176.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.2 m -136.65 157.0 36.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 124.655 1.182 . . . . 0.0 110.127 172.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.34 119.59 39.94 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 104.732 -2.322 . . . . 0.0 104.732 177.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 57.2 mt -121.29 114.51 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 CA-C-N 119.488 1.04 . . . . 0.0 108.48 -172.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 24.0 ttm-85 -71.54 138.12 48.61 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 104.967 -2.235 . . . . 0.0 104.967 168.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.4 p -136.31 116.49 17.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 178.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -81.7 142.83 32.33 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 169.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.1 t -67.72 117.01 9.06 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 169.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -143.57 43.11 0.42 Allowed Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 123.781 0.833 . . . . 0.0 108.921 168.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -56.56 131.98 48.99 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.063 1.842 . . . . 0.0 111.731 -169.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.2 ttp180 39.44 30.96 0.06 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 127.281 2.232 . . . . 0.0 113.849 -171.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.3 m 52.53 22.18 2.07 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.449 1.5 . . . . 0.0 113.661 -174.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -97.07 -15.39 39.04 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 124.507 1.051 . . . . 0.0 112.584 -176.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -140.81 60.75 13.7 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 125.229 1.412 . . . . 0.0 108.985 177.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -65.17 135.22 42.52 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 123.083 2.522 . . . . 0.0 112.204 -170.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 38.94 45.69 1.0 Allowed 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 127.494 2.318 . . . . 0.0 113.382 -176.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.29 -37.33 87.11 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.616 -1.174 . . . . 0.0 110.506 176.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -157.38 174.64 15.11 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.591 1.956 . . . . 0.0 107.415 -170.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.0 m -141.86 157.49 44.93 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.941 0.896 . . . . 0.0 110.435 173.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -148.98 165.28 32.1 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 127.767 2.427 . . . . 0.0 106.651 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -125.93 126.89 45.12 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.341 -1.725 . . . . 0.0 106.341 170.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 30.4 pt -110.01 155.51 11.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 125.044 1.338 . . . . 0.0 110.267 175.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 24.5 t -120.43 125.89 74.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 -175.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.4 mmp_? -129.65 146.59 51.43 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.965 1.306 . . . . 0.0 107.739 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -172.98 133.99 2.81 Favored Glycine 0 N--CA 1.453 -0.208 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 169.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.405 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 10.7 m-85 -152.21 159.72 43.51 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -177.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -78.73 -26.13 44.7 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 121.793 -0.567 . . . . 0.0 109.894 -176.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.405 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 12.9 p-90 -61.33 -31.99 71.87 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 119.183 -0.437 . . . . 0.0 111.671 174.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -86.79 71.66 10.29 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 118.735 0.698 . . . . 0.0 109.524 173.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -63.42 -15.39 57.48 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 122.893 0.477 . . . . 0.0 111.775 177.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.41 144.24 51.09 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 126.548 1.939 . . . . 0.0 107.891 177.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 43.6 m80 -68.45 -34.6 76.25 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 119.148 -0.453 . . . . 0.0 112.134 -169.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.08 -28.89 55.85 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 118.311 -0.852 . . . . 0.0 112.645 174.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -68.29 -48.58 64.59 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 119.633 1.106 . . . . 0.0 111.323 -174.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.92 -41.28 89.61 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 CA-C-O 118.438 -0.791 . . . . 0.0 109.772 176.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -61.72 -53.34 57.42 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 118.317 -0.849 . . . . 0.0 109.722 -178.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -60.1 -42.85 95.56 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.16 0.891 . . . . 0.0 111.841 -176.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 31.6 tttt -60.52 -51.14 70.72 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 123.226 0.61 . . . . 0.0 110.796 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 63.9 t -84.74 -36.98 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-O 117.949 -1.024 . . . . 0.0 111.28 -169.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 71.7 p -64.43 -31.89 73.29 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 120.871 1.669 . . . . 0.0 109.684 171.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.66 -50.03 72.11 Favored Glycine 0 C--N 1.337 0.638 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 171.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -62.07 -43.34 99.04 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 118.68 1.24 . . . . 0.0 111.726 178.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 34.6 mmt -60.05 -46.08 90.71 Favored 'General case' 0 C--O 1.225 -0.191 0 N-CA-C 109.776 -0.454 . . . . 0.0 109.776 178.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -68.47 -27.91 66.57 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.606 0.762 . . . . 0.0 112.127 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -68.34 -37.22 80.32 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.34 0.973 . . . . 0.0 109.953 169.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -69.42 -25.37 64.09 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 119.631 1.105 . . . . 0.0 110.494 169.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 120.17 -26.35 7.1 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 127.996 2.713 . . . . 0.0 111.543 177.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 89.7 m -56.06 153.26 9.22 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 126.377 1.871 . . . . 0.0 111.51 -177.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -120.07 140.02 51.66 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -169.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 77.2 m -131.54 165.83 22.74 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 -167.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -153.13 122.48 6.67 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.72 2.008 . . . . 0.0 106.486 172.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.8 p -71.47 120.69 17.41 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 169.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 42.1 mt -68.53 -27.23 65.92 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.996 -0.44 . . . . 0.0 110.109 175.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 171.05 -171.38 43.87 Favored Glycine 0 C--N 1.337 0.592 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 175.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -138.09 164.37 25.56 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 176.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -168.54 -162.16 20.06 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -176.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 57.4 ttt180 -138.78 144.71 39.51 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 121.034 -1.274 . . . . 0.0 107.582 -172.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 99.6 mt -112.28 134.74 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 104.309 -2.478 . . . . 0.0 104.309 172.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.1 m -135.64 164.17 28.47 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 123.753 0.821 . . . . 0.0 108.986 172.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -128.64 21.54 5.99 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.624 1.569 . . . . 0.0 110.65 -175.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -134.04 31.7 3.54 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.964 1.706 . . . . 0.0 108.894 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 90.3 p -67.36 167.72 11.99 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.524 1.129 . . . . 0.0 110.596 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -64.19 -26.14 68.38 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.888 -0.508 . . . . 0.0 110.252 169.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.407 ' O ' ' HE3' ' A' ' 87' ' ' LYS . 34.8 t70 -83.08 -9.85 59.01 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.455 1.102 . . . . 0.0 112.228 178.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 81.8 tttt 65.92 -33.88 0.19 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 128.452 2.701 . . . . 0.0 114.321 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.407 ' HE3' ' O ' ' A' ' 85' ' ' ASP . 0.0 OUTLIER -57.95 157.99 7.15 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 119.495 1.043 . . . . 0.0 109.159 169.625 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.9 pt -58.73 134.97 23.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 168.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 40.9 t60 -132.81 146.62 51.98 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -169.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.9 t -125.08 129.56 73.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 -171.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -161.58 -169.1 2.16 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.673 1.189 . . . . 0.0 107.836 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 103.06 176.11 26.58 Favored Glycine 0 CA--C 1.522 0.53 0 CA-C-N 119.423 1.01 . . . . 0.0 112.113 169.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -151.85 143.85 23.82 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 122.953 0.501 . . . . 0.0 109.965 169.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.8 t -72.79 165.58 24.57 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 168.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 27.7 ptm -103.53 -30.5 10.48 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 118.558 -0.735 . . . . 0.0 110.486 169.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.42 -24.19 53.98 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.403 1.001 . . . . 0.0 111.874 174.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -134.76 -6.98 2.44 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -169.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.24 -173.5 54.91 Favored Glycine 0 CA--C 1.537 1.436 0 CA-C-N 119.325 0.966 . . . . 0.0 113.712 174.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -67.33 156.33 66.66 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.425 2.75 . . . . 0.0 111.116 176.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -104.88 166.16 10.57 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.68 1.192 . . . . 0.0 109.774 171.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -78.99 85.72 4.91 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 169.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -58.43 -16.47 15.06 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -178.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.82 -42.04 78.87 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.595 1.158 . . . . 0.0 111.473 170.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 59.1 mt -65.58 -46.95 88.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.98 -50.51 73.13 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.795 0.838 . . . . 0.0 110.802 -177.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.6 p -66.54 -44.26 82.88 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.891 -174.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -58.09 -43.63 87.18 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.754 1.161 . . . . 0.0 110.34 178.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -69.58 -44.58 70.51 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-O 118.976 -0.535 . . . . 0.0 111.407 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 62.9 mt -66.64 -38.35 81.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 119.674 1.124 . . . . 0.0 109.095 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -59.09 -46.35 88.51 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.805 1.184 . . . . 0.0 109.646 173.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.66 -38.31 90.63 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.398 0.545 . . . . 0.0 111.77 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 39.0 tptt -65.11 -37.61 88.02 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.86 0.864 . . . . 0.0 111.043 176.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -129.27 67.96 79.39 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 124.282 1.033 . . . . 0.0 110.132 -170.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.09 -15.7 39.8 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.754 2.303 . . . . 0.0 113.052 -173.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -71.86 -6.55 42.51 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.996 0.918 . . . . 0.0 112.242 172.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -130.51 -176.02 3.84 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.691 1.996 . . . . 0.0 108.844 -177.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -142.52 160.52 40.13 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 106.671 -1.604 . . . . 0.0 106.671 177.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.1 t -142.55 148.79 19.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 -172.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 17.6 p -137.19 171.35 14.62 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.69 0.796 . . . . 0.0 109.534 177.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 24.8 p-90 -145.16 165.83 27.19 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 121.558 -0.713 . . . . 0.0 111.919 178.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -145.82 164.43 31.94 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.757 2.023 . . . . 0.0 106.622 170.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -107.12 9.25 30.43 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 122.865 0.466 . . . . 0.0 110.783 -174.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -71.97 178.54 3.68 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 121.29 -0.881 . . . . 0.0 108.986 169.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -178.19 -173.05 43.26 Favored Glycine 0 CA--C 1.522 0.492 0 O-C-N 121.334 -0.854 . . . . 0.0 113.99 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 82.8 t80 . . . . . 0 C--O 1.238 0.496 0 C-N-CA 126.402 1.881 . . . . 0.0 112.052 -169.79 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.482 1.148 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.2 153.52 37.68 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 122.061 -0.399 . . . . 0.0 110.02 170.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.9 m -138.46 172.94 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 126.155 1.782 . . . . 0.0 109.026 -176.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.59 172.11 1.74 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.653 0.74 . . . . 0.0 111.056 171.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -150.37 150.17 31.06 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 169.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 68.5 mt -56.83 -32.35 65.66 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -174.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.58 -25.87 66.0 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.039 0.836 . . . . 0.0 112.222 178.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.3 mt -85.24 -23.84 28.06 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 123.786 0.834 . . . . 0.0 111.389 -176.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 61.7 mt -64.64 129.05 94.11 Favored Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 -178.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -44.34 117.11 1.24 Allowed 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 124.494 3.463 . . . . 0.0 111.81 172.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -76.85 -34.93 57.81 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.17 0.51 . . . . 0.0 111.31 -169.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.9 t -137.83 135.78 45.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 174.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -154.16 107.99 2.97 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 169.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 15.6 pt -140.35 164.88 21.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 124.46 1.104 . . . . 0.0 108.419 -172.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.0 -35.29 76.45 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.04 0.936 . . . . 0.0 113.218 -175.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.6 m 55.23 19.28 2.85 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 174.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -132.15 -25.11 2.04 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.93 1.241 . . . . 0.0 112.81 -170.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -146.27 -166.38 12.07 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 123.923 0.773 . . . . 0.0 111.544 176.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 90.4 t -79.18 141.07 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 170.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -159.6 159.74 33.55 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.954 0.902 . . . . 0.0 110.271 177.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -79.76 151.73 30.2 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 169.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.415 ' HH ' ' HB2' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -142.14 158.84 43.29 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.619 1.168 . . . . 0.0 108.466 -178.009 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.9 m -128.37 154.11 38.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 124.662 1.185 . . . . 0.0 109.984 173.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.415 ' HB2' ' HH ' ' A' ' 22' ' ' TYR . 0.9 OUTLIER -110.53 114.46 27.88 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 104.546 -2.39 . . . . 0.0 104.546 178.259 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.2 mt -117.98 121.76 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -172.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -73.47 147.99 43.61 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 169.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.4 t -132.49 146.82 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 178.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -124.95 154.27 41.43 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.604 1.161 . . . . 0.0 108.568 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.3 m -64.26 88.36 0.05 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.034 0.934 . . . . 0.0 111.798 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -136.66 35.39 0.26 Allowed Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 125.295 1.438 . . . . 0.0 112.422 169.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -45.98 141.82 8.78 Favored 'Trans proline' 0 C--N 1.359 1.087 0 CA-C-N 123.009 2.11 . . . . 0.0 111.981 170.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? 37.6 43.84 0.47 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.26 1.824 . . . . 0.0 112.904 -169.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 m 67.35 9.42 6.98 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.932 1.693 . . . . 0.0 113.75 173.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.35 133.91 1.75 Allowed Glycine 0 C--N 1.338 0.683 0 CA-C-N 119.461 1.028 . . . . 0.0 110.675 174.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -147.63 159.69 40.53 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 125.921 1.688 . . . . 0.0 108.301 -177.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.16 -26.2 21.47 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.3 2.0 . . . . 0.0 112.696 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.05 155.71 37.96 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.645 0.778 . . . . 0.0 110.214 173.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.62 34.88 1.16 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.895 1.278 . . . . 0.0 109.87 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.0 mm-40 -82.34 178.24 8.34 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.73 0.812 . . . . 0.0 109.56 177.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.3 m -140.57 159.26 42.6 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.653 1.181 . . . . 0.0 109.051 172.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -149.87 171.28 17.03 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 127.565 2.346 . . . . 0.0 106.185 -173.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.9 mp0 -134.77 152.58 51.87 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 174.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 38.4 pt -130.08 155.06 41.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 125.474 1.51 . . . . 0.0 109.37 176.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 45.4 t -118.42 120.14 63.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.2 mmp_? -128.66 145.01 51.28 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.312 1.445 . . . . 0.0 107.622 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.93 132.92 1.72 Allowed Glycine 0 C--N 1.331 0.282 0 CA-C-N 119.632 1.105 . . . . 0.0 111.142 174.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -154.46 157.87 39.09 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -172.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.3 mttp -58.78 -34.85 71.92 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 119.186 -0.435 . . . . 0.0 111.852 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 15.6 p-90 -65.4 -30.75 71.6 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 118.964 -0.541 . . . . 0.0 112.326 -177.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.53 74.57 10.38 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 119.161 0.891 . . . . 0.0 109.465 175.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.93 -17.36 63.16 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.221 0.608 . . . . 0.0 111.572 175.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.81 144.25 51.09 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 126.147 1.779 . . . . 0.0 108.025 178.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -67.95 -34.93 77.52 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 119.27 -0.395 . . . . 0.0 111.862 -169.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.77 -29.1 53.16 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 118.411 -0.804 . . . . 0.0 112.664 174.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -66.55 -49.88 65.0 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 119.437 1.017 . . . . 0.0 111.394 -172.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.08 -41.4 89.48 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 CA-C-O 118.987 -0.53 . . . . 0.0 110.271 176.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -62.3 -49.05 77.19 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 119.26 -0.4 . . . . 0.0 110.217 -177.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -63.94 -45.3 89.8 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 118.608 0.64 . . . . 0.0 111.149 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 28.7 tttt -57.36 -54.36 47.73 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.523 0.729 . . . . 0.0 110.826 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 91.7 t -80.91 -40.8 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-O 117.799 -1.096 . . . . 0.0 110.827 -169.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 58.2 m -62.94 -25.8 68.51 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 120.77 1.623 . . . . 0.0 110.911 173.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.06 -55.43 29.62 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 169.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -61.26 -39.03 88.84 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 118.645 1.222 . . . . 0.0 112.689 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.462 ' HG3' ' HG ' ' A' ' 71' ' ' CYS . 38.7 mmt -57.26 -47.38 81.56 Favored 'General case' 0 N--CA 1.461 0.077 0 CA-C-N 118.624 0.647 . . . . 0.0 109.515 174.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -67.79 -28.77 67.88 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.15 0.58 . . . . 0.0 112.542 178.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.9 mttm -63.24 -44.34 95.49 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.56 1.073 . . . . 0.0 109.445 169.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -65.93 -25.87 67.33 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 119.183 0.901 . . . . 0.0 110.89 171.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 122.82 -26.25 6.25 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 127.432 2.444 . . . . 0.0 111.64 175.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 97.2 m -53.9 148.46 10.41 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.649 1.98 . . . . 0.0 112.252 -173.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -108.79 138.78 44.56 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -177.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.462 ' HG ' ' HG3' ' A' ' 64' ' ' MET . 91.7 m -141.74 162.16 36.16 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 -168.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -153.01 131.58 12.24 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.595 1.558 . . . . 0.0 107.872 171.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.0 p -69.74 118.5 12.68 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 169.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 43.7 mt -68.49 -25.4 64.95 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.882 -0.511 . . . . 0.0 109.903 172.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.38 -164.29 37.51 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 108.317 -1.913 . . . . 0.0 108.317 173.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -150.88 -179.32 26.53 Favored Glycine 0 N--CA 1.451 -0.303 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 171.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -169.83 -157.19 11.81 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 -175.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -143.45 147.24 34.27 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 -173.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 12.2 mt -121.52 138.93 50.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 -172.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 58.3 p -158.73 -150.75 0.25 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.288 1.835 . . . . 0.0 107.704 -172.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -129.68 164.72 23.33 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.004 1.322 . . . . 0.0 107.596 172.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -59.61 154.51 17.5 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.403 0.621 . . . . 0.0 110.038 175.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.8 m -60.99 -23.23 65.22 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -170.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -139.81 13.64 2.49 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.825 1.25 . . . . 0.0 111.4 -175.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -151.35 147.37 26.84 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.555 1.07 . . . . 0.0 110.477 -176.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -67.5 -12.08 59.48 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -176.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -53.03 131.96 37.09 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 120.153 1.342 . . . . 0.0 108.981 177.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 55.7 mt -66.3 152.02 9.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 -177.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 20.7 t60 -138.87 152.47 47.82 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 121.609 -0.682 . . . . 0.0 109.541 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.6 t -135.01 131.37 52.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 -178.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -160.19 -164.37 1.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 O-C-N 121.486 -0.759 . . . . 0.0 109.388 -177.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.04 -172.23 55.11 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 118.812 0.733 . . . . 0.0 112.457 173.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -162.45 150.07 13.96 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.989 0.915 . . . . 0.0 110.151 -174.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.0 t -78.74 165.59 23.43 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 167.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 21.8 ptp -108.45 -28.99 9.04 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 118.52 -0.752 . . . . 0.0 111.025 171.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.2 -25.16 57.99 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 119.49 1.041 . . . . 0.0 111.602 171.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -133.78 -5.95 2.82 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -169.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.77 -178.07 51.11 Favored Glycine 0 CA--C 1.535 1.335 0 CA-C-N 119.025 0.83 . . . . 0.0 113.575 173.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -68.13 142.31 55.52 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.806 2.337 . . . . 0.0 110.815 174.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.51 177.31 5.4 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 169.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 21.4 mm100 -62.91 -28.59 70.16 Favored 'General case' 0 CA--C 1.535 0.404 0 O-C-N 121.85 -0.532 . . . . 0.0 111.66 172.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . 0.263 38.3 m80 59.45 -27.64 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 128.556 2.742 . . . . 0.0 116.481 -174.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.26 -42.41 99.15 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 119.547 1.067 . . . . 0.0 110.251 173.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 62.2 mt -61.06 -47.26 94.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 176.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.4 -52.35 64.95 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.399 1.079 . . . . 0.0 110.599 -173.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 33.0 p -64.63 -48.47 74.74 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 118.781 -0.628 . . . . 0.0 109.636 -176.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -60.58 -40.24 91.01 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.958 0.799 . . . . 0.0 111.096 -177.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 48.9 mttm -64.78 -46.94 79.97 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 118.877 0.762 . . . . 0.0 111.19 176.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 63.2 mt -62.14 -44.39 98.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -60.19 -44.06 95.38 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.782 0.719 . . . . 0.0 110.336 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.67 -42.07 98.09 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.839 0.456 . . . . 0.0 111.321 178.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -76.66 -25.57 53.87 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 118.475 -0.774 . . . . 0.0 112.553 -178.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -134.61 64.04 61.98 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 124.394 1.078 . . . . 0.0 110.029 -172.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.95 -9.79 27.33 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.169 2.579 . . . . 0.0 113.348 -174.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -66.99 -10.93 54.87 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.97 0.908 . . . . 0.0 112.267 170.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -127.37 175.86 7.88 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.225 1.81 . . . . 0.0 109.103 178.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -136.04 155.32 50.4 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 171.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.3 t -138.09 146.37 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 -169.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.0 p -135.71 170.97 15.13 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.55 1.14 . . . . 0.0 109.283 176.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 34.9 p-90 -147.24 156.81 43.27 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 121.817 -0.552 . . . . 0.0 111.034 172.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -159.23 106.13 1.75 Allowed 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 173.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.63 -13.32 61.98 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -169.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -61.89 -31.79 72.11 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.749 0.82 . . . . 0.0 112.136 176.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -80.46 169.55 52.62 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 111.66 -0.576 . . . . 0.0 111.66 178.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 51.4 p90 . . . . . 0 C--O 1.237 0.397 0 C-N-CA 124.702 1.201 . . . . 0.0 108.303 177.537 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.483 1.178 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.62 163.86 15.45 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.444 0.698 . . . . 0.0 110.521 173.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.9 p -150.49 149.65 14.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 177.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.26 176.3 5.36 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.705 0.802 . . . . 0.0 111.55 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -153.36 149.6 28.0 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 126.488 1.915 . . . . 0.0 106.309 169.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 68.9 mt -54.79 -34.61 62.9 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 123.395 0.678 . . . . 0.0 112.539 -175.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.29 -25.05 65.85 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.861 0.755 . . . . 0.0 112.42 -178.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.8 mt -78.72 -25.05 44.58 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.023 0.529 . . . . 0.0 111.195 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 21.1 mt -70.87 129.39 89.71 Favored Pre-proline 0 CA--C 1.538 0.504 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -176.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -52.87 128.14 27.54 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.703 2.269 . . . . 0.0 110.644 169.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -80.47 -23.71 40.0 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 121.909 -0.495 . . . . 0.0 111.854 176.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.1 t -136.22 131.55 48.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 173.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -163.38 116.04 1.51 Allowed 'General case' 0 C--O 1.233 0.205 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 169.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -142.42 164.41 17.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.379 1.072 . . . . 0.0 109.127 -173.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -132.38 13.84 4.58 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.694 1.598 . . . . 0.0 110.752 175.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.3 m -71.84 66.84 0.57 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.788 1.635 . . . . 0.0 110.534 174.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -72.01 -6.72 44.24 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.784 1.634 . . . . 0.0 112.443 175.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -147.83 -173.58 18.96 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 126.946 2.212 . . . . 0.0 107.665 173.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.4 t -60.65 96.21 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.452 1.101 . . . . 0.0 109.547 -178.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -147.56 157.24 43.48 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 125.156 1.382 . . . . 0.0 109.423 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -71.17 157.1 38.74 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 124.082 0.953 . . . . 0.0 112.073 -171.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -145.31 164.74 30.5 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.066 1.747 . . . . 0.0 107.657 170.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.5 m -131.21 150.92 34.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 C-N-CA 124.28 1.032 . . . . 0.0 109.199 171.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.73 118.67 36.74 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 104.234 -2.506 . . . . 0.0 104.234 173.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 53.6 mt -120.31 124.84 73.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 -177.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -81.18 148.7 29.42 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 169.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.5 t -133.02 147.09 31.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 -175.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -132.49 147.33 52.36 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.815 1.246 . . . . 0.0 107.96 -178.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.8 m -62.25 103.18 0.36 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.524 0.73 . . . . 0.0 111.117 -178.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.462 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -144.45 19.18 0.04 OUTLIER Pre-proline 0 CA--C 1.555 1.146 0 CA-C-O 116.265 -1.826 . . . . 0.0 113.654 169.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.462 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 87.2 Cg_exo -40.81 131.65 2.75 Favored 'Trans proline' 0 C--N 1.365 1.428 0 CA-C-N 123.538 2.299 . . . . 0.0 114.349 178.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . 0.305 1.0 OUTLIER 23.46 47.82 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 130.145 3.378 . . . . 0.0 114.937 -168.723 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.1 m 55.46 24.54 6.87 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.892 1.277 . . . . 0.0 113.419 176.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -147.56 -7.59 0.25 Allowed Glycine 0 CA--C 1.528 0.895 0 CA-C-O 118.413 -1.215 . . . . 0.0 114.974 -169.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.73 133.26 86.31 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 119.553 1.676 . . . . 0.0 110.373 174.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -78.51 -19.87 11.24 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.842 2.362 . . . . 0.0 112.661 178.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.49 160.76 18.64 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.809 0.844 . . . . 0.0 110.859 177.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.08 36.71 1.13 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.428 1.491 . . . . 0.0 109.462 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -87.72 -177.45 5.84 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.327 1.051 . . . . 0.0 109.455 178.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.3 m -141.52 159.24 42.63 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.616 1.166 . . . . 0.0 109.547 175.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -153.41 166.33 33.01 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 127.107 2.163 . . . . 0.0 106.727 -173.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -127.61 154.28 45.42 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 119.577 1.08 . . . . 0.0 108.968 177.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.6 pt -134.73 153.05 34.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 C-N-CA 125.185 1.394 . . . . 0.0 109.37 175.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 43.2 t -118.98 114.22 44.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.4 mmp_? -126.63 147.11 49.95 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 175.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -176.97 141.29 5.32 Favored Glycine 0 C--N 1.331 0.253 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 175.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -152.9 153.83 33.82 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -172.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -59.51 -28.8 67.38 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 8.0 p-90 -70.91 -24.56 62.49 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.115 0.871 . . . . 0.0 112.596 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.42 75.74 9.97 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.586 1.085 . . . . 0.0 110.587 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -63.81 -14.49 53.34 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.288 0.635 . . . . 0.0 112.142 173.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -131.04 136.98 48.96 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.723 1.609 . . . . 0.0 107.317 177.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 34.6 m80 -60.72 -32.5 71.75 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 123.102 0.561 . . . . 0.0 110.594 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.69 -27.85 52.42 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 118.326 -0.845 . . . . 0.0 112.986 172.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -68.43 -49.78 57.5 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 119.619 1.1 . . . . 0.0 110.395 -176.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.36 -40.38 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-O 117.63 -1.176 . . . . 0.0 109.839 175.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -59.88 -47.8 84.28 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 120.301 1.41 . . . . 0.0 110.628 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -64.67 -47.62 77.78 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.569 0.622 . . . . 0.0 111.576 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 46.8 tttt -62.81 -50.75 69.74 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.11 0.564 . . . . 0.0 111.151 -178.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 93.2 t -71.96 -48.41 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-O 118.255 -0.879 . . . . 0.0 108.808 -172.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.9 m -64.21 -26.76 68.65 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 120.098 1.317 . . . . 0.0 111.251 177.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.91 -51.19 57.4 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 170.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -61.01 -43.03 99.48 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 118.495 1.147 . . . . 0.0 111.667 177.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.52 ' HG3' ' HG ' ' A' ' 71' ' ' CYS . 37.3 mmt -59.72 -47.18 86.66 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 118.974 -0.536 . . . . 0.0 109.859 177.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -69.82 -27.54 64.96 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.959 0.8 . . . . 0.0 112.096 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -67.28 -38.29 84.83 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.309 0.959 . . . . 0.0 109.988 169.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -69.02 -26.7 65.13 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 119.655 1.116 . . . . 0.0 110.293 169.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 119.7 -22.73 8.61 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 128.059 2.742 . . . . 0.0 112.219 175.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 92.9 m -52.64 147.98 7.83 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 126.067 1.747 . . . . 0.0 111.791 -178.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -108.11 140.18 41.69 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.52 ' HG ' ' HG3' ' A' ' 64' ' ' MET . 66.7 m -140.71 163.04 33.96 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -168.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -151.78 128.23 10.68 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.515 1.526 . . . . 0.0 107.489 175.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.8 p -70.9 121.46 18.14 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 169.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 51.4 mt -70.17 -27.14 64.28 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.968 -0.457 . . . . 0.0 109.851 171.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.62 -170.34 41.09 Favored Glycine 0 C--N 1.337 0.63 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 173.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -131.98 165.05 23.6 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.399 -0.68 . . . . 0.0 111.399 176.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -166.05 -162.99 18.69 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 125.284 1.421 . . . . 0.0 109.666 177.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 33.8 ptt180 -138.22 159.72 41.31 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 121.067 -1.255 . . . . 0.0 109.2 176.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 84.6 mt -116.91 124.31 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 103.843 -2.651 . . . . 0.0 103.843 -174.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 21.4 m -137.21 176.25 8.88 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 125.392 1.477 . . . . 0.0 109.873 -169.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 62.03 -7.64 0.11 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 128.586 2.754 . . . . 0.0 115.747 172.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -50.51 -31.17 14.74 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.187 1.795 . . . . 0.0 112.381 169.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.8 p -130.31 13.22 5.57 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.96 1.304 . . . . 0.0 111.934 -175.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -125.25 -7.7 7.04 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.879 0.872 . . . . 0.0 111.888 177.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -146.83 -51.52 0.21 Allowed 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.762 1.225 . . . . 0.0 109.58 173.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? 126.26 -40.19 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.482 1 C-N-CA 131.935 4.094 . . . . 0.0 108.8 176.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.1 ttmm -62.42 119.19 8.65 Favored 'General case' 0 C--N 1.343 0.302 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 169.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 21.4 mt -68.25 146.58 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 177.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 20.0 t60 -133.17 146.18 51.31 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 174.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.7 t -137.37 134.84 47.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -171.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -174.42 172.39 3.18 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.253 1.421 . . . . 0.0 107.858 -178.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 144.1 -169.89 26.1 Favored Glycine 0 C--N 1.334 0.441 0 CA-C-N 119.017 0.826 . . . . 0.0 112.249 169.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -160.46 114.11 2.12 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.582 1.553 . . . . 0.0 107.737 -176.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.3 t -72.62 142.65 48.35 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 168.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.0 ppp? -71.64 -39.91 70.07 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 171.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.79 -25.06 35.57 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 118.711 -0.662 . . . . 0.0 112.408 -172.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -134.58 0.47 3.01 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -169.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.94 -175.27 53.95 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-N 119.197 0.908 . . . . 0.0 112.881 176.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -76.16 138.57 20.47 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.975 2.45 . . . . 0.0 109.847 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.48 171.76 9.59 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.094 0.473 . . . . 0.0 110.625 169.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 58.2 mm-40 -64.25 -35.77 81.91 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 119.116 -0.469 . . . . 0.0 111.828 175.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 33.9 m80 59.96 -31.2 0.05 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 128.767 2.827 . . . . 0.0 115.479 -173.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.57 -37.96 85.76 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.132 1.373 . . . . 0.0 112.115 174.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 90.4 mt -63.41 -46.51 95.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 176.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.67 -47.37 84.72 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.193 0.997 . . . . 0.0 110.939 -177.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.9 p -64.23 -51.98 61.01 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 119.137 0.881 . . . . 0.0 110.694 -177.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -60.28 -39.82 88.26 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 118.726 0.694 . . . . 0.0 110.574 -175.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -64.59 -56.05 16.46 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-O 118.462 -0.78 . . . . 0.0 111.187 174.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 66.9 mt -63.36 -41.4 92.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.215 -172.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -54.29 -46.2 72.68 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 120.121 1.328 . . . . 0.0 110.194 175.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -69.28 -28.85 66.65 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -176.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.9 -51.01 62.35 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 119.087 0.858 . . . . 0.0 111.583 -170.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.451 ' H ' ' CD ' ' A' ' 114' ' ' PRO . 37.2 p90 -161.77 -32.6 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.703 0 N-CA-C 117.637 2.458 . . . . 0.0 117.637 -173.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.451 ' CD ' ' H ' ' A' ' 113' ' ' TYR . 88.9 Cg_exo -54.9 130.55 41.23 Favored 'Trans proline' 0 C--N 1.353 0.801 0 CA-C-N 123.196 2.177 . . . . 0.0 114.545 -169.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -76.11 -30.36 58.2 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 168.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -79.56 -158.1 0.15 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 127.643 2.377 . . . . 0.0 108.962 169.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -134.02 169.05 17.71 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.013 -1.054 . . . . 0.0 111.288 -169.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.2 t -134.86 136.69 51.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 16.8 p -137.0 170.79 15.52 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.664 1.12 . . . . 0.0 109.926 176.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 38.5 p-90 -141.49 152.31 44.08 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 172.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -158.53 113.4 2.56 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 103.643 -2.725 . . . . 0.0 103.643 169.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.42 22.34 0.13 Allowed 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 118.808 0.731 . . . . 0.0 112.694 -169.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -61.84 -29.79 70.41 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.949 1.3 . . . . 0.0 111.863 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -88.24 147.09 19.97 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 169.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 . . . . . 0 C--O 1.238 0.463 0 C-N-CA 125.246 1.418 . . . . 0.0 108.855 -174.348 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 N--CA 1.483 1.22 0 CA-C-O 120.557 0.217 . . . . 0.0 110.564 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.78 165.87 26.85 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.278 1.431 . . . . 0.0 107.953 172.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.3 p -150.51 156.83 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 177.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -159.89 -172.82 3.8 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.165 1.786 . . . . 0.0 108.077 -177.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -146.97 147.96 31.24 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 169.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 71.5 mt -57.94 -30.02 65.62 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -173.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.22 -26.71 63.99 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.979 0.809 . . . . 0.0 111.981 177.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.2 mt -83.88 -25.52 30.17 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.772 0.829 . . . . 0.0 111.215 -177.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 51.9 mt -63.34 127.83 91.66 Favored Pre-proline 0 CA--C 1.538 0.506 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -45.9 122.8 5.48 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.968 3.112 . . . . 0.0 111.409 172.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -79.45 -36.24 39.18 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 121.209 0.528 . . . . 0.0 110.768 -172.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 77.9 t -136.69 129.97 45.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 N-CA-C 105.658 -1.978 . . . . 0.0 105.658 175.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -154.69 125.7 7.19 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 170.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.9 pt -144.65 164.16 13.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 124.835 1.254 . . . . 0.0 108.451 -173.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -60.6 144.86 50.79 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.849 0.357 . . . . 0.0 110.152 173.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.0 m -62.25 -35.86 80.24 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.222 1.409 . . . . 0.0 114.45 -169.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -157.61 129.9 7.23 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.366 0.666 . . . . 0.0 109.484 -173.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 149.61 -164.56 29.47 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-O 121.646 0.581 . . . . 0.0 112.503 172.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 93.1 t -125.57 126.55 70.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 169.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -160.47 161.32 32.83 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 122.829 0.452 . . . . 0.0 111.317 -169.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -71.95 156.55 39.13 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 175.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.1 163.74 32.02 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 172.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.2 m -133.29 149.59 31.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 C-N-CA 124.385 1.074 . . . . 0.0 109.15 172.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.53 121.59 41.39 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 104.055 -2.572 . . . . 0.0 104.055 173.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 85.5 mt -122.57 126.47 74.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -177.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -82.14 148.31 28.57 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 169.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.5 t -137.26 147.02 27.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 126.857 2.063 . . . . 0.0 105.606 -173.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -128.11 152.0 48.53 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.684 1.194 . . . . 0.0 108.889 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.8 m -62.86 93.26 0.06 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.31 1.044 . . . . 0.0 111.028 175.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.445 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -141.1 16.39 0.04 OUTLIER Pre-proline 0 CA--C 1.551 0.992 0 CA-C-O 116.245 -1.836 . . . . 0.0 114.115 169.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.445 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 76.8 Cg_exo -46.77 152.58 1.61 Allowed 'Trans proline' 0 C--N 1.363 1.298 0 CA-C-N 124.104 2.501 . . . . 0.0 114.226 175.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.74 12.53 0.41 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.122 1.369 . . . . 0.0 113.359 -173.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.5 m 52.43 29.84 7.47 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.699 1.2 . . . . 0.0 111.511 -169.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -167.25 8.29 0.05 OUTLIER Glycine 0 CA--C 1.531 1.065 0 CA-C-O 118.369 -1.239 . . . . 0.0 115.294 -172.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.33 138.64 67.26 Favored Pre-proline 0 CA--C 1.544 0.747 0 CA-C-N 119.616 1.708 . . . . 0.0 110.294 173.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -77.91 -21.95 10.56 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 122.855 2.37 . . . . 0.0 113.304 -174.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.82 163.01 17.65 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.488 0.715 . . . . 0.0 110.597 176.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.65 35.53 1.16 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.031 1.332 . . . . 0.0 109.824 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -86.61 -178.35 6.37 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.006 0.922 . . . . 0.0 109.587 177.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.9 m -142.17 157.19 45.16 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.711 1.205 . . . . 0.0 109.088 176.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -151.64 167.51 27.9 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 127.146 2.178 . . . . 0.0 106.427 -173.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 -131.88 154.12 49.53 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 175.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 35.8 pt -132.38 155.68 41.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 125.168 1.387 . . . . 0.0 109.852 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 98.6 t -118.16 115.11 47.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 177.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 12.1 mmp_? -125.78 141.93 51.76 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.239 1.416 . . . . 0.0 107.518 176.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -177.9 137.32 3.33 Favored Glycine 0 C--N 1.333 0.363 0 CA-C-N 119.31 0.959 . . . . 0.0 111.113 174.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -153.19 153.3 32.47 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 117.097 0.449 . . . . 0.0 110.54 -169.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -57.26 -32.47 66.62 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.086 0.954 . . . . 0.0 112.274 177.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 13.0 p-90 -67.83 -27.64 66.88 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.853 0.752 . . . . 0.0 112.529 177.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.98 81.63 8.7 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 119.724 1.147 . . . . 0.0 109.438 174.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -64.11 -19.1 65.03 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.266 0.626 . . . . 0.0 112.017 174.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -135.22 152.56 51.67 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 126.327 1.851 . . . . 0.0 108.001 -179.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 44.8 m-70 -73.72 -32.85 64.08 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 121.84 -0.537 . . . . 0.0 109.575 -169.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.0 -28.9 55.64 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 118.481 -0.771 . . . . 0.0 112.597 172.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -66.73 -50.51 62.55 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 119.356 0.98 . . . . 0.0 110.637 -175.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.67 -40.21 85.61 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 CA-C-O 117.257 -1.354 . . . . 0.0 109.826 175.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -60.86 -47.83 84.6 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-N 120.214 1.37 . . . . 0.0 110.243 -178.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -61.73 -46.17 90.78 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.001 0.819 . . . . 0.0 111.886 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 34.4 tttt -61.21 -50.0 74.88 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 123.082 0.553 . . . . 0.0 110.671 178.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 86.6 t -77.54 -39.98 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-O 117.751 -1.119 . . . . 0.0 109.757 -170.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 80.8 p -63.08 -34.16 76.99 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 120.888 1.676 . . . . 0.0 109.617 175.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.65 -53.32 46.34 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 171.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -60.22 -46.26 90.36 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 118.547 1.174 . . . . 0.0 111.813 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.545 ' HG3' ' HG ' ' A' ' 71' ' ' CYS . 38.0 mmt -57.92 -48.96 78.36 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.366 0.666 . . . . 0.0 110.369 177.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -68.21 -28.48 67.28 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.66 0.664 . . . . 0.0 111.996 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -67.95 -38.0 82.28 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 119.243 0.928 . . . . 0.0 110.594 171.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -67.56 -29.86 69.34 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 119.67 1.123 . . . . 0.0 110.437 169.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 126.96 -21.87 5.79 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 127.458 2.456 . . . . 0.0 111.692 174.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 68.1 m -52.45 150.14 5.12 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 125.947 1.699 . . . . 0.0 112.438 -176.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -108.51 136.24 48.45 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 173.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.545 ' HG ' ' HG3' ' A' ' 64' ' ' MET . 99.5 m -144.13 164.96 29.17 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -168.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -149.83 136.17 19.0 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.007 1.723 . . . . 0.0 107.847 171.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.3 p -73.22 125.0 26.75 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 169.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 44.4 mt -75.26 -23.29 57.44 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.812 -0.555 . . . . 0.0 110.398 173.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.01 -174.02 43.52 Favored Glycine 0 C--N 1.337 0.604 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 171.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -123.48 168.07 15.7 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 175.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -172.32 -165.25 29.13 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -173.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -149.38 150.49 32.51 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -169.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 58.7 mt -129.97 147.46 33.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 -172.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.5 p -151.66 168.73 24.07 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.701 1.2 . . . . 0.0 110.744 177.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 4.4 p-80 -170.62 160.67 7.28 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 128.463 2.705 . . . . 0.0 106.194 174.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -154.07 161.42 41.93 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.9 m -55.88 -33.0 64.2 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.163 -0.961 . . . . 0.0 112.104 172.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -92.33 -0.38 57.39 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.199 1.399 . . . . 0.0 111.742 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -150.01 65.47 0.97 Allowed 'General case' 0 C--O 1.233 0.219 0 C-N-CA 125.809 1.644 . . . . 0.0 106.978 -172.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -68.93 -25.85 64.78 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.018 -0.992 . . . . 0.0 113.504 -169.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -60.42 135.84 57.86 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 169.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.6 mt -65.99 150.57 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 170.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 36.2 t60 -131.85 150.74 52.06 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 121.109 -0.995 . . . . 0.0 108.605 177.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.2 t -131.83 136.62 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -178.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -161.0 -161.09 0.79 Allowed 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 125.145 1.378 . . . . 0.0 107.424 -172.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.73 -177.81 45.21 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-O 122.539 1.077 . . . . 0.0 113.451 169.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -164.07 150.64 11.45 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 126.032 1.733 . . . . 0.0 106.793 -169.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.3 t -116.96 145.9 43.35 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.66 1.584 . . . . 0.0 106.813 171.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.0 ptm -87.35 -34.46 18.81 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 118.79 -0.624 . . . . 0.0 110.193 174.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.81 -26.09 56.94 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.117 0.871 . . . . 0.0 111.949 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -131.13 -5.09 3.89 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -169.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.44 173.8 40.27 Favored Glycine 0 CA--C 1.533 1.197 0 CA-C-N 118.858 0.754 . . . . 0.0 112.312 178.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.23 134.37 24.76 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.71 2.273 . . . . 0.0 109.527 177.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.28 166.57 19.86 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.674 0.75 . . . . 0.0 112.433 176.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -77.64 74.87 4.19 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.897 1.279 . . . . 0.0 108.973 169.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -54.15 -22.33 10.93 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -176.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.81 -40.64 89.07 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.955 0.902 . . . . 0.0 111.761 173.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 65.0 mt -63.28 -46.36 95.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.55 -50.86 72.25 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.451 1.1 . . . . 0.0 110.129 -176.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 20.9 p -65.39 -42.61 92.47 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 118.049 -0.977 . . . . 0.0 111.378 -174.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -61.35 -40.86 95.82 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.821 1.191 . . . . 0.0 110.742 178.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 43.4 mttm -66.51 -46.28 76.77 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 121.793 -0.567 . . . . 0.0 111.277 176.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 67.2 mt -64.8 -40.71 89.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -177.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -58.37 -44.37 88.85 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 119.88 1.218 . . . . 0.0 109.862 174.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.52 -38.92 91.83 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 119.11 -0.471 . . . . 0.0 111.63 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 57.4 tttt -72.29 -32.93 67.04 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.99 0.814 . . . . 0.0 111.802 176.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -125.92 63.2 47.05 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 123.784 0.834 . . . . 0.0 111.129 -170.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.44 -14.33 36.91 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.871 2.381 . . . . 0.0 112.984 -176.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -70.92 -7.83 48.67 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.143 0.977 . . . . 0.0 112.175 171.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -129.15 -170.81 2.34 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.818 2.047 . . . . 0.0 108.373 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -134.87 168.69 18.62 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 171.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.7 t -142.55 143.45 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 26.0 p -136.21 172.0 13.65 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.075 0.95 . . . . 0.0 108.912 173.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 45.7 p-90 -145.45 155.62 43.23 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.076 0.465 . . . . 0.0 110.752 172.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -154.85 130.45 9.9 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 104.304 -2.48 . . . . 0.0 104.304 172.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -81.66 35.98 0.42 Allowed 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 119.442 1.019 . . . . 0.0 113.201 -169.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -73.91 -178.29 3.2 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.324 -0.86 . . . . 0.0 109.819 173.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 70.88 -167.5 51.03 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.254 0.93 . . . . 0.0 113.638 175.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 38.5 t80 . . . . . 0 C--O 1.241 0.615 0 C-N-CA 125.633 1.573 . . . . 0.0 109.163 -174.754 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 mpp? . . . . . 0 N--CA 1.483 1.221 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.3 165.39 34.16 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.015 1.326 . . . . 0.0 108.693 175.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.0 t -139.9 137.34 38.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.09 -176.28 3.96 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.287 0.565 . . . . 0.0 110.743 178.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -151.87 152.14 32.2 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.544 1.538 . . . . 0.0 106.864 170.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.2 mt -57.03 -31.66 65.38 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.568 0.622 . . . . 0.0 112.553 -176.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.84 -24.7 65.3 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 118.825 0.739 . . . . 0.0 112.376 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.2 mt -85.31 -18.68 33.15 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.549 0.74 . . . . 0.0 111.499 -176.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 50.1 mt -65.01 131.84 95.32 Favored Pre-proline 0 CA--C 1.54 0.577 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -50.4 115.79 2.13 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 123.503 2.802 . . . . 0.0 110.104 169.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -70.73 -39.18 73.5 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -169.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 45.5 t -140.83 138.5 34.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 176.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -152.51 112.49 3.99 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 169.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 40.0 pt -138.2 36.33 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 124.693 1.197 . . . . 0.0 109.88 -169.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -62.66 92.48 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.052 1.341 . . . . 0.0 111.837 -177.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.6 m -165.06 178.27 7.17 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 127.84 2.456 . . . . 0.0 107.803 176.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -139.9 159.31 42.47 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.344 1.458 . . . . 0.0 108.495 -178.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.93 -165.79 44.74 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -169.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.6 t -72.61 141.43 16.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 171.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -153.42 158.79 41.95 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.58 1.152 . . . . 0.0 108.807 171.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.4 mmtp -74.68 154.57 38.4 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.045 0.938 . . . . 0.0 109.174 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.428 ' HH ' ' HB2' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -145.99 161.58 39.78 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.75 0.82 . . . . 0.0 108.985 176.369 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.6 m -133.79 152.09 34.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 C-N-CA 124.897 1.279 . . . . 0.0 109.331 173.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.428 ' HB2' ' HH ' ' A' ' 22' ' ' TYR . 28.2 tp -108.83 116.12 31.38 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 105.226 -2.138 . . . . 0.0 105.226 177.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 86.0 mt -120.15 119.12 59.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -169.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.3 ttp180 -78.13 145.36 35.75 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 168.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.3 p -139.25 148.85 23.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -130.71 145.95 52.06 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.084 1.353 . . . . 0.0 108.29 -169.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.0 m -61.38 108.23 0.9 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.644 0.778 . . . . 0.0 111.266 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.411 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -150.35 22.25 0.03 OUTLIER Pre-proline 0 CA--C 1.552 1.03 0 C-N-CA 125.185 1.394 . . . . 0.0 112.441 168.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 30' ' ' ALA . 45.5 Cg_endo -60.7 134.07 51.94 Favored 'Trans proline' 0 C--N 1.359 1.087 0 CA-C-N 122.669 1.989 . . . . 0.0 110.998 -171.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 38.16 27.21 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 129.263 3.025 . . . . 0.0 114.21 -169.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.0 m 46.1 33.23 1.64 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.418 1.487 . . . . 0.0 112.371 -171.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -128.41 -28.84 0.81 Allowed Glycine 0 C--N 1.341 0.82 0 CA-C-O 118.688 -1.062 . . . . 0.0 113.766 -169.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.28 140.65 96.9 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 119.241 1.52 . . . . 0.0 109.919 175.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -78.09 -14.74 14.97 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.106 2.537 . . . . 0.0 112.958 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.45 155.83 20.78 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.934 0.894 . . . . 0.0 111.251 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -143.5 36.22 1.32 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.75 1.62 . . . . 0.0 109.007 177.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -85.95 -178.52 6.59 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.393 1.077 . . . . 0.0 109.585 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.4 m -140.71 157.85 44.83 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.393 1.077 . . . . 0.0 109.29 173.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -152.87 168.26 26.35 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 127.354 2.261 . . . . 0.0 106.23 -173.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -130.88 147.39 52.52 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.03 -1.044 . . . . 0.0 108.614 177.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 29.8 pt -130.75 156.0 42.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 125.881 1.672 . . . . 0.0 109.315 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.2 t -131.23 116.53 33.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 -169.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.5 mmt85 -137.22 148.9 46.82 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -176.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 177.69 137.43 2.75 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -154.85 154.09 32.18 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -170.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -59.71 -29.22 67.97 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.274 0.629 . . . . 0.0 112.651 178.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 11.2 p-90 -69.4 -28.21 65.96 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.014 0.825 . . . . 0.0 112.258 178.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.86 77.67 9.67 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 119.41 1.005 . . . . 0.0 109.022 175.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -63.13 -18.59 63.6 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 122.937 0.495 . . . . 0.0 111.303 173.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.65 146.3 51.44 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.64 1.576 . . . . 0.0 107.724 178.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -72.67 -30.22 64.08 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.131 0.572 . . . . 0.0 110.262 -169.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.41 -30.8 42.05 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 118.636 -0.697 . . . . 0.0 112.549 170.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -69.37 -47.61 63.75 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 119.34 0.973 . . . . 0.0 110.902 -175.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.73 -40.8 84.52 Favored 'Isoleucine or valine' 0 C--N 1.34 0.178 0 CA-C-O 117.891 -1.052 . . . . 0.0 110.117 175.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -61.21 -45.65 93.7 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.747 1.158 . . . . 0.0 110.288 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -62.53 -47.16 85.13 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.318 0.508 . . . . 0.0 111.583 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 26.1 tttp -63.62 -54.08 41.5 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 122.814 0.446 . . . . 0.0 110.995 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 97.3 t -71.07 -52.36 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -170.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 33.4 m -67.2 -27.96 67.69 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 119.206 0.912 . . . . 0.0 111.249 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.56 -46.92 93.3 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 170.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -63.23 -42.22 99.22 Favored 'General case' 0 CA--C 1.526 0.053 0 CA-C-N 118.568 1.184 . . . . 0.0 111.245 176.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.5 mmt -59.72 -45.1 93.18 Favored 'General case' 0 C--O 1.226 -0.18 0 CA-C-N 118.242 0.473 . . . . 0.0 110.14 176.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.7 mm-40 -66.72 -30.49 70.74 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.817 0.847 . . . . 0.0 111.912 178.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -68.61 -39.19 80.96 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.718 1.145 . . . . 0.0 110.301 170.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -65.4 -26.25 67.9 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.178 0.899 . . . . 0.0 110.431 169.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 119.09 -22.07 9.19 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 128.152 2.786 . . . . 0.0 111.82 175.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 91.3 m -58.69 150.58 23.04 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 126.452 1.901 . . . . 0.0 111.414 -176.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -108.78 146.03 34.24 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.481 1.113 . . . . 0.0 108.174 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 82.4 m -140.01 162.88 34.14 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -168.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -150.81 122.5 8.03 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 125.417 1.487 . . . . 0.0 107.66 173.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.5 p -69.88 120.0 14.95 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 169.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 45.1 mt -68.1 -25.64 65.41 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.987 -0.445 . . . . 0.0 109.893 172.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 165.55 -167.27 38.9 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 125.434 1.492 . . . . 0.0 109.432 170.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -132.76 170.89 21.88 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 123.977 0.799 . . . . 0.0 111.489 176.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -171.16 -161.31 21.59 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 125.471 1.51 . . . . 0.0 109.719 -177.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -142.29 165.95 26.04 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 121.372 -1.075 . . . . 0.0 108.909 174.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 60.1 mt -119.26 136.66 55.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 123.12 0.568 . . . . 0.0 109.544 -169.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 40.1 m 52.02 -162.0 0.09 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.92 2.488 . . . . 0.0 115.48 169.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -127.07 171.78 11.08 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.839 2.056 . . . . 0.0 106.833 175.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -58.43 -30.32 66.81 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.986 -0.446 . . . . 0.0 111.673 -178.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.9 m -71.93 63.53 0.48 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.824 1.65 . . . . 0.0 110.398 169.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -58.3 -17.04 16.76 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.01 1.324 . . . . 0.0 114.011 -175.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -63.87 -24.87 67.91 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.226 1.01 . . . . 0.0 112.557 173.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -63.16 160.93 14.44 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.202 1.001 . . . . 0.0 110.065 175.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -48.53 134.09 15.87 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 169.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 37.6 mm -63.67 148.33 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 -176.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 24.3 t60 -137.06 158.35 44.65 Favored 'General case' 0 C--N 1.332 -0.193 0 O-C-N 121.508 -0.745 . . . . 0.0 109.506 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.5 t -140.16 132.27 32.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -166.88 -173.69 2.47 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.18 0.992 . . . . 0.0 108.809 -172.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.92 -166.33 21.31 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-N 119.059 0.845 . . . . 0.0 112.263 171.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -155.64 178.22 10.5 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.424 1.09 . . . . 0.0 110.145 178.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.8 t -129.91 151.15 50.79 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 104.824 -2.288 . . . . 0.0 104.824 169.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.3 ptm -88.88 -34.05 17.11 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 118.787 -0.625 . . . . 0.0 110.281 175.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.34 -25.85 55.13 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.08 0.855 . . . . 0.0 111.981 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -130.84 -4.63 4.04 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -169.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.94 175.61 42.19 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-N 118.854 0.752 . . . . 0.0 112.353 177.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -66.7 138.43 49.18 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.428 2.085 . . . . 0.0 110.035 173.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.31 169.31 7.44 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.033 0.533 . . . . 0.0 110.953 171.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 21.2 mm100 -63.25 -30.26 71.43 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 118.975 -0.536 . . . . 0.0 111.428 170.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 40.2 m80 60.8 -31.56 0.07 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 129.017 2.927 . . . . 0.0 115.496 -175.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.09 -41.94 93.57 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.202 1.401 . . . . 0.0 112.318 178.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.8 mt -62.38 -49.15 85.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 177.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.4 m -54.68 -45.16 73.89 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.54 1.136 . . . . 0.0 112.172 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -61.3 -50.0 74.76 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 119.747 1.158 . . . . 0.0 110.315 178.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -61.26 -41.42 96.89 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.972 0.805 . . . . 0.0 110.889 -177.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 24.5 mmtp -68.23 -43.82 77.09 Favored 'General case' 0 C--N 1.338 0.086 0 CA-C-O 118.699 -0.667 . . . . 0.0 111.629 178.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 79.9 mt -67.23 -38.15 80.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 119.958 1.254 . . . . 0.0 109.01 -178.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -58.31 -45.25 88.38 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 119.64 1.109 . . . . 0.0 109.49 173.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.05 -37.88 89.03 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.351 0.523 . . . . 0.0 111.787 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 41.7 tptt -62.34 -44.12 97.23 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 123.943 0.897 . . . . 0.0 110.811 178.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -141.59 73.54 24.21 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 118.401 0.546 . . . . 0.0 110.491 -170.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.89 -6.22 18.66 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.307 2.672 . . . . 0.0 113.602 -173.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -68.21 -19.83 64.79 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.84 0.745 . . . . 0.0 111.515 169.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 22.8 m-30 -109.37 178.37 4.46 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.042 1.337 . . . . 0.0 108.822 169.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -131.85 161.14 33.69 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 171.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.6 t -139.97 141.0 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 -169.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 16.9 p -135.06 171.09 14.92 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.137 0.975 . . . . 0.0 109.241 173.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 35.6 p-90 -143.28 152.24 41.45 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 121.597 -0.69 . . . . 0.0 109.436 172.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.42 119.56 3.8 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.182 -2.155 . . . . 0.0 105.182 170.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.42 -3.72 32.21 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 120.309 -0.557 . . . . 0.0 112.345 -171.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -58.34 -30.74 66.96 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.754 1.221 . . . . 0.0 112.692 -178.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -72.7 134.61 20.79 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 173.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 . . . . . 0 C--O 1.239 0.514 0 C-N-CA 125.606 1.562 . . . . 0.0 108.942 177.014 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.9 tpt . . . . . 0 N--CA 1.482 1.157 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.18 153.77 40.25 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.212 1.405 . . . . 0.0 107.383 169.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.1 t -68.33 126.14 27.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -178.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -76.37 -176.46 3.66 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.363 0.665 . . . . 0.0 110.43 172.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -149.21 147.64 28.65 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 169.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 95.1 mt -55.51 -34.21 64.44 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.537 0.735 . . . . 0.0 112.407 -175.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.05 -25.54 66.31 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.834 0.743 . . . . 0.0 112.249 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.6 mt -79.25 -24.01 43.28 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.178 0.591 . . . . 0.0 111.183 -178.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 39.5 mt -68.31 128.78 93.1 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -176.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -47.42 123.05 7.41 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.939 3.093 . . . . 0.0 111.925 172.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -71.87 -37.52 70.19 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.499 0.72 . . . . 0.0 111.294 -177.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 63.9 t -137.52 134.32 46.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 176.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -152.66 119.96 5.92 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 171.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.5 pt -147.96 168.95 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 124.28 1.032 . . . . 0.0 109.299 -169.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -126.05 97.68 5.2 Favored 'General case' 0 N--CA 1.461 0.123 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 169.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.2 m -70.69 51.22 0.14 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 127.928 2.491 . . . . 0.0 113.054 -171.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -60.2 -37.05 79.08 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.515 1.126 . . . . 0.0 113.004 -169.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 160.12 -56.78 0.32 Allowed Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 174.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 46.9 t -142.14 122.98 11.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 173.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -160.15 151.21 19.18 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.309 1.044 . . . . 0.0 108.771 -174.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -75.66 156.3 34.94 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.491 0.717 . . . . 0.0 110.003 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.44 163.34 35.97 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.004 1.322 . . . . 0.0 107.869 -178.151 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.3 m -135.95 156.04 36.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 C-N-CA 124.304 1.041 . . . . 0.0 109.7 172.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.81 122.23 45.97 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 104.225 -2.509 . . . . 0.0 104.225 173.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 73.9 mt -121.53 122.5 67.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 -176.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 37.6 ttp180 -80.74 146.82 30.84 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 169.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.6 t -132.13 143.77 39.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 -175.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -128.96 138.36 51.93 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 176.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.5 p -67.31 115.87 7.44 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.777 0.799 . . . . 0.0 110.641 -175.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.405 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -148.43 27.49 0.05 OUTLIER Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 125.833 1.653 . . . . 0.0 111.609 169.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.405 ' CD ' ' N ' ' A' ' 30' ' ' ALA . 35.2 Cg_endo -59.73 156.06 39.68 Favored 'Trans proline' 0 C--N 1.358 1.064 0 CA-C-N 122.569 1.953 . . . . 0.0 111.985 -173.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.5 ttp180 50.56 19.06 0.52 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.446 1.898 . . . . 0.0 112.664 -169.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.7 m 50.19 31.46 5.11 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.385 1.474 . . . . 0.0 112.282 -173.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -166.59 1.66 0.04 OUTLIER Glycine 0 C--N 1.343 0.917 0 CA-C-O 118.28 -1.289 . . . . 0.0 115.837 -173.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.76 142.05 78.97 Favored Pre-proline 0 CA--C 1.543 0.702 0 CA-C-N 119.858 1.829 . . . . 0.0 110.493 173.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -78.47 -15.77 13.79 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 123.053 2.502 . . . . 0.0 113.495 -175.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.71 157.92 22.94 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.574 0.75 . . . . 0.0 111.333 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.16 76.62 1.28 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.197 1.399 . . . . 0.0 107.531 176.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -138.22 175.69 9.35 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 126.982 2.113 . . . . 0.0 107.416 -177.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.2 m -140.89 157.86 44.77 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.299 0.64 . . . . 0.0 110.589 -175.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -152.22 167.5 28.38 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 127.586 2.355 . . . . 0.0 106.008 -175.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.9 mp0 -133.21 156.49 47.42 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 120.713 -1.242 . . . . 0.0 108.443 176.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 32.2 pt -136.31 155.35 34.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 125.255 1.422 . . . . 0.0 109.807 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 48.1 t -118.14 122.36 69.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 -179.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.1 mmp_? -129.29 146.18 51.23 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.083 1.353 . . . . 0.0 107.832 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 177.32 131.36 1.5 Allowed Glycine 0 C--N 1.331 0.283 0 CA-C-N 119.173 0.897 . . . . 0.0 111.045 173.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -153.95 152.3 30.42 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -173.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.9 pttm -58.89 -29.4 66.99 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 11.1 p-90 -65.4 -27.52 68.6 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.231 0.923 . . . . 0.0 111.854 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.56 75.67 10.01 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 118.871 0.76 . . . . 0.0 109.052 172.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -67.22 -6.59 18.75 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.685 0.794 . . . . 0.0 111.574 175.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -137.28 146.14 44.34 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 126.63 1.972 . . . . 0.0 107.224 173.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 61.1 m-70 -68.97 -34.29 75.08 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -171.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.97 -26.49 48.47 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 118.355 -0.831 . . . . 0.0 112.766 174.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -69.11 -48.06 63.53 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 119.749 1.159 . . . . 0.0 111.111 -175.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.08 -38.02 81.09 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.024 176.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -62.23 -50.32 72.2 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.612 177.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -60.99 -44.12 97.85 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.798 1.181 . . . . 0.0 112.02 -178.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.6 tppt? -57.08 -54.64 44.45 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.169 0.988 . . . . 0.0 110.527 177.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.2 t -85.26 -34.41 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-O 117.619 -1.182 . . . . 0.0 111.974 -168.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 57.2 p -63.26 -33.18 74.94 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 121.345 1.884 . . . . 0.0 109.485 170.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.74 -52.85 50.5 Favored Glycine 0 C--N 1.338 0.64 0 N-CA-C 110.354 -1.099 . . . . 0.0 110.354 171.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -59.86 -44.6 94.04 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.717 1.258 . . . . 0.0 111.993 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.525 ' HG3' ' HG ' ' A' ' 71' ' ' CYS . 35.4 mmt -60.35 -47.98 83.72 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 123.238 0.615 . . . . 0.0 109.903 178.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -68.57 -28.62 67.11 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 118.501 0.591 . . . . 0.0 111.827 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -67.3 -37.7 83.8 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 118.119 -0.943 . . . . 0.0 110.393 170.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -68.82 -30.04 68.51 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.871 1.214 . . . . 0.0 110.31 169.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 126.2 -22.36 5.98 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 127.625 2.536 . . . . 0.0 111.872 175.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 82.5 m -55.52 152.09 9.49 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 126.188 1.795 . . . . 0.0 112.339 -177.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -110.68 140.86 44.66 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.525 ' HG ' ' HG3' ' A' ' 64' ' ' MET . 96.8 m -143.32 165.03 28.61 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -168.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -151.43 127.24 10.27 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.545 1.538 . . . . 0.0 107.542 175.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.2 p -70.56 120.15 15.77 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 169.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 58.3 mt -71.29 -22.96 61.88 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.932 -0.48 . . . . 0.0 110.424 174.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 165.96 -169.27 40.16 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 172.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -135.76 174.96 21.09 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 174.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -178.53 -168.16 37.4 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 -176.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -137.84 163.05 32.38 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 119.029 1.414 . . . . 0.0 109.73 173.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 75.0 mt -116.76 131.5 69.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 -169.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.4 m 57.05 167.2 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 129.69 3.196 . . . . 0.0 116.011 174.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -156.47 156.69 34.18 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.201 1.401 . . . . 0.0 107.498 174.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -57.62 -30.25 65.19 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.046 0.384 . . . . 0.0 111.298 178.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 m -62.99 -18.04 62.83 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.552 1.541 . . . . 0.0 113.876 177.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.1 mm-40 -137.75 -2.66 1.91 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.287 1.035 . . . . 0.0 112.568 -171.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -44.45 -26.75 0.38 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 127.602 2.361 . . . . 0.0 116.847 -169.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -56.04 -17.68 7.55 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 172.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -140.86 143.21 34.61 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 172.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.3 mp -68.21 147.54 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 178.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 28.1 t60 -135.55 159.18 42.41 Favored 'General case' 0 C--N 1.334 -0.091 0 O-C-N 121.297 -0.877 . . . . 0.0 109.427 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.4 t -141.01 135.65 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -166.26 -174.28 2.86 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.623 0.769 . . . . 0.0 109.664 -172.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.35 -170.48 39.05 Favored Glycine 0 CA--C 1.523 0.581 0 O-C-N 121.77 -0.581 . . . . 0.0 112.101 171.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -159.95 152.88 21.59 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.061 0.944 . . . . 0.0 109.845 -178.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.7 t -82.79 154.77 24.56 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 168.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.8 ppp? -82.29 -39.24 23.2 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 171.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.6 -25.59 45.22 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 119.152 -0.451 . . . . 0.0 111.971 -175.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -132.0 -2.32 3.64 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -169.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.88 -174.79 51.0 Favored Glycine 0 CA--C 1.534 1.281 0 CA-C-N 118.903 0.774 . . . . 0.0 113.101 174.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.98 138.34 43.82 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.963 2.442 . . . . 0.0 110.091 173.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.75 170.93 15.24 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.614 0.721 . . . . 0.0 111.488 170.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -78.86 76.02 5.36 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 169.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -57.62 -18.63 21.16 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -174.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.15 -35.77 76.05 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.194 0.998 . . . . 0.0 112.35 171.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 69.4 mt -65.81 -45.53 91.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 176.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.3 m -58.68 -46.85 86.33 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.998 0.919 . . . . 0.0 111.52 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 21.0 p -60.56 -53.26 59.63 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 119.184 0.902 . . . . 0.0 109.325 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -61.81 -40.96 97.07 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.795 0.725 . . . . 0.0 111.437 -175.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -66.53 -48.13 70.69 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 118.708 0.685 . . . . 0.0 111.481 178.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 73.4 mt -66.36 -37.45 79.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 119.229 0.922 . . . . 0.0 109.003 -178.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 46.7 mtpt -61.75 -43.98 97.79 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.615 1.098 . . . . 0.0 110.118 175.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.44 -38.48 91.31 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.687 0.676 . . . . 0.0 111.37 176.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -65.79 -38.47 89.08 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.597 0.759 . . . . 0.0 111.195 177.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -133.05 69.15 78.78 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 124.448 1.099 . . . . 0.0 110.221 -170.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -69.48 -12.51 33.59 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 123.069 2.513 . . . . 0.0 113.429 -172.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -70.37 -8.09 47.99 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.895 0.878 . . . . 0.0 112.266 171.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -131.21 -178.69 4.95 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.272 1.829 . . . . 0.0 109.086 -179.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -141.44 158.51 43.77 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.602 1.161 . . . . 0.0 108.158 177.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.4 t -139.65 141.48 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 -169.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.3 p -132.51 172.0 13.05 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.084 0.953 . . . . 0.0 109.498 176.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 33.5 p-90 -144.34 153.07 41.6 Favored 'General case' 0 C--O 1.235 0.299 0 O-C-N 121.603 -0.686 . . . . 0.0 109.967 173.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.5 118.41 3.56 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 170.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.71 -2.48 26.54 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 -169.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -63.03 -32.82 74.27 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.39 1.076 . . . . 0.0 112.667 -177.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -69.31 158.01 53.35 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 111.076 -0.809 . . . . 0.0 111.076 178.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 52.1 p90 . . . . . 0 C--O 1.238 0.455 0 C-N-CA 124.968 1.307 . . . . 0.0 110.031 175.588 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.1 tpt . . . . . 0 N--CA 1.481 1.123 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.19 164.91 29.86 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.839 1.256 . . . . 0.0 108.672 175.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.9 t -67.37 124.12 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 178.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -76.25 -174.42 2.79 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.703 0.801 . . . . 0.0 110.816 174.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -152.73 153.98 34.32 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.85 1.66 . . . . 0.0 106.635 170.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.4 mt -53.28 -36.58 61.33 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.038 0.835 . . . . 0.0 112.0 -179.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.02 -25.66 68.22 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.875 0.761 . . . . 0.0 112.506 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.1 mt -83.66 -20.27 33.89 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.38 0.672 . . . . 0.0 111.44 -178.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 32.0 mt -67.38 131.61 93.25 Favored Pre-proline 0 CA--C 1.539 0.52 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -49.76 119.54 4.88 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 123.066 2.511 . . . . 0.0 110.63 169.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -71.15 -39.65 71.82 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.791 0.836 . . . . 0.0 111.155 -175.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.9 t -134.89 139.45 47.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 172.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -152.02 122.87 7.5 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 170.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 45.1 pt -145.29 167.91 9.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 127.366 2.266 . . . . 0.0 105.703 177.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -148.27 -37.56 0.18 Allowed 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.807 -0.558 . . . . 0.0 111.988 178.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.1 m -65.9 162.3 19.37 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.177 0.991 . . . . 0.0 112.194 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -144.49 127.13 16.12 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 172.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 148.84 -126.09 2.19 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 108.382 -1.887 . . . . 0.0 108.382 -169.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.2 t -135.39 119.42 25.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 104.91 -2.256 . . . . 0.0 104.91 173.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -156.6 151.21 25.69 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 118.887 0.767 . . . . 0.0 110.767 -174.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -66.35 155.31 37.68 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.331 0.586 . . . . 0.0 110.523 -178.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -141.48 163.56 32.6 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.309 1.444 . . . . 0.0 107.376 173.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.4 m -138.34 156.56 30.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 C-N-CA 123.905 0.882 . . . . 0.0 109.467 172.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.21 118.86 37.85 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 104.392 -2.448 . . . . 0.0 104.392 176.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 62.8 mt -121.72 115.71 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 119.809 1.186 . . . . 0.0 108.402 -173.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -74.54 140.88 44.77 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 168.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.9 p -134.85 148.01 29.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 178.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -127.52 143.47 51.18 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.184 1.393 . . . . 0.0 108.623 -169.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.8 m -62.49 105.08 0.58 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.574 0.75 . . . . 0.0 111.308 177.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.401 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -149.02 25.27 0.04 OUTLIER Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 125.568 1.547 . . . . 0.0 111.872 168.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 30' ' ' ALA . 43.6 Cg_endo -61.0 133.97 50.38 Favored 'Trans proline' 0 C--N 1.356 0.964 0 CA-C-N 122.263 1.844 . . . . 0.0 111.115 -169.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 37.49 28.29 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 129.063 2.945 . . . . 0.0 114.222 -170.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.6 m 45.17 38.61 3.41 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.191 1.396 . . . . 0.0 112.021 -172.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -149.84 41.0 0.84 Allowed Glycine 0 C--N 1.34 0.772 0 C-N-CA 123.741 0.686 . . . . 0.0 112.453 -169.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -137.36 143.18 40.32 Favored Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 124.251 1.02 . . . . 0.0 108.42 171.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -78.13 -18.37 12.84 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.917 2.411 . . . . 0.0 113.188 -175.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.78 152.36 36.1 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.654 0.781 . . . . 0.0 111.02 -178.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -140.16 28.85 2.06 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.423 1.489 . . . . 0.0 110.013 176.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -76.5 178.36 6.68 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.839 0.855 . . . . 0.0 109.986 176.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.6 m -140.59 161.26 38.17 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.841 1.256 . . . . 0.0 109.186 174.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 58.9 tttt -145.56 165.13 29.54 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 126.947 2.099 . . . . 0.0 107.074 -176.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.7 mp0 -125.31 119.49 28.53 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 173.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 35.5 pt -104.34 154.45 6.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 124.286 1.034 . . . . 0.0 110.078 174.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 45.9 t -121.33 124.28 71.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 -172.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.6 mmp_? -132.36 148.61 52.43 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.185 1.394 . . . . 0.0 108.585 -176.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.97 134.93 2.33 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 169.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -156.69 152.51 27.16 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 124.09 0.956 . . . . 0.0 108.471 -176.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -63.52 -26.83 68.89 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 8.1 p-90 -65.63 -25.52 67.41 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.021 0.828 . . . . 0.0 111.701 178.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.09 83.99 5.88 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 170.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -65.58 -16.21 63.47 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.346 0.658 . . . . 0.0 111.473 174.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -138.74 153.41 48.48 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 126.768 2.027 . . . . 0.0 107.896 178.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 37.8 m-70 -70.99 -34.06 71.02 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -171.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.44 -26.81 44.21 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 118.319 -0.848 . . . . 0.0 112.829 174.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -68.77 -49.75 56.05 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 119.653 1.115 . . . . 0.0 110.892 -175.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.42 -39.44 85.22 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.105 175.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -61.51 -52.52 64.15 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 118.106 -0.95 . . . . 0.0 109.503 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -60.34 -43.49 96.4 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 119.465 1.03 . . . . 0.0 112.002 -177.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.1 tppt? -57.37 -53.66 55.6 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 124.02 0.928 . . . . 0.0 110.596 176.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.2 t -85.42 -36.86 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-O 117.566 -1.207 . . . . 0.0 112.042 -168.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 83.4 p -63.19 -36.65 84.34 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 121.237 1.835 . . . . 0.0 109.432 171.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.45 -48.83 81.88 Favored Glycine 0 C--N 1.34 0.755 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 171.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -62.86 -43.7 98.09 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 118.848 1.324 . . . . 0.0 111.668 178.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 35.7 mmt -60.85 -44.0 97.59 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-N 118.225 0.466 . . . . 0.0 110.065 177.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -66.93 -29.9 69.89 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.048 0.939 . . . . 0.0 111.968 177.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -68.68 -38.71 80.55 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.67 1.123 . . . . 0.0 109.938 169.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -66.93 -24.71 66.11 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 119.269 0.941 . . . . 0.0 110.495 169.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.73 -21.97 12.11 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 128.412 2.911 . . . . 0.0 112.094 176.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 89.5 m -59.37 150.48 26.15 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 126.0 1.72 . . . . 0.0 110.832 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -108.82 153.07 24.03 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 89.9 m -144.59 162.99 35.25 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 -168.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -149.69 125.91 10.72 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 169.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.7 p -68.32 115.19 7.48 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 169.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 53.3 mt -67.45 -23.63 65.54 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 122.072 -0.393 . . . . 0.0 110.206 174.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 172.64 -174.6 45.71 Favored Glycine 0 C--N 1.338 0.674 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 170.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -133.08 166.81 23.59 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 172.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -173.86 -156.74 13.93 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -176.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -141.01 159.39 42.31 Favored 'General case' 0 CA--C 1.518 -0.288 0 O-C-N 120.93 -1.335 . . . . 0.0 110.416 175.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 78.3 mt -111.05 136.46 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 104.299 -2.482 . . . . 0.0 104.299 174.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.5 m -144.97 -175.44 4.69 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.478 1.511 . . . . 0.0 108.58 -177.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -138.78 22.66 2.66 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.003 0.921 . . . . 0.0 111.446 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -66.9 -31.4 71.97 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.586 -0.696 . . . . 0.0 112.096 -170.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 43.7 m -62.19 118.3 7.2 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.118 0.967 . . . . 0.0 110.067 -178.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 90.6 mm-40 50.33 23.94 1.37 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.901 1.281 . . . . 0.0 112.663 -171.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.8 t70 50.54 19.7 0.61 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 127.041 2.136 . . . . 0.0 114.101 -171.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -147.36 -46.47 0.17 Allowed 'General case' 0 N--CA 1.467 0.418 0 O-C-N 121.143 -0.973 . . . . 0.0 112.341 -170.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -68.2 132.85 47.89 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 66.6 mt -67.61 147.48 12.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 106.239 -1.764 . . . . 0.0 106.239 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 30.0 t60 -135.67 151.45 50.22 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 121.493 -0.754 . . . . 0.0 109.119 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.1 t -142.03 118.63 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -173.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -168.05 165.81 13.34 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.942 0.897 . . . . 0.0 108.994 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 136.52 -178.59 18.72 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-N 118.685 0.675 . . . . 0.0 111.511 170.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -141.99 146.38 35.52 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.226 0.61 . . . . 0.0 111.253 169.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.5 t -84.21 153.08 23.84 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 168.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 27.6 ptm -84.39 -35.4 23.16 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 119.128 0.876 . . . . 0.0 109.753 171.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.73 -26.21 57.28 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.68 0.673 . . . . 0.0 112.144 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -132.97 -3.58 3.17 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -169.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 78.42 -176.07 54.45 Favored Glycine 0 CA--C 1.535 1.29 0 CA-C-N 119.114 0.87 . . . . 0.0 113.121 174.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -70.47 167.61 24.87 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 123.765 2.977 . . . . 0.0 111.412 174.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -124.57 166.18 16.53 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.941 1.296 . . . . 0.0 111.003 -173.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 24.6 mm100 -78.85 74.57 5.38 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.81 0.844 . . . . 0.0 109.164 171.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -53.78 -23.63 12.63 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.15 0.98 . . . . 0.0 112.697 176.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -51.71 -42.37 62.18 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.168 1.387 . . . . 0.0 112.688 171.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 78.3 mt -65.42 -48.48 82.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 179.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.4 m -57.39 -48.05 80.1 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.468 1.107 . . . . 0.0 110.845 -177.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.7 p -66.44 -48.62 69.38 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 119.17 0.896 . . . . 0.0 110.713 -177.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -57.47 -42.98 83.67 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 119.332 0.969 . . . . 0.0 110.547 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -70.0 -50.52 40.69 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 118.522 -0.751 . . . . 0.0 111.074 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 76.6 mt -63.55 -38.48 82.33 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 120.097 1.317 . . . . 0.0 109.591 -175.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -56.1 -48.32 76.36 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.651 1.114 . . . . 0.0 109.99 174.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.95 -38.77 89.48 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 122.585 0.354 . . . . 0.0 111.628 -179.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -72.35 -33.03 66.98 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 118.817 -0.611 . . . . 0.0 112.028 -177.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -138.1 64.72 41.62 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 123.695 0.798 . . . . 0.0 110.566 -169.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -70.58 -5.64 17.19 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 123.526 2.818 . . . . 0.0 113.322 -176.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -64.54 -17.17 63.67 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.833 0.853 . . . . 0.0 111.942 170.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -127.65 179.61 5.43 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.589 1.955 . . . . 0.0 108.201 172.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -129.24 159.89 34.67 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 172.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.1 t -136.59 143.75 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 -169.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.4 p -136.5 167.85 20.59 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 123.828 0.851 . . . . 0.0 109.683 175.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 13.4 p-90 -139.15 165.82 26.15 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 170.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -146.97 115.9 6.86 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 176.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.44 -13.52 62.1 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 119.201 -0.428 . . . . 0.0 111.985 174.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -61.44 -29.28 69.85 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.222 1.009 . . . . 0.0 111.718 -175.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -80.11 -167.25 35.37 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 124.094 0.854 . . . . 0.0 112.102 174.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 46.7 p90 . . . . . 0 C--O 1.238 0.458 0 C-N-CA 125.626 1.57 . . . . 0.0 113.392 177.623 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.6 mtt . . . . . 0 N--CA 1.483 1.192 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.7 166.38 13.12 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 169.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.7 t -138.49 152.66 25.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 175.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -157.41 -172.62 4.06 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.754 1.622 . . . . 0.0 108.189 -177.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -145.21 147.67 32.68 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 169.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.2 mt -56.18 -34.41 66.18 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -172.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.16 -22.71 63.91 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.748 0.703 . . . . 0.0 112.54 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.4 mt -81.85 -20.0 39.85 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.376 0.67 . . . . 0.0 111.287 -178.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 46.9 mt -66.52 133.01 94.25 Favored Pre-proline 0 CA--C 1.542 0.643 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -49.48 130.29 25.19 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.304 2.669 . . . . 0.0 111.259 170.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -80.46 -37.87 31.06 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.005 0.431 . . . . 0.0 111.508 -175.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.2 t -136.27 130.44 47.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 176.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -151.93 123.36 7.8 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 169.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.9 pt -147.8 168.83 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.901 1.28 . . . . 0.0 109.732 -169.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -142.55 108.03 5.05 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.719 0.808 . . . . 0.0 110.04 171.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 53.0 m -67.65 162.94 22.49 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.958 0.903 . . . . 0.0 112.212 177.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -151.5 -41.31 0.12 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.251 1.42 . . . . 0.0 109.368 169.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -178.1 -55.63 0.07 OUTLIER Glycine 0 CA--C 1.523 0.58 0 N-CA-C 107.51 -2.236 . . . . 0.0 107.51 169.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 25.4 t -139.16 136.27 41.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 169.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -153.54 148.77 26.94 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 123.841 0.857 . . . . 0.0 109.861 -176.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -76.22 153.08 36.35 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.015 0.526 . . . . 0.0 110.298 -178.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.539 ' HH ' ' CD2' ' A' ' 102' ' ' HIS . 0.4 OUTLIER -145.56 162.2 38.01 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.574 1.15 . . . . 0.0 108.125 176.601 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.0 m -130.31 153.58 39.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 C-N-CA 124.361 1.064 . . . . 0.0 109.493 173.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -108.09 114.79 28.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 103.864 -2.643 . . . . 0.0 103.864 178.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 49.7 mt -118.27 125.84 74.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -171.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 -81.75 149.38 28.45 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 169.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.7 t -132.93 147.77 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 127.325 2.25 . . . . 0.0 105.031 -176.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -132.15 147.93 52.45 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 177.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.3 m -61.0 101.53 0.15 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.649 0.78 . . . . 0.0 110.852 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.446 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -144.45 19.96 0.04 OUTLIER Pre-proline 0 CA--C 1.55 0.971 0 CA-C-O 116.319 -1.8 . . . . 0.0 113.872 169.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.446 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 75.3 Cg_exo -45.97 153.45 0.92 Allowed 'Trans proline' 0 C--N 1.362 1.288 0 CA-C-N 124.015 2.47 . . . . 0.0 113.316 172.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 46.14 18.31 0.05 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.732 1.613 . . . . 0.0 114.862 -170.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.3 m 49.96 30.91 4.3 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.961 1.304 . . . . 0.0 111.826 -169.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 179.95 34.82 0.07 OUTLIER Glycine 0 C--N 1.342 0.862 0 CA-C-O 119.425 -0.653 . . . . 0.0 113.076 -170.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.25 149.29 95.96 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 118.492 1.146 . . . . 0.0 109.071 169.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.96 -24.06 11.71 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.627 2.218 . . . . 0.0 113.068 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.48 160.51 27.41 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.649 0.78 . . . . 0.0 110.738 177.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.35 37.22 1.11 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.351 1.46 . . . . 0.0 109.519 177.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -85.22 -179.94 7.09 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.211 1.004 . . . . 0.0 109.655 178.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.9 m -140.85 157.87 44.77 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.703 1.201 . . . . 0.0 109.068 173.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.7 tmtm? -156.1 165.92 34.99 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.275 1.83 . . . . 0.0 107.408 -169.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.5 mp0 -131.56 155.89 46.69 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.95 1.25 . . . . 0.0 109.334 175.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 41.7 pt -139.66 158.17 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 126.046 1.738 . . . . 0.0 110.084 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.2 t -118.44 118.83 59.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 12.2 mmp_? -127.43 141.36 51.69 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 175.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.87 137.25 2.96 Favored Glycine 0 C--N 1.332 0.329 0 CA-C-N 119.09 0.859 . . . . 0.0 111.493 174.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.405 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 12.9 m-85 -154.02 150.8 28.64 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -170.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -60.13 -29.08 68.4 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 118.681 -0.676 . . . . 0.0 112.197 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.405 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 11.8 p-90 -63.48 -29.18 70.5 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.257 0.935 . . . . 0.0 112.391 177.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.8 73.24 10.65 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 119.204 0.911 . . . . 0.0 109.349 174.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -68.87 -2.42 9.59 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.421 0.688 . . . . 0.0 111.869 177.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -138.93 145.19 39.52 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 126.588 1.955 . . . . 0.0 107.008 172.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -71.27 -32.0 68.17 Favored 'General case' 0 C--O 1.234 0.273 0 O-C-N 121.879 -0.513 . . . . 0.0 110.058 -171.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.61 -27.83 42.19 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 118.438 -0.791 . . . . 0.0 112.629 172.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -68.51 -49.64 58.15 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 119.647 1.112 . . . . 0.0 110.809 -176.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.43 -40.75 87.37 Favored 'Isoleucine or valine' 0 C--N 1.342 0.239 0 CA-C-O 117.837 -1.078 . . . . 0.0 109.619 175.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -61.13 -45.55 94.21 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.781 1.173 . . . . 0.0 110.446 -178.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -63.78 -49.01 74.63 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.864 0.756 . . . . 0.0 111.606 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.4 tttp -59.58 -49.0 79.47 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.422 0.689 . . . . 0.0 111.014 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 88.8 t -75.08 -42.86 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-O 117.686 -1.15 . . . . 0.0 109.244 -172.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 65.4 m -59.11 -36.28 74.89 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 120.572 1.533 . . . . 0.0 110.541 173.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.14 -53.94 41.6 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 172.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -61.61 -46.19 90.88 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 118.718 1.259 . . . . 0.0 111.679 -179.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.528 ' HG3' ' HG ' ' A' ' 71' ' ' CYS . 35.5 mmt -57.62 -51.14 70.7 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.509 0.724 . . . . 0.0 109.793 178.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.9 mm-40 -67.79 -27.19 66.53 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.717 0.69 . . . . 0.0 111.957 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -67.78 -38.14 82.98 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 119.518 1.054 . . . . 0.0 110.576 170.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -68.01 -30.92 70.28 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.808 1.186 . . . . 0.0 109.779 169.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 126.75 -26.24 5.16 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 128.253 2.835 . . . . 0.0 110.875 177.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 89.5 m -49.72 142.01 9.14 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 127.214 2.206 . . . . 0.0 111.799 -174.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -104.67 138.32 41.17 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 178.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.528 ' HG ' ' HG3' ' A' ' 64' ' ' MET . 59.3 m -142.06 160.36 40.37 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -168.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -146.49 134.76 21.77 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.419 1.488 . . . . 0.0 107.998 172.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.3 p -74.0 119.42 18.19 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 169.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 35.0 mt -71.58 -22.04 61.79 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 121.85 -0.531 . . . . 0.0 110.024 172.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.29 -163.78 37.12 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 170.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -149.67 -175.57 22.05 Favored Glycine 0 N--CA 1.451 -0.326 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 170.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -174.17 -161.41 24.1 Favored Glycine 0 CA--C 1.52 0.394 0 N-CA-C 107.598 -2.201 . . . . 0.0 107.598 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.2 ptt180 -134.22 154.27 51.36 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.102 -1.234 . . . . 0.0 108.612 172.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 66.8 mt -113.27 142.01 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 104.429 -2.434 . . . . 0.0 104.429 -177.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.0 m -118.23 134.07 55.34 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 172.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 35.5 t60 -66.05 168.11 8.84 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.021 0.928 . . . . 0.0 110.317 -178.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -59.82 157.81 11.63 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.262 0.625 . . . . 0.0 110.063 173.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.9 m -128.87 -178.82 4.77 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.89 1.276 . . . . 0.0 108.262 169.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -66.06 -8.82 25.62 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.499 0.72 . . . . 0.0 112.67 178.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -142.3 -54.05 0.42 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.933 1.293 . . . . 0.0 110.251 176.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -65.9 139.71 58.29 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.072 0.463 . . . . 0.0 111.264 -175.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -68.92 164.48 22.06 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.079 0.952 . . . . 0.0 111.156 176.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 71.1 mt -63.67 135.95 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 103.609 -2.737 . . . . 0.0 103.609 168.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 27.2 t60 -134.71 156.76 48.24 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 119.322 0.964 . . . . 0.0 110.566 -170.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 22.0 t -138.31 130.46 38.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -168.97 -165.45 0.55 Allowed 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.796 0.839 . . . . 0.0 110.051 -176.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.33 -165.53 54.21 Favored Glycine 0 CA--C 1.524 0.595 0 O-C-N 121.755 -0.591 . . . . 0.0 112.434 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -164.85 157.12 15.98 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.015 0.926 . . . . 0.0 111.015 -173.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.6 t -81.94 159.86 23.5 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 167.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.0 ptm -95.84 -33.63 12.16 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 118.961 0.801 . . . . 0.0 110.424 169.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.95 -25.42 58.86 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.188 0.904 . . . . 0.0 112.039 176.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -131.91 -5.31 3.56 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -169.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.56 -177.49 49.21 Favored Glycine 0 CA--C 1.535 1.339 0 CA-C-N 119.022 0.828 . . . . 0.0 113.506 172.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -69.39 138.22 38.46 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.173 2.582 . . . . 0.0 110.363 173.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -78.42 171.8 14.56 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.035 0.445 . . . . 0.0 109.933 169.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 92.3 mm-40 -77.61 83.95 3.99 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 168.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.539 ' CD2' ' HH ' ' A' ' 22' ' ' TYR . 38.8 m80 -57.55 -13.92 4.47 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -176.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.0 -44.45 87.24 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.93 1.292 . . . . 0.0 110.788 169.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 61.1 mt -64.76 -47.21 89.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 179.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.76 -51.31 70.51 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.044 0.938 . . . . 0.0 110.43 -175.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.6 p -65.91 -46.12 79.43 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 117.862 -1.066 . . . . 0.0 110.313 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -58.71 -42.28 88.32 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 120.239 1.381 . . . . 0.0 110.938 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -65.48 -46.32 80.2 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 118.765 -0.636 . . . . 0.0 111.265 177.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 57.4 mt -64.93 -44.26 96.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 -178.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 26.9 mtpt -62.48 -39.02 92.12 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 119.396 0.998 . . . . 0.0 110.935 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.31 -39.83 91.95 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.676 0.671 . . . . 0.0 111.267 177.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -90.46 -24.68 20.64 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 118.275 0.488 . . . . 0.0 112.052 -175.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -142.74 69.84 19.76 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 126.416 1.886 . . . . 0.0 108.312 -171.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.97 -19.05 30.81 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 122.453 2.102 . . . . 0.0 112.729 -176.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -52.88 127.04 22.23 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.575 1.15 . . . . 0.0 111.504 -175.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 6.9 t80 61.34 0.47 0.44 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.336 2.255 . . . . 0.0 115.239 -177.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 65.03 164.84 0.16 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.501 1.92 . . . . 0.0 113.241 -178.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.4 t -132.21 148.44 32.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 C-N-CA 126.53 1.932 . . . . 0.0 106.491 178.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 20.7 p -134.13 169.07 17.7 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.577 1.151 . . . . 0.0 110.293 -178.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 27.3 p-90 -146.48 155.67 42.71 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.143 0.577 . . . . 0.0 109.923 169.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -160.55 101.95 1.35 Allowed 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 172.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.32 -13.45 62.28 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -169.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -61.65 -33.36 73.83 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.355 1.062 . . . . 0.0 112.393 -178.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -85.17 146.55 21.96 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 173.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 65.3 t80 . . . . . 0 C--O 1.235 0.323 0 CA-C-N 117.937 0.868 . . . . 0.0 108.771 176.368 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.0 mmt . . . . . 0 N--CA 1.483 1.184 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.83 147.95 48.52 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 170.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.2 p -155.84 151.55 9.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -176.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.95 -178.71 5.64 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.164 0.507 . . . . 0.0 110.394 176.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -151.78 150.19 29.88 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 171.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 53.9 mt -57.87 -31.14 66.42 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.268 0.627 . . . . 0.0 112.617 -175.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.44 -25.09 65.73 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.674 0.67 . . . . 0.0 112.278 178.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.1 mt -79.82 -24.79 41.12 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.04 0.536 . . . . 0.0 111.024 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 7.3 mt -68.97 131.99 90.63 Favored Pre-proline 0 C--O 1.237 0.421 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 176.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.66 135.61 31.15 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 121.526 1.484 . . . . 0.0 110.571 176.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.67 -27.27 66.7 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.673 0.789 . . . . 0.0 111.578 -178.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.2 t -139.6 134.87 39.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -178.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -152.41 121.17 6.5 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 169.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.5 pt -146.58 172.17 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 124.497 1.119 . . . . 0.0 110.192 -169.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -129.65 95.28 3.95 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.745 1.218 . . . . 0.0 108.667 171.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.2 m -54.42 148.28 12.23 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.904 1.681 . . . . 0.0 111.634 177.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -161.05 -51.22 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.797 0.839 . . . . 0.0 111.524 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 167.57 -59.21 0.22 Allowed Glycine 0 C--N 1.335 0.527 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 -174.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 60.8 t -144.39 132.25 17.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 126.767 2.027 . . . . 0.0 105.708 172.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -155.52 150.18 26.25 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 123.689 0.795 . . . . 0.0 109.474 175.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.95 152.87 41.2 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -178.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.16 162.14 38.65 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.477 1.111 . . . . 0.0 108.787 -177.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.6 m -134.95 155.38 38.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 C-N-CA 124.492 1.117 . . . . 0.0 110.178 171.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -108.28 117.8 35.1 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 176.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 53.9 mt -119.0 114.77 45.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -173.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -74.22 145.23 44.29 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 168.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.9 p -139.26 148.62 23.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -178.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -130.94 144.98 51.87 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.017 1.327 . . . . 0.0 108.074 -170.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.7 m -62.58 103.85 0.46 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.646 0.778 . . . . 0.0 111.653 -177.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.42 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -146.53 24.02 0.04 OUTLIER Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 125.487 1.515 . . . . 0.0 112.252 168.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.42 ' CD ' ' N ' ' A' ' 30' ' ' ALA . 56.8 Cg_endo -60.93 141.37 94.36 Favored 'Trans proline' 0 C--N 1.357 0.985 0 CA-C-N 122.575 1.955 . . . . 0.0 110.93 -173.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 44.2 19.86 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.706 2.403 . . . . 0.0 114.131 -170.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.7 m 45.72 36.71 2.85 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.833 1.253 . . . . 0.0 111.415 -169.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -161.47 55.81 0.31 Allowed Glycine 0 C--N 1.34 0.802 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 -169.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -135.79 143.69 45.63 Favored Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 169.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -76.51 -19.93 14.39 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.758 2.305 . . . . 0.0 112.998 -175.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.57 152.73 37.92 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.559 0.744 . . . . 0.0 110.737 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -139.29 31.81 2.13 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.623 1.569 . . . . 0.0 109.227 174.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -78.34 178.62 7.53 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.925 0.89 . . . . 0.0 109.745 178.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.7 m -138.95 158.22 44.59 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.464 1.106 . . . . 0.0 108.99 172.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -152.75 175.11 13.21 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 127.629 2.372 . . . . 0.0 105.894 -173.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -140.78 156.35 46.19 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 120.735 -1.228 . . . . 0.0 108.424 177.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 34.7 pt -136.47 155.15 33.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 124.92 1.288 . . . . 0.0 109.255 179.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.7 t -116.14 122.13 68.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 -178.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -126.05 145.28 50.39 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 177.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -179.69 129.77 1.4 Allowed Glycine 0 C--N 1.329 0.177 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 173.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -151.56 153.89 35.4 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -173.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.1 tptt -60.35 -32.93 71.73 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 119.175 -0.441 . . . . 0.0 111.761 -178.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 15.7 p-90 -64.35 -31.03 72.07 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.413 0.551 . . . . 0.0 112.395 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.48 74.86 10.26 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 119.15 0.886 . . . . 0.0 109.187 175.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -63.19 -18.75 63.83 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.195 0.598 . . . . 0.0 111.378 176.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -123.65 146.4 48.23 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.929 1.692 . . . . 0.0 107.99 176.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 39.8 m-70 -71.9 -33.9 68.69 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.327 0.651 . . . . 0.0 109.68 -169.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.73 -28.68 57.07 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 118.379 -0.819 . . . . 0.0 112.545 173.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -68.58 -48.58 63.82 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 119.626 1.103 . . . . 0.0 111.072 -174.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.72 -40.46 87.87 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-O 118.268 -0.873 . . . . 0.0 109.963 176.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -61.94 -50.96 70.05 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 119.401 -0.919 . . . . 0.0 109.74 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -60.76 -44.2 97.02 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 119.31 0.959 . . . . 0.0 111.807 -178.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 22.2 tttp -60.08 -51.56 69.12 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 123.159 0.584 . . . . 0.0 110.71 178.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.7 t -84.56 -33.53 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-O 117.923 -1.037 . . . . 0.0 111.506 -169.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 61.1 p -63.64 -34.69 78.39 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 121.071 1.759 . . . . 0.0 109.403 170.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.15 -51.06 60.7 Favored Glycine 0 C--N 1.338 0.667 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 171.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -60.71 -42.93 98.21 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 118.579 1.189 . . . . 0.0 112.137 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 38.0 mmt -62.67 -45.68 91.7 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 122.814 0.446 . . . . 0.0 110.249 176.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -68.19 -29.06 67.83 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 118.768 0.713 . . . . 0.0 111.843 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -67.57 -37.47 82.67 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 119.163 0.892 . . . . 0.0 110.365 170.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -68.71 -27.73 66.21 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.581 1.082 . . . . 0.0 110.77 169.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 125.69 -25.84 5.53 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 127.441 2.448 . . . . 0.0 111.788 175.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 88.4 m -57.35 151.56 15.92 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 126.389 1.876 . . . . 0.0 112.192 -175.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -109.77 145.31 36.87 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 86.9 m -140.63 165.16 28.22 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -168.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -153.11 126.29 8.54 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.448 1.499 . . . . 0.0 107.735 170.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.7 p -69.69 119.55 14.1 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 169.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 42.5 mt -70.9 -25.47 62.79 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.858 -0.526 . . . . 0.0 110.263 173.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.9 -172.01 43.09 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 109.769 -1.333 . . . . 0.0 109.769 172.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -132.26 177.17 18.94 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 176.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 179.15 -163.71 31.45 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 108.341 -1.904 . . . . 0.0 108.341 -176.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -136.55 152.85 50.95 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 121.005 -1.291 . . . . 0.0 108.506 171.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.7 mt -108.54 139.42 31.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 103.897 -2.631 . . . . 0.0 103.897 178.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.9 m -134.42 136.92 43.62 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 177.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 52.9 m-70 -72.12 -15.7 61.99 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 118.962 -0.542 . . . . 0.0 112.396 -177.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -147.87 146.1 28.93 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.659 1.584 . . . . 0.0 107.892 169.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 75.2 m -146.56 79.09 1.52 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.448 1.499 . . . . 0.0 107.807 171.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 52.87 32.03 11.73 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.279 1.432 . . . . 0.0 111.884 -172.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -155.3 164.08 39.26 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 126.757 2.023 . . . . 0.0 106.293 177.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -79.68 -27.94 40.74 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.387 -0.821 . . . . 0.0 111.217 174.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -72.25 155.29 40.36 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 119.002 0.819 . . . . 0.0 110.812 -178.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 64.8 mt -61.74 148.26 10.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 169.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 35.7 t60 -134.57 156.43 48.69 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.248 1.019 . . . . 0.0 109.349 -178.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.7 t -135.27 129.1 49.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 179.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -165.85 -164.99 0.76 Allowed 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.171 0.988 . . . . 0.0 108.512 -176.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.96 -172.26 55.18 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -160.38 154.33 22.9 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.326 0.65 . . . . 0.0 110.722 -176.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.4 t -82.26 163.54 21.77 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 168.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 20.3 ptp -102.06 -30.97 10.86 Favored 'General case' 0 C--O 1.232 0.156 0 O-C-N 121.524 -0.735 . . . . 0.0 110.444 169.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.92 -26.7 61.49 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.179 0.9 . . . . 0.0 111.737 173.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -133.25 -2.96 3.1 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -169.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.15 -174.68 46.7 Favored Glycine 0 CA--C 1.535 1.33 0 CA-C-N 119.088 0.858 . . . . 0.0 113.051 175.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.97 143.29 54.14 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.814 2.343 . . . . 0.0 110.424 172.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.51 176.94 5.65 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.138 0.575 . . . . 0.0 109.927 169.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 20.8 mm100 -63.34 -28.83 70.27 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.841 -0.537 . . . . 0.0 111.68 171.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 39.2 m80 60.54 -29.72 0.05 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 128.767 2.827 . . . . 0.0 116.311 -175.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.38 -43.08 99.67 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.21 1.004 . . . . 0.0 110.681 173.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 69.1 mt -60.79 -44.41 97.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 177.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.95 -53.46 56.99 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.328 1.051 . . . . 0.0 110.105 -177.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.3 p -63.86 -44.73 92.25 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 117.7 -1.143 . . . . 0.0 110.123 -173.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -58.1 -40.73 81.92 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 120.215 1.37 . . . . 0.0 111.163 -179.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 36.3 mttm -69.82 -44.47 69.92 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 121.782 -0.574 . . . . 0.0 111.061 178.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 58.7 mt -64.65 -43.23 96.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 118.79 0.723 . . . . 0.0 109.115 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -55.85 -43.57 77.21 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 119.605 1.093 . . . . 0.0 109.976 175.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.79 -48.84 70.42 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 119.273 -0.394 . . . . 0.0 111.38 -177.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -93.17 -39.05 11.24 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -169.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -74.26 147.22 85.25 Favored Pre-proline 0 CA--C 1.541 0.629 0 CA-C-N 119.421 1.01 . . . . 0.0 110.146 -170.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -52.08 -36.06 64.28 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.629 2.886 . . . . 0.0 114.759 178.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -79.89 101.22 8.44 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 169.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -73.68 6.98 2.72 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.779 0.832 . . . . 0.0 113.171 -172.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -133.16 146.82 51.9 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.768 1.167 . . . . 0.0 109.588 174.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.2 t -153.77 154.24 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 -172.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 19.8 p -129.3 168.51 16.13 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.784 0.834 . . . . 0.0 110.219 175.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 43.9 p-90 -146.06 162.18 38.48 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 121.742 -0.599 . . . . 0.0 109.728 169.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.16 142.04 21.15 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 169.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -82.42 77.13 9.24 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 174.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -139.84 -157.68 0.79 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.992 2.117 . . . . 0.0 105.363 170.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 92.42 -168.88 31.17 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-N 120.78 1.627 . . . . 0.0 113.244 170.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 57.7 t80 . . . . . 0 C--O 1.238 0.452 0 C-N-CA 125.917 1.687 . . . . 0.0 112.034 -172.344 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.3 tpt . . . . . 0 N--CA 1.481 1.107 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.83 167.05 30.98 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.09 1.356 . . . . 0.0 108.73 177.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.5 t -141.95 133.33 26.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 177.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -76.93 -179.41 5.47 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.156 0.582 . . . . 0.0 110.389 172.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -149.84 146.16 26.97 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 169.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 80.9 mt -55.11 -33.32 62.74 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.83 0.852 . . . . 0.0 112.657 -175.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.74 -25.69 67.4 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.087 0.858 . . . . 0.0 112.341 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.2 mt -78.54 -25.51 45.51 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.189 0.596 . . . . 0.0 111.094 -178.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.8 mt -70.6 131.38 88.02 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -172.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -49.57 119.93 5.24 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 123.525 2.817 . . . . 0.0 111.359 169.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -74.04 -29.88 62.14 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.15 0.5 . . . . 0.0 111.49 -176.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.9 t -141.84 131.54 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 174.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -149.39 111.35 4.59 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 169.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.9 pt -139.01 162.28 28.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 124.01 0.924 . . . . 0.0 109.7 -169.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.434 ' C ' ' H ' ' A' ' 17' ' ' ASP . 27.3 t70 -128.07 62.05 1.43 Allowed 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 125.099 1.36 . . . . 0.0 108.383 174.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.5 p -67.69 18.73 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.486 2.314 . . . . 0.0 113.284 176.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.434 ' H ' ' C ' ' A' ' 15' ' ' ASP . 20.0 t70 -59.85 -17.77 39.09 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.66 1.984 . . . . 0.0 112.112 172.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -141.83 165.83 26.42 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 169.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.8 t -76.92 91.39 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 -178.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -138.07 165.52 26.39 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.134 0.974 . . . . 0.0 111.892 -169.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -65.55 156.18 33.42 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 124.834 1.254 . . . . 0.0 111.684 -169.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.473 ' HH ' ' CD2' ' A' ' 102' ' ' HIS . 0.2 OUTLIER -147.17 161.17 41.44 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.082 1.353 . . . . 0.0 108.257 171.573 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.5 m -130.0 154.62 40.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 C-N-CA 124.782 1.233 . . . . 0.0 109.803 174.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.05 115.65 30.52 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 104.212 -2.514 . . . . 0.0 104.212 176.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 73.3 mt -119.65 124.51 73.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -173.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -81.41 145.08 30.98 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 169.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.2 t -129.68 143.44 41.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 -175.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -130.96 132.97 45.39 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 -178.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.0 t -66.43 118.66 10.38 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -175.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.401 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -151.05 32.06 0.06 OUTLIER Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 126.163 1.785 . . . . 0.0 109.77 168.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 30' ' ' ALA . 44.8 Cg_endo -61.3 156.24 47.06 Favored 'Trans proline' 0 C--N 1.357 1.012 0 CA-C-N 121.913 1.719 . . . . 0.0 111.458 -171.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 41.8 tpt85 54.44 9.91 0.29 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.091 1.756 . . . . 0.0 112.891 -169.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.0 m 51.98 32.31 9.93 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.023 1.329 . . . . 0.0 111.412 -170.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -163.95 -3.91 0.04 OUTLIER Glycine 0 CA--C 1.531 1.043 0 CA-C-O 118.382 -1.232 . . . . 0.0 115.264 -173.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.7 144.79 84.72 Favored Pre-proline 0 CA--C 1.542 0.65 0 CA-C-N 119.768 1.784 . . . . 0.0 110.799 174.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -76.22 -19.11 15.66 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.934 2.423 . . . . 0.0 112.88 179.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.46 152.33 34.76 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.017 0.927 . . . . 0.0 111.071 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.45 28.52 1.19 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.99 1.316 . . . . 0.0 110.943 178.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -70.45 174.01 6.27 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.352 0.661 . . . . 0.0 110.0 172.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.4 m -137.55 161.88 35.23 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.303 1.041 . . . . 0.0 110.112 177.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.6 tttp -148.85 165.45 31.46 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.533 2.333 . . . . 0.0 106.137 -174.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -137.52 140.15 40.93 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 106.09 -1.818 . . . . 0.0 106.09 175.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 41.2 pt -134.3 156.83 41.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 124.218 1.007 . . . . 0.0 110.724 -172.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 95.7 t -121.55 118.75 56.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 -177.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 27.2 mmt85 -136.02 144.23 45.17 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 177.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.22 135.57 2.42 Favored Glycine 0 C--N 1.331 0.284 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 -178.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -153.58 160.94 42.59 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 117.356 0.578 . . . . 0.0 110.122 -169.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.5 mtmm -59.88 -33.86 72.39 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -179.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.433 ' CH2' ' HE2' ' A' ' 59' ' ' LYS . 9.5 p-90 -68.66 -24.23 64.5 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.835 0.743 . . . . 0.0 112.634 -179.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.47 82.13 8.54 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 119.588 1.085 . . . . 0.0 109.297 176.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -65.45 -19.38 65.91 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.44 171.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -133.89 148.68 51.27 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 126.048 1.739 . . . . 0.0 108.137 -178.058 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -72.56 -30.97 64.89 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 121.925 -0.485 . . . . 0.0 109.897 -171.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.01 -28.64 53.66 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 118.082 -0.961 . . . . 0.0 112.776 172.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -65.53 -55.85 15.53 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.669 1.122 . . . . 0.0 109.583 -179.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -66.07 -34.62 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-O 117.355 -1.307 . . . . 0.0 110.687 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -60.98 -53.59 55.38 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 120.104 1.32 . . . . 0.0 109.506 175.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -60.37 -42.91 96.77 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.983 0.81 . . . . 0.0 111.896 -178.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.433 ' HE2' ' CH2' ' A' ' 49' ' ' TRP . 0.0 OUTLIER -59.28 -55.54 33.51 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.221 1.008 . . . . 0.0 110.209 178.589 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 89.9 t -77.62 -43.77 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-O 117.801 -1.095 . . . . 0.0 109.881 -169.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.7 p -63.81 -31.26 72.39 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 120.709 1.595 . . . . 0.0 109.937 175.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.29 -51.31 59.57 Favored Glycine 0 C--N 1.337 0.636 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 171.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -61.71 -44.53 96.74 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 118.835 1.318 . . . . 0.0 111.68 178.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.451 ' HG3' ' HG ' ' A' ' 71' ' ' CYS . 38.4 mmt -59.12 -46.96 86.98 Favored 'General case' 0 C--O 1.227 -0.081 0 CA-C-O 119.231 -0.414 . . . . 0.0 110.045 177.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -69.27 -28.27 66.15 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.654 0.661 . . . . 0.0 112.152 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -67.59 -37.41 82.53 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.342 0.974 . . . . 0.0 110.255 170.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -68.25 -31.01 70.2 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.772 1.169 . . . . 0.0 110.106 169.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 127.5 -23.43 5.41 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 127.93 2.681 . . . . 0.0 111.662 174.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 95.8 m -55.92 154.42 7.36 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 126.404 1.882 . . . . 0.0 112.602 -177.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -112.49 145.47 40.18 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.909 1.284 . . . . 0.0 108.066 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.451 ' HG ' ' HG3' ' A' ' 64' ' ' MET . 74.9 m -144.64 164.33 31.29 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -168.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -149.02 130.57 14.88 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.289 1.435 . . . . 0.0 107.713 171.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.6 p -75.06 114.73 13.89 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 169.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 39.7 mt -68.65 -25.33 64.77 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.823 -0.548 . . . . 0.0 110.374 176.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.14 -164.88 37.83 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 175.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -154.32 -175.5 25.58 Favored Glycine 0 N--CA 1.452 -0.268 0 N-CA-C 111.509 -0.636 . . . . 0.0 111.509 171.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -171.49 -153.71 9.26 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 108.488 -1.845 . . . . 0.0 108.488 -176.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -143.25 142.96 31.55 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 -174.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 61.7 mt -108.17 151.31 10.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -171.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.3 m 62.19 -175.39 0.14 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.574 1.949 . . . . 0.0 110.887 -170.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -153.78 169.51 23.18 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.98 1.312 . . . . 0.0 108.555 177.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 20.9 tp60 -66.42 -25.52 66.79 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.246 0.619 . . . . 0.0 112.055 -178.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.3 m -57.85 148.8 24.22 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.367 1.067 . . . . 0.0 111.531 -178.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -76.33 -9.56 58.73 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.644 0.778 . . . . 0.0 112.87 -174.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -56.53 127.07 29.41 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.246 1.018 . . . . 0.0 109.957 177.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -67.73 -23.41 65.26 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.446 0.698 . . . . 0.0 111.869 179.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -55.88 129.61 40.26 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 177.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 50.0 mt -68.99 159.93 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 31.5 t60 -143.94 166.29 25.35 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 120.677 -1.264 . . . . 0.0 109.698 -178.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.9 t -141.41 133.62 28.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 173.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -157.17 -170.04 3.14 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.221 1.008 . . . . 0.0 108.726 -178.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.28 -175.46 45.89 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-N 118.619 0.645 . . . . 0.0 112.145 176.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -162.33 149.4 13.64 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.532 1.133 . . . . 0.0 110.546 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.6 t -71.63 166.2 22.38 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 168.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.5 ptm -111.5 -29.86 7.6 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 118.485 -0.769 . . . . 0.0 111.051 170.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -73.59 -25.55 60.4 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.574 1.079 . . . . 0.0 111.407 172.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -132.65 -9.47 3.18 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.05 0.94 . . . . 0.0 113.037 -169.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 78.68 -176.66 54.37 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-N 118.773 0.715 . . . . 0.0 113.71 171.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.43 137.2 42.31 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.059 2.506 . . . . 0.0 110.482 175.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -78.01 168.8 19.32 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 169.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -77.76 84.69 4.08 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 168.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.473 ' CD2' ' HH ' ' A' ' 22' ' ' TYR . 39.7 m80 -57.86 -13.86 5.09 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -175.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.03 -41.46 96.61 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.651 1.18 . . . . 0.0 110.978 170.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 56.2 mt -65.46 -47.43 86.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 177.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.97 -49.68 76.94 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.066 0.946 . . . . 0.0 110.703 -176.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.4 p -64.4 -47.53 78.82 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 118.182 -0.913 . . . . 0.0 110.989 -176.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -60.01 -40.38 89.07 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.52 1.055 . . . . 0.0 110.537 -178.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 52.9 mttm -67.29 -46.22 74.26 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-O 118.935 -0.555 . . . . 0.0 111.476 177.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 63.8 mt -64.61 -39.87 87.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-N 119.432 1.015 . . . . 0.0 109.006 -179.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -58.98 -47.33 85.55 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 119.855 1.207 . . . . 0.0 109.514 175.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.73 -38.2 89.54 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.033 0.379 . . . . 0.0 111.55 -179.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -69.95 -36.53 75.34 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 118.718 -0.658 . . . . 0.0 111.326 177.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -127.78 63.59 61.22 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 124.087 0.955 . . . . 0.0 110.408 -171.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -70.7 -11.41 29.56 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.158 2.572 . . . . 0.0 113.159 -172.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -67.54 -12.78 61.15 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.731 0.813 . . . . 0.0 112.05 170.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -129.5 -173.57 3.05 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.289 1.836 . . . . 0.0 108.988 178.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -135.78 162.35 33.03 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.409 1.484 . . . . 0.0 107.016 176.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.4 t -139.89 143.64 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 -173.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 16.6 p -134.69 174.42 10.59 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.478 1.111 . . . . 0.0 108.914 174.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 47.5 p-90 -143.16 161.53 37.99 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.669 -0.644 . . . . 0.0 110.657 171.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.05 136.22 20.01 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 171.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -80.62 79.66 7.21 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 172.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -136.29 -175.73 4.09 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.675 1.59 . . . . 0.0 106.736 169.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.22 -157.31 31.71 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 119.544 1.065 . . . . 0.0 111.436 -174.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 86.2 t80 . . . . . 0 C--O 1.238 0.465 0 C-N-CA 125.03 1.332 . . . . 0.0 109.945 177.941 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.3 mtm . . . . . 0 N--CA 1.483 1.191 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.51 106.67 3.3 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 170.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.1 t -63.02 132.86 29.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -171.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -145.08 -169.52 3.21 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.223 1.809 . . . . 0.0 108.126 -175.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -146.73 146.59 30.37 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 169.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 51.0 mt -58.99 -29.22 67.06 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -173.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.61 -26.41 66.24 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.113 0.87 . . . . 0.0 111.883 177.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.7 mt -82.69 -24.18 33.79 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.654 0.782 . . . . 0.0 111.191 -177.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 51.3 mt -65.46 129.01 94.27 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -178.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -44.82 120.72 3.0 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 124.141 3.227 . . . . 0.0 111.599 172.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -78.75 -32.94 46.86 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.283 0.563 . . . . 0.0 111.139 -170.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.2 t -136.85 140.26 43.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 105.091 -2.188 . . . . 0.0 105.091 172.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -151.77 130.15 12.1 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 170.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.9 pt -147.9 160.85 7.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 126.873 2.069 . . . . 0.0 106.9 -178.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -152.08 42.61 0.68 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.701 0.8 . . . . 0.0 110.445 178.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.4 m -144.35 172.02 13.51 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.323 1.049 . . . . 0.0 110.621 -172.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -149.04 165.93 30.2 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 126.798 2.039 . . . . 0.0 107.12 174.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.47 -160.78 54.18 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -169.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.6 t -75.29 131.26 35.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 175.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -154.65 150.86 28.11 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 124.341 1.056 . . . . 0.0 108.955 169.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -77.1 154.98 32.74 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.521 0.728 . . . . 0.0 110.377 -177.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.31 162.51 37.97 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.0 1.32 . . . . 0.0 108.164 179.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.8 m -132.7 154.31 39.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 124.418 1.087 . . . . 0.0 109.488 172.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.35 119.22 38.88 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 104.293 -2.484 . . . . 0.0 104.293 176.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.2 mt -122.26 123.79 69.57 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -173.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.438 ' HE ' ' CE1' ' A' ' 28' ' ' HIS . 36.9 ttp-105 -77.36 147.59 36.03 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 169.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.8 t -133.29 143.72 38.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 -178.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.438 ' CE1' ' HE ' ' A' ' 26' ' ' ARG . 99.9 m-70 -123.68 145.06 49.25 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 125.021 1.329 . . . . 0.0 107.913 174.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.0 m -62.07 107.93 0.96 Allowed 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.439 0.696 . . . . 0.0 110.635 177.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -148.9 29.1 0.05 OUTLIER Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 124.823 1.249 . . . . 0.0 112.404 169.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -70.8 21.26 0.21 Allowed 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 123.489 2.792 . . . . 0.0 115.84 -169.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.83 12.58 0.88 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.877 1.671 . . . . 0.0 110.672 175.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.6 m 50.27 28.11 3.01 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.717 1.207 . . . . 0.0 112.749 -170.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 163.75 32.41 0.02 OUTLIER Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.96 1.267 . . . . 0.0 111.198 -173.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -68.89 153.59 95.86 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 117.813 0.807 . . . . 0.0 109.504 177.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.89 -27.2 17.98 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 122.33 2.02 . . . . 0.0 112.647 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.62 148.83 49.89 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.675 0.79 . . . . 0.0 110.112 176.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -142.77 30.97 1.46 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.039 1.336 . . . . 0.0 110.109 177.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -75.71 177.03 7.16 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.527 0.68 . . . . 0.0 109.812 174.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.6 m -140.92 158.54 43.79 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.822 1.249 . . . . 0.0 108.463 173.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -153.06 170.75 19.7 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 126.894 2.078 . . . . 0.0 106.296 -171.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.401 ' HB2' ' HE3' ' A' ' 108' ' ' LYS . 17.7 mp0 -134.08 157.16 46.85 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 169.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 32.6 pt -132.46 155.39 41.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 125.344 1.458 . . . . 0.0 109.508 178.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 56.7 t -116.9 121.35 67.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 177.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.8 mmp_? -127.52 141.1 51.74 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 177.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -171.64 136.6 3.94 Favored Glycine 0 C--N 1.329 0.192 0 CA-C-N 119.538 1.063 . . . . 0.0 110.609 170.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -153.85 148.55 26.39 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -173.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.5 pttm -54.99 -31.08 60.66 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.355 1.462 . . . . 0.0 113.236 173.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 11.8 p-90 -68.92 -28.71 66.91 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.29 0.95 . . . . 0.0 112.044 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.79 73.6 10.28 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 119.278 0.944 . . . . 0.0 109.235 174.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -65.94 -6.82 13.7 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.861 0.864 . . . . 0.0 111.457 174.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -137.14 144.09 42.8 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.621 1.968 . . . . 0.0 106.809 173.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 44.1 m-70 -70.34 -31.37 68.63 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -171.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.29 -29.84 35.45 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 118.529 -0.748 . . . . 0.0 112.652 172.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -68.85 -48.57 63.14 Favored 'General case' 0 C--N 1.341 0.199 0 CA-C-N 119.39 0.995 . . . . 0.0 111.097 -174.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.36 -41.68 91.82 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.018 176.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -61.83 -50.72 71.15 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 119.296 -0.962 . . . . 0.0 109.668 -178.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -61.13 -44.43 97.34 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.125 0.875 . . . . 0.0 111.91 -178.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 30.5 tttt -59.9 -50.32 74.23 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.315 0.646 . . . . 0.0 110.895 178.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.4 t -85.71 -33.6 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-O 117.572 -1.204 . . . . 0.0 111.401 -169.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 84.6 p -61.57 -36.71 81.41 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 121.306 1.866 . . . . 0.0 109.179 169.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -56.63 -52.47 50.27 Favored Glycine 0 C--N 1.34 0.753 0 C-N-CA 124.218 0.913 . . . . 0.0 111.141 170.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -60.73 -45.16 95.32 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 119.14 1.47 . . . . 0.0 111.854 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.501 ' HG3' ' HG ' ' A' ' 71' ' ' CYS . 35.2 mmt -59.46 -47.03 87.04 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.998 0.519 . . . . 0.0 109.787 178.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -68.17 -30.08 69.11 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.536 0.734 . . . . 0.0 111.937 178.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -66.59 -37.94 85.97 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 119.511 1.051 . . . . 0.0 110.278 171.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -64.62 -46.15 83.83 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.746 1.157 . . . . 0.0 108.486 169.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 142.17 -21.49 2.45 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 127.872 2.653 . . . . 0.0 111.204 174.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 80.8 m -54.65 148.36 12.75 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 126.891 2.076 . . . . 0.0 111.608 -176.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -108.56 141.47 40.42 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.501 ' HG ' ' HG3' ' A' ' 64' ' ' MET . 94.5 m -141.6 165.51 27.29 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -168.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -154.33 130.03 10.02 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.869 1.667 . . . . 0.0 107.431 171.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.1 p -69.82 123.77 22.3 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 169.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 33.9 mt -69.31 -28.3 66.14 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.933 -0.479 . . . . 0.0 109.969 172.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.98 -171.29 43.34 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 174.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -124.78 173.6 17.1 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 174.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -178.2 -164.96 32.2 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 108.254 -1.938 . . . . 0.0 108.254 -176.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 12.0 ptp180 -148.06 161.76 40.74 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 120.741 -1.447 . . . . 0.0 109.208 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 81.9 mt -123.52 149.69 27.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 -171.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.0 p -145.43 158.2 43.88 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.067 1.347 . . . . 0.0 109.137 176.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -155.78 37.27 0.36 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.605 0.762 . . . . 0.0 110.406 173.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -73.47 1.61 9.47 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 121.149 -0.969 . . . . 0.0 111.52 171.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 m -50.23 152.64 1.7 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 128.661 2.784 . . . . 0.0 112.944 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -90.83 12.63 18.74 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.508 1.123 . . . . 0.0 111.185 175.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -150.07 166.59 29.29 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.787 2.035 . . . . 0.0 107.369 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -73.07 35.21 0.08 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.92 1.688 . . . . 0.0 112.756 -175.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.2 ttmm -105.22 107.97 19.24 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 125.248 1.419 . . . . 0.0 107.525 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 82.7 mt -72.29 160.29 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 169.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 21.1 t60 -139.65 155.49 47.37 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 120.519 -1.363 . . . . 0.0 110.359 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.5 t -136.58 137.48 47.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 -177.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -164.96 -171.01 2.1 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.084 -1.01 . . . . 0.0 109.854 -174.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.69 -167.71 54.76 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-O 121.402 0.446 . . . . 0.0 112.278 169.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -158.36 173.2 17.02 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.315 1.046 . . . . 0.0 110.218 -172.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.0 t -107.17 164.0 12.53 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 127.033 2.133 . . . . 0.0 106.2 168.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 21.4 ptp -105.96 -29.89 9.67 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 118.547 -0.739 . . . . 0.0 110.881 172.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -73.12 -26.32 61.18 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.39 0.995 . . . . 0.0 111.563 172.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -132.0 -3.74 3.57 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -169.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 72.52 -177.14 41.01 Favored Glycine 0 CA--C 1.535 1.297 0 CA-C-N 118.908 0.776 . . . . 0.0 112.73 177.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.49 138.13 37.92 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.889 2.393 . . . . 0.0 110.916 175.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.96 176.47 5.69 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.297 0.639 . . . . 0.0 110.026 169.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 21.5 mm100 -65.7 -31.83 73.05 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 121.901 -0.499 . . . . 0.0 112.292 178.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 39.1 m80 61.63 -30.83 0.07 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 128.438 2.695 . . . . 0.0 115.972 -174.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.7 -44.46 96.18 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.224 1.01 . . . . 0.0 110.787 174.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 72.9 mt -60.47 -45.35 97.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 176.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.46 -52.24 66.07 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 124.61 1.164 . . . . 0.0 109.747 -174.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 22.6 p -67.09 -43.07 83.49 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 117.982 -1.009 . . . . 0.0 111.151 -174.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -59.38 -41.9 90.43 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.756 1.162 . . . . 0.0 110.386 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.401 ' HE3' ' HB2' ' A' ' 42' ' ' GLU . 42.1 mttm -66.77 -45.4 78.62 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 119.009 -0.519 . . . . 0.0 111.263 176.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 55.8 mt -63.44 -42.81 97.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 119.111 0.868 . . . . 0.0 108.992 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -58.22 -47.41 83.61 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 120.216 1.371 . . . . 0.0 109.455 176.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.45 -40.28 96.08 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.753 0.421 . . . . 0.0 111.634 -177.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -80.9 -19.89 43.36 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 118.269 -0.872 . . . . 0.0 112.735 -178.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -131.93 64.36 72.19 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 124.524 1.13 . . . . 0.0 109.517 -178.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.8 -14.24 38.6 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.944 2.429 . . . . 0.0 112.922 -175.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -67.22 -11.86 58.54 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.283 1.033 . . . . 0.0 112.068 169.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -125.65 177.54 6.19 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.516 1.927 . . . . 0.0 108.639 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -125.65 165.31 18.79 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 170.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.2 t -144.43 143.51 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 -178.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 22.1 p -137.3 173.96 11.12 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.079 0.952 . . . . 0.0 108.848 172.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 52.1 p-90 -143.79 157.4 44.41 Favored 'General case' 0 C--O 1.235 0.297 0 O-C-N 121.988 -0.445 . . . . 0.0 110.6 173.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -154.13 97.95 2.1 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 176.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -69.16 -8.67 47.69 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -173.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -58.0 -29.98 65.7 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.46 1.104 . . . . 0.0 112.465 170.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -61.89 152.79 42.41 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 111.754 -0.538 . . . . 0.0 111.754 176.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 53.1 p90 . . . . . 0 C--O 1.238 0.464 0 C-N-CA 124.902 1.281 . . . . 0.0 110.011 -179.424 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.484 1.266 0 N-CA-C 110.482 -0.192 . . . . 0.0 110.482 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.84 157.55 27.48 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.956 -0.465 . . . . 0.0 109.758 169.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.5 p -59.46 139.5 19.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 174.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -71.86 177.65 4.13 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.715 0.769 . . . . 0.0 111.454 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -151.27 151.59 32.04 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 126.677 1.991 . . . . 0.0 105.924 170.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 52.4 mt -55.44 -34.49 64.52 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.732 0.696 . . . . 0.0 112.656 -175.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.15 -25.86 64.59 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.744 0.702 . . . . 0.0 112.21 179.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.0 mt -81.83 -23.23 36.57 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.468 0.707 . . . . 0.0 111.178 -178.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.2 mt -64.84 128.03 93.23 Favored Pre-proline 0 CA--C 1.54 0.577 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 178.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -47.41 140.21 15.96 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.588 2.859 . . . . 0.0 111.249 170.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -89.78 -36.06 15.36 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 121.987 -0.446 . . . . 0.0 111.627 -170.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.4 t -140.99 138.96 34.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 124.866 1.266 . . . . 0.0 107.702 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 68.5 t0 -152.93 111.34 3.69 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 169.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 36.6 pt -138.07 40.47 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.913 1.285 . . . . 0.0 109.439 -173.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -63.95 83.07 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.204 1.402 . . . . 0.0 111.97 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.9 m -162.32 177.38 9.64 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 128.193 2.597 . . . . 0.0 107.783 174.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -144.89 161.98 37.97 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.648 1.179 . . . . 0.0 108.976 -176.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.88 -160.26 50.36 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 -170.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.7 t -69.35 136.96 25.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 173.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -157.31 153.76 27.93 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.934 0.894 . . . . 0.0 108.737 168.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -80.05 155.88 27.36 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.91 163.61 32.92 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.997 1.319 . . . . 0.0 108.27 176.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.5 m -133.23 150.83 32.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 124.36 1.064 . . . . 0.0 109.589 172.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.05 117.0 33.6 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 104.139 -2.541 . . . . 0.0 104.139 175.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 76.5 mt -118.93 122.82 70.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 -175.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 36.2 ttp180 -79.46 147.49 32.25 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 169.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.8 t -133.73 145.01 34.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 104.762 -2.31 . . . . 0.0 104.762 -175.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -130.42 150.14 51.77 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.596 1.158 . . . . 0.0 108.129 -179.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.9 m -60.81 100.73 0.12 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.122 0.969 . . . . 0.0 111.773 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.456 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -144.59 17.78 0.04 OUTLIER Pre-proline 0 CA--C 1.554 1.111 0 CA-C-O 116.188 -1.863 . . . . 0.0 113.898 169.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.456 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 66.9 Cg_exo -40.12 130.6 2.23 Favored 'Trans proline' 0 C--N 1.365 1.444 0 CA-C-N 123.702 2.358 . . . . 0.0 114.41 177.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . 0.302 1.2 tpm_? 23.59 47.74 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 130.331 3.452 . . . . 0.0 114.933 -168.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.1 m 55.8 24.4 7.34 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.901 1.28 . . . . 0.0 113.323 176.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -146.95 -7.05 0.29 Allowed Glycine 0 CA--C 1.529 0.931 0 CA-C-O 118.469 -1.184 . . . . 0.0 114.92 -169.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.53 132.63 85.5 Favored Pre-proline 0 CA--C 1.543 0.705 0 CA-C-N 119.522 1.661 . . . . 0.0 110.295 173.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -78.47 -20.09 11.15 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.829 2.353 . . . . 0.0 112.702 178.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.9 160.87 19.58 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.051 0.94 . . . . 0.0 111.12 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.2 60.91 0.97 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.248 1.419 . . . . 0.0 108.487 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -124.22 -173.21 2.71 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.545 1.538 . . . . 0.0 108.75 177.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.1 m -142.76 159.23 42.64 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.786 0.834 . . . . 0.0 110.596 -173.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -151.07 165.95 32.24 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 127.625 2.37 . . . . 0.0 106.168 -174.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.5 mp0 -131.26 154.23 48.69 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 121.039 -1.038 . . . . 0.0 108.494 177.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 39.3 pt -135.26 156.18 38.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 125.277 1.431 . . . . 0.0 109.686 178.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 54.2 t -118.65 120.34 63.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 105.434 -2.062 . . . . 0.0 105.434 177.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.0 mmp_? -130.28 146.23 51.86 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 172.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -179.55 140.51 4.33 Favored Glycine 0 N--CA 1.454 -0.139 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 174.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -154.88 156.06 35.46 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -170.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.5 mmtm -53.05 -39.45 63.26 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.407 1.083 . . . . 0.0 112.026 174.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 12.8 p-90 -67.2 -27.72 67.49 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.519 0.6 . . . . 0.0 112.503 -176.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.96 80.32 9.05 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 119.295 0.952 . . . . 0.0 108.964 173.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -63.73 -18.52 64.11 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.254 0.621 . . . . 0.0 111.488 174.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -132.1 148.87 52.51 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 126.47 1.908 . . . . 0.0 108.043 178.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 37.3 m-70 -72.52 -32.26 65.99 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -170.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.85 -29.08 54.29 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 118.561 -0.733 . . . . 0.0 112.663 172.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -67.14 -49.66 64.04 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 119.338 0.972 . . . . 0.0 110.84 -175.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.8 -38.88 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 CA-C-O 117.557 -1.211 . . . . 0.0 109.995 174.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -60.36 -47.33 86.52 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 120.191 1.36 . . . . 0.0 110.404 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -63.67 -47.91 79.31 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.265 0.484 . . . . 0.0 111.507 179.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 40.9 tttt -62.63 -51.19 68.24 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 123.239 0.616 . . . . 0.0 111.315 -178.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 94.6 t -72.56 -46.33 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-O 118.189 -0.91 . . . . 0.0 108.967 -172.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 56.6 m -64.11 -27.26 68.97 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 120.157 1.344 . . . . 0.0 111.162 175.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.84 -51.28 56.88 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 170.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -60.73 -43.37 98.0 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.418 1.109 . . . . 0.0 111.638 178.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.52 ' HG3' ' HG ' ' A' ' 71' ' ' CYS . 37.5 mmt -59.62 -47.25 86.32 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 123.131 0.573 . . . . 0.0 110.011 177.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -69.48 -28.26 65.92 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.892 0.769 . . . . 0.0 112.066 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -66.92 -38.24 85.84 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 119.179 0.9 . . . . 0.0 110.112 169.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -69.48 -25.66 64.18 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 119.668 1.122 . . . . 0.0 110.496 169.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 118.84 -21.42 9.62 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 127.919 2.676 . . . . 0.0 112.456 175.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 92.2 m -53.08 149.59 6.61 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 126.112 1.765 . . . . 0.0 112.1 -178.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -108.48 138.65 44.43 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 177.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.52 ' HG ' ' HG3' ' A' ' 64' ' ' MET . 97.3 m -141.41 164.18 30.92 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -168.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -153.79 130.26 10.61 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.499 1.52 . . . . 0.0 107.49 174.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 5.9 p -70.92 122.1 19.34 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 169.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 41.9 mt -70.12 -25.67 63.6 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.861 -0.525 . . . . 0.0 109.941 170.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.93 -171.78 43.03 Favored Glycine 0 C--N 1.337 0.608 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 170.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -128.84 171.87 19.68 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 175.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -176.81 -162.71 27.84 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 108.6 -1.8 . . . . 0.0 108.6 -176.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -146.0 163.67 34.47 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 121.055 -1.262 . . . . 0.0 108.547 -178.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 81.4 mt -133.28 143.87 37.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 -170.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 69.6 m -144.17 170.58 15.69 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.546 1.538 . . . . 0.0 108.765 170.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -145.79 140.11 26.9 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.002 1.321 . . . . 0.0 107.693 176.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -137.65 51.15 1.92 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.107 1.363 . . . . 0.0 108.821 -177.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.8 m 60.33 -173.77 0.12 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.596 1.559 . . . . 0.0 112.458 175.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -62.48 -20.13 64.25 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 120.723 -1.236 . . . . 0.0 111.868 174.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -67.86 -39.48 83.77 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.171 0.988 . . . . 0.0 112.668 -178.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 26.4 mtmm -132.46 8.36 4.25 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -176.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.2 mptt 63.2 -178.17 0.15 Allowed 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 126.277 1.831 . . . . 0.0 113.545 169.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 59.4 mt -81.71 149.06 4.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 169.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 54.2 t60 -143.93 149.41 36.78 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 121.193 -0.942 . . . . 0.0 109.69 -179.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 18.7 t -127.81 128.95 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.114 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -160.81 -172.4 3.48 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.236 -0.915 . . . . 0.0 111.132 -169.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 66.29 -166.21 38.14 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-O 121.425 0.459 . . . . 0.0 112.616 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -162.08 157.2 23.04 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.083 0.953 . . . . 0.0 110.502 -170.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.9 t -85.24 164.38 18.09 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 168.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.0 ptm -104.83 -31.8 9.12 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 118.625 -0.702 . . . . 0.0 110.646 169.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.8 -26.41 61.5 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.324 0.965 . . . . 0.0 111.556 174.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -132.46 -3.56 3.39 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.925 0.89 . . . . 0.0 113.089 -169.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.46 -177.3 43.74 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-N 118.779 0.718 . . . . 0.0 112.997 175.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -67.89 142.07 55.92 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.652 2.234 . . . . 0.0 110.41 172.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.19 173.89 9.5 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 122.369 1.08 . . . . 0.0 110.322 169.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -81.47 79.48 8.06 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 103.828 -2.656 . . . . 0.0 103.828 167.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 51.6 m80 -60.95 -13.74 18.04 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -169.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.86 -35.91 77.8 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.554 0.742 . . . . 0.0 111.622 172.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 83.8 mt -65.15 -44.16 95.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 177.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.87 -48.44 81.37 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.158 0.983 . . . . 0.0 110.684 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.4 p -66.38 -42.46 87.91 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 117.813 -1.089 . . . . 0.0 110.661 -177.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -58.22 -44.11 88.02 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 120.226 1.376 . . . . 0.0 110.772 177.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -69.13 -44.21 72.84 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.873 -0.517 . . . . 0.0 111.635 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 81.5 mt -71.55 -34.19 51.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 O-C-N 121.257 -0.902 . . . . 0.0 109.478 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -57.73 -46.62 84.18 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.684 1.129 . . . . 0.0 109.483 170.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.27 -35.77 80.01 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.163 0.438 . . . . 0.0 111.499 177.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 56.0 tttm -65.6 -34.29 77.89 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.774 0.715 . . . . 0.0 111.496 176.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -131.16 73.49 80.52 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 123.83 0.852 . . . . 0.0 111.285 -173.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -55.08 -26.58 51.04 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.143 2.562 . . . . 0.0 114.25 176.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -72.73 -7.52 50.92 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.29 1.036 . . . . 0.0 112.738 178.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -127.63 -175.69 3.54 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.27 1.828 . . . . 0.0 108.948 -177.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -138.8 165.86 25.91 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 170.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.6 t -141.82 143.76 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 -173.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 19.3 p -133.05 168.8 17.83 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.198 0.999 . . . . 0.0 108.676 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 57.9 p-90 -139.99 157.61 45.39 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.178 0.513 . . . . 0.0 111.802 173.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -148.94 140.35 23.31 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 170.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.02 -18.86 59.09 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.937 -0.477 . . . . 0.0 111.222 -174.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.24 153.97 24.81 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.427 -0.796 . . . . 0.0 110.989 176.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 151.38 -163.08 29.78 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.486 -1.045 . . . . 0.0 110.486 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 36.7 p90 . . . . . 0 C--O 1.239 0.535 0 C-N-CA 125.282 1.433 . . . . 0.0 109.115 174.375 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ttt . . . . . 0 N--CA 1.483 1.219 0 CA-C-O 119.5 -0.286 . . . . 0.0 110.519 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.89 176.93 10.95 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.229 1.412 . . . . 0.0 108.874 -179.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.7 p -142.37 156.83 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 123.522 0.729 . . . . 0.0 109.305 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -157.11 -177.05 6.32 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.866 2.467 . . . . 0.0 106.484 175.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -141.95 142.41 33.0 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 169.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 81.5 mt -57.46 -32.36 66.87 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.734 0.814 . . . . 0.0 112.713 -171.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.84 -25.52 64.69 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.895 0.77 . . . . 0.0 112.1 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.5 mt -80.53 -24.92 38.99 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.37 0.668 . . . . 0.0 111.186 -177.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 41.0 mt -67.24 128.49 93.75 Favored Pre-proline 0 C--O 1.24 0.558 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -175.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -46.9 127.05 11.8 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.885 3.057 . . . . 0.0 111.341 171.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -81.4 -34.1 31.83 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 121.051 0.453 . . . . 0.0 111.311 -170.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.0 t -138.77 133.7 41.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 174.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -147.95 133.49 18.73 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 170.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 38.6 pt -147.42 156.82 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 127.113 2.165 . . . . 0.0 106.102 -177.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -150.01 46.02 0.92 Allowed 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 122.113 0.958 . . . . 0.0 109.973 178.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.9 m -145.8 173.73 11.85 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.795 1.638 . . . . 0.0 109.623 -176.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -150.68 168.98 22.73 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 125.288 1.435 . . . . 0.0 108.306 174.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.66 -92.5 1.72 Allowed Glycine 0 C--N 1.331 0.304 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 178.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.5 t -145.73 141.09 22.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 C-N-CA 128.034 2.534 . . . . 0.0 105.076 174.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -160.35 152.13 19.95 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 119.034 0.834 . . . . 0.0 110.444 172.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.25 152.03 39.79 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.62 0.768 . . . . 0.0 109.35 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.98 161.15 41.94 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.296 1.038 . . . . 0.0 109.082 -178.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.4 m -131.21 153.69 39.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 C-N-CA 124.4 1.08 . . . . 0.0 110.097 173.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -108.39 115.02 29.34 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 104.345 -2.465 . . . . 0.0 104.345 177.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 54.4 mt -119.37 124.53 73.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 -172.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -78.55 148.97 33.16 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 169.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.5 t -133.56 148.17 30.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 105.55 -2.019 . . . . 0.0 105.55 -179.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -129.59 156.2 44.58 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.806 1.243 . . . . 0.0 109.357 -178.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.1 m -68.75 44.41 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.1 1.76 . . . . 0.0 114.626 178.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -72.7 -9.41 0.15 Allowed Pre-proline 0 CA--C 1.557 1.234 0 N-CA-C 117.846 2.535 . . . . 0.0 117.846 170.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -46.29 159.22 0.28 Allowed 'Trans proline' 0 C--N 1.362 1.262 0 C-N-CA 123.82 3.013 . . . . 0.0 116.67 -177.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . 0.25 8.2 ptp180 46.63 22.1 0.16 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 126.222 1.809 . . . . 0.0 113.313 -169.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.7 m 49.69 27.14 2.08 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.971 1.708 . . . . 0.0 112.811 -172.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 169.28 30.29 0.02 OUTLIER Glycine 0 CA--C 1.528 0.858 0 CA-C-O 118.7 -1.055 . . . . 0.0 114.796 -173.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.22 148.78 29.23 Favored Pre-proline 0 CA--C 1.544 0.739 0 CA-C-N 119.168 1.484 . . . . 0.0 110.213 171.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.1 -25.5 19.17 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 122.494 2.13 . . . . 0.0 112.768 -176.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.44 157.52 33.99 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.711 0.804 . . . . 0.0 110.472 174.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -142.78 36.38 1.43 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.227 1.411 . . . . 0.0 109.044 174.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -81.67 176.18 9.85 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.862 0.865 . . . . 0.0 109.34 178.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.5 m -141.16 160.36 40.26 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.61 1.164 . . . . 0.0 108.984 171.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -149.59 169.83 20.07 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 127.338 2.255 . . . . 0.0 106.457 -173.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.1 mp0 -133.27 152.79 51.94 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 176.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 38.9 pt -133.96 155.73 40.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 125.551 1.54 . . . . 0.0 109.589 178.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 89.1 t -117.08 120.09 63.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 105.696 -1.965 . . . . 0.0 105.696 177.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 10.4 mmp_? -127.69 142.17 51.41 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 174.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -172.63 139.84 5.42 Favored Glycine 0 C--N 1.332 0.321 0 CA-C-N 119.429 1.013 . . . . 0.0 111.412 172.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.423 ' CD2' ' CZ2' ' A' ' 49' ' ' TRP . 30.1 m-85 -154.81 156.61 36.54 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.673 0.789 . . . . 0.0 109.893 -171.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.3 mttp -67.68 -32.02 72.39 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 118.793 -0.622 . . . . 0.0 111.007 175.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.423 ' CZ2' ' CD2' ' A' ' 47' ' ' TYR . 14.5 p-90 -62.57 -30.86 71.63 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.723 0.692 . . . . 0.0 111.575 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.73 71.04 6.68 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.357 0.663 . . . . 0.0 109.47 171.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -61.33 -18.3 57.94 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.502 0.721 . . . . 0.0 111.454 176.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -125.02 146.97 49.18 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 126.466 1.906 . . . . 0.0 107.764 176.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 60.9 m80 -73.12 -31.35 64.26 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 122.887 0.475 . . . . 0.0 110.441 -169.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.02 -30.83 49.21 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 118.612 -0.709 . . . . 0.0 112.4 172.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -69.67 -49.13 56.49 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 119.321 0.964 . . . . 0.0 111.084 -176.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.79 -40.18 86.94 Favored 'Isoleucine or valine' 0 C--N 1.342 0.274 0 CA-C-O 117.518 -1.23 . . . . 0.0 109.699 175.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -59.98 -50.55 73.29 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 119.726 1.148 . . . . 0.0 109.96 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -61.14 -45.35 95.02 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 119.059 0.845 . . . . 0.0 112.028 -178.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 30.7 tttt -61.4 -49.09 78.28 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 122.912 0.485 . . . . 0.0 110.574 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 85.0 t -78.91 -39.42 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 117.692 -1.146 . . . . 0.0 109.954 -170.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 91.5 p -61.42 -39.23 90.02 Favored 'General case' 0 C--N 1.339 0.122 0 CA-C-N 120.757 1.617 . . . . 0.0 109.13 174.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -57.28 -51.66 56.23 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 123.948 0.785 . . . . 0.0 111.363 172.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -61.73 -46.31 90.19 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 118.943 1.372 . . . . 0.0 111.68 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.5 ' HG3' ' HG ' ' A' ' 71' ' ' CYS . 36.0 mmt -59.41 -47.52 85.14 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.349 0.66 . . . . 0.0 110.456 177.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -62.84 -35.82 81.21 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.788 0.835 . . . . 0.0 111.279 177.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -66.38 -35.5 80.5 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 118.043 -0.98 . . . . 0.0 111.302 172.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -71.73 -17.51 62.2 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 119.972 1.26 . . . . 0.0 112.159 170.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.37 -8.57 41.19 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.696 1.617 . . . . 0.0 112.543 178.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 90.4 m -65.96 165.44 13.2 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.636 1.218 . . . . 0.0 110.863 176.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -125.33 148.3 48.79 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 170.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.5 ' HG ' ' HG3' ' A' ' 64' ' ' MET . 65.9 m -145.31 165.34 28.73 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -168.307 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -149.22 137.64 20.9 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.811 1.645 . . . . 0.0 106.921 169.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.4 p -77.69 115.48 17.47 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 169.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 36.9 mt -67.99 -24.43 65.13 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 121.981 -0.449 . . . . 0.0 110.149 174.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.92 -165.73 38.69 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 170.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -147.7 178.84 25.04 Favored Glycine 0 CA--C 1.519 0.318 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 172.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -176.29 -157.84 18.41 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 107.546 -2.221 . . . . 0.0 107.546 -176.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 31.0 ptt-85 -137.02 157.78 45.95 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 120.616 -1.52 . . . . 0.0 108.811 173.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 97.4 mt -114.71 142.55 27.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 -177.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.0 m -135.86 148.53 48.68 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.123 0.969 . . . . 0.0 108.71 178.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -138.83 -34.45 0.61 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.525 1.13 . . . . 0.0 110.779 -177.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -83.17 34.06 0.46 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 119.075 0.852 . . . . 0.0 109.93 169.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.8 m -66.99 -176.52 0.53 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.901 2.08 . . . . 0.0 111.295 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 20.6 tp60 -57.98 -21.54 45.09 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.317 1.047 . . . . 0.0 112.459 177.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -139.27 155.13 47.96 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.902 1.681 . . . . 0.0 107.189 169.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 59.2 mtmt -64.97 -18.07 64.95 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -176.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -54.91 127.94 31.02 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 120.13 1.332 . . . . 0.0 108.366 174.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 69.3 mt -65.63 150.69 10.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 -178.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 24.5 t60 -136.87 155.61 49.54 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 121.171 -0.956 . . . . 0.0 109.652 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.6 t -137.37 124.89 30.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -164.48 -178.3 5.33 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 121.468 -0.77 . . . . 0.0 109.909 -172.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.49 -174.04 55.19 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -178.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -157.3 155.79 31.31 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.05 0.54 . . . . 0.0 111.958 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.1 t -75.81 164.67 26.0 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 168.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.3 ptm -108.53 -30.5 8.22 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 118.492 -0.766 . . . . 0.0 111.122 170.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.06 -26.06 60.18 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.551 1.069 . . . . 0.0 111.431 173.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -131.91 -7.42 3.53 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.915 0.886 . . . . 0.0 113.015 -169.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.92 -177.13 52.49 Favored Glycine 0 CA--C 1.535 1.293 0 CA-C-N 118.673 0.669 . . . . 0.0 113.607 171.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.08 135.65 38.16 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.092 2.528 . . . . 0.0 110.404 176.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.04 167.94 20.95 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.131 0.491 . . . . 0.0 110.128 169.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 -78.92 82.63 5.1 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 168.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -57.57 -15.09 6.34 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -176.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.55 -43.96 80.42 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.22 1.408 . . . . 0.0 111.215 169.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 64.1 mt -64.58 -47.12 90.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.91 -50.94 71.63 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.777 0.831 . . . . 0.0 110.923 -176.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.6 p -65.05 -46.95 79.13 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.593 -174.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -60.04 -40.2 88.56 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.311 0.959 . . . . 0.0 110.592 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -66.39 -47.52 73.06 Favored 'General case' 0 CA--C 1.528 0.12 0 O-C-N 121.86 -0.525 . . . . 0.0 111.457 176.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 61.7 mt -64.82 -40.25 88.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 119.369 0.986 . . . . 0.0 109.128 -177.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -58.53 -47.51 83.93 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 119.449 1.022 . . . . 0.0 109.551 174.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.28 -39.42 94.55 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.57 0.348 . . . . 0.0 111.489 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -66.34 -36.28 82.5 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 118.674 -0.679 . . . . 0.0 111.108 177.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -130.23 69.55 81.98 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 123.569 0.748 . . . . 0.0 111.198 -171.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -56.94 -21.96 43.84 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 123.39 2.727 . . . . 0.0 114.615 179.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -69.16 -8.15 42.91 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.234 1.013 . . . . 0.0 112.683 176.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -128.36 178.32 6.35 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.425 1.89 . . . . 0.0 108.935 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -135.26 158.54 44.09 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 170.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.5 t -139.37 142.16 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 -169.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.3 p -134.53 171.59 14.1 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.481 1.112 . . . . 0.0 109.4 176.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 27.6 p-90 -143.83 163.28 33.81 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 121.674 -0.641 . . . . 0.0 110.709 173.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.19 131.76 14.84 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 172.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.76 -8.13 57.54 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 122.731 0.412 . . . . 0.0 111.117 178.022 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -63.15 -27.97 69.74 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.136 1.374 . . . . 0.0 113.001 -178.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -60.09 159.6 23.3 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 123.744 0.688 . . . . 0.0 112.73 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 52.4 p90 . . . . . 0 C--O 1.239 0.525 0 C-N-CA 124.95 1.3 . . . . 0.0 110.542 -176.625 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 mtt . . . . . 0 N--CA 1.482 1.147 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.15 162.66 40.46 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.039 1.335 . . . . 0.0 108.623 176.098 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.4 p -148.32 148.04 16.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 179.759 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.15 174.76 6.72 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.499 0.666 . . . . 0.0 110.785 179.209 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -152.93 152.12 31.11 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 170.235 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 57.0 mt -53.54 -36.88 62.29 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 118.627 0.649 . . . . 0.0 112.12 -178.165 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.56 -25.21 68.13 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.871 0.759 . . . . 0.0 112.509 -179.09 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.4 mt -83.57 -20.81 33.11 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.316 0.646 . . . . 0.0 111.561 -176.961 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 24.0 mt -68.07 128.94 93.26 Favored Pre-proline 0 CA--C 1.539 0.527 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -177.085 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -50.81 117.94 3.76 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 123.337 2.691 . . . . 0.0 110.705 169.705 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -73.01 -34.37 66.34 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 122.65 0.38 . . . . 0.0 111.532 -171.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.7 t -141.64 123.06 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 177.847 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -143.58 107.68 4.74 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 106.86 -1.534 . . . . 0.0 106.86 171.35 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.6 pt -136.92 157.21 35.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 123.599 0.76 . . . . 0.0 110.49 -169.794 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -128.4 -13.2 4.94 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.536 2.334 . . . . 0.0 110.362 176.072 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.6 m -68.49 47.4 0.06 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.857 2.063 . . . . 0.0 113.247 172.751 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -65.6 -36.91 85.11 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 120.985 -1.072 . . . . 0.0 108.915 169.093 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -89.36 171.78 38.8 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 108.53 -1.828 . . . . 0.0 108.53 168.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.2 t -68.69 92.6 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 123.223 0.609 . . . . 0.0 110.38 -171.701 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -146.06 167.02 24.4 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 126.33 1.852 . . . . 0.0 108.771 176.282 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -73.76 162.91 28.64 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.219 1.008 . . . . 0.0 112.548 -170.277 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -151.3 163.41 38.97 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.514 1.926 . . . . 0.0 108.006 169.813 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.3 m -131.07 155.9 42.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 124.756 1.222 . . . . 0.0 109.816 172.125 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.1 117.67 34.75 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 178.233 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 69.1 mt -121.49 113.85 40.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -171.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.5 ttm-85 -69.88 142.41 53.01 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 168.699 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.8 p -140.86 147.81 22.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -122.13 151.77 40.6 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.929 1.292 . . . . 0.0 109.347 -174.61 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 56.0 m -62.51 93.28 0.05 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.094 0.958 . . . . 0.0 110.955 172.376 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.404 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -138.87 24.3 0.07 OUTLIER Pre-proline 0 CA--C 1.552 1.027 0 CA-C-O 116.767 -1.587 . . . . 0.0 114.015 169.442 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.404 ' CD ' ' N ' ' A' ' 30' ' ' ALA . 83.5 Cg_exo -44.39 137.71 7.85 Favored 'Trans proline' 0 C--N 1.359 1.091 0 CA-C-N 123.774 2.383 . . . . 0.0 113.606 172.409 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 43.69 22.98 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.779 2.031 . . . . 0.0 114.495 -171.856 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.7 m 50.05 30.4 4.12 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.133 1.373 . . . . 0.0 112.402 -171.357 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -154.19 2.25 0.23 Allowed Glycine 0 CA--C 1.53 1.019 0 CA-C-O 118.6 -1.111 . . . . 0.0 114.892 -170.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.07 141.06 77.11 Favored Pre-proline 0 CA--C 1.544 0.719 0 CA-C-N 119.427 1.613 . . . . 0.0 110.42 172.281 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.77 -23.47 10.94 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.733 2.289 . . . . 0.0 112.927 -178.851 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.37 157.8 30.9 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.795 0.838 . . . . 0.0 110.583 177.729 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -141.52 27.63 1.87 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.815 1.246 . . . . 0.0 110.825 177.714 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -76.72 177.99 7.14 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.734 0.814 . . . . 0.0 110.05 173.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.4 m -141.89 160.98 39.09 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.097 1.359 . . . . 0.0 109.004 176.659 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.8 tttt -148.24 165.77 29.96 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 126.963 2.105 . . . . 0.0 107.117 -174.462 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -125.64 131.38 52.65 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 169.782 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 44.2 pt -112.85 159.59 12.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 125.414 1.486 . . . . 0.0 110.569 174.068 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 25.0 t -126.24 121.77 59.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 -173.63 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 26.4 mmt85 -139.34 147.02 40.98 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.382 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.53 135.71 2.49 Favored Glycine 0 C--N 1.331 0.305 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 -179.656 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -153.57 155.71 36.65 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -171.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -59.36 -29.98 68.07 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -179.049 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 8.9 p-90 -68.46 -23.75 64.62 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.78 0.718 . . . . 0.0 112.4 -179.481 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.03 78.61 8.7 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 119.346 0.975 . . . . 0.0 110.085 177.064 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -62.3 -18.39 61.2 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.943 0.897 . . . . 0.0 111.468 172.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -128.1 143.15 51.05 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.771 1.629 . . . . 0.0 106.888 178.829 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -65.08 -30.92 71.92 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 118.478 0.581 . . . . 0.0 109.828 176.623 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.54 -29.35 58.78 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 118.484 -0.77 . . . . 0.0 112.788 171.445 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -68.71 -49.5 58.4 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.559 1.072 . . . . 0.0 110.476 -175.255 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.93 -38.08 80.68 Favored 'Isoleucine or valine' 0 C--N 1.34 0.18 0 CA-C-O 117.859 -1.067 . . . . 0.0 110.157 175.8 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -61.95 -47.67 83.82 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 119.776 1.171 . . . . 0.0 110.275 179.036 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -61.96 -46.71 88.09 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.319 0.509 . . . . 0.0 111.362 179.163 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 32.6 tttt -62.92 -54.8 32.9 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 123.027 0.531 . . . . 0.0 111.078 -179.451 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 86.2 t -72.3 -49.3 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-O 118.183 -0.913 . . . . 0.0 109.161 -170.549 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.8 m -65.45 -28.27 69.11 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 120.048 1.294 . . . . 0.0 110.992 178.866 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.13 -49.29 76.4 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 170.219 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -62.45 -44.3 96.73 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 118.734 1.267 . . . . 0.0 111.304 177.458 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 39.2 mmt -55.99 -49.34 73.88 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-O 119.133 -0.461 . . . . 0.0 110.032 175.183 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -66.75 -29.11 69.0 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.965 0.802 . . . . 0.0 112.281 179.598 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -67.59 -37.33 82.43 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.718 1.144 . . . . 0.0 110.511 171.014 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -69.1 -27.5 65.65 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 119.546 1.066 . . . . 0.0 110.479 169.549 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 122.37 -25.72 6.55 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 127.914 2.673 . . . . 0.0 111.215 177.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 95.9 m -54.16 142.92 24.14 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 126.732 2.013 . . . . 0.0 110.792 -175.538 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -108.84 142.0 40.06 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -176.219 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 85.7 m -137.57 165.55 26.05 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 -167.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -153.03 125.74 8.31 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.864 2.066 . . . . 0.0 107.124 173.748 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.8 p -73.55 124.71 26.42 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 169.435 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 35.1 mt -71.41 -25.74 62.46 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.796 -0.565 . . . . 0.0 110.257 172.38 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 162.69 -165.34 36.22 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 108.477 -1.849 . . . . 0.0 108.477 177.89 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -148.04 173.35 28.11 Favored Glycine 0 CA--C 1.519 0.329 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 173.624 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -168.36 -160.23 15.7 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 108.501 -1.84 . . . . 0.0 108.501 -178.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 35.6 ptt-85 -136.4 160.16 39.58 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 121.084 -1.245 . . . . 0.0 108.057 177.357 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 86.5 mt -115.49 148.63 18.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 -170.803 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 38.9 m 62.08 174.23 0.13 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.678 1.991 . . . . 0.0 112.433 -172.066 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -153.68 -168.44 2.98 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.257 1.823 . . . . 0.0 107.768 -179.918 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -54.65 156.24 3.66 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.567 0.747 . . . . 0.0 111.236 176.731 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.5 m -67.65 19.8 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.662 1.985 . . . . 0.0 114.424 -179.009 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -63.19 -21.97 66.56 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.256 1.022 . . . . 0.0 111.092 174.238 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -146.97 173.78 12.12 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.64 1.576 . . . . 0.0 107.733 172.9 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -114.08 -18.79 11.6 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.641 1.576 . . . . 0.0 110.887 178.422 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -55.83 135.35 51.96 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 169.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.4 mp -68.71 156.07 7.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 -179.171 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 23.7 t60 -136.38 164.26 28.55 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 121.435 -0.791 . . . . 0.0 109.399 -179.404 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.1 t -145.45 133.94 16.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 176.274 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -169.74 -176.97 2.54 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.07 0.948 . . . . 0.0 109.302 -179.416 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 102.71 -170.06 19.77 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.407 -0.677 . . . . 0.0 111.407 173.824 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -157.92 151.51 23.67 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.858 0.863 . . . . 0.0 109.833 179.48 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.8 t -84.36 148.24 26.73 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 168.678 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 4.5 ptt? -76.27 -41.06 50.15 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 169.795 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.26 -25.14 54.66 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 118.881 -0.581 . . . . 0.0 112.246 -173.19 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -135.05 -1.83 2.62 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -169.619 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.04 -178.08 49.46 Favored Glycine 0 CA--C 1.535 1.297 0 CA-C-N 119.141 0.882 . . . . 0.0 113.089 176.415 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.86 139.57 33.59 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.999 2.466 . . . . 0.0 110.129 175.181 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.49 170.49 16.46 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.045 0.538 . . . . 0.0 110.58 169.758 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -78.4 84.0 4.59 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 168.605 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 48.5 m80 -57.95 -14.14 5.82 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -175.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.78 -41.1 85.86 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.429 1.492 . . . . 0.0 111.937 169.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 67.7 mt -65.8 -45.07 92.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.856 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.61 -49.38 76.62 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.354 1.061 . . . . 0.0 110.917 -179.006 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.4 p -63.19 -48.58 77.77 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 118.295 -0.86 . . . . 0.0 110.763 -176.438 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -60.08 -39.3 85.59 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.248 0.931 . . . . 0.0 110.764 -177.33 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 52.9 mttm -71.24 -45.05 64.11 Favored 'General case' 0 CA--C 1.528 0.112 0 O-C-N 121.839 -0.538 . . . . 0.0 111.817 178.652 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 73.9 mt -65.73 -38.29 81.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-N 119.363 0.983 . . . . 0.0 108.943 -179.444 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -57.93 -50.85 71.95 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.471 1.032 . . . . 0.0 109.115 171.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.5 -30.06 69.48 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -177.205 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -61.03 -40.58 94.14 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.998 0.817 . . . . 0.0 110.809 177.172 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -150.63 78.2 7.66 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 123.331 0.653 . . . . 0.0 109.285 -173.446 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -70.86 -4.75 15.4 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.215 2.61 . . . . 0.0 114.053 -169.868 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -68.92 -21.6 64.2 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 118.958 0.799 . . . . 0.0 111.399 169.794 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 22.8 m-30 -104.26 175.85 5.35 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.686 1.194 . . . . 0.0 109.037 169.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -138.35 158.3 44.55 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.434 1.094 . . . . 0.0 108.461 179.412 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.7 t -140.51 143.96 28.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -169.762 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.7 p -133.01 169.9 16.16 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.353 1.061 . . . . 0.0 109.76 177.606 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 41.6 p-90 -143.57 150.95 39.59 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 171.231 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.09 101.78 1.94 Allowed 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 104.665 -2.346 . . . . 0.0 104.665 172.361 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.05 -22.96 66.45 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -169.258 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -53.39 -27.23 22.99 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 126.934 2.093 . . . . 0.0 114.879 -169.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -63.84 -22.24 66.22 Favored Glycine 0 CA--C 1.537 1.442 0 CA-C-O 118.553 -1.137 . . . . 0.0 113.243 177.266 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 . . . . . 0 N--CA 1.47 0.558 0 C-N-CA 127.613 2.365 . . . . 0.0 113.469 177.683 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.335 0 CA-C-O 121.98 0.895 . . . . 0.0 110.281 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -148.74 149.94 32.26 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 105.053 -2.202 . . . . 0.0 105.053 169.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 17.0 mt -60.23 -26.93 66.78 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -171.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.58 -28.06 65.64 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.888 0.767 . . . . 0.0 112.434 175.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.8 mt -79.3 -28.08 42.19 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 123.334 0.654 . . . . 0.0 111.149 -177.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 39.9 mt -64.85 128.0 93.22 Favored Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -47.16 130.31 16.56 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.41 2.74 . . . . 0.0 110.944 171.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -81.74 -37.63 26.97 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.357 0.599 . . . . 0.0 110.922 -173.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 43.8 t -134.73 135.13 53.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 170.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -152.93 123.54 7.27 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 169.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 20.2 pt . . . . . 0 CA--C 1.534 0.349 0 C-N-CA 125.601 1.56 . . . . 0.0 107.334 -171.768 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 32.2 p90 . . . . . 0 C--O 1.235 0.299 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -81.8 155.83 25.22 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 123.213 0.605 . . . . 0.0 110.772 -172.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -144.54 160.42 41.14 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.73 1.212 . . . . 0.0 108.174 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.1 m -132.85 152.34 35.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 C-N-CA 124.299 1.04 . . . . 0.0 109.169 173.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.36 123.65 47.22 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 103.654 -2.721 . . . . 0.0 103.654 173.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.7 mt -125.55 121.16 59.53 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 -177.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 23.1 ttp180 -76.64 143.47 40.12 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 169.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.2 t -133.66 142.45 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 C-N-CA 128.568 2.747 . . . . 0.0 104.593 -172.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -127.77 151.95 48.37 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.164 0.985 . . . . 0.0 108.806 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.509 ' HG ' ' N ' ' A' ' 39' ' ' GLU . 39.1 m -63.7 90.74 0.06 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.997 0.919 . . . . 0.0 111.48 175.153 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.42 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -136.32 19.21 0.05 OUTLIER Pre-proline 0 CA--C 1.552 1.025 0 CA-C-O 116.473 -1.727 . . . . 0.0 113.201 168.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.42 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 77.0 Cg_exo . . . . . 0 C--N 1.362 1.284 0 CA-C-N 123.915 2.434 . . . . 0.0 113.064 172.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.509 ' N ' ' HG ' ' A' ' 29' ' ' SER . 7.5 mm-40 . . . . . 0 CA--C 1.539 0.52 0 CA-C-O 121.358 0.599 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 12.5 m -140.28 158.55 43.85 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.503 1.121 . . . . 0.0 108.66 170.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -150.95 165.4 33.83 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 127.284 2.233 . . . . 0.0 105.822 -173.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.9 mp0 -128.72 147.87 50.8 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 176.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.3 pt -127.11 154.38 37.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 124.623 1.169 . . . . 0.0 109.456 176.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.0 t -117.66 119.28 61.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 178.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.414 ' HG3' HG21 ' A' ' 60' ' ' VAL . 9.9 mmp_? -129.49 145.28 51.46 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.007 1.323 . . . . 0.0 107.454 176.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.98 134.43 2.32 Favored Glycine 0 N--CA 1.452 -0.282 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 177.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -151.92 150.2 29.78 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -170.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -60.69 -27.57 67.96 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 118.88 -0.581 . . . . 0.0 112.407 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 11.3 p-90 -69.72 -26.16 64.2 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.259 0.936 . . . . 0.0 113.02 176.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.02 82.27 7.68 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 119.926 1.239 . . . . 0.0 109.667 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -66.34 -12.45 56.79 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.029 0.932 . . . . 0.0 111.884 176.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -142.06 152.01 42.92 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.522 1.929 . . . . 0.0 107.946 178.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -73.9 -32.88 63.78 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 121.692 -0.63 . . . . 0.0 110.308 -170.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.09 -28.39 52.13 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-O 118.561 -0.733 . . . . 0.0 112.265 172.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -66.43 -48.72 69.1 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 119.269 0.941 . . . . 0.0 110.731 -176.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.427 ' H ' HG12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -67.89 -42.85 86.12 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.675 177.568 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -61.51 -44.63 96.73 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 119.896 1.225 . . . . 0.0 110.098 -177.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -63.03 -48.55 78.25 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.888 0.767 . . . . 0.0 111.936 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 36.1 tttt -62.41 -52.89 61.77 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.387 0.675 . . . . 0.0 110.951 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.414 HG21 ' HG3' ' A' ' 45' ' ' ARG . 78.4 t -70.86 -49.61 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-O 118.231 -0.89 . . . . 0.0 109.125 -170.07 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 66.7 m -68.25 -23.4 64.78 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 119.721 1.146 . . . . 0.0 111.186 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.6 -48.82 78.77 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 169.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.419 ' HA ' ' HE3' ' A' ' 66' ' ' LYS . 18.4 t70 -62.27 -45.79 91.68 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 118.448 1.124 . . . . 0.0 111.816 176.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 39.0 mmt -55.99 -48.2 76.32 Favored 'General case' 0 C--O 1.227 -0.083 0 CA-C-N 118.17 0.441 . . . . 0.0 110.463 176.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -69.82 -27.56 64.97 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 118.779 0.718 . . . . 0.0 112.037 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.419 ' HE3' ' HA ' ' A' ' 63' ' ' ASP . 52.1 mtmt -66.58 -36.48 82.73 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.37 0.986 . . . . 0.0 110.25 169.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -70.36 -30.91 67.97 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 120.0 1.273 . . . . 0.0 110.44 169.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 129.62 -26.63 4.29 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 127.618 2.532 . . . . 0.0 111.365 174.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 85.6 m -51.15 142.36 12.72 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 126.306 1.842 . . . . 0.0 111.861 -175.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -101.96 146.73 27.46 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 176.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 79.2 m -143.1 163.28 33.29 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -168.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -150.65 128.88 11.97 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 169.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 9.2 p -66.95 131.58 46.18 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 169.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 38.8 mt -74.83 -21.52 59.23 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 120.974 -1.079 . . . . 0.0 110.176 170.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 162.53 -168.35 37.42 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 108.66 -1.776 . . . . 0.0 108.66 175.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -133.34 172.83 21.36 Favored Glycine 0 CA--C 1.521 0.421 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 173.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -171.59 -163.99 26.47 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 108.084 -2.006 . . . . 0.0 108.084 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 29.2 ptt180 -135.47 154.81 51.3 Favored 'General case' 0 CA--C 1.512 -0.511 0 O-C-N 120.639 -1.506 . . . . 0.0 109.294 172.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.9 mt . . . . . 0 N--CA 1.445 -0.704 0 N-CA-C 104.331 -2.47 . . . . 0.0 104.331 178.399 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 22.3 t60 . . . . . 0 N--CA 1.451 -0.381 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.6 t -133.82 130.43 55.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -173.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -171.26 -175.48 1.68 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.474 0.579 . . . . 0.0 110.235 -169.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.47 -166.47 39.94 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 174.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -157.67 161.09 38.57 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.391 0.676 . . . . 0.0 111.629 175.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.9 t -87.74 154.46 20.55 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 168.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.4 ptm -92.34 -32.37 15.01 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 119.024 0.829 . . . . 0.0 110.422 173.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.19 -24.35 59.34 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.048 0.84 . . . . 0.0 111.836 175.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -133.92 -4.9 2.79 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -169.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.4 -177.21 52.92 Favored Glycine 0 CA--C 1.535 1.317 0 CA-C-N 119.412 1.006 . . . . 0.0 113.124 175.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.58 138.55 38.66 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.232 2.621 . . . . 0.0 110.41 176.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.45 169.56 18.01 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.694 0.798 . . . . 0.0 111.192 169.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -79.5 80.85 5.83 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 169.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 41.9 m80 -56.1 -20.13 16.03 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.843 0.857 . . . . 0.0 113.244 -178.081 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.23 -44.3 71.6 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.428 1.491 . . . . 0.0 112.352 169.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 70.7 mt -66.25 -44.7 91.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.43 -49.38 76.42 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.921 0.888 . . . . 0.0 110.78 -178.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.46 HG22 HG12 ' A' ' 118' ' ' VAL . 13.1 p -64.55 -46.71 81.68 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 118.362 -0.827 . . . . 0.0 110.708 -175.485 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -60.87 -40.1 91.69 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 119.295 0.952 . . . . 0.0 110.705 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 45.1 mttm -68.36 -46.97 68.68 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.807 -0.558 . . . . 0.0 111.509 177.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 68.8 mt -66.63 -38.51 81.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 119.469 1.031 . . . . 0.0 109.198 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 93.7 mttt . . . . . 0 N--CA 1.468 0.44 0 CA-C-N 119.696 1.134 . . . . 0.0 109.56 173.597 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.46 HG12 HG22 ' A' ' 106' ' ' THR . 3.1 t . . . . . 0 C--O 1.234 0.289 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.6 p -136.83 170.18 16.52 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.496 1.119 . . . . 0.0 109.507 177.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 41.8 p-90 . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 172.452 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.366 0 CA-C-O 121.776 0.798 . . . . 0.0 111.631 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -146.29 143.72 29.35 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 105.558 -2.016 . . . . 0.0 105.558 169.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 76.6 mt -55.69 -33.03 63.8 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -171.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.82 -25.44 66.44 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.911 0.778 . . . . 0.0 112.318 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.1 mt -81.23 -24.39 37.43 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.481 0.712 . . . . 0.0 111.397 -176.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 52.3 mt -70.9 131.02 87.74 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-O 118.145 -0.931 . . . . 0.0 108.783 -169.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -47.27 120.38 4.32 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 124.26 3.307 . . . . 0.0 112.894 172.069 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -66.13 -35.76 81.35 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.475 1.51 . . . . 0.0 111.739 -178.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.9 t -143.41 138.23 26.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 176.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -153.19 113.82 4.06 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 169.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.2 pt . . . . . 0 CA--C 1.534 0.331 0 C-N-CA 123.145 0.578 . . . . 0.0 110.878 -169.685 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 . . . . . 0 C--O 1.237 0.433 0 CA-C-O 121.351 0.596 . . . . 0.0 109.782 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.4 mttm -70.48 156.2 39.69 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.63 1.172 . . . . 0.0 111.785 -172.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -144.54 161.59 38.72 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.614 1.966 . . . . 0.0 107.639 169.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.1 m -129.15 151.76 36.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 124.971 1.309 . . . . 0.0 109.537 173.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.97 120.34 39.66 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 104.202 -2.518 . . . . 0.0 104.202 171.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 46.1 mt -122.06 127.34 75.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 -177.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -81.36 148.0 29.56 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 169.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.1 t -133.03 144.25 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 -177.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -125.65 154.19 42.7 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.534 1.134 . . . . 0.0 109.396 -176.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 44.3 m -69.54 47.45 0.08 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.996 1.718 . . . . 0.0 114.157 177.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.13 -5.4 0.09 OUTLIER Pre-proline 0 CA--C 1.556 1.192 0 CA-C-O 114.775 -2.536 . . . . 0.0 117.334 169.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo . . . . . 0 C--N 1.363 1.292 0 C-N-CA 123.599 2.866 . . . . 0.0 115.543 178.026 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 . . . . . 0 C--O 1.24 0.589 0 CA-C-O 121.647 0.737 . . . . 0.0 109.903 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.5 m -140.71 160.38 40.17 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.862 1.265 . . . . 0.0 108.778 172.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -148.28 170.19 18.45 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 127.43 2.292 . . . . 0.0 106.291 -173.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.3 mp0 -133.15 154.08 50.94 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 121.084 -1.01 . . . . 0.0 108.294 178.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 34.2 pt -137.69 156.58 32.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 C-N-CA 125.712 1.605 . . . . 0.0 109.337 178.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 85.4 t -118.7 119.42 61.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.0 mmt85 -134.84 143.46 47.03 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -179.99 136.24 2.69 Favored Glycine 0 CA--C 1.509 -0.287 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -178.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -154.74 153.3 31.03 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -169.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -55.05 -29.67 57.96 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 178.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 8.7 p-90 -73.53 -22.54 60.07 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.969 0.804 . . . . 0.0 113.124 -179.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.86 83.5 7.17 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-N 120.056 1.298 . . . . 0.0 110.047 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -64.18 -18.41 64.46 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.976 0.91 . . . . 0.0 112.003 176.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -138.08 146.85 43.43 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.746 1.619 . . . . 0.0 108.398 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 29.2 m80 -65.03 -33.77 76.83 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.133 0.573 . . . . 0.0 110.832 -175.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.93 -25.82 45.03 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 118.382 -0.818 . . . . 0.0 112.987 173.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -67.75 -50.83 55.12 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 119.705 1.139 . . . . 0.0 110.569 -176.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.414 HG12 ' H ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -67.65 -37.17 78.2 Favored 'Isoleucine or valine' 0 C--N 1.339 0.147 0 CA-C-O 117.913 -1.041 . . . . 0.0 109.976 176.333 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -60.3 -49.47 77.46 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.651 1.114 . . . . 0.0 110.45 178.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -63.2 -47.1 84.01 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.345 0.52 . . . . 0.0 111.3 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.2 tttt -61.1 -53.7 53.76 Favored 'General case' 0 CA--C 1.522 -0.124 0 C-N-CA 123.126 0.571 . . . . 0.0 111.091 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 95.4 t -71.94 -44.91 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 117.937 -1.03 . . . . 0.0 109.294 -171.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.0 m -62.73 -33.77 75.82 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 120.292 1.406 . . . . 0.0 110.703 177.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.33 -47.6 89.93 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-N 118.946 0.794 . . . . 0.0 111.273 171.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -63.04 -46.29 88.23 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 118.625 1.213 . . . . 0.0 111.363 178.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 38.2 mmt -57.27 -45.93 83.57 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 123.488 0.715 . . . . 0.0 110.727 175.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -63.79 -36.42 83.82 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.786 0.835 . . . . 0.0 111.696 177.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -66.89 -37.21 83.96 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 119.232 0.923 . . . . 0.0 110.917 172.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -68.78 -23.65 64.33 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 119.283 0.947 . . . . 0.0 111.965 171.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 118.1 -12.93 12.76 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 126.248 1.88 . . . . 0.0 112.626 174.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 91.0 m -67.27 168.45 10.49 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.022 1.329 . . . . 0.0 111.55 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -125.44 152.11 45.33 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 170.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 65.4 m -143.44 163.69 32.41 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -168.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -148.71 137.59 21.49 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.042 1.737 . . . . 0.0 106.843 170.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.9 p -78.7 118.49 20.83 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 169.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 44.3 mt -70.85 -22.59 62.29 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 122.023 -0.423 . . . . 0.0 110.381 174.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 163.42 -166.76 37.34 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 172.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -151.68 175.66 30.39 Favored Glycine 0 CA--C 1.52 0.344 0 N-CA-C 111.807 -0.517 . . . . 0.0 111.807 171.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -166.6 -162.07 17.25 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 108.366 -1.894 . . . . 0.0 108.366 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.95 164.94 25.84 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 120.893 -1.357 . . . . 0.0 108.515 174.127 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 68.8 mt . . . . . 0 C--N 1.325 -0.474 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 -171.931 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 19.5 t60 . . . . . 0 N--CA 1.452 -0.336 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.0 t -141.84 137.11 31.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -163.03 -179.58 6.83 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.953 0.901 . . . . 0.0 109.247 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.9 -166.5 19.22 Favored Glycine 0 CA--C 1.523 0.553 0 O-C-N 121.695 -0.628 . . . . 0.0 112.592 169.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -159.07 157.85 31.87 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.903 1.281 . . . . 0.0 109.527 178.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.4 t -89.96 147.33 23.77 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 168.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.42 -42.46 62.02 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 171.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -80.72 -24.6 38.67 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 118.912 -0.566 . . . . 0.0 112.205 -171.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -132.49 -1.07 3.53 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -169.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.11 -179.72 49.81 Favored Glycine 0 CA--C 1.534 1.249 0 CA-C-N 118.964 0.802 . . . . 0.0 113.288 173.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.38 138.63 33.19 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.935 2.423 . . . . 0.0 109.981 175.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.07 168.1 20.65 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.254 0.55 . . . . 0.0 111.094 170.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -79.26 81.82 5.48 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 168.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -57.04 -18.38 13.85 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -174.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.82 -40.36 69.49 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.018 1.327 . . . . 0.0 112.151 170.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 61.2 mt -66.06 -47.28 85.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 178.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.42 -49.29 78.37 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.315 1.046 . . . . 0.0 110.798 -176.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 31.0 p -63.32 -49.12 75.2 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 118.642 -0.694 . . . . 0.0 109.568 -175.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -59.35 -40.72 87.34 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.11 0.868 . . . . 0.0 111.31 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 44.4 mttm -65.72 -47.15 76.31 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 118.507 0.594 . . . . 0.0 111.338 177.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 67.7 mt -64.01 -39.26 84.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 CA-C-N 119.202 0.91 . . . . 0.0 109.235 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.0 mtpt . . . . . 0 N--CA 1.469 0.502 0 CA-C-N 119.351 0.978 . . . . 0.0 109.999 177.348 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.2 t . . . . . 0 N--CA 1.448 -0.534 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 9.7 p -135.08 171.25 14.69 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.694 1.198 . . . . 0.0 108.764 176.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 55.7 p-90 . . . . . 0 C--O 1.235 0.326 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 172.393 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.435 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -146.21 153.06 40.18 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.675 1.99 . . . . 0.0 105.887 169.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 54.4 mt -53.15 -36.2 60.58 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.036 0.835 . . . . 0.0 112.077 -177.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.24 -25.72 68.19 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 118.801 0.728 . . . . 0.0 112.571 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.9 mt -83.73 -22.24 32.04 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.465 0.706 . . . . 0.0 111.489 -177.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 15.9 mt -66.48 131.71 94.2 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -50.39 128.9 24.49 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.842 2.361 . . . . 0.0 110.786 171.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -74.66 -41.69 59.86 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.378 0.671 . . . . 0.0 110.794 -176.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 53.5 t -136.29 129.18 46.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 177.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -152.12 111.94 4.0 Favored 'General case' 0 CA--C 1.521 -0.173 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 171.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 9.5 pt . . . . . 0 CA--C 1.535 0.386 0 C-N-CA 125.077 1.351 . . . . 0.0 109.067 -169.733 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 30.4 p90 . . . . . 0 CA--C 1.533 0.318 0 CA-C-O 121.248 0.547 . . . . 0.0 109.787 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.5 mttt -99.62 151.7 20.89 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.603 1.161 . . . . 0.0 108.83 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -142.91 162.8 34.5 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.232 1.013 . . . . 0.0 108.984 -174.004 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.0 m -133.6 155.25 40.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 C-N-CA 124.542 1.137 . . . . 0.0 109.718 173.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -106.96 116.73 32.44 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 178.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 80.3 mt -120.71 115.11 45.98 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -173.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -72.76 142.83 48.13 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 168.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.6 p -138.75 146.9 25.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -127.85 146.83 50.49 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.884 1.274 . . . . 0.0 108.484 -171.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 61.2 m -61.95 100.21 0.15 Allowed 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.598 0.759 . . . . 0.0 111.077 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.499 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -144.98 22.75 0.04 OUTLIER Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 126.029 1.732 . . . . 0.0 112.976 168.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.499 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 72.0 Cg_exo . . . . . 0 C--N 1.361 1.235 0 CA-C-N 123.872 2.419 . . . . 0.0 114.991 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 . . . . . 0 CA--C 1.542 0.653 0 CA-C-O 121.234 0.54 . . . . 0.0 109.891 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.9 m -143.27 159.94 41.4 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.964 1.306 . . . . 0.0 108.936 176.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.8 tttt -149.6 165.54 31.96 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 126.768 2.027 . . . . 0.0 107.246 -174.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -124.95 128.4 48.54 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 169.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 39.5 pt -108.89 155.07 10.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 124.84 1.256 . . . . 0.0 110.257 173.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 33.1 t -119.32 114.92 46.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 -175.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 12.7 mmp_? -128.38 146.84 50.66 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.084 1.353 . . . . 0.0 108.404 -177.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 174.98 137.55 2.52 Favored Glycine 0 C--N 1.332 0.306 0 CA-C-N 118.849 0.75 . . . . 0.0 111.303 176.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -153.33 154.16 34.02 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -169.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -56.92 -34.47 68.0 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 118.591 -0.719 . . . . 0.0 112.556 175.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 10.1 p-90 -65.5 -27.31 68.39 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.1 0.864 . . . . 0.0 112.294 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -87.29 73.22 9.72 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 119.033 0.833 . . . . 0.0 109.585 175.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -67.9 -5.05 14.89 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.458 0.703 . . . . 0.0 111.648 175.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -138.66 147.96 43.45 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 126.197 1.799 . . . . 0.0 107.142 173.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 59.9 m80 -73.89 -31.49 63.14 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 121.812 -0.555 . . . . 0.0 110.185 -169.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.76 -28.72 50.69 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 118.333 -0.842 . . . . 0.0 112.586 171.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -67.49 -49.31 64.06 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 119.624 1.102 . . . . 0.0 110.729 -177.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.401 ' H ' HG12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -67.35 -38.5 80.95 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 CA-C-O 117.732 -1.127 . . . . 0.0 110.045 177.058 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -64.43 -41.88 96.34 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 120.19 1.359 . . . . 0.0 110.669 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -63.43 -48.83 76.14 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.315 0.961 . . . . 0.0 111.304 176.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -56.79 -55.7 30.89 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.372 1.069 . . . . 0.0 110.628 178.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 81.1 t -77.08 -44.43 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-O 117.79 -1.1 . . . . 0.0 109.791 -169.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.1 t -62.73 -36.85 84.36 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 120.555 1.525 . . . . 0.0 109.266 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.51 -50.74 64.51 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 172.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -62.71 -45.95 90.36 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 118.728 1.264 . . . . 0.0 111.755 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 38.7 mmt -57.31 -47.86 80.42 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.377 0.671 . . . . 0.0 110.145 176.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -66.54 -30.92 71.33 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 118.698 -0.668 . . . . 0.0 111.805 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -67.48 -35.13 78.56 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.757 1.162 . . . . 0.0 110.724 170.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -72.8 -15.05 61.64 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 119.525 1.057 . . . . 0.0 111.208 169.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 110.04 -25.5 16.2 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 127.431 2.443 . . . . 0.0 112.247 177.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 93.3 m -55.8 149.28 14.95 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.957 1.703 . . . . 0.0 111.936 -175.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -108.87 143.36 38.18 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 177.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 96.1 m -141.3 164.91 28.98 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -168.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -151.41 128.37 11.04 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.794 1.637 . . . . 0.0 106.932 171.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.1 p -73.48 117.3 15.07 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 169.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 39.4 mt -70.76 -23.42 62.41 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.904 -0.497 . . . . 0.0 110.563 174.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.42 -170.97 42.46 Favored Glycine 0 C--N 1.337 0.626 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 171.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -132.23 169.91 22.02 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 174.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -174.34 -161.57 24.49 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -177.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 50.0 ttt180 -141.65 152.22 43.75 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 125.082 1.353 . . . . 0.0 107.816 -172.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 40.6 mt . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 173.752 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 22.9 t60 . . . . . 0 CA--C 1.517 -0.307 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.9 t -129.11 125.02 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -164.77 -167.98 1.36 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.694 0.798 . . . . 0.0 109.076 -171.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.71 -176.09 53.95 Favored Glycine 0 CA--C 1.527 0.793 0 O-C-N 121.633 -0.667 . . . . 0.0 111.473 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -158.97 149.84 20.01 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.01 0.924 . . . . 0.0 110.804 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.0 t -75.37 162.48 28.35 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 168.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.2 ptm -103.72 -31.27 9.93 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 118.629 -0.7 . . . . 0.0 110.783 170.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -73.71 -25.74 60.36 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 119.351 0.978 . . . . 0.0 111.6 174.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -132.49 -6.17 3.3 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.941 0.896 . . . . 0.0 113.351 -169.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.94 -176.1 54.1 Favored Glycine 0 CA--C 1.534 1.277 0 CA-C-N 118.945 0.793 . . . . 0.0 113.39 173.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -67.67 135.23 35.18 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.267 2.645 . . . . 0.0 110.471 175.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.69 168.23 20.44 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.11 0.564 . . . . 0.0 110.891 169.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -81.56 80.07 8.01 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 169.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -55.46 -20.5 12.77 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.09 -44.29 67.47 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.925 1.29 . . . . 0.0 112.196 170.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 71.7 mt -64.59 -48.35 85.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.46 -50.94 71.41 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.508 1.123 . . . . 0.0 110.443 -176.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.2 p -64.69 -46.25 83.19 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 119.347 0.976 . . . . 0.0 111.048 -175.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -60.7 -39.92 90.28 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.564 1.074 . . . . 0.0 110.625 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.3 mttt -72.55 -41.34 65.87 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 121.676 -0.64 . . . . 0.0 111.965 178.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 76.8 mt -65.76 -41.75 90.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 119.289 0.95 . . . . 0.0 108.662 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 91.6 mttt . . . . . 0 N--CA 1.467 0.385 0 CA-C-N 119.54 1.063 . . . . 0.0 109.882 173.184 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 C--O 1.234 0.249 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 21.6 p -136.18 168.17 19.89 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.778 1.231 . . . . 0.0 109.247 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 36.5 p-90 . . . . . 0 C--O 1.236 0.346 0 O-C-N 121.838 -0.539 . . . . 0.0 110.321 172.578 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.344 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -139.28 149.11 43.89 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 170.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.0 mt -54.75 -33.72 61.62 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.684 0.794 . . . . 0.0 112.343 -174.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.0 -25.22 68.03 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.077 0.853 . . . . 0.0 112.561 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 79.6 mt -78.28 -25.68 46.8 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.205 0.602 . . . . 0.0 111.369 -177.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.0 mt -69.63 130.43 90.48 Favored Pre-proline 0 CA--C 1.538 0.502 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -173.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -50.67 127.6 21.42 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.856 2.371 . . . . 0.0 109.884 169.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -82.39 -34.07 28.48 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 121.88 -0.512 . . . . 0.0 111.481 -171.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 52.5 t -133.92 131.86 56.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 171.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -152.99 126.86 8.93 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 174.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.3 pt . . . . . 0 CA--C 1.535 0.394 0 C-N-CA 124.097 0.959 . . . . 0.0 110.349 -169.758 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 21.2 p90 . . . . . 0 N--CA 1.466 0.355 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -72.61 156.19 39.25 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 122.952 0.501 . . . . 0.0 110.464 -176.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -147.64 164.86 32.2 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.472 1.109 . . . . 0.0 108.302 172.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.4 m -133.92 153.08 35.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 C-N-CA 124.725 1.21 . . . . 0.0 108.963 173.028 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.1 114.71 28.82 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 54.0 mt -119.38 117.92 55.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -170.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.7 ttp180 -73.63 147.13 44.06 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 169.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.0 t -135.2 150.3 29.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 127.097 2.159 . . . . 0.0 105.517 -176.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -131.8 153.86 49.69 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.691 1.196 . . . . 0.0 108.245 176.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.46 ' HG ' ' N ' ' A' ' 39' ' ' GLU . 19.2 m -68.87 44.71 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.946 1.698 . . . . 0.0 114.111 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -73.96 -5.56 0.09 OUTLIER Pre-proline 0 CA--C 1.551 1.004 0 CA-C-O 115.159 -2.353 . . . . 0.0 116.824 172.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo . . . . . 0 C--N 1.359 1.118 0 CA-C-N 125.263 2.915 . . . . 0.0 112.068 169.543 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.46 ' N ' ' HG ' ' A' ' 29' ' ' SER . 19.0 mm-40 . . . . . 0 CA--C 1.541 0.613 0 CA-C-O 121.512 0.672 . . . . 0.0 109.635 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.1 m -141.58 161.18 38.56 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.288 1.435 . . . . 0.0 108.969 174.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.5 tttt -149.63 162.19 40.69 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 126.203 1.801 . . . . 0.0 107.772 -172.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.5 mp0 -130.22 119.75 23.4 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 172.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 43.9 pt -104.99 159.24 5.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 C-N-CA 125.137 1.375 . . . . 0.0 110.705 178.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.4 t -118.14 120.59 64.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.447 ' HG3' HG21 ' A' ' 60' ' ' VAL . 9.4 mmp_? -126.55 141.09 51.98 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 176.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.04 131.81 1.83 Allowed Glycine 0 C--N 1.331 0.256 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 174.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -148.81 147.47 28.8 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -169.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -57.5 -27.31 62.43 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 177.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 12.2 p-90 -68.09 -27.97 66.94 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.221 0.918 . . . . 0.0 112.438 176.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.44 83.39 7.95 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 119.411 1.005 . . . . 0.0 109.054 175.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -66.85 -16.97 64.65 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 122.859 0.464 . . . . 0.0 111.65 176.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -134.3 152.69 51.95 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.028 1.731 . . . . 0.0 108.441 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 76.8 m-70 -73.3 -33.27 65.09 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -169.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.39 -28.75 56.02 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 118.408 -0.806 . . . . 0.0 112.71 173.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -67.63 -49.61 62.12 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 119.443 1.02 . . . . 0.0 110.46 -177.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.21 -42.79 91.7 Favored 'Isoleucine or valine' 0 C--N 1.341 0.209 0 CA-C-O 117.933 -1.032 . . . . 0.0 109.659 175.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -61.05 -45.13 96.03 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.687 1.131 . . . . 0.0 110.68 -177.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -63.32 -49.09 75.34 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.2 0.909 . . . . 0.0 111.655 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 31.5 tttt -59.13 -50.41 74.14 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.599 0.76 . . . . 0.0 110.883 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.447 HG21 ' HG3' ' A' ' 45' ' ' ARG . 91.9 t -72.73 -42.33 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-O 117.832 -1.08 . . . . 0.0 109.012 -172.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 63.0 m -60.15 -33.27 71.94 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-N 120.65 1.568 . . . . 0.0 111.087 173.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.03 -53.92 39.04 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-N 119.468 1.031 . . . . 0.0 110.54 172.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.449 ' HA ' ' HE3' ' A' ' 66' ' ' LYS . 19.0 t70 -60.32 -46.1 91.06 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.442 1.121 . . . . 0.0 111.828 -178.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 35.3 mmt -59.45 -50.21 74.83 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.963 0.905 . . . . 0.0 110.119 178.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -67.07 -29.73 69.59 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 118.461 0.573 . . . . 0.0 111.605 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.449 ' HE3' ' HA ' ' A' ' 63' ' ' ASP . 52.3 mtmt -66.06 -36.55 83.52 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.343 0.974 . . . . 0.0 110.861 170.295 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -72.44 -13.14 61.37 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.817 1.189 . . . . 0.0 112.069 169.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.76 -10.85 66.49 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 126.267 1.889 . . . . 0.0 112.346 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 85.1 m -56.38 153.0 10.4 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.815 1.308 . . . . 0.0 111.233 175.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -114.3 139.36 49.5 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 170.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 35.4 m -141.56 161.24 38.41 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -168.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -153.35 126.84 8.68 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 176.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.7 p -70.59 121.27 17.55 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 169.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 36.6 mt -66.9 -24.5 66.11 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.864 -0.523 . . . . 0.0 109.82 170.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.91 -170.21 42.66 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 125.3 1.429 . . . . 0.0 109.612 169.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -124.15 169.29 16.23 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 173.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -175.83 -166.29 33.06 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -175.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -143.88 160.38 40.89 Favored 'General case' 0 CA--C 1.516 -0.344 0 O-C-N 120.906 -1.349 . . . . 0.0 109.561 178.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 95.2 mt . . . . . 0 N--CA 1.448 -0.546 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 -176.856 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 21.6 t60 . . . . . 0 CA--C 1.521 -0.166 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.3 t -133.36 135.22 56.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 -178.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -170.56 -171.18 1.02 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -170.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 109.65 -172.74 16.24 Favored Glycine 0 CA--C 1.523 0.55 0 CA-C-N 119.3 0.955 . . . . 0.0 113.32 169.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -157.4 154.02 28.17 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.923 1.689 . . . . 0.0 107.668 -169.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.5 t -126.27 140.25 52.68 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 169.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 21.7 ptp -80.62 -34.98 34.63 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 118.71 -0.662 . . . . 0.0 110.11 173.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.65 -25.03 49.32 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.068 0.849 . . . . 0.0 112.182 -177.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -133.13 -5.29 3.06 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -169.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.87 171.83 42.96 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-N 118.964 0.802 . . . . 0.0 112.044 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.78 137.24 34.92 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.299 2.0 . . . . 0.0 109.312 177.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.18 170.75 6.56 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.16 0.505 . . . . 0.0 111.114 171.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 21.6 mm100 -64.99 -32.82 74.73 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 119.255 -0.402 . . . . 0.0 111.955 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 35.8 m80 61.7 -30.99 0.07 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 128.316 2.646 . . . . 0.0 115.526 -174.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.56 -45.94 88.21 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.649 1.18 . . . . 0.0 111.179 173.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 73.5 mt -61.21 -46.16 97.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.43 -52.04 66.98 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.891 1.276 . . . . 0.0 110.522 -174.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.2 p -64.57 -44.13 91.7 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.418 -177.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -60.63 -41.53 95.08 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.811 1.187 . . . . 0.0 110.736 -179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 25.7 mmtp -65.93 -47.9 73.16 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 118.735 0.698 . . . . 0.0 111.102 176.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 56.6 mt -64.67 -41.87 93.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 119.194 0.906 . . . . 0.0 109.237 -176.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 92.4 mttt . . . . . 0 N--CA 1.467 0.416 0 CA-C-N 119.776 1.171 . . . . 0.0 109.619 175.059 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 CA--C 1.532 0.253 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 17.2 p -136.15 168.21 19.81 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.809 1.244 . . . . 0.0 109.501 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 31.6 p-90 . . . . . 0 C--O 1.235 0.331 0 O-C-N 121.762 -0.586 . . . . 0.0 110.411 171.797 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.548 0 CA-C-O 121.507 0.67 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -152.93 146.5 25.04 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 169.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 61.3 mt -55.18 -34.3 63.73 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -173.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.22 -26.24 65.61 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.845 0.748 . . . . 0.0 112.159 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.2 mt -81.47 -23.46 37.4 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.513 0.725 . . . . 0.0 111.22 -177.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.8 mt -66.31 129.29 94.17 Favored Pre-proline 0 CA--C 1.538 0.514 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 -175.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -46.65 116.22 1.53 Allowed 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 124.195 3.263 . . . . 0.0 111.777 170.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -72.63 -31.73 65.36 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.603 0.761 . . . . 0.0 111.577 -172.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 64.2 t -141.72 137.24 31.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 171.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -151.18 110.84 4.02 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 169.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 40.5 pt . . . . . 0 C--O 1.236 0.357 0 C-N-CA 124.211 1.005 . . . . 0.0 109.195 -170.111 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 16.5 p90 . . . . . 0 N--CA 1.469 0.494 0 CA-C-O 120.49 0.186 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.1 mmtm -72.46 152.65 41.81 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 173.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -142.1 160.05 41.0 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 175.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.4 m -130.15 152.98 38.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 124.615 1.166 . . . . 0.0 109.433 173.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.2 114.92 29.17 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 104.201 -2.518 . . . . 0.0 104.201 177.484 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 54.5 mt -118.88 124.88 73.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -172.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -78.24 148.09 34.1 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 169.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.3 t -132.12 145.53 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -127.55 148.51 50.34 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.762 1.225 . . . . 0.0 108.218 178.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.5 ' HG ' ' N ' ' A' ' 39' ' ' GLU . 35.4 m -62.35 99.13 0.13 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.759 0.824 . . . . 0.0 110.92 177.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.488 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -142.44 20.15 0.04 OUTLIER Pre-proline 0 CA--C 1.552 1.028 0 CA-C-O 116.491 -1.719 . . . . 0.0 113.502 169.119 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.488 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 76.3 Cg_exo . . . . . 0 C--N 1.363 1.301 0 CA-C-N 123.817 2.399 . . . . 0.0 114.174 177.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.5 ' N ' ' HG ' ' A' ' 29' ' ' SER . 43.0 mt-10 . . . . . 0 CA--C 1.541 0.617 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.5 m -141.84 160.5 40.06 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.628 1.171 . . . . 0.0 109.403 174.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -152.0 171.56 17.64 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 127.393 2.277 . . . . 0.0 106.509 -172.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.8 mp0 -133.24 157.66 44.86 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 172.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 30.3 pt -137.13 156.03 33.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 C-N-CA 125.717 1.607 . . . . 0.0 109.114 177.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 52.9 t -118.54 120.87 65.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 178.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 25.6 mmt85 -135.63 144.89 46.34 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 176.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 178.44 134.72 2.15 Favored Glycine 0 N--CA 1.453 -0.202 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -178.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.405 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 9.7 m-85 -154.79 155.53 34.64 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -169.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -58.02 -34.13 69.71 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.714 0.806 . . . . 0.0 112.07 -178.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.405 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 13.9 p-90 -67.32 -27.55 67.24 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 118.707 -0.663 . . . . 0.0 112.613 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.36 80.5 9.19 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 119.635 1.107 . . . . 0.0 109.104 175.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -64.23 -18.13 64.23 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.062 0.545 . . . . 0.0 112.0 175.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -134.07 151.05 51.24 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 126.601 1.961 . . . . 0.0 108.023 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -74.1 -31.92 63.0 Favored 'General case' 0 C--O 1.234 0.254 0 O-C-N 121.847 -0.533 . . . . 0.0 110.064 -169.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.32 -29.76 48.96 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 118.564 -0.731 . . . . 0.0 112.48 172.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -67.75 -50.65 56.12 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 119.289 0.95 . . . . 0.0 110.796 -175.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.442 ' H ' HG12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -67.36 -38.26 80.5 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.157 0 CA-C-O 117.846 -1.073 . . . . 0.0 110.036 176.009 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -59.92 -48.35 82.06 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.76 1.163 . . . . 0.0 110.317 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -63.54 -47.68 80.61 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.347 0.521 . . . . 0.0 111.495 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 31.6 tttt -61.2 -52.81 63.24 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 123.198 0.599 . . . . 0.0 111.144 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 92.6 t -70.94 -46.1 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-O 118.024 -0.989 . . . . 0.0 108.975 -172.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.8 m -62.32 -31.95 72.64 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 120.283 1.402 . . . . 0.0 111.055 176.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.16 -49.78 74.39 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-N 119.038 0.835 . . . . 0.0 111.077 171.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -61.68 -44.19 97.41 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 118.654 1.227 . . . . 0.0 111.61 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.6 mmt -59.39 -47.82 84.0 Favored 'General case' 0 C--O 1.226 -0.159 0 C-N-CA 123.06 0.544 . . . . 0.0 110.053 176.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -67.49 -28.61 67.99 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.85 0.75 . . . . 0.0 112.025 179.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -68.05 -36.98 80.79 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 119.585 1.084 . . . . 0.0 110.418 170.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -68.04 -29.74 68.79 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 119.625 1.102 . . . . 0.0 110.122 169.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 122.37 -23.17 7.26 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 128.13 2.776 . . . . 0.0 111.297 177.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 84.6 m -53.82 146.5 13.74 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 126.682 1.993 . . . . 0.0 111.321 -175.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -107.87 142.01 38.6 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 72.7 m -142.44 163.86 31.71 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -168.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -151.81 133.79 15.0 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.552 1.541 . . . . 0.0 107.668 170.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.6 p -72.22 115.76 11.84 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 169.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 45.6 mt -67.04 -24.98 66.05 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.986 -0.446 . . . . 0.0 110.002 172.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.92 -164.32 37.74 Favored Glycine 0 C--N 1.336 0.536 0 N-CA-C 108.374 -1.89 . . . . 0.0 108.374 172.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -155.13 -176.41 27.31 Favored Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 111.004 -0.838 . . . . 0.0 111.004 171.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -171.44 -156.4 11.82 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 -175.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.1 ttp180 -135.66 147.0 48.41 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 -177.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.3 mt . . . . . 0 C--O 1.235 0.337 0 N-CA-C 106.484 -1.672 . . . . 0.0 106.484 -174.757 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 19.4 t60 . . . . . 0 CA--C 1.515 -0.367 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.6 t -133.22 132.57 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 -176.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -160.15 -167.93 2.07 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.937 1.295 . . . . 0.0 108.886 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.15 -171.34 42.96 Favored Glycine 0 CA--C 1.525 0.703 0 O-C-N 121.612 -0.68 . . . . 0.0 113.632 176.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -161.87 152.89 18.01 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.523 1.129 . . . . 0.0 110.123 -169.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.5 t -81.59 168.45 18.17 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 167.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 20.8 ptp -111.44 -29.68 7.69 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 121.215 -0.928 . . . . 0.0 111.39 170.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.19 -25.76 59.88 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.716 1.144 . . . . 0.0 111.434 171.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -131.76 -7.14 3.6 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.886 0.874 . . . . 0.0 113.015 -169.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.39 -179.11 48.94 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 123.735 0.683 . . . . 0.0 113.638 172.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -68.4 142.08 53.33 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.83 2.354 . . . . 0.0 110.743 173.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.68 178.19 6.26 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 168.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -63.61 -28.4 69.9 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 119.045 -0.503 . . . . 0.0 111.868 170.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 59.08 -23.16 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 128.283 2.633 . . . . 0.0 116.63 -173.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.72 -39.04 93.31 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.688 1.195 . . . . 0.0 110.794 172.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 75.3 mt -63.33 -44.44 99.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 175.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.1 -44.62 94.71 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.135 0.974 . . . . 0.0 111.252 -177.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.54 -51.0 67.3 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 119.275 0.943 . . . . 0.0 110.611 176.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -57.6 -43.98 85.1 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.027 0.83 . . . . 0.0 110.62 -177.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -71.41 -40.27 70.57 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 118.102 -0.951 . . . . 0.0 111.832 -178.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 83.8 mt -69.3 -34.89 64.96 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-N 120.78 1.627 . . . . 0.0 108.957 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 94.4 mttt . . . . . 0 N--CA 1.47 0.559 0 CA-C-N 120.404 1.457 . . . . 0.0 110.385 171.083 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.7 p . . . . . 0 N--CA 1.45 -0.471 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 21.2 p -139.05 171.48 14.25 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.923 0.889 . . . . 0.0 109.399 171.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 19.6 p-90 . . . . . 0 C--O 1.235 0.338 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 169.471 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.504 0 CA-C-O 121.542 0.687 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -149.68 153.22 36.63 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 125.963 1.705 . . . . 0.0 106.486 171.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 44.2 mt -56.39 -33.18 65.5 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 118.697 0.681 . . . . 0.0 112.666 -176.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.52 -25.49 65.87 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.919 0.781 . . . . 0.0 112.167 177.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.1 mt -86.64 -21.91 26.47 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.87 0.868 . . . . 0.0 111.372 -176.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 56.7 mt -64.54 128.56 93.55 Favored Pre-proline 0 CA--C 1.54 0.559 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 178.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -46.3 114.94 0.97 Allowed 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 124.232 3.288 . . . . 0.0 111.58 172.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -72.08 -30.81 65.49 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.369 0.668 . . . . 0.0 112.071 -169.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 42.3 t -143.12 142.47 25.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 171.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -151.38 127.8 10.67 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 169.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 40.9 pt . . . . . 0 CA--C 1.54 0.581 0 C-N-CA 127.622 2.369 . . . . 0.0 106.219 -176.745 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 36.5 p90 . . . . . 0 N--CA 1.468 0.429 0 CA-C-O 120.997 0.427 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -77.86 154.12 32.07 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.019 0.928 . . . . 0.0 110.495 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -142.28 164.91 28.88 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.313 1.045 . . . . 0.0 108.891 175.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.9 m -132.14 152.91 37.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 C-N-CA 124.589 1.156 . . . . 0.0 109.287 172.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.2 tp -108.11 117.95 35.49 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 177.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 95.4 mt -122.7 123.04 67.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -171.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -79.57 147.8 31.98 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 169.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.5 p -138.38 146.99 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 175.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 -120.01 156.96 29.85 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.852 1.261 . . . . 0.0 108.78 -176.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.505 ' HG ' ' N ' ' A' ' 39' ' ' GLU . 14.4 m -63.15 87.64 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.698 1.199 . . . . 0.0 111.922 177.303 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.415 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -138.55 19.39 0.05 OUTLIER Pre-proline 0 CA--C 1.551 1.019 0 CA-C-O 116.405 -1.759 . . . . 0.0 114.449 169.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 30' ' ' ALA . 80.1 Cg_exo . . . . . 0 C--N 1.36 1.157 0 CA-C-N 123.976 2.456 . . . . 0.0 113.681 172.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.505 ' N ' ' HG ' ' A' ' 29' ' ' SER . 8.9 pt-20 . . . . . 0 CA--C 1.537 0.466 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.8 m -142.26 158.17 44.02 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.958 0.903 . . . . 0.0 110.334 -174.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -149.21 166.01 30.16 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 127.56 2.344 . . . . 0.0 105.947 -175.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.8 mp0 -125.33 151.6 45.83 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 174.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 21.2 pt -127.27 155.04 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 125.997 1.719 . . . . 0.0 108.594 173.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 85.1 t -127.87 115.96 41.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 -173.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 26.7 mmt85 -135.33 139.82 44.6 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -176.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -170.92 141.61 6.6 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 178.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -156.1 149.02 24.15 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -171.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -58.77 -32.83 69.65 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 118.839 -0.6 . . . . 0.0 111.61 174.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 9.7 p-90 -65.32 -26.83 68.22 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.018 0.826 . . . . 0.0 112.489 177.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.41 73.44 10.5 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 119.337 0.971 . . . . 0.0 109.524 175.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -65.67 -8.56 21.27 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.35 0.66 . . . . 0.0 112.104 176.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -138.17 144.91 40.94 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 126.896 2.079 . . . . 0.0 106.836 177.021 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 60.9 m80 -71.44 -31.13 66.84 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 121.885 -0.509 . . . . 0.0 109.979 -171.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.47 -27.27 47.31 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 118.258 -0.877 . . . . 0.0 112.676 171.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -68.33 -48.93 63.58 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 119.818 1.19 . . . . 0.0 110.763 -176.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.438 ' H ' HG12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -67.32 -40.26 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 CA-C-O 117.732 -1.127 . . . . 0.0 109.782 175.78 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -62.49 -44.66 95.85 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 120.047 1.294 . . . . 0.0 110.599 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -62.49 -47.34 84.42 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.818 0.735 . . . . 0.0 111.369 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 31.7 tttt -62.29 -53.59 52.92 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.245 0.618 . . . . 0.0 110.999 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 92.0 t -73.52 -48.35 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-O 118.539 -0.743 . . . . 0.0 109.179 -171.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.0 t -63.32 -34.74 78.35 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 119.568 1.076 . . . . 0.0 109.759 178.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.28 -48.59 85.24 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-N 118.978 0.808 . . . . 0.0 111.182 172.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -63.02 -43.6 98.29 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 118.69 1.245 . . . . 0.0 111.596 178.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 39.2 mmt -59.27 -47.31 85.85 Favored 'General case' 0 CA--C 1.527 0.077 0 C-N-CA 122.769 0.428 . . . . 0.0 110.111 176.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -64.92 -32.69 74.53 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.423 0.689 . . . . 0.0 111.274 179.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -67.4 -35.65 79.71 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.443 1.019 . . . . 0.0 111.052 170.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -69.03 -15.8 63.55 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 119.838 1.199 . . . . 0.0 111.286 169.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 109.17 -18.82 30.46 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 126.838 2.161 . . . . 0.0 111.94 177.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 73.1 m -57.05 162.91 2.27 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.654 1.982 . . . . 0.0 112.874 -175.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -123.25 137.35 54.89 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 176.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 80.4 m -142.69 166.17 25.4 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -168.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -151.09 131.65 13.88 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.797 1.239 . . . . 0.0 108.32 170.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.3 p -69.74 115.77 9.36 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 169.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 64.3 mt -66.97 -26.93 67.06 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.984 0.514 . . . . 0.0 109.95 173.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.08 -172.97 42.92 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 169.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -123.13 165.52 15.76 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 110.951 -0.859 . . . . 0.0 110.951 175.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -168.54 -163.56 22.74 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -178.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.7 ttp180 -146.45 158.37 43.88 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 121.141 -1.211 . . . . 0.0 107.763 -175.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 56.7 mt . . . . . 0 N--CA 1.449 -0.478 0 N-CA-C 104.851 -2.278 . . . . 0.0 104.851 -178.512 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 12.4 t60 . . . . . 0 N--CA 1.446 -0.671 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 54.5 t -131.82 106.0 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 -169.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -164.16 162.86 23.02 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.311 0.644 . . . . 0.0 109.517 -175.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 143.08 -169.08 25.85 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -155.85 151.66 27.41 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.101 0.56 . . . . 0.0 110.64 171.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.4 t -90.41 161.34 15.61 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 168.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 27.6 ptm -94.04 -33.91 13.22 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 118.995 0.816 . . . . 0.0 110.018 169.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.6 -25.38 56.94 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.905 0.775 . . . . 0.0 112.006 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -133.46 -4.13 2.98 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -169.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.83 -175.39 52.03 Favored Glycine 0 CA--C 1.535 1.326 0 CA-C-N 119.031 0.832 . . . . 0.0 113.344 173.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.99 138.8 37.93 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.385 2.724 . . . . 0.0 111.206 175.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.24 168.44 17.29 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 168.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 23.0 mm100 -68.55 -27.07 65.76 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.856 -0.528 . . . . 0.0 111.864 172.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 37.6 m80 60.48 -29.24 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 128.962 2.905 . . . . 0.0 115.895 -175.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.8 -40.66 93.5 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.536 1.134 . . . . 0.0 112.467 -179.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.3 mp -62.55 -46.33 96.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 177.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.3 m -59.47 -47.22 86.34 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 123.892 0.877 . . . . 0.0 110.621 -176.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.5 p -64.77 -41.12 96.1 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 118.097 -0.954 . . . . 0.0 111.065 -176.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -58.91 -45.51 90.13 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.951 1.25 . . . . 0.0 110.649 177.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 44.3 mttm -67.41 -46.24 73.79 Favored 'General case' 0 N--CA 1.462 0.158 0 O-C-N 122.128 -0.358 . . . . 0.0 111.037 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 55.7 mt -68.57 -38.05 78.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -176.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 96.1 mttt . . . . . 0 N--CA 1.471 0.592 0 CA-C-N 120.523 1.511 . . . . 0.0 110.031 174.26 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.4 t . . . . . 0 CA--C 1.534 0.36 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 6.3 p -139.66 170.23 16.28 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.335 1.054 . . . . 0.0 109.879 177.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 39.5 p-90 . . . . . 0 C--O 1.236 0.361 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 169.775 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.501 0 CA-C-O 121.246 0.545 . . . . 0.0 110.526 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -152.39 151.25 30.59 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 169.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 78.1 mt -56.08 -34.62 66.14 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.273 0.629 . . . . 0.0 112.549 -176.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.1 -25.21 65.21 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.691 0.678 . . . . 0.0 112.08 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.5 mt -83.41 -21.74 32.91 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.539 0.736 . . . . 0.0 111.328 -177.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.4 mt -65.34 127.48 92.96 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 177.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -47.76 125.38 11.15 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 123.649 2.899 . . . . 0.0 111.193 171.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -76.48 -36.44 57.84 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.097 0.475 . . . . 0.0 111.008 -173.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.6 t -140.67 133.07 31.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 177.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -154.56 119.76 5.02 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 105.072 -2.196 . . . . 0.0 105.072 169.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.7 pp . . . . . 0 C--O 1.235 0.34 0 C-N-CA 124.477 1.111 . . . . 0.0 109.53 -171.075 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.5 p90 . . . . . 0 N--CA 1.466 0.344 0 CA-C-O 120.937 0.399 . . . . 0.0 110.385 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -72.94 151.32 41.91 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.702 0.801 . . . . 0.0 110.758 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -144.12 161.85 37.78 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.848 1.259 . . . . 0.0 107.845 177.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.5 m -130.34 151.45 35.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 C-N-CA 124.24 1.016 . . . . 0.0 109.349 174.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.74 114.58 28.88 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 103.643 -2.725 . . . . 0.0 103.643 176.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.8 mt -120.31 124.79 73.28 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -172.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.2 ttm180 -78.93 143.69 35.57 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 168.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.5 p -137.39 136.88 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 178.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -107.18 148.91 28.29 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.889 1.275 . . . . 0.0 109.006 -172.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.1 p -72.43 85.25 1.12 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.56 0.695 . . . . 0.0 111.138 178.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -131.52 33.07 0.23 Allowed Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 124.602 1.161 . . . . 0.0 112.368 169.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo . . . . . 0 C--N 1.354 0.824 0 CA-C-N 122.133 1.798 . . . . 0.0 109.961 -178.521 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 . . . . . 0 C--O 1.238 0.45 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.6 m -139.85 158.85 43.41 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.639 0.776 . . . . 0.0 110.256 175.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -142.07 166.41 24.78 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 127.973 2.509 . . . . 0.0 105.417 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 30.7 mp0 -126.69 149.75 49.38 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.1 pt -132.94 155.62 41.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 C-N-CA 125.059 1.344 . . . . 0.0 109.86 178.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 85.3 t -117.66 114.93 46.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.9 mmp_? -126.6 147.14 49.93 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 173.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 178.72 139.27 3.46 Favored Glycine 0 C--N 1.331 0.259 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 176.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.404 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 20.6 m-85 -154.59 150.22 27.49 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 123.397 0.679 . . . . 0.0 109.344 -171.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.4 tptt -62.31 -26.55 68.49 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 118.578 -0.725 . . . . 0.0 112.055 177.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.404 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 9.9 p-90 -63.86 -27.93 69.5 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.677 1.126 . . . . 0.0 112.28 176.028 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.63 76.05 10.04 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 119.242 0.928 . . . . 0.0 109.491 174.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -66.77 -5.79 13.49 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.219 0.607 . . . . 0.0 112.135 175.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -139.43 144.39 38.05 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 126.471 1.908 . . . . 0.0 107.026 175.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -70.62 -30.98 67.77 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 121.979 -0.451 . . . . 0.0 110.036 -171.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.55 -30.15 40.5 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 118.759 -0.639 . . . . 0.0 112.627 172.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -68.09 -50.52 54.4 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 119.134 0.879 . . . . 0.0 110.804 -175.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.431 ' H ' HG12 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -67.08 -38.42 81.2 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.19 0 CA-C-O 117.761 -1.114 . . . . 0.0 109.935 174.85 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -60.16 -46.11 90.79 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 120.191 1.36 . . . . 0.0 110.91 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -65.35 -48.47 72.87 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 122.644 0.377 . . . . 0.0 111.275 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 44.3 tttt -62.29 -49.12 76.91 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 123.304 0.642 . . . . 0.0 111.479 -176.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 86.7 t -75.15 -45.5 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-O 118.423 -0.799 . . . . 0.0 109.33 -172.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.9 m -61.85 -35.82 79.42 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 119.423 1.01 . . . . 0.0 110.103 175.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.7 -48.02 87.15 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 173.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -63.35 -45.27 91.99 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 118.96 1.38 . . . . 0.0 111.429 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 39.1 mmt -59.57 -43.9 93.47 Favored 'General case' 0 C--O 1.227 -0.091 0 CA-C-N 118.202 0.456 . . . . 0.0 109.933 177.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -68.58 -27.92 66.48 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.716 0.807 . . . . 0.0 111.752 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -69.39 -36.86 77.18 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 119.455 1.025 . . . . 0.0 109.749 169.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -68.09 -25.79 65.5 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 119.928 1.24 . . . . 0.0 110.266 169.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 122.25 -27.63 6.04 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 128.237 2.827 . . . . 0.0 111.313 174.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 97.2 m -58.58 145.23 40.2 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 126.07 1.748 . . . . 0.0 110.691 -177.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -108.43 156.28 19.62 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 177.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 86.1 m -141.48 165.42 27.56 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 -168.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -150.92 132.7 14.98 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.546 1.538 . . . . 0.0 107.085 169.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.6 p -70.82 121.05 17.32 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 169.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 38.1 mt -70.34 -23.2 62.77 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.99 -0.444 . . . . 0.0 109.902 171.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.94 -166.27 39.04 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 170.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -146.86 173.12 27.17 Favored Glycine 0 CA--C 1.52 0.387 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 172.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -172.35 -156.13 12.07 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 107.356 -2.298 . . . . 0.0 107.356 -178.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 26.9 ptt-85 -142.31 160.25 40.62 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 120.614 -1.521 . . . . 0.0 109.403 176.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 93.7 mt . . . . . 0 C--N 1.321 -0.65 0 N-CA-C 104.404 -2.443 . . . . 0.0 104.404 -174.179 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 23.1 t60 . . . . . 0 C--O 1.233 0.199 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.0 t -137.49 130.89 43.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -162.28 -173.99 3.86 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.047 0.939 . . . . 0.0 109.869 -172.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.38 -172.33 50.4 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 123.659 0.647 . . . . 0.0 112.285 178.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -160.79 151.55 18.47 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.716 0.806 . . . . 0.0 111.05 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.0 t -72.43 164.86 25.67 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 168.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 23.0 ptp -111.69 -28.92 7.91 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 118.359 -0.829 . . . . 0.0 111.174 171.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.14 -26.5 60.36 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.737 1.153 . . . . 0.0 111.428 171.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -131.13 -6.04 3.88 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.777 0.831 . . . . 0.0 113.139 -169.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.18 -179.21 42.79 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 123.603 0.62 . . . . 0.0 113.504 173.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.17 135.62 40.99 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.067 2.512 . . . . 0.0 110.633 176.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.74 169.36 18.43 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 169.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -77.98 81.93 4.36 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 168.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -57.45 -14.94 5.57 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -175.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.58 -39.91 89.79 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.019 1.328 . . . . 0.0 111.47 170.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 63.0 mt -64.5 -47.18 90.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 176.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.9 -50.12 74.42 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.142 0.977 . . . . 0.0 110.526 -176.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 10.1 p -64.56 -47.48 78.58 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 119.243 0.929 . . . . 0.0 111.276 -176.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -60.21 -40.3 89.63 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.397 0.999 . . . . 0.0 110.475 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 49.2 mttm -65.45 -49.08 70.46 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 119.187 -0.435 . . . . 0.0 111.356 176.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 62.9 mt -64.54 -40.14 88.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-N 119.067 0.849 . . . . 0.0 109.16 -176.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 93.9 mttt . . . . . 0 N--CA 1.468 0.473 0 CA-C-N 119.605 1.093 . . . . 0.0 109.633 174.922 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.4 t . . . . . 0 N--CA 1.453 -0.302 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.3 p -134.55 173.67 11.39 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 169.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 37.6 p-90 . . . . . 0 N--CA 1.452 -0.373 0 CA-C-O 121.242 0.544 . . . . 0.0 109.905 174.556 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.572 0 CA-C-O 120.888 0.375 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -155.04 153.22 30.61 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.226 1.011 . . . . 0.0 108.399 177.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.0 mt -54.36 -32.83 57.82 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.771 0.828 . . . . 0.0 112.401 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.79 -23.61 67.43 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.76 0.709 . . . . 0.0 112.527 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 76.0 mt -74.83 -26.72 59.91 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 118.512 0.596 . . . . 0.0 110.944 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.2 mt -72.42 133.03 83.33 Favored Pre-proline 0 C--O 1.239 0.503 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 -177.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.23 135.0 48.21 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 121.067 1.178 . . . . 0.0 109.229 169.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -72.61 -33.48 66.7 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.325 0.583 . . . . 0.0 111.404 -175.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 51.0 t -135.25 138.89 47.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 105.221 -2.14 . . . . 0.0 105.221 172.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -149.92 129.4 13.03 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 169.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.5 pt . . . . . 0 CA--C 1.537 0.451 0 C-N-CA 126.676 1.99 . . . . 0.0 106.305 -179.801 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 23.5 p90 . . . . . 0 N--CA 1.467 0.389 0 CA-C-O 120.805 0.336 . . . . 0.0 110.594 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -79.53 158.11 27.26 Favored 'General case' 0 C--O 1.233 0.231 0 O-C-N 121.697 -0.627 . . . . 0.0 109.653 176.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.3 163.35 35.79 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.365 1.066 . . . . 0.0 108.805 176.13 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.2 m -136.65 157.0 36.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 124.655 1.182 . . . . 0.0 110.127 172.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.34 119.59 39.94 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 104.732 -2.322 . . . . 0.0 104.732 177.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 57.2 mt -121.29 114.51 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 CA-C-N 119.488 1.04 . . . . 0.0 108.48 -172.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 24.0 ttm-85 -71.54 138.12 48.61 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 104.967 -2.235 . . . . 0.0 104.967 168.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.4 p -136.31 116.49 17.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 178.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -81.7 142.83 32.33 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 169.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.1 t -67.72 117.01 9.06 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 169.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.444 ' N ' ' HD3' ' A' ' 31' ' ' PRO . . . -143.57 43.11 0.42 Allowed Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 123.781 0.833 . . . . 0.0 108.921 168.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.444 ' HD3' ' N ' ' A' ' 30' ' ' ALA . 31.9 Cg_exo . . . . . 0 C--N 1.351 0.679 0 C-N-CA 122.063 1.842 . . . . 0.0 111.731 -169.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 . . . . . 0 CA--C 1.536 0.44 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.0 m -141.86 157.49 44.93 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.941 0.896 . . . . 0.0 110.435 173.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -148.98 165.28 32.1 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 127.767 2.427 . . . . 0.0 106.651 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -125.93 126.89 45.12 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.341 -1.725 . . . . 0.0 106.341 170.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 30.4 pt -110.01 155.51 11.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 125.044 1.338 . . . . 0.0 110.267 175.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 24.5 t -120.43 125.89 74.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 -175.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.4 mmp_? -129.65 146.59 51.43 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.965 1.306 . . . . 0.0 107.739 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -172.98 133.99 2.81 Favored Glycine 0 N--CA 1.453 -0.208 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 169.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.405 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 10.7 m-85 -152.21 159.72 43.51 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -177.329 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -78.73 -26.13 44.7 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 121.793 -0.567 . . . . 0.0 109.894 -176.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.405 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 12.9 p-90 -61.33 -31.99 71.87 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 119.183 -0.437 . . . . 0.0 111.671 174.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -86.79 71.66 10.29 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 118.735 0.698 . . . . 0.0 109.524 173.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -63.42 -15.39 57.48 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 122.893 0.477 . . . . 0.0 111.775 177.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.41 144.24 51.09 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 126.548 1.939 . . . . 0.0 107.891 177.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 43.6 m80 -68.45 -34.6 76.25 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 119.148 -0.453 . . . . 0.0 112.134 -169.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.08 -28.89 55.85 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 118.311 -0.852 . . . . 0.0 112.645 174.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -68.29 -48.58 64.59 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 119.633 1.106 . . . . 0.0 111.323 -174.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.418 ' H ' HG12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -65.92 -41.28 89.61 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 CA-C-O 118.438 -0.791 . . . . 0.0 109.772 176.152 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -61.72 -53.34 57.42 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 118.317 -0.849 . . . . 0.0 109.722 -178.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -60.1 -42.85 95.56 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.16 0.891 . . . . 0.0 111.841 -176.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 31.6 tttt -60.52 -51.14 70.72 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 123.226 0.61 . . . . 0.0 110.796 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 63.9 t -84.74 -36.98 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-O 117.949 -1.024 . . . . 0.0 111.28 -169.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 71.7 p -64.43 -31.89 73.29 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 120.871 1.669 . . . . 0.0 109.684 171.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.66 -50.03 72.11 Favored Glycine 0 C--N 1.337 0.638 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 171.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -62.07 -43.34 99.04 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 118.68 1.24 . . . . 0.0 111.726 178.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 34.6 mmt -60.05 -46.08 90.71 Favored 'General case' 0 C--O 1.225 -0.191 0 N-CA-C 109.776 -0.454 . . . . 0.0 109.776 178.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -68.47 -27.91 66.57 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.606 0.762 . . . . 0.0 112.127 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -68.34 -37.22 80.32 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.34 0.973 . . . . 0.0 109.953 169.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -69.42 -25.37 64.09 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 119.631 1.105 . . . . 0.0 110.494 169.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 120.17 -26.35 7.1 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 127.996 2.713 . . . . 0.0 111.543 177.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 89.7 m -56.06 153.26 9.22 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 126.377 1.871 . . . . 0.0 111.51 -177.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -120.07 140.02 51.66 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -169.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 77.2 m -131.54 165.83 22.74 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 -167.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -153.13 122.48 6.67 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.72 2.008 . . . . 0.0 106.486 172.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.8 p -71.47 120.69 17.41 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 169.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 42.1 mt -68.53 -27.23 65.92 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.996 -0.44 . . . . 0.0 110.109 175.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 171.05 -171.38 43.87 Favored Glycine 0 C--N 1.337 0.592 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 175.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -138.09 164.37 25.56 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 176.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -168.54 -162.16 20.06 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -176.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 57.4 ttt180 -138.78 144.71 39.51 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 121.034 -1.274 . . . . 0.0 107.582 -172.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 99.6 mt . . . . . 0 N--CA 1.448 -0.535 0 N-CA-C 104.309 -2.478 . . . . 0.0 104.309 172.937 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 40.9 t60 . . . . . 0 N--CA 1.452 -0.361 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.9 t -125.08 129.56 73.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 -171.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -161.58 -169.1 2.16 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.673 1.189 . . . . 0.0 107.836 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 103.06 176.11 26.58 Favored Glycine 0 CA--C 1.522 0.53 0 CA-C-N 119.423 1.01 . . . . 0.0 112.113 169.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -151.85 143.85 23.82 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 122.953 0.501 . . . . 0.0 109.965 169.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.8 t -72.79 165.58 24.57 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 168.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 27.7 ptm -103.53 -30.5 10.48 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 118.558 -0.735 . . . . 0.0 110.486 169.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.42 -24.19 53.98 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.403 1.001 . . . . 0.0 111.874 174.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -134.76 -6.98 2.44 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -169.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.24 -173.5 54.91 Favored Glycine 0 CA--C 1.537 1.436 0 CA-C-N 119.325 0.966 . . . . 0.0 113.712 174.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -67.33 156.33 66.66 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.425 2.75 . . . . 0.0 111.116 176.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -104.88 166.16 10.57 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.68 1.192 . . . . 0.0 109.774 171.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -78.99 85.72 4.91 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 169.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -58.43 -16.47 15.06 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -178.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.82 -42.04 78.87 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.595 1.158 . . . . 0.0 111.473 170.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 59.1 mt -65.58 -46.95 88.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.98 -50.51 73.13 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.795 0.838 . . . . 0.0 110.802 -177.369 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.6 p -66.54 -44.26 82.88 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.891 -174.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -58.09 -43.63 87.18 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.754 1.161 . . . . 0.0 110.34 178.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -69.58 -44.58 70.51 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-O 118.976 -0.535 . . . . 0.0 111.407 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 62.9 mt -66.64 -38.35 81.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 119.674 1.124 . . . . 0.0 109.095 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 94.2 mttt . . . . . 0 N--CA 1.468 0.465 0 CA-C-N 119.805 1.184 . . . . 0.0 109.646 173.244 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 C--O 1.234 0.25 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 17.6 p -137.19 171.35 14.62 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.69 0.796 . . . . 0.0 109.534 177.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 24.8 p-90 . . . . . 0 C--O 1.235 0.328 0 O-C-N 121.558 -0.713 . . . . 0.0 111.919 178.194 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.5 0 CA-C-O 121.653 0.74 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -150.37 150.17 31.06 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 169.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 68.5 mt -56.83 -32.35 65.66 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -174.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.58 -25.87 66.0 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.039 0.836 . . . . 0.0 112.222 178.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.3 mt -85.24 -23.84 28.06 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 123.786 0.834 . . . . 0.0 111.389 -176.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 61.7 mt -64.64 129.05 94.11 Favored Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 -178.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -44.34 117.11 1.24 Allowed 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 124.494 3.463 . . . . 0.0 111.81 172.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -76.85 -34.93 57.81 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.17 0.51 . . . . 0.0 111.31 -169.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.9 t -137.83 135.78 45.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 174.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -154.16 107.99 2.97 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 169.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 15.6 pt . . . . . 0 CA--C 1.537 0.462 0 C-N-CA 124.46 1.104 . . . . 0.0 108.419 -172.756 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 23.7 p90 . . . . . 0 N--CA 1.465 0.31 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -79.76 151.73 30.2 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 169.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -142.14 158.84 43.29 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.619 1.168 . . . . 0.0 108.466 -178.009 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.9 m -128.37 154.11 38.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 124.662 1.185 . . . . 0.0 109.984 173.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -110.53 114.46 27.88 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 104.546 -2.39 . . . . 0.0 104.546 178.259 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.2 mt -117.98 121.76 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -172.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -73.47 147.99 43.61 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 169.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.4 t -132.49 146.82 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 178.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -124.95 154.27 41.43 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.604 1.161 . . . . 0.0 108.568 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.514 ' HG ' ' N ' ' A' ' 39' ' ' GLU . 30.3 m -64.26 88.36 0.05 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.034 0.934 . . . . 0.0 111.798 177.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -136.66 35.39 0.26 Allowed Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 125.295 1.438 . . . . 0.0 112.422 169.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo . . . . . 0 C--N 1.359 1.087 0 CA-C-N 123.009 2.11 . . . . 0.0 111.981 170.26 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.514 ' N ' ' HG ' ' A' ' 29' ' ' SER . 46.0 mm-40 . . . . . 0 CA--C 1.539 0.541 0 CA-C-O 121.367 0.604 . . . . 0.0 109.56 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.3 m -140.57 159.26 42.6 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.653 1.181 . . . . 0.0 109.051 172.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -149.87 171.28 17.03 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 127.565 2.346 . . . . 0.0 106.185 -173.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.9 mp0 -134.77 152.58 51.87 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 174.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 38.4 pt -130.08 155.06 41.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 125.474 1.51 . . . . 0.0 109.37 176.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 45.4 t -118.42 120.14 63.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.2 mmp_? -128.66 145.01 51.28 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.312 1.445 . . . . 0.0 107.622 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.93 132.92 1.72 Allowed Glycine 0 C--N 1.331 0.282 0 CA-C-N 119.632 1.105 . . . . 0.0 111.142 174.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -154.46 157.87 39.09 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -172.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.3 mttp -58.78 -34.85 71.92 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 119.186 -0.435 . . . . 0.0 111.852 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 15.6 p-90 -65.4 -30.75 71.6 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 118.964 -0.541 . . . . 0.0 112.326 -177.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.53 74.57 10.38 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 119.161 0.891 . . . . 0.0 109.465 175.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.93 -17.36 63.16 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.221 0.608 . . . . 0.0 111.572 175.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.81 144.25 51.09 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 126.147 1.779 . . . . 0.0 108.025 178.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -67.95 -34.93 77.52 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 119.27 -0.395 . . . . 0.0 111.862 -169.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.77 -29.1 53.16 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 118.411 -0.804 . . . . 0.0 112.664 174.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -66.55 -49.88 65.0 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 119.437 1.017 . . . . 0.0 111.394 -172.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.45 ' H ' HG12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -66.08 -41.4 89.48 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 CA-C-O 118.987 -0.53 . . . . 0.0 110.271 176.293 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -62.3 -49.05 77.19 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 119.26 -0.4 . . . . 0.0 110.217 -177.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -63.94 -45.3 89.8 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 118.608 0.64 . . . . 0.0 111.149 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 28.7 tttt -57.36 -54.36 47.73 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.523 0.729 . . . . 0.0 110.826 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 91.7 t -80.91 -40.8 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-O 117.799 -1.096 . . . . 0.0 110.827 -169.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 58.2 m -62.94 -25.8 68.51 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 120.77 1.623 . . . . 0.0 110.911 173.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.06 -55.43 29.62 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 169.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -61.26 -39.03 88.84 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 118.645 1.222 . . . . 0.0 112.689 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 38.7 mmt -57.26 -47.38 81.56 Favored 'General case' 0 N--CA 1.461 0.077 0 CA-C-N 118.624 0.647 . . . . 0.0 109.515 174.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -67.79 -28.77 67.88 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.15 0.58 . . . . 0.0 112.542 178.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.9 mttm -63.24 -44.34 95.49 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.56 1.073 . . . . 0.0 109.445 169.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -65.93 -25.87 67.33 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 119.183 0.901 . . . . 0.0 110.89 171.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 122.82 -26.25 6.25 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 127.432 2.444 . . . . 0.0 111.64 175.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 97.2 m -53.9 148.46 10.41 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.649 1.98 . . . . 0.0 112.252 -173.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -108.79 138.78 44.56 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -177.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 91.7 m -141.74 162.16 36.16 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 -168.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -153.01 131.58 12.24 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.595 1.558 . . . . 0.0 107.872 171.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.0 p -69.74 118.5 12.68 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 169.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 43.7 mt -68.49 -25.4 64.95 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.882 -0.511 . . . . 0.0 109.903 172.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.38 -164.29 37.51 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 108.317 -1.913 . . . . 0.0 108.317 173.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -150.88 -179.32 26.53 Favored Glycine 0 N--CA 1.451 -0.303 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 171.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -169.83 -157.19 11.81 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 -175.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -143.45 147.24 34.27 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 -173.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 12.2 mt . . . . . 0 C--N 1.33 -0.27 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 -172.555 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 20.7 t60 . . . . . 0 N--CA 1.451 -0.41 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.6 t -135.01 131.37 52.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 -178.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -160.19 -164.37 1.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 O-C-N 121.486 -0.759 . . . . 0.0 109.388 -177.157 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.04 -172.23 55.11 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 118.812 0.733 . . . . 0.0 112.457 173.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -162.45 150.07 13.96 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.989 0.915 . . . . 0.0 110.151 -174.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.0 t -78.74 165.59 23.43 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 167.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 21.8 ptp -108.45 -28.99 9.04 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 118.52 -0.752 . . . . 0.0 111.025 171.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.2 -25.16 57.99 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 119.49 1.041 . . . . 0.0 111.602 171.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -133.78 -5.95 2.82 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -169.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.77 -178.07 51.11 Favored Glycine 0 CA--C 1.535 1.335 0 CA-C-N 119.025 0.83 . . . . 0.0 113.575 173.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -68.13 142.31 55.52 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.806 2.337 . . . . 0.0 110.815 174.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.51 177.31 5.4 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 169.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 21.4 mm100 -62.91 -28.59 70.16 Favored 'General case' 0 CA--C 1.535 0.404 0 O-C-N 121.85 -0.532 . . . . 0.0 111.66 172.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . 0.263 68.9 m-70 59.45 -27.64 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 128.556 2.742 . . . . 0.0 116.481 -174.159 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.26 -42.41 99.15 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 119.547 1.067 . . . . 0.0 110.251 173.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 62.2 mt -61.06 -47.26 94.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 176.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.4 -52.35 64.95 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.399 1.079 . . . . 0.0 110.599 -173.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 33.0 p -64.63 -48.47 74.74 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 118.781 -0.628 . . . . 0.0 109.636 -176.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -60.58 -40.24 91.01 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.958 0.799 . . . . 0.0 111.096 -177.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 48.9 mttm -64.78 -46.94 79.97 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 118.877 0.762 . . . . 0.0 111.19 176.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 63.2 mt -62.14 -44.39 98.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt . . . . . 0 N--CA 1.466 0.366 0 CA-C-N 118.782 0.719 . . . . 0.0 110.336 179.552 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.3 t . . . . . 0 N--CA 1.451 -0.408 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.0 p -135.71 170.97 15.13 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.55 1.14 . . . . 0.0 109.283 176.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 34.9 p-90 . . . . . 0 C--O 1.234 0.266 0 O-C-N 121.817 -0.552 . . . . 0.0 111.034 172.015 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.514 0 CA-C-O 121.619 0.723 . . . . 0.0 111.55 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -153.36 149.6 28.0 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 126.488 1.915 . . . . 0.0 106.309 169.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 68.9 mt -54.79 -34.61 62.9 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 123.395 0.678 . . . . 0.0 112.539 -175.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.29 -25.05 65.85 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.861 0.755 . . . . 0.0 112.42 -178.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.8 mt -78.72 -25.05 44.58 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.023 0.529 . . . . 0.0 111.195 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 21.1 mt -70.87 129.39 89.71 Favored Pre-proline 0 CA--C 1.538 0.504 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -176.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -52.87 128.14 27.54 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.703 2.269 . . . . 0.0 110.644 169.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -80.47 -23.71 40.0 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 121.909 -0.495 . . . . 0.0 111.854 176.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.1 t -136.22 131.55 48.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 173.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -163.38 116.04 1.51 Allowed 'General case' 0 C--O 1.233 0.205 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 169.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.536 0.44 0 C-N-CA 124.379 1.072 . . . . 0.0 109.127 -173.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 . . . . . 0 C--O 1.238 0.469 0 CA-C-O 121.33 0.586 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -71.17 157.1 38.74 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 124.082 0.953 . . . . 0.0 112.073 -171.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -145.31 164.74 30.5 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.066 1.747 . . . . 0.0 107.657 170.204 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.5 m -131.21 150.92 34.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 C-N-CA 124.28 1.032 . . . . 0.0 109.199 171.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.73 118.67 36.74 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 104.234 -2.506 . . . . 0.0 104.234 173.18 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 53.6 mt -120.31 124.84 73.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 -177.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -81.18 148.7 29.42 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 169.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.5 t -133.02 147.09 31.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 -175.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -132.49 147.33 52.36 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.815 1.246 . . . . 0.0 107.96 -178.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.539 ' HG ' ' N ' ' A' ' 39' ' ' GLU . 19.8 m -62.25 103.18 0.36 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.524 0.73 . . . . 0.0 111.117 -178.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.515 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -144.45 19.18 0.04 OUTLIER Pre-proline 0 CA--C 1.555 1.146 0 CA-C-O 116.265 -1.826 . . . . 0.0 113.654 169.131 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.515 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 87.2 Cg_exo . . . . . 0 C--N 1.365 1.428 0 CA-C-N 123.538 2.299 . . . . 0.0 114.349 178.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.539 ' N ' ' HG ' ' A' ' 29' ' ' SER . 42.6 mt-10 . . . . . 0 CA--C 1.54 0.567 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.3 m -141.52 159.24 42.63 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.616 1.166 . . . . 0.0 109.547 175.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -153.41 166.33 33.01 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 127.107 2.163 . . . . 0.0 106.727 -173.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -127.61 154.28 45.42 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 119.577 1.08 . . . . 0.0 108.968 177.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.6 pt -134.73 153.05 34.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 C-N-CA 125.185 1.394 . . . . 0.0 109.37 175.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 43.2 t -118.98 114.22 44.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.4 mmp_? -126.63 147.11 49.95 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 175.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -176.97 141.29 5.32 Favored Glycine 0 C--N 1.331 0.253 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 175.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -152.9 153.83 33.82 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -172.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -59.51 -28.8 67.38 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 8.0 p-90 -70.91 -24.56 62.49 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.115 0.871 . . . . 0.0 112.596 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.42 75.74 9.97 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.586 1.085 . . . . 0.0 110.587 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -63.81 -14.49 53.34 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.288 0.635 . . . . 0.0 112.142 173.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -131.04 136.98 48.96 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.723 1.609 . . . . 0.0 107.317 177.308 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 34.6 m80 -60.72 -32.5 71.75 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 123.102 0.561 . . . . 0.0 110.594 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.69 -27.85 52.42 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 118.326 -0.845 . . . . 0.0 112.986 172.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -68.43 -49.78 57.5 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 119.619 1.1 . . . . 0.0 110.395 -176.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.42 ' H ' HG12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -67.36 -40.38 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-O 117.63 -1.176 . . . . 0.0 109.839 175.636 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -59.88 -47.8 84.28 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 120.301 1.41 . . . . 0.0 110.628 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -64.67 -47.62 77.78 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.569 0.622 . . . . 0.0 111.576 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 46.8 tttt -62.81 -50.75 69.74 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.11 0.564 . . . . 0.0 111.151 -178.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 93.2 t -71.96 -48.41 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-O 118.255 -0.879 . . . . 0.0 108.808 -172.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.9 m -64.21 -26.76 68.65 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 120.098 1.317 . . . . 0.0 111.251 177.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.91 -51.19 57.4 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 170.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -61.01 -43.03 99.48 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 118.495 1.147 . . . . 0.0 111.667 177.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.3 mmt -59.72 -47.18 86.66 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 118.974 -0.536 . . . . 0.0 109.859 177.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -69.82 -27.54 64.96 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.959 0.8 . . . . 0.0 112.096 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -67.28 -38.29 84.83 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.309 0.959 . . . . 0.0 109.988 169.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -69.02 -26.7 65.13 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 119.655 1.116 . . . . 0.0 110.293 169.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 119.7 -22.73 8.61 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 128.059 2.742 . . . . 0.0 112.219 175.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 92.9 m -52.64 147.98 7.83 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 126.067 1.747 . . . . 0.0 111.791 -178.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -108.11 140.18 41.69 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 66.7 m -140.71 163.04 33.96 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -168.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -151.78 128.23 10.68 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.515 1.526 . . . . 0.0 107.489 175.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.8 p -70.9 121.46 18.14 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 169.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 51.4 mt -70.17 -27.14 64.28 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.968 -0.457 . . . . 0.0 109.851 171.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.62 -170.34 41.09 Favored Glycine 0 C--N 1.337 0.63 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 173.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -131.98 165.05 23.6 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.399 -0.68 . . . . 0.0 111.399 176.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -166.05 -162.99 18.69 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 125.284 1.421 . . . . 0.0 109.666 177.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 33.8 ptt180 -138.22 159.72 41.31 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 121.067 -1.255 . . . . 0.0 109.2 176.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 84.6 mt . . . . . 0 N--CA 1.45 -0.464 0 N-CA-C 103.843 -2.651 . . . . 0.0 103.843 -174.459 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 20.0 t60 . . . . . 0 N--CA 1.451 -0.381 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.7 t -137.37 134.84 47.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -171.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -174.42 172.39 3.18 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.253 1.421 . . . . 0.0 107.858 -178.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 144.1 -169.89 26.1 Favored Glycine 0 C--N 1.334 0.441 0 CA-C-N 119.017 0.826 . . . . 0.0 112.249 169.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -160.46 114.11 2.12 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.582 1.553 . . . . 0.0 107.737 -176.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.3 t -72.62 142.65 48.35 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 168.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.0 ppp? -71.64 -39.91 70.07 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 171.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.79 -25.06 35.57 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 118.711 -0.662 . . . . 0.0 112.408 -172.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -134.58 0.47 3.01 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -169.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.94 -175.27 53.95 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-N 119.197 0.908 . . . . 0.0 112.881 176.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -76.16 138.57 20.47 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.975 2.45 . . . . 0.0 109.847 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.48 171.76 9.59 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.094 0.473 . . . . 0.0 110.625 169.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 58.2 mm-40 -64.25 -35.77 81.91 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 119.116 -0.469 . . . . 0.0 111.828 175.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 33.9 m80 59.96 -31.2 0.05 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 128.767 2.827 . . . . 0.0 115.479 -173.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.57 -37.96 85.76 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.132 1.373 . . . . 0.0 112.115 174.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 90.4 mt -63.41 -46.51 95.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 176.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.67 -47.37 84.72 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.193 0.997 . . . . 0.0 110.939 -177.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.513 HG22 HG12 ' A' ' 118' ' ' VAL . 5.9 p -64.23 -51.98 61.01 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 119.137 0.881 . . . . 0.0 110.694 -177.075 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -60.28 -39.82 88.26 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 118.726 0.694 . . . . 0.0 110.574 -175.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -64.59 -56.05 16.46 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-O 118.462 -0.78 . . . . 0.0 111.187 174.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 66.9 mt -63.36 -41.4 92.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.215 -172.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 94.0 mttt . . . . . 0 N--CA 1.472 0.652 0 CA-C-N 120.121 1.328 . . . . 0.0 110.194 175.517 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.513 HG12 HG22 ' A' ' 106' ' ' THR . 5.2 t . . . . . 0 CA--C 1.533 0.323 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 16.8 p -137.0 170.79 15.52 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.664 1.12 . . . . 0.0 109.926 176.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 38.5 p-90 . . . . . 0 C--O 1.235 0.334 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 172.434 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.386 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -146.97 147.96 31.24 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 169.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 71.5 mt -57.94 -30.02 65.62 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -173.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.22 -26.71 63.99 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.979 0.809 . . . . 0.0 111.981 177.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.2 mt -83.88 -25.52 30.17 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.772 0.829 . . . . 0.0 111.215 -177.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 51.9 mt -63.34 127.83 91.66 Favored Pre-proline 0 CA--C 1.538 0.506 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -45.9 122.8 5.48 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.968 3.112 . . . . 0.0 111.409 172.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -79.45 -36.24 39.18 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 121.209 0.528 . . . . 0.0 110.768 -172.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 77.9 t -136.69 129.97 45.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 N-CA-C 105.658 -1.978 . . . . 0.0 105.658 175.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -154.69 125.7 7.19 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 170.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.9 pt . . . . . 0 C--O 1.237 0.399 0 C-N-CA 124.835 1.254 . . . . 0.0 108.451 -173.841 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 9.4 p90 . . . . . 0 C--O 1.234 0.258 0 CA-C-O 120.484 0.183 . . . . 0.0 111.317 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -71.95 156.55 39.13 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 175.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.1 163.74 32.02 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 172.284 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.2 m -133.29 149.59 31.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 C-N-CA 124.385 1.074 . . . . 0.0 109.15 172.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.53 121.59 41.39 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 104.055 -2.572 . . . . 0.0 104.055 173.128 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 85.5 mt -122.57 126.47 74.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -177.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -82.14 148.31 28.57 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 169.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.5 t -137.26 147.02 27.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 126.857 2.063 . . . . 0.0 105.606 -173.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -128.11 152.0 48.53 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.684 1.194 . . . . 0.0 108.889 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.521 ' HG ' ' N ' ' A' ' 39' ' ' GLU . 45.8 m -62.86 93.26 0.06 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.31 1.044 . . . . 0.0 111.028 175.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.51 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -141.1 16.39 0.04 OUTLIER Pre-proline 0 CA--C 1.551 0.992 0 CA-C-O 116.245 -1.836 . . . . 0.0 114.115 169.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.51 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 76.8 Cg_exo . . . . . 0 C--N 1.363 1.298 0 CA-C-N 124.104 2.501 . . . . 0.0 114.226 175.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.521 ' N ' ' HG ' ' A' ' 29' ' ' SER . 42.8 mt-10 . . . . . 0 CA--C 1.539 0.53 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.9 m -142.17 157.19 45.16 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.711 1.205 . . . . 0.0 109.088 176.038 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -151.64 167.51 27.9 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 127.146 2.178 . . . . 0.0 106.427 -173.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 -131.88 154.12 49.53 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 175.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 35.8 pt -132.38 155.68 41.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 125.168 1.387 . . . . 0.0 109.852 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 98.6 t -118.16 115.11 47.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 177.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 12.1 mmp_? -125.78 141.93 51.76 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.239 1.416 . . . . 0.0 107.518 176.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -177.9 137.32 3.33 Favored Glycine 0 C--N 1.333 0.363 0 CA-C-N 119.31 0.959 . . . . 0.0 111.113 174.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -153.19 153.3 32.47 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 117.097 0.449 . . . . 0.0 110.54 -169.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -57.26 -32.47 66.62 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.086 0.954 . . . . 0.0 112.274 177.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 13.0 p-90 -67.83 -27.64 66.88 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.853 0.752 . . . . 0.0 112.529 177.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.98 81.63 8.7 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 119.724 1.147 . . . . 0.0 109.438 174.458 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -64.11 -19.1 65.03 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.266 0.626 . . . . 0.0 112.017 174.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -135.22 152.56 51.67 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 126.327 1.851 . . . . 0.0 108.001 -179.325 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 44.8 m-70 -73.72 -32.85 64.08 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 121.84 -0.537 . . . . 0.0 109.575 -169.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.0 -28.9 55.64 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 118.481 -0.771 . . . . 0.0 112.597 172.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -66.73 -50.51 62.55 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 119.356 0.98 . . . . 0.0 110.637 -175.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.4 ' H ' HG12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -66.67 -40.21 85.61 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 CA-C-O 117.257 -1.354 . . . . 0.0 109.826 175.533 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -60.86 -47.83 84.6 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-N 120.214 1.37 . . . . 0.0 110.243 -178.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -61.73 -46.17 90.78 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.001 0.819 . . . . 0.0 111.886 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 34.4 tttt -61.21 -50.0 74.88 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 123.082 0.553 . . . . 0.0 110.671 178.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 86.6 t -77.54 -39.98 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-O 117.751 -1.119 . . . . 0.0 109.757 -170.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 80.8 p -63.08 -34.16 76.99 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 120.888 1.676 . . . . 0.0 109.617 175.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.65 -53.32 46.34 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 171.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -60.22 -46.26 90.36 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 118.547 1.174 . . . . 0.0 111.813 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 38.0 mmt -57.92 -48.96 78.36 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.366 0.666 . . . . 0.0 110.369 177.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -68.21 -28.48 67.28 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.66 0.664 . . . . 0.0 111.996 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -67.95 -38.0 82.28 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 119.243 0.928 . . . . 0.0 110.594 171.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -67.56 -29.86 69.34 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 119.67 1.123 . . . . 0.0 110.437 169.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 126.96 -21.87 5.79 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 127.458 2.456 . . . . 0.0 111.692 174.019 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 68.1 m -52.45 150.14 5.12 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 125.947 1.699 . . . . 0.0 112.438 -176.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -108.51 136.24 48.45 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 173.331 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 99.5 m -144.13 164.96 29.17 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -168.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -149.83 136.17 19.0 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.007 1.723 . . . . 0.0 107.847 171.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.3 p -73.22 125.0 26.75 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 169.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 44.4 mt -75.26 -23.29 57.44 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.812 -0.555 . . . . 0.0 110.398 173.338 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.01 -174.02 43.52 Favored Glycine 0 C--N 1.337 0.604 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 171.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -123.48 168.07 15.7 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 175.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -172.32 -165.25 29.13 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -173.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -149.38 150.49 32.51 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -169.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 58.7 mt . . . . . 0 C--O 1.235 0.341 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 -172.161 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 36.2 t60 . . . . . 0 N--CA 1.451 -0.416 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.2 t -131.83 136.62 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -178.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -161.0 -161.09 0.79 Allowed 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 125.145 1.378 . . . . 0.0 107.424 -172.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.73 -177.81 45.21 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-O 122.539 1.077 . . . . 0.0 113.451 169.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -164.07 150.64 11.45 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 126.032 1.733 . . . . 0.0 106.793 -169.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.3 t -116.96 145.9 43.35 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.66 1.584 . . . . 0.0 106.813 171.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.0 ptm -87.35 -34.46 18.81 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 118.79 -0.624 . . . . 0.0 110.193 174.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.81 -26.09 56.94 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.117 0.871 . . . . 0.0 111.949 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -131.13 -5.09 3.89 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -169.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.44 173.8 40.27 Favored Glycine 0 CA--C 1.533 1.197 0 CA-C-N 118.858 0.754 . . . . 0.0 112.312 178.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.23 134.37 24.76 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.71 2.273 . . . . 0.0 109.527 177.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.28 166.57 19.86 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.674 0.75 . . . . 0.0 112.433 176.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -77.64 74.87 4.19 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.897 1.279 . . . . 0.0 108.973 169.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -54.15 -22.33 10.93 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -176.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.81 -40.64 89.07 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.955 0.902 . . . . 0.0 111.761 173.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 65.0 mt -63.28 -46.36 95.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.55 -50.86 72.25 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.451 1.1 . . . . 0.0 110.129 -176.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 20.9 p -65.39 -42.61 92.47 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 118.049 -0.977 . . . . 0.0 111.378 -174.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -61.35 -40.86 95.82 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.821 1.191 . . . . 0.0 110.742 178.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 43.4 mttm -66.51 -46.28 76.77 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 121.793 -0.567 . . . . 0.0 111.277 176.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 67.2 mt -64.8 -40.71 89.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -177.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 89.7 mttt . . . . . 0 N--CA 1.47 0.528 0 CA-C-N 119.88 1.218 . . . . 0.0 109.862 174.898 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.451 -0.418 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 26.0 p -136.21 172.0 13.65 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.075 0.95 . . . . 0.0 108.912 173.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 45.7 p-90 . . . . . 0 C--O 1.234 0.282 0 CA-C-O 121.076 0.465 . . . . 0.0 110.752 172.593 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.517 0 CA-C-O 121.287 0.565 . . . . 0.0 110.743 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -151.87 152.14 32.2 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.544 1.538 . . . . 0.0 106.864 170.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.2 mt -57.03 -31.66 65.38 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.568 0.622 . . . . 0.0 112.553 -176.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.84 -24.7 65.3 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 118.825 0.739 . . . . 0.0 112.376 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.2 mt -85.31 -18.68 33.15 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.549 0.74 . . . . 0.0 111.499 -176.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 50.1 mt -65.01 131.84 95.32 Favored Pre-proline 0 CA--C 1.54 0.577 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -50.4 115.79 2.13 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 123.503 2.802 . . . . 0.0 110.104 169.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -70.73 -39.18 73.5 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -169.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 45.5 t -140.83 138.5 34.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 176.361 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -152.51 112.49 3.99 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 169.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 40.0 pt . . . . . 0 CA--C 1.54 0.578 0 C-N-CA 124.693 1.197 . . . . 0.0 109.88 -169.95 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 25.1 p90 . . . . . 0 C--O 1.237 0.423 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.4 mmtp -74.68 154.57 38.4 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.045 0.938 . . . . 0.0 109.174 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.99 161.58 39.78 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.75 0.82 . . . . 0.0 108.985 176.369 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.6 m -133.79 152.09 34.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 C-N-CA 124.897 1.279 . . . . 0.0 109.331 173.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 28.2 tp -108.83 116.12 31.38 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 105.226 -2.138 . . . . 0.0 105.226 177.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 86.0 mt -120.15 119.12 59.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -169.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.3 ttp180 -78.13 145.36 35.75 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 168.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.3 p -139.25 148.85 23.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -130.71 145.95 52.06 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.084 1.353 . . . . 0.0 108.29 -169.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.521 ' HG ' ' N ' ' A' ' 39' ' ' GLU . 23.0 m -61.38 108.23 0.9 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.644 0.778 . . . . 0.0 111.266 -178.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.411 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -150.35 22.25 0.03 OUTLIER Pre-proline 0 CA--C 1.552 1.03 0 C-N-CA 125.185 1.394 . . . . 0.0 112.441 168.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 30' ' ' ALA . 45.5 Cg_endo . . . . . 0 C--N 1.359 1.087 0 CA-C-N 122.669 1.989 . . . . 0.0 110.998 -171.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.521 ' N ' ' HG ' ' A' ' 29' ' ' SER . 45.6 mm-40 . . . . . 0 CA--C 1.537 0.475 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.4 m -140.71 157.85 44.83 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.393 1.077 . . . . 0.0 109.29 173.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -152.87 168.26 26.35 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 127.354 2.261 . . . . 0.0 106.23 -173.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -130.88 147.39 52.52 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.03 -1.044 . . . . 0.0 108.614 177.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 29.8 pt -130.75 156.0 42.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 125.881 1.672 . . . . 0.0 109.315 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.2 t -131.23 116.53 33.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 -169.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.5 mmt85 -137.22 148.9 46.82 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -176.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 177.69 137.43 2.75 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -154.85 154.09 32.18 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -170.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -59.71 -29.22 67.97 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.274 0.629 . . . . 0.0 112.651 178.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 11.2 p-90 -69.4 -28.21 65.96 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.014 0.825 . . . . 0.0 112.258 178.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.86 77.67 9.67 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 119.41 1.005 . . . . 0.0 109.022 175.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -63.13 -18.59 63.6 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 122.937 0.495 . . . . 0.0 111.303 173.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.65 146.3 51.44 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.64 1.576 . . . . 0.0 107.724 178.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -72.67 -30.22 64.08 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.131 0.572 . . . . 0.0 110.262 -169.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.41 -30.8 42.05 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 118.636 -0.697 . . . . 0.0 112.549 170.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -69.37 -47.61 63.75 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 119.34 0.973 . . . . 0.0 110.902 -175.18 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.446 ' H ' HG12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -67.73 -40.8 84.52 Favored 'Isoleucine or valine' 0 C--N 1.34 0.178 0 CA-C-O 117.891 -1.052 . . . . 0.0 110.117 175.635 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -61.21 -45.65 93.7 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.747 1.158 . . . . 0.0 110.288 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -62.53 -47.16 85.13 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.318 0.508 . . . . 0.0 111.583 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 26.1 tttp -63.62 -54.08 41.5 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 122.814 0.446 . . . . 0.0 110.995 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 97.3 t -71.07 -52.36 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -170.011 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 33.4 m -67.2 -27.96 67.69 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 119.206 0.912 . . . . 0.0 111.249 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.56 -46.92 93.3 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 170.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -63.23 -42.22 99.22 Favored 'General case' 0 CA--C 1.526 0.053 0 CA-C-N 118.568 1.184 . . . . 0.0 111.245 176.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.5 mmt -59.72 -45.1 93.18 Favored 'General case' 0 C--O 1.226 -0.18 0 CA-C-N 118.242 0.473 . . . . 0.0 110.14 176.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.7 mm-40 -66.72 -30.49 70.74 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.817 0.847 . . . . 0.0 111.912 178.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -68.61 -39.19 80.96 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.718 1.145 . . . . 0.0 110.301 170.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -65.4 -26.25 67.9 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.178 0.899 . . . . 0.0 110.431 169.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 119.09 -22.07 9.19 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 128.152 2.786 . . . . 0.0 111.82 175.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 91.3 m -58.69 150.58 23.04 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 126.452 1.901 . . . . 0.0 111.414 -176.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -108.78 146.03 34.24 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.481 1.113 . . . . 0.0 108.174 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 82.4 m -140.01 162.88 34.14 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -168.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -150.81 122.5 8.03 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 125.417 1.487 . . . . 0.0 107.66 173.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.5 p -69.88 120.0 14.95 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 169.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 45.1 mt -68.1 -25.64 65.41 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.987 -0.445 . . . . 0.0 109.893 172.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 165.55 -167.27 38.9 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 125.434 1.492 . . . . 0.0 109.432 170.046 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -132.76 170.89 21.88 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 123.977 0.799 . . . . 0.0 111.489 176.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -171.16 -161.31 21.59 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 125.471 1.51 . . . . 0.0 109.719 -177.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -142.29 165.95 26.04 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 121.372 -1.075 . . . . 0.0 108.909 174.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 60.1 mt . . . . . 0 CA--C 1.532 0.276 0 C-N-CA 123.12 0.568 . . . . 0.0 109.544 -169.61 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 24.3 t60 . . . . . 0 CA--C 1.521 -0.152 0 N-CA-C 109.506 -0.554 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.5 t -140.16 132.27 32.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -166.88 -173.69 2.47 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.18 0.992 . . . . 0.0 108.809 -172.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.92 -166.33 21.31 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-N 119.059 0.845 . . . . 0.0 112.263 171.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -155.64 178.22 10.5 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.424 1.09 . . . . 0.0 110.145 178.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.8 t -129.91 151.15 50.79 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 104.824 -2.288 . . . . 0.0 104.824 169.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.3 ptm -88.88 -34.05 17.11 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 118.787 -0.625 . . . . 0.0 110.281 175.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.34 -25.85 55.13 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.08 0.855 . . . . 0.0 111.981 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -130.84 -4.63 4.04 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -169.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.94 175.61 42.19 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-N 118.854 0.752 . . . . 0.0 112.353 177.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -66.7 138.43 49.18 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.428 2.085 . . . . 0.0 110.035 173.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.31 169.31 7.44 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.033 0.533 . . . . 0.0 110.953 171.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 21.2 mm100 -63.25 -30.26 71.43 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 118.975 -0.536 . . . . 0.0 111.428 170.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 40.2 m80 60.8 -31.56 0.07 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 129.017 2.927 . . . . 0.0 115.496 -175.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.09 -41.94 93.57 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.202 1.401 . . . . 0.0 112.318 178.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.8 mt -62.38 -49.15 85.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 177.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.4 m -54.68 -45.16 73.89 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.54 1.136 . . . . 0.0 112.172 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.527 HG22 HG12 ' A' ' 118' ' ' VAL . 1.0 OUTLIER -61.3 -50.0 74.76 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 119.747 1.158 . . . . 0.0 110.315 178.442 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -61.26 -41.42 96.89 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.972 0.805 . . . . 0.0 110.889 -177.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 24.5 mmtp -68.23 -43.82 77.09 Favored 'General case' 0 C--N 1.338 0.086 0 CA-C-O 118.699 -0.667 . . . . 0.0 111.629 178.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 79.9 mt -67.23 -38.15 80.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 119.958 1.254 . . . . 0.0 109.01 -178.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 91.8 mttt . . . . . 0 N--CA 1.469 0.485 0 CA-C-N 119.64 1.109 . . . . 0.0 109.49 173.548 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.527 HG12 HG22 ' A' ' 106' ' ' THR . 2.6 t . . . . . 0 N--CA 1.452 -0.34 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 16.9 p -135.06 171.09 14.92 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.137 0.975 . . . . 0.0 109.241 173.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 35.6 p-90 . . . . . 0 C--O 1.235 0.298 0 O-C-N 121.597 -0.69 . . . . 0.0 109.436 172.865 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.535 0 CA-C-O 121.263 0.554 . . . . 0.0 110.43 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -149.21 147.64 28.65 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 169.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 95.1 mt -55.51 -34.21 64.44 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.537 0.735 . . . . 0.0 112.407 -175.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.05 -25.54 66.31 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.834 0.743 . . . . 0.0 112.249 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.6 mt -79.25 -24.01 43.28 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.178 0.591 . . . . 0.0 111.183 -178.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 39.5 mt -68.31 128.78 93.1 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -176.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -47.42 123.05 7.41 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.939 3.093 . . . . 0.0 111.925 172.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -71.87 -37.52 70.19 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.499 0.72 . . . . 0.0 111.294 -177.117 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 63.9 t -137.52 134.32 46.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 176.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -152.66 119.96 5.92 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 171.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.5 pt . . . . . 0 CA--C 1.534 0.347 0 C-N-CA 124.28 1.032 . . . . 0.0 109.299 -169.937 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 23.2 p90 . . . . . 0 C--O 1.237 0.421 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -75.66 156.3 34.94 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.491 0.717 . . . . 0.0 110.003 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.44 163.34 35.97 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.004 1.322 . . . . 0.0 107.869 -178.151 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.3 m -135.95 156.04 36.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 C-N-CA 124.304 1.041 . . . . 0.0 109.7 172.18 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.81 122.23 45.97 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 104.225 -2.509 . . . . 0.0 104.225 173.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 73.9 mt -121.53 122.5 67.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 -176.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 37.6 ttp180 -80.74 146.82 30.84 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 169.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.6 t -132.13 143.77 39.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 -175.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -128.96 138.36 51.93 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 176.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.5 p -67.31 115.87 7.44 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.777 0.799 . . . . 0.0 110.641 -175.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.405 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -148.43 27.49 0.05 OUTLIER Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 125.833 1.653 . . . . 0.0 111.609 169.158 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.405 ' CD ' ' N ' ' A' ' 30' ' ' ALA . 35.2 Cg_endo . . . . . 0 C--N 1.358 1.064 0 CA-C-N 122.569 1.953 . . . . 0.0 111.985 -173.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 . . . . . 0 C--O 1.238 0.466 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.2 m -140.89 157.86 44.77 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.299 0.64 . . . . 0.0 110.589 -175.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -152.22 167.5 28.38 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 127.586 2.355 . . . . 0.0 106.008 -175.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.9 mp0 -133.21 156.49 47.42 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 120.713 -1.242 . . . . 0.0 108.443 176.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 32.2 pt -136.31 155.35 34.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 125.255 1.422 . . . . 0.0 109.807 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 48.1 t -118.14 122.36 69.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 -179.035 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.1 mmp_? -129.29 146.18 51.23 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.083 1.353 . . . . 0.0 107.832 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 177.32 131.36 1.5 Allowed Glycine 0 C--N 1.331 0.283 0 CA-C-N 119.173 0.897 . . . . 0.0 111.045 173.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -153.95 152.3 30.42 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -173.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.9 pttm -58.89 -29.4 66.99 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 11.1 p-90 -65.4 -27.52 68.6 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.231 0.923 . . . . 0.0 111.854 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.56 75.67 10.01 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 118.871 0.76 . . . . 0.0 109.052 172.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -67.22 -6.59 18.75 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.685 0.794 . . . . 0.0 111.574 175.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -137.28 146.14 44.34 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 126.63 1.972 . . . . 0.0 107.224 173.257 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -68.97 -34.29 75.08 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -171.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.97 -26.49 48.47 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 118.355 -0.831 . . . . 0.0 112.766 174.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -69.11 -48.06 63.53 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 119.749 1.159 . . . . 0.0 111.111 -175.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.416 ' H ' HG12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -66.08 -38.02 81.09 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.024 176.284 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -62.23 -50.32 72.2 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.612 177.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -60.99 -44.12 97.85 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.798 1.181 . . . . 0.0 112.02 -178.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.6 tppt? -57.08 -54.64 44.45 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.169 0.988 . . . . 0.0 110.527 177.132 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.2 t -85.26 -34.41 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-O 117.619 -1.182 . . . . 0.0 111.974 -168.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 57.2 p -63.26 -33.18 74.94 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 121.345 1.884 . . . . 0.0 109.485 170.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.74 -52.85 50.5 Favored Glycine 0 C--N 1.338 0.64 0 N-CA-C 110.354 -1.099 . . . . 0.0 110.354 171.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.403 ' HA ' ' HE3' ' A' ' 66' ' ' LYS . 19.8 t70 -59.86 -44.6 94.04 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.717 1.258 . . . . 0.0 111.993 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 35.4 mmt -60.35 -47.98 83.72 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 123.238 0.615 . . . . 0.0 109.903 178.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -68.57 -28.62 67.11 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 118.501 0.591 . . . . 0.0 111.827 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.403 ' HE3' ' HA ' ' A' ' 63' ' ' ASP . 53.1 mtmt -67.3 -37.7 83.8 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 118.119 -0.943 . . . . 0.0 110.393 170.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -68.82 -30.04 68.51 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.871 1.214 . . . . 0.0 110.31 169.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 126.2 -22.36 5.98 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 127.625 2.536 . . . . 0.0 111.872 175.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 82.5 m -55.52 152.09 9.49 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 126.188 1.795 . . . . 0.0 112.339 -177.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -110.68 140.86 44.66 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 96.8 m -143.32 165.03 28.61 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -168.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -151.43 127.24 10.27 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.545 1.538 . . . . 0.0 107.542 175.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.2 p -70.56 120.15 15.77 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 169.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 58.3 mt -71.29 -22.96 61.88 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.932 -0.48 . . . . 0.0 110.424 174.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 165.96 -169.27 40.16 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 172.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -135.76 174.96 21.09 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 174.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -178.53 -168.16 37.4 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 -176.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -137.84 163.05 32.38 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 119.029 1.414 . . . . 0.0 109.73 173.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 75.0 mt . . . . . 0 C--N 1.33 -0.264 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 -169.698 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 28.1 t60 . . . . . 0 N--CA 1.46 0.068 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.4 t -141.01 135.65 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -166.26 -174.28 2.86 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.623 0.769 . . . . 0.0 109.664 -172.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.35 -170.48 39.05 Favored Glycine 0 CA--C 1.523 0.581 0 O-C-N 121.77 -0.581 . . . . 0.0 112.101 171.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -159.95 152.88 21.59 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.061 0.944 . . . . 0.0 109.845 -178.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.7 t -82.79 154.77 24.56 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 168.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.8 ppp? -82.29 -39.24 23.2 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 171.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.6 -25.59 45.22 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 119.152 -0.451 . . . . 0.0 111.971 -175.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -132.0 -2.32 3.64 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -169.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.88 -174.79 51.0 Favored Glycine 0 CA--C 1.534 1.281 0 CA-C-N 118.903 0.774 . . . . 0.0 113.101 174.12 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.98 138.34 43.82 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.963 2.442 . . . . 0.0 110.091 173.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.75 170.93 15.24 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.614 0.721 . . . . 0.0 111.488 170.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -78.86 76.02 5.36 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 169.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -57.62 -18.63 21.16 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -174.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.15 -35.77 76.05 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.194 0.998 . . . . 0.0 112.35 171.017 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 69.4 mt -65.81 -45.53 91.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 176.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.3 m -58.68 -46.85 86.33 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.998 0.919 . . . . 0.0 111.52 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 21.0 p -60.56 -53.26 59.63 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 119.184 0.902 . . . . 0.0 109.325 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -61.81 -40.96 97.07 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.795 0.725 . . . . 0.0 111.437 -175.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -66.53 -48.13 70.69 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 118.708 0.685 . . . . 0.0 111.481 178.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 73.4 mt -66.36 -37.45 79.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 119.229 0.922 . . . . 0.0 109.003 -178.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 46.7 mtpt . . . . . 0 N--CA 1.469 0.518 0 CA-C-N 119.615 1.098 . . . . 0.0 110.118 175.103 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.4 t . . . . . 0 N--CA 1.45 -0.447 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.3 p -132.51 172.0 13.05 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.084 0.953 . . . . 0.0 109.498 176.246 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 33.5 p-90 . . . . . 0 C--O 1.235 0.299 0 O-C-N 121.603 -0.686 . . . . 0.0 109.967 173.024 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.576 0 CA-C-O 121.339 0.59 . . . . 0.0 110.816 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -152.73 153.98 34.32 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.85 1.66 . . . . 0.0 106.635 170.031 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.4 mt -53.28 -36.58 61.33 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.038 0.835 . . . . 0.0 112.0 -179.087 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.02 -25.66 68.22 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.875 0.761 . . . . 0.0 112.506 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.1 mt -83.66 -20.27 33.89 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.38 0.672 . . . . 0.0 111.44 -178.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 32.0 mt -67.38 131.61 93.25 Favored Pre-proline 0 CA--C 1.539 0.52 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -49.76 119.54 4.88 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 123.066 2.511 . . . . 0.0 110.63 169.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -71.15 -39.65 71.82 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.791 0.836 . . . . 0.0 111.155 -175.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.9 t -134.89 139.45 47.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 172.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -152.02 122.87 7.5 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 170.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 45.1 pt . . . . . 0 CA--C 1.538 0.496 0 C-N-CA 127.366 2.266 . . . . 0.0 105.703 177.387 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.8 p90 . . . . . 0 N--CA 1.467 0.386 0 N-CA-C 110.767 -0.086 . . . . 0.0 110.767 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -66.35 155.31 37.68 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.331 0.586 . . . . 0.0 110.523 -178.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -141.48 163.56 32.6 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.309 1.444 . . . . 0.0 107.376 173.41 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.4 m -138.34 156.56 30.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 C-N-CA 123.905 0.882 . . . . 0.0 109.467 172.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.21 118.86 37.85 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 104.392 -2.448 . . . . 0.0 104.392 176.031 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 62.8 mt -121.72 115.71 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 119.809 1.186 . . . . 0.0 108.402 -173.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -74.54 140.88 44.77 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 168.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.9 p -134.85 148.01 29.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 178.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -127.52 143.47 51.18 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.184 1.393 . . . . 0.0 108.623 -169.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.8 m -62.49 105.08 0.58 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.574 0.75 . . . . 0.0 111.308 177.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.401 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -149.02 25.27 0.04 OUTLIER Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 125.568 1.547 . . . . 0.0 111.872 168.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 30' ' ' ALA . 43.6 Cg_endo . . . . . 0 C--N 1.356 0.964 0 CA-C-N 122.263 1.844 . . . . 0.0 111.115 -169.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 . . . . . 0 CA--C 1.541 0.6 0 CA-C-O 121.344 0.592 . . . . 0.0 109.986 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.6 m -140.59 161.26 38.17 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.841 1.256 . . . . 0.0 109.186 174.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 58.9 tttt -145.56 165.13 29.54 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 126.947 2.099 . . . . 0.0 107.074 -176.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.7 mp0 -125.31 119.49 28.53 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 173.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 35.5 pt -104.34 154.45 6.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 124.286 1.034 . . . . 0.0 110.078 174.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 45.9 t -121.33 124.28 71.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 -172.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.6 mmp_? -132.36 148.61 52.43 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.185 1.394 . . . . 0.0 108.585 -176.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.97 134.93 2.33 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 169.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -156.69 152.51 27.16 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 124.09 0.956 . . . . 0.0 108.471 -176.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -63.52 -26.83 68.89 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 8.1 p-90 -65.63 -25.52 67.41 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.021 0.828 . . . . 0.0 111.701 178.054 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.09 83.99 5.88 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 170.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -65.58 -16.21 63.47 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.346 0.658 . . . . 0.0 111.473 174.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -138.74 153.41 48.48 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 126.768 2.027 . . . . 0.0 107.896 178.463 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 37.8 m-70 -70.99 -34.06 71.02 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -171.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.44 -26.81 44.21 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 118.319 -0.848 . . . . 0.0 112.829 174.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -68.77 -49.75 56.05 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 119.653 1.115 . . . . 0.0 110.892 -175.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.436 ' H ' HG12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -65.42 -39.44 85.22 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.105 175.892 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -61.51 -52.52 64.15 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 118.106 -0.95 . . . . 0.0 109.503 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -60.34 -43.49 96.4 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 119.465 1.03 . . . . 0.0 112.002 -177.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.1 tppt? -57.37 -53.66 55.6 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 124.02 0.928 . . . . 0.0 110.596 176.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.2 t -85.42 -36.86 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-O 117.566 -1.207 . . . . 0.0 112.042 -168.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 83.4 p -63.19 -36.65 84.34 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 121.237 1.835 . . . . 0.0 109.432 171.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.45 -48.83 81.88 Favored Glycine 0 C--N 1.34 0.755 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 171.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -62.86 -43.7 98.09 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 118.848 1.324 . . . . 0.0 111.668 178.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 35.7 mmt -60.85 -44.0 97.59 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-N 118.225 0.466 . . . . 0.0 110.065 177.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -66.93 -29.9 69.89 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.048 0.939 . . . . 0.0 111.968 177.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -68.68 -38.71 80.55 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.67 1.123 . . . . 0.0 109.938 169.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -66.93 -24.71 66.11 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 119.269 0.941 . . . . 0.0 110.495 169.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.73 -21.97 12.11 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 128.412 2.911 . . . . 0.0 112.094 176.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 89.5 m -59.37 150.48 26.15 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 126.0 1.72 . . . . 0.0 110.832 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -108.82 153.07 24.03 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 89.9 m -144.59 162.99 35.25 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 -168.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -149.69 125.91 10.72 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 169.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.7 p -68.32 115.19 7.48 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 169.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 53.3 mt -67.45 -23.63 65.54 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 122.072 -0.393 . . . . 0.0 110.206 174.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 172.64 -174.6 45.71 Favored Glycine 0 C--N 1.338 0.674 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 170.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -133.08 166.81 23.59 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 172.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -173.86 -156.74 13.93 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -176.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -141.01 159.39 42.31 Favored 'General case' 0 CA--C 1.518 -0.288 0 O-C-N 120.93 -1.335 . . . . 0.0 110.416 175.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 78.3 mt . . . . . 0 N--CA 1.448 -0.549 0 N-CA-C 104.299 -2.482 . . . . 0.0 104.299 174.658 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 30.0 t60 . . . . . 0 N--CA 1.454 -0.243 0 N-CA-C 109.119 -0.696 . . . . 0.0 109.119 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.1 t -142.03 118.63 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -173.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -168.05 165.81 13.34 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.942 0.897 . . . . 0.0 108.994 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 136.52 -178.59 18.72 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-N 118.685 0.675 . . . . 0.0 111.511 170.236 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -141.99 146.38 35.52 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.226 0.61 . . . . 0.0 111.253 169.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.5 t -84.21 153.08 23.84 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 168.132 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 27.6 ptm -84.39 -35.4 23.16 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 119.128 0.876 . . . . 0.0 109.753 171.1 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.73 -26.21 57.28 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.68 0.673 . . . . 0.0 112.144 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -132.97 -3.58 3.17 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -169.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 78.42 -176.07 54.45 Favored Glycine 0 CA--C 1.535 1.29 0 CA-C-N 119.114 0.87 . . . . 0.0 113.121 174.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -70.47 167.61 24.87 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 123.765 2.977 . . . . 0.0 111.412 174.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -124.57 166.18 16.53 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.941 1.296 . . . . 0.0 111.003 -173.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 24.6 mm100 -78.85 74.57 5.38 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.81 0.844 . . . . 0.0 109.164 171.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -53.78 -23.63 12.63 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.15 0.98 . . . . 0.0 112.697 176.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -51.71 -42.37 62.18 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.168 1.387 . . . . 0.0 112.688 171.092 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 78.3 mt -65.42 -48.48 82.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 179.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.4 m -57.39 -48.05 80.1 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.468 1.107 . . . . 0.0 110.845 -177.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.7 p -66.44 -48.62 69.38 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 119.17 0.896 . . . . 0.0 110.713 -177.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -57.47 -42.98 83.67 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 119.332 0.969 . . . . 0.0 110.547 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -70.0 -50.52 40.69 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 118.522 -0.751 . . . . 0.0 111.074 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 76.6 mt -63.55 -38.48 82.33 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 120.097 1.317 . . . . 0.0 109.591 -175.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 94.9 mttt . . . . . 0 N--CA 1.469 0.501 0 CA-C-N 119.651 1.114 . . . . 0.0 109.99 174.47 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.4 p -136.5 167.85 20.59 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 123.828 0.851 . . . . 0.0 109.683 175.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 13.4 p-90 . . . . . 0 C--O 1.237 0.415 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 170.074 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.389 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -145.21 147.67 32.68 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 169.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.2 mt -56.18 -34.41 66.18 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -172.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.16 -22.71 63.91 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.748 0.703 . . . . 0.0 112.54 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.4 mt -81.85 -20.0 39.85 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.376 0.67 . . . . 0.0 111.287 -178.107 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 46.9 mt -66.52 133.01 94.25 Favored Pre-proline 0 CA--C 1.542 0.643 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -49.48 130.29 25.19 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.304 2.669 . . . . 0.0 111.259 170.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -80.46 -37.87 31.06 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.005 0.431 . . . . 0.0 111.508 -175.084 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.2 t -136.27 130.44 47.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 176.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -151.93 123.36 7.8 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 169.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.9 pt . . . . . 0 CA--C 1.535 0.376 0 C-N-CA 124.901 1.28 . . . . 0.0 109.732 -169.301 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 31.8 p90 . . . . . 0 C--O 1.232 0.153 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -76.22 153.08 36.35 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.015 0.526 . . . . 0.0 110.298 -178.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -145.56 162.2 38.01 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.574 1.15 . . . . 0.0 108.125 176.601 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.0 m -130.31 153.58 39.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 C-N-CA 124.361 1.064 . . . . 0.0 109.493 173.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -108.09 114.79 28.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 103.864 -2.643 . . . . 0.0 103.864 178.246 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 49.7 mt -118.27 125.84 74.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -171.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 -81.75 149.38 28.45 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 169.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.7 t -132.93 147.77 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 127.325 2.25 . . . . 0.0 105.031 -176.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -132.15 147.93 52.45 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 177.005 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.571 ' HG ' ' N ' ' A' ' 39' ' ' GLU . 45.3 m -61.0 101.53 0.15 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.649 0.78 . . . . 0.0 110.852 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.5 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -144.45 19.96 0.04 OUTLIER Pre-proline 0 CA--C 1.55 0.971 0 CA-C-O 116.319 -1.8 . . . . 0.0 113.872 169.462 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.5 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 75.3 Cg_exo . . . . . 0 C--N 1.362 1.288 0 CA-C-N 124.015 2.47 . . . . 0.0 113.316 172.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.571 ' N ' ' HG ' ' A' ' 29' ' ' SER . 47.7 mm-40 . . . . . 0 CA--C 1.539 0.549 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.9 m -140.85 157.87 44.77 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.703 1.201 . . . . 0.0 109.068 173.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.7 tmtm? -156.1 165.92 34.99 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.275 1.83 . . . . 0.0 107.408 -169.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.5 mp0 -131.56 155.89 46.69 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.95 1.25 . . . . 0.0 109.334 175.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 41.7 pt -139.66 158.17 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 126.046 1.738 . . . . 0.0 110.084 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.2 t -118.44 118.83 59.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 12.2 mmp_? -127.43 141.36 51.69 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 175.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.87 137.25 2.96 Favored Glycine 0 C--N 1.332 0.329 0 CA-C-N 119.09 0.859 . . . . 0.0 111.493 174.011 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.405 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 12.9 m-85 -154.02 150.8 28.64 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -170.038 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -60.13 -29.08 68.4 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 118.681 -0.676 . . . . 0.0 112.197 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.405 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 11.8 p-90 -63.48 -29.18 70.5 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.257 0.935 . . . . 0.0 112.391 177.554 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.8 73.24 10.65 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 119.204 0.911 . . . . 0.0 109.349 174.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -68.87 -2.42 9.59 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.421 0.688 . . . . 0.0 111.869 177.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -138.93 145.19 39.52 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 126.588 1.955 . . . . 0.0 107.008 172.364 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -71.27 -32.0 68.17 Favored 'General case' 0 C--O 1.234 0.273 0 O-C-N 121.879 -0.513 . . . . 0.0 110.058 -171.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.61 -27.83 42.19 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 118.438 -0.791 . . . . 0.0 112.629 172.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -68.51 -49.64 58.15 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 119.647 1.112 . . . . 0.0 110.809 -176.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.43 -40.75 87.37 Favored 'Isoleucine or valine' 0 C--N 1.342 0.239 0 CA-C-O 117.837 -1.078 . . . . 0.0 109.619 175.244 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -61.13 -45.55 94.21 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.781 1.173 . . . . 0.0 110.446 -178.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -63.78 -49.01 74.63 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.864 0.756 . . . . 0.0 111.606 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.4 tttp -59.58 -49.0 79.47 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.422 0.689 . . . . 0.0 111.014 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 88.8 t -75.08 -42.86 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-O 117.686 -1.15 . . . . 0.0 109.244 -172.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 65.4 m -59.11 -36.28 74.89 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 120.572 1.533 . . . . 0.0 110.541 173.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.14 -53.94 41.6 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 172.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.421 ' HA ' ' HE3' ' A' ' 66' ' ' LYS . 18.4 t70 -61.61 -46.19 90.88 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 118.718 1.259 . . . . 0.0 111.679 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 35.5 mmt -57.62 -51.14 70.7 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.509 0.724 . . . . 0.0 109.793 178.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.9 mm-40 -67.79 -27.19 66.53 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.717 0.69 . . . . 0.0 111.957 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.421 ' HE3' ' HA ' ' A' ' 63' ' ' ASP . 51.1 mtmt -67.78 -38.14 82.98 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 119.518 1.054 . . . . 0.0 110.576 170.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -68.01 -30.92 70.28 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.808 1.186 . . . . 0.0 109.779 169.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 126.75 -26.24 5.16 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 128.253 2.835 . . . . 0.0 110.875 177.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 89.5 m -49.72 142.01 9.14 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 127.214 2.206 . . . . 0.0 111.799 -174.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -104.67 138.32 41.17 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 178.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 59.3 m -142.06 160.36 40.37 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -168.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -146.49 134.76 21.77 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.419 1.488 . . . . 0.0 107.998 172.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.3 p -74.0 119.42 18.19 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 169.026 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 35.0 mt -71.58 -22.04 61.79 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 121.85 -0.531 . . . . 0.0 110.024 172.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.29 -163.78 37.12 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 170.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -149.67 -175.57 22.05 Favored Glycine 0 N--CA 1.451 -0.326 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 170.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -174.17 -161.41 24.1 Favored Glycine 0 CA--C 1.52 0.394 0 N-CA-C 107.598 -2.201 . . . . 0.0 107.598 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.2 ptt180 -134.22 154.27 51.36 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.102 -1.234 . . . . 0.0 108.612 172.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 66.8 mt . . . . . 0 N--CA 1.445 -0.687 0 N-CA-C 104.429 -2.434 . . . . 0.0 104.429 -177.092 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 27.2 t60 . . . . . 0 CA--C 1.522 -0.116 0 CA-C-O 119.691 -0.195 . . . . 0.0 110.566 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 22.0 t -138.31 130.46 38.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -168.97 -165.45 0.55 Allowed 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.796 0.839 . . . . 0.0 110.051 -176.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.33 -165.53 54.21 Favored Glycine 0 CA--C 1.524 0.595 0 O-C-N 121.755 -0.591 . . . . 0.0 112.434 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -164.85 157.12 15.98 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.015 0.926 . . . . 0.0 111.015 -173.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.6 t -81.94 159.86 23.5 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 167.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.0 ptm -95.84 -33.63 12.16 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 118.961 0.801 . . . . 0.0 110.424 169.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.95 -25.42 58.86 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.188 0.904 . . . . 0.0 112.039 176.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -131.91 -5.31 3.56 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -169.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.56 -177.49 49.21 Favored Glycine 0 CA--C 1.535 1.339 0 CA-C-N 119.022 0.828 . . . . 0.0 113.506 172.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -69.39 138.22 38.46 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.173 2.582 . . . . 0.0 110.363 173.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -78.42 171.8 14.56 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.035 0.445 . . . . 0.0 109.933 169.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 92.3 mm-40 -77.61 83.95 3.99 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 168.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -57.55 -13.92 4.47 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -176.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.0 -44.45 87.24 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.93 1.292 . . . . 0.0 110.788 169.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 61.1 mt -64.76 -47.21 89.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 179.005 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.76 -51.31 70.51 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.044 0.938 . . . . 0.0 110.43 -175.328 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.6 p -65.91 -46.12 79.43 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 117.862 -1.066 . . . . 0.0 110.313 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -58.71 -42.28 88.32 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 120.239 1.381 . . . . 0.0 110.938 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -65.48 -46.32 80.2 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 118.765 -0.636 . . . . 0.0 111.265 177.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 57.4 mt -64.93 -44.26 96.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 -178.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 26.9 mtpt . . . . . 0 N--CA 1.465 0.29 0 CA-C-N 119.396 0.998 . . . . 0.0 110.935 -178.773 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.4 t . . . . . 0 C--O 1.239 0.511 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 20.7 p -134.13 169.07 17.7 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.577 1.151 . . . . 0.0 110.293 -178.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 27.3 p-90 . . . . . 0 C--O 1.235 0.313 0 C-N-CA 123.143 0.577 . . . . 0.0 109.923 169.883 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.542 0 CA-C-O 121.164 0.507 . . . . 0.0 110.394 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -151.78 150.19 29.88 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 171.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 53.9 mt -57.87 -31.14 66.42 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.268 0.627 . . . . 0.0 112.617 -175.363 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.44 -25.09 65.73 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.674 0.67 . . . . 0.0 112.278 178.302 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.1 mt -79.82 -24.79 41.12 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.04 0.536 . . . . 0.0 111.024 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 7.3 mt -68.97 131.99 90.63 Favored Pre-proline 0 C--O 1.237 0.421 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 176.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.66 135.61 31.15 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 121.526 1.484 . . . . 0.0 110.571 176.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.67 -27.27 66.7 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.673 0.789 . . . . 0.0 111.578 -178.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.2 t -139.6 134.87 39.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -178.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -152.41 121.17 6.5 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 169.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.5 pt . . . . . 0 CA--C 1.534 0.361 0 C-N-CA 124.497 1.119 . . . . 0.0 110.192 -169.466 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 37.0 p90 . . . . . 0 C--O 1.234 0.237 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.95 152.87 41.2 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -178.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.16 162.14 38.65 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.477 1.111 . . . . 0.0 108.787 -177.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.6 m -134.95 155.38 38.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 C-N-CA 124.492 1.117 . . . . 0.0 110.178 171.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -108.28 117.8 35.1 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 176.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 53.9 mt -119.0 114.77 45.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -173.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -74.22 145.23 44.29 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 168.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.9 p -139.26 148.62 23.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -178.063 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -130.94 144.98 51.87 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.017 1.327 . . . . 0.0 108.074 -170.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.7 m -62.58 103.85 0.46 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.646 0.778 . . . . 0.0 111.653 -177.077 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.42 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -146.53 24.02 0.04 OUTLIER Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 125.487 1.515 . . . . 0.0 112.252 168.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.42 ' CD ' ' N ' ' A' ' 30' ' ' ALA . 56.8 Cg_endo . . . . . 0 C--N 1.357 0.985 0 CA-C-N 122.575 1.955 . . . . 0.0 110.93 -173.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 . . . . . 0 CA--C 1.538 0.518 0 CA-C-O 121.511 0.672 . . . . 0.0 109.745 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.7 m -138.95 158.22 44.59 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.464 1.106 . . . . 0.0 108.99 172.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -152.75 175.11 13.21 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 127.629 2.372 . . . . 0.0 105.894 -173.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -140.78 156.35 46.19 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 120.735 -1.228 . . . . 0.0 108.424 177.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 34.7 pt -136.47 155.15 33.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 124.92 1.288 . . . . 0.0 109.255 179.121 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.7 t -116.14 122.13 68.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 -178.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -126.05 145.28 50.39 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 177.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -179.69 129.77 1.4 Allowed Glycine 0 C--N 1.329 0.177 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 173.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -151.56 153.89 35.4 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -173.221 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.1 tptt -60.35 -32.93 71.73 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 119.175 -0.441 . . . . 0.0 111.761 -178.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 15.7 p-90 -64.35 -31.03 72.07 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.413 0.551 . . . . 0.0 112.395 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.48 74.86 10.26 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 119.15 0.886 . . . . 0.0 109.187 175.114 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -63.19 -18.75 63.83 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.195 0.598 . . . . 0.0 111.378 176.004 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -123.65 146.4 48.23 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.929 1.692 . . . . 0.0 107.99 176.768 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 39.8 m-70 -71.9 -33.9 68.69 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.327 0.651 . . . . 0.0 109.68 -169.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.73 -28.68 57.07 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 118.379 -0.819 . . . . 0.0 112.545 173.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -68.58 -48.58 63.82 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 119.626 1.103 . . . . 0.0 111.072 -174.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.437 ' H ' HG12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -65.72 -40.46 87.87 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-O 118.268 -0.873 . . . . 0.0 109.963 176.174 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -61.94 -50.96 70.05 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 119.401 -0.919 . . . . 0.0 109.74 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -60.76 -44.2 97.02 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 119.31 0.959 . . . . 0.0 111.807 -178.026 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 22.2 tttp -60.08 -51.56 69.12 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 123.159 0.584 . . . . 0.0 110.71 178.171 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.7 t -84.56 -33.53 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-O 117.923 -1.037 . . . . 0.0 111.506 -169.407 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 61.1 p -63.64 -34.69 78.39 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 121.071 1.759 . . . . 0.0 109.403 170.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.15 -51.06 60.7 Favored Glycine 0 C--N 1.338 0.667 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 171.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -60.71 -42.93 98.21 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 118.579 1.189 . . . . 0.0 112.137 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 38.0 mmt -62.67 -45.68 91.7 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 122.814 0.446 . . . . 0.0 110.249 176.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -68.19 -29.06 67.83 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 118.768 0.713 . . . . 0.0 111.843 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -67.57 -37.47 82.67 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 119.163 0.892 . . . . 0.0 110.365 170.305 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -68.71 -27.73 66.21 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.581 1.082 . . . . 0.0 110.77 169.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 125.69 -25.84 5.53 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 127.441 2.448 . . . . 0.0 111.788 175.099 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 88.4 m -57.35 151.56 15.92 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 126.389 1.876 . . . . 0.0 112.192 -175.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -109.77 145.31 36.87 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 86.9 m -140.63 165.16 28.22 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -168.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -153.11 126.29 8.54 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.448 1.499 . . . . 0.0 107.735 170.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.7 p -69.69 119.55 14.1 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 169.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 42.5 mt -70.9 -25.47 62.79 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.858 -0.526 . . . . 0.0 110.263 173.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.9 -172.01 43.09 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 109.769 -1.333 . . . . 0.0 109.769 172.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -132.26 177.17 18.94 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 176.235 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 179.15 -163.71 31.45 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 108.341 -1.904 . . . . 0.0 108.341 -176.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -136.55 152.85 50.95 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 121.005 -1.291 . . . . 0.0 108.506 171.074 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.7 mt . . . . . 0 C--N 1.322 -0.606 0 N-CA-C 103.897 -2.631 . . . . 0.0 103.897 178.821 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 35.7 t60 . . . . . 0 N--CA 1.45 -0.445 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.7 t -135.27 129.1 49.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 179.097 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -165.85 -164.99 0.76 Allowed 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.171 0.988 . . . . 0.0 108.512 -176.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.96 -172.26 55.18 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -160.38 154.33 22.9 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.326 0.65 . . . . 0.0 110.722 -176.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.4 t -82.26 163.54 21.77 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 168.077 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 20.3 ptp -102.06 -30.97 10.86 Favored 'General case' 0 C--O 1.232 0.156 0 O-C-N 121.524 -0.735 . . . . 0.0 110.444 169.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.92 -26.7 61.49 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.179 0.9 . . . . 0.0 111.737 173.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -133.25 -2.96 3.1 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -169.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.15 -174.68 46.7 Favored Glycine 0 CA--C 1.535 1.33 0 CA-C-N 119.088 0.858 . . . . 0.0 113.051 175.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.97 143.29 54.14 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.814 2.343 . . . . 0.0 110.424 172.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.51 176.94 5.65 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.138 0.575 . . . . 0.0 109.927 169.121 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 20.8 mm100 -63.34 -28.83 70.27 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.841 -0.537 . . . . 0.0 111.68 171.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 60.54 -29.72 0.05 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 128.767 2.827 . . . . 0.0 116.311 -175.175 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.38 -43.08 99.67 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.21 1.004 . . . . 0.0 110.681 173.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 69.1 mt -60.79 -44.41 97.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 177.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.95 -53.46 56.99 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.328 1.051 . . . . 0.0 110.105 -177.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.3 p -63.86 -44.73 92.25 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 117.7 -1.143 . . . . 0.0 110.123 -173.272 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -58.1 -40.73 81.92 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 120.215 1.37 . . . . 0.0 111.163 -179.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 36.3 mttm -69.82 -44.47 69.92 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 121.782 -0.574 . . . . 0.0 111.061 178.311 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 58.7 mt -64.65 -43.23 96.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 118.79 0.723 . . . . 0.0 109.115 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 93.6 mttt . . . . . 0 N--CA 1.467 0.407 0 CA-C-N 119.605 1.093 . . . . 0.0 109.976 175.968 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.2 t . . . . . 0 CA--C 1.536 0.408 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 19.8 p -129.3 168.51 16.13 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.784 0.834 . . . . 0.0 110.219 175.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 43.9 p-90 . . . . . 0 C--O 1.235 0.322 0 O-C-N 121.742 -0.599 . . . . 0.0 109.728 169.879 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.508 0 CA-C-O 121.127 0.489 . . . . 0.0 110.389 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -149.84 146.16 26.97 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 169.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 80.9 mt -55.11 -33.32 62.74 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.83 0.852 . . . . 0.0 112.657 -175.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.74 -25.69 67.4 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.087 0.858 . . . . 0.0 112.341 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.2 mt -78.54 -25.51 45.51 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.189 0.596 . . . . 0.0 111.094 -178.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.8 mt -70.6 131.38 88.02 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -172.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -49.57 119.93 5.24 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 123.525 2.817 . . . . 0.0 111.359 169.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -74.04 -29.88 62.14 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.15 0.5 . . . . 0.0 111.49 -176.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.9 t -141.84 131.54 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 174.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -149.39 111.35 4.59 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 169.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.9 pt . . . . . 0 C--O 1.234 0.269 0 C-N-CA 124.01 0.924 . . . . 0.0 109.7 -169.651 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 . . . . . 0 C--O 1.235 0.319 0 CA-C-O 121.477 0.655 . . . . 0.0 111.892 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -65.55 156.18 33.42 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 124.834 1.254 . . . . 0.0 111.684 -169.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -147.17 161.17 41.44 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.082 1.353 . . . . 0.0 108.257 171.573 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.5 m -130.0 154.62 40.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 C-N-CA 124.782 1.233 . . . . 0.0 109.803 174.027 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.05 115.65 30.52 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 104.212 -2.514 . . . . 0.0 104.212 176.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 73.3 mt -119.65 124.51 73.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -173.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -81.41 145.08 30.98 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 169.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.2 t -129.68 143.44 41.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 -175.125 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -130.96 132.97 45.39 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 -178.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.0 t -66.43 118.66 10.38 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -175.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.401 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -151.05 32.06 0.06 OUTLIER Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 126.163 1.785 . . . . 0.0 109.77 168.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 30' ' ' ALA . 44.8 Cg_endo . . . . . 0 C--N 1.357 1.012 0 CA-C-N 121.913 1.719 . . . . 0.0 111.458 -171.216 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 . . . . . 0 CA--C 1.541 0.62 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.4 m -137.55 161.88 35.23 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.303 1.041 . . . . 0.0 110.112 177.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.6 tttp -148.85 165.45 31.46 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.533 2.333 . . . . 0.0 106.137 -174.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -137.52 140.15 40.93 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 106.09 -1.818 . . . . 0.0 106.09 175.118 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 41.2 pt -134.3 156.83 41.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 124.218 1.007 . . . . 0.0 110.724 -172.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 95.7 t -121.55 118.75 56.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 -177.276 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 27.2 mmt85 -136.02 144.23 45.17 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 177.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.22 135.57 2.42 Favored Glycine 0 C--N 1.331 0.284 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 -178.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -153.58 160.94 42.59 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 117.356 0.578 . . . . 0.0 110.122 -169.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.5 mtmm -59.88 -33.86 72.39 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -179.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.446 ' CH2' ' HE2' ' A' ' 59' ' ' LYS . 9.5 p-90 -68.66 -24.23 64.5 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.835 0.743 . . . . 0.0 112.634 -179.335 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.47 82.13 8.54 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 119.588 1.085 . . . . 0.0 109.297 176.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -65.45 -19.38 65.91 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.44 171.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -133.89 148.68 51.27 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 126.048 1.739 . . . . 0.0 108.137 -178.058 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -72.56 -30.97 64.89 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 121.925 -0.485 . . . . 0.0 109.897 -171.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.01 -28.64 53.66 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 118.082 -0.961 . . . . 0.0 112.776 172.086 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -65.53 -55.85 15.53 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.669 1.122 . . . . 0.0 109.583 -179.1 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.423 HG12 ' H ' ' A' ' 56' ' ' ILE . 0.1 OUTLIER -66.07 -34.62 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-O 117.355 -1.307 . . . . 0.0 110.687 -179.502 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -60.98 -53.59 55.38 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 120.104 1.32 . . . . 0.0 109.506 175.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -60.37 -42.91 96.77 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.983 0.81 . . . . 0.0 111.896 -178.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.446 ' HE2' ' CH2' ' A' ' 49' ' ' TRP . 0.0 OUTLIER -59.28 -55.54 33.51 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.221 1.008 . . . . 0.0 110.209 178.589 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 89.9 t -77.62 -43.77 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-O 117.801 -1.095 . . . . 0.0 109.881 -169.522 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.7 p -63.81 -31.26 72.39 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 120.709 1.595 . . . . 0.0 109.937 175.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.29 -51.31 59.57 Favored Glycine 0 C--N 1.337 0.636 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 171.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -61.71 -44.53 96.74 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 118.835 1.318 . . . . 0.0 111.68 178.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 38.4 mmt -59.12 -46.96 86.98 Favored 'General case' 0 C--O 1.227 -0.081 0 CA-C-O 119.231 -0.414 . . . . 0.0 110.045 177.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -69.27 -28.27 66.15 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.654 0.661 . . . . 0.0 112.152 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -67.59 -37.41 82.53 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.342 0.974 . . . . 0.0 110.255 170.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -68.25 -31.01 70.2 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.772 1.169 . . . . 0.0 110.106 169.418 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 127.5 -23.43 5.41 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 127.93 2.681 . . . . 0.0 111.662 174.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 95.8 m -55.92 154.42 7.36 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 126.404 1.882 . . . . 0.0 112.602 -177.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -112.49 145.47 40.18 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.909 1.284 . . . . 0.0 108.066 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 74.9 m -144.64 164.33 31.29 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -168.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -149.02 130.57 14.88 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.289 1.435 . . . . 0.0 107.713 171.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.6 p -75.06 114.73 13.89 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 169.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 39.7 mt -68.65 -25.33 64.77 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.823 -0.548 . . . . 0.0 110.374 176.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.14 -164.88 37.83 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 175.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -154.32 -175.5 25.58 Favored Glycine 0 N--CA 1.452 -0.268 0 N-CA-C 111.509 -0.636 . . . . 0.0 111.509 171.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -171.49 -153.71 9.26 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 108.488 -1.845 . . . . 0.0 108.488 -176.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -143.25 142.96 31.55 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 -174.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 61.7 mt . . . . . 0 C--O 1.235 0.315 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -171.312 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 31.5 t60 . . . . . 0 C--O 1.232 0.184 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.9 t -141.41 133.62 28.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 173.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -157.17 -170.04 3.14 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.221 1.008 . . . . 0.0 108.726 -178.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.28 -175.46 45.89 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-N 118.619 0.645 . . . . 0.0 112.145 176.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -162.33 149.4 13.64 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.532 1.133 . . . . 0.0 110.546 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.6 t -71.63 166.2 22.38 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 168.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.5 ptm -111.5 -29.86 7.6 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 118.485 -0.769 . . . . 0.0 111.051 170.315 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -73.59 -25.55 60.4 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.574 1.079 . . . . 0.0 111.407 172.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -132.65 -9.47 3.18 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.05 0.94 . . . . 0.0 113.037 -169.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 78.68 -176.66 54.37 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-N 118.773 0.715 . . . . 0.0 113.71 171.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.43 137.2 42.31 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.059 2.506 . . . . 0.0 110.482 175.347 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -78.01 168.8 19.32 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 169.128 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -77.76 84.69 4.08 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 168.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -57.86 -13.86 5.09 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -175.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.03 -41.46 96.61 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.651 1.18 . . . . 0.0 110.978 170.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 56.2 mt -65.46 -47.43 86.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 177.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.97 -49.68 76.94 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.066 0.946 . . . . 0.0 110.703 -176.056 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.4 p -64.4 -47.53 78.82 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 118.182 -0.913 . . . . 0.0 110.989 -176.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -60.01 -40.38 89.07 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.52 1.055 . . . . 0.0 110.537 -178.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 52.9 mttm -67.29 -46.22 74.26 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-O 118.935 -0.555 . . . . 0.0 111.476 177.13 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 63.8 mt -64.61 -39.87 87.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-N 119.432 1.015 . . . . 0.0 109.006 -179.362 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 92.3 mttt . . . . . 0 N--CA 1.469 0.509 0 CA-C-N 119.855 1.207 . . . . 0.0 109.514 175.063 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.4 t . . . . . 0 N--CA 1.454 -0.262 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 16.6 p -134.69 174.42 10.59 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.478 1.111 . . . . 0.0 108.914 174.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 47.5 p-90 . . . . . 0 C--O 1.235 0.318 0 O-C-N 121.669 -0.644 . . . . 0.0 110.657 171.271 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.397 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -146.73 146.59 30.37 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 169.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 51.0 mt -58.99 -29.22 67.06 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -173.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.61 -26.41 66.24 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.113 0.87 . . . . 0.0 111.883 177.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.7 mt -82.69 -24.18 33.79 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.654 0.782 . . . . 0.0 111.191 -177.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 51.3 mt -65.46 129.01 94.27 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -178.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -44.82 120.72 3.0 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 124.141 3.227 . . . . 0.0 111.599 172.11 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -78.75 -32.94 46.86 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.283 0.563 . . . . 0.0 111.139 -170.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.2 t -136.85 140.26 43.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 105.091 -2.188 . . . . 0.0 105.091 172.031 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -151.77 130.15 12.1 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 170.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.9 pt . . . . . 0 CA--C 1.537 0.477 0 C-N-CA 126.873 2.069 . . . . 0.0 106.9 -178.355 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.4 p90 . . . . . 0 N--CA 1.464 0.24 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -77.1 154.98 32.74 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.521 0.728 . . . . 0.0 110.377 -177.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.31 162.51 37.97 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.0 1.32 . . . . 0.0 108.164 179.342 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.8 m -132.7 154.31 39.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 124.418 1.087 . . . . 0.0 109.488 172.363 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.35 119.22 38.88 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 104.293 -2.484 . . . . 0.0 104.293 176.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.2 mt -122.26 123.79 69.57 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -173.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.453 ' HE ' ' CE1' ' A' ' 28' ' ' HIS . 36.9 ttp-105 -77.36 147.59 36.03 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 169.715 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.8 t -133.29 143.72 38.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 -178.424 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.453 ' CE1' ' HE ' ' A' ' 26' ' ' ARG . 99.9 m-70 -123.68 145.06 49.25 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 125.021 1.329 . . . . 0.0 107.913 174.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.0 m -62.07 107.93 0.96 Allowed 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.439 0.696 . . . . 0.0 110.635 177.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -148.9 29.1 0.05 OUTLIER Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 124.823 1.249 . . . . 0.0 112.404 169.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo . . . . . 0 CA--C 1.545 1.075 0 C-N-CA 123.489 2.792 . . . . 0.0 115.84 -169.809 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 . . . . . 0 CA--C 1.54 0.563 0 CA-C-O 121.527 0.68 . . . . 0.0 109.812 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.6 m -140.92 158.54 43.79 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.822 1.249 . . . . 0.0 108.463 173.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -153.06 170.75 19.7 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 126.894 2.078 . . . . 0.0 106.296 -171.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.408 ' HB2' ' HE3' ' A' ' 108' ' ' LYS . 17.7 mp0 -134.08 157.16 46.85 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 169.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 32.6 pt -132.46 155.39 41.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 125.344 1.458 . . . . 0.0 109.508 178.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 56.7 t -116.9 121.35 67.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 177.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.8 mmp_? -127.52 141.1 51.74 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 177.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -171.64 136.6 3.94 Favored Glycine 0 C--N 1.329 0.192 0 CA-C-N 119.538 1.063 . . . . 0.0 110.609 170.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -153.85 148.55 26.39 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -173.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.5 pttm -54.99 -31.08 60.66 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.355 1.462 . . . . 0.0 113.236 173.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 11.8 p-90 -68.92 -28.71 66.91 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.29 0.95 . . . . 0.0 112.044 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.79 73.6 10.28 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 119.278 0.944 . . . . 0.0 109.235 174.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -65.94 -6.82 13.7 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.861 0.864 . . . . 0.0 111.457 174.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -137.14 144.09 42.8 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.621 1.968 . . . . 0.0 106.809 173.187 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 44.1 m-70 -70.34 -31.37 68.63 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -171.12 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.29 -29.84 35.45 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 118.529 -0.748 . . . . 0.0 112.652 172.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -68.85 -48.57 63.14 Favored 'General case' 0 C--N 1.341 0.199 0 CA-C-N 119.39 0.995 . . . . 0.0 111.097 -174.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.434 ' H ' HG12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -65.36 -41.68 91.82 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.018 176.168 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -61.83 -50.72 71.15 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 119.296 -0.962 . . . . 0.0 109.668 -178.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -61.13 -44.43 97.34 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.125 0.875 . . . . 0.0 111.91 -178.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 30.5 tttt -59.9 -50.32 74.23 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.315 0.646 . . . . 0.0 110.895 178.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.4 t -85.71 -33.6 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-O 117.572 -1.204 . . . . 0.0 111.401 -169.447 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 84.6 p -61.57 -36.71 81.41 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 121.306 1.866 . . . . 0.0 109.179 169.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -56.63 -52.47 50.27 Favored Glycine 0 C--N 1.34 0.753 0 C-N-CA 124.218 0.913 . . . . 0.0 111.141 170.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -60.73 -45.16 95.32 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 119.14 1.47 . . . . 0.0 111.854 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 35.2 mmt -59.46 -47.03 87.04 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.998 0.519 . . . . 0.0 109.787 178.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -68.17 -30.08 69.11 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.536 0.734 . . . . 0.0 111.937 178.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -66.59 -37.94 85.97 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 119.511 1.051 . . . . 0.0 110.278 171.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -64.62 -46.15 83.83 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.746 1.157 . . . . 0.0 108.486 169.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 142.17 -21.49 2.45 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 127.872 2.653 . . . . 0.0 111.204 174.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 80.8 m -54.65 148.36 12.75 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 126.891 2.076 . . . . 0.0 111.608 -176.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -108.56 141.47 40.42 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 94.5 m -141.6 165.51 27.29 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -168.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -154.33 130.03 10.02 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.869 1.667 . . . . 0.0 107.431 171.559 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.1 p -69.82 123.77 22.3 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 169.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 33.9 mt -69.31 -28.3 66.14 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.933 -0.479 . . . . 0.0 109.969 172.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.98 -171.29 43.34 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 174.212 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -124.78 173.6 17.1 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 174.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -178.2 -164.96 32.2 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 108.254 -1.938 . . . . 0.0 108.254 -176.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 12.0 ptp180 -148.06 161.76 40.74 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 120.741 -1.447 . . . . 0.0 109.208 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 81.9 mt . . . . . 0 C--N 1.324 -0.538 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 -171.837 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 21.1 t60 . . . . . 0 C--O 1.233 0.187 0 N-CA-C 110.359 -0.237 . . . . 0.0 110.359 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.5 t -136.58 137.48 47.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 -177.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -164.96 -171.01 2.1 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.084 -1.01 . . . . 0.0 109.854 -174.048 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.69 -167.71 54.76 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-O 121.402 0.446 . . . . 0.0 112.278 169.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -158.36 173.2 17.02 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.315 1.046 . . . . 0.0 110.218 -172.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.0 t -107.17 164.0 12.53 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 127.033 2.133 . . . . 0.0 106.2 168.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 21.4 ptp -105.96 -29.89 9.67 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 118.547 -0.739 . . . . 0.0 110.881 172.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -73.12 -26.32 61.18 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.39 0.995 . . . . 0.0 111.563 172.214 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -132.0 -3.74 3.57 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -169.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 72.52 -177.14 41.01 Favored Glycine 0 CA--C 1.535 1.297 0 CA-C-N 118.908 0.776 . . . . 0.0 112.73 177.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.49 138.13 37.92 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.889 2.393 . . . . 0.0 110.916 175.326 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.96 176.47 5.69 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.297 0.639 . . . . 0.0 110.026 169.071 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 21.5 mm100 -65.7 -31.83 73.05 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 121.901 -0.499 . . . . 0.0 112.292 178.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 39.1 m80 61.63 -30.83 0.07 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 128.438 2.695 . . . . 0.0 115.972 -174.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.7 -44.46 96.18 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.224 1.01 . . . . 0.0 110.787 174.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 72.9 mt -60.47 -45.35 97.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 176.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.46 -52.24 66.07 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 124.61 1.164 . . . . 0.0 109.747 -174.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 22.6 p -67.09 -43.07 83.49 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 117.982 -1.009 . . . . 0.0 111.151 -174.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -59.38 -41.9 90.43 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.756 1.162 . . . . 0.0 110.386 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.408 ' HE3' ' HB2' ' A' ' 42' ' ' GLU . 42.1 mttm -66.77 -45.4 78.62 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 119.009 -0.519 . . . . 0.0 111.263 176.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 55.8 mt -63.44 -42.81 97.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 119.111 0.868 . . . . 0.0 108.992 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 92.3 mttt . . . . . 0 N--CA 1.47 0.53 0 CA-C-N 120.216 1.371 . . . . 0.0 109.455 176.26 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.454 -0.273 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 22.1 p -137.3 173.96 11.12 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.079 0.952 . . . . 0.0 108.848 172.079 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 52.1 p-90 . . . . . 0 C--O 1.235 0.297 0 O-C-N 121.988 -0.445 . . . . 0.0 110.6 173.727 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.541 0 CA-C-O 121.715 0.769 . . . . 0.0 111.454 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -151.27 151.59 32.04 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 126.677 1.991 . . . . 0.0 105.924 170.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 52.4 mt -55.44 -34.49 64.52 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.732 0.696 . . . . 0.0 112.656 -175.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.15 -25.86 64.59 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.744 0.702 . . . . 0.0 112.21 179.484 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.0 mt -81.83 -23.23 36.57 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.468 0.707 . . . . 0.0 111.178 -178.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.2 mt -64.84 128.03 93.23 Favored Pre-proline 0 CA--C 1.54 0.577 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 178.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -47.41 140.21 15.96 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.588 2.859 . . . . 0.0 111.249 170.019 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -89.78 -36.06 15.36 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 121.987 -0.446 . . . . 0.0 111.627 -170.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.4 t -140.99 138.96 34.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 124.866 1.266 . . . . 0.0 107.702 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 68.5 t0 -152.93 111.34 3.69 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 169.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 36.6 pt . . . . . 0 CA--C 1.537 0.459 0 C-N-CA 124.913 1.285 . . . . 0.0 109.439 -173.562 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 43.0 p90 . . . . . 0 C--O 1.235 0.328 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -80.05 155.88 27.36 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.91 163.61 32.92 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.997 1.319 . . . . 0.0 108.27 176.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.5 m -133.23 150.83 32.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 124.36 1.064 . . . . 0.0 109.589 172.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.05 117.0 33.6 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 104.139 -2.541 . . . . 0.0 104.139 175.335 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 76.5 mt -118.93 122.82 70.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 -175.014 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 36.2 ttp180 -79.46 147.49 32.25 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 169.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.8 t -133.73 145.01 34.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 104.762 -2.31 . . . . 0.0 104.762 -175.498 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -130.42 150.14 51.77 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.596 1.158 . . . . 0.0 108.129 -179.282 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.524 ' HG ' ' N ' ' A' ' 39' ' ' GLU . 15.9 m -60.81 100.73 0.12 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.122 0.969 . . . . 0.0 111.773 -179.029 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.518 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -144.59 17.78 0.04 OUTLIER Pre-proline 0 CA--C 1.554 1.111 0 CA-C-O 116.188 -1.863 . . . . 0.0 113.898 169.155 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.518 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 66.9 Cg_exo . . . . . 0 C--N 1.365 1.444 0 CA-C-N 123.702 2.358 . . . . 0.0 114.41 177.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.524 ' N ' ' HG ' ' A' ' 29' ' ' SER . 9.2 pt-20 . . . . . 0 CA--C 1.536 0.416 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.1 m -142.76 159.23 42.64 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.786 0.834 . . . . 0.0 110.596 -173.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -151.07 165.95 32.24 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 127.625 2.37 . . . . 0.0 106.168 -174.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.5 mp0 -131.26 154.23 48.69 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 121.039 -1.038 . . . . 0.0 108.494 177.043 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 39.3 pt -135.26 156.18 38.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 125.277 1.431 . . . . 0.0 109.686 178.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 54.2 t -118.65 120.34 63.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 105.434 -2.062 . . . . 0.0 105.434 177.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.0 mmp_? -130.28 146.23 51.86 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 172.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -179.55 140.51 4.33 Favored Glycine 0 N--CA 1.454 -0.139 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 174.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -154.88 156.06 35.46 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -170.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.5 mmtm -53.05 -39.45 63.26 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.407 1.083 . . . . 0.0 112.026 174.068 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 12.8 p-90 -67.2 -27.72 67.49 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.519 0.6 . . . . 0.0 112.503 -176.157 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.96 80.32 9.05 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 119.295 0.952 . . . . 0.0 108.964 173.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -63.73 -18.52 64.11 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.254 0.621 . . . . 0.0 111.488 174.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -132.1 148.87 52.51 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 126.47 1.908 . . . . 0.0 108.043 178.604 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 37.3 m-70 -72.52 -32.26 65.99 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -170.14 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.85 -29.08 54.29 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 118.561 -0.733 . . . . 0.0 112.663 172.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -67.14 -49.66 64.04 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 119.338 0.972 . . . . 0.0 110.84 -175.231 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.421 ' H ' HG12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -66.8 -38.88 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 CA-C-O 117.557 -1.211 . . . . 0.0 109.995 174.977 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -60.36 -47.33 86.52 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 120.191 1.36 . . . . 0.0 110.404 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -63.67 -47.91 79.31 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.265 0.484 . . . . 0.0 111.507 179.162 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 40.9 tttt -62.63 -51.19 68.24 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 123.239 0.616 . . . . 0.0 111.315 -178.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 94.6 t -72.56 -46.33 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-O 118.189 -0.91 . . . . 0.0 108.967 -172.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 56.6 m -64.11 -27.26 68.97 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 120.157 1.344 . . . . 0.0 111.162 175.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.84 -51.28 56.88 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 170.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -60.73 -43.37 98.0 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.418 1.109 . . . . 0.0 111.638 178.108 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.5 mmt -59.62 -47.25 86.32 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 123.131 0.573 . . . . 0.0 110.011 177.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -69.48 -28.26 65.92 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.892 0.769 . . . . 0.0 112.066 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -66.92 -38.24 85.84 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 119.179 0.9 . . . . 0.0 110.112 169.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -69.48 -25.66 64.18 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 119.668 1.122 . . . . 0.0 110.496 169.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 118.84 -21.42 9.62 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 127.919 2.676 . . . . 0.0 112.456 175.284 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 92.2 m -53.08 149.59 6.61 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 126.112 1.765 . . . . 0.0 112.1 -178.154 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -108.48 138.65 44.43 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 177.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 97.3 m -141.41 164.18 30.92 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -168.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -153.79 130.26 10.61 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.499 1.52 . . . . 0.0 107.49 174.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 5.9 p -70.92 122.1 19.34 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 169.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 41.9 mt -70.12 -25.67 63.6 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.861 -0.525 . . . . 0.0 109.941 170.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.93 -171.78 43.03 Favored Glycine 0 C--N 1.337 0.608 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 170.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -128.84 171.87 19.68 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 175.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -176.81 -162.71 27.84 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 108.6 -1.8 . . . . 0.0 108.6 -176.044 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -146.0 163.67 34.47 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 121.055 -1.262 . . . . 0.0 108.547 -178.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 81.4 mt . . . . . 0 C--N 1.324 -0.5 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 -170.596 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 54.2 t60 . . . . . 0 C--O 1.234 0.28 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 18.7 t -127.81 128.95 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.114 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -160.81 -172.4 3.48 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.236 -0.915 . . . . 0.0 111.132 -169.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 66.29 -166.21 38.14 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-O 121.425 0.459 . . . . 0.0 112.616 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -162.08 157.2 23.04 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.083 0.953 . . . . 0.0 110.502 -170.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.9 t -85.24 164.38 18.09 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 168.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.0 ptm -104.83 -31.8 9.12 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 118.625 -0.702 . . . . 0.0 110.646 169.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.8 -26.41 61.5 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.324 0.965 . . . . 0.0 111.556 174.302 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -132.46 -3.56 3.39 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.925 0.89 . . . . 0.0 113.089 -169.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.46 -177.3 43.74 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-N 118.779 0.718 . . . . 0.0 112.997 175.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -67.89 142.07 55.92 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.652 2.234 . . . . 0.0 110.41 172.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.19 173.89 9.5 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 122.369 1.08 . . . . 0.0 110.322 169.078 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -81.47 79.48 8.06 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 103.828 -2.656 . . . . 0.0 103.828 167.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -60.95 -13.74 18.04 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -169.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.86 -35.91 77.8 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.554 0.742 . . . . 0.0 111.622 172.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 83.8 mt -65.15 -44.16 95.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 177.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.87 -48.44 81.37 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.158 0.983 . . . . 0.0 110.684 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.4 p -66.38 -42.46 87.91 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 117.813 -1.089 . . . . 0.0 110.661 -177.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -58.22 -44.11 88.02 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 120.226 1.376 . . . . 0.0 110.772 177.044 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -69.13 -44.21 72.84 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.873 -0.517 . . . . 0.0 111.635 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 81.5 mt -71.55 -34.19 51.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 O-C-N 121.257 -0.902 . . . . 0.0 109.478 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 91.6 mttt . . . . . 0 N--CA 1.469 0.477 0 CA-C-N 119.684 1.129 . . . . 0.0 109.483 170.707 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.6 t . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 19.3 p -133.05 168.8 17.83 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.198 0.999 . . . . 0.0 108.676 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 57.9 p-90 . . . . . 0 C--O 1.234 0.268 0 CA-C-O 121.178 0.513 . . . . 0.0 111.802 173.733 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.451 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -141.95 142.41 33.0 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 169.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 81.5 mt -57.46 -32.36 66.87 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.734 0.814 . . . . 0.0 112.713 -171.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.84 -25.52 64.69 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.895 0.77 . . . . 0.0 112.1 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.5 mt -80.53 -24.92 38.99 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.37 0.668 . . . . 0.0 111.186 -177.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 41.0 mt -67.24 128.49 93.75 Favored Pre-proline 0 C--O 1.24 0.558 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -175.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -46.9 127.05 11.8 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.885 3.057 . . . . 0.0 111.341 171.289 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -81.4 -34.1 31.83 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 121.051 0.453 . . . . 0.0 111.311 -170.281 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.0 t -138.77 133.7 41.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 174.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -147.95 133.49 18.73 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 170.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 38.6 pt . . . . . 0 CA--C 1.537 0.461 0 C-N-CA 127.113 2.165 . . . . 0.0 106.102 -177.458 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 37.2 p90 . . . . . 0 N--CA 1.463 0.204 0 CA-C-O 120.777 0.322 . . . . 0.0 110.444 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.25 152.03 39.79 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.62 0.768 . . . . 0.0 109.35 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.98 161.15 41.94 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.296 1.038 . . . . 0.0 109.082 -178.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.4 m -131.21 153.69 39.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 C-N-CA 124.4 1.08 . . . . 0.0 110.097 173.222 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -108.39 115.02 29.34 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 104.345 -2.465 . . . . 0.0 104.345 177.453 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 54.4 mt -119.37 124.53 73.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 -172.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -78.55 148.97 33.16 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 169.241 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.5 t -133.56 148.17 30.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 105.55 -2.019 . . . . 0.0 105.55 -179.01 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -129.59 156.2 44.58 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.806 1.243 . . . . 0.0 109.357 -178.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.517 ' HG ' ' N ' ' A' ' 39' ' ' GLU . 18.1 m -68.75 44.41 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.1 1.76 . . . . 0.0 114.626 178.034 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -72.7 -9.41 0.15 Allowed Pre-proline 0 CA--C 1.557 1.234 0 N-CA-C 117.846 2.535 . . . . 0.0 117.846 170.197 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo . . . . . 0 C--N 1.362 1.262 0 C-N-CA 123.82 3.013 . . . . 0.0 116.67 -177.612 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.517 ' N ' ' HG ' ' A' ' 29' ' ' SER . 44.1 mm-40 . . . . . 0 CA--C 1.539 0.53 0 CA-C-O 121.453 0.644 . . . . 0.0 109.34 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.5 m -141.16 160.36 40.26 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.61 1.164 . . . . 0.0 108.984 171.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -149.59 169.83 20.07 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 127.338 2.255 . . . . 0.0 106.457 -173.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.1 mp0 -133.27 152.79 51.94 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 176.195 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 38.9 pt -133.96 155.73 40.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 125.551 1.54 . . . . 0.0 109.589 178.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 89.1 t -117.08 120.09 63.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 105.696 -1.965 . . . . 0.0 105.696 177.246 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.426 ' HG3' HG21 ' A' ' 60' ' ' VAL . 10.4 mmp_? -127.69 142.17 51.41 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 174.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -172.63 139.84 5.42 Favored Glycine 0 C--N 1.332 0.321 0 CA-C-N 119.429 1.013 . . . . 0.0 111.412 172.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.423 ' CD2' ' CZ2' ' A' ' 49' ' ' TRP . 30.1 m-85 -154.81 156.61 36.54 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.673 0.789 . . . . 0.0 109.893 -171.078 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.3 mttp -67.68 -32.02 72.39 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 118.793 -0.622 . . . . 0.0 111.007 175.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.423 ' CZ2' ' CD2' ' A' ' 47' ' ' TYR . 14.5 p-90 -62.57 -30.86 71.63 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.723 0.692 . . . . 0.0 111.575 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.73 71.04 6.68 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.357 0.663 . . . . 0.0 109.47 171.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -61.33 -18.3 57.94 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.502 0.721 . . . . 0.0 111.454 176.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -125.02 146.97 49.18 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 126.466 1.906 . . . . 0.0 107.764 176.446 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 60.9 m80 -73.12 -31.35 64.26 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 122.887 0.475 . . . . 0.0 110.441 -169.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.02 -30.83 49.21 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 118.612 -0.709 . . . . 0.0 112.4 172.287 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -69.67 -49.13 56.49 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 119.321 0.964 . . . . 0.0 111.084 -176.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.429 HG12 ' H ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -65.79 -40.18 86.94 Favored 'Isoleucine or valine' 0 C--N 1.342 0.274 0 CA-C-O 117.518 -1.23 . . . . 0.0 109.699 175.391 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -59.98 -50.55 73.29 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 119.726 1.148 . . . . 0.0 109.96 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -61.14 -45.35 95.02 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 119.059 0.845 . . . . 0.0 112.028 -178.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 30.7 tttt -61.4 -49.09 78.28 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 122.912 0.485 . . . . 0.0 110.574 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.426 HG21 ' HG3' ' A' ' 45' ' ' ARG . 85.0 t -78.91 -39.42 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 117.692 -1.146 . . . . 0.0 109.954 -170.165 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 91.5 p -61.42 -39.23 90.02 Favored 'General case' 0 C--N 1.339 0.122 0 CA-C-N 120.757 1.617 . . . . 0.0 109.13 174.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -57.28 -51.66 56.23 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 123.948 0.785 . . . . 0.0 111.363 172.586 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -61.73 -46.31 90.19 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 118.943 1.372 . . . . 0.0 111.68 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 36.0 mmt -59.41 -47.52 85.14 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.349 0.66 . . . . 0.0 110.456 177.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -62.84 -35.82 81.21 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.788 0.835 . . . . 0.0 111.279 177.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -66.38 -35.5 80.5 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 118.043 -0.98 . . . . 0.0 111.302 172.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -71.73 -17.51 62.2 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 119.972 1.26 . . . . 0.0 112.159 170.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.37 -8.57 41.19 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.696 1.617 . . . . 0.0 112.543 178.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 90.4 m -65.96 165.44 13.2 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.636 1.218 . . . . 0.0 110.863 176.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -125.33 148.3 48.79 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 170.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 65.9 m -145.31 165.34 28.73 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -168.307 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -149.22 137.64 20.9 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.811 1.645 . . . . 0.0 106.921 169.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.4 p -77.69 115.48 17.47 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 169.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 36.9 mt -67.99 -24.43 65.13 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 121.981 -0.449 . . . . 0.0 110.149 174.244 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.92 -165.73 38.69 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 170.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -147.7 178.84 25.04 Favored Glycine 0 CA--C 1.519 0.318 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 172.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -176.29 -157.84 18.41 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 107.546 -2.221 . . . . 0.0 107.546 -176.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 31.0 ptt-85 -137.02 157.78 45.95 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 120.616 -1.52 . . . . 0.0 108.811 173.259 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 97.4 mt . . . . . 0 C--N 1.322 -0.597 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 -177.517 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 24.5 t60 . . . . . 0 N--CA 1.455 -0.199 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.6 t -137.37 124.89 30.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -164.48 -178.3 5.33 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 121.468 -0.77 . . . . 0.0 109.909 -172.77 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.49 -174.04 55.19 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -178.244 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -157.3 155.79 31.31 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.05 0.54 . . . . 0.0 111.958 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.1 t -75.81 164.67 26.0 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 168.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.3 ptm -108.53 -30.5 8.22 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 118.492 -0.766 . . . . 0.0 111.122 170.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.06 -26.06 60.18 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.551 1.069 . . . . 0.0 111.431 173.438 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -131.91 -7.42 3.53 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.915 0.886 . . . . 0.0 113.015 -169.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.92 -177.13 52.49 Favored Glycine 0 CA--C 1.535 1.293 0 CA-C-N 118.673 0.669 . . . . 0.0 113.607 171.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.08 135.65 38.16 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.092 2.528 . . . . 0.0 110.404 176.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.04 167.94 20.95 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.131 0.491 . . . . 0.0 110.128 169.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 -78.92 82.63 5.1 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 168.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -57.57 -15.09 6.34 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -176.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.55 -43.96 80.42 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.22 1.408 . . . . 0.0 111.215 169.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 64.1 mt -64.58 -47.12 90.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.91 -50.94 71.63 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.777 0.831 . . . . 0.0 110.923 -176.273 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.6 p -65.05 -46.95 79.13 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.593 -174.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -60.04 -40.2 88.56 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.311 0.959 . . . . 0.0 110.592 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -66.39 -47.52 73.06 Favored 'General case' 0 CA--C 1.528 0.12 0 O-C-N 121.86 -0.525 . . . . 0.0 111.457 176.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 61.7 mt -64.82 -40.25 88.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 119.369 0.986 . . . . 0.0 109.128 -177.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 92.8 mttt . . . . . 0 N--CA 1.469 0.475 0 CA-C-N 119.449 1.022 . . . . 0.0 109.551 174.852 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.5 t . . . . . 0 N--CA 1.454 -0.275 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.3 p -134.53 171.59 14.1 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.481 1.112 . . . . 0.0 109.4 176.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 27.6 p-90 . . . . . 0 C--O 1.234 0.276 0 O-C-N 121.674 -0.641 . . . . 0.0 110.709 173.984 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.442 0 CA-C-O 121.499 0.666 . . . . 0.0 110.785 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -152.93 152.12 31.11 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 170.235 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 57.0 mt -53.54 -36.88 62.29 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 118.627 0.649 . . . . 0.0 112.12 -178.165 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.56 -25.21 68.13 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.871 0.759 . . . . 0.0 112.509 -179.09 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.4 mt -83.57 -20.81 33.11 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.316 0.646 . . . . 0.0 111.561 -176.961 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 24.0 mt -68.07 128.94 93.26 Favored Pre-proline 0 CA--C 1.539 0.527 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -177.085 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -50.81 117.94 3.76 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 123.337 2.691 . . . . 0.0 110.705 169.705 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -73.01 -34.37 66.34 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 122.65 0.38 . . . . 0.0 111.532 -171.93 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.7 t -141.64 123.06 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 177.847 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -143.58 107.68 4.74 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 106.86 -1.534 . . . . 0.0 106.86 171.35 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.6 pt . . . . . 0 CA--C 1.532 0.256 0 C-N-CA 123.599 0.76 . . . . 0.0 110.49 -169.794 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 . . . . . 0 C--O 1.238 0.465 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -73.76 162.91 28.64 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.219 1.008 . . . . 0.0 112.548 -170.277 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -151.3 163.41 38.97 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.514 1.926 . . . . 0.0 108.006 169.813 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.3 m -131.07 155.9 42.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 124.756 1.222 . . . . 0.0 109.816 172.125 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.1 117.67 34.75 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 178.233 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 69.1 mt -121.49 113.85 40.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -171.953 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.5 ttm-85 -69.88 142.41 53.01 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 168.699 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.8 p -140.86 147.81 22.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -122.13 151.77 40.6 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.929 1.292 . . . . 0.0 109.347 -174.61 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 56.0 m -62.51 93.28 0.05 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.094 0.958 . . . . 0.0 110.955 172.376 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.404 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -138.87 24.3 0.07 OUTLIER Pre-proline 0 CA--C 1.552 1.027 0 CA-C-O 116.767 -1.587 . . . . 0.0 114.015 169.442 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.404 ' CD ' ' N ' ' A' ' 30' ' ' ALA . 83.5 Cg_exo . . . . . 0 C--N 1.359 1.091 0 CA-C-N 123.774 2.383 . . . . 0.0 113.606 172.409 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 . . . . . 0 CA--C 1.541 0.633 0 CA-C-O 121.455 0.645 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.4 m -141.89 160.98 39.09 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.097 1.359 . . . . 0.0 109.004 176.659 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.8 tttt -148.24 165.77 29.96 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 126.963 2.105 . . . . 0.0 107.117 -174.462 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -125.64 131.38 52.65 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 169.782 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 44.2 pt -112.85 159.59 12.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 125.414 1.486 . . . . 0.0 110.569 174.068 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 25.0 t -126.24 121.77 59.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 -173.63 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 26.4 mmt85 -139.34 147.02 40.98 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.382 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.53 135.71 2.49 Favored Glycine 0 C--N 1.331 0.305 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 -179.656 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -153.57 155.71 36.65 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -171.966 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -59.36 -29.98 68.07 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -179.049 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 8.9 p-90 -68.46 -23.75 64.62 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.78 0.718 . . . . 0.0 112.4 -179.481 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.03 78.61 8.7 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 119.346 0.975 . . . . 0.0 110.085 177.064 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -62.3 -18.39 61.2 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.943 0.897 . . . . 0.0 111.468 172.919 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -128.1 143.15 51.05 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.771 1.629 . . . . 0.0 106.888 178.829 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -65.08 -30.92 71.92 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 118.478 0.581 . . . . 0.0 109.828 176.623 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.54 -29.35 58.78 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 118.484 -0.77 . . . . 0.0 112.788 171.445 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -68.71 -49.5 58.4 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.559 1.072 . . . . 0.0 110.476 -175.255 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.444 ' H ' HG12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -66.93 -38.08 80.68 Favored 'Isoleucine or valine' 0 C--N 1.34 0.18 0 CA-C-O 117.859 -1.067 . . . . 0.0 110.157 175.8 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -61.95 -47.67 83.82 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 119.776 1.171 . . . . 0.0 110.275 179.036 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -61.96 -46.71 88.09 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.319 0.509 . . . . 0.0 111.362 179.163 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 32.6 tttt -62.92 -54.8 32.9 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 123.027 0.531 . . . . 0.0 111.078 -179.451 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 86.2 t -72.3 -49.3 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-O 118.183 -0.913 . . . . 0.0 109.161 -170.549 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.8 m -65.45 -28.27 69.11 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 120.048 1.294 . . . . 0.0 110.992 178.866 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.13 -49.29 76.4 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 170.219 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -62.45 -44.3 96.73 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 118.734 1.267 . . . . 0.0 111.304 177.458 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 39.2 mmt -55.99 -49.34 73.88 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-O 119.133 -0.461 . . . . 0.0 110.032 175.183 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -66.75 -29.11 69.0 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.965 0.802 . . . . 0.0 112.281 179.598 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -67.59 -37.33 82.43 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.718 1.144 . . . . 0.0 110.511 171.014 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -69.1 -27.5 65.65 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 119.546 1.066 . . . . 0.0 110.479 169.549 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 122.37 -25.72 6.55 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 127.914 2.673 . . . . 0.0 111.215 177.952 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 95.9 m -54.16 142.92 24.14 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 126.732 2.013 . . . . 0.0 110.792 -175.538 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -108.84 142.0 40.06 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -176.219 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 85.7 m -137.57 165.55 26.05 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 -167.975 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -153.03 125.74 8.31 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.864 2.066 . . . . 0.0 107.124 173.748 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.8 p -73.55 124.71 26.42 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 169.435 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 35.1 mt -71.41 -25.74 62.46 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.796 -0.565 . . . . 0.0 110.257 172.38 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 162.69 -165.34 36.22 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 108.477 -1.849 . . . . 0.0 108.477 177.89 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -148.04 173.35 28.11 Favored Glycine 0 CA--C 1.519 0.329 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 173.624 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -168.36 -160.23 15.7 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 108.501 -1.84 . . . . 0.0 108.501 -178.966 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 35.6 ptt-85 -136.4 160.16 39.58 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 121.084 -1.245 . . . . 0.0 108.057 177.357 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 86.5 mt . . . . . 0 C--N 1.325 -0.487 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 -170.803 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 23.7 t60 . . . . . 0 C--O 1.232 0.132 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.1 t -145.45 133.94 16.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 176.274 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -169.74 -176.97 2.54 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.07 0.948 . . . . 0.0 109.302 -179.416 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 102.71 -170.06 19.77 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.407 -0.677 . . . . 0.0 111.407 173.824 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -157.92 151.51 23.67 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.858 0.863 . . . . 0.0 109.833 179.48 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.8 t -84.36 148.24 26.73 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 168.678 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 4.5 ptt? -76.27 -41.06 50.15 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 169.795 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.26 -25.14 54.66 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 118.881 -0.581 . . . . 0.0 112.246 -173.19 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -135.05 -1.83 2.62 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -169.619 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.04 -178.08 49.46 Favored Glycine 0 CA--C 1.535 1.297 0 CA-C-N 119.141 0.882 . . . . 0.0 113.089 176.415 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.86 139.57 33.59 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.999 2.466 . . . . 0.0 110.129 175.181 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.49 170.49 16.46 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.045 0.538 . . . . 0.0 110.58 169.758 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -78.4 84.0 4.59 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 168.605 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -57.95 -14.14 5.82 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -175.933 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.78 -41.1 85.86 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.429 1.492 . . . . 0.0 111.937 169.914 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 67.7 mt -65.8 -45.07 92.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.856 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.61 -49.38 76.62 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.354 1.061 . . . . 0.0 110.917 -179.006 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.4 p -63.19 -48.58 77.77 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 118.295 -0.86 . . . . 0.0 110.763 -176.438 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -60.08 -39.3 85.59 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.248 0.931 . . . . 0.0 110.764 -177.33 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 52.9 mttm -71.24 -45.05 64.11 Favored 'General case' 0 CA--C 1.528 0.112 0 O-C-N 121.839 -0.538 . . . . 0.0 111.817 178.652 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 73.9 mt -65.73 -38.29 81.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-N 119.363 0.983 . . . . 0.0 108.943 -179.444 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 92.7 mttt . . . . . 0 N--CA 1.468 0.431 0 CA-C-N 119.471 1.032 . . . . 0.0 109.115 171.905 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 C--O 1.235 0.293 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.7 p -133.01 169.9 16.16 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.353 1.061 . . . . 0.0 109.76 177.606 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 41.6 p-90 . . . . . 0 C--O 1.235 0.339 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 171.231 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.3 mmt . . . . . 0 N--CA 1.482 1.164 0 CA-C-O 121.74 0.781 . . . . 0.0 111.037 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.52 164.57 31.21 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 126.665 1.986 . . . . 0.0 105.958 169.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.6 p -138.69 120.46 17.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 175.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.54 174.57 4.06 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.98 0.895 . . . . 0.0 110.281 175.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -148.74 149.94 32.26 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 105.053 -2.202 . . . . 0.0 105.053 169.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 17.0 mt -60.23 -26.93 66.78 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -171.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.58 -28.06 65.64 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.888 0.767 . . . . 0.0 112.434 175.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.8 mt -79.3 -28.08 42.19 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 123.334 0.654 . . . . 0.0 111.149 -177.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 39.9 mt -64.85 128.0 93.22 Favored Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -47.16 130.31 16.56 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.41 2.74 . . . . 0.0 110.944 171.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -81.74 -37.63 26.97 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.357 0.599 . . . . 0.0 110.922 -173.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 43.8 t -134.73 135.13 53.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 170.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -152.93 123.54 7.27 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 169.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 20.2 pt -148.57 159.33 6.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 125.601 1.56 . . . . 0.0 107.334 -171.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -126.42 102.13 7.01 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 170.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.6 m -116.83 131.94 56.82 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.499 1.12 . . . . 0.0 111.354 -168.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -159.05 40.15 0.22 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.02 0.928 . . . . 0.0 110.775 171.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 155.48 -119.53 0.93 Allowed Glycine 0 C--N 1.339 0.746 0 O-C-N 120.91 -1.119 . . . . 0.0 111.333 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 91.1 t -123.98 122.77 65.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 126.836 2.054 . . . . 0.0 106.275 -177.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -161.1 156.17 24.11 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.281 1.032 . . . . 0.0 108.786 -175.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -81.8 155.83 25.22 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 123.213 0.605 . . . . 0.0 110.772 -172.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -144.54 160.42 41.14 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.73 1.212 . . . . 0.0 108.174 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.1 m -132.85 152.34 35.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 C-N-CA 124.299 1.04 . . . . 0.0 109.169 173.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.36 123.65 47.22 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 103.654 -2.721 . . . . 0.0 103.654 173.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.7 mt -125.55 121.16 59.53 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 -177.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 23.1 ttp180 -76.64 143.47 40.12 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 169.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.2 t -133.66 142.45 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 C-N-CA 128.568 2.747 . . . . 0.0 104.593 -172.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -127.77 151.95 48.37 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.164 0.985 . . . . 0.0 108.806 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 39.1 m -63.7 90.74 0.06 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.997 0.919 . . . . 0.0 111.48 175.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.42 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -136.32 19.21 0.05 OUTLIER Pre-proline 0 CA--C 1.552 1.025 0 CA-C-O 116.473 -1.727 . . . . 0.0 113.201 168.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.42 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 77.0 Cg_exo -46.67 147.26 4.63 Favored 'Trans proline' 0 C--N 1.362 1.284 0 CA-C-N 123.915 2.434 . . . . 0.0 113.064 172.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.9 mmm180 52.1 10.26 0.12 Allowed 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -173.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.8 m 52.1 29.09 5.99 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.291 1.036 . . . . 0.0 110.957 -169.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -164.17 3.03 0.06 OUTLIER Glycine 0 C--N 1.344 0.973 0 CA-C-O 118.445 -1.197 . . . . 0.0 114.984 -169.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.08 137.4 73.63 Favored Pre-proline 0 CA--C 1.544 0.731 0 CA-C-N 119.617 1.708 . . . . 0.0 109.586 169.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.23 -19.91 14.97 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.708 2.272 . . . . 0.0 112.967 -175.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.44 159.41 18.44 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.725 0.81 . . . . 0.0 110.762 176.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -142.88 35.39 1.4 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.338 1.455 . . . . 0.0 109.295 177.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -79.65 177.16 9.08 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.672 0.789 . . . . 0.0 109.437 176.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 12.5 m -140.28 158.55 43.85 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.503 1.121 . . . . 0.0 108.66 170.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -150.95 165.4 33.83 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 127.284 2.233 . . . . 0.0 105.822 -173.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.9 mp0 -128.72 147.87 50.8 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 176.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.3 pt -127.11 154.38 37.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 124.623 1.169 . . . . 0.0 109.456 176.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.0 t -117.66 119.28 61.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 178.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.414 ' HG3' HG21 ' A' ' 60' ' ' VAL . 9.9 mmp_? -129.49 145.28 51.46 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.007 1.323 . . . . 0.0 107.454 176.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.98 134.43 2.32 Favored Glycine 0 N--CA 1.452 -0.282 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 177.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -151.92 150.2 29.78 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -170.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -60.69 -27.57 67.96 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 118.88 -0.581 . . . . 0.0 112.407 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 11.3 p-90 -69.72 -26.16 64.2 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.259 0.936 . . . . 0.0 113.02 176.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.02 82.27 7.68 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 119.926 1.239 . . . . 0.0 109.667 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -66.34 -12.45 56.79 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.029 0.932 . . . . 0.0 111.884 176.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -142.06 152.01 42.92 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.522 1.929 . . . . 0.0 107.946 178.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -73.9 -32.88 63.78 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 121.692 -0.63 . . . . 0.0 110.308 -170.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.09 -28.39 52.13 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-O 118.561 -0.733 . . . . 0.0 112.265 172.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -66.43 -48.72 69.1 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 119.269 0.941 . . . . 0.0 110.731 -176.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.427 ' H ' HG12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -67.89 -42.85 86.12 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.675 177.568 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -61.51 -44.63 96.73 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 119.896 1.225 . . . . 0.0 110.098 -177.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -63.03 -48.55 78.25 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.888 0.767 . . . . 0.0 111.936 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 36.1 tttt -62.41 -52.89 61.77 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.387 0.675 . . . . 0.0 110.951 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.414 HG21 ' HG3' ' A' ' 45' ' ' ARG . 78.4 t -70.86 -49.61 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-O 118.231 -0.89 . . . . 0.0 109.125 -170.07 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 66.7 m -68.25 -23.4 64.78 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 119.721 1.146 . . . . 0.0 111.186 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.6 -48.82 78.77 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 169.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.419 ' HA ' ' HE3' ' A' ' 66' ' ' LYS . 18.4 t70 -62.27 -45.79 91.68 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 118.448 1.124 . . . . 0.0 111.816 176.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 39.0 mmt -55.99 -48.2 76.32 Favored 'General case' 0 C--O 1.227 -0.083 0 CA-C-N 118.17 0.441 . . . . 0.0 110.463 176.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -69.82 -27.56 64.97 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 118.779 0.718 . . . . 0.0 112.037 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.419 ' HE3' ' HA ' ' A' ' 63' ' ' ASP . 52.1 mtmt -66.58 -36.48 82.73 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.37 0.986 . . . . 0.0 110.25 169.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -70.36 -30.91 67.97 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 120.0 1.273 . . . . 0.0 110.44 169.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 129.62 -26.63 4.29 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 127.618 2.532 . . . . 0.0 111.365 174.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 85.6 m -51.15 142.36 12.72 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 126.306 1.842 . . . . 0.0 111.861 -175.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -101.96 146.73 27.46 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 176.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 79.2 m -143.1 163.28 33.29 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -168.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -150.65 128.88 11.97 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 169.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 9.2 p -66.95 131.58 46.18 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 169.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 38.8 mt -74.83 -21.52 59.23 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 120.974 -1.079 . . . . 0.0 110.176 170.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 162.53 -168.35 37.42 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 108.66 -1.776 . . . . 0.0 108.66 175.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -133.34 172.83 21.36 Favored Glycine 0 CA--C 1.521 0.421 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 173.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -171.59 -163.99 26.47 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 108.084 -2.006 . . . . 0.0 108.084 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 29.2 ptt180 -135.47 154.81 51.3 Favored 'General case' 0 CA--C 1.512 -0.511 0 O-C-N 120.639 -1.506 . . . . 0.0 109.294 172.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.9 mt -110.41 134.96 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 104.331 -2.47 . . . . 0.0 104.331 178.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 18.9 m -139.58 158.87 43.39 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 173.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -148.54 26.43 0.94 Allowed 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.702 -0.624 . . . . 0.0 111.125 176.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -73.1 -96.67 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.42 1.488 . . . . 0.0 108.698 -176.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.2 m 42.44 -150.99 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.202 1.801 . . . . 0.0 112.675 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 -127.07 21.14 6.84 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.621 1.568 . . . . 0.0 108.232 169.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -143.23 118.44 10.16 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 102.792 -3.04 . . . . 0.0 102.792 -177.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.45 ' HD2' ' H ' ' A' ' 86' ' ' LYS . 2.5 mptt -74.28 -0.3 16.55 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 123.887 0.875 . . . . 0.0 113.052 -169.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.1 ttmt -50.55 121.53 5.88 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.409 1.084 . . . . 0.0 108.315 171.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 93.3 mt -66.22 149.29 11.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 175.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 22.3 t60 -136.18 144.88 45.2 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 121.162 -0.961 . . . . 0.0 109.811 -173.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.6 t -133.82 130.43 55.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -173.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -171.26 -175.48 1.68 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.474 0.579 . . . . 0.0 110.235 -169.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.47 -166.47 39.94 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 174.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -157.67 161.09 38.57 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.391 0.676 . . . . 0.0 111.629 175.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.9 t -87.74 154.46 20.55 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 168.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.4 ptm -92.34 -32.37 15.01 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 119.024 0.829 . . . . 0.0 110.422 173.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.19 -24.35 59.34 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.048 0.84 . . . . 0.0 111.836 175.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -133.92 -4.9 2.79 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -169.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.4 -177.21 52.92 Favored Glycine 0 CA--C 1.535 1.317 0 CA-C-N 119.412 1.006 . . . . 0.0 113.124 175.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.58 138.55 38.66 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.232 2.621 . . . . 0.0 110.41 176.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.45 169.56 18.01 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.694 0.798 . . . . 0.0 111.192 169.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -79.5 80.85 5.83 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 169.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 41.9 m80 -56.1 -20.13 16.03 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.843 0.857 . . . . 0.0 113.244 -178.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.23 -44.3 71.6 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.428 1.491 . . . . 0.0 112.352 169.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 70.7 mt -66.25 -44.7 91.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.43 -49.38 76.42 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.921 0.888 . . . . 0.0 110.78 -178.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.46 HG22 HG12 ' A' ' 118' ' ' VAL . 13.1 p -64.55 -46.71 81.68 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 118.362 -0.827 . . . . 0.0 110.708 -175.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -60.87 -40.1 91.69 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 119.295 0.952 . . . . 0.0 110.705 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 45.1 mttm -68.36 -46.97 68.68 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.807 -0.558 . . . . 0.0 111.509 177.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 68.8 mt -66.63 -38.51 81.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 119.469 1.031 . . . . 0.0 109.198 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -57.68 -47.82 81.25 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 119.696 1.134 . . . . 0.0 109.56 173.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.56 -35.79 81.66 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.051 0.387 . . . . 0.0 111.54 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 21.3 tptt -69.97 -36.27 75.08 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.277 0.631 . . . . 0.0 111.287 178.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -128.37 70.0 78.99 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 124.867 1.267 . . . . 0.0 110.026 -175.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -68.32 -14.77 41.07 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.835 2.357 . . . . 0.0 112.859 -176.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -67.69 -20.93 65.34 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.895 0.878 . . . . 0.0 112.017 172.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -116.18 -175.65 2.79 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.729 2.011 . . . . 0.0 108.331 -178.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -136.68 161.81 34.91 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 171.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.46 HG12 HG22 ' A' ' 106' ' ' THR . 3.1 t -140.75 144.78 26.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 -172.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.6 p -136.83 170.18 16.52 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.496 1.119 . . . . 0.0 109.507 177.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 41.8 p-90 -143.75 155.63 44.24 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 172.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.39 120.4 4.41 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 171.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -77.61 1.01 20.98 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 120.341 -0.544 . . . . 0.0 112.277 -171.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -61.32 -33.05 72.95 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.68 1.592 . . . . 0.0 113.007 -176.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -82.86 -171.03 46.7 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 123.561 0.6 . . . . 0.0 112.815 -173.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 2.1 t80 . . . . . 0 C--O 1.236 0.369 0 C-N-CA 124.513 1.125 . . . . 0.0 110.545 -169.582 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 126' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptp . . . . . 0 N--CA 1.484 1.23 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.14 165.61 33.35 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.988 1.315 . . . . 0.0 108.914 174.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.9 m -67.67 169.28 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 C-N-CA 123.979 0.912 . . . . 0.0 110.665 173.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -74.15 173.87 9.5 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.776 0.798 . . . . 0.0 111.631 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -146.29 143.72 29.35 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 105.558 -2.016 . . . . 0.0 105.558 169.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 76.6 mt -55.69 -33.03 63.8 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -171.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.82 -25.44 66.44 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.911 0.778 . . . . 0.0 112.318 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.1 mt -81.23 -24.39 37.43 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.481 0.712 . . . . 0.0 111.397 -176.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 52.3 mt -70.9 131.02 87.74 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-O 118.145 -0.931 . . . . 0.0 108.783 -169.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -47.27 120.38 4.32 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 124.26 3.307 . . . . 0.0 112.894 172.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -66.13 -35.76 81.35 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.475 1.51 . . . . 0.0 111.739 -178.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.9 t -143.41 138.23 26.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 176.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -153.19 113.82 4.06 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 169.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.2 pt -141.64 158.48 21.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 123.145 0.578 . . . . 0.0 110.878 -169.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -147.41 43.1 1.1 Allowed 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.427 1.491 . . . . 0.0 109.336 169.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.6 m -72.92 70.24 1.0 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.433 1.093 . . . . 0.0 108.753 170.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -74.96 36.27 0.11 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.352 1.861 . . . . 0.0 112.151 -177.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 159.69 -174.38 36.53 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 127.237 2.351 . . . . 0.0 107.858 -170.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.0 t -70.25 98.95 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 174.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -142.58 158.01 44.12 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.676 1.19 . . . . 0.0 109.782 -177.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.4 mttm -70.48 156.2 39.69 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.63 1.172 . . . . 0.0 111.785 -172.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -144.54 161.59 38.72 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.614 1.966 . . . . 0.0 107.639 169.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.1 m -129.15 151.76 36.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 124.971 1.309 . . . . 0.0 109.537 173.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.97 120.34 39.66 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 104.202 -2.518 . . . . 0.0 104.202 171.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 46.1 mt -122.06 127.34 75.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 -177.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -81.36 148.0 29.56 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 169.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.1 t -133.03 144.25 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 -177.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -125.65 154.19 42.7 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.534 1.134 . . . . 0.0 109.396 -176.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 44.3 m -69.54 47.45 0.08 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.996 1.718 . . . . 0.0 114.157 177.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.13 -5.4 0.09 OUTLIER Pre-proline 0 CA--C 1.556 1.192 0 CA-C-O 114.775 -2.536 . . . . 0.0 117.334 169.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -43.43 153.65 0.22 Allowed 'Trans proline' 0 C--N 1.363 1.292 0 C-N-CA 123.599 2.866 . . . . 0.0 115.543 178.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 42.6 ttt180 55.15 14.51 1.02 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.232 1.413 . . . . 0.0 112.707 -169.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.1 m 51.36 25.59 2.66 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.212 1.405 . . . . 0.0 112.099 -169.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 170.69 25.72 0.02 OUTLIER Glycine 0 C--N 1.343 0.96 0 CA-C-O 118.569 -1.128 . . . . 0.0 115.29 -172.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.84 149.41 23.05 Favored Pre-proline 0 CA--C 1.544 0.741 0 CA-C-N 119.446 1.623 . . . . 0.0 110.245 170.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.41 -24.47 19.27 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 122.536 2.158 . . . . 0.0 113.152 -174.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.92 155.03 39.56 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.45 0.7 . . . . 0.0 110.376 175.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -141.11 30.59 1.79 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.827 1.251 . . . . 0.0 110.109 176.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 -74.15 173.77 9.65 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-O 121.647 0.737 . . . . 0.0 109.903 174.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.5 m -140.71 160.38 40.17 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.862 1.265 . . . . 0.0 108.778 172.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -148.28 170.19 18.45 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 127.43 2.292 . . . . 0.0 106.291 -173.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.3 mp0 -133.15 154.08 50.94 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 121.084 -1.01 . . . . 0.0 108.294 178.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 34.2 pt -137.69 156.58 32.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 C-N-CA 125.712 1.605 . . . . 0.0 109.337 178.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 85.4 t -118.7 119.42 61.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.0 mmt85 -134.84 143.46 47.03 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -179.99 136.24 2.69 Favored Glycine 0 CA--C 1.509 -0.287 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -178.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -154.74 153.3 31.03 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -169.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -55.05 -29.67 57.96 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 178.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 8.7 p-90 -73.53 -22.54 60.07 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.969 0.804 . . . . 0.0 113.124 -179.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.86 83.5 7.17 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-N 120.056 1.298 . . . . 0.0 110.047 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -64.18 -18.41 64.46 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.976 0.91 . . . . 0.0 112.003 176.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -138.08 146.85 43.43 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.746 1.619 . . . . 0.0 108.398 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 29.2 m80 -65.03 -33.77 76.83 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.133 0.573 . . . . 0.0 110.832 -175.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.93 -25.82 45.03 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 118.382 -0.818 . . . . 0.0 112.987 173.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -67.75 -50.83 55.12 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 119.705 1.139 . . . . 0.0 110.569 -176.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.414 HG12 ' H ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -67.65 -37.17 78.2 Favored 'Isoleucine or valine' 0 C--N 1.339 0.147 0 CA-C-O 117.913 -1.041 . . . . 0.0 109.976 176.333 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -60.3 -49.47 77.46 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.651 1.114 . . . . 0.0 110.45 178.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -63.2 -47.1 84.01 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.345 0.52 . . . . 0.0 111.3 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.2 tttt -61.1 -53.7 53.76 Favored 'General case' 0 CA--C 1.522 -0.124 0 C-N-CA 123.126 0.571 . . . . 0.0 111.091 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 95.4 t -71.94 -44.91 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 117.937 -1.03 . . . . 0.0 109.294 -171.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.0 m -62.73 -33.77 75.82 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 120.292 1.406 . . . . 0.0 110.703 177.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.33 -47.6 89.93 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-N 118.946 0.794 . . . . 0.0 111.273 171.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -63.04 -46.29 88.23 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 118.625 1.213 . . . . 0.0 111.363 178.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 38.2 mmt -57.27 -45.93 83.57 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 123.488 0.715 . . . . 0.0 110.727 175.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -63.79 -36.42 83.82 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.786 0.835 . . . . 0.0 111.696 177.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -66.89 -37.21 83.96 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 119.232 0.923 . . . . 0.0 110.917 172.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -68.78 -23.65 64.33 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 119.283 0.947 . . . . 0.0 111.965 171.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 118.1 -12.93 12.76 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 126.248 1.88 . . . . 0.0 112.626 174.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 91.0 m -67.27 168.45 10.49 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.022 1.329 . . . . 0.0 111.55 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -125.44 152.11 45.33 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 170.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 65.4 m -143.44 163.69 32.41 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -168.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -148.71 137.59 21.49 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.042 1.737 . . . . 0.0 106.843 170.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.9 p -78.7 118.49 20.83 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 169.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 44.3 mt -70.85 -22.59 62.29 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 122.023 -0.423 . . . . 0.0 110.381 174.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 163.42 -166.76 37.34 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 172.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -151.68 175.66 30.39 Favored Glycine 0 CA--C 1.52 0.344 0 N-CA-C 111.807 -0.517 . . . . 0.0 111.807 171.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -166.6 -162.07 17.25 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 108.366 -1.894 . . . . 0.0 108.366 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.95 164.94 25.84 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 120.893 -1.357 . . . . 0.0 108.515 174.127 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 68.8 mt -114.53 144.1 22.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 -171.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 39.0 p -155.88 -152.55 0.39 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.855 1.662 . . . . 0.0 108.345 -175.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.41 160.01 41.78 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.139 1.376 . . . . 0.0 109.009 173.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -124.89 77.79 1.64 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.13 0.972 . . . . 0.0 109.765 -170.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.5 m 58.66 12.93 2.38 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 169.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -142.13 138.55 31.7 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 174.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -58.77 -26.99 64.56 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -169.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 35.9 mtmt -118.91 11.39 12.55 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 118.103 -0.951 . . . . 0.0 113.032 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -95.68 86.04 4.31 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 169.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 78.8 mt -60.72 158.75 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 172.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -141.1 160.09 40.83 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 120.611 -1.305 . . . . 0.0 110.124 -177.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.0 t -141.84 137.11 31.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -163.03 -179.58 6.83 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.953 0.901 . . . . 0.0 109.247 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.9 -166.5 19.22 Favored Glycine 0 CA--C 1.523 0.553 0 O-C-N 121.695 -0.628 . . . . 0.0 112.592 169.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -159.07 157.85 31.87 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.903 1.281 . . . . 0.0 109.527 178.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.4 t -89.96 147.33 23.77 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 168.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.42 -42.46 62.02 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 171.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -80.72 -24.6 38.67 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 118.912 -0.566 . . . . 0.0 112.205 -171.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -132.49 -1.07 3.53 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -169.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.11 -179.72 49.81 Favored Glycine 0 CA--C 1.534 1.249 0 CA-C-N 118.964 0.802 . . . . 0.0 113.288 173.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.38 138.63 33.19 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.935 2.423 . . . . 0.0 109.981 175.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.07 168.1 20.65 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.254 0.55 . . . . 0.0 111.094 170.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -79.26 81.82 5.48 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 168.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 45.7 m80 -57.04 -18.38 13.85 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -174.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.82 -40.36 69.49 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.018 1.327 . . . . 0.0 112.151 170.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 61.2 mt -66.06 -47.28 85.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 178.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.42 -49.29 78.37 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.315 1.046 . . . . 0.0 110.798 -176.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 31.0 p -63.32 -49.12 75.2 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 118.642 -0.694 . . . . 0.0 109.568 -175.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -59.35 -40.72 87.34 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.11 0.868 . . . . 0.0 111.31 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 44.4 mttm -65.72 -47.15 76.31 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 118.507 0.594 . . . . 0.0 111.338 177.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 67.7 mt -64.01 -39.26 84.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 CA-C-N 119.202 0.91 . . . . 0.0 109.235 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.0 mtpt -61.91 -44.23 97.22 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.351 0.978 . . . . 0.0 109.999 177.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.13 -40.19 96.87 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.156 0.434 . . . . 0.0 111.15 176.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.457 ' HE2' ' HA ' ' A' ' 112' ' ' LYS . 0.7 OUTLIER -66.16 -32.27 73.62 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 118.056 -0.973 . . . . 0.0 111.835 178.939 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -133.36 73.28 73.94 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 119.208 0.913 . . . . 0.0 110.213 -173.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.31 -26.08 50.62 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 123.446 2.764 . . . . 0.0 115.141 -176.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -72.63 -11.82 60.8 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.493 0.717 . . . . 0.0 112.642 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -112.87 174.85 5.7 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.865 1.666 . . . . 0.0 109.039 -178.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -133.62 160.57 37.1 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 169.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.2 t -144.14 142.73 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 -174.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 9.7 p -135.08 171.25 14.69 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.694 1.198 . . . . 0.0 108.764 176.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 55.7 p-90 -142.81 156.54 44.98 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 172.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -154.57 102.76 2.42 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 174.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.07 -0.6 22.39 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -169.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -58.1 -30.12 66.02 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.373 1.069 . . . . 0.0 112.201 178.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -73.84 131.8 14.65 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 170.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 . . . . . 0 C--O 1.239 0.535 0 C-N-CA 125.614 1.566 . . . . 0.0 108.747 178.302 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 126' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.7 mmm . . . . . 0 N--CA 1.483 1.215 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.52 -174.07 3.94 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.456 1.502 . . . . 0.0 108.827 175.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.0 p -145.55 153.91 13.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 124.848 1.259 . . . . 0.0 107.861 177.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -162.95 -162.85 0.8 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.798 2.039 . . . . 0.0 107.463 -175.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -146.21 153.06 40.18 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.675 1.99 . . . . 0.0 105.887 169.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 54.4 mt -53.15 -36.2 60.58 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.036 0.835 . . . . 0.0 112.077 -177.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.24 -25.72 68.19 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 118.801 0.728 . . . . 0.0 112.571 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.9 mt -83.73 -22.24 32.04 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.465 0.706 . . . . 0.0 111.489 -177.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 15.9 mt -66.48 131.71 94.2 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -50.39 128.9 24.49 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.842 2.361 . . . . 0.0 110.786 171.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -74.66 -41.69 59.86 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.378 0.671 . . . . 0.0 110.794 -176.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 53.5 t -136.29 129.18 46.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 177.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -152.12 111.94 4.0 Favored 'General case' 0 CA--C 1.521 -0.173 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 171.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 9.5 pt -147.86 157.97 8.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 125.077 1.351 . . . . 0.0 109.067 -169.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -59.23 -51.12 71.33 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.837 0.855 . . . . 0.0 112.697 -176.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.8 m 41.97 43.77 2.77 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.977 1.711 . . . . 0.0 114.65 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -132.02 11.25 4.66 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.289 1.035 . . . . 0.0 111.187 173.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.33 -161.84 35.41 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 94.5 t -71.48 140.69 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 123.679 0.792 . . . . 0.0 108.946 169.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -163.85 167.42 20.78 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.844 1.257 . . . . 0.0 109.787 169.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.5 mttt -99.62 151.7 20.89 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.603 1.161 . . . . 0.0 108.83 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -142.91 162.8 34.5 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.232 1.013 . . . . 0.0 108.984 -174.004 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.0 m -133.6 155.25 40.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 C-N-CA 124.542 1.137 . . . . 0.0 109.718 173.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -106.96 116.73 32.44 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 178.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 80.3 mt -120.71 115.11 45.98 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -173.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -72.76 142.83 48.13 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 168.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.6 p -138.75 146.9 25.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -127.85 146.83 50.49 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.884 1.274 . . . . 0.0 108.484 -171.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 61.2 m -61.95 100.21 0.15 Allowed 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.598 0.759 . . . . 0.0 111.077 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.499 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -144.98 22.75 0.04 OUTLIER Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 126.029 1.732 . . . . 0.0 112.976 168.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.499 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 72.0 Cg_exo -46.36 150.77 2.02 Favored 'Trans proline' 0 C--N 1.361 1.235 0 CA-C-N 123.872 2.419 . . . . 0.0 114.991 178.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.9 14.19 0.3 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.562 1.545 . . . . 0.0 113.282 -171.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.6 m 53.68 31.34 12.57 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.664 1.185 . . . . 0.0 111.69 -169.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -163.99 0.85 0.05 OUTLIER Glycine 0 CA--C 1.533 1.169 0 CA-C-O 118.326 -1.263 . . . . 0.0 115.982 -174.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.28 142.07 76.37 Favored Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 119.842 1.821 . . . . 0.0 110.911 176.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -79.22 -20.36 9.9 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.015 2.477 . . . . 0.0 113.743 -174.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.96 159.53 22.72 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.612 0.765 . . . . 0.0 110.838 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -143.43 30.05 1.4 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.563 1.145 . . . . 0.0 111.214 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -76.36 176.25 8.36 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.234 0.54 . . . . 0.0 109.891 171.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.9 m -143.27 159.94 41.4 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.964 1.306 . . . . 0.0 108.936 176.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.8 tttt -149.6 165.54 31.96 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 126.768 2.027 . . . . 0.0 107.246 -174.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -124.95 128.4 48.54 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 169.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 39.5 pt -108.89 155.07 10.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 124.84 1.256 . . . . 0.0 110.257 173.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 33.1 t -119.32 114.92 46.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 -175.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 12.7 mmp_? -128.38 146.84 50.66 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.084 1.353 . . . . 0.0 108.404 -177.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 174.98 137.55 2.52 Favored Glycine 0 C--N 1.332 0.306 0 CA-C-N 118.849 0.75 . . . . 0.0 111.303 176.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -153.33 154.16 34.02 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -169.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -56.92 -34.47 68.0 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 118.591 -0.719 . . . . 0.0 112.556 175.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 10.1 p-90 -65.5 -27.31 68.39 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.1 0.864 . . . . 0.0 112.294 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -87.29 73.22 9.72 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 119.033 0.833 . . . . 0.0 109.585 175.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -67.9 -5.05 14.89 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.458 0.703 . . . . 0.0 111.648 175.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -138.66 147.96 43.45 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 126.197 1.799 . . . . 0.0 107.142 173.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 59.9 m80 -73.89 -31.49 63.14 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 121.812 -0.555 . . . . 0.0 110.185 -169.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.76 -28.72 50.69 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 118.333 -0.842 . . . . 0.0 112.586 171.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -67.49 -49.31 64.06 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 119.624 1.102 . . . . 0.0 110.729 -177.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.401 ' H ' HG12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -67.35 -38.5 80.95 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 CA-C-O 117.732 -1.127 . . . . 0.0 110.045 177.058 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -64.43 -41.88 96.34 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 120.19 1.359 . . . . 0.0 110.669 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -63.43 -48.83 76.14 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.315 0.961 . . . . 0.0 111.304 176.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -56.79 -55.7 30.89 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.372 1.069 . . . . 0.0 110.628 178.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 81.1 t -77.08 -44.43 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-O 117.79 -1.1 . . . . 0.0 109.791 -169.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.1 t -62.73 -36.85 84.36 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 120.555 1.525 . . . . 0.0 109.266 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.51 -50.74 64.51 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 172.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -62.71 -45.95 90.36 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 118.728 1.264 . . . . 0.0 111.755 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 38.7 mmt -57.31 -47.86 80.42 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.377 0.671 . . . . 0.0 110.145 176.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -66.54 -30.92 71.33 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 118.698 -0.668 . . . . 0.0 111.805 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -67.48 -35.13 78.56 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.757 1.162 . . . . 0.0 110.724 170.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -72.8 -15.05 61.64 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 119.525 1.057 . . . . 0.0 111.208 169.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 110.04 -25.5 16.2 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 127.431 2.443 . . . . 0.0 112.247 177.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 93.3 m -55.8 149.28 14.95 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.957 1.703 . . . . 0.0 111.936 -175.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -108.87 143.36 38.18 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 177.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 96.1 m -141.3 164.91 28.98 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -168.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -151.41 128.37 11.04 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.794 1.637 . . . . 0.0 106.932 171.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.1 p -73.48 117.3 15.07 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 169.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 39.4 mt -70.76 -23.42 62.41 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.904 -0.497 . . . . 0.0 110.563 174.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.42 -170.97 42.46 Favored Glycine 0 C--N 1.337 0.626 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 171.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -132.23 169.91 22.02 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 174.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -174.34 -161.57 24.49 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -177.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 50.0 ttt180 -141.65 152.22 43.75 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 125.082 1.353 . . . . 0.0 107.816 -172.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 40.6 mt -123.79 139.89 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 173.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 18.6 m -140.47 151.5 44.9 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 172.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 72.0 m-70 -76.27 -17.09 59.63 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 118.737 -0.649 . . . . 0.0 112.173 178.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 38.1 mm-40 -145.61 143.52 29.92 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.5 1.92 . . . . 0.0 106.949 171.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 65.1 m -148.36 -149.71 0.31 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.326 1.45 . . . . 0.0 108.222 174.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -60.25 -8.38 2.51 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.839 1.256 . . . . 0.0 113.415 171.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -127.4 150.74 49.49 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.429 1.492 . . . . 0.0 107.919 169.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -84.05 -2.36 56.55 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -169.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.43 174.74 9.3 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 120.503 1.502 . . . . 0.0 109.097 169.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 77.3 mt -60.5 130.45 24.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 102.478 -3.156 . . . . 0.0 102.478 167.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 22.9 t60 -121.86 150.44 41.93 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 118.868 0.758 . . . . 0.0 110.378 -169.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.9 t -129.11 125.02 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -164.77 -167.98 1.36 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.694 0.798 . . . . 0.0 109.076 -171.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.71 -176.09 53.95 Favored Glycine 0 CA--C 1.527 0.793 0 O-C-N 121.633 -0.667 . . . . 0.0 111.473 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -158.97 149.84 20.01 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.01 0.924 . . . . 0.0 110.804 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.0 t -75.37 162.48 28.35 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 168.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.2 ptm -103.72 -31.27 9.93 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 118.629 -0.7 . . . . 0.0 110.783 170.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -73.71 -25.74 60.36 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 119.351 0.978 . . . . 0.0 111.6 174.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -132.49 -6.17 3.3 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.941 0.896 . . . . 0.0 113.351 -169.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.94 -176.1 54.1 Favored Glycine 0 CA--C 1.534 1.277 0 CA-C-N 118.945 0.793 . . . . 0.0 113.39 173.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -67.67 135.23 35.18 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.267 2.645 . . . . 0.0 110.471 175.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.69 168.23 20.44 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.11 0.564 . . . . 0.0 110.891 169.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -81.56 80.07 8.01 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 169.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -55.46 -20.5 12.77 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.09 -44.29 67.47 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.925 1.29 . . . . 0.0 112.196 170.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 71.7 mt -64.59 -48.35 85.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.46 -50.94 71.41 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.508 1.123 . . . . 0.0 110.443 -176.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.2 p -64.69 -46.25 83.19 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 119.347 0.976 . . . . 0.0 111.048 -175.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -60.7 -39.92 90.28 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.564 1.074 . . . . 0.0 110.625 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.3 mttt -72.55 -41.34 65.87 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 121.676 -0.64 . . . . 0.0 111.965 178.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 76.8 mt -65.76 -41.75 90.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 119.289 0.95 . . . . 0.0 108.662 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -55.88 -47.42 77.41 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.54 1.063 . . . . 0.0 109.882 173.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.43 -41.82 98.99 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 119.2 -0.428 . . . . 0.0 111.646 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -72.19 -33.6 67.78 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.787 0.721 . . . . 0.0 111.591 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -126.1 63.89 50.98 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 124.092 0.957 . . . . 0.0 110.502 -170.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.68 -10.64 29.13 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.154 2.569 . . . . 0.0 113.309 -174.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -67.77 -10.24 50.99 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.981 0.912 . . . . 0.0 112.231 170.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -129.2 179.64 5.65 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.288 1.835 . . . . 0.0 109.099 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -135.56 155.88 49.76 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 172.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.1 t -137.99 146.74 26.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 -169.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 21.6 p -136.18 168.17 19.89 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.778 1.231 . . . . 0.0 109.247 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 36.5 p-90 -146.1 162.41 38.0 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.838 -0.539 . . . . 0.0 110.321 172.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -152.27 139.05 18.88 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 169.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -81.12 78.58 7.91 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 172.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -141.23 -175.09 4.21 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.043 1.737 . . . . 0.0 106.334 170.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 103.53 -153.41 17.95 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-N 119.526 1.057 . . . . 0.0 111.038 -175.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 87.4 t80 . . . . . 0 C--O 1.238 0.47 0 C-N-CA 125.167 1.387 . . . . 0.0 109.558 176.18 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 126' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.7 ttp . . . . . 0 N--CA 1.482 1.139 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.34 -173.3 3.61 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.627 0.771 . . . . 0.0 110.184 172.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 49.9 t -132.83 148.55 31.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 169.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -153.31 -174.35 4.91 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.174 1.79 . . . . 0.0 107.916 -177.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -139.28 149.11 43.89 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 170.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.0 mt -54.75 -33.72 61.62 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.684 0.794 . . . . 0.0 112.343 -174.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.0 -25.22 68.03 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.077 0.853 . . . . 0.0 112.561 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 79.6 mt -78.28 -25.68 46.8 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.205 0.602 . . . . 0.0 111.369 -177.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.0 mt -69.63 130.43 90.48 Favored Pre-proline 0 CA--C 1.538 0.502 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -173.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -50.67 127.6 21.42 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.856 2.371 . . . . 0.0 109.884 169.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -82.39 -34.07 28.48 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 121.88 -0.512 . . . . 0.0 111.481 -171.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 52.5 t -133.92 131.86 56.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 171.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -152.99 126.86 8.93 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 174.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.3 pt -147.93 167.18 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.097 0.959 . . . . 0.0 110.349 -169.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -144.08 89.66 2.05 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.553 1.141 . . . . 0.0 108.588 169.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.1 m -65.11 170.87 4.08 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.901 1.68 . . . . 0.0 113.125 -173.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -146.65 -43.85 0.19 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.669 1.188 . . . . 0.0 110.572 169.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.98 -40.28 0.25 Allowed Glycine 0 CA--C 1.525 0.693 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 177.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 96.6 t -143.26 120.83 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 103.874 -2.639 . . . . 0.0 103.874 169.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -153.9 148.3 26.05 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.055 0.843 . . . . 0.0 110.382 -175.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -72.61 156.19 39.25 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 122.952 0.501 . . . . 0.0 110.464 -176.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -147.64 164.86 32.2 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.472 1.109 . . . . 0.0 108.302 172.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.4 m -133.92 153.08 35.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 C-N-CA 124.725 1.21 . . . . 0.0 108.963 173.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.1 114.71 28.82 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 54.0 mt -119.38 117.92 55.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -170.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.7 ttp180 -73.63 147.13 44.06 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 169.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.0 t -135.2 150.3 29.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 127.097 2.159 . . . . 0.0 105.517 -176.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -131.8 153.86 49.69 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.691 1.196 . . . . 0.0 108.245 176.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.2 m -68.87 44.71 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.946 1.698 . . . . 0.0 114.111 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -73.96 -5.56 0.09 OUTLIER Pre-proline 0 CA--C 1.551 1.004 0 CA-C-O 115.159 -2.353 . . . . 0.0 116.824 172.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -50.18 158.0 2.66 Favored 'Trans proline' 0 C--N 1.359 1.118 0 CA-C-N 125.263 2.915 . . . . 0.0 112.068 169.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 21.8 ttp180 54.32 26.58 7.04 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 121.518 -0.739 . . . . 0.0 110.606 -169.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.6 m 49.87 24.21 1.24 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.169 1.788 . . . . 0.0 113.672 -170.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 143.39 77.88 0.04 OUTLIER Glycine 0 C--N 1.34 0.79 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -176.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -72.43 148.93 91.02 Favored Pre-proline 0 CA--C 1.541 0.618 0 CA-C-N 117.997 0.898 . . . . 0.0 108.932 178.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -54.9 -27.63 54.61 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.418 2.745 . . . . 0.0 115.797 -172.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.15 -40.92 97.58 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.758 0.823 . . . . 0.0 112.339 -175.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 44.82 35.03 1.33 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.631 1.572 . . . . 0.0 113.267 -170.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -83.35 -179.86 7.49 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.278 1.031 . . . . 0.0 109.635 175.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.1 m -141.58 161.18 38.56 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.288 1.435 . . . . 0.0 108.969 174.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.5 tttt -149.63 162.19 40.69 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 126.203 1.801 . . . . 0.0 107.772 -172.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.5 mp0 -130.22 119.75 23.4 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 172.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 43.9 pt -104.99 159.24 5.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 C-N-CA 125.137 1.375 . . . . 0.0 110.705 178.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.4 t -118.14 120.59 64.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.447 ' HG3' HG21 ' A' ' 60' ' ' VAL . 9.4 mmp_? -126.55 141.09 51.98 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 176.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.04 131.81 1.83 Allowed Glycine 0 C--N 1.331 0.256 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 174.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -148.81 147.47 28.8 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -169.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -57.5 -27.31 62.43 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 177.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 12.2 p-90 -68.09 -27.97 66.94 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.221 0.918 . . . . 0.0 112.438 176.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.44 83.39 7.95 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 119.411 1.005 . . . . 0.0 109.054 175.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -66.85 -16.97 64.65 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 122.859 0.464 . . . . 0.0 111.65 176.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -134.3 152.69 51.95 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.028 1.731 . . . . 0.0 108.441 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 76.8 m-70 -73.3 -33.27 65.09 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -169.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.39 -28.75 56.02 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 118.408 -0.806 . . . . 0.0 112.71 173.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -67.63 -49.61 62.12 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 119.443 1.02 . . . . 0.0 110.46 -177.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.21 -42.79 91.7 Favored 'Isoleucine or valine' 0 C--N 1.341 0.209 0 CA-C-O 117.933 -1.032 . . . . 0.0 109.659 175.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -61.05 -45.13 96.03 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.687 1.131 . . . . 0.0 110.68 -177.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -63.32 -49.09 75.34 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.2 0.909 . . . . 0.0 111.655 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 31.5 tttt -59.13 -50.41 74.14 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.599 0.76 . . . . 0.0 110.883 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.447 HG21 ' HG3' ' A' ' 45' ' ' ARG . 91.9 t -72.73 -42.33 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-O 117.832 -1.08 . . . . 0.0 109.012 -172.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 63.0 m -60.15 -33.27 71.94 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-N 120.65 1.568 . . . . 0.0 111.087 173.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.03 -53.92 39.04 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-N 119.468 1.031 . . . . 0.0 110.54 172.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.449 ' HA ' ' HE3' ' A' ' 66' ' ' LYS . 19.0 t70 -60.32 -46.1 91.06 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.442 1.121 . . . . 0.0 111.828 -178.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 35.3 mmt -59.45 -50.21 74.83 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.963 0.905 . . . . 0.0 110.119 178.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -67.07 -29.73 69.59 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 118.461 0.573 . . . . 0.0 111.605 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.449 ' HE3' ' HA ' ' A' ' 63' ' ' ASP . 52.3 mtmt -66.06 -36.55 83.52 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.343 0.974 . . . . 0.0 110.861 170.295 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -72.44 -13.14 61.37 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.817 1.189 . . . . 0.0 112.069 169.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.76 -10.85 66.49 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 126.267 1.889 . . . . 0.0 112.346 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 85.1 m -56.38 153.0 10.4 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.815 1.308 . . . . 0.0 111.233 175.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -114.3 139.36 49.5 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 170.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 35.4 m -141.56 161.24 38.41 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -168.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -153.35 126.84 8.68 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 176.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.7 p -70.59 121.27 17.55 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 169.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 36.6 mt -66.9 -24.5 66.11 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.864 -0.523 . . . . 0.0 109.82 170.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.91 -170.21 42.66 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 125.3 1.429 . . . . 0.0 109.612 169.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -124.15 169.29 16.23 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 173.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -175.83 -166.29 33.06 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -175.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -143.88 160.38 40.89 Favored 'General case' 0 CA--C 1.516 -0.344 0 O-C-N 120.906 -1.349 . . . . 0.0 109.561 178.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 95.2 mt -123.26 141.48 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 -176.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 18.8 m -139.4 146.4 40.11 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 123.579 0.549 . . . . 0.0 111.237 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.85 171.02 9.95 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.369 1.868 . . . . 0.0 112.988 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -63.8 6.56 0.15 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 127.6 2.36 . . . . 0.0 114.51 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.0 m -113.27 11.61 18.72 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.852 1.261 . . . . 0.0 111.11 174.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 19.9 tp60 -124.19 -19.09 5.66 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.491 1.516 . . . . 0.0 110.358 172.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -150.26 163.48 38.18 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.66 1.984 . . . . 0.0 106.707 171.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -57.19 -28.04 62.49 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.938 0.79 . . . . 0.0 112.831 178.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -127.34 176.45 7.42 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.3 1.44 . . . . 0.0 108.617 179.126 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 77.9 mt -64.41 132.15 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 N-CA-C 104.255 -2.498 . . . . 0.0 104.255 169.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 21.6 t60 -129.4 150.84 50.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 118.73 0.695 . . . . 0.0 110.308 -169.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.3 t -133.36 135.22 56.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 -178.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -170.56 -171.18 1.02 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -170.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 109.65 -172.74 16.24 Favored Glycine 0 CA--C 1.523 0.55 0 CA-C-N 119.3 0.955 . . . . 0.0 113.32 169.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -157.4 154.02 28.17 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.923 1.689 . . . . 0.0 107.668 -169.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.5 t -126.27 140.25 52.68 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 169.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 21.7 ptp -80.62 -34.98 34.63 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 118.71 -0.662 . . . . 0.0 110.11 173.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.65 -25.03 49.32 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.068 0.849 . . . . 0.0 112.182 -177.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -133.13 -5.29 3.06 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -169.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.87 171.83 42.96 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-N 118.964 0.802 . . . . 0.0 112.044 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.78 137.24 34.92 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.299 2.0 . . . . 0.0 109.312 177.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.18 170.75 6.56 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.16 0.505 . . . . 0.0 111.114 171.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 21.6 mm100 -64.99 -32.82 74.73 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 119.255 -0.402 . . . . 0.0 111.955 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 35.8 m80 61.7 -30.99 0.07 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 128.316 2.646 . . . . 0.0 115.526 -174.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.56 -45.94 88.21 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.649 1.18 . . . . 0.0 111.179 173.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 73.5 mt -61.21 -46.16 97.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.43 -52.04 66.98 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.891 1.276 . . . . 0.0 110.522 -174.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.2 p -64.57 -44.13 91.7 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.418 -177.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -60.63 -41.53 95.08 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.811 1.187 . . . . 0.0 110.736 -179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 25.7 mmtp -65.93 -47.9 73.16 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 118.735 0.698 . . . . 0.0 111.102 176.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 56.6 mt -64.67 -41.87 93.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 119.194 0.906 . . . . 0.0 109.237 -176.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -56.59 -49.48 74.77 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 119.776 1.171 . . . . 0.0 109.619 175.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.76 -36.5 83.28 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 122.478 0.311 . . . . 0.0 111.765 -176.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -90.18 -15.29 31.78 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 118.674 -0.679 . . . . 0.0 112.452 -175.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -132.91 63.94 69.07 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 124.883 1.273 . . . . 0.0 109.369 176.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -71.05 -7.07 20.6 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.133 2.555 . . . . 0.0 112.835 -175.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -61.9 -20.27 63.57 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.382 1.073 . . . . 0.0 112.255 174.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -143.6 -165.97 2.22 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.48 1.112 . . . . 0.0 109.508 176.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -131.76 158.77 40.35 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.116 1.367 . . . . 0.0 108.988 -174.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.2 t -137.25 146.46 27.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 -172.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 17.2 p -136.15 168.21 19.81 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.809 1.244 . . . . 0.0 109.501 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 31.6 p-90 -146.62 156.07 42.94 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 121.762 -0.586 . . . . 0.0 110.411 171.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -159.27 117.96 2.89 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 169.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.76 -1.36 21.67 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 118.458 0.572 . . . . 0.0 112.297 -171.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -58.68 -31.36 68.14 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.441 1.096 . . . . 0.0 112.248 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -78.51 135.3 15.52 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 175.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 52.1 p90 . . . . . 0 C--O 1.239 0.519 0 C-N-CA 125.593 1.557 . . . . 0.0 109.397 171.625 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 126' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.9 tpp . . . . . 0 N--CA 1.482 1.135 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.08 168.3 20.63 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.427 1.091 . . . . 0.0 109.661 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.7 t -136.39 119.92 23.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 -178.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.67 -177.63 3.8 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.783 0.833 . . . . 0.0 111.111 177.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -152.93 146.5 25.04 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 169.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 61.3 mt -55.18 -34.3 63.73 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -173.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.22 -26.24 65.61 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.845 0.748 . . . . 0.0 112.159 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.2 mt -81.47 -23.46 37.4 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.513 0.725 . . . . 0.0 111.22 -177.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.8 mt -66.31 129.29 94.17 Favored Pre-proline 0 CA--C 1.538 0.514 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 -175.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -46.65 116.22 1.53 Allowed 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 124.195 3.263 . . . . 0.0 111.777 170.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -72.63 -31.73 65.36 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.603 0.761 . . . . 0.0 111.577 -172.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 64.2 t -141.72 137.24 31.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 171.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -151.18 110.84 4.02 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 169.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 40.5 pt -141.37 158.05 22.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 C-N-CA 124.211 1.005 . . . . 0.0 109.195 -170.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -75.21 -178.54 3.96 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.507 0.723 . . . . 0.0 110.308 172.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.2 m -147.91 0.09 0.63 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.963 1.305 . . . . 0.0 113.114 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -67.15 -25.36 66.13 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 120.159 1.345 . . . . 0.0 113.39 -171.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 176.79 -160.8 28.31 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -174.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.4 t -64.17 143.3 15.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 123.618 0.767 . . . . 0.0 109.243 172.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -156.58 157.84 36.03 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.179 0.991 . . . . 0.0 111.145 173.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.1 mmtm -72.46 152.65 41.81 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 173.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -142.1 160.05 41.0 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 175.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.4 m -130.15 152.98 38.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 124.615 1.166 . . . . 0.0 109.433 173.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.2 114.92 29.17 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 104.201 -2.518 . . . . 0.0 104.201 177.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 54.5 mt -118.88 124.88 73.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -172.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -78.24 148.09 34.1 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 169.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.3 t -132.12 145.53 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -127.55 148.51 50.34 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.762 1.225 . . . . 0.0 108.218 178.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.4 m -62.35 99.13 0.13 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.759 0.824 . . . . 0.0 110.92 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.488 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -142.44 20.15 0.04 OUTLIER Pre-proline 0 CA--C 1.552 1.028 0 CA-C-O 116.491 -1.719 . . . . 0.0 113.502 169.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.488 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 76.3 Cg_exo -45.29 140.53 7.97 Favored 'Trans proline' 0 C--N 1.363 1.301 0 CA-C-N 123.817 2.399 . . . . 0.0 114.174 177.081 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.3 tpp180 43.23 24.65 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.509 2.323 . . . . 0.0 114.325 -172.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.9 m 50.85 30.33 5.06 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.2 1.4 . . . . 0.0 112.353 -173.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -155.52 -2.04 0.12 Allowed Glycine 0 CA--C 1.53 0.998 0 CA-C-O 118.504 -1.164 . . . . 0.0 114.895 -171.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.09 137.86 80.08 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-N 119.517 1.658 . . . . 0.0 110.283 172.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -77.62 -20.86 11.84 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.866 2.377 . . . . 0.0 113.089 -178.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.93 159.63 22.43 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.598 0.759 . . . . 0.0 110.823 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -143.55 35.48 1.3 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.247 1.419 . . . . 0.0 109.624 178.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -84.29 -179.67 7.25 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.027 0.931 . . . . 0.0 109.448 177.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.5 m -141.84 160.5 40.06 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.628 1.171 . . . . 0.0 109.403 174.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -152.0 171.56 17.64 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 127.393 2.277 . . . . 0.0 106.509 -172.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.8 mp0 -133.24 157.66 44.86 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 172.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 30.3 pt -137.13 156.03 33.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 C-N-CA 125.717 1.607 . . . . 0.0 109.114 177.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 52.9 t -118.54 120.87 65.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 178.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 25.6 mmt85 -135.63 144.89 46.34 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 176.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 178.44 134.72 2.15 Favored Glycine 0 N--CA 1.453 -0.202 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -178.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.405 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 9.7 m-85 -154.79 155.53 34.64 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -169.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -58.02 -34.13 69.71 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.714 0.806 . . . . 0.0 112.07 -178.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.405 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 13.9 p-90 -67.32 -27.55 67.24 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 118.707 -0.663 . . . . 0.0 112.613 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.36 80.5 9.19 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 119.635 1.107 . . . . 0.0 109.104 175.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -64.23 -18.13 64.23 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.062 0.545 . . . . 0.0 112.0 175.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -134.07 151.05 51.24 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 126.601 1.961 . . . . 0.0 108.023 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -74.1 -31.92 63.0 Favored 'General case' 0 C--O 1.234 0.254 0 O-C-N 121.847 -0.533 . . . . 0.0 110.064 -169.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.32 -29.76 48.96 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 118.564 -0.731 . . . . 0.0 112.48 172.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -67.75 -50.65 56.12 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 119.289 0.95 . . . . 0.0 110.796 -175.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.442 ' H ' HG12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -67.36 -38.26 80.5 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.157 0 CA-C-O 117.846 -1.073 . . . . 0.0 110.036 176.009 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -59.92 -48.35 82.06 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.76 1.163 . . . . 0.0 110.317 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -63.54 -47.68 80.61 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.347 0.521 . . . . 0.0 111.495 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 31.6 tttt -61.2 -52.81 63.24 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 123.198 0.599 . . . . 0.0 111.144 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 92.6 t -70.94 -46.1 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-O 118.024 -0.989 . . . . 0.0 108.975 -172.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.8 m -62.32 -31.95 72.64 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 120.283 1.402 . . . . 0.0 111.055 176.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.16 -49.78 74.39 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-N 119.038 0.835 . . . . 0.0 111.077 171.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -61.68 -44.19 97.41 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 118.654 1.227 . . . . 0.0 111.61 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.6 mmt -59.39 -47.82 84.0 Favored 'General case' 0 C--O 1.226 -0.159 0 C-N-CA 123.06 0.544 . . . . 0.0 110.053 176.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -67.49 -28.61 67.99 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.85 0.75 . . . . 0.0 112.025 179.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -68.05 -36.98 80.79 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 119.585 1.084 . . . . 0.0 110.418 170.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -68.04 -29.74 68.79 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 119.625 1.102 . . . . 0.0 110.122 169.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 122.37 -23.17 7.26 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 128.13 2.776 . . . . 0.0 111.297 177.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 84.6 m -53.82 146.5 13.74 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 126.682 1.993 . . . . 0.0 111.321 -175.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -107.87 142.01 38.6 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 72.7 m -142.44 163.86 31.71 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -168.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -151.81 133.79 15.0 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.552 1.541 . . . . 0.0 107.668 170.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.6 p -72.22 115.76 11.84 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 169.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 45.6 mt -67.04 -24.98 66.05 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.986 -0.446 . . . . 0.0 110.002 172.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.92 -164.32 37.74 Favored Glycine 0 C--N 1.336 0.536 0 N-CA-C 108.374 -1.89 . . . . 0.0 108.374 172.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -155.13 -176.41 27.31 Favored Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 111.004 -0.838 . . . . 0.0 111.004 171.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -171.44 -156.4 11.82 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 -175.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.1 ttp180 -135.66 147.0 48.41 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 -177.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.3 mt -121.79 141.2 43.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 106.484 -1.672 . . . . 0.0 106.484 -174.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.2 m -141.43 170.06 16.44 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.018 1.327 . . . . 0.0 110.657 -171.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 7.0 m170 65.17 179.9 0.19 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.948 2.099 . . . . 0.0 111.546 -170.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -142.62 152.92 42.99 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.558 1.143 . . . . 0.0 108.799 -172.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.7 m -66.66 7.99 0.3 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.144 2.178 . . . . 0.0 115.163 -171.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -139.04 18.03 2.63 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.75 1.62 . . . . 0.0 110.04 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -137.05 -52.56 0.68 Allowed 'General case' 0 N--CA 1.467 0.384 0 O-C-N 121.581 -0.699 . . . . 0.0 112.291 -170.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -159.39 159.63 33.98 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.709 1.204 . . . . 0.0 107.768 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 42.0 pttt -48.34 137.01 11.7 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 172.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 41.7 mm -59.21 149.04 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 176.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 19.4 t60 -131.15 152.32 50.56 Favored 'General case' 0 CA--C 1.515 -0.367 0 O-C-N 121.554 -0.716 . . . . 0.0 109.699 176.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.6 t -133.22 132.57 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 -176.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -160.15 -167.93 2.07 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.937 1.295 . . . . 0.0 108.886 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.15 -171.34 42.96 Favored Glycine 0 CA--C 1.525 0.703 0 O-C-N 121.612 -0.68 . . . . 0.0 113.632 176.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -161.87 152.89 18.01 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.523 1.129 . . . . 0.0 110.123 -169.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.5 t -81.59 168.45 18.17 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 167.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 20.8 ptp -111.44 -29.68 7.69 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 121.215 -0.928 . . . . 0.0 111.39 170.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.19 -25.76 59.88 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.716 1.144 . . . . 0.0 111.434 171.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -131.76 -7.14 3.6 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.886 0.874 . . . . 0.0 113.015 -169.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.39 -179.11 48.94 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 123.735 0.683 . . . . 0.0 113.638 172.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -68.4 142.08 53.33 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.83 2.354 . . . . 0.0 110.743 173.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.68 178.19 6.26 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 168.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -63.61 -28.4 69.9 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 119.045 -0.503 . . . . 0.0 111.868 170.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 59.08 -23.16 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 128.283 2.633 . . . . 0.0 116.63 -173.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.72 -39.04 93.31 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.688 1.195 . . . . 0.0 110.794 172.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 75.3 mt -63.33 -44.44 99.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 175.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.1 -44.62 94.71 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.135 0.974 . . . . 0.0 111.252 -177.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.54 -51.0 67.3 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 119.275 0.943 . . . . 0.0 110.611 176.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -57.6 -43.98 85.1 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.027 0.83 . . . . 0.0 110.62 -177.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -71.41 -40.27 70.57 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 118.102 -0.951 . . . . 0.0 111.832 -178.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 83.8 mt -69.3 -34.89 64.96 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-N 120.78 1.627 . . . . 0.0 108.957 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -61.84 -43.72 98.29 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 120.404 1.457 . . . . 0.0 110.385 171.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.86 -37.67 87.78 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.922 0.783 . . . . 0.0 111.615 178.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 41.6 tptt -66.61 -38.2 86.49 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.804 0.842 . . . . 0.0 111.142 176.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -130.7 68.97 82.24 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 124.208 1.003 . . . . 0.0 110.048 -171.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -68.47 -19.4 42.99 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.536 2.158 . . . . 0.0 112.519 -175.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -73.53 -5.37 39.71 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.706 1.202 . . . . 0.0 112.258 172.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -136.64 -168.43 2.26 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.824 1.65 . . . . 0.0 109.396 -173.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -147.62 164.01 34.83 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.774 0.797 . . . . 0.0 110.138 -178.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.7 p -145.99 154.26 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 126.163 1.785 . . . . 0.0 106.755 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 21.2 p -139.05 171.48 14.25 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.923 0.889 . . . . 0.0 109.399 171.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 19.6 p-90 -141.56 151.95 43.65 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 169.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.46 137.05 12.13 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 103.933 -2.617 . . . . 0.0 103.933 169.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -80.7 46.49 0.88 Allowed 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 119.395 0.998 . . . . 0.0 109.708 178.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -67.28 -28.47 68.04 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 125.584 1.554 . . . . 0.0 112.442 -169.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -170.49 -175.37 39.19 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 125.194 1.378 . . . . 0.0 109.737 -178.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 73.8 t80 . . . . . 0 C--O 1.234 0.272 0 CA-C-O 121.267 0.556 . . . . 0.0 109.926 -178.719 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 126' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtt . . . . . 0 N--CA 1.482 1.163 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.09 169.5 22.23 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.223 1.409 . . . . 0.0 108.693 176.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.52 140.6 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 177.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -76.65 179.91 5.72 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.472 0.709 . . . . 0.0 110.895 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -149.68 153.22 36.63 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 125.963 1.705 . . . . 0.0 106.486 171.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 44.2 mt -56.39 -33.18 65.5 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 118.697 0.681 . . . . 0.0 112.666 -176.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.52 -25.49 65.87 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.919 0.781 . . . . 0.0 112.167 177.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.1 mt -86.64 -21.91 26.47 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.87 0.868 . . . . 0.0 111.372 -176.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 56.7 mt -64.54 128.56 93.55 Favored Pre-proline 0 CA--C 1.54 0.559 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 178.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -46.3 114.94 0.97 Allowed 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 124.232 3.288 . . . . 0.0 111.58 172.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -72.08 -30.81 65.49 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.369 0.668 . . . . 0.0 112.071 -169.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 42.3 t -143.12 142.47 25.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 171.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -151.38 127.8 10.67 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 169.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 40.9 pt -147.53 163.98 6.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 127.622 2.369 . . . . 0.0 106.219 -176.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -143.82 -37.55 0.33 Allowed 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.01 165.69 12.87 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.27 0.628 . . . . 0.0 111.069 172.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -143.97 84.78 1.79 Allowed 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.844 1.258 . . . . 0.0 108.089 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.3 -166.05 39.38 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 -173.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 66.6 t -66.45 126.75 26.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 169.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -160.05 158.37 30.34 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.782 0.833 . . . . 0.0 110.815 169.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -77.86 154.12 32.07 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.019 0.928 . . . . 0.0 110.495 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -142.28 164.91 28.88 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.313 1.045 . . . . 0.0 108.891 175.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.9 m -132.14 152.91 37.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 C-N-CA 124.589 1.156 . . . . 0.0 109.287 172.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.2 tp -108.11 117.95 35.49 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 177.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 95.4 mt -122.7 123.04 67.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -171.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -79.57 147.8 31.98 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 169.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.5 p -138.38 146.99 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 175.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 -120.01 156.96 29.85 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.852 1.261 . . . . 0.0 108.78 -176.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.4 m -63.15 87.64 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.698 1.199 . . . . 0.0 111.922 177.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.415 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -138.55 19.39 0.05 OUTLIER Pre-proline 0 CA--C 1.551 1.019 0 CA-C-O 116.405 -1.759 . . . . 0.0 114.449 169.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 30' ' ' ALA . 80.1 Cg_exo -43.96 137.33 6.98 Favored 'Trans proline' 0 C--N 1.36 1.157 0 CA-C-N 123.976 2.456 . . . . 0.0 113.681 172.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.4 mmp_? 42.38 25.45 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 127.497 2.319 . . . . 0.0 114.339 -172.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.2 m 50.4 30.57 4.66 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.028 1.331 . . . . 0.0 112.236 -173.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -153.47 -1.61 0.17 Allowed Glycine 0 CA--C 1.53 0.992 0 CA-C-O 118.508 -1.162 . . . . 0.0 114.684 -169.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.29 135.25 75.66 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 119.462 1.631 . . . . 0.0 109.846 170.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -77.99 -21.31 10.96 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.764 2.309 . . . . 0.0 113.201 -176.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.16 162.95 18.69 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.696 0.799 . . . . 0.0 110.851 177.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.24 66.9 0.96 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.996 1.319 . . . . 0.0 108.42 177.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -133.38 -172.26 2.91 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.739 1.616 . . . . 0.0 108.514 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.8 m -142.26 158.17 44.02 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.958 0.903 . . . . 0.0 110.334 -174.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -149.21 166.01 30.16 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 127.56 2.344 . . . . 0.0 105.947 -175.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.8 mp0 -125.33 151.6 45.83 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 174.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 21.2 pt -127.27 155.04 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 125.997 1.719 . . . . 0.0 108.594 173.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 85.1 t -127.87 115.96 41.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 -173.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 26.7 mmt85 -135.33 139.82 44.6 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -176.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -170.92 141.61 6.6 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 178.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -156.1 149.02 24.15 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -171.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -58.77 -32.83 69.65 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 118.839 -0.6 . . . . 0.0 111.61 174.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 9.7 p-90 -65.32 -26.83 68.22 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.018 0.826 . . . . 0.0 112.489 177.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.41 73.44 10.5 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 119.337 0.971 . . . . 0.0 109.524 175.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -65.67 -8.56 21.27 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.35 0.66 . . . . 0.0 112.104 176.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -138.17 144.91 40.94 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 126.896 2.079 . . . . 0.0 106.836 177.021 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 60.9 m80 -71.44 -31.13 66.84 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 121.885 -0.509 . . . . 0.0 109.979 -171.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.47 -27.27 47.31 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 118.258 -0.877 . . . . 0.0 112.676 171.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -68.33 -48.93 63.58 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 119.818 1.19 . . . . 0.0 110.763 -176.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.438 ' H ' HG12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -67.32 -40.26 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 CA-C-O 117.732 -1.127 . . . . 0.0 109.782 175.78 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -62.49 -44.66 95.85 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 120.047 1.294 . . . . 0.0 110.599 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -62.49 -47.34 84.42 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.818 0.735 . . . . 0.0 111.369 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 31.7 tttt -62.29 -53.59 52.92 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.245 0.618 . . . . 0.0 110.999 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 92.0 t -73.52 -48.35 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-O 118.539 -0.743 . . . . 0.0 109.179 -171.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.0 t -63.32 -34.74 78.35 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 119.568 1.076 . . . . 0.0 109.759 178.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.28 -48.59 85.24 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-N 118.978 0.808 . . . . 0.0 111.182 172.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -63.02 -43.6 98.29 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 118.69 1.245 . . . . 0.0 111.596 178.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 39.2 mmt -59.27 -47.31 85.85 Favored 'General case' 0 CA--C 1.527 0.077 0 C-N-CA 122.769 0.428 . . . . 0.0 110.111 176.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -64.92 -32.69 74.53 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.423 0.689 . . . . 0.0 111.274 179.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -67.4 -35.65 79.71 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.443 1.019 . . . . 0.0 111.052 170.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -69.03 -15.8 63.55 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 119.838 1.199 . . . . 0.0 111.286 169.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 109.17 -18.82 30.46 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 126.838 2.161 . . . . 0.0 111.94 177.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 73.1 m -57.05 162.91 2.27 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.654 1.982 . . . . 0.0 112.874 -175.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -123.25 137.35 54.89 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 176.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 80.4 m -142.69 166.17 25.4 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -168.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -151.09 131.65 13.88 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.797 1.239 . . . . 0.0 108.32 170.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.3 p -69.74 115.77 9.36 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 169.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 64.3 mt -66.97 -26.93 67.06 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.984 0.514 . . . . 0.0 109.95 173.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.08 -172.97 42.92 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 169.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -123.13 165.52 15.76 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 110.951 -0.859 . . . . 0.0 110.951 175.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -168.54 -163.56 22.74 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -178.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.7 ttp180 -146.45 158.37 43.88 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 121.141 -1.211 . . . . 0.0 107.763 -175.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 56.7 mt -120.98 130.79 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 104.851 -2.278 . . . . 0.0 104.851 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 30.1 m -152.33 176.49 11.56 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.478 1.911 . . . . 0.0 108.237 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -81.24 150.57 28.53 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 168.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -62.29 -35.46 79.1 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.888 0.767 . . . . 0.0 112.876 -174.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 77.7 p -170.73 -147.9 0.06 Allowed 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 -172.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -64.54 -20.36 66.18 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.486 0.585 . . . . 0.0 110.52 168.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -76.24 136.16 39.68 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 123.538 0.735 . . . . 0.0 109.161 169.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -80.92 -6.59 58.87 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 117.405 -1.283 . . . . 0.0 113.909 -169.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -50.37 129.25 21.45 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 120.052 1.296 . . . . 0.0 108.587 177.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 49.6 mm -69.12 146.0 12.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -176.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 12.4 t60 -130.29 143.11 50.58 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 54.5 t -131.82 106.0 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 -169.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -164.16 162.86 23.02 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.311 0.644 . . . . 0.0 109.517 -175.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 143.08 -169.08 25.85 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -155.85 151.66 27.41 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.101 0.56 . . . . 0.0 110.64 171.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.4 t -90.41 161.34 15.61 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 168.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 27.6 ptm -94.04 -33.91 13.22 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 118.995 0.816 . . . . 0.0 110.018 169.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.6 -25.38 56.94 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.905 0.775 . . . . 0.0 112.006 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -133.46 -4.13 2.98 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -169.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.83 -175.39 52.03 Favored Glycine 0 CA--C 1.535 1.326 0 CA-C-N 119.031 0.832 . . . . 0.0 113.344 173.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.99 138.8 37.93 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.385 2.724 . . . . 0.0 111.206 175.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.24 168.44 17.29 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 168.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 23.0 mm100 -68.55 -27.07 65.76 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.856 -0.528 . . . . 0.0 111.864 172.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 37.6 m80 60.48 -29.24 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 128.962 2.905 . . . . 0.0 115.895 -175.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.8 -40.66 93.5 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.536 1.134 . . . . 0.0 112.467 -179.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.3 mp -62.55 -46.33 96.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 177.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.3 m -59.47 -47.22 86.34 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 123.892 0.877 . . . . 0.0 110.621 -176.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.5 p -64.77 -41.12 96.1 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 118.097 -0.954 . . . . 0.0 111.065 -176.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -58.91 -45.51 90.13 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.951 1.25 . . . . 0.0 110.649 177.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 44.3 mttm -67.41 -46.24 73.79 Favored 'General case' 0 N--CA 1.462 0.158 0 O-C-N 122.128 -0.358 . . . . 0.0 111.037 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 55.7 mt -68.57 -38.05 78.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -176.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -58.62 -42.15 87.56 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 120.523 1.511 . . . . 0.0 110.031 174.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.0 -40.41 96.3 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.646 0.657 . . . . 0.0 111.369 177.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -66.89 -23.06 65.95 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.197 0.599 . . . . 0.0 112.205 174.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 9.9 t80 50.19 53.19 13.78 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 126.327 1.851 . . . . 0.0 113.244 174.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -71.19 -16.08 31.76 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 122.193 1.928 . . . . 0.0 111.78 173.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -148.5 166.66 27.53 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 127.481 2.312 . . . . 0.0 106.861 177.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -49.58 -40.73 39.7 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.938 1.295 . . . . 0.0 112.695 178.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -157.64 165.87 34.35 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 119.197 0.908 . . . . 0.0 110.757 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.4 t -140.12 143.94 28.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 126.389 1.876 . . . . 0.0 106.04 -175.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 6.3 p -139.66 170.23 16.28 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.335 1.054 . . . . 0.0 109.879 177.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 39.5 p-90 -140.96 161.28 38.21 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 169.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -158.47 141.92 15.11 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 103.915 -2.624 . . . . 0.0 103.915 169.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -80.84 48.83 1.13 Allowed 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 119.216 0.917 . . . . 0.0 109.269 176.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -66.7 -33.68 76.17 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 125.018 1.327 . . . . 0.0 113.476 -169.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 162.75 -159.94 32.31 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -171.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 86.1 t80 . . . . . 0 C--O 1.237 0.443 0 CA-C-O 121.46 0.647 . . . . 0.0 109.899 173.911 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 126' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 N--CA 1.484 1.261 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.25 168.73 23.17 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.329 1.452 . . . . 0.0 108.627 176.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.2 p -147.35 143.33 19.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 178.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -81.0 -176.42 5.92 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.205 0.602 . . . . 0.0 110.526 178.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -152.39 151.25 30.59 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 169.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 78.1 mt -56.08 -34.62 66.14 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.273 0.629 . . . . 0.0 112.549 -176.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.1 -25.21 65.21 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.691 0.678 . . . . 0.0 112.08 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.5 mt -83.41 -21.74 32.91 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.539 0.736 . . . . 0.0 111.328 -177.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.4 mt -65.34 127.48 92.96 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 177.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -47.76 125.38 11.15 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 123.649 2.899 . . . . 0.0 111.193 171.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -76.48 -36.44 57.84 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.097 0.475 . . . . 0.0 111.008 -173.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.6 t -140.67 133.07 31.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 177.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -154.56 119.76 5.02 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 105.072 -2.196 . . . . 0.0 105.072 169.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.7 pp -145.6 158.9 12.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 C-N-CA 124.477 1.111 . . . . 0.0 109.53 -171.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -74.11 -179.61 3.91 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.963 1.705 . . . . 0.0 110.455 171.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.9 m -142.92 22.3 1.93 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.978 1.311 . . . . 0.0 111.227 -177.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -57.48 -39.99 77.63 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -169.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 152.95 -50.35 0.51 Allowed Glycine 0 C--N 1.336 0.534 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 177.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.3 t -146.32 130.62 10.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 105.642 -1.985 . . . . 0.0 105.642 170.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -159.34 152.85 22.64 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.931 0.787 . . . . 0.0 110.385 178.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -72.94 151.32 41.91 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.702 0.801 . . . . 0.0 110.758 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -144.12 161.85 37.78 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.848 1.259 . . . . 0.0 107.845 177.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.5 m -130.34 151.45 35.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 C-N-CA 124.24 1.016 . . . . 0.0 109.349 174.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.74 114.58 28.88 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 103.643 -2.725 . . . . 0.0 103.643 176.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.8 mt -120.31 124.79 73.28 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -172.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.2 ttm180 -78.93 143.69 35.57 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 168.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.5 p -137.39 136.88 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 178.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -107.18 148.91 28.29 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.889 1.275 . . . . 0.0 109.006 -172.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.1 p -72.43 85.25 1.12 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.56 0.695 . . . . 0.0 111.138 178.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -131.52 33.07 0.23 Allowed Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 124.602 1.161 . . . . 0.0 112.368 169.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -60.61 141.94 96.54 Favored 'Trans proline' 0 C--N 1.354 0.824 0 CA-C-N 122.133 1.798 . . . . 0.0 109.961 -178.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.0 mmp_? 44.37 21.86 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.86 2.064 . . . . 0.0 113.953 -169.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.5 m 48.2 30.89 2.34 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.362 1.465 . . . . 0.0 112.428 -171.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -125.03 -18.81 2.53 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-O 118.751 -1.027 . . . . 0.0 114.068 -169.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.29 133.37 95.44 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 119.124 1.462 . . . . 0.0 110.013 176.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -79.36 -14.94 12.86 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.087 2.524 . . . . 0.0 112.599 176.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.4 164.57 8.94 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.117 0.967 . . . . 0.0 111.089 176.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -148.86 48.91 1.0 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.968 1.307 . . . . 0.0 108.573 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -102.4 175.89 5.36 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 125.963 1.705 . . . . 0.0 108.692 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.6 m -139.85 158.85 43.41 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.639 0.776 . . . . 0.0 110.256 175.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -142.07 166.41 24.78 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 127.973 2.509 . . . . 0.0 105.417 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 30.7 mp0 -126.69 149.75 49.38 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.1 pt -132.94 155.62 41.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 C-N-CA 125.059 1.344 . . . . 0.0 109.86 178.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 85.3 t -117.66 114.93 46.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.9 mmp_? -126.6 147.14 49.93 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 173.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 178.72 139.27 3.46 Favored Glycine 0 C--N 1.331 0.259 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 176.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.404 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 20.6 m-85 -154.59 150.22 27.49 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 123.397 0.679 . . . . 0.0 109.344 -171.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.4 tptt -62.31 -26.55 68.49 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 118.578 -0.725 . . . . 0.0 112.055 177.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.404 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 9.9 p-90 -63.86 -27.93 69.5 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.677 1.126 . . . . 0.0 112.28 176.028 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.63 76.05 10.04 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 119.242 0.928 . . . . 0.0 109.491 174.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -66.77 -5.79 13.49 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.219 0.607 . . . . 0.0 112.135 175.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -139.43 144.39 38.05 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 126.471 1.908 . . . . 0.0 107.026 175.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -70.62 -30.98 67.77 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 121.979 -0.451 . . . . 0.0 110.036 -171.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.55 -30.15 40.5 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 118.759 -0.639 . . . . 0.0 112.627 172.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -68.09 -50.52 54.4 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 119.134 0.879 . . . . 0.0 110.804 -175.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.431 ' H ' HG12 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -67.08 -38.42 81.2 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.19 0 CA-C-O 117.761 -1.114 . . . . 0.0 109.935 174.85 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -60.16 -46.11 90.79 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 120.191 1.36 . . . . 0.0 110.91 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -65.35 -48.47 72.87 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 122.644 0.377 . . . . 0.0 111.275 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 44.3 tttt -62.29 -49.12 76.91 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 123.304 0.642 . . . . 0.0 111.479 -176.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 86.7 t -75.15 -45.5 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-O 118.423 -0.799 . . . . 0.0 109.33 -172.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.9 m -61.85 -35.82 79.42 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 119.423 1.01 . . . . 0.0 110.103 175.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.7 -48.02 87.15 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 173.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -63.35 -45.27 91.99 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 118.96 1.38 . . . . 0.0 111.429 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 39.1 mmt -59.57 -43.9 93.47 Favored 'General case' 0 C--O 1.227 -0.091 0 CA-C-N 118.202 0.456 . . . . 0.0 109.933 177.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -68.58 -27.92 66.48 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.716 0.807 . . . . 0.0 111.752 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -69.39 -36.86 77.18 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 119.455 1.025 . . . . 0.0 109.749 169.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -68.09 -25.79 65.5 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 119.928 1.24 . . . . 0.0 110.266 169.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 122.25 -27.63 6.04 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 128.237 2.827 . . . . 0.0 111.313 174.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 97.2 m -58.58 145.23 40.2 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 126.07 1.748 . . . . 0.0 110.691 -177.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -108.43 156.28 19.62 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 177.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 86.1 m -141.48 165.42 27.56 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 -168.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -150.92 132.7 14.98 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.546 1.538 . . . . 0.0 107.085 169.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.6 p -70.82 121.05 17.32 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 169.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 38.1 mt -70.34 -23.2 62.77 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.99 -0.444 . . . . 0.0 109.902 171.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.94 -166.27 39.04 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 170.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -146.86 173.12 27.17 Favored Glycine 0 CA--C 1.52 0.387 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 172.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -172.35 -156.13 12.07 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 107.356 -2.298 . . . . 0.0 107.356 -178.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 26.9 ptt-85 -142.31 160.25 40.62 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 120.614 -1.521 . . . . 0.0 109.403 176.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 93.7 mt -118.09 145.03 24.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 104.404 -2.443 . . . . 0.0 104.404 -174.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.8 p -144.5 163.07 34.94 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 123.424 0.69 . . . . 0.0 110.393 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -112.08 31.36 6.3 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.089 1.356 . . . . 0.0 109.723 176.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 51.74 -164.8 0.06 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 127.368 2.267 . . . . 0.0 112.677 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.4 p -67.01 -46.92 73.03 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.875 1.27 . . . . 0.0 111.043 176.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -158.36 -39.47 0.06 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.829 0.851 . . . . 0.0 111.522 -177.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -60.09 140.28 56.96 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 118.422 0.556 . . . . 0.0 110.696 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -70.78 -12.94 61.85 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -169.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -58.68 127.53 32.66 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 120.783 1.628 . . . . 0.0 108.167 177.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 71.6 mt -75.18 154.34 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 105.642 -1.984 . . . . 0.0 105.642 174.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 23.1 t60 -138.36 159.08 42.97 Favored 'General case' 0 C--N 1.331 -0.221 0 O-C-N 120.836 -1.165 . . . . 0.0 109.98 177.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.0 t -137.49 130.89 43.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -162.28 -173.99 3.86 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.047 0.939 . . . . 0.0 109.869 -172.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.38 -172.33 50.4 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 123.659 0.647 . . . . 0.0 112.285 178.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -160.79 151.55 18.47 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.716 0.806 . . . . 0.0 111.05 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.0 t -72.43 164.86 25.67 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 168.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 23.0 ptp -111.69 -28.92 7.91 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 118.359 -0.829 . . . . 0.0 111.174 171.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.14 -26.5 60.36 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.737 1.153 . . . . 0.0 111.428 171.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -131.13 -6.04 3.88 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.777 0.831 . . . . 0.0 113.139 -169.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.18 -179.21 42.79 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 123.603 0.62 . . . . 0.0 113.504 173.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.17 135.62 40.99 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.067 2.512 . . . . 0.0 110.633 176.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.74 169.36 18.43 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 169.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -77.98 81.93 4.36 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 168.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -57.45 -14.94 5.57 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -175.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.58 -39.91 89.79 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.019 1.328 . . . . 0.0 111.47 170.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 63.0 mt -64.5 -47.18 90.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 176.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.9 -50.12 74.42 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.142 0.977 . . . . 0.0 110.526 -176.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 10.1 p -64.56 -47.48 78.58 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 119.243 0.929 . . . . 0.0 111.276 -176.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -60.21 -40.3 89.63 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.397 0.999 . . . . 0.0 110.475 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 49.2 mttm -65.45 -49.08 70.46 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 119.187 -0.435 . . . . 0.0 111.356 176.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 62.9 mt -64.54 -40.14 88.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-N 119.067 0.849 . . . . 0.0 109.16 -176.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -58.62 -48.13 82.04 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.605 1.093 . . . . 0.0 109.633 174.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.86 -39.06 93.27 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.56 0.344 . . . . 0.0 111.328 -178.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 21.7 tptm -67.19 -38.99 86.32 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 118.758 -0.639 . . . . 0.0 110.987 177.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -128.32 69.13 78.08 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 123.808 0.843 . . . . 0.0 110.605 -169.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.34 -12.63 35.5 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 122.857 2.372 . . . . 0.0 112.991 -177.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.45 -9.73 54.93 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.209 1.003 . . . . 0.0 112.274 170.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -126.84 -178.37 4.37 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.613 1.965 . . . . 0.0 108.647 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -136.91 159.17 42.66 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 171.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.4 t -141.01 140.19 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 -171.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.3 p -134.55 173.67 11.39 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 169.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 37.6 p-90 -142.27 156.17 45.27 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.242 0.544 . . . . 0.0 109.905 174.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.71 123.89 5.28 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 103.161 -2.903 . . . . 0.0 103.161 173.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -80.28 27.5 0.33 Allowed 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.484 1.038 . . . . 0.0 113.171 -169.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -67.24 -178.0 0.76 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.783 0.833 . . . . 0.0 109.486 169.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 91.53 -143.2 16.45 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.044 -1.223 . . . . 0.0 110.044 -176.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 86.5 t80 . . . . . 0 C--O 1.239 0.523 0 C-N-CA 124.827 1.251 . . . . 0.0 109.523 -176.628 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 126' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 N--CA 1.483 1.178 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.79 172.09 14.18 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 125.23 1.412 . . . . 0.0 108.421 174.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.2 p -152.36 166.17 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 174.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.56 176.03 3.14 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 118.454 0.57 . . . . 0.0 110.933 178.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -155.04 153.22 30.61 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.226 1.011 . . . . 0.0 108.399 177.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.0 mt -54.36 -32.83 57.82 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.771 0.828 . . . . 0.0 112.401 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.79 -23.61 67.43 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.76 0.709 . . . . 0.0 112.527 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 76.0 mt -74.83 -26.72 59.91 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 118.512 0.596 . . . . 0.0 110.944 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.2 mt -72.42 133.03 83.33 Favored Pre-proline 0 C--O 1.239 0.503 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 -177.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.23 135.0 48.21 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 121.067 1.178 . . . . 0.0 109.229 169.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -72.61 -33.48 66.7 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.325 0.583 . . . . 0.0 111.404 -175.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 51.0 t -135.25 138.89 47.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 105.221 -2.14 . . . . 0.0 105.221 172.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -149.92 129.4 13.03 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 169.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.5 pt -146.3 158.9 11.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 126.676 1.99 . . . . 0.0 106.305 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -151.39 44.89 0.79 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 122.004 0.907 . . . . 0.0 110.047 177.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.5 m -145.71 172.39 13.36 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.549 1.54 . . . . 0.0 110.045 -177.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -155.48 167.09 31.52 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.515 1.526 . . . . 0.0 108.232 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.15 -72.14 2.89 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 124.781 1.181 . . . . 0.0 111.194 175.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 70.7 t -154.39 130.4 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 126.511 1.924 . . . . 0.0 106.871 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -163.88 158.31 19.74 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.097 0.959 . . . . 0.0 110.594 169.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -79.53 158.11 27.26 Favored 'General case' 0 C--O 1.233 0.231 0 O-C-N 121.697 -0.627 . . . . 0.0 109.653 176.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.3 163.35 35.79 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.365 1.066 . . . . 0.0 108.805 176.13 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.2 m -136.65 157.0 36.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 124.655 1.182 . . . . 0.0 110.127 172.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.34 119.59 39.94 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 104.732 -2.322 . . . . 0.0 104.732 177.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 57.2 mt -121.29 114.51 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 CA-C-N 119.488 1.04 . . . . 0.0 108.48 -172.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 24.0 ttm-85 -71.54 138.12 48.61 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 104.967 -2.235 . . . . 0.0 104.967 168.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.4 p -136.31 116.49 17.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 178.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -81.7 142.83 32.33 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 169.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.1 t -67.72 117.01 9.06 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 169.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.444 ' N ' ' HD3' ' A' ' 31' ' ' PRO . . . -143.57 43.11 0.42 Allowed Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 123.781 0.833 . . . . 0.0 108.921 168.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.444 ' HD3' ' N ' ' A' ' 30' ' ' ALA . 31.9 Cg_exo -56.56 131.98 48.99 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.063 1.842 . . . . 0.0 111.731 -169.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.2 ttp180 39.44 30.96 0.06 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 127.281 2.232 . . . . 0.0 113.849 -171.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.3 m 52.53 22.18 2.07 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.449 1.5 . . . . 0.0 113.661 -174.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -97.07 -15.39 39.04 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 124.507 1.051 . . . . 0.0 112.584 -176.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -140.81 60.75 13.7 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 125.229 1.412 . . . . 0.0 108.985 177.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -65.17 135.22 42.52 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 123.083 2.522 . . . . 0.0 112.204 -170.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 38.94 45.69 1.0 Allowed 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 127.494 2.318 . . . . 0.0 113.382 -176.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.29 -37.33 87.11 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.616 -1.174 . . . . 0.0 110.506 176.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -157.38 174.64 15.11 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.591 1.956 . . . . 0.0 107.415 -170.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.0 m -141.86 157.49 44.93 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.941 0.896 . . . . 0.0 110.435 173.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -148.98 165.28 32.1 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 127.767 2.427 . . . . 0.0 106.651 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -125.93 126.89 45.12 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.341 -1.725 . . . . 0.0 106.341 170.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 30.4 pt -110.01 155.51 11.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 125.044 1.338 . . . . 0.0 110.267 175.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 24.5 t -120.43 125.89 74.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 -175.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.4 mmp_? -129.65 146.59 51.43 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.965 1.306 . . . . 0.0 107.739 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -172.98 133.99 2.81 Favored Glycine 0 N--CA 1.453 -0.208 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 169.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.405 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 10.7 m-85 -152.21 159.72 43.51 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -177.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -78.73 -26.13 44.7 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 121.793 -0.567 . . . . 0.0 109.894 -176.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.405 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 12.9 p-90 -61.33 -31.99 71.87 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 119.183 -0.437 . . . . 0.0 111.671 174.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -86.79 71.66 10.29 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 118.735 0.698 . . . . 0.0 109.524 173.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -63.42 -15.39 57.48 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 122.893 0.477 . . . . 0.0 111.775 177.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.41 144.24 51.09 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 126.548 1.939 . . . . 0.0 107.891 177.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 43.6 m80 -68.45 -34.6 76.25 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 119.148 -0.453 . . . . 0.0 112.134 -169.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.08 -28.89 55.85 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 118.311 -0.852 . . . . 0.0 112.645 174.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -68.29 -48.58 64.59 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 119.633 1.106 . . . . 0.0 111.323 -174.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.418 ' H ' HG12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -65.92 -41.28 89.61 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 CA-C-O 118.438 -0.791 . . . . 0.0 109.772 176.152 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -61.72 -53.34 57.42 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 118.317 -0.849 . . . . 0.0 109.722 -178.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -60.1 -42.85 95.56 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.16 0.891 . . . . 0.0 111.841 -176.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 31.6 tttt -60.52 -51.14 70.72 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 123.226 0.61 . . . . 0.0 110.796 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 63.9 t -84.74 -36.98 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-O 117.949 -1.024 . . . . 0.0 111.28 -169.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 71.7 p -64.43 -31.89 73.29 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 120.871 1.669 . . . . 0.0 109.684 171.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.66 -50.03 72.11 Favored Glycine 0 C--N 1.337 0.638 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 171.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -62.07 -43.34 99.04 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 118.68 1.24 . . . . 0.0 111.726 178.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 34.6 mmt -60.05 -46.08 90.71 Favored 'General case' 0 C--O 1.225 -0.191 0 N-CA-C 109.776 -0.454 . . . . 0.0 109.776 178.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -68.47 -27.91 66.57 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.606 0.762 . . . . 0.0 112.127 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -68.34 -37.22 80.32 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.34 0.973 . . . . 0.0 109.953 169.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -69.42 -25.37 64.09 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 119.631 1.105 . . . . 0.0 110.494 169.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 120.17 -26.35 7.1 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 127.996 2.713 . . . . 0.0 111.543 177.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 89.7 m -56.06 153.26 9.22 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 126.377 1.871 . . . . 0.0 111.51 -177.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -120.07 140.02 51.66 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -169.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 77.2 m -131.54 165.83 22.74 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 -167.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -153.13 122.48 6.67 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.72 2.008 . . . . 0.0 106.486 172.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.8 p -71.47 120.69 17.41 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 169.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 42.1 mt -68.53 -27.23 65.92 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.996 -0.44 . . . . 0.0 110.109 175.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 171.05 -171.38 43.87 Favored Glycine 0 C--N 1.337 0.592 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 175.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -138.09 164.37 25.56 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 176.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -168.54 -162.16 20.06 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -176.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 57.4 ttt180 -138.78 144.71 39.51 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 121.034 -1.274 . . . . 0.0 107.582 -172.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 99.6 mt -112.28 134.74 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 104.309 -2.478 . . . . 0.0 104.309 172.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.1 m -135.64 164.17 28.47 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 123.753 0.821 . . . . 0.0 108.986 172.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -128.64 21.54 5.99 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.624 1.569 . . . . 0.0 110.65 -175.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -134.04 31.7 3.54 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.964 1.706 . . . . 0.0 108.894 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 90.3 p -67.36 167.72 11.99 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.524 1.129 . . . . 0.0 110.596 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -64.19 -26.14 68.38 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.888 -0.508 . . . . 0.0 110.252 169.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.414 ' O ' ' HE3' ' A' ' 87' ' ' LYS . 34.8 t70 -83.08 -9.85 59.01 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.455 1.102 . . . . 0.0 112.228 178.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 81.8 tttt 65.92 -33.88 0.19 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 128.452 2.701 . . . . 0.0 114.321 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.414 ' HE3' ' O ' ' A' ' 85' ' ' ASP . 0.0 OUTLIER -57.95 157.99 7.15 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 119.495 1.043 . . . . 0.0 109.159 169.625 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.9 pt -58.73 134.97 23.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 168.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 40.9 t60 -132.81 146.62 51.98 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -169.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.9 t -125.08 129.56 73.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 -171.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -161.58 -169.1 2.16 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.673 1.189 . . . . 0.0 107.836 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 103.06 176.11 26.58 Favored Glycine 0 CA--C 1.522 0.53 0 CA-C-N 119.423 1.01 . . . . 0.0 112.113 169.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -151.85 143.85 23.82 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 122.953 0.501 . . . . 0.0 109.965 169.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.8 t -72.79 165.58 24.57 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 168.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 27.7 ptm -103.53 -30.5 10.48 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 118.558 -0.735 . . . . 0.0 110.486 169.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.42 -24.19 53.98 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.403 1.001 . . . . 0.0 111.874 174.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -134.76 -6.98 2.44 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -169.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.24 -173.5 54.91 Favored Glycine 0 CA--C 1.537 1.436 0 CA-C-N 119.325 0.966 . . . . 0.0 113.712 174.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -67.33 156.33 66.66 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.425 2.75 . . . . 0.0 111.116 176.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -104.88 166.16 10.57 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.68 1.192 . . . . 0.0 109.774 171.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -78.99 85.72 4.91 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 169.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -58.43 -16.47 15.06 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -178.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.82 -42.04 78.87 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.595 1.158 . . . . 0.0 111.473 170.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 59.1 mt -65.58 -46.95 88.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.98 -50.51 73.13 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.795 0.838 . . . . 0.0 110.802 -177.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.6 p -66.54 -44.26 82.88 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.891 -174.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -58.09 -43.63 87.18 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.754 1.161 . . . . 0.0 110.34 178.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -69.58 -44.58 70.51 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-O 118.976 -0.535 . . . . 0.0 111.407 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 62.9 mt -66.64 -38.35 81.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 119.674 1.124 . . . . 0.0 109.095 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -59.09 -46.35 88.51 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.805 1.184 . . . . 0.0 109.646 173.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.66 -38.31 90.63 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.398 0.545 . . . . 0.0 111.77 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 39.0 tptt -65.11 -37.61 88.02 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.86 0.864 . . . . 0.0 111.043 176.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -129.27 67.96 79.39 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 124.282 1.033 . . . . 0.0 110.132 -170.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.09 -15.7 39.8 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.754 2.303 . . . . 0.0 113.052 -173.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -71.86 -6.55 42.51 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.996 0.918 . . . . 0.0 112.242 172.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -130.51 -176.02 3.84 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.691 1.996 . . . . 0.0 108.844 -177.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -142.52 160.52 40.13 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 106.671 -1.604 . . . . 0.0 106.671 177.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.1 t -142.55 148.79 19.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 -172.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 17.6 p -137.19 171.35 14.62 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.69 0.796 . . . . 0.0 109.534 177.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 24.8 p-90 -145.16 165.83 27.19 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 121.558 -0.713 . . . . 0.0 111.919 178.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -145.82 164.43 31.94 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.757 2.023 . . . . 0.0 106.622 170.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -107.12 9.25 30.43 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 122.865 0.466 . . . . 0.0 110.783 -174.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -71.97 178.54 3.68 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 121.29 -0.881 . . . . 0.0 108.986 169.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -178.19 -173.05 43.26 Favored Glycine 0 CA--C 1.522 0.492 0 O-C-N 121.334 -0.854 . . . . 0.0 113.99 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 82.8 t80 . . . . . 0 C--O 1.238 0.496 0 C-N-CA 126.402 1.881 . . . . 0.0 112.052 -169.79 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 126' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.482 1.148 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.2 153.52 37.68 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 122.061 -0.399 . . . . 0.0 110.02 170.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.9 m -138.46 172.94 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 126.155 1.782 . . . . 0.0 109.026 -176.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.59 172.11 1.74 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.653 0.74 . . . . 0.0 111.056 171.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -150.37 150.17 31.06 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 169.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 68.5 mt -56.83 -32.35 65.66 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -174.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.58 -25.87 66.0 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.039 0.836 . . . . 0.0 112.222 178.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.3 mt -85.24 -23.84 28.06 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 123.786 0.834 . . . . 0.0 111.389 -176.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 61.7 mt -64.64 129.05 94.11 Favored Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 -178.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -44.34 117.11 1.24 Allowed 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 124.494 3.463 . . . . 0.0 111.81 172.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -76.85 -34.93 57.81 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.17 0.51 . . . . 0.0 111.31 -169.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.9 t -137.83 135.78 45.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 174.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -154.16 107.99 2.97 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 169.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 15.6 pt -140.35 164.88 21.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 124.46 1.104 . . . . 0.0 108.419 -172.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.0 -35.29 76.45 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.04 0.936 . . . . 0.0 113.218 -175.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.6 m 55.23 19.28 2.85 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 174.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -132.15 -25.11 2.04 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.93 1.241 . . . . 0.0 112.81 -170.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -146.27 -166.38 12.07 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 123.923 0.773 . . . . 0.0 111.544 176.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 90.4 t -79.18 141.07 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 170.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -159.6 159.74 33.55 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.954 0.902 . . . . 0.0 110.271 177.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -79.76 151.73 30.2 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 169.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -142.14 158.84 43.29 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.619 1.168 . . . . 0.0 108.466 -178.009 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.9 m -128.37 154.11 38.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 124.662 1.185 . . . . 0.0 109.984 173.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -110.53 114.46 27.88 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 104.546 -2.39 . . . . 0.0 104.546 178.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.2 mt -117.98 121.76 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -172.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -73.47 147.99 43.61 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 169.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.4 t -132.49 146.82 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 178.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -124.95 154.27 41.43 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.604 1.161 . . . . 0.0 108.568 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.3 m -64.26 88.36 0.05 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.034 0.934 . . . . 0.0 111.798 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -136.66 35.39 0.26 Allowed Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 125.295 1.438 . . . . 0.0 112.422 169.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -45.98 141.82 8.78 Favored 'Trans proline' 0 C--N 1.359 1.087 0 CA-C-N 123.009 2.11 . . . . 0.0 111.981 170.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? 37.6 43.84 0.47 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.26 1.824 . . . . 0.0 112.904 -169.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 m 67.35 9.42 6.98 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.932 1.693 . . . . 0.0 113.75 173.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.35 133.91 1.75 Allowed Glycine 0 C--N 1.338 0.683 0 CA-C-N 119.461 1.028 . . . . 0.0 110.675 174.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -147.63 159.69 40.53 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 125.921 1.688 . . . . 0.0 108.301 -177.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.16 -26.2 21.47 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.3 2.0 . . . . 0.0 112.696 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.05 155.71 37.96 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.645 0.778 . . . . 0.0 110.214 173.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.62 34.88 1.16 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.895 1.278 . . . . 0.0 109.87 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.0 mm-40 -82.34 178.24 8.34 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.73 0.812 . . . . 0.0 109.56 177.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.3 m -140.57 159.26 42.6 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.653 1.181 . . . . 0.0 109.051 172.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -149.87 171.28 17.03 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 127.565 2.346 . . . . 0.0 106.185 -173.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.9 mp0 -134.77 152.58 51.87 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 174.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 38.4 pt -130.08 155.06 41.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 125.474 1.51 . . . . 0.0 109.37 176.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 45.4 t -118.42 120.14 63.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.2 mmp_? -128.66 145.01 51.28 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.312 1.445 . . . . 0.0 107.622 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.93 132.92 1.72 Allowed Glycine 0 C--N 1.331 0.282 0 CA-C-N 119.632 1.105 . . . . 0.0 111.142 174.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -154.46 157.87 39.09 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -172.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.3 mttp -58.78 -34.85 71.92 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 119.186 -0.435 . . . . 0.0 111.852 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 15.6 p-90 -65.4 -30.75 71.6 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 118.964 -0.541 . . . . 0.0 112.326 -177.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.53 74.57 10.38 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 119.161 0.891 . . . . 0.0 109.465 175.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.93 -17.36 63.16 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.221 0.608 . . . . 0.0 111.572 175.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.81 144.25 51.09 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 126.147 1.779 . . . . 0.0 108.025 178.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -67.95 -34.93 77.52 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 119.27 -0.395 . . . . 0.0 111.862 -169.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.77 -29.1 53.16 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 118.411 -0.804 . . . . 0.0 112.664 174.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -66.55 -49.88 65.0 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 119.437 1.017 . . . . 0.0 111.394 -172.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.45 ' H ' HG12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -66.08 -41.4 89.48 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 CA-C-O 118.987 -0.53 . . . . 0.0 110.271 176.293 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -62.3 -49.05 77.19 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 119.26 -0.4 . . . . 0.0 110.217 -177.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -63.94 -45.3 89.8 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 118.608 0.64 . . . . 0.0 111.149 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 28.7 tttt -57.36 -54.36 47.73 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.523 0.729 . . . . 0.0 110.826 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 91.7 t -80.91 -40.8 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-O 117.799 -1.096 . . . . 0.0 110.827 -169.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 58.2 m -62.94 -25.8 68.51 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 120.77 1.623 . . . . 0.0 110.911 173.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.06 -55.43 29.62 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 169.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -61.26 -39.03 88.84 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 118.645 1.222 . . . . 0.0 112.689 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 38.7 mmt -57.26 -47.38 81.56 Favored 'General case' 0 N--CA 1.461 0.077 0 CA-C-N 118.624 0.647 . . . . 0.0 109.515 174.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -67.79 -28.77 67.88 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.15 0.58 . . . . 0.0 112.542 178.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.9 mttm -63.24 -44.34 95.49 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.56 1.073 . . . . 0.0 109.445 169.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -65.93 -25.87 67.33 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 119.183 0.901 . . . . 0.0 110.89 171.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 122.82 -26.25 6.25 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 127.432 2.444 . . . . 0.0 111.64 175.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 97.2 m -53.9 148.46 10.41 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.649 1.98 . . . . 0.0 112.252 -173.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -108.79 138.78 44.56 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -177.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 91.7 m -141.74 162.16 36.16 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 -168.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -153.01 131.58 12.24 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.595 1.558 . . . . 0.0 107.872 171.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.0 p -69.74 118.5 12.68 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 169.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 43.7 mt -68.49 -25.4 64.95 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.882 -0.511 . . . . 0.0 109.903 172.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.38 -164.29 37.51 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 108.317 -1.913 . . . . 0.0 108.317 173.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -150.88 -179.32 26.53 Favored Glycine 0 N--CA 1.451 -0.303 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 171.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -169.83 -157.19 11.81 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 -175.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -143.45 147.24 34.27 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 -173.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 12.2 mt -121.52 138.93 50.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 -172.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 58.3 p -158.73 -150.75 0.25 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.288 1.835 . . . . 0.0 107.704 -172.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -129.68 164.72 23.33 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.004 1.322 . . . . 0.0 107.596 172.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -59.61 154.51 17.5 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.403 0.621 . . . . 0.0 110.038 175.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.8 m -60.99 -23.23 65.22 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -170.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -139.81 13.64 2.49 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.825 1.25 . . . . 0.0 111.4 -175.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -151.35 147.37 26.84 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.555 1.07 . . . . 0.0 110.477 -176.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -67.5 -12.08 59.48 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -176.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -53.03 131.96 37.09 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 120.153 1.342 . . . . 0.0 108.981 177.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 55.7 mt -66.3 152.02 9.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 -177.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 20.7 t60 -138.87 152.47 47.82 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 121.609 -0.682 . . . . 0.0 109.541 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.6 t -135.01 131.37 52.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 -178.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -160.19 -164.37 1.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 O-C-N 121.486 -0.759 . . . . 0.0 109.388 -177.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.04 -172.23 55.11 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 118.812 0.733 . . . . 0.0 112.457 173.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -162.45 150.07 13.96 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.989 0.915 . . . . 0.0 110.151 -174.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.0 t -78.74 165.59 23.43 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 167.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 21.8 ptp -108.45 -28.99 9.04 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 118.52 -0.752 . . . . 0.0 111.025 171.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.2 -25.16 57.99 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 119.49 1.041 . . . . 0.0 111.602 171.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -133.78 -5.95 2.82 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -169.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.77 -178.07 51.11 Favored Glycine 0 CA--C 1.535 1.335 0 CA-C-N 119.025 0.83 . . . . 0.0 113.575 173.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -68.13 142.31 55.52 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.806 2.337 . . . . 0.0 110.815 174.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.51 177.31 5.4 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 169.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 21.4 mm100 -62.91 -28.59 70.16 Favored 'General case' 0 CA--C 1.535 0.404 0 O-C-N 121.85 -0.532 . . . . 0.0 111.66 172.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . 0.263 38.3 m80 59.45 -27.64 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 128.556 2.742 . . . . 0.0 116.481 -174.159 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.26 -42.41 99.15 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 119.547 1.067 . . . . 0.0 110.251 173.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 62.2 mt -61.06 -47.26 94.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 176.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.4 -52.35 64.95 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.399 1.079 . . . . 0.0 110.599 -173.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 33.0 p -64.63 -48.47 74.74 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 118.781 -0.628 . . . . 0.0 109.636 -176.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -60.58 -40.24 91.01 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.958 0.799 . . . . 0.0 111.096 -177.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 48.9 mttm -64.78 -46.94 79.97 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 118.877 0.762 . . . . 0.0 111.19 176.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 63.2 mt -62.14 -44.39 98.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -60.19 -44.06 95.38 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.782 0.719 . . . . 0.0 110.336 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.67 -42.07 98.09 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.839 0.456 . . . . 0.0 111.321 178.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -76.66 -25.57 53.87 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 118.475 -0.774 . . . . 0.0 112.553 -178.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -134.61 64.04 61.98 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 124.394 1.078 . . . . 0.0 110.029 -172.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.95 -9.79 27.33 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.169 2.579 . . . . 0.0 113.348 -174.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -66.99 -10.93 54.87 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.97 0.908 . . . . 0.0 112.267 170.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -127.37 175.86 7.88 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.225 1.81 . . . . 0.0 109.103 178.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -136.04 155.32 50.4 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 171.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.3 t -138.09 146.37 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 -169.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.0 p -135.71 170.97 15.13 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.55 1.14 . . . . 0.0 109.283 176.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 34.9 p-90 -147.24 156.81 43.27 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 121.817 -0.552 . . . . 0.0 111.034 172.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -159.23 106.13 1.75 Allowed 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 173.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.63 -13.32 61.98 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -169.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -61.89 -31.79 72.11 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.749 0.82 . . . . 0.0 112.136 176.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -80.46 169.55 52.62 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 111.66 -0.576 . . . . 0.0 111.66 178.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 51.4 p90 . . . . . 0 C--O 1.237 0.397 0 C-N-CA 124.702 1.201 . . . . 0.0 108.303 177.537 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 126' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.483 1.178 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.62 163.86 15.45 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.444 0.698 . . . . 0.0 110.521 173.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.9 p -150.49 149.65 14.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 177.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.26 176.3 5.36 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.705 0.802 . . . . 0.0 111.55 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -153.36 149.6 28.0 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 126.488 1.915 . . . . 0.0 106.309 169.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 68.9 mt -54.79 -34.61 62.9 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 123.395 0.678 . . . . 0.0 112.539 -175.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.29 -25.05 65.85 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.861 0.755 . . . . 0.0 112.42 -178.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.8 mt -78.72 -25.05 44.58 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.023 0.529 . . . . 0.0 111.195 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 21.1 mt -70.87 129.39 89.71 Favored Pre-proline 0 CA--C 1.538 0.504 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -176.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -52.87 128.14 27.54 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.703 2.269 . . . . 0.0 110.644 169.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -80.47 -23.71 40.0 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 121.909 -0.495 . . . . 0.0 111.854 176.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.1 t -136.22 131.55 48.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 173.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -163.38 116.04 1.51 Allowed 'General case' 0 C--O 1.233 0.205 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 169.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -142.42 164.41 17.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.379 1.072 . . . . 0.0 109.127 -173.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -132.38 13.84 4.58 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.694 1.598 . . . . 0.0 110.752 175.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.3 m -71.84 66.84 0.57 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.788 1.635 . . . . 0.0 110.534 174.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -72.01 -6.72 44.24 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.784 1.634 . . . . 0.0 112.443 175.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -147.83 -173.58 18.96 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 126.946 2.212 . . . . 0.0 107.665 173.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.4 t -60.65 96.21 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.452 1.101 . . . . 0.0 109.547 -178.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -147.56 157.24 43.48 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 125.156 1.382 . . . . 0.0 109.423 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -71.17 157.1 38.74 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 124.082 0.953 . . . . 0.0 112.073 -171.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -145.31 164.74 30.5 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.066 1.747 . . . . 0.0 107.657 170.204 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.5 m -131.21 150.92 34.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 C-N-CA 124.28 1.032 . . . . 0.0 109.199 171.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.73 118.67 36.74 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 104.234 -2.506 . . . . 0.0 104.234 173.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 53.6 mt -120.31 124.84 73.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 -177.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -81.18 148.7 29.42 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 169.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.5 t -133.02 147.09 31.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 -175.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -132.49 147.33 52.36 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.815 1.246 . . . . 0.0 107.96 -178.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.8 m -62.25 103.18 0.36 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.524 0.73 . . . . 0.0 111.117 -178.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.515 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -144.45 19.18 0.04 OUTLIER Pre-proline 0 CA--C 1.555 1.146 0 CA-C-O 116.265 -1.826 . . . . 0.0 113.654 169.131 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.515 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 87.2 Cg_exo -40.81 131.65 2.75 Favored 'Trans proline' 0 C--N 1.365 1.428 0 CA-C-N 123.538 2.299 . . . . 0.0 114.349 178.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . 0.305 1.0 OUTLIER 23.46 47.82 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 130.145 3.378 . . . . 0.0 114.937 -168.723 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.1 m 55.46 24.54 6.87 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.892 1.277 . . . . 0.0 113.419 176.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -147.56 -7.59 0.25 Allowed Glycine 0 CA--C 1.528 0.895 0 CA-C-O 118.413 -1.215 . . . . 0.0 114.974 -169.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.73 133.26 86.31 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 119.553 1.676 . . . . 0.0 110.373 174.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -78.51 -19.87 11.24 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.842 2.362 . . . . 0.0 112.661 178.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.49 160.76 18.64 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.809 0.844 . . . . 0.0 110.859 177.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.08 36.71 1.13 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.428 1.491 . . . . 0.0 109.462 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -87.72 -177.45 5.84 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.327 1.051 . . . . 0.0 109.455 178.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.3 m -141.52 159.24 42.63 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.616 1.166 . . . . 0.0 109.547 175.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -153.41 166.33 33.01 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 127.107 2.163 . . . . 0.0 106.727 -173.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -127.61 154.28 45.42 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 119.577 1.08 . . . . 0.0 108.968 177.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.6 pt -134.73 153.05 34.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 C-N-CA 125.185 1.394 . . . . 0.0 109.37 175.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 43.2 t -118.98 114.22 44.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.4 mmp_? -126.63 147.11 49.95 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 175.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -176.97 141.29 5.32 Favored Glycine 0 C--N 1.331 0.253 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 175.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -152.9 153.83 33.82 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -172.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -59.51 -28.8 67.38 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 8.0 p-90 -70.91 -24.56 62.49 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.115 0.871 . . . . 0.0 112.596 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.42 75.74 9.97 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.586 1.085 . . . . 0.0 110.587 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -63.81 -14.49 53.34 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.288 0.635 . . . . 0.0 112.142 173.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -131.04 136.98 48.96 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.723 1.609 . . . . 0.0 107.317 177.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 34.6 m80 -60.72 -32.5 71.75 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 123.102 0.561 . . . . 0.0 110.594 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.69 -27.85 52.42 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 118.326 -0.845 . . . . 0.0 112.986 172.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -68.43 -49.78 57.5 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 119.619 1.1 . . . . 0.0 110.395 -176.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.42 ' H ' HG12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -67.36 -40.38 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-O 117.63 -1.176 . . . . 0.0 109.839 175.636 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -59.88 -47.8 84.28 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 120.301 1.41 . . . . 0.0 110.628 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -64.67 -47.62 77.78 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.569 0.622 . . . . 0.0 111.576 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 46.8 tttt -62.81 -50.75 69.74 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.11 0.564 . . . . 0.0 111.151 -178.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 93.2 t -71.96 -48.41 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-O 118.255 -0.879 . . . . 0.0 108.808 -172.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.9 m -64.21 -26.76 68.65 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 120.098 1.317 . . . . 0.0 111.251 177.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.91 -51.19 57.4 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 170.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -61.01 -43.03 99.48 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 118.495 1.147 . . . . 0.0 111.667 177.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.3 mmt -59.72 -47.18 86.66 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 118.974 -0.536 . . . . 0.0 109.859 177.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -69.82 -27.54 64.96 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.959 0.8 . . . . 0.0 112.096 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -67.28 -38.29 84.83 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.309 0.959 . . . . 0.0 109.988 169.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -69.02 -26.7 65.13 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 119.655 1.116 . . . . 0.0 110.293 169.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 119.7 -22.73 8.61 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 128.059 2.742 . . . . 0.0 112.219 175.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 92.9 m -52.64 147.98 7.83 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 126.067 1.747 . . . . 0.0 111.791 -178.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -108.11 140.18 41.69 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 66.7 m -140.71 163.04 33.96 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -168.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -151.78 128.23 10.68 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.515 1.526 . . . . 0.0 107.489 175.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.8 p -70.9 121.46 18.14 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 169.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 51.4 mt -70.17 -27.14 64.28 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.968 -0.457 . . . . 0.0 109.851 171.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.62 -170.34 41.09 Favored Glycine 0 C--N 1.337 0.63 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 173.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -131.98 165.05 23.6 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.399 -0.68 . . . . 0.0 111.399 176.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -166.05 -162.99 18.69 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 125.284 1.421 . . . . 0.0 109.666 177.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 33.8 ptt180 -138.22 159.72 41.31 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 121.067 -1.255 . . . . 0.0 109.2 176.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 84.6 mt -116.91 124.31 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 103.843 -2.651 . . . . 0.0 103.843 -174.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 21.4 m -137.21 176.25 8.88 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 125.392 1.477 . . . . 0.0 109.873 -169.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 62.03 -7.64 0.11 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 128.586 2.754 . . . . 0.0 115.747 172.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -50.51 -31.17 14.74 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.187 1.795 . . . . 0.0 112.381 169.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.8 p -130.31 13.22 5.57 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.96 1.304 . . . . 0.0 111.934 -175.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -125.25 -7.7 7.04 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.879 0.872 . . . . 0.0 111.888 177.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -146.83 -51.52 0.21 Allowed 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.762 1.225 . . . . 0.0 109.58 173.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? 126.26 -40.19 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.482 1 C-N-CA 131.935 4.094 . . . . 0.0 108.8 176.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.1 ttmm -62.42 119.19 8.65 Favored 'General case' 0 C--N 1.343 0.302 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 169.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.468 ' HB ' HG13 ' A' ' 118' ' ' VAL . 21.4 mt -68.25 146.58 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 177.265 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 20.0 t60 -133.17 146.18 51.31 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 174.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.7 t -137.37 134.84 47.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -171.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -174.42 172.39 3.18 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.253 1.421 . . . . 0.0 107.858 -178.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 144.1 -169.89 26.1 Favored Glycine 0 C--N 1.334 0.441 0 CA-C-N 119.017 0.826 . . . . 0.0 112.249 169.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -160.46 114.11 2.12 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.582 1.553 . . . . 0.0 107.737 -176.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.3 t -72.62 142.65 48.35 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 168.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.0 ppp? -71.64 -39.91 70.07 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 171.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.79 -25.06 35.57 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 118.711 -0.662 . . . . 0.0 112.408 -172.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -134.58 0.47 3.01 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -169.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.94 -175.27 53.95 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-N 119.197 0.908 . . . . 0.0 112.881 176.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -76.16 138.57 20.47 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.975 2.45 . . . . 0.0 109.847 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.48 171.76 9.59 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.094 0.473 . . . . 0.0 110.625 169.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 58.2 mm-40 -64.25 -35.77 81.91 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 119.116 -0.469 . . . . 0.0 111.828 175.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 33.9 m80 59.96 -31.2 0.05 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 128.767 2.827 . . . . 0.0 115.479 -173.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.57 -37.96 85.76 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.132 1.373 . . . . 0.0 112.115 174.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 90.4 mt -63.41 -46.51 95.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 176.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.67 -47.37 84.72 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.193 0.997 . . . . 0.0 110.939 -177.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.513 HG22 HG12 ' A' ' 118' ' ' VAL . 5.9 p -64.23 -51.98 61.01 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 119.137 0.881 . . . . 0.0 110.694 -177.075 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -60.28 -39.82 88.26 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 118.726 0.694 . . . . 0.0 110.574 -175.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -64.59 -56.05 16.46 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-O 118.462 -0.78 . . . . 0.0 111.187 174.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 66.9 mt -63.36 -41.4 92.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.215 -172.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -54.29 -46.2 72.68 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 120.121 1.328 . . . . 0.0 110.194 175.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -69.28 -28.85 66.65 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -176.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.42 ' HA ' ' HE3' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -65.9 -51.01 62.35 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 119.087 0.858 . . . . 0.0 111.583 -170.002 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.518 ' H ' ' CD ' ' A' ' 114' ' ' PRO . 37.2 p90 -161.77 -32.6 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.703 0 N-CA-C 117.637 2.458 . . . . 0.0 117.637 -173.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.518 ' CD ' ' H ' ' A' ' 113' ' ' TYR . 88.9 Cg_exo -54.9 130.55 41.23 Favored 'Trans proline' 0 C--N 1.353 0.801 0 CA-C-N 123.196 2.177 . . . . 0.0 114.545 -169.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -76.11 -30.36 58.2 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 168.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -79.56 -158.1 0.15 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 127.643 2.377 . . . . 0.0 108.962 169.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -134.02 169.05 17.71 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.013 -1.054 . . . . 0.0 111.288 -169.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.513 HG12 HG22 ' A' ' 106' ' ' THR . 5.2 t -134.86 136.69 51.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 16.8 p -137.0 170.79 15.52 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.664 1.12 . . . . 0.0 109.926 176.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 38.5 p-90 -141.49 152.31 44.08 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 172.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -158.53 113.4 2.56 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 103.643 -2.725 . . . . 0.0 103.643 169.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.42 22.34 0.13 Allowed 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 118.808 0.731 . . . . 0.0 112.694 -169.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -61.84 -29.79 70.41 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.949 1.3 . . . . 0.0 111.863 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -88.24 147.09 19.97 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 169.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 . . . . . 0 C--O 1.238 0.463 0 C-N-CA 125.246 1.418 . . . . 0.0 108.855 -174.348 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 126' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 N--CA 1.483 1.22 0 CA-C-O 120.557 0.217 . . . . 0.0 110.564 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.78 165.87 26.85 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.278 1.431 . . . . 0.0 107.953 172.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.3 p -150.51 156.83 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 177.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -159.89 -172.82 3.8 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.165 1.786 . . . . 0.0 108.077 -177.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -146.97 147.96 31.24 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 169.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 71.5 mt -57.94 -30.02 65.62 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -173.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.22 -26.71 63.99 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.979 0.809 . . . . 0.0 111.981 177.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.2 mt -83.88 -25.52 30.17 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.772 0.829 . . . . 0.0 111.215 -177.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 51.9 mt -63.34 127.83 91.66 Favored Pre-proline 0 CA--C 1.538 0.506 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -45.9 122.8 5.48 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.968 3.112 . . . . 0.0 111.409 172.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -79.45 -36.24 39.18 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 121.209 0.528 . . . . 0.0 110.768 -172.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 77.9 t -136.69 129.97 45.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 N-CA-C 105.658 -1.978 . . . . 0.0 105.658 175.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -154.69 125.7 7.19 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 170.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.9 pt -144.65 164.16 13.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 124.835 1.254 . . . . 0.0 108.451 -173.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -60.6 144.86 50.79 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.849 0.357 . . . . 0.0 110.152 173.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.0 m -62.25 -35.86 80.24 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.222 1.409 . . . . 0.0 114.45 -169.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -157.61 129.9 7.23 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.366 0.666 . . . . 0.0 109.484 -173.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 149.61 -164.56 29.47 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-O 121.646 0.581 . . . . 0.0 112.503 172.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 93.1 t -125.57 126.55 70.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 169.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -160.47 161.32 32.83 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 122.829 0.452 . . . . 0.0 111.317 -169.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -71.95 156.55 39.13 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 175.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.1 163.74 32.02 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 172.284 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.2 m -133.29 149.59 31.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 C-N-CA 124.385 1.074 . . . . 0.0 109.15 172.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.53 121.59 41.39 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 104.055 -2.572 . . . . 0.0 104.055 173.128 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 85.5 mt -122.57 126.47 74.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -177.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -82.14 148.31 28.57 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 169.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.5 t -137.26 147.02 27.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 126.857 2.063 . . . . 0.0 105.606 -173.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -128.11 152.0 48.53 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.684 1.194 . . . . 0.0 108.889 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.8 m -62.86 93.26 0.06 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.31 1.044 . . . . 0.0 111.028 175.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.51 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -141.1 16.39 0.04 OUTLIER Pre-proline 0 CA--C 1.551 0.992 0 CA-C-O 116.245 -1.836 . . . . 0.0 114.115 169.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.51 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 76.8 Cg_exo -46.77 152.58 1.61 Allowed 'Trans proline' 0 C--N 1.363 1.298 0 CA-C-N 124.104 2.501 . . . . 0.0 114.226 175.179 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.74 12.53 0.41 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.122 1.369 . . . . 0.0 113.359 -173.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.5 m 52.43 29.84 7.47 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.699 1.2 . . . . 0.0 111.511 -169.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -167.25 8.29 0.05 OUTLIER Glycine 0 CA--C 1.531 1.065 0 CA-C-O 118.369 -1.239 . . . . 0.0 115.294 -172.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.33 138.64 67.26 Favored Pre-proline 0 CA--C 1.544 0.747 0 CA-C-N 119.616 1.708 . . . . 0.0 110.294 173.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -77.91 -21.95 10.56 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 122.855 2.37 . . . . 0.0 113.304 -174.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.82 163.01 17.65 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.488 0.715 . . . . 0.0 110.597 176.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.65 35.53 1.16 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.031 1.332 . . . . 0.0 109.824 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -86.61 -178.35 6.37 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.006 0.922 . . . . 0.0 109.587 177.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.9 m -142.17 157.19 45.16 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.711 1.205 . . . . 0.0 109.088 176.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -151.64 167.51 27.9 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 127.146 2.178 . . . . 0.0 106.427 -173.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 -131.88 154.12 49.53 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 175.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 35.8 pt -132.38 155.68 41.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 125.168 1.387 . . . . 0.0 109.852 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 98.6 t -118.16 115.11 47.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 177.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 12.1 mmp_? -125.78 141.93 51.76 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.239 1.416 . . . . 0.0 107.518 176.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -177.9 137.32 3.33 Favored Glycine 0 C--N 1.333 0.363 0 CA-C-N 119.31 0.959 . . . . 0.0 111.113 174.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -153.19 153.3 32.47 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 117.097 0.449 . . . . 0.0 110.54 -169.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -57.26 -32.47 66.62 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.086 0.954 . . . . 0.0 112.274 177.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 13.0 p-90 -67.83 -27.64 66.88 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.853 0.752 . . . . 0.0 112.529 177.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.98 81.63 8.7 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 119.724 1.147 . . . . 0.0 109.438 174.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -64.11 -19.1 65.03 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.266 0.626 . . . . 0.0 112.017 174.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -135.22 152.56 51.67 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 126.327 1.851 . . . . 0.0 108.001 -179.325 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 44.8 m-70 -73.72 -32.85 64.08 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 121.84 -0.537 . . . . 0.0 109.575 -169.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.0 -28.9 55.64 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 118.481 -0.771 . . . . 0.0 112.597 172.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -66.73 -50.51 62.55 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 119.356 0.98 . . . . 0.0 110.637 -175.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.4 ' H ' HG12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -66.67 -40.21 85.61 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 CA-C-O 117.257 -1.354 . . . . 0.0 109.826 175.533 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -60.86 -47.83 84.6 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-N 120.214 1.37 . . . . 0.0 110.243 -178.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -61.73 -46.17 90.78 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.001 0.819 . . . . 0.0 111.886 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 34.4 tttt -61.21 -50.0 74.88 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 123.082 0.553 . . . . 0.0 110.671 178.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 86.6 t -77.54 -39.98 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-O 117.751 -1.119 . . . . 0.0 109.757 -170.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 80.8 p -63.08 -34.16 76.99 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 120.888 1.676 . . . . 0.0 109.617 175.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.65 -53.32 46.34 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 171.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -60.22 -46.26 90.36 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 118.547 1.174 . . . . 0.0 111.813 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 38.0 mmt -57.92 -48.96 78.36 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.366 0.666 . . . . 0.0 110.369 177.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -68.21 -28.48 67.28 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.66 0.664 . . . . 0.0 111.996 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -67.95 -38.0 82.28 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 119.243 0.928 . . . . 0.0 110.594 171.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -67.56 -29.86 69.34 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 119.67 1.123 . . . . 0.0 110.437 169.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 126.96 -21.87 5.79 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 127.458 2.456 . . . . 0.0 111.692 174.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 68.1 m -52.45 150.14 5.12 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 125.947 1.699 . . . . 0.0 112.438 -176.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -108.51 136.24 48.45 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 173.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 99.5 m -144.13 164.96 29.17 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -168.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -149.83 136.17 19.0 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.007 1.723 . . . . 0.0 107.847 171.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.3 p -73.22 125.0 26.75 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 169.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 44.4 mt -75.26 -23.29 57.44 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.812 -0.555 . . . . 0.0 110.398 173.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.01 -174.02 43.52 Favored Glycine 0 C--N 1.337 0.604 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 171.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -123.48 168.07 15.7 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 175.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -172.32 -165.25 29.13 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -173.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -149.38 150.49 32.51 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -169.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 58.7 mt -129.97 147.46 33.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 -172.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.5 p -151.66 168.73 24.07 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.701 1.2 . . . . 0.0 110.744 177.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 4.4 p-80 -170.62 160.67 7.28 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 128.463 2.705 . . . . 0.0 106.194 174.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -154.07 161.42 41.93 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.9 m -55.88 -33.0 64.2 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.163 -0.961 . . . . 0.0 112.104 172.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -92.33 -0.38 57.39 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.199 1.399 . . . . 0.0 111.742 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -150.01 65.47 0.97 Allowed 'General case' 0 C--O 1.233 0.219 0 C-N-CA 125.809 1.644 . . . . 0.0 106.978 -172.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -68.93 -25.85 64.78 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.018 -0.992 . . . . 0.0 113.504 -169.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -60.42 135.84 57.86 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 169.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.6 mt -65.99 150.57 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 170.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 36.2 t60 -131.85 150.74 52.06 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 121.109 -0.995 . . . . 0.0 108.605 177.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.2 t -131.83 136.62 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -178.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -161.0 -161.09 0.79 Allowed 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 125.145 1.378 . . . . 0.0 107.424 -172.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.73 -177.81 45.21 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-O 122.539 1.077 . . . . 0.0 113.451 169.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -164.07 150.64 11.45 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 126.032 1.733 . . . . 0.0 106.793 -169.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.3 t -116.96 145.9 43.35 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.66 1.584 . . . . 0.0 106.813 171.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.0 ptm -87.35 -34.46 18.81 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 118.79 -0.624 . . . . 0.0 110.193 174.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.81 -26.09 56.94 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.117 0.871 . . . . 0.0 111.949 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -131.13 -5.09 3.89 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -169.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.44 173.8 40.27 Favored Glycine 0 CA--C 1.533 1.197 0 CA-C-N 118.858 0.754 . . . . 0.0 112.312 178.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.23 134.37 24.76 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.71 2.273 . . . . 0.0 109.527 177.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.28 166.57 19.86 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.674 0.75 . . . . 0.0 112.433 176.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -77.64 74.87 4.19 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.897 1.279 . . . . 0.0 108.973 169.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -54.15 -22.33 10.93 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -176.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.81 -40.64 89.07 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.955 0.902 . . . . 0.0 111.761 173.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 65.0 mt -63.28 -46.36 95.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.55 -50.86 72.25 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.451 1.1 . . . . 0.0 110.129 -176.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 20.9 p -65.39 -42.61 92.47 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 118.049 -0.977 . . . . 0.0 111.378 -174.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -61.35 -40.86 95.82 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.821 1.191 . . . . 0.0 110.742 178.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 43.4 mttm -66.51 -46.28 76.77 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 121.793 -0.567 . . . . 0.0 111.277 176.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 67.2 mt -64.8 -40.71 89.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -177.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -58.37 -44.37 88.85 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 119.88 1.218 . . . . 0.0 109.862 174.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.52 -38.92 91.83 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 119.11 -0.471 . . . . 0.0 111.63 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 57.4 tttt -72.29 -32.93 67.04 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.99 0.814 . . . . 0.0 111.802 176.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -125.92 63.2 47.05 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 123.784 0.834 . . . . 0.0 111.129 -170.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.44 -14.33 36.91 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.871 2.381 . . . . 0.0 112.984 -176.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -70.92 -7.83 48.67 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.143 0.977 . . . . 0.0 112.175 171.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -129.15 -170.81 2.34 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.818 2.047 . . . . 0.0 108.373 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -134.87 168.69 18.62 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 171.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.7 t -142.55 143.45 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 26.0 p -136.21 172.0 13.65 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.075 0.95 . . . . 0.0 108.912 173.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 45.7 p-90 -145.45 155.62 43.23 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.076 0.465 . . . . 0.0 110.752 172.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -154.85 130.45 9.9 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 104.304 -2.48 . . . . 0.0 104.304 172.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -81.66 35.98 0.42 Allowed 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 119.442 1.019 . . . . 0.0 113.201 -169.439 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -73.91 -178.29 3.2 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.324 -0.86 . . . . 0.0 109.819 173.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 70.88 -167.5 51.03 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.254 0.93 . . . . 0.0 113.638 175.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 38.5 t80 . . . . . 0 C--O 1.241 0.615 0 C-N-CA 125.633 1.573 . . . . 0.0 109.163 -174.754 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 126' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 mpp? . . . . . 0 N--CA 1.483 1.221 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.3 165.39 34.16 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.015 1.326 . . . . 0.0 108.693 175.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.0 t -139.9 137.34 38.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.09 -176.28 3.96 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.287 0.565 . . . . 0.0 110.743 178.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -151.87 152.14 32.2 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.544 1.538 . . . . 0.0 106.864 170.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.2 mt -57.03 -31.66 65.38 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.568 0.622 . . . . 0.0 112.553 -176.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.84 -24.7 65.3 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 118.825 0.739 . . . . 0.0 112.376 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.2 mt -85.31 -18.68 33.15 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.549 0.74 . . . . 0.0 111.499 -176.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 50.1 mt -65.01 131.84 95.32 Favored Pre-proline 0 CA--C 1.54 0.577 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -50.4 115.79 2.13 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 123.503 2.802 . . . . 0.0 110.104 169.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -70.73 -39.18 73.5 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -169.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 45.5 t -140.83 138.5 34.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 176.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -152.51 112.49 3.99 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 169.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 40.0 pt -138.2 36.33 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 124.693 1.197 . . . . 0.0 109.88 -169.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -62.66 92.48 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.052 1.341 . . . . 0.0 111.837 -177.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.6 m -165.06 178.27 7.17 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 127.84 2.456 . . . . 0.0 107.803 176.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -139.9 159.31 42.47 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.344 1.458 . . . . 0.0 108.495 -178.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.93 -165.79 44.74 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -169.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.6 t -72.61 141.43 16.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 171.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -153.42 158.79 41.95 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.58 1.152 . . . . 0.0 108.807 171.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.4 mmtp -74.68 154.57 38.4 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.045 0.938 . . . . 0.0 109.174 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.99 161.58 39.78 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.75 0.82 . . . . 0.0 108.985 176.369 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.6 m -133.79 152.09 34.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 C-N-CA 124.897 1.279 . . . . 0.0 109.331 173.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 28.2 tp -108.83 116.12 31.38 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 105.226 -2.138 . . . . 0.0 105.226 177.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 86.0 mt -120.15 119.12 59.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -169.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.3 ttp180 -78.13 145.36 35.75 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 168.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.3 p -139.25 148.85 23.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -130.71 145.95 52.06 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.084 1.353 . . . . 0.0 108.29 -169.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.0 m -61.38 108.23 0.9 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.644 0.778 . . . . 0.0 111.266 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.411 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -150.35 22.25 0.03 OUTLIER Pre-proline 0 CA--C 1.552 1.03 0 C-N-CA 125.185 1.394 . . . . 0.0 112.441 168.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 30' ' ' ALA . 45.5 Cg_endo -60.7 134.07 51.94 Favored 'Trans proline' 0 C--N 1.359 1.087 0 CA-C-N 122.669 1.989 . . . . 0.0 110.998 -171.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 38.16 27.21 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 129.263 3.025 . . . . 0.0 114.21 -169.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.0 m 46.1 33.23 1.64 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.418 1.487 . . . . 0.0 112.371 -171.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -128.41 -28.84 0.81 Allowed Glycine 0 C--N 1.341 0.82 0 CA-C-O 118.688 -1.062 . . . . 0.0 113.766 -169.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.28 140.65 96.9 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 119.241 1.52 . . . . 0.0 109.919 175.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -78.09 -14.74 14.97 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.106 2.537 . . . . 0.0 112.958 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.45 155.83 20.78 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.934 0.894 . . . . 0.0 111.251 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -143.5 36.22 1.32 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.75 1.62 . . . . 0.0 109.007 177.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -85.95 -178.52 6.59 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.393 1.077 . . . . 0.0 109.585 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.4 m -140.71 157.85 44.83 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.393 1.077 . . . . 0.0 109.29 173.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -152.87 168.26 26.35 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 127.354 2.261 . . . . 0.0 106.23 -173.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -130.88 147.39 52.52 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.03 -1.044 . . . . 0.0 108.614 177.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 29.8 pt -130.75 156.0 42.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 125.881 1.672 . . . . 0.0 109.315 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.2 t -131.23 116.53 33.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 -169.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.5 mmt85 -137.22 148.9 46.82 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -176.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 177.69 137.43 2.75 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -154.85 154.09 32.18 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -170.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -59.71 -29.22 67.97 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.274 0.629 . . . . 0.0 112.651 178.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 11.2 p-90 -69.4 -28.21 65.96 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.014 0.825 . . . . 0.0 112.258 178.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.86 77.67 9.67 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 119.41 1.005 . . . . 0.0 109.022 175.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -63.13 -18.59 63.6 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 122.937 0.495 . . . . 0.0 111.303 173.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.65 146.3 51.44 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.64 1.576 . . . . 0.0 107.724 178.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -72.67 -30.22 64.08 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.131 0.572 . . . . 0.0 110.262 -169.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.41 -30.8 42.05 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 118.636 -0.697 . . . . 0.0 112.549 170.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -69.37 -47.61 63.75 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 119.34 0.973 . . . . 0.0 110.902 -175.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.446 ' H ' HG12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -67.73 -40.8 84.52 Favored 'Isoleucine or valine' 0 C--N 1.34 0.178 0 CA-C-O 117.891 -1.052 . . . . 0.0 110.117 175.635 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -61.21 -45.65 93.7 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.747 1.158 . . . . 0.0 110.288 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -62.53 -47.16 85.13 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.318 0.508 . . . . 0.0 111.583 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 26.1 tttp -63.62 -54.08 41.5 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 122.814 0.446 . . . . 0.0 110.995 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 97.3 t -71.07 -52.36 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -170.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 33.4 m -67.2 -27.96 67.69 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 119.206 0.912 . . . . 0.0 111.249 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.56 -46.92 93.3 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 170.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -63.23 -42.22 99.22 Favored 'General case' 0 CA--C 1.526 0.053 0 CA-C-N 118.568 1.184 . . . . 0.0 111.245 176.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.5 mmt -59.72 -45.1 93.18 Favored 'General case' 0 C--O 1.226 -0.18 0 CA-C-N 118.242 0.473 . . . . 0.0 110.14 176.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.7 mm-40 -66.72 -30.49 70.74 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.817 0.847 . . . . 0.0 111.912 178.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -68.61 -39.19 80.96 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.718 1.145 . . . . 0.0 110.301 170.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -65.4 -26.25 67.9 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.178 0.899 . . . . 0.0 110.431 169.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 119.09 -22.07 9.19 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 128.152 2.786 . . . . 0.0 111.82 175.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 91.3 m -58.69 150.58 23.04 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 126.452 1.901 . . . . 0.0 111.414 -176.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -108.78 146.03 34.24 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.481 1.113 . . . . 0.0 108.174 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 82.4 m -140.01 162.88 34.14 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -168.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -150.81 122.5 8.03 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 125.417 1.487 . . . . 0.0 107.66 173.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.5 p -69.88 120.0 14.95 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 169.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 45.1 mt -68.1 -25.64 65.41 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.987 -0.445 . . . . 0.0 109.893 172.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 165.55 -167.27 38.9 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 125.434 1.492 . . . . 0.0 109.432 170.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -132.76 170.89 21.88 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 123.977 0.799 . . . . 0.0 111.489 176.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -171.16 -161.31 21.59 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 125.471 1.51 . . . . 0.0 109.719 -177.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -142.29 165.95 26.04 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 121.372 -1.075 . . . . 0.0 108.909 174.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 60.1 mt -119.26 136.66 55.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 123.12 0.568 . . . . 0.0 109.544 -169.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 40.1 m 52.02 -162.0 0.09 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.92 2.488 . . . . 0.0 115.48 169.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -127.07 171.78 11.08 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.839 2.056 . . . . 0.0 106.833 175.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -58.43 -30.32 66.81 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.986 -0.446 . . . . 0.0 111.673 -178.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.9 m -71.93 63.53 0.48 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.824 1.65 . . . . 0.0 110.398 169.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -58.3 -17.04 16.76 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.01 1.324 . . . . 0.0 114.011 -175.013 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -63.87 -24.87 67.91 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.226 1.01 . . . . 0.0 112.557 173.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -63.16 160.93 14.44 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.202 1.001 . . . . 0.0 110.065 175.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -48.53 134.09 15.87 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 169.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 37.6 mm -63.67 148.33 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 -176.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 24.3 t60 -137.06 158.35 44.65 Favored 'General case' 0 C--N 1.332 -0.193 0 O-C-N 121.508 -0.745 . . . . 0.0 109.506 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.5 t -140.16 132.27 32.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -166.88 -173.69 2.47 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.18 0.992 . . . . 0.0 108.809 -172.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.92 -166.33 21.31 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-N 119.059 0.845 . . . . 0.0 112.263 171.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -155.64 178.22 10.5 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.424 1.09 . . . . 0.0 110.145 178.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.8 t -129.91 151.15 50.79 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 104.824 -2.288 . . . . 0.0 104.824 169.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.3 ptm -88.88 -34.05 17.11 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 118.787 -0.625 . . . . 0.0 110.281 175.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.34 -25.85 55.13 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.08 0.855 . . . . 0.0 111.981 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -130.84 -4.63 4.04 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -169.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.94 175.61 42.19 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-N 118.854 0.752 . . . . 0.0 112.353 177.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -66.7 138.43 49.18 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.428 2.085 . . . . 0.0 110.035 173.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.31 169.31 7.44 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.033 0.533 . . . . 0.0 110.953 171.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 21.2 mm100 -63.25 -30.26 71.43 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 118.975 -0.536 . . . . 0.0 111.428 170.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 40.2 m80 60.8 -31.56 0.07 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 129.017 2.927 . . . . 0.0 115.496 -175.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.09 -41.94 93.57 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.202 1.401 . . . . 0.0 112.318 178.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.8 mt -62.38 -49.15 85.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 177.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.4 m -54.68 -45.16 73.89 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.54 1.136 . . . . 0.0 112.172 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.527 HG22 HG12 ' A' ' 118' ' ' VAL . 1.0 OUTLIER -61.3 -50.0 74.76 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 119.747 1.158 . . . . 0.0 110.315 178.442 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -61.26 -41.42 96.89 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.972 0.805 . . . . 0.0 110.889 -177.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 24.5 mmtp -68.23 -43.82 77.09 Favored 'General case' 0 C--N 1.338 0.086 0 CA-C-O 118.699 -0.667 . . . . 0.0 111.629 178.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 79.9 mt -67.23 -38.15 80.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 119.958 1.254 . . . . 0.0 109.01 -178.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -58.31 -45.25 88.38 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 119.64 1.109 . . . . 0.0 109.49 173.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.05 -37.88 89.03 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.351 0.523 . . . . 0.0 111.787 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 41.7 tptt -62.34 -44.12 97.23 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 123.943 0.897 . . . . 0.0 110.811 178.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -141.59 73.54 24.21 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 118.401 0.546 . . . . 0.0 110.491 -170.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.89 -6.22 18.66 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.307 2.672 . . . . 0.0 113.602 -173.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -68.21 -19.83 64.79 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.84 0.745 . . . . 0.0 111.515 169.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 22.8 m-30 -109.37 178.37 4.46 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.042 1.337 . . . . 0.0 108.822 169.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -131.85 161.14 33.69 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 171.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.527 HG12 HG22 ' A' ' 106' ' ' THR . 2.6 t -139.97 141.0 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 -169.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 16.9 p -135.06 171.09 14.92 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.137 0.975 . . . . 0.0 109.241 173.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 35.6 p-90 -143.28 152.24 41.45 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 121.597 -0.69 . . . . 0.0 109.436 172.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.42 119.56 3.8 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.182 -2.155 . . . . 0.0 105.182 170.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.42 -3.72 32.21 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 120.309 -0.557 . . . . 0.0 112.345 -171.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -58.34 -30.74 66.96 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.754 1.221 . . . . 0.0 112.692 -178.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -72.7 134.61 20.79 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 173.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 . . . . . 0 C--O 1.239 0.514 0 C-N-CA 125.606 1.562 . . . . 0.0 108.942 177.014 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 126' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.9 tpt . . . . . 0 N--CA 1.482 1.157 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.18 153.77 40.25 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.212 1.405 . . . . 0.0 107.383 169.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.1 t -68.33 126.14 27.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -178.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -76.37 -176.46 3.66 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.363 0.665 . . . . 0.0 110.43 172.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -149.21 147.64 28.65 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 169.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 95.1 mt -55.51 -34.21 64.44 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.537 0.735 . . . . 0.0 112.407 -175.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.05 -25.54 66.31 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.834 0.743 . . . . 0.0 112.249 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.6 mt -79.25 -24.01 43.28 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.178 0.591 . . . . 0.0 111.183 -178.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 39.5 mt -68.31 128.78 93.1 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -176.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -47.42 123.05 7.41 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.939 3.093 . . . . 0.0 111.925 172.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -71.87 -37.52 70.19 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.499 0.72 . . . . 0.0 111.294 -177.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 63.9 t -137.52 134.32 46.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 176.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -152.66 119.96 5.92 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 171.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.5 pt -147.96 168.95 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 124.28 1.032 . . . . 0.0 109.299 -169.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -126.05 97.68 5.2 Favored 'General case' 0 N--CA 1.461 0.123 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 169.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.2 m -70.69 51.22 0.14 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 127.928 2.491 . . . . 0.0 113.054 -171.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -60.2 -37.05 79.08 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.515 1.126 . . . . 0.0 113.004 -169.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 160.12 -56.78 0.32 Allowed Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 174.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 46.9 t -142.14 122.98 11.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 173.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -160.15 151.21 19.18 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.309 1.044 . . . . 0.0 108.771 -174.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -75.66 156.3 34.94 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.491 0.717 . . . . 0.0 110.003 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.44 163.34 35.97 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.004 1.322 . . . . 0.0 107.869 -178.151 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.3 m -135.95 156.04 36.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 C-N-CA 124.304 1.041 . . . . 0.0 109.7 172.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.81 122.23 45.97 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 104.225 -2.509 . . . . 0.0 104.225 173.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 73.9 mt -121.53 122.5 67.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 -176.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 37.6 ttp180 -80.74 146.82 30.84 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 169.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.6 t -132.13 143.77 39.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 -175.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -128.96 138.36 51.93 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 176.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.5 p -67.31 115.87 7.44 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.777 0.799 . . . . 0.0 110.641 -175.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.405 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -148.43 27.49 0.05 OUTLIER Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 125.833 1.653 . . . . 0.0 111.609 169.158 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.405 ' CD ' ' N ' ' A' ' 30' ' ' ALA . 35.2 Cg_endo -59.73 156.06 39.68 Favored 'Trans proline' 0 C--N 1.358 1.064 0 CA-C-N 122.569 1.953 . . . . 0.0 111.985 -173.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.5 ttp180 50.56 19.06 0.52 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.446 1.898 . . . . 0.0 112.664 -169.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.7 m 50.19 31.46 5.11 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.385 1.474 . . . . 0.0 112.282 -173.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -166.59 1.66 0.04 OUTLIER Glycine 0 C--N 1.343 0.917 0 CA-C-O 118.28 -1.289 . . . . 0.0 115.837 -173.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.76 142.05 78.97 Favored Pre-proline 0 CA--C 1.543 0.702 0 CA-C-N 119.858 1.829 . . . . 0.0 110.493 173.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -78.47 -15.77 13.79 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 123.053 2.502 . . . . 0.0 113.495 -175.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.71 157.92 22.94 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.574 0.75 . . . . 0.0 111.333 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.16 76.62 1.28 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.197 1.399 . . . . 0.0 107.531 176.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -138.22 175.69 9.35 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 126.982 2.113 . . . . 0.0 107.416 -177.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.2 m -140.89 157.86 44.77 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.299 0.64 . . . . 0.0 110.589 -175.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -152.22 167.5 28.38 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 127.586 2.355 . . . . 0.0 106.008 -175.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.9 mp0 -133.21 156.49 47.42 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 120.713 -1.242 . . . . 0.0 108.443 176.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 32.2 pt -136.31 155.35 34.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 125.255 1.422 . . . . 0.0 109.807 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 48.1 t -118.14 122.36 69.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 -179.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.1 mmp_? -129.29 146.18 51.23 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.083 1.353 . . . . 0.0 107.832 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 177.32 131.36 1.5 Allowed Glycine 0 C--N 1.331 0.283 0 CA-C-N 119.173 0.897 . . . . 0.0 111.045 173.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -153.95 152.3 30.42 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -173.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.9 pttm -58.89 -29.4 66.99 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 11.1 p-90 -65.4 -27.52 68.6 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.231 0.923 . . . . 0.0 111.854 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.56 75.67 10.01 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 118.871 0.76 . . . . 0.0 109.052 172.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -67.22 -6.59 18.75 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.685 0.794 . . . . 0.0 111.574 175.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -137.28 146.14 44.34 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 126.63 1.972 . . . . 0.0 107.224 173.257 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -68.97 -34.29 75.08 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -171.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.97 -26.49 48.47 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 118.355 -0.831 . . . . 0.0 112.766 174.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -69.11 -48.06 63.53 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 119.749 1.159 . . . . 0.0 111.111 -175.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.416 ' H ' HG12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -66.08 -38.02 81.09 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.024 176.284 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -62.23 -50.32 72.2 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.612 177.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -60.99 -44.12 97.85 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.798 1.181 . . . . 0.0 112.02 -178.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.6 tppt? -57.08 -54.64 44.45 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.169 0.988 . . . . 0.0 110.527 177.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.2 t -85.26 -34.41 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-O 117.619 -1.182 . . . . 0.0 111.974 -168.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 57.2 p -63.26 -33.18 74.94 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 121.345 1.884 . . . . 0.0 109.485 170.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.74 -52.85 50.5 Favored Glycine 0 C--N 1.338 0.64 0 N-CA-C 110.354 -1.099 . . . . 0.0 110.354 171.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.403 ' HA ' ' HE3' ' A' ' 66' ' ' LYS . 19.8 t70 -59.86 -44.6 94.04 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.717 1.258 . . . . 0.0 111.993 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 35.4 mmt -60.35 -47.98 83.72 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 123.238 0.615 . . . . 0.0 109.903 178.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -68.57 -28.62 67.11 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 118.501 0.591 . . . . 0.0 111.827 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.403 ' HE3' ' HA ' ' A' ' 63' ' ' ASP . 53.1 mtmt -67.3 -37.7 83.8 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 118.119 -0.943 . . . . 0.0 110.393 170.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -68.82 -30.04 68.51 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.871 1.214 . . . . 0.0 110.31 169.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 126.2 -22.36 5.98 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 127.625 2.536 . . . . 0.0 111.872 175.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 82.5 m -55.52 152.09 9.49 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 126.188 1.795 . . . . 0.0 112.339 -177.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -110.68 140.86 44.66 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 96.8 m -143.32 165.03 28.61 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -168.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -151.43 127.24 10.27 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.545 1.538 . . . . 0.0 107.542 175.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.2 p -70.56 120.15 15.77 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 169.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 58.3 mt -71.29 -22.96 61.88 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.932 -0.48 . . . . 0.0 110.424 174.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 165.96 -169.27 40.16 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 172.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -135.76 174.96 21.09 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 174.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -178.53 -168.16 37.4 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 -176.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -137.84 163.05 32.38 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 119.029 1.414 . . . . 0.0 109.73 173.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 75.0 mt -116.76 131.5 69.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 -169.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.4 m 57.05 167.2 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 129.69 3.196 . . . . 0.0 116.011 174.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -156.47 156.69 34.18 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.201 1.401 . . . . 0.0 107.498 174.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -57.62 -30.25 65.19 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.046 0.384 . . . . 0.0 111.298 178.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 m -62.99 -18.04 62.83 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.552 1.541 . . . . 0.0 113.876 177.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.1 mm-40 -137.75 -2.66 1.91 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.287 1.035 . . . . 0.0 112.568 -171.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -44.45 -26.75 0.38 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 127.602 2.361 . . . . 0.0 116.847 -169.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -56.04 -17.68 7.55 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 172.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -140.86 143.21 34.61 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 172.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.419 ' H ' HD12 ' A' ' 88' ' ' ILE . 5.3 mp -68.21 147.54 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 178.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 28.1 t60 -135.55 159.18 42.41 Favored 'General case' 0 C--N 1.334 -0.091 0 O-C-N 121.297 -0.877 . . . . 0.0 109.427 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.4 t -141.01 135.65 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -166.26 -174.28 2.86 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.623 0.769 . . . . 0.0 109.664 -172.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.35 -170.48 39.05 Favored Glycine 0 CA--C 1.523 0.581 0 O-C-N 121.77 -0.581 . . . . 0.0 112.101 171.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -159.95 152.88 21.59 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.061 0.944 . . . . 0.0 109.845 -178.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.7 t -82.79 154.77 24.56 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 168.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.8 ppp? -82.29 -39.24 23.2 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 171.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.6 -25.59 45.22 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 119.152 -0.451 . . . . 0.0 111.971 -175.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -132.0 -2.32 3.64 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -169.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.88 -174.79 51.0 Favored Glycine 0 CA--C 1.534 1.281 0 CA-C-N 118.903 0.774 . . . . 0.0 113.101 174.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.98 138.34 43.82 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.963 2.442 . . . . 0.0 110.091 173.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.75 170.93 15.24 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.614 0.721 . . . . 0.0 111.488 170.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -78.86 76.02 5.36 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 169.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -57.62 -18.63 21.16 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -174.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.15 -35.77 76.05 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.194 0.998 . . . . 0.0 112.35 171.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 69.4 mt -65.81 -45.53 91.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 176.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.3 m -58.68 -46.85 86.33 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.998 0.919 . . . . 0.0 111.52 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 21.0 p -60.56 -53.26 59.63 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 119.184 0.902 . . . . 0.0 109.325 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -61.81 -40.96 97.07 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.795 0.725 . . . . 0.0 111.437 -175.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -66.53 -48.13 70.69 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 118.708 0.685 . . . . 0.0 111.481 178.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 73.4 mt -66.36 -37.45 79.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 119.229 0.922 . . . . 0.0 109.003 -178.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 46.7 mtpt -61.75 -43.98 97.79 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.615 1.098 . . . . 0.0 110.118 175.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.44 -38.48 91.31 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.687 0.676 . . . . 0.0 111.37 176.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -65.79 -38.47 89.08 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.597 0.759 . . . . 0.0 111.195 177.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -133.05 69.15 78.78 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 124.448 1.099 . . . . 0.0 110.221 -170.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -69.48 -12.51 33.59 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 123.069 2.513 . . . . 0.0 113.429 -172.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -70.37 -8.09 47.99 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.895 0.878 . . . . 0.0 112.266 171.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -131.21 -178.69 4.95 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.272 1.829 . . . . 0.0 109.086 -179.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -141.44 158.51 43.77 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.602 1.161 . . . . 0.0 108.158 177.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.4 t -139.65 141.48 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 -169.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.3 p -132.51 172.0 13.05 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.084 0.953 . . . . 0.0 109.498 176.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 33.5 p-90 -144.34 153.07 41.6 Favored 'General case' 0 C--O 1.235 0.299 0 O-C-N 121.603 -0.686 . . . . 0.0 109.967 173.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.5 118.41 3.56 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 170.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.71 -2.48 26.54 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 -169.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -63.03 -32.82 74.27 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.39 1.076 . . . . 0.0 112.667 -177.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -69.31 158.01 53.35 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 111.076 -0.809 . . . . 0.0 111.076 178.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 52.1 p90 . . . . . 0 C--O 1.238 0.455 0 C-N-CA 124.968 1.307 . . . . 0.0 110.031 175.588 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 126' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.1 tpt . . . . . 0 N--CA 1.481 1.123 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.19 164.91 29.86 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.839 1.256 . . . . 0.0 108.672 175.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.9 t -67.37 124.12 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 178.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -76.25 -174.42 2.79 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.703 0.801 . . . . 0.0 110.816 174.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -152.73 153.98 34.32 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.85 1.66 . . . . 0.0 106.635 170.031 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.4 mt -53.28 -36.58 61.33 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.038 0.835 . . . . 0.0 112.0 -179.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.02 -25.66 68.22 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.875 0.761 . . . . 0.0 112.506 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.1 mt -83.66 -20.27 33.89 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.38 0.672 . . . . 0.0 111.44 -178.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 32.0 mt -67.38 131.61 93.25 Favored Pre-proline 0 CA--C 1.539 0.52 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -49.76 119.54 4.88 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 123.066 2.511 . . . . 0.0 110.63 169.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -71.15 -39.65 71.82 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.791 0.836 . . . . 0.0 111.155 -175.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.9 t -134.89 139.45 47.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 172.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -152.02 122.87 7.5 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 170.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 45.1 pt -145.29 167.91 9.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 127.366 2.266 . . . . 0.0 105.703 177.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -148.27 -37.56 0.18 Allowed 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.807 -0.558 . . . . 0.0 111.988 178.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.1 m -65.9 162.3 19.37 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.177 0.991 . . . . 0.0 112.194 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -144.49 127.13 16.12 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 172.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 148.84 -126.09 2.19 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 108.382 -1.887 . . . . 0.0 108.382 -169.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.2 t -135.39 119.42 25.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 104.91 -2.256 . . . . 0.0 104.91 173.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -156.6 151.21 25.69 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 118.887 0.767 . . . . 0.0 110.767 -174.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -66.35 155.31 37.68 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.331 0.586 . . . . 0.0 110.523 -178.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -141.48 163.56 32.6 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.309 1.444 . . . . 0.0 107.376 173.41 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.4 m -138.34 156.56 30.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 C-N-CA 123.905 0.882 . . . . 0.0 109.467 172.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.21 118.86 37.85 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 104.392 -2.448 . . . . 0.0 104.392 176.031 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 62.8 mt -121.72 115.71 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 119.809 1.186 . . . . 0.0 108.402 -173.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -74.54 140.88 44.77 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 168.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.9 p -134.85 148.01 29.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 178.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -127.52 143.47 51.18 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.184 1.393 . . . . 0.0 108.623 -169.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.8 m -62.49 105.08 0.58 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.574 0.75 . . . . 0.0 111.308 177.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.401 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -149.02 25.27 0.04 OUTLIER Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 125.568 1.547 . . . . 0.0 111.872 168.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 30' ' ' ALA . 43.6 Cg_endo -61.0 133.97 50.38 Favored 'Trans proline' 0 C--N 1.356 0.964 0 CA-C-N 122.263 1.844 . . . . 0.0 111.115 -169.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 37.49 28.29 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 129.063 2.945 . . . . 0.0 114.222 -170.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.6 m 45.17 38.61 3.41 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.191 1.396 . . . . 0.0 112.021 -172.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -149.84 41.0 0.84 Allowed Glycine 0 C--N 1.34 0.772 0 C-N-CA 123.741 0.686 . . . . 0.0 112.453 -169.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -137.36 143.18 40.32 Favored Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 124.251 1.02 . . . . 0.0 108.42 171.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -78.13 -18.37 12.84 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.917 2.411 . . . . 0.0 113.188 -175.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.78 152.36 36.1 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.654 0.781 . . . . 0.0 111.02 -178.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -140.16 28.85 2.06 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.423 1.489 . . . . 0.0 110.013 176.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -76.5 178.36 6.68 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.839 0.855 . . . . 0.0 109.986 176.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.6 m -140.59 161.26 38.17 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.841 1.256 . . . . 0.0 109.186 174.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 58.9 tttt -145.56 165.13 29.54 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 126.947 2.099 . . . . 0.0 107.074 -176.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.7 mp0 -125.31 119.49 28.53 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 173.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 35.5 pt -104.34 154.45 6.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 124.286 1.034 . . . . 0.0 110.078 174.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 45.9 t -121.33 124.28 71.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 -172.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.6 mmp_? -132.36 148.61 52.43 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.185 1.394 . . . . 0.0 108.585 -176.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.97 134.93 2.33 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 169.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -156.69 152.51 27.16 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 124.09 0.956 . . . . 0.0 108.471 -176.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -63.52 -26.83 68.89 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 8.1 p-90 -65.63 -25.52 67.41 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.021 0.828 . . . . 0.0 111.701 178.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.09 83.99 5.88 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 170.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -65.58 -16.21 63.47 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.346 0.658 . . . . 0.0 111.473 174.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -138.74 153.41 48.48 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 126.768 2.027 . . . . 0.0 107.896 178.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 37.8 m-70 -70.99 -34.06 71.02 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -171.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.44 -26.81 44.21 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 118.319 -0.848 . . . . 0.0 112.829 174.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -68.77 -49.75 56.05 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 119.653 1.115 . . . . 0.0 110.892 -175.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.436 ' H ' HG12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -65.42 -39.44 85.22 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.105 175.892 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -61.51 -52.52 64.15 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 118.106 -0.95 . . . . 0.0 109.503 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -60.34 -43.49 96.4 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 119.465 1.03 . . . . 0.0 112.002 -177.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.1 tppt? -57.37 -53.66 55.6 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 124.02 0.928 . . . . 0.0 110.596 176.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.2 t -85.42 -36.86 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-O 117.566 -1.207 . . . . 0.0 112.042 -168.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 83.4 p -63.19 -36.65 84.34 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 121.237 1.835 . . . . 0.0 109.432 171.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.45 -48.83 81.88 Favored Glycine 0 C--N 1.34 0.755 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 171.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -62.86 -43.7 98.09 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 118.848 1.324 . . . . 0.0 111.668 178.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 35.7 mmt -60.85 -44.0 97.59 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-N 118.225 0.466 . . . . 0.0 110.065 177.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -66.93 -29.9 69.89 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.048 0.939 . . . . 0.0 111.968 177.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -68.68 -38.71 80.55 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.67 1.123 . . . . 0.0 109.938 169.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -66.93 -24.71 66.11 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 119.269 0.941 . . . . 0.0 110.495 169.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.73 -21.97 12.11 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 128.412 2.911 . . . . 0.0 112.094 176.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 89.5 m -59.37 150.48 26.15 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 126.0 1.72 . . . . 0.0 110.832 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -108.82 153.07 24.03 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 89.9 m -144.59 162.99 35.25 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 -168.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -149.69 125.91 10.72 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 169.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.7 p -68.32 115.19 7.48 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 169.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 53.3 mt -67.45 -23.63 65.54 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 122.072 -0.393 . . . . 0.0 110.206 174.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 172.64 -174.6 45.71 Favored Glycine 0 C--N 1.338 0.674 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 170.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -133.08 166.81 23.59 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 172.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -173.86 -156.74 13.93 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -176.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -141.01 159.39 42.31 Favored 'General case' 0 CA--C 1.518 -0.288 0 O-C-N 120.93 -1.335 . . . . 0.0 110.416 175.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 78.3 mt -111.05 136.46 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 104.299 -2.482 . . . . 0.0 104.299 174.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.5 m -144.97 -175.44 4.69 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.478 1.511 . . . . 0.0 108.58 -177.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -138.78 22.66 2.66 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.003 0.921 . . . . 0.0 111.446 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -66.9 -31.4 71.97 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.586 -0.696 . . . . 0.0 112.096 -170.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 43.7 m -62.19 118.3 7.2 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.118 0.967 . . . . 0.0 110.067 -178.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 90.6 mm-40 50.33 23.94 1.37 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.901 1.281 . . . . 0.0 112.663 -171.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.8 t70 50.54 19.7 0.61 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 127.041 2.136 . . . . 0.0 114.101 -171.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -147.36 -46.47 0.17 Allowed 'General case' 0 N--CA 1.467 0.418 0 O-C-N 121.143 -0.973 . . . . 0.0 112.341 -170.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -68.2 132.85 47.89 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 66.6 mt -67.61 147.48 12.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 106.239 -1.764 . . . . 0.0 106.239 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 30.0 t60 -135.67 151.45 50.22 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 121.493 -0.754 . . . . 0.0 109.119 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.1 t -142.03 118.63 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -173.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -168.05 165.81 13.34 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.942 0.897 . . . . 0.0 108.994 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 136.52 -178.59 18.72 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-N 118.685 0.675 . . . . 0.0 111.511 170.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -141.99 146.38 35.52 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.226 0.61 . . . . 0.0 111.253 169.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.5 t -84.21 153.08 23.84 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 168.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 27.6 ptm -84.39 -35.4 23.16 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 119.128 0.876 . . . . 0.0 109.753 171.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.73 -26.21 57.28 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.68 0.673 . . . . 0.0 112.144 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -132.97 -3.58 3.17 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -169.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 78.42 -176.07 54.45 Favored Glycine 0 CA--C 1.535 1.29 0 CA-C-N 119.114 0.87 . . . . 0.0 113.121 174.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -70.47 167.61 24.87 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 123.765 2.977 . . . . 0.0 111.412 174.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -124.57 166.18 16.53 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.941 1.296 . . . . 0.0 111.003 -173.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 24.6 mm100 -78.85 74.57 5.38 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.81 0.844 . . . . 0.0 109.164 171.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -53.78 -23.63 12.63 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.15 0.98 . . . . 0.0 112.697 176.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -51.71 -42.37 62.18 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.168 1.387 . . . . 0.0 112.688 171.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 78.3 mt -65.42 -48.48 82.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 179.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.4 m -57.39 -48.05 80.1 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.468 1.107 . . . . 0.0 110.845 -177.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.7 p -66.44 -48.62 69.38 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 119.17 0.896 . . . . 0.0 110.713 -177.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -57.47 -42.98 83.67 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 119.332 0.969 . . . . 0.0 110.547 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -70.0 -50.52 40.69 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 118.522 -0.751 . . . . 0.0 111.074 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 76.6 mt -63.55 -38.48 82.33 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 120.097 1.317 . . . . 0.0 109.591 -175.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -56.1 -48.32 76.36 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.651 1.114 . . . . 0.0 109.99 174.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.95 -38.77 89.48 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 122.585 0.354 . . . . 0.0 111.628 -179.117 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -72.35 -33.03 66.98 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 118.817 -0.611 . . . . 0.0 112.028 -177.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -138.1 64.72 41.62 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 123.695 0.798 . . . . 0.0 110.566 -169.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -70.58 -5.64 17.19 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 123.526 2.818 . . . . 0.0 113.322 -176.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -64.54 -17.17 63.67 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.833 0.853 . . . . 0.0 111.942 170.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -127.65 179.61 5.43 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.589 1.955 . . . . 0.0 108.201 172.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -129.24 159.89 34.67 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 172.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.1 t -136.59 143.75 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 -169.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.4 p -136.5 167.85 20.59 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 123.828 0.851 . . . . 0.0 109.683 175.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 13.4 p-90 -139.15 165.82 26.15 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 170.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -146.97 115.9 6.86 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 176.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -67.44 -13.52 62.1 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 119.201 -0.428 . . . . 0.0 111.985 174.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -61.44 -29.28 69.85 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.222 1.009 . . . . 0.0 111.718 -175.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -80.11 -167.25 35.37 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 124.094 0.854 . . . . 0.0 112.102 174.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 46.7 p90 . . . . . 0 C--O 1.238 0.458 0 C-N-CA 125.626 1.57 . . . . 0.0 113.392 177.623 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 126' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.6 mtt . . . . . 0 N--CA 1.483 1.192 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.7 166.38 13.12 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 169.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.7 t -138.49 152.66 25.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 175.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -157.41 -172.62 4.06 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.754 1.622 . . . . 0.0 108.189 -177.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -145.21 147.67 32.68 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 169.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.2 mt -56.18 -34.41 66.18 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -172.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.16 -22.71 63.91 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.748 0.703 . . . . 0.0 112.54 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.4 mt -81.85 -20.0 39.85 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.376 0.67 . . . . 0.0 111.287 -178.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 46.9 mt -66.52 133.01 94.25 Favored Pre-proline 0 CA--C 1.542 0.643 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -49.48 130.29 25.19 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.304 2.669 . . . . 0.0 111.259 170.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -80.46 -37.87 31.06 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.005 0.431 . . . . 0.0 111.508 -175.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.2 t -136.27 130.44 47.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 176.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -151.93 123.36 7.8 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 169.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.9 pt -147.8 168.83 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.901 1.28 . . . . 0.0 109.732 -169.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -142.55 108.03 5.05 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.719 0.808 . . . . 0.0 110.04 171.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 53.0 m -67.65 162.94 22.49 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.958 0.903 . . . . 0.0 112.212 177.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -151.5 -41.31 0.12 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.251 1.42 . . . . 0.0 109.368 169.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -178.1 -55.63 0.07 OUTLIER Glycine 0 CA--C 1.523 0.58 0 N-CA-C 107.51 -2.236 . . . . 0.0 107.51 169.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 25.4 t -139.16 136.27 41.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 169.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -153.54 148.77 26.94 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 123.841 0.857 . . . . 0.0 109.861 -176.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -76.22 153.08 36.35 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.015 0.526 . . . . 0.0 110.298 -178.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -145.56 162.2 38.01 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.574 1.15 . . . . 0.0 108.125 176.601 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.0 m -130.31 153.58 39.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 C-N-CA 124.361 1.064 . . . . 0.0 109.493 173.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -108.09 114.79 28.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 103.864 -2.643 . . . . 0.0 103.864 178.246 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 49.7 mt -118.27 125.84 74.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -171.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 -81.75 149.38 28.45 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 169.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.7 t -132.93 147.77 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 127.325 2.25 . . . . 0.0 105.031 -176.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -132.15 147.93 52.45 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 177.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.3 m -61.0 101.53 0.15 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.649 0.78 . . . . 0.0 110.852 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.5 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -144.45 19.96 0.04 OUTLIER Pre-proline 0 CA--C 1.55 0.971 0 CA-C-O 116.319 -1.8 . . . . 0.0 113.872 169.462 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.5 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 75.3 Cg_exo -45.97 153.45 0.92 Allowed 'Trans proline' 0 C--N 1.362 1.288 0 CA-C-N 124.015 2.47 . . . . 0.0 113.316 172.035 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 46.14 18.31 0.05 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.732 1.613 . . . . 0.0 114.862 -170.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.3 m 49.96 30.91 4.3 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.961 1.304 . . . . 0.0 111.826 -169.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 179.95 34.82 0.07 OUTLIER Glycine 0 C--N 1.342 0.862 0 CA-C-O 119.425 -0.653 . . . . 0.0 113.076 -170.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.25 149.29 95.96 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 118.492 1.146 . . . . 0.0 109.071 169.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.96 -24.06 11.71 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.627 2.218 . . . . 0.0 113.068 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.48 160.51 27.41 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.649 0.78 . . . . 0.0 110.738 177.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.35 37.22 1.11 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.351 1.46 . . . . 0.0 109.519 177.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -85.22 -179.94 7.09 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.211 1.004 . . . . 0.0 109.655 178.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.9 m -140.85 157.87 44.77 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.703 1.201 . . . . 0.0 109.068 173.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.7 tmtm? -156.1 165.92 34.99 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.275 1.83 . . . . 0.0 107.408 -169.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.5 mp0 -131.56 155.89 46.69 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.95 1.25 . . . . 0.0 109.334 175.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 41.7 pt -139.66 158.17 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 126.046 1.738 . . . . 0.0 110.084 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.2 t -118.44 118.83 59.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 12.2 mmp_? -127.43 141.36 51.69 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 175.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.87 137.25 2.96 Favored Glycine 0 C--N 1.332 0.329 0 CA-C-N 119.09 0.859 . . . . 0.0 111.493 174.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.405 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 12.9 m-85 -154.02 150.8 28.64 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -170.038 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -60.13 -29.08 68.4 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 118.681 -0.676 . . . . 0.0 112.197 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.405 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 11.8 p-90 -63.48 -29.18 70.5 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.257 0.935 . . . . 0.0 112.391 177.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.8 73.24 10.65 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 119.204 0.911 . . . . 0.0 109.349 174.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -68.87 -2.42 9.59 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.421 0.688 . . . . 0.0 111.869 177.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -138.93 145.19 39.52 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 126.588 1.955 . . . . 0.0 107.008 172.364 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -71.27 -32.0 68.17 Favored 'General case' 0 C--O 1.234 0.273 0 O-C-N 121.879 -0.513 . . . . 0.0 110.058 -171.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.61 -27.83 42.19 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 118.438 -0.791 . . . . 0.0 112.629 172.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -68.51 -49.64 58.15 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 119.647 1.112 . . . . 0.0 110.809 -176.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.43 -40.75 87.37 Favored 'Isoleucine or valine' 0 C--N 1.342 0.239 0 CA-C-O 117.837 -1.078 . . . . 0.0 109.619 175.244 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -61.13 -45.55 94.21 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.781 1.173 . . . . 0.0 110.446 -178.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -63.78 -49.01 74.63 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.864 0.756 . . . . 0.0 111.606 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.4 tttp -59.58 -49.0 79.47 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.422 0.689 . . . . 0.0 111.014 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 88.8 t -75.08 -42.86 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-O 117.686 -1.15 . . . . 0.0 109.244 -172.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 65.4 m -59.11 -36.28 74.89 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 120.572 1.533 . . . . 0.0 110.541 173.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.14 -53.94 41.6 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 172.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.421 ' HA ' ' HE3' ' A' ' 66' ' ' LYS . 18.4 t70 -61.61 -46.19 90.88 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 118.718 1.259 . . . . 0.0 111.679 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 35.5 mmt -57.62 -51.14 70.7 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.509 0.724 . . . . 0.0 109.793 178.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.9 mm-40 -67.79 -27.19 66.53 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.717 0.69 . . . . 0.0 111.957 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.421 ' HE3' ' HA ' ' A' ' 63' ' ' ASP . 51.1 mtmt -67.78 -38.14 82.98 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 119.518 1.054 . . . . 0.0 110.576 170.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -68.01 -30.92 70.28 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.808 1.186 . . . . 0.0 109.779 169.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 126.75 -26.24 5.16 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 128.253 2.835 . . . . 0.0 110.875 177.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 89.5 m -49.72 142.01 9.14 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 127.214 2.206 . . . . 0.0 111.799 -174.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -104.67 138.32 41.17 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 178.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 59.3 m -142.06 160.36 40.37 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -168.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -146.49 134.76 21.77 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.419 1.488 . . . . 0.0 107.998 172.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.3 p -74.0 119.42 18.19 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 169.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 35.0 mt -71.58 -22.04 61.79 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 121.85 -0.531 . . . . 0.0 110.024 172.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.29 -163.78 37.12 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 170.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -149.67 -175.57 22.05 Favored Glycine 0 N--CA 1.451 -0.326 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 170.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -174.17 -161.41 24.1 Favored Glycine 0 CA--C 1.52 0.394 0 N-CA-C 107.598 -2.201 . . . . 0.0 107.598 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.2 ptt180 -134.22 154.27 51.36 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.102 -1.234 . . . . 0.0 108.612 172.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 66.8 mt -113.27 142.01 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 104.429 -2.434 . . . . 0.0 104.429 -177.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.0 m -118.23 134.07 55.34 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 172.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 35.5 t60 -66.05 168.11 8.84 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.021 0.928 . . . . 0.0 110.317 -178.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -59.82 157.81 11.63 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.262 0.625 . . . . 0.0 110.063 173.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.9 m -128.87 -178.82 4.77 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.89 1.276 . . . . 0.0 108.262 169.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -66.06 -8.82 25.62 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.499 0.72 . . . . 0.0 112.67 178.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -142.3 -54.05 0.42 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.933 1.293 . . . . 0.0 110.251 176.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -65.9 139.71 58.29 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.072 0.463 . . . . 0.0 111.264 -175.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -68.92 164.48 22.06 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.079 0.952 . . . . 0.0 111.156 176.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 71.1 mt -63.67 135.95 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 103.609 -2.737 . . . . 0.0 103.609 168.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 27.2 t60 -134.71 156.76 48.24 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 119.322 0.964 . . . . 0.0 110.566 -170.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 22.0 t -138.31 130.46 38.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -168.97 -165.45 0.55 Allowed 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.796 0.839 . . . . 0.0 110.051 -176.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.33 -165.53 54.21 Favored Glycine 0 CA--C 1.524 0.595 0 O-C-N 121.755 -0.591 . . . . 0.0 112.434 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -164.85 157.12 15.98 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.015 0.926 . . . . 0.0 111.015 -173.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.6 t -81.94 159.86 23.5 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 167.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.0 ptm -95.84 -33.63 12.16 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 118.961 0.801 . . . . 0.0 110.424 169.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.95 -25.42 58.86 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.188 0.904 . . . . 0.0 112.039 176.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -131.91 -5.31 3.56 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -169.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.56 -177.49 49.21 Favored Glycine 0 CA--C 1.535 1.339 0 CA-C-N 119.022 0.828 . . . . 0.0 113.506 172.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -69.39 138.22 38.46 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.173 2.582 . . . . 0.0 110.363 173.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -78.42 171.8 14.56 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.035 0.445 . . . . 0.0 109.933 169.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 92.3 mm-40 -77.61 83.95 3.99 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 168.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -57.55 -13.92 4.47 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -176.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.0 -44.45 87.24 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.93 1.292 . . . . 0.0 110.788 169.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 61.1 mt -64.76 -47.21 89.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 179.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.76 -51.31 70.51 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.044 0.938 . . . . 0.0 110.43 -175.328 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.6 p -65.91 -46.12 79.43 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 117.862 -1.066 . . . . 0.0 110.313 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -58.71 -42.28 88.32 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 120.239 1.381 . . . . 0.0 110.938 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -65.48 -46.32 80.2 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 118.765 -0.636 . . . . 0.0 111.265 177.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 57.4 mt -64.93 -44.26 96.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 -178.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 26.9 mtpt -62.48 -39.02 92.12 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 119.396 0.998 . . . . 0.0 110.935 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.31 -39.83 91.95 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.676 0.671 . . . . 0.0 111.267 177.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -90.46 -24.68 20.64 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 118.275 0.488 . . . . 0.0 112.052 -175.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -142.74 69.84 19.76 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 126.416 1.886 . . . . 0.0 108.312 -171.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.97 -19.05 30.81 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 122.453 2.102 . . . . 0.0 112.729 -176.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -52.88 127.04 22.23 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.575 1.15 . . . . 0.0 111.504 -175.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 6.9 t80 61.34 0.47 0.44 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.336 2.255 . . . . 0.0 115.239 -177.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 65.03 164.84 0.16 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.501 1.92 . . . . 0.0 113.241 -178.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.4 t -132.21 148.44 32.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 C-N-CA 126.53 1.932 . . . . 0.0 106.491 178.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 20.7 p -134.13 169.07 17.7 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.577 1.151 . . . . 0.0 110.293 -178.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 27.3 p-90 -146.48 155.67 42.71 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.143 0.577 . . . . 0.0 109.923 169.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -160.55 101.95 1.35 Allowed 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 172.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.32 -13.45 62.28 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -169.445 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -61.65 -33.36 73.83 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.355 1.062 . . . . 0.0 112.393 -178.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -85.17 146.55 21.96 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 173.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 65.3 t80 . . . . . 0 C--O 1.235 0.323 0 CA-C-N 117.937 0.868 . . . . 0.0 108.771 176.368 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 126' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.0 mmt . . . . . 0 N--CA 1.483 1.184 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.83 147.95 48.52 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 170.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.2 p -155.84 151.55 9.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -176.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.95 -178.71 5.64 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.164 0.507 . . . . 0.0 110.394 176.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -151.78 150.19 29.88 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 171.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 53.9 mt -57.87 -31.14 66.42 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.268 0.627 . . . . 0.0 112.617 -175.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.44 -25.09 65.73 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.674 0.67 . . . . 0.0 112.278 178.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.1 mt -79.82 -24.79 41.12 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.04 0.536 . . . . 0.0 111.024 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 7.3 mt -68.97 131.99 90.63 Favored Pre-proline 0 C--O 1.237 0.421 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 176.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.66 135.61 31.15 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 121.526 1.484 . . . . 0.0 110.571 176.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.67 -27.27 66.7 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.673 0.789 . . . . 0.0 111.578 -178.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.2 t -139.6 134.87 39.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -178.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -152.41 121.17 6.5 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 169.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.5 pt -146.58 172.17 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 124.497 1.119 . . . . 0.0 110.192 -169.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -129.65 95.28 3.95 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.745 1.218 . . . . 0.0 108.667 171.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.2 m -54.42 148.28 12.23 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.904 1.681 . . . . 0.0 111.634 177.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -161.05 -51.22 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.797 0.839 . . . . 0.0 111.524 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 167.57 -59.21 0.22 Allowed Glycine 0 C--N 1.335 0.527 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 -174.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 60.8 t -144.39 132.25 17.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 126.767 2.027 . . . . 0.0 105.708 172.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -155.52 150.18 26.25 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 123.689 0.795 . . . . 0.0 109.474 175.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.95 152.87 41.2 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -178.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.16 162.14 38.65 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.477 1.111 . . . . 0.0 108.787 -177.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.6 m -134.95 155.38 38.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 C-N-CA 124.492 1.117 . . . . 0.0 110.178 171.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -108.28 117.8 35.1 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 176.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 53.9 mt -119.0 114.77 45.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -173.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -74.22 145.23 44.29 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 168.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.9 p -139.26 148.62 23.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -178.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -130.94 144.98 51.87 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.017 1.327 . . . . 0.0 108.074 -170.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.7 m -62.58 103.85 0.46 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.646 0.778 . . . . 0.0 111.653 -177.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.42 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -146.53 24.02 0.04 OUTLIER Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 125.487 1.515 . . . . 0.0 112.252 168.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.42 ' CD ' ' N ' ' A' ' 30' ' ' ALA . 56.8 Cg_endo -60.93 141.37 94.36 Favored 'Trans proline' 0 C--N 1.357 0.985 0 CA-C-N 122.575 1.955 . . . . 0.0 110.93 -173.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 44.2 19.86 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.706 2.403 . . . . 0.0 114.131 -170.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.7 m 45.72 36.71 2.85 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.833 1.253 . . . . 0.0 111.415 -169.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -161.47 55.81 0.31 Allowed Glycine 0 C--N 1.34 0.802 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 -169.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -135.79 143.69 45.63 Favored Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 169.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -76.51 -19.93 14.39 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.758 2.305 . . . . 0.0 112.998 -175.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.57 152.73 37.92 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.559 0.744 . . . . 0.0 110.737 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -139.29 31.81 2.13 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.623 1.569 . . . . 0.0 109.227 174.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -78.34 178.62 7.53 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.925 0.89 . . . . 0.0 109.745 178.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.7 m -138.95 158.22 44.59 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.464 1.106 . . . . 0.0 108.99 172.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -152.75 175.11 13.21 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 127.629 2.372 . . . . 0.0 105.894 -173.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -140.78 156.35 46.19 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 120.735 -1.228 . . . . 0.0 108.424 177.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 34.7 pt -136.47 155.15 33.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 124.92 1.288 . . . . 0.0 109.255 179.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.7 t -116.14 122.13 68.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 -178.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -126.05 145.28 50.39 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 177.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -179.69 129.77 1.4 Allowed Glycine 0 C--N 1.329 0.177 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 173.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -151.56 153.89 35.4 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -173.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.1 tptt -60.35 -32.93 71.73 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 119.175 -0.441 . . . . 0.0 111.761 -178.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 15.7 p-90 -64.35 -31.03 72.07 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.413 0.551 . . . . 0.0 112.395 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.48 74.86 10.26 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 119.15 0.886 . . . . 0.0 109.187 175.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -63.19 -18.75 63.83 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.195 0.598 . . . . 0.0 111.378 176.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -123.65 146.4 48.23 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.929 1.692 . . . . 0.0 107.99 176.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 39.8 m-70 -71.9 -33.9 68.69 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.327 0.651 . . . . 0.0 109.68 -169.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.73 -28.68 57.07 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 118.379 -0.819 . . . . 0.0 112.545 173.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -68.58 -48.58 63.82 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 119.626 1.103 . . . . 0.0 111.072 -174.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.437 ' H ' HG12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -65.72 -40.46 87.87 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-O 118.268 -0.873 . . . . 0.0 109.963 176.174 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -61.94 -50.96 70.05 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 119.401 -0.919 . . . . 0.0 109.74 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -60.76 -44.2 97.02 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 119.31 0.959 . . . . 0.0 111.807 -178.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 22.2 tttp -60.08 -51.56 69.12 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 123.159 0.584 . . . . 0.0 110.71 178.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.7 t -84.56 -33.53 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-O 117.923 -1.037 . . . . 0.0 111.506 -169.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 61.1 p -63.64 -34.69 78.39 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 121.071 1.759 . . . . 0.0 109.403 170.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.15 -51.06 60.7 Favored Glycine 0 C--N 1.338 0.667 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 171.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -60.71 -42.93 98.21 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 118.579 1.189 . . . . 0.0 112.137 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 38.0 mmt -62.67 -45.68 91.7 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 122.814 0.446 . . . . 0.0 110.249 176.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -68.19 -29.06 67.83 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 118.768 0.713 . . . . 0.0 111.843 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -67.57 -37.47 82.67 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 119.163 0.892 . . . . 0.0 110.365 170.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -68.71 -27.73 66.21 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.581 1.082 . . . . 0.0 110.77 169.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 125.69 -25.84 5.53 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 127.441 2.448 . . . . 0.0 111.788 175.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 88.4 m -57.35 151.56 15.92 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 126.389 1.876 . . . . 0.0 112.192 -175.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -109.77 145.31 36.87 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 86.9 m -140.63 165.16 28.22 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -168.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -153.11 126.29 8.54 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.448 1.499 . . . . 0.0 107.735 170.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.7 p -69.69 119.55 14.1 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 169.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 42.5 mt -70.9 -25.47 62.79 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.858 -0.526 . . . . 0.0 110.263 173.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.9 -172.01 43.09 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 109.769 -1.333 . . . . 0.0 109.769 172.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -132.26 177.17 18.94 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 176.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 179.15 -163.71 31.45 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 108.341 -1.904 . . . . 0.0 108.341 -176.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -136.55 152.85 50.95 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 121.005 -1.291 . . . . 0.0 108.506 171.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.7 mt -108.54 139.42 31.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 103.897 -2.631 . . . . 0.0 103.897 178.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.9 m -134.42 136.92 43.62 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 177.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 52.9 m-70 -72.12 -15.7 61.99 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 118.962 -0.542 . . . . 0.0 112.396 -177.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -147.87 146.1 28.93 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.659 1.584 . . . . 0.0 107.892 169.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 75.2 m -146.56 79.09 1.52 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.448 1.499 . . . . 0.0 107.807 171.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 52.87 32.03 11.73 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.279 1.432 . . . . 0.0 111.884 -172.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -155.3 164.08 39.26 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 126.757 2.023 . . . . 0.0 106.293 177.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -79.68 -27.94 40.74 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.387 -0.821 . . . . 0.0 111.217 174.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -72.25 155.29 40.36 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 119.002 0.819 . . . . 0.0 110.812 -178.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 64.8 mt -61.74 148.26 10.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 169.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 35.7 t60 -134.57 156.43 48.69 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.248 1.019 . . . . 0.0 109.349 -178.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.7 t -135.27 129.1 49.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 179.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -165.85 -164.99 0.76 Allowed 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.171 0.988 . . . . 0.0 108.512 -176.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.96 -172.26 55.18 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -160.38 154.33 22.9 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.326 0.65 . . . . 0.0 110.722 -176.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.4 t -82.26 163.54 21.77 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 168.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 20.3 ptp -102.06 -30.97 10.86 Favored 'General case' 0 C--O 1.232 0.156 0 O-C-N 121.524 -0.735 . . . . 0.0 110.444 169.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.92 -26.7 61.49 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.179 0.9 . . . . 0.0 111.737 173.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -133.25 -2.96 3.1 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -169.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.15 -174.68 46.7 Favored Glycine 0 CA--C 1.535 1.33 0 CA-C-N 119.088 0.858 . . . . 0.0 113.051 175.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.97 143.29 54.14 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.814 2.343 . . . . 0.0 110.424 172.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.51 176.94 5.65 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.138 0.575 . . . . 0.0 109.927 169.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 20.8 mm100 -63.34 -28.83 70.27 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.841 -0.537 . . . . 0.0 111.68 171.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 60.54 -29.72 0.05 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 128.767 2.827 . . . . 0.0 116.311 -175.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.38 -43.08 99.67 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.21 1.004 . . . . 0.0 110.681 173.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 69.1 mt -60.79 -44.41 97.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 177.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.95 -53.46 56.99 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.328 1.051 . . . . 0.0 110.105 -177.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.3 p -63.86 -44.73 92.25 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 117.7 -1.143 . . . . 0.0 110.123 -173.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -58.1 -40.73 81.92 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 120.215 1.37 . . . . 0.0 111.163 -179.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 36.3 mttm -69.82 -44.47 69.92 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 121.782 -0.574 . . . . 0.0 111.061 178.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 58.7 mt -64.65 -43.23 96.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 118.79 0.723 . . . . 0.0 109.115 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -55.85 -43.57 77.21 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 119.605 1.093 . . . . 0.0 109.976 175.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.79 -48.84 70.42 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 119.273 -0.394 . . . . 0.0 111.38 -177.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -93.17 -39.05 11.24 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -169.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -74.26 147.22 85.25 Favored Pre-proline 0 CA--C 1.541 0.629 0 CA-C-N 119.421 1.01 . . . . 0.0 110.146 -170.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -52.08 -36.06 64.28 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.629 2.886 . . . . 0.0 114.759 178.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -79.89 101.22 8.44 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 169.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -73.68 6.98 2.72 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.779 0.832 . . . . 0.0 113.171 -172.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -133.16 146.82 51.9 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.768 1.167 . . . . 0.0 109.588 174.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.2 t -153.77 154.24 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 -172.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 19.8 p -129.3 168.51 16.13 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.784 0.834 . . . . 0.0 110.219 175.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 43.9 p-90 -146.06 162.18 38.48 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 121.742 -0.599 . . . . 0.0 109.728 169.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.16 142.04 21.15 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 169.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -82.42 77.13 9.24 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 174.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -139.84 -157.68 0.79 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.992 2.117 . . . . 0.0 105.363 170.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 92.42 -168.88 31.17 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-N 120.78 1.627 . . . . 0.0 113.244 170.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 57.7 t80 . . . . . 0 C--O 1.238 0.452 0 C-N-CA 125.917 1.687 . . . . 0.0 112.034 -172.344 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 126' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.3 tpt . . . . . 0 N--CA 1.481 1.107 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.83 167.05 30.98 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.09 1.356 . . . . 0.0 108.73 177.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.5 t -141.95 133.33 26.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 177.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -76.93 -179.41 5.47 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.156 0.582 . . . . 0.0 110.389 172.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -149.84 146.16 26.97 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 169.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 80.9 mt -55.11 -33.32 62.74 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.83 0.852 . . . . 0.0 112.657 -175.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.74 -25.69 67.4 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.087 0.858 . . . . 0.0 112.341 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.2 mt -78.54 -25.51 45.51 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.189 0.596 . . . . 0.0 111.094 -178.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.8 mt -70.6 131.38 88.02 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -172.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -49.57 119.93 5.24 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 123.525 2.817 . . . . 0.0 111.359 169.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -74.04 -29.88 62.14 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.15 0.5 . . . . 0.0 111.49 -176.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.9 t -141.84 131.54 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 174.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -149.39 111.35 4.59 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 169.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.9 pt -139.01 162.28 28.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 124.01 0.924 . . . . 0.0 109.7 -169.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -128.07 62.05 1.43 Allowed 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 125.099 1.36 . . . . 0.0 108.383 174.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.5 p -67.69 18.73 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.486 2.314 . . . . 0.0 113.284 176.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -59.85 -17.77 39.09 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.66 1.984 . . . . 0.0 112.112 172.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -141.83 165.83 26.42 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 169.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.8 t -76.92 91.39 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 -178.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -138.07 165.52 26.39 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.134 0.974 . . . . 0.0 111.892 -169.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -65.55 156.18 33.42 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 124.834 1.254 . . . . 0.0 111.684 -169.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -147.17 161.17 41.44 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.082 1.353 . . . . 0.0 108.257 171.573 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.5 m -130.0 154.62 40.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 C-N-CA 124.782 1.233 . . . . 0.0 109.803 174.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.05 115.65 30.52 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 104.212 -2.514 . . . . 0.0 104.212 176.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 73.3 mt -119.65 124.51 73.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -173.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -81.41 145.08 30.98 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 169.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.2 t -129.68 143.44 41.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 -175.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -130.96 132.97 45.39 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 -178.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.0 t -66.43 118.66 10.38 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -175.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.401 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -151.05 32.06 0.06 OUTLIER Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 126.163 1.785 . . . . 0.0 109.77 168.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 30' ' ' ALA . 44.8 Cg_endo -61.3 156.24 47.06 Favored 'Trans proline' 0 C--N 1.357 1.012 0 CA-C-N 121.913 1.719 . . . . 0.0 111.458 -171.216 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 41.8 tpt85 54.44 9.91 0.29 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.091 1.756 . . . . 0.0 112.891 -169.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.0 m 51.98 32.31 9.93 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.023 1.329 . . . . 0.0 111.412 -170.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -163.95 -3.91 0.04 OUTLIER Glycine 0 CA--C 1.531 1.043 0 CA-C-O 118.382 -1.232 . . . . 0.0 115.264 -173.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.7 144.79 84.72 Favored Pre-proline 0 CA--C 1.542 0.65 0 CA-C-N 119.768 1.784 . . . . 0.0 110.799 174.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -76.22 -19.11 15.66 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.934 2.423 . . . . 0.0 112.88 179.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.46 152.33 34.76 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.017 0.927 . . . . 0.0 111.071 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.45 28.52 1.19 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.99 1.316 . . . . 0.0 110.943 178.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -70.45 174.01 6.27 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.352 0.661 . . . . 0.0 110.0 172.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.4 m -137.55 161.88 35.23 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.303 1.041 . . . . 0.0 110.112 177.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.6 tttp -148.85 165.45 31.46 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.533 2.333 . . . . 0.0 106.137 -174.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -137.52 140.15 40.93 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 106.09 -1.818 . . . . 0.0 106.09 175.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 41.2 pt -134.3 156.83 41.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 124.218 1.007 . . . . 0.0 110.724 -172.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 95.7 t -121.55 118.75 56.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 -177.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 27.2 mmt85 -136.02 144.23 45.17 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 177.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.22 135.57 2.42 Favored Glycine 0 C--N 1.331 0.284 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 -178.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -153.58 160.94 42.59 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 117.356 0.578 . . . . 0.0 110.122 -169.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.5 mtmm -59.88 -33.86 72.39 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -179.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.446 ' CH2' ' HE2' ' A' ' 59' ' ' LYS . 9.5 p-90 -68.66 -24.23 64.5 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.835 0.743 . . . . 0.0 112.634 -179.335 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.47 82.13 8.54 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 119.588 1.085 . . . . 0.0 109.297 176.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -65.45 -19.38 65.91 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.44 171.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -133.89 148.68 51.27 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 126.048 1.739 . . . . 0.0 108.137 -178.058 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -72.56 -30.97 64.89 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 121.925 -0.485 . . . . 0.0 109.897 -171.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.01 -28.64 53.66 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 118.082 -0.961 . . . . 0.0 112.776 172.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -65.53 -55.85 15.53 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.669 1.122 . . . . 0.0 109.583 -179.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.423 HG12 ' H ' ' A' ' 56' ' ' ILE . 0.1 OUTLIER -66.07 -34.62 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-O 117.355 -1.307 . . . . 0.0 110.687 -179.502 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -60.98 -53.59 55.38 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 120.104 1.32 . . . . 0.0 109.506 175.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -60.37 -42.91 96.77 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.983 0.81 . . . . 0.0 111.896 -178.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.446 ' HE2' ' CH2' ' A' ' 49' ' ' TRP . 0.0 OUTLIER -59.28 -55.54 33.51 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.221 1.008 . . . . 0.0 110.209 178.589 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 89.9 t -77.62 -43.77 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-O 117.801 -1.095 . . . . 0.0 109.881 -169.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.7 p -63.81 -31.26 72.39 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 120.709 1.595 . . . . 0.0 109.937 175.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.29 -51.31 59.57 Favored Glycine 0 C--N 1.337 0.636 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 171.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -61.71 -44.53 96.74 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 118.835 1.318 . . . . 0.0 111.68 178.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 38.4 mmt -59.12 -46.96 86.98 Favored 'General case' 0 C--O 1.227 -0.081 0 CA-C-O 119.231 -0.414 . . . . 0.0 110.045 177.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -69.27 -28.27 66.15 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.654 0.661 . . . . 0.0 112.152 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -67.59 -37.41 82.53 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.342 0.974 . . . . 0.0 110.255 170.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -68.25 -31.01 70.2 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.772 1.169 . . . . 0.0 110.106 169.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 127.5 -23.43 5.41 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 127.93 2.681 . . . . 0.0 111.662 174.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 95.8 m -55.92 154.42 7.36 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 126.404 1.882 . . . . 0.0 112.602 -177.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -112.49 145.47 40.18 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.909 1.284 . . . . 0.0 108.066 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 74.9 m -144.64 164.33 31.29 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -168.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -149.02 130.57 14.88 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.289 1.435 . . . . 0.0 107.713 171.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.6 p -75.06 114.73 13.89 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 169.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 39.7 mt -68.65 -25.33 64.77 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.823 -0.548 . . . . 0.0 110.374 176.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.14 -164.88 37.83 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 175.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -154.32 -175.5 25.58 Favored Glycine 0 N--CA 1.452 -0.268 0 N-CA-C 111.509 -0.636 . . . . 0.0 111.509 171.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -171.49 -153.71 9.26 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 108.488 -1.845 . . . . 0.0 108.488 -176.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -143.25 142.96 31.55 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 -174.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 61.7 mt -108.17 151.31 10.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -171.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.3 m 62.19 -175.39 0.14 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.574 1.949 . . . . 0.0 110.887 -170.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -153.78 169.51 23.18 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.98 1.312 . . . . 0.0 108.555 177.423 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 20.9 tp60 -66.42 -25.52 66.79 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.246 0.619 . . . . 0.0 112.055 -178.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.3 m -57.85 148.8 24.22 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.367 1.067 . . . . 0.0 111.531 -178.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -76.33 -9.56 58.73 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.644 0.778 . . . . 0.0 112.87 -174.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -56.53 127.07 29.41 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.246 1.018 . . . . 0.0 109.957 177.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -67.73 -23.41 65.26 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.446 0.698 . . . . 0.0 111.869 179.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -55.88 129.61 40.26 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 177.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 50.0 mt -68.99 159.93 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 31.5 t60 -143.94 166.29 25.35 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 120.677 -1.264 . . . . 0.0 109.698 -178.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.9 t -141.41 133.62 28.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 173.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -157.17 -170.04 3.14 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.221 1.008 . . . . 0.0 108.726 -178.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.28 -175.46 45.89 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-N 118.619 0.645 . . . . 0.0 112.145 176.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -162.33 149.4 13.64 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.532 1.133 . . . . 0.0 110.546 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.6 t -71.63 166.2 22.38 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 168.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.5 ptm -111.5 -29.86 7.6 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 118.485 -0.769 . . . . 0.0 111.051 170.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -73.59 -25.55 60.4 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.574 1.079 . . . . 0.0 111.407 172.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -132.65 -9.47 3.18 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.05 0.94 . . . . 0.0 113.037 -169.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 78.68 -176.66 54.37 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-N 118.773 0.715 . . . . 0.0 113.71 171.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.43 137.2 42.31 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.059 2.506 . . . . 0.0 110.482 175.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -78.01 168.8 19.32 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 169.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -77.76 84.69 4.08 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 168.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -57.86 -13.86 5.09 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -175.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.03 -41.46 96.61 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.651 1.18 . . . . 0.0 110.978 170.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 56.2 mt -65.46 -47.43 86.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 177.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.97 -49.68 76.94 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.066 0.946 . . . . 0.0 110.703 -176.056 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.4 p -64.4 -47.53 78.82 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 118.182 -0.913 . . . . 0.0 110.989 -176.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -60.01 -40.38 89.07 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.52 1.055 . . . . 0.0 110.537 -178.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 52.9 mttm -67.29 -46.22 74.26 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-O 118.935 -0.555 . . . . 0.0 111.476 177.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 63.8 mt -64.61 -39.87 87.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-N 119.432 1.015 . . . . 0.0 109.006 -179.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -58.98 -47.33 85.55 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 119.855 1.207 . . . . 0.0 109.514 175.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.73 -38.2 89.54 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.033 0.379 . . . . 0.0 111.55 -179.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -69.95 -36.53 75.34 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 118.718 -0.658 . . . . 0.0 111.326 177.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -127.78 63.59 61.22 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 124.087 0.955 . . . . 0.0 110.408 -171.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -70.7 -11.41 29.56 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.158 2.572 . . . . 0.0 113.159 -172.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -67.54 -12.78 61.15 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.731 0.813 . . . . 0.0 112.05 170.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -129.5 -173.57 3.05 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.289 1.836 . . . . 0.0 108.988 178.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -135.78 162.35 33.03 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.409 1.484 . . . . 0.0 107.016 176.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.4 t -139.89 143.64 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 -173.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 16.6 p -134.69 174.42 10.59 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.478 1.111 . . . . 0.0 108.914 174.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 47.5 p-90 -143.16 161.53 37.99 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.669 -0.644 . . . . 0.0 110.657 171.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.05 136.22 20.01 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 171.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -80.62 79.66 7.21 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 172.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -136.29 -175.73 4.09 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.675 1.59 . . . . 0.0 106.736 169.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.22 -157.31 31.71 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 119.544 1.065 . . . . 0.0 111.436 -174.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 86.2 t80 . . . . . 0 C--O 1.238 0.465 0 C-N-CA 125.03 1.332 . . . . 0.0 109.945 177.941 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 126' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.3 mtm . . . . . 0 N--CA 1.483 1.191 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.51 106.67 3.3 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 170.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.1 t -63.02 132.86 29.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -171.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -145.08 -169.52 3.21 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.223 1.809 . . . . 0.0 108.126 -175.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -146.73 146.59 30.37 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 169.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 51.0 mt -58.99 -29.22 67.06 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -173.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.61 -26.41 66.24 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.113 0.87 . . . . 0.0 111.883 177.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.7 mt -82.69 -24.18 33.79 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.654 0.782 . . . . 0.0 111.191 -177.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 51.3 mt -65.46 129.01 94.27 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -178.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -44.82 120.72 3.0 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 124.141 3.227 . . . . 0.0 111.599 172.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -78.75 -32.94 46.86 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.283 0.563 . . . . 0.0 111.139 -170.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.2 t -136.85 140.26 43.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 105.091 -2.188 . . . . 0.0 105.091 172.031 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -151.77 130.15 12.1 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 170.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.9 pt -147.9 160.85 7.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 126.873 2.069 . . . . 0.0 106.9 -178.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -152.08 42.61 0.68 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.701 0.8 . . . . 0.0 110.445 178.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.4 m -144.35 172.02 13.51 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.323 1.049 . . . . 0.0 110.621 -172.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -149.04 165.93 30.2 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 126.798 2.039 . . . . 0.0 107.12 174.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.47 -160.78 54.18 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -169.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.6 t -75.29 131.26 35.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 175.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -154.65 150.86 28.11 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 124.341 1.056 . . . . 0.0 108.955 169.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -77.1 154.98 32.74 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.521 0.728 . . . . 0.0 110.377 -177.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.31 162.51 37.97 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.0 1.32 . . . . 0.0 108.164 179.342 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.8 m -132.7 154.31 39.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 124.418 1.087 . . . . 0.0 109.488 172.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.35 119.22 38.88 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 104.293 -2.484 . . . . 0.0 104.293 176.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.2 mt -122.26 123.79 69.57 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -173.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.453 ' HE ' ' CE1' ' A' ' 28' ' ' HIS . 36.9 ttp-105 -77.36 147.59 36.03 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 169.715 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.8 t -133.29 143.72 38.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 -178.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.453 ' CE1' ' HE ' ' A' ' 26' ' ' ARG . 99.9 m-70 -123.68 145.06 49.25 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 125.021 1.329 . . . . 0.0 107.913 174.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.0 m -62.07 107.93 0.96 Allowed 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.439 0.696 . . . . 0.0 110.635 177.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -148.9 29.1 0.05 OUTLIER Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 124.823 1.249 . . . . 0.0 112.404 169.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -70.8 21.26 0.21 Allowed 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 123.489 2.792 . . . . 0.0 115.84 -169.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.83 12.58 0.88 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.877 1.671 . . . . 0.0 110.672 175.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.6 m 50.27 28.11 3.01 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.717 1.207 . . . . 0.0 112.749 -170.194 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 163.75 32.41 0.02 OUTLIER Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.96 1.267 . . . . 0.0 111.198 -173.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -68.89 153.59 95.86 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 117.813 0.807 . . . . 0.0 109.504 177.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.89 -27.2 17.98 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 122.33 2.02 . . . . 0.0 112.647 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.62 148.83 49.89 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.675 0.79 . . . . 0.0 110.112 176.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -142.77 30.97 1.46 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.039 1.336 . . . . 0.0 110.109 177.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -75.71 177.03 7.16 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.527 0.68 . . . . 0.0 109.812 174.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.6 m -140.92 158.54 43.79 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.822 1.249 . . . . 0.0 108.463 173.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -153.06 170.75 19.7 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 126.894 2.078 . . . . 0.0 106.296 -171.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.408 ' HB2' ' HE3' ' A' ' 108' ' ' LYS . 17.7 mp0 -134.08 157.16 46.85 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 169.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 32.6 pt -132.46 155.39 41.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 125.344 1.458 . . . . 0.0 109.508 178.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 56.7 t -116.9 121.35 67.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 177.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.8 mmp_? -127.52 141.1 51.74 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 177.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -171.64 136.6 3.94 Favored Glycine 0 C--N 1.329 0.192 0 CA-C-N 119.538 1.063 . . . . 0.0 110.609 170.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -153.85 148.55 26.39 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -173.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.5 pttm -54.99 -31.08 60.66 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.355 1.462 . . . . 0.0 113.236 173.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 11.8 p-90 -68.92 -28.71 66.91 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.29 0.95 . . . . 0.0 112.044 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.79 73.6 10.28 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 119.278 0.944 . . . . 0.0 109.235 174.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -65.94 -6.82 13.7 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.861 0.864 . . . . 0.0 111.457 174.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -137.14 144.09 42.8 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.621 1.968 . . . . 0.0 106.809 173.187 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 44.1 m-70 -70.34 -31.37 68.63 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -171.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.29 -29.84 35.45 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 118.529 -0.748 . . . . 0.0 112.652 172.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -68.85 -48.57 63.14 Favored 'General case' 0 C--N 1.341 0.199 0 CA-C-N 119.39 0.995 . . . . 0.0 111.097 -174.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.434 ' H ' HG12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -65.36 -41.68 91.82 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.018 176.168 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -61.83 -50.72 71.15 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 119.296 -0.962 . . . . 0.0 109.668 -178.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -61.13 -44.43 97.34 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.125 0.875 . . . . 0.0 111.91 -178.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 30.5 tttt -59.9 -50.32 74.23 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.315 0.646 . . . . 0.0 110.895 178.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.4 t -85.71 -33.6 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-O 117.572 -1.204 . . . . 0.0 111.401 -169.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 84.6 p -61.57 -36.71 81.41 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 121.306 1.866 . . . . 0.0 109.179 169.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -56.63 -52.47 50.27 Favored Glycine 0 C--N 1.34 0.753 0 C-N-CA 124.218 0.913 . . . . 0.0 111.141 170.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -60.73 -45.16 95.32 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 119.14 1.47 . . . . 0.0 111.854 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 35.2 mmt -59.46 -47.03 87.04 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.998 0.519 . . . . 0.0 109.787 178.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -68.17 -30.08 69.11 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.536 0.734 . . . . 0.0 111.937 178.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -66.59 -37.94 85.97 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 119.511 1.051 . . . . 0.0 110.278 171.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -64.62 -46.15 83.83 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.746 1.157 . . . . 0.0 108.486 169.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 142.17 -21.49 2.45 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 127.872 2.653 . . . . 0.0 111.204 174.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 80.8 m -54.65 148.36 12.75 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 126.891 2.076 . . . . 0.0 111.608 -176.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -108.56 141.47 40.42 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 94.5 m -141.6 165.51 27.29 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -168.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -154.33 130.03 10.02 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.869 1.667 . . . . 0.0 107.431 171.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.1 p -69.82 123.77 22.3 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 169.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 33.9 mt -69.31 -28.3 66.14 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.933 -0.479 . . . . 0.0 109.969 172.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.98 -171.29 43.34 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 174.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -124.78 173.6 17.1 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 174.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -178.2 -164.96 32.2 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 108.254 -1.938 . . . . 0.0 108.254 -176.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 12.0 ptp180 -148.06 161.76 40.74 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 120.741 -1.447 . . . . 0.0 109.208 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 81.9 mt -123.52 149.69 27.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 -171.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.0 p -145.43 158.2 43.88 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.067 1.347 . . . . 0.0 109.137 176.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -155.78 37.27 0.36 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.605 0.762 . . . . 0.0 110.406 173.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -73.47 1.61 9.47 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 121.149 -0.969 . . . . 0.0 111.52 171.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 m -50.23 152.64 1.7 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 128.661 2.784 . . . . 0.0 112.944 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -90.83 12.63 18.74 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.508 1.123 . . . . 0.0 111.185 175.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -150.07 166.59 29.29 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.787 2.035 . . . . 0.0 107.369 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -73.07 35.21 0.08 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.92 1.688 . . . . 0.0 112.756 -175.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.2 ttmm -105.22 107.97 19.24 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 125.248 1.419 . . . . 0.0 107.525 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 82.7 mt -72.29 160.29 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 169.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 21.1 t60 -139.65 155.49 47.37 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 120.519 -1.363 . . . . 0.0 110.359 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.5 t -136.58 137.48 47.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 -177.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -164.96 -171.01 2.1 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.084 -1.01 . . . . 0.0 109.854 -174.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.69 -167.71 54.76 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-O 121.402 0.446 . . . . 0.0 112.278 169.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -158.36 173.2 17.02 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.315 1.046 . . . . 0.0 110.218 -172.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.0 t -107.17 164.0 12.53 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 127.033 2.133 . . . . 0.0 106.2 168.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 21.4 ptp -105.96 -29.89 9.67 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 118.547 -0.739 . . . . 0.0 110.881 172.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -73.12 -26.32 61.18 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.39 0.995 . . . . 0.0 111.563 172.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -132.0 -3.74 3.57 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -169.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 72.52 -177.14 41.01 Favored Glycine 0 CA--C 1.535 1.297 0 CA-C-N 118.908 0.776 . . . . 0.0 112.73 177.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.49 138.13 37.92 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.889 2.393 . . . . 0.0 110.916 175.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.96 176.47 5.69 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.297 0.639 . . . . 0.0 110.026 169.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 21.5 mm100 -65.7 -31.83 73.05 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 121.901 -0.499 . . . . 0.0 112.292 178.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 39.1 m80 61.63 -30.83 0.07 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 128.438 2.695 . . . . 0.0 115.972 -174.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.7 -44.46 96.18 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.224 1.01 . . . . 0.0 110.787 174.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 72.9 mt -60.47 -45.35 97.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 176.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.46 -52.24 66.07 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 124.61 1.164 . . . . 0.0 109.747 -174.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 22.6 p -67.09 -43.07 83.49 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 117.982 -1.009 . . . . 0.0 111.151 -174.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -59.38 -41.9 90.43 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.756 1.162 . . . . 0.0 110.386 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.408 ' HE3' ' HB2' ' A' ' 42' ' ' GLU . 42.1 mttm -66.77 -45.4 78.62 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 119.009 -0.519 . . . . 0.0 111.263 176.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 55.8 mt -63.44 -42.81 97.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 119.111 0.868 . . . . 0.0 108.992 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -58.22 -47.41 83.61 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 120.216 1.371 . . . . 0.0 109.455 176.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.45 -40.28 96.08 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.753 0.421 . . . . 0.0 111.634 -177.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -80.9 -19.89 43.36 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 118.269 -0.872 . . . . 0.0 112.735 -178.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -131.93 64.36 72.19 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 124.524 1.13 . . . . 0.0 109.517 -178.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.8 -14.24 38.6 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.944 2.429 . . . . 0.0 112.922 -175.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -67.22 -11.86 58.54 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.283 1.033 . . . . 0.0 112.068 169.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -125.65 177.54 6.19 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.516 1.927 . . . . 0.0 108.639 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -125.65 165.31 18.79 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 170.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.2 t -144.43 143.51 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 -178.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 22.1 p -137.3 173.96 11.12 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.079 0.952 . . . . 0.0 108.848 172.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 52.1 p-90 -143.79 157.4 44.41 Favored 'General case' 0 C--O 1.235 0.297 0 O-C-N 121.988 -0.445 . . . . 0.0 110.6 173.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -154.13 97.95 2.1 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 176.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -69.16 -8.67 47.69 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -173.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -58.0 -29.98 65.7 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.46 1.104 . . . . 0.0 112.465 170.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -61.89 152.79 42.41 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 111.754 -0.538 . . . . 0.0 111.754 176.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 53.1 p90 . . . . . 0 C--O 1.238 0.464 0 C-N-CA 124.902 1.281 . . . . 0.0 110.011 -179.424 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 126' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.484 1.266 0 N-CA-C 110.482 -0.192 . . . . 0.0 110.482 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.84 157.55 27.48 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.956 -0.465 . . . . 0.0 109.758 169.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.5 p -59.46 139.5 19.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 174.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -71.86 177.65 4.13 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.715 0.769 . . . . 0.0 111.454 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -151.27 151.59 32.04 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 126.677 1.991 . . . . 0.0 105.924 170.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 52.4 mt -55.44 -34.49 64.52 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.732 0.696 . . . . 0.0 112.656 -175.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.15 -25.86 64.59 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.744 0.702 . . . . 0.0 112.21 179.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.0 mt -81.83 -23.23 36.57 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.468 0.707 . . . . 0.0 111.178 -178.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.2 mt -64.84 128.03 93.23 Favored Pre-proline 0 CA--C 1.54 0.577 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 178.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -47.41 140.21 15.96 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.588 2.859 . . . . 0.0 111.249 170.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -89.78 -36.06 15.36 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 121.987 -0.446 . . . . 0.0 111.627 -170.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.4 t -140.99 138.96 34.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 124.866 1.266 . . . . 0.0 107.702 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 68.5 t0 -152.93 111.34 3.69 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 169.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 36.6 pt -138.07 40.47 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.913 1.285 . . . . 0.0 109.439 -173.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -63.95 83.07 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.204 1.402 . . . . 0.0 111.97 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.9 m -162.32 177.38 9.64 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 128.193 2.597 . . . . 0.0 107.783 174.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -144.89 161.98 37.97 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.648 1.179 . . . . 0.0 108.976 -176.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.88 -160.26 50.36 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 -170.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.7 t -69.35 136.96 25.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 173.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -157.31 153.76 27.93 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.934 0.894 . . . . 0.0 108.737 168.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -80.05 155.88 27.36 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.91 163.61 32.92 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.997 1.319 . . . . 0.0 108.27 176.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.5 m -133.23 150.83 32.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 124.36 1.064 . . . . 0.0 109.589 172.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.05 117.0 33.6 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 104.139 -2.541 . . . . 0.0 104.139 175.335 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 76.5 mt -118.93 122.82 70.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 -175.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 36.2 ttp180 -79.46 147.49 32.25 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 169.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.8 t -133.73 145.01 34.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 104.762 -2.31 . . . . 0.0 104.762 -175.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -130.42 150.14 51.77 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.596 1.158 . . . . 0.0 108.129 -179.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.9 m -60.81 100.73 0.12 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.122 0.969 . . . . 0.0 111.773 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.518 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -144.59 17.78 0.04 OUTLIER Pre-proline 0 CA--C 1.554 1.111 0 CA-C-O 116.188 -1.863 . . . . 0.0 113.898 169.155 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.518 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 66.9 Cg_exo -40.12 130.6 2.23 Favored 'Trans proline' 0 C--N 1.365 1.444 0 CA-C-N 123.702 2.358 . . . . 0.0 114.41 177.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . 0.302 1.2 tpm_? 23.59 47.74 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 130.331 3.452 . . . . 0.0 114.933 -168.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.1 m 55.8 24.4 7.34 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.901 1.28 . . . . 0.0 113.323 176.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -146.95 -7.05 0.29 Allowed Glycine 0 CA--C 1.529 0.931 0 CA-C-O 118.469 -1.184 . . . . 0.0 114.92 -169.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.53 132.63 85.5 Favored Pre-proline 0 CA--C 1.543 0.705 0 CA-C-N 119.522 1.661 . . . . 0.0 110.295 173.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -78.47 -20.09 11.15 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.829 2.353 . . . . 0.0 112.702 178.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.9 160.87 19.58 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.051 0.94 . . . . 0.0 111.12 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.2 60.91 0.97 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.248 1.419 . . . . 0.0 108.487 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -124.22 -173.21 2.71 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.545 1.538 . . . . 0.0 108.75 177.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.1 m -142.76 159.23 42.64 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.786 0.834 . . . . 0.0 110.596 -173.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -151.07 165.95 32.24 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 127.625 2.37 . . . . 0.0 106.168 -174.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.5 mp0 -131.26 154.23 48.69 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 121.039 -1.038 . . . . 0.0 108.494 177.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 39.3 pt -135.26 156.18 38.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 125.277 1.431 . . . . 0.0 109.686 178.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 54.2 t -118.65 120.34 63.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 105.434 -2.062 . . . . 0.0 105.434 177.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.0 mmp_? -130.28 146.23 51.86 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 172.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -179.55 140.51 4.33 Favored Glycine 0 N--CA 1.454 -0.139 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 174.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -154.88 156.06 35.46 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -170.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.5 mmtm -53.05 -39.45 63.26 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.407 1.083 . . . . 0.0 112.026 174.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 12.8 p-90 -67.2 -27.72 67.49 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.519 0.6 . . . . 0.0 112.503 -176.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.96 80.32 9.05 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 119.295 0.952 . . . . 0.0 108.964 173.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -63.73 -18.52 64.11 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.254 0.621 . . . . 0.0 111.488 174.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -132.1 148.87 52.51 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 126.47 1.908 . . . . 0.0 108.043 178.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 37.3 m-70 -72.52 -32.26 65.99 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -170.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.85 -29.08 54.29 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 118.561 -0.733 . . . . 0.0 112.663 172.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -67.14 -49.66 64.04 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 119.338 0.972 . . . . 0.0 110.84 -175.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.421 ' H ' HG12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -66.8 -38.88 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 CA-C-O 117.557 -1.211 . . . . 0.0 109.995 174.977 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -60.36 -47.33 86.52 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 120.191 1.36 . . . . 0.0 110.404 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -63.67 -47.91 79.31 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.265 0.484 . . . . 0.0 111.507 179.162 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 40.9 tttt -62.63 -51.19 68.24 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 123.239 0.616 . . . . 0.0 111.315 -178.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 94.6 t -72.56 -46.33 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-O 118.189 -0.91 . . . . 0.0 108.967 -172.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 56.6 m -64.11 -27.26 68.97 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 120.157 1.344 . . . . 0.0 111.162 175.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.84 -51.28 56.88 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 170.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -60.73 -43.37 98.0 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.418 1.109 . . . . 0.0 111.638 178.108 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.5 mmt -59.62 -47.25 86.32 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 123.131 0.573 . . . . 0.0 110.011 177.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -69.48 -28.26 65.92 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.892 0.769 . . . . 0.0 112.066 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -66.92 -38.24 85.84 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 119.179 0.9 . . . . 0.0 110.112 169.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -69.48 -25.66 64.18 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 119.668 1.122 . . . . 0.0 110.496 169.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 118.84 -21.42 9.62 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 127.919 2.676 . . . . 0.0 112.456 175.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 92.2 m -53.08 149.59 6.61 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 126.112 1.765 . . . . 0.0 112.1 -178.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -108.48 138.65 44.43 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 177.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 97.3 m -141.41 164.18 30.92 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -168.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -153.79 130.26 10.61 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.499 1.52 . . . . 0.0 107.49 174.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 5.9 p -70.92 122.1 19.34 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 169.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 41.9 mt -70.12 -25.67 63.6 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.861 -0.525 . . . . 0.0 109.941 170.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.93 -171.78 43.03 Favored Glycine 0 C--N 1.337 0.608 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 170.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -128.84 171.87 19.68 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 175.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -176.81 -162.71 27.84 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 108.6 -1.8 . . . . 0.0 108.6 -176.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -146.0 163.67 34.47 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 121.055 -1.262 . . . . 0.0 108.547 -178.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 81.4 mt -133.28 143.87 37.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 -170.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 69.6 m -144.17 170.58 15.69 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.546 1.538 . . . . 0.0 108.765 170.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -145.79 140.11 26.9 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.002 1.321 . . . . 0.0 107.693 176.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -137.65 51.15 1.92 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.107 1.363 . . . . 0.0 108.821 -177.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.8 m 60.33 -173.77 0.12 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.596 1.559 . . . . 0.0 112.458 175.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -62.48 -20.13 64.25 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 120.723 -1.236 . . . . 0.0 111.868 174.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -67.86 -39.48 83.77 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.171 0.988 . . . . 0.0 112.668 -178.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 26.4 mtmm -132.46 8.36 4.25 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -176.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.2 mptt 63.2 -178.17 0.15 Allowed 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 126.277 1.831 . . . . 0.0 113.545 169.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 59.4 mt -81.71 149.06 4.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 169.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 54.2 t60 -143.93 149.41 36.78 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 121.193 -0.942 . . . . 0.0 109.69 -179.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 18.7 t -127.81 128.95 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.114 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -160.81 -172.4 3.48 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.236 -0.915 . . . . 0.0 111.132 -169.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 66.29 -166.21 38.14 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-O 121.425 0.459 . . . . 0.0 112.616 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -162.08 157.2 23.04 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.083 0.953 . . . . 0.0 110.502 -170.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.9 t -85.24 164.38 18.09 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 168.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.0 ptm -104.83 -31.8 9.12 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 118.625 -0.702 . . . . 0.0 110.646 169.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.8 -26.41 61.5 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.324 0.965 . . . . 0.0 111.556 174.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -132.46 -3.56 3.39 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.925 0.89 . . . . 0.0 113.089 -169.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.46 -177.3 43.74 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-N 118.779 0.718 . . . . 0.0 112.997 175.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -67.89 142.07 55.92 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.652 2.234 . . . . 0.0 110.41 172.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.19 173.89 9.5 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 122.369 1.08 . . . . 0.0 110.322 169.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -81.47 79.48 8.06 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 103.828 -2.656 . . . . 0.0 103.828 167.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -60.95 -13.74 18.04 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -169.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.86 -35.91 77.8 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.554 0.742 . . . . 0.0 111.622 172.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 83.8 mt -65.15 -44.16 95.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 177.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.87 -48.44 81.37 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.158 0.983 . . . . 0.0 110.684 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.4 p -66.38 -42.46 87.91 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 117.813 -1.089 . . . . 0.0 110.661 -177.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -58.22 -44.11 88.02 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 120.226 1.376 . . . . 0.0 110.772 177.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -69.13 -44.21 72.84 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.873 -0.517 . . . . 0.0 111.635 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 81.5 mt -71.55 -34.19 51.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 O-C-N 121.257 -0.902 . . . . 0.0 109.478 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -57.73 -46.62 84.18 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.684 1.129 . . . . 0.0 109.483 170.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.27 -35.77 80.01 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.163 0.438 . . . . 0.0 111.499 177.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 56.0 tttm -65.6 -34.29 77.89 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.774 0.715 . . . . 0.0 111.496 176.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -131.16 73.49 80.52 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 123.83 0.852 . . . . 0.0 111.285 -173.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -55.08 -26.58 51.04 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.143 2.562 . . . . 0.0 114.25 176.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -72.73 -7.52 50.92 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.29 1.036 . . . . 0.0 112.738 178.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -127.63 -175.69 3.54 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.27 1.828 . . . . 0.0 108.948 -177.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -138.8 165.86 25.91 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 170.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.6 t -141.82 143.76 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 -173.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 19.3 p -133.05 168.8 17.83 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.198 0.999 . . . . 0.0 108.676 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 57.9 p-90 -139.99 157.61 45.39 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.178 0.513 . . . . 0.0 111.802 173.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -148.94 140.35 23.31 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 170.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.02 -18.86 59.09 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.937 -0.477 . . . . 0.0 111.222 -174.418 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.24 153.97 24.81 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.427 -0.796 . . . . 0.0 110.989 176.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 151.38 -163.08 29.78 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.486 -1.045 . . . . 0.0 110.486 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 36.7 p90 . . . . . 0 C--O 1.239 0.535 0 C-N-CA 125.282 1.433 . . . . 0.0 109.115 174.375 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 126' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ttt . . . . . 0 N--CA 1.483 1.219 0 CA-C-O 119.5 -0.286 . . . . 0.0 110.519 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.89 176.93 10.95 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.229 1.412 . . . . 0.0 108.874 -179.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.7 p -142.37 156.83 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 123.522 0.729 . . . . 0.0 109.305 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -157.11 -177.05 6.32 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.866 2.467 . . . . 0.0 106.484 175.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -141.95 142.41 33.0 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 169.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 81.5 mt -57.46 -32.36 66.87 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.734 0.814 . . . . 0.0 112.713 -171.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.84 -25.52 64.69 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.895 0.77 . . . . 0.0 112.1 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.5 mt -80.53 -24.92 38.99 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.37 0.668 . . . . 0.0 111.186 -177.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 41.0 mt -67.24 128.49 93.75 Favored Pre-proline 0 C--O 1.24 0.558 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -175.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -46.9 127.05 11.8 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.885 3.057 . . . . 0.0 111.341 171.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -81.4 -34.1 31.83 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 121.051 0.453 . . . . 0.0 111.311 -170.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.0 t -138.77 133.7 41.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 174.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -147.95 133.49 18.73 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 170.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 38.6 pt -147.42 156.82 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 127.113 2.165 . . . . 0.0 106.102 -177.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -150.01 46.02 0.92 Allowed 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 122.113 0.958 . . . . 0.0 109.973 178.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.9 m -145.8 173.73 11.85 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.795 1.638 . . . . 0.0 109.623 -176.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -150.68 168.98 22.73 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 125.288 1.435 . . . . 0.0 108.306 174.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.66 -92.5 1.72 Allowed Glycine 0 C--N 1.331 0.304 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 178.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.5 t -145.73 141.09 22.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 C-N-CA 128.034 2.534 . . . . 0.0 105.076 174.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -160.35 152.13 19.95 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 119.034 0.834 . . . . 0.0 110.444 172.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.25 152.03 39.79 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.62 0.768 . . . . 0.0 109.35 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.98 161.15 41.94 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.296 1.038 . . . . 0.0 109.082 -178.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.4 m -131.21 153.69 39.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 C-N-CA 124.4 1.08 . . . . 0.0 110.097 173.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -108.39 115.02 29.34 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 104.345 -2.465 . . . . 0.0 104.345 177.453 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 54.4 mt -119.37 124.53 73.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 -172.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -78.55 148.97 33.16 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 169.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.5 t -133.56 148.17 30.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 105.55 -2.019 . . . . 0.0 105.55 -179.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -129.59 156.2 44.58 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.806 1.243 . . . . 0.0 109.357 -178.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.1 m -68.75 44.41 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.1 1.76 . . . . 0.0 114.626 178.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -72.7 -9.41 0.15 Allowed Pre-proline 0 CA--C 1.557 1.234 0 N-CA-C 117.846 2.535 . . . . 0.0 117.846 170.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -46.29 159.22 0.28 Allowed 'Trans proline' 0 C--N 1.362 1.262 0 C-N-CA 123.82 3.013 . . . . 0.0 116.67 -177.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . 0.25 8.2 ptp180 46.63 22.1 0.16 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 126.222 1.809 . . . . 0.0 113.313 -169.474 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.7 m 49.69 27.14 2.08 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.971 1.708 . . . . 0.0 112.811 -172.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 169.28 30.29 0.02 OUTLIER Glycine 0 CA--C 1.528 0.858 0 CA-C-O 118.7 -1.055 . . . . 0.0 114.796 -173.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.22 148.78 29.23 Favored Pre-proline 0 CA--C 1.544 0.739 0 CA-C-N 119.168 1.484 . . . . 0.0 110.213 171.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.1 -25.5 19.17 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 122.494 2.13 . . . . 0.0 112.768 -176.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.44 157.52 33.99 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.711 0.804 . . . . 0.0 110.472 174.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -142.78 36.38 1.43 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.227 1.411 . . . . 0.0 109.044 174.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -81.67 176.18 9.85 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.862 0.865 . . . . 0.0 109.34 178.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.5 m -141.16 160.36 40.26 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.61 1.164 . . . . 0.0 108.984 171.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -149.59 169.83 20.07 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 127.338 2.255 . . . . 0.0 106.457 -173.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.1 mp0 -133.27 152.79 51.94 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 176.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 38.9 pt -133.96 155.73 40.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 125.551 1.54 . . . . 0.0 109.589 178.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 89.1 t -117.08 120.09 63.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 105.696 -1.965 . . . . 0.0 105.696 177.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.426 ' HG3' HG21 ' A' ' 60' ' ' VAL . 10.4 mmp_? -127.69 142.17 51.41 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 174.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -172.63 139.84 5.42 Favored Glycine 0 C--N 1.332 0.321 0 CA-C-N 119.429 1.013 . . . . 0.0 111.412 172.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.423 ' CD2' ' CZ2' ' A' ' 49' ' ' TRP . 30.1 m-85 -154.81 156.61 36.54 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.673 0.789 . . . . 0.0 109.893 -171.078 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.3 mttp -67.68 -32.02 72.39 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 118.793 -0.622 . . . . 0.0 111.007 175.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.423 ' CZ2' ' CD2' ' A' ' 47' ' ' TYR . 14.5 p-90 -62.57 -30.86 71.63 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.723 0.692 . . . . 0.0 111.575 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.73 71.04 6.68 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.357 0.663 . . . . 0.0 109.47 171.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -61.33 -18.3 57.94 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.502 0.721 . . . . 0.0 111.454 176.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -125.02 146.97 49.18 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 126.466 1.906 . . . . 0.0 107.764 176.446 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 60.9 m80 -73.12 -31.35 64.26 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 122.887 0.475 . . . . 0.0 110.441 -169.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.02 -30.83 49.21 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 118.612 -0.709 . . . . 0.0 112.4 172.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -69.67 -49.13 56.49 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 119.321 0.964 . . . . 0.0 111.084 -176.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.429 HG12 ' H ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -65.79 -40.18 86.94 Favored 'Isoleucine or valine' 0 C--N 1.342 0.274 0 CA-C-O 117.518 -1.23 . . . . 0.0 109.699 175.391 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -59.98 -50.55 73.29 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 119.726 1.148 . . . . 0.0 109.96 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -61.14 -45.35 95.02 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 119.059 0.845 . . . . 0.0 112.028 -178.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 30.7 tttt -61.4 -49.09 78.28 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 122.912 0.485 . . . . 0.0 110.574 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.426 HG21 ' HG3' ' A' ' 45' ' ' ARG . 85.0 t -78.91 -39.42 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 117.692 -1.146 . . . . 0.0 109.954 -170.165 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 91.5 p -61.42 -39.23 90.02 Favored 'General case' 0 C--N 1.339 0.122 0 CA-C-N 120.757 1.617 . . . . 0.0 109.13 174.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -57.28 -51.66 56.23 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 123.948 0.785 . . . . 0.0 111.363 172.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -61.73 -46.31 90.19 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 118.943 1.372 . . . . 0.0 111.68 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 36.0 mmt -59.41 -47.52 85.14 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.349 0.66 . . . . 0.0 110.456 177.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -62.84 -35.82 81.21 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.788 0.835 . . . . 0.0 111.279 177.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -66.38 -35.5 80.5 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 118.043 -0.98 . . . . 0.0 111.302 172.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -71.73 -17.51 62.2 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 119.972 1.26 . . . . 0.0 112.159 170.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.37 -8.57 41.19 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.696 1.617 . . . . 0.0 112.543 178.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 90.4 m -65.96 165.44 13.2 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.636 1.218 . . . . 0.0 110.863 176.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -125.33 148.3 48.79 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 170.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 65.9 m -145.31 165.34 28.73 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -168.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -149.22 137.64 20.9 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.811 1.645 . . . . 0.0 106.921 169.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.4 p -77.69 115.48 17.47 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 169.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 36.9 mt -67.99 -24.43 65.13 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 121.981 -0.449 . . . . 0.0 110.149 174.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.92 -165.73 38.69 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 170.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -147.7 178.84 25.04 Favored Glycine 0 CA--C 1.519 0.318 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 172.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -176.29 -157.84 18.41 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 107.546 -2.221 . . . . 0.0 107.546 -176.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 31.0 ptt-85 -137.02 157.78 45.95 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 120.616 -1.52 . . . . 0.0 108.811 173.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 97.4 mt -114.71 142.55 27.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 -177.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.0 m -135.86 148.53 48.68 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.123 0.969 . . . . 0.0 108.71 178.362 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -138.83 -34.45 0.61 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.525 1.13 . . . . 0.0 110.779 -177.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -83.17 34.06 0.46 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 119.075 0.852 . . . . 0.0 109.93 169.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.8 m -66.99 -176.52 0.53 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.901 2.08 . . . . 0.0 111.295 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 20.6 tp60 -57.98 -21.54 45.09 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.317 1.047 . . . . 0.0 112.459 177.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -139.27 155.13 47.96 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.902 1.681 . . . . 0.0 107.189 169.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 59.2 mtmt -64.97 -18.07 64.95 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -176.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -54.91 127.94 31.02 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 120.13 1.332 . . . . 0.0 108.366 174.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 69.3 mt -65.63 150.69 10.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 -178.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 24.5 t60 -136.87 155.61 49.54 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 121.171 -0.956 . . . . 0.0 109.652 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.6 t -137.37 124.89 30.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -164.48 -178.3 5.33 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 121.468 -0.77 . . . . 0.0 109.909 -172.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.49 -174.04 55.19 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -178.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -157.3 155.79 31.31 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.05 0.54 . . . . 0.0 111.958 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.1 t -75.81 164.67 26.0 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 168.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.3 ptm -108.53 -30.5 8.22 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 118.492 -0.766 . . . . 0.0 111.122 170.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.06 -26.06 60.18 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.551 1.069 . . . . 0.0 111.431 173.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -131.91 -7.42 3.53 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.915 0.886 . . . . 0.0 113.015 -169.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.92 -177.13 52.49 Favored Glycine 0 CA--C 1.535 1.293 0 CA-C-N 118.673 0.669 . . . . 0.0 113.607 171.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.08 135.65 38.16 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.092 2.528 . . . . 0.0 110.404 176.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.04 167.94 20.95 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.131 0.491 . . . . 0.0 110.128 169.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 -78.92 82.63 5.1 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 168.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -57.57 -15.09 6.34 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -176.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.55 -43.96 80.42 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.22 1.408 . . . . 0.0 111.215 169.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 64.1 mt -64.58 -47.12 90.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.91 -50.94 71.63 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.777 0.831 . . . . 0.0 110.923 -176.273 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.6 p -65.05 -46.95 79.13 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.593 -174.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -60.04 -40.2 88.56 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.311 0.959 . . . . 0.0 110.592 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -66.39 -47.52 73.06 Favored 'General case' 0 CA--C 1.528 0.12 0 O-C-N 121.86 -0.525 . . . . 0.0 111.457 176.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 61.7 mt -64.82 -40.25 88.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 119.369 0.986 . . . . 0.0 109.128 -177.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -58.53 -47.51 83.93 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 119.449 1.022 . . . . 0.0 109.551 174.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.28 -39.42 94.55 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.57 0.348 . . . . 0.0 111.489 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -66.34 -36.28 82.5 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 118.674 -0.679 . . . . 0.0 111.108 177.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -130.23 69.55 81.98 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 123.569 0.748 . . . . 0.0 111.198 -171.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -56.94 -21.96 43.84 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 123.39 2.727 . . . . 0.0 114.615 179.035 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -69.16 -8.15 42.91 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.234 1.013 . . . . 0.0 112.683 176.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -128.36 178.32 6.35 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.425 1.89 . . . . 0.0 108.935 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -135.26 158.54 44.09 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 170.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.5 t -139.37 142.16 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 -169.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.3 p -134.53 171.59 14.1 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.481 1.112 . . . . 0.0 109.4 176.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 27.6 p-90 -143.83 163.28 33.81 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 121.674 -0.641 . . . . 0.0 110.709 173.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.19 131.76 14.84 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 172.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.76 -8.13 57.54 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 122.731 0.412 . . . . 0.0 111.117 178.022 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -63.15 -27.97 69.74 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.136 1.374 . . . . 0.0 113.001 -178.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -60.09 159.6 23.3 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 123.744 0.688 . . . . 0.0 112.73 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 52.4 p90 . . . . . 0 C--O 1.239 0.525 0 C-N-CA 124.95 1.3 . . . . 0.0 110.542 -176.625 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 126' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 mtt . . . . . 0 N--CA 1.482 1.147 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.15 162.66 40.46 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.039 1.335 . . . . 0.0 108.623 176.098 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.4 p -148.32 148.04 16.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 179.759 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.15 174.76 6.72 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.499 0.666 . . . . 0.0 110.785 179.209 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -152.93 152.12 31.11 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 170.235 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 57.0 mt -53.54 -36.88 62.29 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 118.627 0.649 . . . . 0.0 112.12 -178.165 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.56 -25.21 68.13 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.871 0.759 . . . . 0.0 112.509 -179.09 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.4 mt -83.57 -20.81 33.11 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.316 0.646 . . . . 0.0 111.561 -176.961 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 24.0 mt -68.07 128.94 93.26 Favored Pre-proline 0 CA--C 1.539 0.527 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -177.085 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -50.81 117.94 3.76 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 123.337 2.691 . . . . 0.0 110.705 169.705 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -73.01 -34.37 66.34 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 122.65 0.38 . . . . 0.0 111.532 -171.93 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.7 t -141.64 123.06 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 177.847 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -143.58 107.68 4.74 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 106.86 -1.534 . . . . 0.0 106.86 171.35 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.6 pt -136.92 157.21 35.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 123.599 0.76 . . . . 0.0 110.49 -169.794 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -128.4 -13.2 4.94 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.536 2.334 . . . . 0.0 110.362 176.072 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.6 m -68.49 47.4 0.06 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.857 2.063 . . . . 0.0 113.247 172.751 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -65.6 -36.91 85.11 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 120.985 -1.072 . . . . 0.0 108.915 169.093 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -89.36 171.78 38.8 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 108.53 -1.828 . . . . 0.0 108.53 168.93 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.2 t -68.69 92.6 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 123.223 0.609 . . . . 0.0 110.38 -171.701 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -146.06 167.02 24.4 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 126.33 1.852 . . . . 0.0 108.771 176.282 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -73.76 162.91 28.64 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.219 1.008 . . . . 0.0 112.548 -170.277 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -151.3 163.41 38.97 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.514 1.926 . . . . 0.0 108.006 169.813 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.3 m -131.07 155.9 42.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 124.756 1.222 . . . . 0.0 109.816 172.125 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.1 117.67 34.75 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 178.233 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 69.1 mt -121.49 113.85 40.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -171.953 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.5 ttm-85 -69.88 142.41 53.01 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 168.699 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.8 p -140.86 147.81 22.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -122.13 151.77 40.6 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.929 1.292 . . . . 0.0 109.347 -174.61 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 56.0 m -62.51 93.28 0.05 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.094 0.958 . . . . 0.0 110.955 172.376 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.404 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -138.87 24.3 0.07 OUTLIER Pre-proline 0 CA--C 1.552 1.027 0 CA-C-O 116.767 -1.587 . . . . 0.0 114.015 169.442 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.404 ' CD ' ' N ' ' A' ' 30' ' ' ALA . 83.5 Cg_exo -44.39 137.71 7.85 Favored 'Trans proline' 0 C--N 1.359 1.091 0 CA-C-N 123.774 2.383 . . . . 0.0 113.606 172.409 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 43.69 22.98 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.779 2.031 . . . . 0.0 114.495 -171.856 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.7 m 50.05 30.4 4.12 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.133 1.373 . . . . 0.0 112.402 -171.357 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -154.19 2.25 0.23 Allowed Glycine 0 CA--C 1.53 1.019 0 CA-C-O 118.6 -1.111 . . . . 0.0 114.892 -170.96 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.07 141.06 77.11 Favored Pre-proline 0 CA--C 1.544 0.719 0 CA-C-N 119.427 1.613 . . . . 0.0 110.42 172.281 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.77 -23.47 10.94 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.733 2.289 . . . . 0.0 112.927 -178.851 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.37 157.8 30.9 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.795 0.838 . . . . 0.0 110.583 177.729 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -141.52 27.63 1.87 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.815 1.246 . . . . 0.0 110.825 177.714 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -76.72 177.99 7.14 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.734 0.814 . . . . 0.0 110.05 173.891 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.4 m -141.89 160.98 39.09 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.097 1.359 . . . . 0.0 109.004 176.659 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.8 tttt -148.24 165.77 29.96 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 126.963 2.105 . . . . 0.0 107.117 -174.462 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -125.64 131.38 52.65 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 169.782 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 44.2 pt -112.85 159.59 12.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 125.414 1.486 . . . . 0.0 110.569 174.068 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 25.0 t -126.24 121.77 59.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 -173.63 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 26.4 mmt85 -139.34 147.02 40.98 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.382 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.53 135.71 2.49 Favored Glycine 0 C--N 1.331 0.305 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 -179.656 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -153.57 155.71 36.65 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -171.966 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -59.36 -29.98 68.07 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -179.049 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 8.9 p-90 -68.46 -23.75 64.62 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.78 0.718 . . . . 0.0 112.4 -179.481 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.03 78.61 8.7 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 119.346 0.975 . . . . 0.0 110.085 177.064 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -62.3 -18.39 61.2 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.943 0.897 . . . . 0.0 111.468 172.919 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -128.1 143.15 51.05 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.771 1.629 . . . . 0.0 106.888 178.829 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -65.08 -30.92 71.92 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 118.478 0.581 . . . . 0.0 109.828 176.623 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.54 -29.35 58.78 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 118.484 -0.77 . . . . 0.0 112.788 171.445 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -68.71 -49.5 58.4 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.559 1.072 . . . . 0.0 110.476 -175.255 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.444 ' H ' HG12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -66.93 -38.08 80.68 Favored 'Isoleucine or valine' 0 C--N 1.34 0.18 0 CA-C-O 117.859 -1.067 . . . . 0.0 110.157 175.8 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -61.95 -47.67 83.82 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 119.776 1.171 . . . . 0.0 110.275 179.036 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -61.96 -46.71 88.09 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.319 0.509 . . . . 0.0 111.362 179.163 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 32.6 tttt -62.92 -54.8 32.9 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 123.027 0.531 . . . . 0.0 111.078 -179.451 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 86.2 t -72.3 -49.3 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-O 118.183 -0.913 . . . . 0.0 109.161 -170.549 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.8 m -65.45 -28.27 69.11 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 120.048 1.294 . . . . 0.0 110.992 178.866 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.13 -49.29 76.4 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 170.219 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -62.45 -44.3 96.73 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 118.734 1.267 . . . . 0.0 111.304 177.458 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 39.2 mmt -55.99 -49.34 73.88 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-O 119.133 -0.461 . . . . 0.0 110.032 175.183 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -66.75 -29.11 69.0 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.965 0.802 . . . . 0.0 112.281 179.598 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -67.59 -37.33 82.43 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.718 1.144 . . . . 0.0 110.511 171.014 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -69.1 -27.5 65.65 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 119.546 1.066 . . . . 0.0 110.479 169.549 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 122.37 -25.72 6.55 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 127.914 2.673 . . . . 0.0 111.215 177.952 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 95.9 m -54.16 142.92 24.14 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 126.732 2.013 . . . . 0.0 110.792 -175.538 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -108.84 142.0 40.06 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -176.219 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 85.7 m -137.57 165.55 26.05 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 -167.975 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -153.03 125.74 8.31 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.864 2.066 . . . . 0.0 107.124 173.748 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.8 p -73.55 124.71 26.42 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 169.435 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 35.1 mt -71.41 -25.74 62.46 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.796 -0.565 . . . . 0.0 110.257 172.38 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 162.69 -165.34 36.22 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 108.477 -1.849 . . . . 0.0 108.477 177.89 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -148.04 173.35 28.11 Favored Glycine 0 CA--C 1.519 0.329 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 173.624 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -168.36 -160.23 15.7 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 108.501 -1.84 . . . . 0.0 108.501 -178.966 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 35.6 ptt-85 -136.4 160.16 39.58 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 121.084 -1.245 . . . . 0.0 108.057 177.357 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 86.5 mt -115.49 148.63 18.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 -170.803 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 38.9 m 62.08 174.23 0.13 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.678 1.991 . . . . 0.0 112.433 -172.066 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -153.68 -168.44 2.98 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.257 1.823 . . . . 0.0 107.768 -179.918 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -54.65 156.24 3.66 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.567 0.747 . . . . 0.0 111.236 176.731 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.5 m -67.65 19.8 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.662 1.985 . . . . 0.0 114.424 -179.009 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -63.19 -21.97 66.56 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.256 1.022 . . . . 0.0 111.092 174.238 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -146.97 173.78 12.12 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.64 1.576 . . . . 0.0 107.733 172.9 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -114.08 -18.79 11.6 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.641 1.576 . . . . 0.0 110.887 178.422 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -55.83 135.35 51.96 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 169.903 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.412 ' H ' HD12 ' A' ' 88' ' ' ILE . 5.4 mp -68.71 156.07 7.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 -179.171 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 23.7 t60 -136.38 164.26 28.55 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 121.435 -0.791 . . . . 0.0 109.399 -179.404 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.1 t -145.45 133.94 16.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 176.274 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -169.74 -176.97 2.54 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.07 0.948 . . . . 0.0 109.302 -179.416 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 102.71 -170.06 19.77 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.407 -0.677 . . . . 0.0 111.407 173.824 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -157.92 151.51 23.67 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.858 0.863 . . . . 0.0 109.833 179.48 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.8 t -84.36 148.24 26.73 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 168.678 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 4.5 ptt? -76.27 -41.06 50.15 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 169.795 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.26 -25.14 54.66 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 118.881 -0.581 . . . . 0.0 112.246 -173.19 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -135.05 -1.83 2.62 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -169.619 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.04 -178.08 49.46 Favored Glycine 0 CA--C 1.535 1.297 0 CA-C-N 119.141 0.882 . . . . 0.0 113.089 176.415 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.86 139.57 33.59 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.999 2.466 . . . . 0.0 110.129 175.181 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.49 170.49 16.46 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.045 0.538 . . . . 0.0 110.58 169.758 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -78.4 84.0 4.59 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 168.605 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 48.5 m80 -57.95 -14.14 5.82 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -175.933 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.78 -41.1 85.86 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.429 1.492 . . . . 0.0 111.937 169.914 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 67.7 mt -65.8 -45.07 92.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.856 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.61 -49.38 76.62 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.354 1.061 . . . . 0.0 110.917 -179.006 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.4 p -63.19 -48.58 77.77 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 118.295 -0.86 . . . . 0.0 110.763 -176.438 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -60.08 -39.3 85.59 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.248 0.931 . . . . 0.0 110.764 -177.33 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 52.9 mttm -71.24 -45.05 64.11 Favored 'General case' 0 CA--C 1.528 0.112 0 O-C-N 121.839 -0.538 . . . . 0.0 111.817 178.652 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 73.9 mt -65.73 -38.29 81.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-N 119.363 0.983 . . . . 0.0 108.943 -179.444 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -57.93 -50.85 71.95 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.471 1.032 . . . . 0.0 109.115 171.905 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.5 -30.06 69.48 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -177.205 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -61.03 -40.58 94.14 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.998 0.817 . . . . 0.0 110.809 177.172 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -150.63 78.2 7.66 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 123.331 0.653 . . . . 0.0 109.285 -173.446 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -70.86 -4.75 15.4 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.215 2.61 . . . . 0.0 114.053 -169.868 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -68.92 -21.6 64.2 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 118.958 0.799 . . . . 0.0 111.399 169.794 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 22.8 m-30 -104.26 175.85 5.35 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.686 1.194 . . . . 0.0 109.037 169.891 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -138.35 158.3 44.55 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.434 1.094 . . . . 0.0 108.461 179.412 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.7 t -140.51 143.96 28.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -169.762 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.7 p -133.01 169.9 16.16 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.353 1.061 . . . . 0.0 109.76 177.606 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 41.6 p-90 -143.57 150.95 39.59 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 171.231 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.09 101.78 1.94 Allowed 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 104.665 -2.346 . . . . 0.0 104.665 172.361 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.05 -22.96 66.45 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -169.258 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -53.39 -27.23 22.99 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 126.934 2.093 . . . . 0.0 114.879 -169.905 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -63.84 -22.24 66.22 Favored Glycine 0 CA--C 1.537 1.442 0 CA-C-O 118.553 -1.137 . . . . 0.0 113.243 177.266 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 . . . . . 0 N--CA 1.47 0.558 0 C-N-CA 127.613 2.365 . . . . 0.0 113.469 177.683 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 126' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.335 0 CA-C-O 121.98 0.895 . . . . 0.0 110.281 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -148.74 149.94 32.26 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 105.053 -2.202 . . . . 0.0 105.053 169.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 17.0 mt -60.23 -26.93 66.78 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -171.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.58 -28.06 65.64 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.888 0.767 . . . . 0.0 112.434 175.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.8 mt -79.3 -28.08 42.19 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 123.334 0.654 . . . . 0.0 111.149 -177.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 39.9 mt -64.85 128.0 93.22 Favored Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -47.16 130.31 16.56 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.41 2.74 . . . . 0.0 110.944 171.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -81.74 -37.63 26.97 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.357 0.599 . . . . 0.0 110.922 -173.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 43.8 t -134.73 135.13 53.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 170.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -152.93 123.54 7.27 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 169.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 20.2 pt . . . . . 0 CA--C 1.534 0.349 0 C-N-CA 125.601 1.56 . . . . 0.0 107.334 -171.768 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 32.2 p90 . . . . . 0 C--O 1.235 0.299 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -81.8 155.83 25.22 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 123.213 0.605 . . . . 0.0 110.772 -172.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -144.54 160.42 41.14 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.73 1.212 . . . . 0.0 108.174 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.1 m -132.85 152.34 35.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 C-N-CA 124.299 1.04 . . . . 0.0 109.169 173.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.36 123.65 47.22 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 103.654 -2.721 . . . . 0.0 103.654 173.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.7 mt -125.55 121.16 59.53 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 -177.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 23.1 ttp180 -76.64 143.47 40.12 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 169.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.2 t -133.66 142.45 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 C-N-CA 128.568 2.747 . . . . 0.0 104.593 -172.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -127.77 151.95 48.37 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.164 0.985 . . . . 0.0 108.806 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.509 ' HG ' ' N ' ' A' ' 39' ' ' GLU . 39.1 m -63.7 90.74 0.06 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.997 0.919 . . . . 0.0 111.48 175.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.42 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -136.32 19.21 0.05 OUTLIER Pre-proline 0 CA--C 1.552 1.025 0 CA-C-O 116.473 -1.727 . . . . 0.0 113.201 168.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.42 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 77.0 Cg_exo . . . . . 0 C--N 1.362 1.284 0 CA-C-N 123.915 2.434 . . . . 0.0 113.064 172.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.509 ' N ' ' HG ' ' A' ' 29' ' ' SER . 7.5 mm-40 . . . . . 0 CA--C 1.539 0.52 0 CA-C-O 121.358 0.599 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 12.5 m -140.28 158.55 43.85 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.503 1.121 . . . . 0.0 108.66 170.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -150.95 165.4 33.83 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 127.284 2.233 . . . . 0.0 105.822 -173.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.9 mp0 -128.72 147.87 50.8 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 176.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.3 pt -127.11 154.38 37.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 124.623 1.169 . . . . 0.0 109.456 176.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.0 t -117.66 119.28 61.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 178.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.414 ' HG3' HG21 ' A' ' 60' ' ' VAL . 9.9 mmp_? -129.49 145.28 51.46 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.007 1.323 . . . . 0.0 107.454 176.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.98 134.43 2.32 Favored Glycine 0 N--CA 1.452 -0.282 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 177.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -151.92 150.2 29.78 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -170.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -60.69 -27.57 67.96 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 118.88 -0.581 . . . . 0.0 112.407 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 11.3 p-90 -69.72 -26.16 64.2 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.259 0.936 . . . . 0.0 113.02 176.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.02 82.27 7.68 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 119.926 1.239 . . . . 0.0 109.667 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -66.34 -12.45 56.79 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.029 0.932 . . . . 0.0 111.884 176.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -142.06 152.01 42.92 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.522 1.929 . . . . 0.0 107.946 178.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -73.9 -32.88 63.78 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 121.692 -0.63 . . . . 0.0 110.308 -170.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.09 -28.39 52.13 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-O 118.561 -0.733 . . . . 0.0 112.265 172.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -66.43 -48.72 69.1 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 119.269 0.941 . . . . 0.0 110.731 -176.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.427 HG12 ' H ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -67.89 -42.85 86.12 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.675 177.568 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -61.51 -44.63 96.73 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 119.896 1.225 . . . . 0.0 110.098 -177.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -63.03 -48.55 78.25 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.888 0.767 . . . . 0.0 111.936 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 36.1 tttt -62.41 -52.89 61.77 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.387 0.675 . . . . 0.0 110.951 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.414 HG21 ' HG3' ' A' ' 45' ' ' ARG . 78.4 t -70.86 -49.61 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-O 118.231 -0.89 . . . . 0.0 109.125 -170.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 66.7 m -68.25 -23.4 64.78 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 119.721 1.146 . . . . 0.0 111.186 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.6 -48.82 78.77 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 169.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.419 ' HA ' ' HE3' ' A' ' 66' ' ' LYS . 18.4 t70 -62.27 -45.79 91.68 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 118.448 1.124 . . . . 0.0 111.816 176.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 39.0 mmt -55.99 -48.2 76.32 Favored 'General case' 0 C--O 1.227 -0.083 0 CA-C-N 118.17 0.441 . . . . 0.0 110.463 176.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -69.82 -27.56 64.97 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 118.779 0.718 . . . . 0.0 112.037 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.419 ' HE3' ' HA ' ' A' ' 63' ' ' ASP . 52.1 mtmt -66.58 -36.48 82.73 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.37 0.986 . . . . 0.0 110.25 169.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -70.36 -30.91 67.97 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 120.0 1.273 . . . . 0.0 110.44 169.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 129.62 -26.63 4.29 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 127.618 2.532 . . . . 0.0 111.365 174.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 85.6 m -51.15 142.36 12.72 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 126.306 1.842 . . . . 0.0 111.861 -175.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -101.96 146.73 27.46 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 176.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 79.2 m -143.1 163.28 33.29 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -168.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -150.65 128.88 11.97 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 169.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 9.2 p -66.95 131.58 46.18 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 169.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 38.8 mt -74.83 -21.52 59.23 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 120.974 -1.079 . . . . 0.0 110.176 170.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 162.53 -168.35 37.42 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 108.66 -1.776 . . . . 0.0 108.66 175.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -133.34 172.83 21.36 Favored Glycine 0 CA--C 1.521 0.421 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 173.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -171.59 -163.99 26.47 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 108.084 -2.006 . . . . 0.0 108.084 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 29.2 ptt180 -135.47 154.81 51.3 Favored 'General case' 0 CA--C 1.512 -0.511 0 O-C-N 120.639 -1.506 . . . . 0.0 109.294 172.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.9 mt . . . . . 0 N--CA 1.445 -0.704 0 N-CA-C 104.331 -2.47 . . . . 0.0 104.331 178.399 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 22.3 t60 . . . . . 0 N--CA 1.451 -0.381 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.6 t -133.82 130.43 55.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -173.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -171.26 -175.48 1.68 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.474 0.579 . . . . 0.0 110.235 -169.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.47 -166.47 39.94 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 174.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -157.67 161.09 38.57 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.391 0.676 . . . . 0.0 111.629 175.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.9 t -87.74 154.46 20.55 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 168.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.4 ptm -92.34 -32.37 15.01 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 119.024 0.829 . . . . 0.0 110.422 173.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.19 -24.35 59.34 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.048 0.84 . . . . 0.0 111.836 175.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -133.92 -4.9 2.79 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -169.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.4 -177.21 52.92 Favored Glycine 0 CA--C 1.535 1.317 0 CA-C-N 119.412 1.006 . . . . 0.0 113.124 175.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.58 138.55 38.66 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.232 2.621 . . . . 0.0 110.41 176.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.45 169.56 18.01 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.694 0.798 . . . . 0.0 111.192 169.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -79.5 80.85 5.83 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 169.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 41.9 m80 -56.1 -20.13 16.03 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.843 0.857 . . . . 0.0 113.244 -178.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.23 -44.3 71.6 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.428 1.491 . . . . 0.0 112.352 169.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 70.7 mt -66.25 -44.7 91.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.43 -49.38 76.42 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.921 0.888 . . . . 0.0 110.78 -178.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.46 HG22 HG12 ' A' ' 118' ' ' VAL . 13.1 p -64.55 -46.71 81.68 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 118.362 -0.827 . . . . 0.0 110.708 -175.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -60.87 -40.1 91.69 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 119.295 0.952 . . . . 0.0 110.705 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 45.1 mttm -68.36 -46.97 68.68 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.807 -0.558 . . . . 0.0 111.509 177.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 68.8 mt -66.63 -38.51 81.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 119.469 1.031 . . . . 0.0 109.198 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 93.7 mttt . . . . . 0 N--CA 1.468 0.44 0 CA-C-N 119.696 1.134 . . . . 0.0 109.56 173.597 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.46 HG12 HG22 ' A' ' 106' ' ' THR . 3.1 t . . . . . 0 C--O 1.234 0.289 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.6 p -136.83 170.18 16.52 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.496 1.119 . . . . 0.0 109.507 177.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 41.8 p-90 . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 172.452 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.366 0 CA-C-O 121.776 0.798 . . . . 0.0 111.631 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -146.29 143.72 29.35 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 105.558 -2.016 . . . . 0.0 105.558 169.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 76.6 mt -55.69 -33.03 63.8 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -171.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.82 -25.44 66.44 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.911 0.778 . . . . 0.0 112.318 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.1 mt -81.23 -24.39 37.43 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.481 0.712 . . . . 0.0 111.397 -176.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 52.3 mt -70.9 131.02 87.74 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-O 118.145 -0.931 . . . . 0.0 108.783 -169.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -47.27 120.38 4.32 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 124.26 3.307 . . . . 0.0 112.894 172.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -66.13 -35.76 81.35 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.475 1.51 . . . . 0.0 111.739 -178.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.9 t -143.41 138.23 26.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 176.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -153.19 113.82 4.06 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 169.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.2 pt . . . . . 0 CA--C 1.534 0.331 0 C-N-CA 123.145 0.578 . . . . 0.0 110.878 -169.685 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 . . . . . 0 C--O 1.237 0.433 0 CA-C-O 121.351 0.596 . . . . 0.0 109.782 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.4 mttm -70.48 156.2 39.69 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.63 1.172 . . . . 0.0 111.785 -172.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -144.54 161.59 38.72 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.614 1.966 . . . . 0.0 107.639 169.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.1 m -129.15 151.76 36.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 124.971 1.309 . . . . 0.0 109.537 173.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.97 120.34 39.66 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 104.202 -2.518 . . . . 0.0 104.202 171.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 46.1 mt -122.06 127.34 75.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 -177.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -81.36 148.0 29.56 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 169.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.1 t -133.03 144.25 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 -177.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -125.65 154.19 42.7 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.534 1.134 . . . . 0.0 109.396 -176.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 44.3 m -69.54 47.45 0.08 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.996 1.718 . . . . 0.0 114.157 177.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.13 -5.4 0.09 OUTLIER Pre-proline 0 CA--C 1.556 1.192 0 CA-C-O 114.775 -2.536 . . . . 0.0 117.334 169.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo . . . . . 0 C--N 1.363 1.292 0 C-N-CA 123.599 2.866 . . . . 0.0 115.543 178.026 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 . . . . . 0 C--O 1.24 0.589 0 CA-C-O 121.647 0.737 . . . . 0.0 109.903 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.5 m -140.71 160.38 40.17 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.862 1.265 . . . . 0.0 108.778 172.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -148.28 170.19 18.45 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 127.43 2.292 . . . . 0.0 106.291 -173.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.3 mp0 -133.15 154.08 50.94 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 121.084 -1.01 . . . . 0.0 108.294 178.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 34.2 pt -137.69 156.58 32.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 C-N-CA 125.712 1.605 . . . . 0.0 109.337 178.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 85.4 t -118.7 119.42 61.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.0 mmt85 -134.84 143.46 47.03 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -179.99 136.24 2.69 Favored Glycine 0 CA--C 1.509 -0.287 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -178.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -154.74 153.3 31.03 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -169.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -55.05 -29.67 57.96 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 178.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 8.7 p-90 -73.53 -22.54 60.07 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.969 0.804 . . . . 0.0 113.124 -179.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.86 83.5 7.17 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-N 120.056 1.298 . . . . 0.0 110.047 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -64.18 -18.41 64.46 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.976 0.91 . . . . 0.0 112.003 176.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -138.08 146.85 43.43 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.746 1.619 . . . . 0.0 108.398 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 29.2 m80 -65.03 -33.77 76.83 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.133 0.573 . . . . 0.0 110.832 -175.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.93 -25.82 45.03 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 118.382 -0.818 . . . . 0.0 112.987 173.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -67.75 -50.83 55.12 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 119.705 1.139 . . . . 0.0 110.569 -176.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.414 HG12 ' H ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -67.65 -37.17 78.2 Favored 'Isoleucine or valine' 0 C--N 1.339 0.147 0 CA-C-O 117.913 -1.041 . . . . 0.0 109.976 176.333 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -60.3 -49.47 77.46 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.651 1.114 . . . . 0.0 110.45 178.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -63.2 -47.1 84.01 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.345 0.52 . . . . 0.0 111.3 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.2 tttt -61.1 -53.7 53.76 Favored 'General case' 0 CA--C 1.522 -0.124 0 C-N-CA 123.126 0.571 . . . . 0.0 111.091 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 95.4 t -71.94 -44.91 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 117.937 -1.03 . . . . 0.0 109.294 -171.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.0 m -62.73 -33.77 75.82 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 120.292 1.406 . . . . 0.0 110.703 177.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.33 -47.6 89.93 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-N 118.946 0.794 . . . . 0.0 111.273 171.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -63.04 -46.29 88.23 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 118.625 1.213 . . . . 0.0 111.363 178.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 38.2 mmt -57.27 -45.93 83.57 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 123.488 0.715 . . . . 0.0 110.727 175.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -63.79 -36.42 83.82 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.786 0.835 . . . . 0.0 111.696 177.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -66.89 -37.21 83.96 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 119.232 0.923 . . . . 0.0 110.917 172.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -68.78 -23.65 64.33 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 119.283 0.947 . . . . 0.0 111.965 171.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 118.1 -12.93 12.76 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 126.248 1.88 . . . . 0.0 112.626 174.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 91.0 m -67.27 168.45 10.49 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.022 1.329 . . . . 0.0 111.55 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -125.44 152.11 45.33 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 170.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 65.4 m -143.44 163.69 32.41 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -168.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -148.71 137.59 21.49 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.042 1.737 . . . . 0.0 106.843 170.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.9 p -78.7 118.49 20.83 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 169.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 44.3 mt -70.85 -22.59 62.29 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 122.023 -0.423 . . . . 0.0 110.381 174.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 163.42 -166.76 37.34 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 172.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -151.68 175.66 30.39 Favored Glycine 0 CA--C 1.52 0.344 0 N-CA-C 111.807 -0.517 . . . . 0.0 111.807 171.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -166.6 -162.07 17.25 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 108.366 -1.894 . . . . 0.0 108.366 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.95 164.94 25.84 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 120.893 -1.357 . . . . 0.0 108.515 174.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 68.8 mt . . . . . 0 C--N 1.325 -0.474 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 -171.931 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 19.5 t60 . . . . . 0 N--CA 1.452 -0.336 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.0 t -141.84 137.11 31.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -163.03 -179.58 6.83 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.953 0.901 . . . . 0.0 109.247 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.9 -166.5 19.22 Favored Glycine 0 CA--C 1.523 0.553 0 O-C-N 121.695 -0.628 . . . . 0.0 112.592 169.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -159.07 157.85 31.87 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.903 1.281 . . . . 0.0 109.527 178.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.4 t -89.96 147.33 23.77 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 168.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.42 -42.46 62.02 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 171.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -80.72 -24.6 38.67 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 118.912 -0.566 . . . . 0.0 112.205 -171.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -132.49 -1.07 3.53 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -169.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.11 -179.72 49.81 Favored Glycine 0 CA--C 1.534 1.249 0 CA-C-N 118.964 0.802 . . . . 0.0 113.288 173.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.38 138.63 33.19 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.935 2.423 . . . . 0.0 109.981 175.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.07 168.1 20.65 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.254 0.55 . . . . 0.0 111.094 170.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -79.26 81.82 5.48 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 168.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 45.7 m80 -57.04 -18.38 13.85 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -174.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.82 -40.36 69.49 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.018 1.327 . . . . 0.0 112.151 170.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 61.2 mt -66.06 -47.28 85.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 178.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.42 -49.29 78.37 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.315 1.046 . . . . 0.0 110.798 -176.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 31.0 p -63.32 -49.12 75.2 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 118.642 -0.694 . . . . 0.0 109.568 -175.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -59.35 -40.72 87.34 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.11 0.868 . . . . 0.0 111.31 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 44.4 mttm -65.72 -47.15 76.31 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 118.507 0.594 . . . . 0.0 111.338 177.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 67.7 mt -64.01 -39.26 84.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 CA-C-N 119.202 0.91 . . . . 0.0 109.235 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.0 mtpt . . . . . 0 N--CA 1.469 0.502 0 CA-C-N 119.351 0.978 . . . . 0.0 109.999 177.348 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.2 t . . . . . 0 N--CA 1.448 -0.534 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 9.7 p -135.08 171.25 14.69 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.694 1.198 . . . . 0.0 108.764 176.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 55.7 p-90 . . . . . 0 C--O 1.235 0.326 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 172.393 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.435 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -146.21 153.06 40.18 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.675 1.99 . . . . 0.0 105.887 169.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 54.4 mt -53.15 -36.2 60.58 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.036 0.835 . . . . 0.0 112.077 -177.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.24 -25.72 68.19 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 118.801 0.728 . . . . 0.0 112.571 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.9 mt -83.73 -22.24 32.04 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.465 0.706 . . . . 0.0 111.489 -177.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 15.9 mt -66.48 131.71 94.2 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -50.39 128.9 24.49 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.842 2.361 . . . . 0.0 110.786 171.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -74.66 -41.69 59.86 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.378 0.671 . . . . 0.0 110.794 -176.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 53.5 t -136.29 129.18 46.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 177.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -152.12 111.94 4.0 Favored 'General case' 0 CA--C 1.521 -0.173 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 171.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 9.5 pt . . . . . 0 CA--C 1.535 0.386 0 C-N-CA 125.077 1.351 . . . . 0.0 109.067 -169.733 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 30.4 p90 . . . . . 0 CA--C 1.533 0.318 0 CA-C-O 121.248 0.547 . . . . 0.0 109.787 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.5 mttt -99.62 151.7 20.89 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.603 1.161 . . . . 0.0 108.83 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -142.91 162.8 34.5 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.232 1.013 . . . . 0.0 108.984 -174.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.0 m -133.6 155.25 40.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 C-N-CA 124.542 1.137 . . . . 0.0 109.718 173.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -106.96 116.73 32.44 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 178.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 80.3 mt -120.71 115.11 45.98 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -173.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -72.76 142.83 48.13 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 168.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.6 p -138.75 146.9 25.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -127.85 146.83 50.49 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.884 1.274 . . . . 0.0 108.484 -171.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 61.2 m -61.95 100.21 0.15 Allowed 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.598 0.759 . . . . 0.0 111.077 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.499 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -144.98 22.75 0.04 OUTLIER Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 126.029 1.732 . . . . 0.0 112.976 168.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.499 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 72.0 Cg_exo . . . . . 0 C--N 1.361 1.235 0 CA-C-N 123.872 2.419 . . . . 0.0 114.991 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 . . . . . 0 CA--C 1.542 0.653 0 CA-C-O 121.234 0.54 . . . . 0.0 109.891 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.9 m -143.27 159.94 41.4 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.964 1.306 . . . . 0.0 108.936 176.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.8 tttt -149.6 165.54 31.96 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 126.768 2.027 . . . . 0.0 107.246 -174.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -124.95 128.4 48.54 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 169.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 39.5 pt -108.89 155.07 10.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 124.84 1.256 . . . . 0.0 110.257 173.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 33.1 t -119.32 114.92 46.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 -175.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 12.7 mmp_? -128.38 146.84 50.66 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.084 1.353 . . . . 0.0 108.404 -177.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 174.98 137.55 2.52 Favored Glycine 0 C--N 1.332 0.306 0 CA-C-N 118.849 0.75 . . . . 0.0 111.303 176.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -153.33 154.16 34.02 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -169.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -56.92 -34.47 68.0 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 118.591 -0.719 . . . . 0.0 112.556 175.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 10.1 p-90 -65.5 -27.31 68.39 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.1 0.864 . . . . 0.0 112.294 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -87.29 73.22 9.72 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 119.033 0.833 . . . . 0.0 109.585 175.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -67.9 -5.05 14.89 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.458 0.703 . . . . 0.0 111.648 175.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -138.66 147.96 43.45 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 126.197 1.799 . . . . 0.0 107.142 173.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 59.9 m80 -73.89 -31.49 63.14 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 121.812 -0.555 . . . . 0.0 110.185 -169.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.76 -28.72 50.69 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 118.333 -0.842 . . . . 0.0 112.586 171.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -67.49 -49.31 64.06 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 119.624 1.102 . . . . 0.0 110.729 -177.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.401 ' H ' HG12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -67.35 -38.5 80.95 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 CA-C-O 117.732 -1.127 . . . . 0.0 110.045 177.058 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -64.43 -41.88 96.34 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 120.19 1.359 . . . . 0.0 110.669 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -63.43 -48.83 76.14 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.315 0.961 . . . . 0.0 111.304 176.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -56.79 -55.7 30.89 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.372 1.069 . . . . 0.0 110.628 178.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 81.1 t -77.08 -44.43 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-O 117.79 -1.1 . . . . 0.0 109.791 -169.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.1 t -62.73 -36.85 84.36 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 120.555 1.525 . . . . 0.0 109.266 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.51 -50.74 64.51 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 172.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -62.71 -45.95 90.36 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 118.728 1.264 . . . . 0.0 111.755 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 38.7 mmt -57.31 -47.86 80.42 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.377 0.671 . . . . 0.0 110.145 176.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -66.54 -30.92 71.33 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 118.698 -0.668 . . . . 0.0 111.805 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -67.48 -35.13 78.56 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.757 1.162 . . . . 0.0 110.724 170.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -72.8 -15.05 61.64 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 119.525 1.057 . . . . 0.0 111.208 169.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 110.04 -25.5 16.2 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 127.431 2.443 . . . . 0.0 112.247 177.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 93.3 m -55.8 149.28 14.95 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.957 1.703 . . . . 0.0 111.936 -175.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -108.87 143.36 38.18 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 177.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 96.1 m -141.3 164.91 28.98 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -168.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -151.41 128.37 11.04 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.794 1.637 . . . . 0.0 106.932 171.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.1 p -73.48 117.3 15.07 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 169.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 39.4 mt -70.76 -23.42 62.41 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.904 -0.497 . . . . 0.0 110.563 174.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.42 -170.97 42.46 Favored Glycine 0 C--N 1.337 0.626 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 171.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -132.23 169.91 22.02 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 174.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -174.34 -161.57 24.49 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -177.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 50.0 ttt180 -141.65 152.22 43.75 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 125.082 1.353 . . . . 0.0 107.816 -172.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 40.6 mt . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 173.752 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 22.9 t60 . . . . . 0 CA--C 1.517 -0.307 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.9 t -129.11 125.02 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -164.77 -167.98 1.36 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.694 0.798 . . . . 0.0 109.076 -171.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.71 -176.09 53.95 Favored Glycine 0 CA--C 1.527 0.793 0 O-C-N 121.633 -0.667 . . . . 0.0 111.473 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -158.97 149.84 20.01 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.01 0.924 . . . . 0.0 110.804 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.0 t -75.37 162.48 28.35 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 168.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.2 ptm -103.72 -31.27 9.93 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 118.629 -0.7 . . . . 0.0 110.783 170.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -73.71 -25.74 60.36 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 119.351 0.978 . . . . 0.0 111.6 174.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -132.49 -6.17 3.3 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.941 0.896 . . . . 0.0 113.351 -169.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.94 -176.1 54.1 Favored Glycine 0 CA--C 1.534 1.277 0 CA-C-N 118.945 0.793 . . . . 0.0 113.39 173.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -67.67 135.23 35.18 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.267 2.645 . . . . 0.0 110.471 175.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.69 168.23 20.44 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.11 0.564 . . . . 0.0 110.891 169.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -81.56 80.07 8.01 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 169.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -55.46 -20.5 12.77 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.09 -44.29 67.47 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.925 1.29 . . . . 0.0 112.196 170.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 71.7 mt -64.59 -48.35 85.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.46 -50.94 71.41 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.508 1.123 . . . . 0.0 110.443 -176.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.2 p -64.69 -46.25 83.19 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 119.347 0.976 . . . . 0.0 111.048 -175.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -60.7 -39.92 90.28 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.564 1.074 . . . . 0.0 110.625 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.3 mttt -72.55 -41.34 65.87 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 121.676 -0.64 . . . . 0.0 111.965 178.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 76.8 mt -65.76 -41.75 90.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 119.289 0.95 . . . . 0.0 108.662 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 91.6 mttt . . . . . 0 N--CA 1.467 0.385 0 CA-C-N 119.54 1.063 . . . . 0.0 109.882 173.184 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 C--O 1.234 0.249 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 21.6 p -136.18 168.17 19.89 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.778 1.231 . . . . 0.0 109.247 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 36.5 p-90 . . . . . 0 C--O 1.236 0.346 0 O-C-N 121.838 -0.539 . . . . 0.0 110.321 172.578 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.344 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -139.28 149.11 43.89 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 170.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.0 mt -54.75 -33.72 61.62 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.684 0.794 . . . . 0.0 112.343 -174.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.0 -25.22 68.03 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.077 0.853 . . . . 0.0 112.561 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 79.6 mt -78.28 -25.68 46.8 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.205 0.602 . . . . 0.0 111.369 -177.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.0 mt -69.63 130.43 90.48 Favored Pre-proline 0 CA--C 1.538 0.502 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -173.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -50.67 127.6 21.42 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.856 2.371 . . . . 0.0 109.884 169.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -82.39 -34.07 28.48 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 121.88 -0.512 . . . . 0.0 111.481 -171.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 52.5 t -133.92 131.86 56.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 171.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -152.99 126.86 8.93 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 174.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.3 pt . . . . . 0 CA--C 1.535 0.394 0 C-N-CA 124.097 0.959 . . . . 0.0 110.349 -169.758 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 21.2 p90 . . . . . 0 N--CA 1.466 0.355 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -72.61 156.19 39.25 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 122.952 0.501 . . . . 0.0 110.464 -176.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -147.64 164.86 32.2 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.472 1.109 . . . . 0.0 108.302 172.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.4 m -133.92 153.08 35.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 C-N-CA 124.725 1.21 . . . . 0.0 108.963 173.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.1 114.71 28.82 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 54.0 mt -119.38 117.92 55.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -170.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.7 ttp180 -73.63 147.13 44.06 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 169.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.0 t -135.2 150.3 29.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 127.097 2.159 . . . . 0.0 105.517 -176.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -131.8 153.86 49.69 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.691 1.196 . . . . 0.0 108.245 176.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.46 ' HG ' ' N ' ' A' ' 39' ' ' GLU . 19.2 m -68.87 44.71 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.946 1.698 . . . . 0.0 114.111 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -73.96 -5.56 0.09 OUTLIER Pre-proline 0 CA--C 1.551 1.004 0 CA-C-O 115.159 -2.353 . . . . 0.0 116.824 172.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo . . . . . 0 C--N 1.359 1.118 0 CA-C-N 125.263 2.915 . . . . 0.0 112.068 169.543 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.46 ' N ' ' HG ' ' A' ' 29' ' ' SER . 19.0 mm-40 . . . . . 0 CA--C 1.541 0.613 0 CA-C-O 121.512 0.672 . . . . 0.0 109.635 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.1 m -141.58 161.18 38.56 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.288 1.435 . . . . 0.0 108.969 174.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.5 tttt -149.63 162.19 40.69 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 126.203 1.801 . . . . 0.0 107.772 -172.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.5 mp0 -130.22 119.75 23.4 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 172.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 43.9 pt -104.99 159.24 5.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 C-N-CA 125.137 1.375 . . . . 0.0 110.705 178.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.4 t -118.14 120.59 64.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.447 ' HG3' HG21 ' A' ' 60' ' ' VAL . 9.4 mmp_? -126.55 141.09 51.98 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 176.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.04 131.81 1.83 Allowed Glycine 0 C--N 1.331 0.256 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 174.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -148.81 147.47 28.8 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -169.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -57.5 -27.31 62.43 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 177.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 12.2 p-90 -68.09 -27.97 66.94 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.221 0.918 . . . . 0.0 112.438 176.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.44 83.39 7.95 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 119.411 1.005 . . . . 0.0 109.054 175.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -66.85 -16.97 64.65 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 122.859 0.464 . . . . 0.0 111.65 176.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -134.3 152.69 51.95 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.028 1.731 . . . . 0.0 108.441 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 76.8 m-70 -73.3 -33.27 65.09 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -169.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.39 -28.75 56.02 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 118.408 -0.806 . . . . 0.0 112.71 173.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -67.63 -49.61 62.12 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 119.443 1.02 . . . . 0.0 110.46 -177.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.21 -42.79 91.7 Favored 'Isoleucine or valine' 0 C--N 1.341 0.209 0 CA-C-O 117.933 -1.032 . . . . 0.0 109.659 175.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -61.05 -45.13 96.03 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.687 1.131 . . . . 0.0 110.68 -177.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -63.32 -49.09 75.34 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.2 0.909 . . . . 0.0 111.655 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 31.5 tttt -59.13 -50.41 74.14 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.599 0.76 . . . . 0.0 110.883 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.447 HG21 ' HG3' ' A' ' 45' ' ' ARG . 91.9 t -72.73 -42.33 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-O 117.832 -1.08 . . . . 0.0 109.012 -172.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 63.0 m -60.15 -33.27 71.94 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-N 120.65 1.568 . . . . 0.0 111.087 173.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.03 -53.92 39.04 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-N 119.468 1.031 . . . . 0.0 110.54 172.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.449 ' HA ' ' HE3' ' A' ' 66' ' ' LYS . 19.0 t70 -60.32 -46.1 91.06 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.442 1.121 . . . . 0.0 111.828 -178.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 35.3 mmt -59.45 -50.21 74.83 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.963 0.905 . . . . 0.0 110.119 178.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -67.07 -29.73 69.59 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 118.461 0.573 . . . . 0.0 111.605 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.449 ' HE3' ' HA ' ' A' ' 63' ' ' ASP . 52.3 mtmt -66.06 -36.55 83.52 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.343 0.974 . . . . 0.0 110.861 170.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -72.44 -13.14 61.37 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.817 1.189 . . . . 0.0 112.069 169.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.76 -10.85 66.49 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 126.267 1.889 . . . . 0.0 112.346 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 85.1 m -56.38 153.0 10.4 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.815 1.308 . . . . 0.0 111.233 175.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -114.3 139.36 49.5 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 170.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 35.4 m -141.56 161.24 38.41 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -168.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -153.35 126.84 8.68 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 176.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.7 p -70.59 121.27 17.55 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 169.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 36.6 mt -66.9 -24.5 66.11 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.864 -0.523 . . . . 0.0 109.82 170.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.91 -170.21 42.66 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 125.3 1.429 . . . . 0.0 109.612 169.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -124.15 169.29 16.23 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 173.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -175.83 -166.29 33.06 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -175.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -143.88 160.38 40.89 Favored 'General case' 0 CA--C 1.516 -0.344 0 O-C-N 120.906 -1.349 . . . . 0.0 109.561 178.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 95.2 mt . . . . . 0 N--CA 1.448 -0.546 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 -176.856 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 21.6 t60 . . . . . 0 CA--C 1.521 -0.166 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.3 t -133.36 135.22 56.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 -178.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -170.56 -171.18 1.02 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -170.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 109.65 -172.74 16.24 Favored Glycine 0 CA--C 1.523 0.55 0 CA-C-N 119.3 0.955 . . . . 0.0 113.32 169.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -157.4 154.02 28.17 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.923 1.689 . . . . 0.0 107.668 -169.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.5 t -126.27 140.25 52.68 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 169.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 21.7 ptp -80.62 -34.98 34.63 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 118.71 -0.662 . . . . 0.0 110.11 173.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.65 -25.03 49.32 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.068 0.849 . . . . 0.0 112.182 -177.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -133.13 -5.29 3.06 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -169.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.87 171.83 42.96 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-N 118.964 0.802 . . . . 0.0 112.044 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.78 137.24 34.92 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.299 2.0 . . . . 0.0 109.312 177.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.18 170.75 6.56 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.16 0.505 . . . . 0.0 111.114 171.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 21.6 mm100 -64.99 -32.82 74.73 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 119.255 -0.402 . . . . 0.0 111.955 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 35.8 m80 61.7 -30.99 0.07 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 128.316 2.646 . . . . 0.0 115.526 -174.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.56 -45.94 88.21 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.649 1.18 . . . . 0.0 111.179 173.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 73.5 mt -61.21 -46.16 97.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.43 -52.04 66.98 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.891 1.276 . . . . 0.0 110.522 -174.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.2 p -64.57 -44.13 91.7 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.418 -177.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -60.63 -41.53 95.08 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.811 1.187 . . . . 0.0 110.736 -179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 25.7 mmtp -65.93 -47.9 73.16 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 118.735 0.698 . . . . 0.0 111.102 176.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 56.6 mt -64.67 -41.87 93.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 119.194 0.906 . . . . 0.0 109.237 -176.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 92.4 mttt . . . . . 0 N--CA 1.467 0.416 0 CA-C-N 119.776 1.171 . . . . 0.0 109.619 175.059 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 CA--C 1.532 0.253 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 17.2 p -136.15 168.21 19.81 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.809 1.244 . . . . 0.0 109.501 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 31.6 p-90 . . . . . 0 C--O 1.235 0.331 0 O-C-N 121.762 -0.586 . . . . 0.0 110.411 171.797 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.548 0 CA-C-O 121.507 0.67 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -152.93 146.5 25.04 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 169.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 61.3 mt -55.18 -34.3 63.73 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -173.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.22 -26.24 65.61 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.845 0.748 . . . . 0.0 112.159 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.2 mt -81.47 -23.46 37.4 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.513 0.725 . . . . 0.0 111.22 -177.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.8 mt -66.31 129.29 94.17 Favored Pre-proline 0 CA--C 1.538 0.514 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 -175.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -46.65 116.22 1.53 Allowed 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 124.195 3.263 . . . . 0.0 111.777 170.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -72.63 -31.73 65.36 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.603 0.761 . . . . 0.0 111.577 -172.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 64.2 t -141.72 137.24 31.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 171.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -151.18 110.84 4.02 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 169.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 40.5 pt . . . . . 0 C--O 1.236 0.357 0 C-N-CA 124.211 1.005 . . . . 0.0 109.195 -170.111 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 16.5 p90 . . . . . 0 N--CA 1.469 0.494 0 CA-C-O 120.49 0.186 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.1 mmtm -72.46 152.65 41.81 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 173.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -142.1 160.05 41.0 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 175.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.4 m -130.15 152.98 38.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 124.615 1.166 . . . . 0.0 109.433 173.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.2 114.92 29.17 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 104.201 -2.518 . . . . 0.0 104.201 177.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 54.5 mt -118.88 124.88 73.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -172.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -78.24 148.09 34.1 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 169.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.3 t -132.12 145.53 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -127.55 148.51 50.34 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.762 1.225 . . . . 0.0 108.218 178.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.5 ' HG ' ' N ' ' A' ' 39' ' ' GLU . 35.4 m -62.35 99.13 0.13 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.759 0.824 . . . . 0.0 110.92 177.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.488 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -142.44 20.15 0.04 OUTLIER Pre-proline 0 CA--C 1.552 1.028 0 CA-C-O 116.491 -1.719 . . . . 0.0 113.502 169.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.488 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 76.3 Cg_exo . . . . . 0 C--N 1.363 1.301 0 CA-C-N 123.817 2.399 . . . . 0.0 114.174 177.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.5 ' N ' ' HG ' ' A' ' 29' ' ' SER . 43.0 mt-10 . . . . . 0 CA--C 1.541 0.617 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.5 m -141.84 160.5 40.06 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.628 1.171 . . . . 0.0 109.403 174.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -152.0 171.56 17.64 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 127.393 2.277 . . . . 0.0 106.509 -172.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.8 mp0 -133.24 157.66 44.86 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 172.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 30.3 pt -137.13 156.03 33.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 C-N-CA 125.717 1.607 . . . . 0.0 109.114 177.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 52.9 t -118.54 120.87 65.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 178.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 25.6 mmt85 -135.63 144.89 46.34 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 176.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 178.44 134.72 2.15 Favored Glycine 0 N--CA 1.453 -0.202 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -178.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.405 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 9.7 m-85 -154.79 155.53 34.64 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -169.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -58.02 -34.13 69.71 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.714 0.806 . . . . 0.0 112.07 -178.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.405 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 13.9 p-90 -67.32 -27.55 67.24 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 118.707 -0.663 . . . . 0.0 112.613 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.36 80.5 9.19 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 119.635 1.107 . . . . 0.0 109.104 175.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -64.23 -18.13 64.23 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.062 0.545 . . . . 0.0 112.0 175.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -134.07 151.05 51.24 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 126.601 1.961 . . . . 0.0 108.023 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -74.1 -31.92 63.0 Favored 'General case' 0 C--O 1.234 0.254 0 O-C-N 121.847 -0.533 . . . . 0.0 110.064 -169.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.32 -29.76 48.96 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 118.564 -0.731 . . . . 0.0 112.48 172.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -67.75 -50.65 56.12 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 119.289 0.95 . . . . 0.0 110.796 -175.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.442 HG12 ' H ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -67.36 -38.26 80.5 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.157 0 CA-C-O 117.846 -1.073 . . . . 0.0 110.036 176.009 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -59.92 -48.35 82.06 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.76 1.163 . . . . 0.0 110.317 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -63.54 -47.68 80.61 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.347 0.521 . . . . 0.0 111.495 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 31.6 tttt -61.2 -52.81 63.24 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 123.198 0.599 . . . . 0.0 111.144 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 92.6 t -70.94 -46.1 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-O 118.024 -0.989 . . . . 0.0 108.975 -172.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.8 m -62.32 -31.95 72.64 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 120.283 1.402 . . . . 0.0 111.055 176.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.16 -49.78 74.39 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-N 119.038 0.835 . . . . 0.0 111.077 171.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -61.68 -44.19 97.41 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 118.654 1.227 . . . . 0.0 111.61 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.6 mmt -59.39 -47.82 84.0 Favored 'General case' 0 C--O 1.226 -0.159 0 C-N-CA 123.06 0.544 . . . . 0.0 110.053 176.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -67.49 -28.61 67.99 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.85 0.75 . . . . 0.0 112.025 179.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -68.05 -36.98 80.79 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 119.585 1.084 . . . . 0.0 110.418 170.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -68.04 -29.74 68.79 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 119.625 1.102 . . . . 0.0 110.122 169.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 122.37 -23.17 7.26 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 128.13 2.776 . . . . 0.0 111.297 177.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 84.6 m -53.82 146.5 13.74 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 126.682 1.993 . . . . 0.0 111.321 -175.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -107.87 142.01 38.6 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 72.7 m -142.44 163.86 31.71 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -168.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -151.81 133.79 15.0 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.552 1.541 . . . . 0.0 107.668 170.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.6 p -72.22 115.76 11.84 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 169.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 45.6 mt -67.04 -24.98 66.05 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.986 -0.446 . . . . 0.0 110.002 172.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.92 -164.32 37.74 Favored Glycine 0 C--N 1.336 0.536 0 N-CA-C 108.374 -1.89 . . . . 0.0 108.374 172.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -155.13 -176.41 27.31 Favored Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 111.004 -0.838 . . . . 0.0 111.004 171.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -171.44 -156.4 11.82 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 -175.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.1 ttp180 -135.66 147.0 48.41 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 -177.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.3 mt . . . . . 0 C--O 1.235 0.337 0 N-CA-C 106.484 -1.672 . . . . 0.0 106.484 -174.757 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 19.4 t60 . . . . . 0 CA--C 1.515 -0.367 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.6 t -133.22 132.57 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 -176.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -160.15 -167.93 2.07 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.937 1.295 . . . . 0.0 108.886 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.15 -171.34 42.96 Favored Glycine 0 CA--C 1.525 0.703 0 O-C-N 121.612 -0.68 . . . . 0.0 113.632 176.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -161.87 152.89 18.01 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.523 1.129 . . . . 0.0 110.123 -169.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.5 t -81.59 168.45 18.17 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 167.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 20.8 ptp -111.44 -29.68 7.69 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 121.215 -0.928 . . . . 0.0 111.39 170.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.19 -25.76 59.88 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.716 1.144 . . . . 0.0 111.434 171.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -131.76 -7.14 3.6 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.886 0.874 . . . . 0.0 113.015 -169.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.39 -179.11 48.94 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 123.735 0.683 . . . . 0.0 113.638 172.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -68.4 142.08 53.33 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.83 2.354 . . . . 0.0 110.743 173.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.68 178.19 6.26 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 168.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -63.61 -28.4 69.9 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 119.045 -0.503 . . . . 0.0 111.868 170.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 42.4 m80 59.08 -23.16 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 128.283 2.633 . . . . 0.0 116.63 -173.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.72 -39.04 93.31 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.688 1.195 . . . . 0.0 110.794 172.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 75.3 mt -63.33 -44.44 99.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 175.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.1 -44.62 94.71 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.135 0.974 . . . . 0.0 111.252 -177.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.54 -51.0 67.3 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 119.275 0.943 . . . . 0.0 110.611 176.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -57.6 -43.98 85.1 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.027 0.83 . . . . 0.0 110.62 -177.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -71.41 -40.27 70.57 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 118.102 -0.951 . . . . 0.0 111.832 -178.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 83.8 mt -69.3 -34.89 64.96 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-N 120.78 1.627 . . . . 0.0 108.957 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 94.4 mttt . . . . . 0 N--CA 1.47 0.559 0 CA-C-N 120.404 1.457 . . . . 0.0 110.385 171.083 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.7 p . . . . . 0 N--CA 1.45 -0.471 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 21.2 p -139.05 171.48 14.25 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.923 0.889 . . . . 0.0 109.399 171.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 19.6 p-90 . . . . . 0 C--O 1.235 0.338 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 169.471 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.504 0 CA-C-O 121.542 0.687 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -149.68 153.22 36.63 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 125.963 1.705 . . . . 0.0 106.486 171.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 44.2 mt -56.39 -33.18 65.5 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 118.697 0.681 . . . . 0.0 112.666 -176.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.52 -25.49 65.87 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.919 0.781 . . . . 0.0 112.167 177.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.1 mt -86.64 -21.91 26.47 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.87 0.868 . . . . 0.0 111.372 -176.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 56.7 mt -64.54 128.56 93.55 Favored Pre-proline 0 CA--C 1.54 0.559 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 178.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -46.3 114.94 0.97 Allowed 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 124.232 3.288 . . . . 0.0 111.58 172.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -72.08 -30.81 65.49 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.369 0.668 . . . . 0.0 112.071 -169.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 42.3 t -143.12 142.47 25.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 171.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -151.38 127.8 10.67 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 169.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 40.9 pt . . . . . 0 CA--C 1.54 0.581 0 C-N-CA 127.622 2.369 . . . . 0.0 106.219 -176.745 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 36.5 p90 . . . . . 0 N--CA 1.468 0.429 0 CA-C-O 120.997 0.427 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -77.86 154.12 32.07 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.019 0.928 . . . . 0.0 110.495 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -142.28 164.91 28.88 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.313 1.045 . . . . 0.0 108.891 175.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.9 m -132.14 152.91 37.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 C-N-CA 124.589 1.156 . . . . 0.0 109.287 172.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.2 tp -108.11 117.95 35.49 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 177.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 95.4 mt -122.7 123.04 67.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -171.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -79.57 147.8 31.98 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 169.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.5 p -138.38 146.99 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 175.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 -120.01 156.96 29.85 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.852 1.261 . . . . 0.0 108.78 -176.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.505 ' HG ' ' N ' ' A' ' 39' ' ' GLU . 14.4 m -63.15 87.64 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.698 1.199 . . . . 0.0 111.922 177.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.415 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -138.55 19.39 0.05 OUTLIER Pre-proline 0 CA--C 1.551 1.019 0 CA-C-O 116.405 -1.759 . . . . 0.0 114.449 169.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 30' ' ' ALA . 80.1 Cg_exo . . . . . 0 C--N 1.36 1.157 0 CA-C-N 123.976 2.456 . . . . 0.0 113.681 172.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.505 ' N ' ' HG ' ' A' ' 29' ' ' SER . 8.9 pt-20 . . . . . 0 CA--C 1.537 0.466 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.8 m -142.26 158.17 44.02 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.958 0.903 . . . . 0.0 110.334 -174.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -149.21 166.01 30.16 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 127.56 2.344 . . . . 0.0 105.947 -175.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.8 mp0 -125.33 151.6 45.83 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 174.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 21.2 pt -127.27 155.04 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 125.997 1.719 . . . . 0.0 108.594 173.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 85.1 t -127.87 115.96 41.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 -173.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 26.7 mmt85 -135.33 139.82 44.6 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -176.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -170.92 141.61 6.6 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 178.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -156.1 149.02 24.15 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -171.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -58.77 -32.83 69.65 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 118.839 -0.6 . . . . 0.0 111.61 174.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 9.7 p-90 -65.32 -26.83 68.22 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.018 0.826 . . . . 0.0 112.489 177.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.41 73.44 10.5 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 119.337 0.971 . . . . 0.0 109.524 175.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -65.67 -8.56 21.27 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.35 0.66 . . . . 0.0 112.104 176.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -138.17 144.91 40.94 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 126.896 2.079 . . . . 0.0 106.836 177.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 60.9 m80 -71.44 -31.13 66.84 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 121.885 -0.509 . . . . 0.0 109.979 -171.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.47 -27.27 47.31 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 118.258 -0.877 . . . . 0.0 112.676 171.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -68.33 -48.93 63.58 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 119.818 1.19 . . . . 0.0 110.763 -176.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.438 HG12 ' H ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -67.32 -40.26 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 CA-C-O 117.732 -1.127 . . . . 0.0 109.782 175.78 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -62.49 -44.66 95.85 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 120.047 1.294 . . . . 0.0 110.599 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -62.49 -47.34 84.42 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.818 0.735 . . . . 0.0 111.369 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 31.7 tttt -62.29 -53.59 52.92 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.245 0.618 . . . . 0.0 110.999 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 92.0 t -73.52 -48.35 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-O 118.539 -0.743 . . . . 0.0 109.179 -171.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.0 t -63.32 -34.74 78.35 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 119.568 1.076 . . . . 0.0 109.759 178.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.28 -48.59 85.24 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-N 118.978 0.808 . . . . 0.0 111.182 172.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -63.02 -43.6 98.29 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 118.69 1.245 . . . . 0.0 111.596 178.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 39.2 mmt -59.27 -47.31 85.85 Favored 'General case' 0 CA--C 1.527 0.077 0 C-N-CA 122.769 0.428 . . . . 0.0 110.111 176.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -64.92 -32.69 74.53 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.423 0.689 . . . . 0.0 111.274 179.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -67.4 -35.65 79.71 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.443 1.019 . . . . 0.0 111.052 170.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -69.03 -15.8 63.55 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 119.838 1.199 . . . . 0.0 111.286 169.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 109.17 -18.82 30.46 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 126.838 2.161 . . . . 0.0 111.94 177.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 73.1 m -57.05 162.91 2.27 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.654 1.982 . . . . 0.0 112.874 -175.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -123.25 137.35 54.89 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 176.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 80.4 m -142.69 166.17 25.4 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -168.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -151.09 131.65 13.88 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.797 1.239 . . . . 0.0 108.32 170.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.3 p -69.74 115.77 9.36 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 169.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 64.3 mt -66.97 -26.93 67.06 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.984 0.514 . . . . 0.0 109.95 173.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.08 -172.97 42.92 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 169.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -123.13 165.52 15.76 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 110.951 -0.859 . . . . 0.0 110.951 175.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -168.54 -163.56 22.74 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -178.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.7 ttp180 -146.45 158.37 43.88 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 121.141 -1.211 . . . . 0.0 107.763 -175.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 56.7 mt . . . . . 0 N--CA 1.449 -0.478 0 N-CA-C 104.851 -2.278 . . . . 0.0 104.851 -178.512 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 12.4 t60 . . . . . 0 N--CA 1.446 -0.671 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 54.5 t -131.82 106.0 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 -169.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -164.16 162.86 23.02 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.311 0.644 . . . . 0.0 109.517 -175.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 143.08 -169.08 25.85 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -155.85 151.66 27.41 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.101 0.56 . . . . 0.0 110.64 171.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.4 t -90.41 161.34 15.61 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 168.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 27.6 ptm -94.04 -33.91 13.22 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 118.995 0.816 . . . . 0.0 110.018 169.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.6 -25.38 56.94 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.905 0.775 . . . . 0.0 112.006 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -133.46 -4.13 2.98 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -169.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.83 -175.39 52.03 Favored Glycine 0 CA--C 1.535 1.326 0 CA-C-N 119.031 0.832 . . . . 0.0 113.344 173.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.99 138.8 37.93 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.385 2.724 . . . . 0.0 111.206 175.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.24 168.44 17.29 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 168.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 23.0 mm100 -68.55 -27.07 65.76 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.856 -0.528 . . . . 0.0 111.864 172.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 37.6 m80 60.48 -29.24 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 128.962 2.905 . . . . 0.0 115.895 -175.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.8 -40.66 93.5 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.536 1.134 . . . . 0.0 112.467 -179.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.3 mp -62.55 -46.33 96.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 177.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.3 m -59.47 -47.22 86.34 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 123.892 0.877 . . . . 0.0 110.621 -176.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.5 p -64.77 -41.12 96.1 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 118.097 -0.954 . . . . 0.0 111.065 -176.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -58.91 -45.51 90.13 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.951 1.25 . . . . 0.0 110.649 177.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 44.3 mttm -67.41 -46.24 73.79 Favored 'General case' 0 N--CA 1.462 0.158 0 O-C-N 122.128 -0.358 . . . . 0.0 111.037 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 55.7 mt -68.57 -38.05 78.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -176.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 96.1 mttt . . . . . 0 N--CA 1.471 0.592 0 CA-C-N 120.523 1.511 . . . . 0.0 110.031 174.26 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.4 t . . . . . 0 CA--C 1.534 0.36 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 6.3 p -139.66 170.23 16.28 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.335 1.054 . . . . 0.0 109.879 177.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 39.5 p-90 . . . . . 0 C--O 1.236 0.361 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 169.775 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.501 0 CA-C-O 121.246 0.545 . . . . 0.0 110.526 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -152.39 151.25 30.59 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 169.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 78.1 mt -56.08 -34.62 66.14 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.273 0.629 . . . . 0.0 112.549 -176.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.1 -25.21 65.21 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.691 0.678 . . . . 0.0 112.08 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.5 mt -83.41 -21.74 32.91 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.539 0.736 . . . . 0.0 111.328 -177.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.4 mt -65.34 127.48 92.96 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 177.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -47.76 125.38 11.15 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 123.649 2.899 . . . . 0.0 111.193 171.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -76.48 -36.44 57.84 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.097 0.475 . . . . 0.0 111.008 -173.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.6 t -140.67 133.07 31.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 177.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -154.56 119.76 5.02 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 105.072 -2.196 . . . . 0.0 105.072 169.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.7 pp . . . . . 0 C--O 1.235 0.34 0 C-N-CA 124.477 1.111 . . . . 0.0 109.53 -171.075 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.5 p90 . . . . . 0 N--CA 1.466 0.344 0 CA-C-O 120.937 0.399 . . . . 0.0 110.385 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -72.94 151.32 41.91 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.702 0.801 . . . . 0.0 110.758 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -144.12 161.85 37.78 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.848 1.259 . . . . 0.0 107.845 177.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.5 m -130.34 151.45 35.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 C-N-CA 124.24 1.016 . . . . 0.0 109.349 174.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.74 114.58 28.88 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 103.643 -2.725 . . . . 0.0 103.643 176.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.8 mt -120.31 124.79 73.28 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -172.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.2 ttm180 -78.93 143.69 35.57 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 168.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.5 p -137.39 136.88 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 178.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -107.18 148.91 28.29 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.889 1.275 . . . . 0.0 109.006 -172.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.1 p -72.43 85.25 1.12 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.56 0.695 . . . . 0.0 111.138 178.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -131.52 33.07 0.23 Allowed Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 124.602 1.161 . . . . 0.0 112.368 169.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo . . . . . 0 C--N 1.354 0.824 0 CA-C-N 122.133 1.798 . . . . 0.0 109.961 -178.521 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 . . . . . 0 C--O 1.238 0.45 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.6 m -139.85 158.85 43.41 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.639 0.776 . . . . 0.0 110.256 175.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -142.07 166.41 24.78 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 127.973 2.509 . . . . 0.0 105.417 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 30.7 mp0 -126.69 149.75 49.38 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.1 pt -132.94 155.62 41.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 C-N-CA 125.059 1.344 . . . . 0.0 109.86 178.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 85.3 t -117.66 114.93 46.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.9 mmp_? -126.6 147.14 49.93 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 173.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 178.72 139.27 3.46 Favored Glycine 0 C--N 1.331 0.259 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 176.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.404 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 20.6 m-85 -154.59 150.22 27.49 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 123.397 0.679 . . . . 0.0 109.344 -171.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.4 tptt -62.31 -26.55 68.49 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 118.578 -0.725 . . . . 0.0 112.055 177.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.404 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 9.9 p-90 -63.86 -27.93 69.5 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.677 1.126 . . . . 0.0 112.28 176.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.63 76.05 10.04 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 119.242 0.928 . . . . 0.0 109.491 174.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -66.77 -5.79 13.49 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.219 0.607 . . . . 0.0 112.135 175.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -139.43 144.39 38.05 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 126.471 1.908 . . . . 0.0 107.026 175.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -70.62 -30.98 67.77 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 121.979 -0.451 . . . . 0.0 110.036 -171.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.55 -30.15 40.5 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 118.759 -0.639 . . . . 0.0 112.627 172.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -68.09 -50.52 54.4 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 119.134 0.879 . . . . 0.0 110.804 -175.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.431 HG12 ' H ' ' A' ' 56' ' ' ILE . 0.1 OUTLIER -67.08 -38.42 81.2 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.19 0 CA-C-O 117.761 -1.114 . . . . 0.0 109.935 174.85 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -60.16 -46.11 90.79 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 120.191 1.36 . . . . 0.0 110.91 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -65.35 -48.47 72.87 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 122.644 0.377 . . . . 0.0 111.275 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 44.3 tttt -62.29 -49.12 76.91 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 123.304 0.642 . . . . 0.0 111.479 -176.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 86.7 t -75.15 -45.5 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-O 118.423 -0.799 . . . . 0.0 109.33 -172.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.9 m -61.85 -35.82 79.42 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 119.423 1.01 . . . . 0.0 110.103 175.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.7 -48.02 87.15 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 173.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -63.35 -45.27 91.99 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 118.96 1.38 . . . . 0.0 111.429 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 39.1 mmt -59.57 -43.9 93.47 Favored 'General case' 0 C--O 1.227 -0.091 0 CA-C-N 118.202 0.456 . . . . 0.0 109.933 177.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -68.58 -27.92 66.48 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.716 0.807 . . . . 0.0 111.752 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -69.39 -36.86 77.18 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 119.455 1.025 . . . . 0.0 109.749 169.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -68.09 -25.79 65.5 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 119.928 1.24 . . . . 0.0 110.266 169.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 122.25 -27.63 6.04 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 128.237 2.827 . . . . 0.0 111.313 174.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 97.2 m -58.58 145.23 40.2 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 126.07 1.748 . . . . 0.0 110.691 -177.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -108.43 156.28 19.62 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 177.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 86.1 m -141.48 165.42 27.56 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 -168.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -150.92 132.7 14.98 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.546 1.538 . . . . 0.0 107.085 169.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.6 p -70.82 121.05 17.32 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 169.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 38.1 mt -70.34 -23.2 62.77 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.99 -0.444 . . . . 0.0 109.902 171.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.94 -166.27 39.04 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 170.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -146.86 173.12 27.17 Favored Glycine 0 CA--C 1.52 0.387 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 172.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -172.35 -156.13 12.07 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 107.356 -2.298 . . . . 0.0 107.356 -178.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 26.9 ptt-85 -142.31 160.25 40.62 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 120.614 -1.521 . . . . 0.0 109.403 176.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 93.7 mt . . . . . 0 C--N 1.321 -0.65 0 N-CA-C 104.404 -2.443 . . . . 0.0 104.404 -174.179 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 23.1 t60 . . . . . 0 C--O 1.233 0.199 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.0 t -137.49 130.89 43.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -162.28 -173.99 3.86 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.047 0.939 . . . . 0.0 109.869 -172.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.38 -172.33 50.4 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 123.659 0.647 . . . . 0.0 112.285 178.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -160.79 151.55 18.47 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.716 0.806 . . . . 0.0 111.05 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.0 t -72.43 164.86 25.67 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 168.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 23.0 ptp -111.69 -28.92 7.91 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 118.359 -0.829 . . . . 0.0 111.174 171.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.14 -26.5 60.36 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.737 1.153 . . . . 0.0 111.428 171.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -131.13 -6.04 3.88 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.777 0.831 . . . . 0.0 113.139 -169.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.18 -179.21 42.79 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 123.603 0.62 . . . . 0.0 113.504 173.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.17 135.62 40.99 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.067 2.512 . . . . 0.0 110.633 176.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.74 169.36 18.43 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 169.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -77.98 81.93 4.36 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 168.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -57.45 -14.94 5.57 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -175.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.58 -39.91 89.79 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.019 1.328 . . . . 0.0 111.47 170.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 63.0 mt -64.5 -47.18 90.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 176.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.9 -50.12 74.42 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.142 0.977 . . . . 0.0 110.526 -176.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 10.1 p -64.56 -47.48 78.58 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 119.243 0.929 . . . . 0.0 111.276 -176.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -60.21 -40.3 89.63 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.397 0.999 . . . . 0.0 110.475 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 49.2 mttm -65.45 -49.08 70.46 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 119.187 -0.435 . . . . 0.0 111.356 176.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 62.9 mt -64.54 -40.14 88.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-N 119.067 0.849 . . . . 0.0 109.16 -176.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 93.9 mttt . . . . . 0 N--CA 1.468 0.473 0 CA-C-N 119.605 1.093 . . . . 0.0 109.633 174.922 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.4 t . . . . . 0 N--CA 1.453 -0.302 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.3 p -134.55 173.67 11.39 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 169.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 37.6 p-90 . . . . . 0 N--CA 1.452 -0.373 0 CA-C-O 121.242 0.544 . . . . 0.0 109.905 174.556 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.572 0 CA-C-O 120.888 0.375 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -155.04 153.22 30.61 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.226 1.011 . . . . 0.0 108.399 177.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.0 mt -54.36 -32.83 57.82 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.771 0.828 . . . . 0.0 112.401 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.79 -23.61 67.43 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.76 0.709 . . . . 0.0 112.527 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 76.0 mt -74.83 -26.72 59.91 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 118.512 0.596 . . . . 0.0 110.944 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.2 mt -72.42 133.03 83.33 Favored Pre-proline 0 C--O 1.239 0.503 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 -177.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.23 135.0 48.21 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 121.067 1.178 . . . . 0.0 109.229 169.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -72.61 -33.48 66.7 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.325 0.583 . . . . 0.0 111.404 -175.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 51.0 t -135.25 138.89 47.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 105.221 -2.14 . . . . 0.0 105.221 172.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -149.92 129.4 13.03 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 169.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.5 pt . . . . . 0 CA--C 1.537 0.451 0 C-N-CA 126.676 1.99 . . . . 0.0 106.305 -179.801 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 23.5 p90 . . . . . 0 N--CA 1.467 0.389 0 CA-C-O 120.805 0.336 . . . . 0.0 110.594 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -79.53 158.11 27.26 Favored 'General case' 0 C--O 1.233 0.231 0 O-C-N 121.697 -0.627 . . . . 0.0 109.653 176.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.3 163.35 35.79 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.365 1.066 . . . . 0.0 108.805 176.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.2 m -136.65 157.0 36.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 124.655 1.182 . . . . 0.0 110.127 172.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.34 119.59 39.94 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 104.732 -2.322 . . . . 0.0 104.732 177.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 57.2 mt -121.29 114.51 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 CA-C-N 119.488 1.04 . . . . 0.0 108.48 -172.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 24.0 ttm-85 -71.54 138.12 48.61 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 104.967 -2.235 . . . . 0.0 104.967 168.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.4 p -136.31 116.49 17.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 178.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -81.7 142.83 32.33 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 169.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.1 t -67.72 117.01 9.06 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 169.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.444 ' N ' ' HD3' ' A' ' 31' ' ' PRO . . . -143.57 43.11 0.42 Allowed Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 123.781 0.833 . . . . 0.0 108.921 168.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.444 ' HD3' ' N ' ' A' ' 30' ' ' ALA . 31.9 Cg_exo . . . . . 0 C--N 1.351 0.679 0 C-N-CA 122.063 1.842 . . . . 0.0 111.731 -169.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 . . . . . 0 CA--C 1.536 0.44 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.0 m -141.86 157.49 44.93 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.941 0.896 . . . . 0.0 110.435 173.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -148.98 165.28 32.1 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 127.767 2.427 . . . . 0.0 106.651 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -125.93 126.89 45.12 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.341 -1.725 . . . . 0.0 106.341 170.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 30.4 pt -110.01 155.51 11.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 125.044 1.338 . . . . 0.0 110.267 175.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 24.5 t -120.43 125.89 74.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 -175.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.4 mmp_? -129.65 146.59 51.43 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.965 1.306 . . . . 0.0 107.739 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -172.98 133.99 2.81 Favored Glycine 0 N--CA 1.453 -0.208 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 169.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.405 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 10.7 m-85 -152.21 159.72 43.51 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -177.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -78.73 -26.13 44.7 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 121.793 -0.567 . . . . 0.0 109.894 -176.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.405 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 12.9 p-90 -61.33 -31.99 71.87 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 119.183 -0.437 . . . . 0.0 111.671 174.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -86.79 71.66 10.29 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 118.735 0.698 . . . . 0.0 109.524 173.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -63.42 -15.39 57.48 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 122.893 0.477 . . . . 0.0 111.775 177.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.41 144.24 51.09 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 126.548 1.939 . . . . 0.0 107.891 177.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 43.6 m80 -68.45 -34.6 76.25 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 119.148 -0.453 . . . . 0.0 112.134 -169.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.08 -28.89 55.85 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 118.311 -0.852 . . . . 0.0 112.645 174.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -68.29 -48.58 64.59 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 119.633 1.106 . . . . 0.0 111.323 -174.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.418 HG12 ' H ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -65.92 -41.28 89.61 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 CA-C-O 118.438 -0.791 . . . . 0.0 109.772 176.152 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -61.72 -53.34 57.42 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 118.317 -0.849 . . . . 0.0 109.722 -178.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -60.1 -42.85 95.56 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.16 0.891 . . . . 0.0 111.841 -176.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 31.6 tttt -60.52 -51.14 70.72 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 123.226 0.61 . . . . 0.0 110.796 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 63.9 t -84.74 -36.98 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-O 117.949 -1.024 . . . . 0.0 111.28 -169.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 71.7 p -64.43 -31.89 73.29 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 120.871 1.669 . . . . 0.0 109.684 171.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.66 -50.03 72.11 Favored Glycine 0 C--N 1.337 0.638 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 171.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -62.07 -43.34 99.04 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 118.68 1.24 . . . . 0.0 111.726 178.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 34.6 mmt -60.05 -46.08 90.71 Favored 'General case' 0 C--O 1.225 -0.191 0 N-CA-C 109.776 -0.454 . . . . 0.0 109.776 178.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -68.47 -27.91 66.57 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.606 0.762 . . . . 0.0 112.127 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -68.34 -37.22 80.32 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.34 0.973 . . . . 0.0 109.953 169.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -69.42 -25.37 64.09 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 119.631 1.105 . . . . 0.0 110.494 169.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 120.17 -26.35 7.1 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 127.996 2.713 . . . . 0.0 111.543 177.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 89.7 m -56.06 153.26 9.22 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 126.377 1.871 . . . . 0.0 111.51 -177.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -120.07 140.02 51.66 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -169.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 77.2 m -131.54 165.83 22.74 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 -167.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -153.13 122.48 6.67 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.72 2.008 . . . . 0.0 106.486 172.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.8 p -71.47 120.69 17.41 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 169.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 42.1 mt -68.53 -27.23 65.92 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.996 -0.44 . . . . 0.0 110.109 175.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 171.05 -171.38 43.87 Favored Glycine 0 C--N 1.337 0.592 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 175.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -138.09 164.37 25.56 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 176.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -168.54 -162.16 20.06 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -176.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 57.4 ttt180 -138.78 144.71 39.51 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 121.034 -1.274 . . . . 0.0 107.582 -172.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 99.6 mt . . . . . 0 N--CA 1.448 -0.535 0 N-CA-C 104.309 -2.478 . . . . 0.0 104.309 172.937 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 40.9 t60 . . . . . 0 N--CA 1.452 -0.361 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.9 t -125.08 129.56 73.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 -171.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -161.58 -169.1 2.16 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.673 1.189 . . . . 0.0 107.836 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 103.06 176.11 26.58 Favored Glycine 0 CA--C 1.522 0.53 0 CA-C-N 119.423 1.01 . . . . 0.0 112.113 169.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -151.85 143.85 23.82 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 122.953 0.501 . . . . 0.0 109.965 169.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.8 t -72.79 165.58 24.57 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 168.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 27.7 ptm -103.53 -30.5 10.48 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 118.558 -0.735 . . . . 0.0 110.486 169.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.42 -24.19 53.98 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.403 1.001 . . . . 0.0 111.874 174.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -134.76 -6.98 2.44 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -169.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.24 -173.5 54.91 Favored Glycine 0 CA--C 1.537 1.436 0 CA-C-N 119.325 0.966 . . . . 0.0 113.712 174.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -67.33 156.33 66.66 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.425 2.75 . . . . 0.0 111.116 176.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -104.88 166.16 10.57 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.68 1.192 . . . . 0.0 109.774 171.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -78.99 85.72 4.91 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 169.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -58.43 -16.47 15.06 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -178.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.82 -42.04 78.87 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.595 1.158 . . . . 0.0 111.473 170.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 59.1 mt -65.58 -46.95 88.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.98 -50.51 73.13 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.795 0.838 . . . . 0.0 110.802 -177.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.6 p -66.54 -44.26 82.88 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.891 -174.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -58.09 -43.63 87.18 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.754 1.161 . . . . 0.0 110.34 178.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -69.58 -44.58 70.51 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-O 118.976 -0.535 . . . . 0.0 111.407 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 62.9 mt -66.64 -38.35 81.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 119.674 1.124 . . . . 0.0 109.095 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 94.2 mttt . . . . . 0 N--CA 1.468 0.465 0 CA-C-N 119.805 1.184 . . . . 0.0 109.646 173.244 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 C--O 1.234 0.25 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 17.6 p -137.19 171.35 14.62 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.69 0.796 . . . . 0.0 109.534 177.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 24.8 p-90 . . . . . 0 C--O 1.235 0.328 0 O-C-N 121.558 -0.713 . . . . 0.0 111.919 178.194 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.5 0 CA-C-O 121.653 0.74 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -150.37 150.17 31.06 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 169.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 68.5 mt -56.83 -32.35 65.66 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -174.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.58 -25.87 66.0 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.039 0.836 . . . . 0.0 112.222 178.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.3 mt -85.24 -23.84 28.06 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 123.786 0.834 . . . . 0.0 111.389 -176.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 61.7 mt -64.64 129.05 94.11 Favored Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 -178.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -44.34 117.11 1.24 Allowed 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 124.494 3.463 . . . . 0.0 111.81 172.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -76.85 -34.93 57.81 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.17 0.51 . . . . 0.0 111.31 -169.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.9 t -137.83 135.78 45.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 174.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -154.16 107.99 2.97 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 169.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 15.6 pt . . . . . 0 CA--C 1.537 0.462 0 C-N-CA 124.46 1.104 . . . . 0.0 108.419 -172.756 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 23.7 p90 . . . . . 0 N--CA 1.465 0.31 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -79.76 151.73 30.2 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 169.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -142.14 158.84 43.29 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.619 1.168 . . . . 0.0 108.466 -178.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.9 m -128.37 154.11 38.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 124.662 1.185 . . . . 0.0 109.984 173.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -110.53 114.46 27.88 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 104.546 -2.39 . . . . 0.0 104.546 178.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.2 mt -117.98 121.76 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -172.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -73.47 147.99 43.61 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 169.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.4 t -132.49 146.82 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 178.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -124.95 154.27 41.43 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.604 1.161 . . . . 0.0 108.568 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.514 ' HG ' ' N ' ' A' ' 39' ' ' GLU . 30.3 m -64.26 88.36 0.05 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.034 0.934 . . . . 0.0 111.798 177.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -136.66 35.39 0.26 Allowed Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 125.295 1.438 . . . . 0.0 112.422 169.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo . . . . . 0 C--N 1.359 1.087 0 CA-C-N 123.009 2.11 . . . . 0.0 111.981 170.26 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.514 ' N ' ' HG ' ' A' ' 29' ' ' SER . 46.0 mm-40 . . . . . 0 CA--C 1.539 0.541 0 CA-C-O 121.367 0.604 . . . . 0.0 109.56 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.3 m -140.57 159.26 42.6 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.653 1.181 . . . . 0.0 109.051 172.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -149.87 171.28 17.03 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 127.565 2.346 . . . . 0.0 106.185 -173.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.9 mp0 -134.77 152.58 51.87 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 174.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 38.4 pt -130.08 155.06 41.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 125.474 1.51 . . . . 0.0 109.37 176.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 45.4 t -118.42 120.14 63.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.2 mmp_? -128.66 145.01 51.28 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.312 1.445 . . . . 0.0 107.622 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.93 132.92 1.72 Allowed Glycine 0 C--N 1.331 0.282 0 CA-C-N 119.632 1.105 . . . . 0.0 111.142 174.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -154.46 157.87 39.09 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -172.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.3 mttp -58.78 -34.85 71.92 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 119.186 -0.435 . . . . 0.0 111.852 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 15.6 p-90 -65.4 -30.75 71.6 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 118.964 -0.541 . . . . 0.0 112.326 -177.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.53 74.57 10.38 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 119.161 0.891 . . . . 0.0 109.465 175.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.93 -17.36 63.16 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.221 0.608 . . . . 0.0 111.572 175.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.81 144.25 51.09 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 126.147 1.779 . . . . 0.0 108.025 178.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -67.95 -34.93 77.52 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 119.27 -0.395 . . . . 0.0 111.862 -169.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.77 -29.1 53.16 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 118.411 -0.804 . . . . 0.0 112.664 174.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -66.55 -49.88 65.0 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 119.437 1.017 . . . . 0.0 111.394 -172.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.45 HG12 ' H ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -66.08 -41.4 89.48 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 CA-C-O 118.987 -0.53 . . . . 0.0 110.271 176.293 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -62.3 -49.05 77.19 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 119.26 -0.4 . . . . 0.0 110.217 -177.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -63.94 -45.3 89.8 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 118.608 0.64 . . . . 0.0 111.149 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 28.7 tttt -57.36 -54.36 47.73 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.523 0.729 . . . . 0.0 110.826 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 91.7 t -80.91 -40.8 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-O 117.799 -1.096 . . . . 0.0 110.827 -169.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 58.2 m -62.94 -25.8 68.51 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 120.77 1.623 . . . . 0.0 110.911 173.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.06 -55.43 29.62 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 169.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -61.26 -39.03 88.84 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 118.645 1.222 . . . . 0.0 112.689 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 38.7 mmt -57.26 -47.38 81.56 Favored 'General case' 0 N--CA 1.461 0.077 0 CA-C-N 118.624 0.647 . . . . 0.0 109.515 174.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -67.79 -28.77 67.88 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.15 0.58 . . . . 0.0 112.542 178.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.9 mttm -63.24 -44.34 95.49 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.56 1.073 . . . . 0.0 109.445 169.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -65.93 -25.87 67.33 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 119.183 0.901 . . . . 0.0 110.89 171.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 122.82 -26.25 6.25 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 127.432 2.444 . . . . 0.0 111.64 175.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 97.2 m -53.9 148.46 10.41 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.649 1.98 . . . . 0.0 112.252 -173.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -108.79 138.78 44.56 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -177.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 91.7 m -141.74 162.16 36.16 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 -168.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -153.01 131.58 12.24 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.595 1.558 . . . . 0.0 107.872 171.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.0 p -69.74 118.5 12.68 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 169.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 43.7 mt -68.49 -25.4 64.95 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.882 -0.511 . . . . 0.0 109.903 172.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.38 -164.29 37.51 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 108.317 -1.913 . . . . 0.0 108.317 173.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -150.88 -179.32 26.53 Favored Glycine 0 N--CA 1.451 -0.303 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 171.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -169.83 -157.19 11.81 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 -175.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -143.45 147.24 34.27 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 -173.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 12.2 mt . . . . . 0 C--N 1.33 -0.27 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 -172.555 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 20.7 t60 . . . . . 0 N--CA 1.451 -0.41 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.6 t -135.01 131.37 52.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 -178.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -160.19 -164.37 1.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 O-C-N 121.486 -0.759 . . . . 0.0 109.388 -177.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.04 -172.23 55.11 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 118.812 0.733 . . . . 0.0 112.457 173.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -162.45 150.07 13.96 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.989 0.915 . . . . 0.0 110.151 -174.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.0 t -78.74 165.59 23.43 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 167.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 21.8 ptp -108.45 -28.99 9.04 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 118.52 -0.752 . . . . 0.0 111.025 171.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.2 -25.16 57.99 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 119.49 1.041 . . . . 0.0 111.602 171.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -133.78 -5.95 2.82 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -169.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.77 -178.07 51.11 Favored Glycine 0 CA--C 1.535 1.335 0 CA-C-N 119.025 0.83 . . . . 0.0 113.575 173.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -68.13 142.31 55.52 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.806 2.337 . . . . 0.0 110.815 174.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.51 177.31 5.4 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 169.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 21.4 mm100 -62.91 -28.59 70.16 Favored 'General case' 0 CA--C 1.535 0.404 0 O-C-N 121.85 -0.532 . . . . 0.0 111.66 172.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . 0.263 38.3 m80 59.45 -27.64 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 128.556 2.742 . . . . 0.0 116.481 -174.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.26 -42.41 99.15 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 119.547 1.067 . . . . 0.0 110.251 173.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 62.2 mt -61.06 -47.26 94.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 176.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.4 -52.35 64.95 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.399 1.079 . . . . 0.0 110.599 -173.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 33.0 p -64.63 -48.47 74.74 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 118.781 -0.628 . . . . 0.0 109.636 -176.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -60.58 -40.24 91.01 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.958 0.799 . . . . 0.0 111.096 -177.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 48.9 mttm -64.78 -46.94 79.97 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 118.877 0.762 . . . . 0.0 111.19 176.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 63.2 mt -62.14 -44.39 98.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt . . . . . 0 N--CA 1.466 0.366 0 CA-C-N 118.782 0.719 . . . . 0.0 110.336 179.552 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.3 t . . . . . 0 N--CA 1.451 -0.408 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.0 p -135.71 170.97 15.13 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.55 1.14 . . . . 0.0 109.283 176.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 34.9 p-90 . . . . . 0 C--O 1.234 0.266 0 O-C-N 121.817 -0.552 . . . . 0.0 111.034 172.015 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.514 0 CA-C-O 121.619 0.723 . . . . 0.0 111.55 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -153.36 149.6 28.0 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 126.488 1.915 . . . . 0.0 106.309 169.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 68.9 mt -54.79 -34.61 62.9 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 123.395 0.678 . . . . 0.0 112.539 -175.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.29 -25.05 65.85 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.861 0.755 . . . . 0.0 112.42 -178.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.8 mt -78.72 -25.05 44.58 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.023 0.529 . . . . 0.0 111.195 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 21.1 mt -70.87 129.39 89.71 Favored Pre-proline 0 CA--C 1.538 0.504 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -176.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -52.87 128.14 27.54 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.703 2.269 . . . . 0.0 110.644 169.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -80.47 -23.71 40.0 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 121.909 -0.495 . . . . 0.0 111.854 176.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.1 t -136.22 131.55 48.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 173.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -163.38 116.04 1.51 Allowed 'General case' 0 C--O 1.233 0.205 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 169.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.536 0.44 0 C-N-CA 124.379 1.072 . . . . 0.0 109.127 -173.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 . . . . . 0 C--O 1.238 0.469 0 CA-C-O 121.33 0.586 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -71.17 157.1 38.74 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 124.082 0.953 . . . . 0.0 112.073 -171.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -145.31 164.74 30.5 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.066 1.747 . . . . 0.0 107.657 170.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.5 m -131.21 150.92 34.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 C-N-CA 124.28 1.032 . . . . 0.0 109.199 171.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.73 118.67 36.74 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 104.234 -2.506 . . . . 0.0 104.234 173.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 53.6 mt -120.31 124.84 73.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 -177.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -81.18 148.7 29.42 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 169.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.5 t -133.02 147.09 31.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 -175.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -132.49 147.33 52.36 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.815 1.246 . . . . 0.0 107.96 -178.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.539 ' HG ' ' N ' ' A' ' 39' ' ' GLU . 19.8 m -62.25 103.18 0.36 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.524 0.73 . . . . 0.0 111.117 -178.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.515 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -144.45 19.18 0.04 OUTLIER Pre-proline 0 CA--C 1.555 1.146 0 CA-C-O 116.265 -1.826 . . . . 0.0 113.654 169.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.515 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 87.2 Cg_exo . . . . . 0 C--N 1.365 1.428 0 CA-C-N 123.538 2.299 . . . . 0.0 114.349 178.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.539 ' N ' ' HG ' ' A' ' 29' ' ' SER . 42.6 mt-10 . . . . . 0 CA--C 1.54 0.567 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.3 m -141.52 159.24 42.63 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.616 1.166 . . . . 0.0 109.547 175.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -153.41 166.33 33.01 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 127.107 2.163 . . . . 0.0 106.727 -173.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -127.61 154.28 45.42 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 119.577 1.08 . . . . 0.0 108.968 177.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.6 pt -134.73 153.05 34.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 C-N-CA 125.185 1.394 . . . . 0.0 109.37 175.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 43.2 t -118.98 114.22 44.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.4 mmp_? -126.63 147.11 49.95 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 175.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -176.97 141.29 5.32 Favored Glycine 0 C--N 1.331 0.253 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 175.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -152.9 153.83 33.82 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -172.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -59.51 -28.8 67.38 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 8.0 p-90 -70.91 -24.56 62.49 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.115 0.871 . . . . 0.0 112.596 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.42 75.74 9.97 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.586 1.085 . . . . 0.0 110.587 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -63.81 -14.49 53.34 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.288 0.635 . . . . 0.0 112.142 173.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -131.04 136.98 48.96 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.723 1.609 . . . . 0.0 107.317 177.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 34.6 m80 -60.72 -32.5 71.75 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 123.102 0.561 . . . . 0.0 110.594 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.69 -27.85 52.42 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 118.326 -0.845 . . . . 0.0 112.986 172.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -68.43 -49.78 57.5 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 119.619 1.1 . . . . 0.0 110.395 -176.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.42 HG12 ' H ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -67.36 -40.38 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-O 117.63 -1.176 . . . . 0.0 109.839 175.636 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -59.88 -47.8 84.28 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 120.301 1.41 . . . . 0.0 110.628 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -64.67 -47.62 77.78 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.569 0.622 . . . . 0.0 111.576 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 46.8 tttt -62.81 -50.75 69.74 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.11 0.564 . . . . 0.0 111.151 -178.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 93.2 t -71.96 -48.41 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-O 118.255 -0.879 . . . . 0.0 108.808 -172.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.9 m -64.21 -26.76 68.65 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 120.098 1.317 . . . . 0.0 111.251 177.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.91 -51.19 57.4 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 170.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -61.01 -43.03 99.48 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 118.495 1.147 . . . . 0.0 111.667 177.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.3 mmt -59.72 -47.18 86.66 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 118.974 -0.536 . . . . 0.0 109.859 177.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -69.82 -27.54 64.96 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.959 0.8 . . . . 0.0 112.096 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -67.28 -38.29 84.83 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.309 0.959 . . . . 0.0 109.988 169.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -69.02 -26.7 65.13 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 119.655 1.116 . . . . 0.0 110.293 169.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 119.7 -22.73 8.61 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 128.059 2.742 . . . . 0.0 112.219 175.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 92.9 m -52.64 147.98 7.83 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 126.067 1.747 . . . . 0.0 111.791 -178.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -108.11 140.18 41.69 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 66.7 m -140.71 163.04 33.96 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -168.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -151.78 128.23 10.68 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.515 1.526 . . . . 0.0 107.489 175.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.8 p -70.9 121.46 18.14 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 169.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 51.4 mt -70.17 -27.14 64.28 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.968 -0.457 . . . . 0.0 109.851 171.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.62 -170.34 41.09 Favored Glycine 0 C--N 1.337 0.63 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 173.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -131.98 165.05 23.6 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.399 -0.68 . . . . 0.0 111.399 176.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -166.05 -162.99 18.69 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 125.284 1.421 . . . . 0.0 109.666 177.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 33.8 ptt180 -138.22 159.72 41.31 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 121.067 -1.255 . . . . 0.0 109.2 176.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 84.6 mt . . . . . 0 N--CA 1.45 -0.464 0 N-CA-C 103.843 -2.651 . . . . 0.0 103.843 -174.459 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 20.0 t60 . . . . . 0 N--CA 1.451 -0.381 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.7 t -137.37 134.84 47.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -171.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -174.42 172.39 3.18 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.253 1.421 . . . . 0.0 107.858 -178.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 144.1 -169.89 26.1 Favored Glycine 0 C--N 1.334 0.441 0 CA-C-N 119.017 0.826 . . . . 0.0 112.249 169.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -160.46 114.11 2.12 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.582 1.553 . . . . 0.0 107.737 -176.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.3 t -72.62 142.65 48.35 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 168.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.0 ppp? -71.64 -39.91 70.07 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 171.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.79 -25.06 35.57 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 118.711 -0.662 . . . . 0.0 112.408 -172.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -134.58 0.47 3.01 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -169.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.94 -175.27 53.95 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-N 119.197 0.908 . . . . 0.0 112.881 176.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -76.16 138.57 20.47 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.975 2.45 . . . . 0.0 109.847 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.48 171.76 9.59 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.094 0.473 . . . . 0.0 110.625 169.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 58.2 mm-40 -64.25 -35.77 81.91 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 119.116 -0.469 . . . . 0.0 111.828 175.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 33.9 m80 59.96 -31.2 0.05 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 128.767 2.827 . . . . 0.0 115.479 -173.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.57 -37.96 85.76 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.132 1.373 . . . . 0.0 112.115 174.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 90.4 mt -63.41 -46.51 95.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 176.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.67 -47.37 84.72 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.193 0.997 . . . . 0.0 110.939 -177.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.513 HG22 HG12 ' A' ' 118' ' ' VAL . 5.9 p -64.23 -51.98 61.01 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 119.137 0.881 . . . . 0.0 110.694 -177.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -60.28 -39.82 88.26 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 118.726 0.694 . . . . 0.0 110.574 -175.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -64.59 -56.05 16.46 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-O 118.462 -0.78 . . . . 0.0 111.187 174.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 66.9 mt -63.36 -41.4 92.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.215 -172.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 94.0 mttt . . . . . 0 N--CA 1.472 0.652 0 CA-C-N 120.121 1.328 . . . . 0.0 110.194 175.517 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.513 HG12 HG22 ' A' ' 106' ' ' THR . 5.2 t . . . . . 0 CA--C 1.533 0.323 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 16.8 p -137.0 170.79 15.52 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.664 1.12 . . . . 0.0 109.926 176.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 38.5 p-90 . . . . . 0 C--O 1.235 0.334 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 172.434 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.386 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -146.97 147.96 31.24 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 169.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 71.5 mt -57.94 -30.02 65.62 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -173.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.22 -26.71 63.99 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.979 0.809 . . . . 0.0 111.981 177.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.2 mt -83.88 -25.52 30.17 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.772 0.829 . . . . 0.0 111.215 -177.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 51.9 mt -63.34 127.83 91.66 Favored Pre-proline 0 CA--C 1.538 0.506 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -45.9 122.8 5.48 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.968 3.112 . . . . 0.0 111.409 172.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -79.45 -36.24 39.18 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 121.209 0.528 . . . . 0.0 110.768 -172.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 77.9 t -136.69 129.97 45.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 N-CA-C 105.658 -1.978 . . . . 0.0 105.658 175.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -154.69 125.7 7.19 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 170.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.9 pt . . . . . 0 C--O 1.237 0.399 0 C-N-CA 124.835 1.254 . . . . 0.0 108.451 -173.841 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 9.4 p90 . . . . . 0 C--O 1.234 0.258 0 CA-C-O 120.484 0.183 . . . . 0.0 111.317 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -71.95 156.55 39.13 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 175.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.1 163.74 32.02 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 172.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.2 m -133.29 149.59 31.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 C-N-CA 124.385 1.074 . . . . 0.0 109.15 172.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.53 121.59 41.39 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 104.055 -2.572 . . . . 0.0 104.055 173.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 85.5 mt -122.57 126.47 74.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -177.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -82.14 148.31 28.57 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 169.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.5 t -137.26 147.02 27.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 126.857 2.063 . . . . 0.0 105.606 -173.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -128.11 152.0 48.53 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.684 1.194 . . . . 0.0 108.889 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.521 ' HG ' ' N ' ' A' ' 39' ' ' GLU . 45.8 m -62.86 93.26 0.06 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.31 1.044 . . . . 0.0 111.028 175.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.51 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -141.1 16.39 0.04 OUTLIER Pre-proline 0 CA--C 1.551 0.992 0 CA-C-O 116.245 -1.836 . . . . 0.0 114.115 169.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.51 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 76.8 Cg_exo . . . . . 0 C--N 1.363 1.298 0 CA-C-N 124.104 2.501 . . . . 0.0 114.226 175.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.521 ' N ' ' HG ' ' A' ' 29' ' ' SER . 42.8 mt-10 . . . . . 0 CA--C 1.539 0.53 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.9 m -142.17 157.19 45.16 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.711 1.205 . . . . 0.0 109.088 176.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -151.64 167.51 27.9 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 127.146 2.178 . . . . 0.0 106.427 -173.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 -131.88 154.12 49.53 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 175.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 35.8 pt -132.38 155.68 41.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 125.168 1.387 . . . . 0.0 109.852 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 98.6 t -118.16 115.11 47.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 177.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 12.1 mmp_? -125.78 141.93 51.76 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.239 1.416 . . . . 0.0 107.518 176.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -177.9 137.32 3.33 Favored Glycine 0 C--N 1.333 0.363 0 CA-C-N 119.31 0.959 . . . . 0.0 111.113 174.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -153.19 153.3 32.47 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 117.097 0.449 . . . . 0.0 110.54 -169.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -57.26 -32.47 66.62 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.086 0.954 . . . . 0.0 112.274 177.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 13.0 p-90 -67.83 -27.64 66.88 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.853 0.752 . . . . 0.0 112.529 177.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.98 81.63 8.7 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 119.724 1.147 . . . . 0.0 109.438 174.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -64.11 -19.1 65.03 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.266 0.626 . . . . 0.0 112.017 174.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -135.22 152.56 51.67 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 126.327 1.851 . . . . 0.0 108.001 -179.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 44.8 m-70 -73.72 -32.85 64.08 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 121.84 -0.537 . . . . 0.0 109.575 -169.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.0 -28.9 55.64 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 118.481 -0.771 . . . . 0.0 112.597 172.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -66.73 -50.51 62.55 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 119.356 0.98 . . . . 0.0 110.637 -175.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.4 ' H ' HG12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -66.67 -40.21 85.61 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 CA-C-O 117.257 -1.354 . . . . 0.0 109.826 175.533 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -60.86 -47.83 84.6 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-N 120.214 1.37 . . . . 0.0 110.243 -178.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -61.73 -46.17 90.78 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.001 0.819 . . . . 0.0 111.886 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 34.4 tttt -61.21 -50.0 74.88 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 123.082 0.553 . . . . 0.0 110.671 178.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 86.6 t -77.54 -39.98 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-O 117.751 -1.119 . . . . 0.0 109.757 -170.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 80.8 p -63.08 -34.16 76.99 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 120.888 1.676 . . . . 0.0 109.617 175.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.65 -53.32 46.34 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 171.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -60.22 -46.26 90.36 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 118.547 1.174 . . . . 0.0 111.813 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 38.0 mmt -57.92 -48.96 78.36 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.366 0.666 . . . . 0.0 110.369 177.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -68.21 -28.48 67.28 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.66 0.664 . . . . 0.0 111.996 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -67.95 -38.0 82.28 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 119.243 0.928 . . . . 0.0 110.594 171.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -67.56 -29.86 69.34 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 119.67 1.123 . . . . 0.0 110.437 169.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 126.96 -21.87 5.79 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 127.458 2.456 . . . . 0.0 111.692 174.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 68.1 m -52.45 150.14 5.12 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 125.947 1.699 . . . . 0.0 112.438 -176.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -108.51 136.24 48.45 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 173.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 99.5 m -144.13 164.96 29.17 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -168.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -149.83 136.17 19.0 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.007 1.723 . . . . 0.0 107.847 171.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.3 p -73.22 125.0 26.75 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 169.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 44.4 mt -75.26 -23.29 57.44 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.812 -0.555 . . . . 0.0 110.398 173.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.01 -174.02 43.52 Favored Glycine 0 C--N 1.337 0.604 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 171.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -123.48 168.07 15.7 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 175.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -172.32 -165.25 29.13 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -173.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -149.38 150.49 32.51 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -169.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 58.7 mt . . . . . 0 C--O 1.235 0.341 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 -172.161 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 36.2 t60 . . . . . 0 N--CA 1.451 -0.416 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.2 t -131.83 136.62 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -178.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -161.0 -161.09 0.79 Allowed 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 125.145 1.378 . . . . 0.0 107.424 -172.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.73 -177.81 45.21 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-O 122.539 1.077 . . . . 0.0 113.451 169.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -164.07 150.64 11.45 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 126.032 1.733 . . . . 0.0 106.793 -169.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.3 t -116.96 145.9 43.35 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.66 1.584 . . . . 0.0 106.813 171.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.0 ptm -87.35 -34.46 18.81 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 118.79 -0.624 . . . . 0.0 110.193 174.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.81 -26.09 56.94 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.117 0.871 . . . . 0.0 111.949 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -131.13 -5.09 3.89 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -169.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.44 173.8 40.27 Favored Glycine 0 CA--C 1.533 1.197 0 CA-C-N 118.858 0.754 . . . . 0.0 112.312 178.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.23 134.37 24.76 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.71 2.273 . . . . 0.0 109.527 177.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.28 166.57 19.86 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.674 0.75 . . . . 0.0 112.433 176.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -77.64 74.87 4.19 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.897 1.279 . . . . 0.0 108.973 169.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -54.15 -22.33 10.93 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -176.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.81 -40.64 89.07 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.955 0.902 . . . . 0.0 111.761 173.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 65.0 mt -63.28 -46.36 95.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.55 -50.86 72.25 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.451 1.1 . . . . 0.0 110.129 -176.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 20.9 p -65.39 -42.61 92.47 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 118.049 -0.977 . . . . 0.0 111.378 -174.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -61.35 -40.86 95.82 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.821 1.191 . . . . 0.0 110.742 178.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 43.4 mttm -66.51 -46.28 76.77 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 121.793 -0.567 . . . . 0.0 111.277 176.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 67.2 mt -64.8 -40.71 89.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -177.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 89.7 mttt . . . . . 0 N--CA 1.47 0.528 0 CA-C-N 119.88 1.218 . . . . 0.0 109.862 174.898 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.451 -0.418 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 26.0 p -136.21 172.0 13.65 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.075 0.95 . . . . 0.0 108.912 173.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 45.7 p-90 . . . . . 0 C--O 1.234 0.282 0 CA-C-O 121.076 0.465 . . . . 0.0 110.752 172.593 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.517 0 CA-C-O 121.287 0.565 . . . . 0.0 110.743 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -151.87 152.14 32.2 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.544 1.538 . . . . 0.0 106.864 170.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.2 mt -57.03 -31.66 65.38 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.568 0.622 . . . . 0.0 112.553 -176.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.84 -24.7 65.3 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 118.825 0.739 . . . . 0.0 112.376 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.2 mt -85.31 -18.68 33.15 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.549 0.74 . . . . 0.0 111.499 -176.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 50.1 mt -65.01 131.84 95.32 Favored Pre-proline 0 CA--C 1.54 0.577 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -50.4 115.79 2.13 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 123.503 2.802 . . . . 0.0 110.104 169.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -70.73 -39.18 73.5 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -169.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 45.5 t -140.83 138.5 34.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 176.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -152.51 112.49 3.99 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 169.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 40.0 pt . . . . . 0 CA--C 1.54 0.578 0 C-N-CA 124.693 1.197 . . . . 0.0 109.88 -169.95 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 25.1 p90 . . . . . 0 C--O 1.237 0.423 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.4 mmtp -74.68 154.57 38.4 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.045 0.938 . . . . 0.0 109.174 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.99 161.58 39.78 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.75 0.82 . . . . 0.0 108.985 176.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.6 m -133.79 152.09 34.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 C-N-CA 124.897 1.279 . . . . 0.0 109.331 173.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 28.2 tp -108.83 116.12 31.38 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 105.226 -2.138 . . . . 0.0 105.226 177.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 86.0 mt -120.15 119.12 59.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -169.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.3 ttp180 -78.13 145.36 35.75 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 168.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.3 p -139.25 148.85 23.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -130.71 145.95 52.06 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.084 1.353 . . . . 0.0 108.29 -169.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.521 ' HG ' ' N ' ' A' ' 39' ' ' GLU . 23.0 m -61.38 108.23 0.9 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.644 0.778 . . . . 0.0 111.266 -178.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.411 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -150.35 22.25 0.03 OUTLIER Pre-proline 0 CA--C 1.552 1.03 0 C-N-CA 125.185 1.394 . . . . 0.0 112.441 168.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 30' ' ' ALA . 45.5 Cg_endo . . . . . 0 C--N 1.359 1.087 0 CA-C-N 122.669 1.989 . . . . 0.0 110.998 -171.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.521 ' N ' ' HG ' ' A' ' 29' ' ' SER . 45.6 mm-40 . . . . . 0 CA--C 1.537 0.475 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.4 m -140.71 157.85 44.83 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.393 1.077 . . . . 0.0 109.29 173.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -152.87 168.26 26.35 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 127.354 2.261 . . . . 0.0 106.23 -173.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -130.88 147.39 52.52 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.03 -1.044 . . . . 0.0 108.614 177.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 29.8 pt -130.75 156.0 42.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 125.881 1.672 . . . . 0.0 109.315 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.2 t -131.23 116.53 33.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 -169.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.5 mmt85 -137.22 148.9 46.82 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -176.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 177.69 137.43 2.75 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -154.85 154.09 32.18 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -170.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -59.71 -29.22 67.97 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.274 0.629 . . . . 0.0 112.651 178.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 11.2 p-90 -69.4 -28.21 65.96 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.014 0.825 . . . . 0.0 112.258 178.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.86 77.67 9.67 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 119.41 1.005 . . . . 0.0 109.022 175.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -63.13 -18.59 63.6 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 122.937 0.495 . . . . 0.0 111.303 173.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.65 146.3 51.44 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.64 1.576 . . . . 0.0 107.724 178.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -72.67 -30.22 64.08 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.131 0.572 . . . . 0.0 110.262 -169.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.41 -30.8 42.05 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 118.636 -0.697 . . . . 0.0 112.549 170.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -69.37 -47.61 63.75 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 119.34 0.973 . . . . 0.0 110.902 -175.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.446 ' H ' HG12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -67.73 -40.8 84.52 Favored 'Isoleucine or valine' 0 C--N 1.34 0.178 0 CA-C-O 117.891 -1.052 . . . . 0.0 110.117 175.635 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -61.21 -45.65 93.7 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.747 1.158 . . . . 0.0 110.288 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -62.53 -47.16 85.13 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.318 0.508 . . . . 0.0 111.583 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 26.1 tttp -63.62 -54.08 41.5 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 122.814 0.446 . . . . 0.0 110.995 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 97.3 t -71.07 -52.36 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -170.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 33.4 m -67.2 -27.96 67.69 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 119.206 0.912 . . . . 0.0 111.249 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.56 -46.92 93.3 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 170.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -63.23 -42.22 99.22 Favored 'General case' 0 CA--C 1.526 0.053 0 CA-C-N 118.568 1.184 . . . . 0.0 111.245 176.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.5 mmt -59.72 -45.1 93.18 Favored 'General case' 0 C--O 1.226 -0.18 0 CA-C-N 118.242 0.473 . . . . 0.0 110.14 176.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.7 mm-40 -66.72 -30.49 70.74 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.817 0.847 . . . . 0.0 111.912 178.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -68.61 -39.19 80.96 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.718 1.145 . . . . 0.0 110.301 170.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -65.4 -26.25 67.9 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.178 0.899 . . . . 0.0 110.431 169.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 119.09 -22.07 9.19 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 128.152 2.786 . . . . 0.0 111.82 175.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 91.3 m -58.69 150.58 23.04 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 126.452 1.901 . . . . 0.0 111.414 -176.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -108.78 146.03 34.24 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.481 1.113 . . . . 0.0 108.174 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 82.4 m -140.01 162.88 34.14 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -168.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -150.81 122.5 8.03 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 125.417 1.487 . . . . 0.0 107.66 173.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.5 p -69.88 120.0 14.95 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 169.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 45.1 mt -68.1 -25.64 65.41 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.987 -0.445 . . . . 0.0 109.893 172.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 165.55 -167.27 38.9 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 125.434 1.492 . . . . 0.0 109.432 170.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -132.76 170.89 21.88 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 123.977 0.799 . . . . 0.0 111.489 176.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -171.16 -161.31 21.59 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 125.471 1.51 . . . . 0.0 109.719 -177.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -142.29 165.95 26.04 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 121.372 -1.075 . . . . 0.0 108.909 174.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 60.1 mt . . . . . 0 CA--C 1.532 0.276 0 C-N-CA 123.12 0.568 . . . . 0.0 109.544 -169.61 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 24.3 t60 . . . . . 0 CA--C 1.521 -0.152 0 N-CA-C 109.506 -0.554 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.5 t -140.16 132.27 32.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -166.88 -173.69 2.47 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.18 0.992 . . . . 0.0 108.809 -172.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.92 -166.33 21.31 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-N 119.059 0.845 . . . . 0.0 112.263 171.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -155.64 178.22 10.5 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.424 1.09 . . . . 0.0 110.145 178.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.8 t -129.91 151.15 50.79 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 104.824 -2.288 . . . . 0.0 104.824 169.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.3 ptm -88.88 -34.05 17.11 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 118.787 -0.625 . . . . 0.0 110.281 175.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.34 -25.85 55.13 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.08 0.855 . . . . 0.0 111.981 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -130.84 -4.63 4.04 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -169.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.94 175.61 42.19 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-N 118.854 0.752 . . . . 0.0 112.353 177.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -66.7 138.43 49.18 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.428 2.085 . . . . 0.0 110.035 173.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.31 169.31 7.44 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.033 0.533 . . . . 0.0 110.953 171.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 21.2 mm100 -63.25 -30.26 71.43 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 118.975 -0.536 . . . . 0.0 111.428 170.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 40.2 m80 60.8 -31.56 0.07 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 129.017 2.927 . . . . 0.0 115.496 -175.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.09 -41.94 93.57 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.202 1.401 . . . . 0.0 112.318 178.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.8 mt -62.38 -49.15 85.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 177.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.4 m -54.68 -45.16 73.89 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.54 1.136 . . . . 0.0 112.172 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.527 HG22 HG12 ' A' ' 118' ' ' VAL . 1.0 OUTLIER -61.3 -50.0 74.76 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 119.747 1.158 . . . . 0.0 110.315 178.442 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -61.26 -41.42 96.89 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.972 0.805 . . . . 0.0 110.889 -177.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 24.5 mmtp -68.23 -43.82 77.09 Favored 'General case' 0 C--N 1.338 0.086 0 CA-C-O 118.699 -0.667 . . . . 0.0 111.629 178.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 79.9 mt -67.23 -38.15 80.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 119.958 1.254 . . . . 0.0 109.01 -178.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 91.8 mttt . . . . . 0 N--CA 1.469 0.485 0 CA-C-N 119.64 1.109 . . . . 0.0 109.49 173.548 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.527 HG12 HG22 ' A' ' 106' ' ' THR . 2.6 t . . . . . 0 N--CA 1.452 -0.34 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 16.9 p -135.06 171.09 14.92 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.137 0.975 . . . . 0.0 109.241 173.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 35.6 p-90 . . . . . 0 C--O 1.235 0.298 0 O-C-N 121.597 -0.69 . . . . 0.0 109.436 172.865 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.535 0 CA-C-O 121.263 0.554 . . . . 0.0 110.43 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -149.21 147.64 28.65 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 169.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 95.1 mt -55.51 -34.21 64.44 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.537 0.735 . . . . 0.0 112.407 -175.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.05 -25.54 66.31 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.834 0.743 . . . . 0.0 112.249 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.6 mt -79.25 -24.01 43.28 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.178 0.591 . . . . 0.0 111.183 -178.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 39.5 mt -68.31 128.78 93.1 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -176.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -47.42 123.05 7.41 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.939 3.093 . . . . 0.0 111.925 172.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -71.87 -37.52 70.19 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.499 0.72 . . . . 0.0 111.294 -177.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 63.9 t -137.52 134.32 46.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 176.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -152.66 119.96 5.92 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 171.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.5 pt . . . . . 0 CA--C 1.534 0.347 0 C-N-CA 124.28 1.032 . . . . 0.0 109.299 -169.937 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 23.2 p90 . . . . . 0 C--O 1.237 0.421 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -75.66 156.3 34.94 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.491 0.717 . . . . 0.0 110.003 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.44 163.34 35.97 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.004 1.322 . . . . 0.0 107.869 -178.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.3 m -135.95 156.04 36.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 C-N-CA 124.304 1.041 . . . . 0.0 109.7 172.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.81 122.23 45.97 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 104.225 -2.509 . . . . 0.0 104.225 173.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 73.9 mt -121.53 122.5 67.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 -176.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 37.6 ttp180 -80.74 146.82 30.84 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 169.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.6 t -132.13 143.77 39.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 -175.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -128.96 138.36 51.93 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 176.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.5 p -67.31 115.87 7.44 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.777 0.799 . . . . 0.0 110.641 -175.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.405 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -148.43 27.49 0.05 OUTLIER Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 125.833 1.653 . . . . 0.0 111.609 169.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.405 ' CD ' ' N ' ' A' ' 30' ' ' ALA . 35.2 Cg_endo . . . . . 0 C--N 1.358 1.064 0 CA-C-N 122.569 1.953 . . . . 0.0 111.985 -173.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 . . . . . 0 C--O 1.238 0.466 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.2 m -140.89 157.86 44.77 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.299 0.64 . . . . 0.0 110.589 -175.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -152.22 167.5 28.38 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 127.586 2.355 . . . . 0.0 106.008 -175.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.9 mp0 -133.21 156.49 47.42 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 120.713 -1.242 . . . . 0.0 108.443 176.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 32.2 pt -136.31 155.35 34.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 125.255 1.422 . . . . 0.0 109.807 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 48.1 t -118.14 122.36 69.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 -179.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.1 mmp_? -129.29 146.18 51.23 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.083 1.353 . . . . 0.0 107.832 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 177.32 131.36 1.5 Allowed Glycine 0 C--N 1.331 0.283 0 CA-C-N 119.173 0.897 . . . . 0.0 111.045 173.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -153.95 152.3 30.42 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -173.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.9 pttm -58.89 -29.4 66.99 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 11.1 p-90 -65.4 -27.52 68.6 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.231 0.923 . . . . 0.0 111.854 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.56 75.67 10.01 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 118.871 0.76 . . . . 0.0 109.052 172.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -67.22 -6.59 18.75 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.685 0.794 . . . . 0.0 111.574 175.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -137.28 146.14 44.34 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 126.63 1.972 . . . . 0.0 107.224 173.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 61.1 m-70 -68.97 -34.29 75.08 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -171.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.97 -26.49 48.47 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 118.355 -0.831 . . . . 0.0 112.766 174.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -69.11 -48.06 63.53 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 119.749 1.159 . . . . 0.0 111.111 -175.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.416 ' H ' HG12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -66.08 -38.02 81.09 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.024 176.284 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -62.23 -50.32 72.2 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.612 177.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -60.99 -44.12 97.85 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.798 1.181 . . . . 0.0 112.02 -178.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.6 tppt? -57.08 -54.64 44.45 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.169 0.988 . . . . 0.0 110.527 177.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.2 t -85.26 -34.41 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-O 117.619 -1.182 . . . . 0.0 111.974 -168.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 57.2 p -63.26 -33.18 74.94 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 121.345 1.884 . . . . 0.0 109.485 170.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.74 -52.85 50.5 Favored Glycine 0 C--N 1.338 0.64 0 N-CA-C 110.354 -1.099 . . . . 0.0 110.354 171.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.403 ' HA ' ' HE3' ' A' ' 66' ' ' LYS . 19.8 t70 -59.86 -44.6 94.04 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.717 1.258 . . . . 0.0 111.993 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 35.4 mmt -60.35 -47.98 83.72 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 123.238 0.615 . . . . 0.0 109.903 178.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -68.57 -28.62 67.11 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 118.501 0.591 . . . . 0.0 111.827 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.403 ' HE3' ' HA ' ' A' ' 63' ' ' ASP . 53.1 mtmt -67.3 -37.7 83.8 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 118.119 -0.943 . . . . 0.0 110.393 170.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -68.82 -30.04 68.51 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.871 1.214 . . . . 0.0 110.31 169.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 126.2 -22.36 5.98 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 127.625 2.536 . . . . 0.0 111.872 175.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 82.5 m -55.52 152.09 9.49 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 126.188 1.795 . . . . 0.0 112.339 -177.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -110.68 140.86 44.66 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 96.8 m -143.32 165.03 28.61 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -168.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -151.43 127.24 10.27 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.545 1.538 . . . . 0.0 107.542 175.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.2 p -70.56 120.15 15.77 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 169.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 58.3 mt -71.29 -22.96 61.88 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.932 -0.48 . . . . 0.0 110.424 174.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 165.96 -169.27 40.16 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 172.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -135.76 174.96 21.09 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 174.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -178.53 -168.16 37.4 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 -176.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -137.84 163.05 32.38 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 119.029 1.414 . . . . 0.0 109.73 173.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 75.0 mt . . . . . 0 C--N 1.33 -0.264 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 -169.698 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 28.1 t60 . . . . . 0 N--CA 1.46 0.068 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.4 t -141.01 135.65 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -166.26 -174.28 2.86 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.623 0.769 . . . . 0.0 109.664 -172.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.35 -170.48 39.05 Favored Glycine 0 CA--C 1.523 0.581 0 O-C-N 121.77 -0.581 . . . . 0.0 112.101 171.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -159.95 152.88 21.59 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.061 0.944 . . . . 0.0 109.845 -178.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.7 t -82.79 154.77 24.56 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 168.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.8 ppp? -82.29 -39.24 23.2 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 171.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.6 -25.59 45.22 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 119.152 -0.451 . . . . 0.0 111.971 -175.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -132.0 -2.32 3.64 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -169.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.88 -174.79 51.0 Favored Glycine 0 CA--C 1.534 1.281 0 CA-C-N 118.903 0.774 . . . . 0.0 113.101 174.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.98 138.34 43.82 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.963 2.442 . . . . 0.0 110.091 173.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.75 170.93 15.24 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.614 0.721 . . . . 0.0 111.488 170.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -78.86 76.02 5.36 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 169.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -57.62 -18.63 21.16 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -174.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.15 -35.77 76.05 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.194 0.998 . . . . 0.0 112.35 171.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 69.4 mt -65.81 -45.53 91.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 176.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.3 m -58.68 -46.85 86.33 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.998 0.919 . . . . 0.0 111.52 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 21.0 p -60.56 -53.26 59.63 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 119.184 0.902 . . . . 0.0 109.325 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -61.81 -40.96 97.07 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.795 0.725 . . . . 0.0 111.437 -175.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -66.53 -48.13 70.69 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 118.708 0.685 . . . . 0.0 111.481 178.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 73.4 mt -66.36 -37.45 79.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 119.229 0.922 . . . . 0.0 109.003 -178.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 46.7 mtpt . . . . . 0 N--CA 1.469 0.518 0 CA-C-N 119.615 1.098 . . . . 0.0 110.118 175.103 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.4 t . . . . . 0 N--CA 1.45 -0.447 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.3 p -132.51 172.0 13.05 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.084 0.953 . . . . 0.0 109.498 176.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 33.5 p-90 . . . . . 0 C--O 1.235 0.299 0 O-C-N 121.603 -0.686 . . . . 0.0 109.967 173.024 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.576 0 CA-C-O 121.339 0.59 . . . . 0.0 110.816 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -152.73 153.98 34.32 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.85 1.66 . . . . 0.0 106.635 170.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.4 mt -53.28 -36.58 61.33 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.038 0.835 . . . . 0.0 112.0 -179.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.02 -25.66 68.22 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.875 0.761 . . . . 0.0 112.506 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.1 mt -83.66 -20.27 33.89 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.38 0.672 . . . . 0.0 111.44 -178.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 32.0 mt -67.38 131.61 93.25 Favored Pre-proline 0 CA--C 1.539 0.52 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -49.76 119.54 4.88 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 123.066 2.511 . . . . 0.0 110.63 169.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -71.15 -39.65 71.82 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.791 0.836 . . . . 0.0 111.155 -175.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.9 t -134.89 139.45 47.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 172.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -152.02 122.87 7.5 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 170.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 45.1 pt . . . . . 0 CA--C 1.538 0.496 0 C-N-CA 127.366 2.266 . . . . 0.0 105.703 177.387 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.8 p90 . . . . . 0 N--CA 1.467 0.386 0 N-CA-C 110.767 -0.086 . . . . 0.0 110.767 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -66.35 155.31 37.68 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.331 0.586 . . . . 0.0 110.523 -178.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -141.48 163.56 32.6 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.309 1.444 . . . . 0.0 107.376 173.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.4 m -138.34 156.56 30.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 C-N-CA 123.905 0.882 . . . . 0.0 109.467 172.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.21 118.86 37.85 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 104.392 -2.448 . . . . 0.0 104.392 176.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 62.8 mt -121.72 115.71 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 119.809 1.186 . . . . 0.0 108.402 -173.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -74.54 140.88 44.77 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 168.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.9 p -134.85 148.01 29.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 178.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -127.52 143.47 51.18 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.184 1.393 . . . . 0.0 108.623 -169.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.8 m -62.49 105.08 0.58 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.574 0.75 . . . . 0.0 111.308 177.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.401 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -149.02 25.27 0.04 OUTLIER Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 125.568 1.547 . . . . 0.0 111.872 168.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 30' ' ' ALA . 43.6 Cg_endo . . . . . 0 C--N 1.356 0.964 0 CA-C-N 122.263 1.844 . . . . 0.0 111.115 -169.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 . . . . . 0 CA--C 1.541 0.6 0 CA-C-O 121.344 0.592 . . . . 0.0 109.986 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.6 m -140.59 161.26 38.17 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.841 1.256 . . . . 0.0 109.186 174.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 58.9 tttt -145.56 165.13 29.54 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 126.947 2.099 . . . . 0.0 107.074 -176.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.7 mp0 -125.31 119.49 28.53 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 173.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 35.5 pt -104.34 154.45 6.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 124.286 1.034 . . . . 0.0 110.078 174.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 45.9 t -121.33 124.28 71.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 -172.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.6 mmp_? -132.36 148.61 52.43 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.185 1.394 . . . . 0.0 108.585 -176.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.97 134.93 2.33 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 169.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -156.69 152.51 27.16 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 124.09 0.956 . . . . 0.0 108.471 -176.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -63.52 -26.83 68.89 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 8.1 p-90 -65.63 -25.52 67.41 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.021 0.828 . . . . 0.0 111.701 178.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.09 83.99 5.88 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 170.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -65.58 -16.21 63.47 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.346 0.658 . . . . 0.0 111.473 174.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -138.74 153.41 48.48 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 126.768 2.027 . . . . 0.0 107.896 178.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 37.8 m-70 -70.99 -34.06 71.02 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -171.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.44 -26.81 44.21 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 118.319 -0.848 . . . . 0.0 112.829 174.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -68.77 -49.75 56.05 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 119.653 1.115 . . . . 0.0 110.892 -175.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.436 HG12 ' H ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -65.42 -39.44 85.22 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.105 175.892 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -61.51 -52.52 64.15 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 118.106 -0.95 . . . . 0.0 109.503 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -60.34 -43.49 96.4 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 119.465 1.03 . . . . 0.0 112.002 -177.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.1 tppt? -57.37 -53.66 55.6 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 124.02 0.928 . . . . 0.0 110.596 176.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.2 t -85.42 -36.86 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-O 117.566 -1.207 . . . . 0.0 112.042 -168.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 83.4 p -63.19 -36.65 84.34 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 121.237 1.835 . . . . 0.0 109.432 171.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.45 -48.83 81.88 Favored Glycine 0 C--N 1.34 0.755 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 171.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -62.86 -43.7 98.09 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 118.848 1.324 . . . . 0.0 111.668 178.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 35.7 mmt -60.85 -44.0 97.59 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-N 118.225 0.466 . . . . 0.0 110.065 177.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -66.93 -29.9 69.89 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.048 0.939 . . . . 0.0 111.968 177.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -68.68 -38.71 80.55 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.67 1.123 . . . . 0.0 109.938 169.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -66.93 -24.71 66.11 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 119.269 0.941 . . . . 0.0 110.495 169.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.73 -21.97 12.11 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 128.412 2.911 . . . . 0.0 112.094 176.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 89.5 m -59.37 150.48 26.15 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 126.0 1.72 . . . . 0.0 110.832 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -108.82 153.07 24.03 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 89.9 m -144.59 162.99 35.25 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 -168.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -149.69 125.91 10.72 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 169.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.7 p -68.32 115.19 7.48 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 169.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 53.3 mt -67.45 -23.63 65.54 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 122.072 -0.393 . . . . 0.0 110.206 174.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 172.64 -174.6 45.71 Favored Glycine 0 C--N 1.338 0.674 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 170.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -133.08 166.81 23.59 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 172.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -173.86 -156.74 13.93 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -176.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -141.01 159.39 42.31 Favored 'General case' 0 CA--C 1.518 -0.288 0 O-C-N 120.93 -1.335 . . . . 0.0 110.416 175.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 78.3 mt . . . . . 0 N--CA 1.448 -0.549 0 N-CA-C 104.299 -2.482 . . . . 0.0 104.299 174.658 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 30.0 t60 . . . . . 0 N--CA 1.454 -0.243 0 N-CA-C 109.119 -0.696 . . . . 0.0 109.119 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.1 t -142.03 118.63 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -173.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -168.05 165.81 13.34 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.942 0.897 . . . . 0.0 108.994 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 136.52 -178.59 18.72 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-N 118.685 0.675 . . . . 0.0 111.511 170.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -141.99 146.38 35.52 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.226 0.61 . . . . 0.0 111.253 169.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.5 t -84.21 153.08 23.84 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 168.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 27.6 ptm -84.39 -35.4 23.16 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 119.128 0.876 . . . . 0.0 109.753 171.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.73 -26.21 57.28 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.68 0.673 . . . . 0.0 112.144 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -132.97 -3.58 3.17 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -169.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 78.42 -176.07 54.45 Favored Glycine 0 CA--C 1.535 1.29 0 CA-C-N 119.114 0.87 . . . . 0.0 113.121 174.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -70.47 167.61 24.87 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 123.765 2.977 . . . . 0.0 111.412 174.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -124.57 166.18 16.53 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.941 1.296 . . . . 0.0 111.003 -173.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 24.6 mm100 -78.85 74.57 5.38 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.81 0.844 . . . . 0.0 109.164 171.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -53.78 -23.63 12.63 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.15 0.98 . . . . 0.0 112.697 176.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -51.71 -42.37 62.18 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.168 1.387 . . . . 0.0 112.688 171.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 78.3 mt -65.42 -48.48 82.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 179.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.4 m -57.39 -48.05 80.1 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.468 1.107 . . . . 0.0 110.845 -177.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.7 p -66.44 -48.62 69.38 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 119.17 0.896 . . . . 0.0 110.713 -177.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -57.47 -42.98 83.67 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 119.332 0.969 . . . . 0.0 110.547 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -70.0 -50.52 40.69 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 118.522 -0.751 . . . . 0.0 111.074 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 76.6 mt -63.55 -38.48 82.33 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 120.097 1.317 . . . . 0.0 109.591 -175.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 94.9 mttt . . . . . 0 N--CA 1.469 0.501 0 CA-C-N 119.651 1.114 . . . . 0.0 109.99 174.47 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.4 p -136.5 167.85 20.59 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 123.828 0.851 . . . . 0.0 109.683 175.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 13.4 p-90 . . . . . 0 C--O 1.237 0.415 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 170.074 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.389 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -145.21 147.67 32.68 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 169.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.2 mt -56.18 -34.41 66.18 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -172.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.16 -22.71 63.91 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.748 0.703 . . . . 0.0 112.54 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.4 mt -81.85 -20.0 39.85 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.376 0.67 . . . . 0.0 111.287 -178.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 46.9 mt -66.52 133.01 94.25 Favored Pre-proline 0 CA--C 1.542 0.643 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -49.48 130.29 25.19 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.304 2.669 . . . . 0.0 111.259 170.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -80.46 -37.87 31.06 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.005 0.431 . . . . 0.0 111.508 -175.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.2 t -136.27 130.44 47.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 176.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -151.93 123.36 7.8 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 169.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.9 pt . . . . . 0 CA--C 1.535 0.376 0 C-N-CA 124.901 1.28 . . . . 0.0 109.732 -169.301 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 31.8 p90 . . . . . 0 C--O 1.232 0.153 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -76.22 153.08 36.35 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.015 0.526 . . . . 0.0 110.298 -178.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -145.56 162.2 38.01 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.574 1.15 . . . . 0.0 108.125 176.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.0 m -130.31 153.58 39.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 C-N-CA 124.361 1.064 . . . . 0.0 109.493 173.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -108.09 114.79 28.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 103.864 -2.643 . . . . 0.0 103.864 178.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 49.7 mt -118.27 125.84 74.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -171.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 -81.75 149.38 28.45 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 169.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.7 t -132.93 147.77 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 127.325 2.25 . . . . 0.0 105.031 -176.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -132.15 147.93 52.45 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 177.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.571 ' HG ' ' N ' ' A' ' 39' ' ' GLU . 45.3 m -61.0 101.53 0.15 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.649 0.78 . . . . 0.0 110.852 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.5 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -144.45 19.96 0.04 OUTLIER Pre-proline 0 CA--C 1.55 0.971 0 CA-C-O 116.319 -1.8 . . . . 0.0 113.872 169.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.5 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 75.3 Cg_exo . . . . . 0 C--N 1.362 1.288 0 CA-C-N 124.015 2.47 . . . . 0.0 113.316 172.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.571 ' N ' ' HG ' ' A' ' 29' ' ' SER . 47.7 mm-40 . . . . . 0 CA--C 1.539 0.549 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.9 m -140.85 157.87 44.77 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.703 1.201 . . . . 0.0 109.068 173.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.7 tmtm? -156.1 165.92 34.99 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.275 1.83 . . . . 0.0 107.408 -169.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.5 mp0 -131.56 155.89 46.69 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.95 1.25 . . . . 0.0 109.334 175.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 41.7 pt -139.66 158.17 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 126.046 1.738 . . . . 0.0 110.084 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.2 t -118.44 118.83 59.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 12.2 mmp_? -127.43 141.36 51.69 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 175.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.87 137.25 2.96 Favored Glycine 0 C--N 1.332 0.329 0 CA-C-N 119.09 0.859 . . . . 0.0 111.493 174.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.405 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 12.9 m-85 -154.02 150.8 28.64 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -170.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -60.13 -29.08 68.4 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 118.681 -0.676 . . . . 0.0 112.197 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.405 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 11.8 p-90 -63.48 -29.18 70.5 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.257 0.935 . . . . 0.0 112.391 177.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.8 73.24 10.65 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 119.204 0.911 . . . . 0.0 109.349 174.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -68.87 -2.42 9.59 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.421 0.688 . . . . 0.0 111.869 177.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -138.93 145.19 39.52 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 126.588 1.955 . . . . 0.0 107.008 172.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -71.27 -32.0 68.17 Favored 'General case' 0 C--O 1.234 0.273 0 O-C-N 121.879 -0.513 . . . . 0.0 110.058 -171.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.61 -27.83 42.19 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 118.438 -0.791 . . . . 0.0 112.629 172.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -68.51 -49.64 58.15 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 119.647 1.112 . . . . 0.0 110.809 -176.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.43 -40.75 87.37 Favored 'Isoleucine or valine' 0 C--N 1.342 0.239 0 CA-C-O 117.837 -1.078 . . . . 0.0 109.619 175.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -61.13 -45.55 94.21 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.781 1.173 . . . . 0.0 110.446 -178.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -63.78 -49.01 74.63 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.864 0.756 . . . . 0.0 111.606 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.4 tttp -59.58 -49.0 79.47 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.422 0.689 . . . . 0.0 111.014 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 88.8 t -75.08 -42.86 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-O 117.686 -1.15 . . . . 0.0 109.244 -172.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 65.4 m -59.11 -36.28 74.89 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 120.572 1.533 . . . . 0.0 110.541 173.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.14 -53.94 41.6 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 172.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.421 ' HA ' ' HE3' ' A' ' 66' ' ' LYS . 18.4 t70 -61.61 -46.19 90.88 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 118.718 1.259 . . . . 0.0 111.679 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 35.5 mmt -57.62 -51.14 70.7 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.509 0.724 . . . . 0.0 109.793 178.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.9 mm-40 -67.79 -27.19 66.53 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.717 0.69 . . . . 0.0 111.957 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.421 ' HE3' ' HA ' ' A' ' 63' ' ' ASP . 51.1 mtmt -67.78 -38.14 82.98 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 119.518 1.054 . . . . 0.0 110.576 170.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -68.01 -30.92 70.28 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.808 1.186 . . . . 0.0 109.779 169.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 126.75 -26.24 5.16 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 128.253 2.835 . . . . 0.0 110.875 177.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 89.5 m -49.72 142.01 9.14 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 127.214 2.206 . . . . 0.0 111.799 -174.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -104.67 138.32 41.17 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 178.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 59.3 m -142.06 160.36 40.37 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -168.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -146.49 134.76 21.77 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.419 1.488 . . . . 0.0 107.998 172.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.3 p -74.0 119.42 18.19 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 169.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 35.0 mt -71.58 -22.04 61.79 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 121.85 -0.531 . . . . 0.0 110.024 172.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.29 -163.78 37.12 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 170.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -149.67 -175.57 22.05 Favored Glycine 0 N--CA 1.451 -0.326 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 170.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -174.17 -161.41 24.1 Favored Glycine 0 CA--C 1.52 0.394 0 N-CA-C 107.598 -2.201 . . . . 0.0 107.598 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.2 ptt180 -134.22 154.27 51.36 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.102 -1.234 . . . . 0.0 108.612 172.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 66.8 mt . . . . . 0 N--CA 1.445 -0.687 0 N-CA-C 104.429 -2.434 . . . . 0.0 104.429 -177.092 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 27.2 t60 . . . . . 0 CA--C 1.522 -0.116 0 CA-C-O 119.691 -0.195 . . . . 0.0 110.566 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 22.0 t -138.31 130.46 38.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -168.97 -165.45 0.55 Allowed 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.796 0.839 . . . . 0.0 110.051 -176.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.33 -165.53 54.21 Favored Glycine 0 CA--C 1.524 0.595 0 O-C-N 121.755 -0.591 . . . . 0.0 112.434 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -164.85 157.12 15.98 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.015 0.926 . . . . 0.0 111.015 -173.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.6 t -81.94 159.86 23.5 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 167.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.0 ptm -95.84 -33.63 12.16 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 118.961 0.801 . . . . 0.0 110.424 169.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.95 -25.42 58.86 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.188 0.904 . . . . 0.0 112.039 176.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -131.91 -5.31 3.56 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -169.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.56 -177.49 49.21 Favored Glycine 0 CA--C 1.535 1.339 0 CA-C-N 119.022 0.828 . . . . 0.0 113.506 172.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -69.39 138.22 38.46 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.173 2.582 . . . . 0.0 110.363 173.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -78.42 171.8 14.56 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.035 0.445 . . . . 0.0 109.933 169.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 92.3 mm-40 -77.61 83.95 3.99 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 168.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -57.55 -13.92 4.47 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -176.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.0 -44.45 87.24 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.93 1.292 . . . . 0.0 110.788 169.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 61.1 mt -64.76 -47.21 89.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 179.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.76 -51.31 70.51 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.044 0.938 . . . . 0.0 110.43 -175.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.6 p -65.91 -46.12 79.43 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 117.862 -1.066 . . . . 0.0 110.313 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -58.71 -42.28 88.32 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 120.239 1.381 . . . . 0.0 110.938 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -65.48 -46.32 80.2 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 118.765 -0.636 . . . . 0.0 111.265 177.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 57.4 mt -64.93 -44.26 96.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 -178.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 26.9 mtpt . . . . . 0 N--CA 1.465 0.29 0 CA-C-N 119.396 0.998 . . . . 0.0 110.935 -178.773 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.4 t . . . . . 0 C--O 1.239 0.511 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 20.7 p -134.13 169.07 17.7 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.577 1.151 . . . . 0.0 110.293 -178.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 27.3 p-90 . . . . . 0 C--O 1.235 0.313 0 C-N-CA 123.143 0.577 . . . . 0.0 109.923 169.883 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.542 0 CA-C-O 121.164 0.507 . . . . 0.0 110.394 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -151.78 150.19 29.88 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 171.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 53.9 mt -57.87 -31.14 66.42 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.268 0.627 . . . . 0.0 112.617 -175.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.44 -25.09 65.73 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.674 0.67 . . . . 0.0 112.278 178.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.1 mt -79.82 -24.79 41.12 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.04 0.536 . . . . 0.0 111.024 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 7.3 mt -68.97 131.99 90.63 Favored Pre-proline 0 C--O 1.237 0.421 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 176.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.66 135.61 31.15 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 121.526 1.484 . . . . 0.0 110.571 176.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.67 -27.27 66.7 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.673 0.789 . . . . 0.0 111.578 -178.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.2 t -139.6 134.87 39.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -178.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -152.41 121.17 6.5 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 169.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.5 pt . . . . . 0 CA--C 1.534 0.361 0 C-N-CA 124.497 1.119 . . . . 0.0 110.192 -169.466 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 37.0 p90 . . . . . 0 C--O 1.234 0.237 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.95 152.87 41.2 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -178.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.16 162.14 38.65 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.477 1.111 . . . . 0.0 108.787 -177.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.6 m -134.95 155.38 38.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 C-N-CA 124.492 1.117 . . . . 0.0 110.178 171.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -108.28 117.8 35.1 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 176.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 53.9 mt -119.0 114.77 45.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -173.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -74.22 145.23 44.29 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 168.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.9 p -139.26 148.62 23.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -178.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -130.94 144.98 51.87 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.017 1.327 . . . . 0.0 108.074 -170.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.7 m -62.58 103.85 0.46 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.646 0.778 . . . . 0.0 111.653 -177.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.42 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -146.53 24.02 0.04 OUTLIER Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 125.487 1.515 . . . . 0.0 112.252 168.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.42 ' CD ' ' N ' ' A' ' 30' ' ' ALA . 56.8 Cg_endo . . . . . 0 C--N 1.357 0.985 0 CA-C-N 122.575 1.955 . . . . 0.0 110.93 -173.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 . . . . . 0 CA--C 1.538 0.518 0 CA-C-O 121.511 0.672 . . . . 0.0 109.745 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.7 m -138.95 158.22 44.59 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.464 1.106 . . . . 0.0 108.99 172.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -152.75 175.11 13.21 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 127.629 2.372 . . . . 0.0 105.894 -173.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -140.78 156.35 46.19 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 120.735 -1.228 . . . . 0.0 108.424 177.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 34.7 pt -136.47 155.15 33.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 124.92 1.288 . . . . 0.0 109.255 179.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.7 t -116.14 122.13 68.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 -178.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -126.05 145.28 50.39 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 177.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -179.69 129.77 1.4 Allowed Glycine 0 C--N 1.329 0.177 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 173.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -151.56 153.89 35.4 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -173.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.1 tptt -60.35 -32.93 71.73 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 119.175 -0.441 . . . . 0.0 111.761 -178.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 15.7 p-90 -64.35 -31.03 72.07 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.413 0.551 . . . . 0.0 112.395 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.48 74.86 10.26 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 119.15 0.886 . . . . 0.0 109.187 175.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -63.19 -18.75 63.83 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.195 0.598 . . . . 0.0 111.378 176.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -123.65 146.4 48.23 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.929 1.692 . . . . 0.0 107.99 176.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 39.8 m-70 -71.9 -33.9 68.69 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.327 0.651 . . . . 0.0 109.68 -169.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.73 -28.68 57.07 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 118.379 -0.819 . . . . 0.0 112.545 173.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -68.58 -48.58 63.82 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 119.626 1.103 . . . . 0.0 111.072 -174.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.437 HG12 ' H ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -65.72 -40.46 87.87 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-O 118.268 -0.873 . . . . 0.0 109.963 176.174 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -61.94 -50.96 70.05 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 119.401 -0.919 . . . . 0.0 109.74 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -60.76 -44.2 97.02 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 119.31 0.959 . . . . 0.0 111.807 -178.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 22.2 tttp -60.08 -51.56 69.12 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 123.159 0.584 . . . . 0.0 110.71 178.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.7 t -84.56 -33.53 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-O 117.923 -1.037 . . . . 0.0 111.506 -169.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 61.1 p -63.64 -34.69 78.39 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 121.071 1.759 . . . . 0.0 109.403 170.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.15 -51.06 60.7 Favored Glycine 0 C--N 1.338 0.667 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 171.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -60.71 -42.93 98.21 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 118.579 1.189 . . . . 0.0 112.137 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 38.0 mmt -62.67 -45.68 91.7 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 122.814 0.446 . . . . 0.0 110.249 176.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -68.19 -29.06 67.83 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 118.768 0.713 . . . . 0.0 111.843 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -67.57 -37.47 82.67 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 119.163 0.892 . . . . 0.0 110.365 170.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -68.71 -27.73 66.21 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.581 1.082 . . . . 0.0 110.77 169.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 125.69 -25.84 5.53 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 127.441 2.448 . . . . 0.0 111.788 175.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 88.4 m -57.35 151.56 15.92 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 126.389 1.876 . . . . 0.0 112.192 -175.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -109.77 145.31 36.87 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 86.9 m -140.63 165.16 28.22 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -168.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -153.11 126.29 8.54 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.448 1.499 . . . . 0.0 107.735 170.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.7 p -69.69 119.55 14.1 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 169.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 42.5 mt -70.9 -25.47 62.79 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.858 -0.526 . . . . 0.0 110.263 173.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.9 -172.01 43.09 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 109.769 -1.333 . . . . 0.0 109.769 172.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -132.26 177.17 18.94 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 176.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 179.15 -163.71 31.45 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 108.341 -1.904 . . . . 0.0 108.341 -176.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -136.55 152.85 50.95 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 121.005 -1.291 . . . . 0.0 108.506 171.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.7 mt . . . . . 0 C--N 1.322 -0.606 0 N-CA-C 103.897 -2.631 . . . . 0.0 103.897 178.821 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 35.7 t60 . . . . . 0 N--CA 1.45 -0.445 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.7 t -135.27 129.1 49.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 179.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -165.85 -164.99 0.76 Allowed 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.171 0.988 . . . . 0.0 108.512 -176.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.96 -172.26 55.18 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -160.38 154.33 22.9 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.326 0.65 . . . . 0.0 110.722 -176.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.4 t -82.26 163.54 21.77 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 168.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 20.3 ptp -102.06 -30.97 10.86 Favored 'General case' 0 C--O 1.232 0.156 0 O-C-N 121.524 -0.735 . . . . 0.0 110.444 169.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.92 -26.7 61.49 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.179 0.9 . . . . 0.0 111.737 173.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -133.25 -2.96 3.1 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -169.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.15 -174.68 46.7 Favored Glycine 0 CA--C 1.535 1.33 0 CA-C-N 119.088 0.858 . . . . 0.0 113.051 175.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.97 143.29 54.14 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.814 2.343 . . . . 0.0 110.424 172.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.51 176.94 5.65 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.138 0.575 . . . . 0.0 109.927 169.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 20.8 mm100 -63.34 -28.83 70.27 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.841 -0.537 . . . . 0.0 111.68 171.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 39.2 m80 60.54 -29.72 0.05 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 128.767 2.827 . . . . 0.0 116.311 -175.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.38 -43.08 99.67 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.21 1.004 . . . . 0.0 110.681 173.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 69.1 mt -60.79 -44.41 97.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 177.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.95 -53.46 56.99 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.328 1.051 . . . . 0.0 110.105 -177.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.3 p -63.86 -44.73 92.25 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 117.7 -1.143 . . . . 0.0 110.123 -173.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -58.1 -40.73 81.92 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 120.215 1.37 . . . . 0.0 111.163 -179.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 36.3 mttm -69.82 -44.47 69.92 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 121.782 -0.574 . . . . 0.0 111.061 178.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 58.7 mt -64.65 -43.23 96.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 118.79 0.723 . . . . 0.0 109.115 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 93.6 mttt . . . . . 0 N--CA 1.467 0.407 0 CA-C-N 119.605 1.093 . . . . 0.0 109.976 175.968 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.2 t . . . . . 0 CA--C 1.536 0.408 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 19.8 p -129.3 168.51 16.13 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.784 0.834 . . . . 0.0 110.219 175.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 43.9 p-90 . . . . . 0 C--O 1.235 0.322 0 O-C-N 121.742 -0.599 . . . . 0.0 109.728 169.879 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.508 0 CA-C-O 121.127 0.489 . . . . 0.0 110.389 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -149.84 146.16 26.97 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 169.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 80.9 mt -55.11 -33.32 62.74 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.83 0.852 . . . . 0.0 112.657 -175.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.74 -25.69 67.4 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.087 0.858 . . . . 0.0 112.341 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.2 mt -78.54 -25.51 45.51 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.189 0.596 . . . . 0.0 111.094 -178.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.8 mt -70.6 131.38 88.02 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -172.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -49.57 119.93 5.24 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 123.525 2.817 . . . . 0.0 111.359 169.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -74.04 -29.88 62.14 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.15 0.5 . . . . 0.0 111.49 -176.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.9 t -141.84 131.54 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 174.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -149.39 111.35 4.59 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 169.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.9 pt . . . . . 0 C--O 1.234 0.269 0 C-N-CA 124.01 0.924 . . . . 0.0 109.7 -169.651 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 . . . . . 0 C--O 1.235 0.319 0 CA-C-O 121.477 0.655 . . . . 0.0 111.892 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -65.55 156.18 33.42 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 124.834 1.254 . . . . 0.0 111.684 -169.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -147.17 161.17 41.44 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.082 1.353 . . . . 0.0 108.257 171.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.5 m -130.0 154.62 40.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 C-N-CA 124.782 1.233 . . . . 0.0 109.803 174.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.05 115.65 30.52 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 104.212 -2.514 . . . . 0.0 104.212 176.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 73.3 mt -119.65 124.51 73.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -173.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -81.41 145.08 30.98 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 169.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.2 t -129.68 143.44 41.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 -175.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -130.96 132.97 45.39 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 -178.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.0 t -66.43 118.66 10.38 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -175.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.401 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -151.05 32.06 0.06 OUTLIER Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 126.163 1.785 . . . . 0.0 109.77 168.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 30' ' ' ALA . 44.8 Cg_endo . . . . . 0 C--N 1.357 1.012 0 CA-C-N 121.913 1.719 . . . . 0.0 111.458 -171.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 . . . . . 0 CA--C 1.541 0.62 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.4 m -137.55 161.88 35.23 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.303 1.041 . . . . 0.0 110.112 177.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.6 tttp -148.85 165.45 31.46 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.533 2.333 . . . . 0.0 106.137 -174.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -137.52 140.15 40.93 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 106.09 -1.818 . . . . 0.0 106.09 175.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 41.2 pt -134.3 156.83 41.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 124.218 1.007 . . . . 0.0 110.724 -172.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 95.7 t -121.55 118.75 56.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 -177.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 27.2 mmt85 -136.02 144.23 45.17 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 177.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.22 135.57 2.42 Favored Glycine 0 C--N 1.331 0.284 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 -178.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -153.58 160.94 42.59 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 117.356 0.578 . . . . 0.0 110.122 -169.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.5 mtmm -59.88 -33.86 72.39 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -179.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.446 ' CH2' ' HE2' ' A' ' 59' ' ' LYS . 9.5 p-90 -68.66 -24.23 64.5 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.835 0.743 . . . . 0.0 112.634 -179.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.47 82.13 8.54 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 119.588 1.085 . . . . 0.0 109.297 176.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -65.45 -19.38 65.91 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.44 171.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -133.89 148.68 51.27 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 126.048 1.739 . . . . 0.0 108.137 -178.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -72.56 -30.97 64.89 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 121.925 -0.485 . . . . 0.0 109.897 -171.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.01 -28.64 53.66 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 118.082 -0.961 . . . . 0.0 112.776 172.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -65.53 -55.85 15.53 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.669 1.122 . . . . 0.0 109.583 -179.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.423 HG12 ' H ' ' A' ' 56' ' ' ILE . 0.1 OUTLIER -66.07 -34.62 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-O 117.355 -1.307 . . . . 0.0 110.687 -179.502 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -60.98 -53.59 55.38 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 120.104 1.32 . . . . 0.0 109.506 175.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -60.37 -42.91 96.77 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.983 0.81 . . . . 0.0 111.896 -178.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.446 ' HE2' ' CH2' ' A' ' 49' ' ' TRP . 0.0 OUTLIER -59.28 -55.54 33.51 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.221 1.008 . . . . 0.0 110.209 178.589 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 89.9 t -77.62 -43.77 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-O 117.801 -1.095 . . . . 0.0 109.881 -169.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.7 p -63.81 -31.26 72.39 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 120.709 1.595 . . . . 0.0 109.937 175.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.29 -51.31 59.57 Favored Glycine 0 C--N 1.337 0.636 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 171.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -61.71 -44.53 96.74 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 118.835 1.318 . . . . 0.0 111.68 178.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 38.4 mmt -59.12 -46.96 86.98 Favored 'General case' 0 C--O 1.227 -0.081 0 CA-C-O 119.231 -0.414 . . . . 0.0 110.045 177.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -69.27 -28.27 66.15 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.654 0.661 . . . . 0.0 112.152 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -67.59 -37.41 82.53 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.342 0.974 . . . . 0.0 110.255 170.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -68.25 -31.01 70.2 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.772 1.169 . . . . 0.0 110.106 169.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 127.5 -23.43 5.41 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 127.93 2.681 . . . . 0.0 111.662 174.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 95.8 m -55.92 154.42 7.36 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 126.404 1.882 . . . . 0.0 112.602 -177.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -112.49 145.47 40.18 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.909 1.284 . . . . 0.0 108.066 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 74.9 m -144.64 164.33 31.29 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -168.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -149.02 130.57 14.88 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.289 1.435 . . . . 0.0 107.713 171.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.6 p -75.06 114.73 13.89 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 169.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 39.7 mt -68.65 -25.33 64.77 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.823 -0.548 . . . . 0.0 110.374 176.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.14 -164.88 37.83 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 175.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -154.32 -175.5 25.58 Favored Glycine 0 N--CA 1.452 -0.268 0 N-CA-C 111.509 -0.636 . . . . 0.0 111.509 171.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -171.49 -153.71 9.26 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 108.488 -1.845 . . . . 0.0 108.488 -176.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -143.25 142.96 31.55 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 -174.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 61.7 mt . . . . . 0 C--O 1.235 0.315 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -171.312 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 31.5 t60 . . . . . 0 C--O 1.232 0.184 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.9 t -141.41 133.62 28.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 173.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -157.17 -170.04 3.14 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.221 1.008 . . . . 0.0 108.726 -178.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.28 -175.46 45.89 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-N 118.619 0.645 . . . . 0.0 112.145 176.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -162.33 149.4 13.64 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.532 1.133 . . . . 0.0 110.546 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.6 t -71.63 166.2 22.38 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 168.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.5 ptm -111.5 -29.86 7.6 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 118.485 -0.769 . . . . 0.0 111.051 170.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -73.59 -25.55 60.4 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.574 1.079 . . . . 0.0 111.407 172.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -132.65 -9.47 3.18 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.05 0.94 . . . . 0.0 113.037 -169.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 78.68 -176.66 54.37 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-N 118.773 0.715 . . . . 0.0 113.71 171.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.43 137.2 42.31 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.059 2.506 . . . . 0.0 110.482 175.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -78.01 168.8 19.32 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 169.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -77.76 84.69 4.08 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 168.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -57.86 -13.86 5.09 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -175.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.03 -41.46 96.61 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.651 1.18 . . . . 0.0 110.978 170.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 56.2 mt -65.46 -47.43 86.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 177.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.97 -49.68 76.94 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.066 0.946 . . . . 0.0 110.703 -176.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.4 p -64.4 -47.53 78.82 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 118.182 -0.913 . . . . 0.0 110.989 -176.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -60.01 -40.38 89.07 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.52 1.055 . . . . 0.0 110.537 -178.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 52.9 mttm -67.29 -46.22 74.26 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-O 118.935 -0.555 . . . . 0.0 111.476 177.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 63.8 mt -64.61 -39.87 87.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-N 119.432 1.015 . . . . 0.0 109.006 -179.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 92.3 mttt . . . . . 0 N--CA 1.469 0.509 0 CA-C-N 119.855 1.207 . . . . 0.0 109.514 175.063 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.4 t . . . . . 0 N--CA 1.454 -0.262 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 16.6 p -134.69 174.42 10.59 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.478 1.111 . . . . 0.0 108.914 174.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 47.5 p-90 . . . . . 0 C--O 1.235 0.318 0 O-C-N 121.669 -0.644 . . . . 0.0 110.657 171.271 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.397 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -146.73 146.59 30.37 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 169.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 51.0 mt -58.99 -29.22 67.06 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -173.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.61 -26.41 66.24 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.113 0.87 . . . . 0.0 111.883 177.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.7 mt -82.69 -24.18 33.79 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.654 0.782 . . . . 0.0 111.191 -177.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 51.3 mt -65.46 129.01 94.27 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -178.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -44.82 120.72 3.0 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 124.141 3.227 . . . . 0.0 111.599 172.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -78.75 -32.94 46.86 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.283 0.563 . . . . 0.0 111.139 -170.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.2 t -136.85 140.26 43.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 105.091 -2.188 . . . . 0.0 105.091 172.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -151.77 130.15 12.1 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 170.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.9 pt . . . . . 0 CA--C 1.537 0.477 0 C-N-CA 126.873 2.069 . . . . 0.0 106.9 -178.355 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.4 p90 . . . . . 0 N--CA 1.464 0.24 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -77.1 154.98 32.74 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.521 0.728 . . . . 0.0 110.377 -177.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.31 162.51 37.97 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.0 1.32 . . . . 0.0 108.164 179.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.8 m -132.7 154.31 39.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 124.418 1.087 . . . . 0.0 109.488 172.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.35 119.22 38.88 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 104.293 -2.484 . . . . 0.0 104.293 176.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.2 mt -122.26 123.79 69.57 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -173.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.453 ' HE ' ' CE1' ' A' ' 28' ' ' HIS . 36.9 ttp-105 -77.36 147.59 36.03 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 169.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.8 t -133.29 143.72 38.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 -178.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.453 ' CE1' ' HE ' ' A' ' 26' ' ' ARG . 99.9 m-70 -123.68 145.06 49.25 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 125.021 1.329 . . . . 0.0 107.913 174.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.0 m -62.07 107.93 0.96 Allowed 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.439 0.696 . . . . 0.0 110.635 177.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -148.9 29.1 0.05 OUTLIER Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 124.823 1.249 . . . . 0.0 112.404 169.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo . . . . . 0 CA--C 1.545 1.075 0 C-N-CA 123.489 2.792 . . . . 0.0 115.84 -169.809 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 . . . . . 0 CA--C 1.54 0.563 0 CA-C-O 121.527 0.68 . . . . 0.0 109.812 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.6 m -140.92 158.54 43.79 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.822 1.249 . . . . 0.0 108.463 173.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -153.06 170.75 19.7 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 126.894 2.078 . . . . 0.0 106.296 -171.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.408 ' HB2' ' HE3' ' A' ' 108' ' ' LYS . 17.7 mp0 -134.08 157.16 46.85 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 169.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 32.6 pt -132.46 155.39 41.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 125.344 1.458 . . . . 0.0 109.508 178.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 56.7 t -116.9 121.35 67.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 177.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.8 mmp_? -127.52 141.1 51.74 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 177.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -171.64 136.6 3.94 Favored Glycine 0 C--N 1.329 0.192 0 CA-C-N 119.538 1.063 . . . . 0.0 110.609 170.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -153.85 148.55 26.39 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -173.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.5 pttm -54.99 -31.08 60.66 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.355 1.462 . . . . 0.0 113.236 173.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 11.8 p-90 -68.92 -28.71 66.91 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.29 0.95 . . . . 0.0 112.044 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.79 73.6 10.28 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 119.278 0.944 . . . . 0.0 109.235 174.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -65.94 -6.82 13.7 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.861 0.864 . . . . 0.0 111.457 174.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -137.14 144.09 42.8 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.621 1.968 . . . . 0.0 106.809 173.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 44.1 m-70 -70.34 -31.37 68.63 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -171.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.29 -29.84 35.45 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 118.529 -0.748 . . . . 0.0 112.652 172.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -68.85 -48.57 63.14 Favored 'General case' 0 C--N 1.341 0.199 0 CA-C-N 119.39 0.995 . . . . 0.0 111.097 -174.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.434 HG12 ' H ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -65.36 -41.68 91.82 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.018 176.168 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -61.83 -50.72 71.15 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 119.296 -0.962 . . . . 0.0 109.668 -178.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -61.13 -44.43 97.34 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.125 0.875 . . . . 0.0 111.91 -178.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 30.5 tttt -59.9 -50.32 74.23 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.315 0.646 . . . . 0.0 110.895 178.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.4 t -85.71 -33.6 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-O 117.572 -1.204 . . . . 0.0 111.401 -169.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 84.6 p -61.57 -36.71 81.41 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 121.306 1.866 . . . . 0.0 109.179 169.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -56.63 -52.47 50.27 Favored Glycine 0 C--N 1.34 0.753 0 C-N-CA 124.218 0.913 . . . . 0.0 111.141 170.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -60.73 -45.16 95.32 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 119.14 1.47 . . . . 0.0 111.854 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 35.2 mmt -59.46 -47.03 87.04 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.998 0.519 . . . . 0.0 109.787 178.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -68.17 -30.08 69.11 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.536 0.734 . . . . 0.0 111.937 178.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -66.59 -37.94 85.97 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 119.511 1.051 . . . . 0.0 110.278 171.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -64.62 -46.15 83.83 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.746 1.157 . . . . 0.0 108.486 169.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 142.17 -21.49 2.45 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 127.872 2.653 . . . . 0.0 111.204 174.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 80.8 m -54.65 148.36 12.75 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 126.891 2.076 . . . . 0.0 111.608 -176.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -108.56 141.47 40.42 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 94.5 m -141.6 165.51 27.29 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -168.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -154.33 130.03 10.02 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.869 1.667 . . . . 0.0 107.431 171.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.1 p -69.82 123.77 22.3 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 169.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 33.9 mt -69.31 -28.3 66.14 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.933 -0.479 . . . . 0.0 109.969 172.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.98 -171.29 43.34 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 174.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -124.78 173.6 17.1 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 174.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -178.2 -164.96 32.2 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 108.254 -1.938 . . . . 0.0 108.254 -176.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 12.0 ptp180 -148.06 161.76 40.74 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 120.741 -1.447 . . . . 0.0 109.208 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 81.9 mt . . . . . 0 C--N 1.324 -0.538 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 -171.837 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 21.1 t60 . . . . . 0 C--O 1.233 0.187 0 N-CA-C 110.359 -0.237 . . . . 0.0 110.359 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.5 t -136.58 137.48 47.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 -177.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -164.96 -171.01 2.1 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.084 -1.01 . . . . 0.0 109.854 -174.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.69 -167.71 54.76 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-O 121.402 0.446 . . . . 0.0 112.278 169.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -158.36 173.2 17.02 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.315 1.046 . . . . 0.0 110.218 -172.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.0 t -107.17 164.0 12.53 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 127.033 2.133 . . . . 0.0 106.2 168.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 21.4 ptp -105.96 -29.89 9.67 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 118.547 -0.739 . . . . 0.0 110.881 172.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -73.12 -26.32 61.18 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.39 0.995 . . . . 0.0 111.563 172.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -132.0 -3.74 3.57 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -169.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 72.52 -177.14 41.01 Favored Glycine 0 CA--C 1.535 1.297 0 CA-C-N 118.908 0.776 . . . . 0.0 112.73 177.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.49 138.13 37.92 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.889 2.393 . . . . 0.0 110.916 175.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.96 176.47 5.69 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.297 0.639 . . . . 0.0 110.026 169.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 21.5 mm100 -65.7 -31.83 73.05 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 121.901 -0.499 . . . . 0.0 112.292 178.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 39.1 m80 61.63 -30.83 0.07 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 128.438 2.695 . . . . 0.0 115.972 -174.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.7 -44.46 96.18 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.224 1.01 . . . . 0.0 110.787 174.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 72.9 mt -60.47 -45.35 97.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 176.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.46 -52.24 66.07 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 124.61 1.164 . . . . 0.0 109.747 -174.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 22.6 p -67.09 -43.07 83.49 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 117.982 -1.009 . . . . 0.0 111.151 -174.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -59.38 -41.9 90.43 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.756 1.162 . . . . 0.0 110.386 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.408 ' HE3' ' HB2' ' A' ' 42' ' ' GLU . 42.1 mttm -66.77 -45.4 78.62 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 119.009 -0.519 . . . . 0.0 111.263 176.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 55.8 mt -63.44 -42.81 97.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 119.111 0.868 . . . . 0.0 108.992 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 92.3 mttt . . . . . 0 N--CA 1.47 0.53 0 CA-C-N 120.216 1.371 . . . . 0.0 109.455 176.26 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.454 -0.273 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 22.1 p -137.3 173.96 11.12 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.079 0.952 . . . . 0.0 108.848 172.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 52.1 p-90 . . . . . 0 C--O 1.235 0.297 0 O-C-N 121.988 -0.445 . . . . 0.0 110.6 173.727 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.541 0 CA-C-O 121.715 0.769 . . . . 0.0 111.454 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -151.27 151.59 32.04 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 126.677 1.991 . . . . 0.0 105.924 170.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 52.4 mt -55.44 -34.49 64.52 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.732 0.696 . . . . 0.0 112.656 -175.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.15 -25.86 64.59 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.744 0.702 . . . . 0.0 112.21 179.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.0 mt -81.83 -23.23 36.57 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.468 0.707 . . . . 0.0 111.178 -178.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.2 mt -64.84 128.03 93.23 Favored Pre-proline 0 CA--C 1.54 0.577 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 178.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -47.41 140.21 15.96 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.588 2.859 . . . . 0.0 111.249 170.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -89.78 -36.06 15.36 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 121.987 -0.446 . . . . 0.0 111.627 -170.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.4 t -140.99 138.96 34.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 124.866 1.266 . . . . 0.0 107.702 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 68.5 t0 -152.93 111.34 3.69 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 169.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 36.6 pt . . . . . 0 CA--C 1.537 0.459 0 C-N-CA 124.913 1.285 . . . . 0.0 109.439 -173.562 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 43.0 p90 . . . . . 0 C--O 1.235 0.328 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -80.05 155.88 27.36 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.91 163.61 32.92 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.997 1.319 . . . . 0.0 108.27 176.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.5 m -133.23 150.83 32.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 124.36 1.064 . . . . 0.0 109.589 172.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.05 117.0 33.6 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 104.139 -2.541 . . . . 0.0 104.139 175.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 76.5 mt -118.93 122.82 70.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 -175.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 36.2 ttp180 -79.46 147.49 32.25 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 169.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.8 t -133.73 145.01 34.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 104.762 -2.31 . . . . 0.0 104.762 -175.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -130.42 150.14 51.77 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.596 1.158 . . . . 0.0 108.129 -179.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.524 ' HG ' ' N ' ' A' ' 39' ' ' GLU . 15.9 m -60.81 100.73 0.12 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.122 0.969 . . . . 0.0 111.773 -179.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.518 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -144.59 17.78 0.04 OUTLIER Pre-proline 0 CA--C 1.554 1.111 0 CA-C-O 116.188 -1.863 . . . . 0.0 113.898 169.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.518 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 66.9 Cg_exo . . . . . 0 C--N 1.365 1.444 0 CA-C-N 123.702 2.358 . . . . 0.0 114.41 177.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.524 ' N ' ' HG ' ' A' ' 29' ' ' SER . 9.2 pt-20 . . . . . 0 CA--C 1.536 0.416 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.1 m -142.76 159.23 42.64 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.786 0.834 . . . . 0.0 110.596 -173.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -151.07 165.95 32.24 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 127.625 2.37 . . . . 0.0 106.168 -174.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.5 mp0 -131.26 154.23 48.69 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 121.039 -1.038 . . . . 0.0 108.494 177.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 39.3 pt -135.26 156.18 38.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 125.277 1.431 . . . . 0.0 109.686 178.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 54.2 t -118.65 120.34 63.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 105.434 -2.062 . . . . 0.0 105.434 177.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.0 mmp_? -130.28 146.23 51.86 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 172.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -179.55 140.51 4.33 Favored Glycine 0 N--CA 1.454 -0.139 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 174.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -154.88 156.06 35.46 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -170.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.5 mmtm -53.05 -39.45 63.26 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.407 1.083 . . . . 0.0 112.026 174.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 12.8 p-90 -67.2 -27.72 67.49 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.519 0.6 . . . . 0.0 112.503 -176.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.96 80.32 9.05 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 119.295 0.952 . . . . 0.0 108.964 173.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -63.73 -18.52 64.11 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.254 0.621 . . . . 0.0 111.488 174.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -132.1 148.87 52.51 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 126.47 1.908 . . . . 0.0 108.043 178.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 37.3 m-70 -72.52 -32.26 65.99 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -170.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.85 -29.08 54.29 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 118.561 -0.733 . . . . 0.0 112.663 172.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -67.14 -49.66 64.04 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 119.338 0.972 . . . . 0.0 110.84 -175.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.421 ' H ' HG12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -66.8 -38.88 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 CA-C-O 117.557 -1.211 . . . . 0.0 109.995 174.977 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -60.36 -47.33 86.52 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 120.191 1.36 . . . . 0.0 110.404 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -63.67 -47.91 79.31 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.265 0.484 . . . . 0.0 111.507 179.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 40.9 tttt -62.63 -51.19 68.24 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 123.239 0.616 . . . . 0.0 111.315 -178.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 94.6 t -72.56 -46.33 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-O 118.189 -0.91 . . . . 0.0 108.967 -172.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 56.6 m -64.11 -27.26 68.97 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 120.157 1.344 . . . . 0.0 111.162 175.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.84 -51.28 56.88 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 170.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -60.73 -43.37 98.0 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.418 1.109 . . . . 0.0 111.638 178.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.5 mmt -59.62 -47.25 86.32 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 123.131 0.573 . . . . 0.0 110.011 177.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -69.48 -28.26 65.92 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.892 0.769 . . . . 0.0 112.066 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -66.92 -38.24 85.84 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 119.179 0.9 . . . . 0.0 110.112 169.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -69.48 -25.66 64.18 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 119.668 1.122 . . . . 0.0 110.496 169.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 118.84 -21.42 9.62 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 127.919 2.676 . . . . 0.0 112.456 175.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 92.2 m -53.08 149.59 6.61 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 126.112 1.765 . . . . 0.0 112.1 -178.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -108.48 138.65 44.43 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 177.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 97.3 m -141.41 164.18 30.92 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -168.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -153.79 130.26 10.61 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.499 1.52 . . . . 0.0 107.49 174.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 5.9 p -70.92 122.1 19.34 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 169.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 41.9 mt -70.12 -25.67 63.6 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.861 -0.525 . . . . 0.0 109.941 170.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.93 -171.78 43.03 Favored Glycine 0 C--N 1.337 0.608 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 170.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -128.84 171.87 19.68 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 175.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -176.81 -162.71 27.84 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 108.6 -1.8 . . . . 0.0 108.6 -176.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -146.0 163.67 34.47 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 121.055 -1.262 . . . . 0.0 108.547 -178.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 81.4 mt . . . . . 0 C--N 1.324 -0.5 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 -170.596 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 54.2 t60 . . . . . 0 C--O 1.234 0.28 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 18.7 t -127.81 128.95 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.114 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -160.81 -172.4 3.48 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.236 -0.915 . . . . 0.0 111.132 -169.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 66.29 -166.21 38.14 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-O 121.425 0.459 . . . . 0.0 112.616 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -162.08 157.2 23.04 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.083 0.953 . . . . 0.0 110.502 -170.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.9 t -85.24 164.38 18.09 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 168.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.0 ptm -104.83 -31.8 9.12 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 118.625 -0.702 . . . . 0.0 110.646 169.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.8 -26.41 61.5 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.324 0.965 . . . . 0.0 111.556 174.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -132.46 -3.56 3.39 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.925 0.89 . . . . 0.0 113.089 -169.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.46 -177.3 43.74 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-N 118.779 0.718 . . . . 0.0 112.997 175.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -67.89 142.07 55.92 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.652 2.234 . . . . 0.0 110.41 172.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.19 173.89 9.5 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 122.369 1.08 . . . . 0.0 110.322 169.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -81.47 79.48 8.06 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 103.828 -2.656 . . . . 0.0 103.828 167.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 51.6 m80 -60.95 -13.74 18.04 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -169.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.86 -35.91 77.8 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.554 0.742 . . . . 0.0 111.622 172.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 83.8 mt -65.15 -44.16 95.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 177.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.87 -48.44 81.37 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.158 0.983 . . . . 0.0 110.684 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.4 p -66.38 -42.46 87.91 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 117.813 -1.089 . . . . 0.0 110.661 -177.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -58.22 -44.11 88.02 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 120.226 1.376 . . . . 0.0 110.772 177.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -69.13 -44.21 72.84 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.873 -0.517 . . . . 0.0 111.635 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 81.5 mt -71.55 -34.19 51.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 O-C-N 121.257 -0.902 . . . . 0.0 109.478 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 91.6 mttt . . . . . 0 N--CA 1.469 0.477 0 CA-C-N 119.684 1.129 . . . . 0.0 109.483 170.707 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.6 t . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 19.3 p -133.05 168.8 17.83 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.198 0.999 . . . . 0.0 108.676 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 57.9 p-90 . . . . . 0 C--O 1.234 0.268 0 CA-C-O 121.178 0.513 . . . . 0.0 111.802 173.733 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.451 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -141.95 142.41 33.0 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 169.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 81.5 mt -57.46 -32.36 66.87 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.734 0.814 . . . . 0.0 112.713 -171.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.84 -25.52 64.69 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.895 0.77 . . . . 0.0 112.1 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.5 mt -80.53 -24.92 38.99 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.37 0.668 . . . . 0.0 111.186 -177.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 41.0 mt -67.24 128.49 93.75 Favored Pre-proline 0 C--O 1.24 0.558 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -175.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -46.9 127.05 11.8 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.885 3.057 . . . . 0.0 111.341 171.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -81.4 -34.1 31.83 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 121.051 0.453 . . . . 0.0 111.311 -170.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.0 t -138.77 133.7 41.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 174.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -147.95 133.49 18.73 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 170.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 38.6 pt . . . . . 0 CA--C 1.537 0.461 0 C-N-CA 127.113 2.165 . . . . 0.0 106.102 -177.458 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 37.2 p90 . . . . . 0 N--CA 1.463 0.204 0 CA-C-O 120.777 0.322 . . . . 0.0 110.444 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.25 152.03 39.79 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.62 0.768 . . . . 0.0 109.35 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.98 161.15 41.94 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.296 1.038 . . . . 0.0 109.082 -178.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.4 m -131.21 153.69 39.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 C-N-CA 124.4 1.08 . . . . 0.0 110.097 173.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -108.39 115.02 29.34 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 104.345 -2.465 . . . . 0.0 104.345 177.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 54.4 mt -119.37 124.53 73.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 -172.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -78.55 148.97 33.16 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 169.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.5 t -133.56 148.17 30.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 105.55 -2.019 . . . . 0.0 105.55 -179.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -129.59 156.2 44.58 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.806 1.243 . . . . 0.0 109.357 -178.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.517 ' HG ' ' N ' ' A' ' 39' ' ' GLU . 18.1 m -68.75 44.41 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.1 1.76 . . . . 0.0 114.626 178.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -72.7 -9.41 0.15 Allowed Pre-proline 0 CA--C 1.557 1.234 0 N-CA-C 117.846 2.535 . . . . 0.0 117.846 170.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo . . . . . 0 C--N 1.362 1.262 0 C-N-CA 123.82 3.013 . . . . 0.0 116.67 -177.612 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.517 ' N ' ' HG ' ' A' ' 29' ' ' SER . 44.1 mm-40 . . . . . 0 CA--C 1.539 0.53 0 CA-C-O 121.453 0.644 . . . . 0.0 109.34 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.5 m -141.16 160.36 40.26 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.61 1.164 . . . . 0.0 108.984 171.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -149.59 169.83 20.07 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 127.338 2.255 . . . . 0.0 106.457 -173.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.1 mp0 -133.27 152.79 51.94 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 176.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 38.9 pt -133.96 155.73 40.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 125.551 1.54 . . . . 0.0 109.589 178.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 89.1 t -117.08 120.09 63.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 105.696 -1.965 . . . . 0.0 105.696 177.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.426 ' HG3' HG21 ' A' ' 60' ' ' VAL . 10.4 mmp_? -127.69 142.17 51.41 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 174.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -172.63 139.84 5.42 Favored Glycine 0 C--N 1.332 0.321 0 CA-C-N 119.429 1.013 . . . . 0.0 111.412 172.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.423 ' CD2' ' CZ2' ' A' ' 49' ' ' TRP . 30.1 m-85 -154.81 156.61 36.54 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.673 0.789 . . . . 0.0 109.893 -171.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.3 mttp -67.68 -32.02 72.39 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 118.793 -0.622 . . . . 0.0 111.007 175.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.423 ' CZ2' ' CD2' ' A' ' 47' ' ' TYR . 14.5 p-90 -62.57 -30.86 71.63 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.723 0.692 . . . . 0.0 111.575 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.73 71.04 6.68 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.357 0.663 . . . . 0.0 109.47 171.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -61.33 -18.3 57.94 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.502 0.721 . . . . 0.0 111.454 176.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -125.02 146.97 49.18 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 126.466 1.906 . . . . 0.0 107.764 176.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 60.9 m80 -73.12 -31.35 64.26 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 122.887 0.475 . . . . 0.0 110.441 -169.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.02 -30.83 49.21 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 118.612 -0.709 . . . . 0.0 112.4 172.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -69.67 -49.13 56.49 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 119.321 0.964 . . . . 0.0 111.084 -176.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.429 HG12 ' H ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -65.79 -40.18 86.94 Favored 'Isoleucine or valine' 0 C--N 1.342 0.274 0 CA-C-O 117.518 -1.23 . . . . 0.0 109.699 175.391 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -59.98 -50.55 73.29 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 119.726 1.148 . . . . 0.0 109.96 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -61.14 -45.35 95.02 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 119.059 0.845 . . . . 0.0 112.028 -178.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 30.7 tttt -61.4 -49.09 78.28 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 122.912 0.485 . . . . 0.0 110.574 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.426 HG21 ' HG3' ' A' ' 45' ' ' ARG . 85.0 t -78.91 -39.42 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 117.692 -1.146 . . . . 0.0 109.954 -170.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 91.5 p -61.42 -39.23 90.02 Favored 'General case' 0 C--N 1.339 0.122 0 CA-C-N 120.757 1.617 . . . . 0.0 109.13 174.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -57.28 -51.66 56.23 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 123.948 0.785 . . . . 0.0 111.363 172.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -61.73 -46.31 90.19 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 118.943 1.372 . . . . 0.0 111.68 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 36.0 mmt -59.41 -47.52 85.14 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.349 0.66 . . . . 0.0 110.456 177.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -62.84 -35.82 81.21 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.788 0.835 . . . . 0.0 111.279 177.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -66.38 -35.5 80.5 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 118.043 -0.98 . . . . 0.0 111.302 172.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -71.73 -17.51 62.2 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 119.972 1.26 . . . . 0.0 112.159 170.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.37 -8.57 41.19 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.696 1.617 . . . . 0.0 112.543 178.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 90.4 m -65.96 165.44 13.2 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.636 1.218 . . . . 0.0 110.863 176.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -125.33 148.3 48.79 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 170.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 65.9 m -145.31 165.34 28.73 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -168.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -149.22 137.64 20.9 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.811 1.645 . . . . 0.0 106.921 169.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.4 p -77.69 115.48 17.47 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 169.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 36.9 mt -67.99 -24.43 65.13 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 121.981 -0.449 . . . . 0.0 110.149 174.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.92 -165.73 38.69 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 170.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -147.7 178.84 25.04 Favored Glycine 0 CA--C 1.519 0.318 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 172.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -176.29 -157.84 18.41 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 107.546 -2.221 . . . . 0.0 107.546 -176.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 31.0 ptt-85 -137.02 157.78 45.95 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 120.616 -1.52 . . . . 0.0 108.811 173.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 97.4 mt . . . . . 0 C--N 1.322 -0.597 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 -177.517 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 24.5 t60 . . . . . 0 N--CA 1.455 -0.199 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.6 t -137.37 124.89 30.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -164.48 -178.3 5.33 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 121.468 -0.77 . . . . 0.0 109.909 -172.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.49 -174.04 55.19 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -178.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -157.3 155.79 31.31 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.05 0.54 . . . . 0.0 111.958 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.1 t -75.81 164.67 26.0 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 168.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.3 ptm -108.53 -30.5 8.22 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 118.492 -0.766 . . . . 0.0 111.122 170.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.06 -26.06 60.18 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.551 1.069 . . . . 0.0 111.431 173.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -131.91 -7.42 3.53 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.915 0.886 . . . . 0.0 113.015 -169.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.92 -177.13 52.49 Favored Glycine 0 CA--C 1.535 1.293 0 CA-C-N 118.673 0.669 . . . . 0.0 113.607 171.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.08 135.65 38.16 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.092 2.528 . . . . 0.0 110.404 176.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.04 167.94 20.95 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.131 0.491 . . . . 0.0 110.128 169.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 -78.92 82.63 5.1 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 168.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -57.57 -15.09 6.34 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -176.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.55 -43.96 80.42 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.22 1.408 . . . . 0.0 111.215 169.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 64.1 mt -64.58 -47.12 90.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.91 -50.94 71.63 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.777 0.831 . . . . 0.0 110.923 -176.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.6 p -65.05 -46.95 79.13 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.593 -174.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -60.04 -40.2 88.56 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.311 0.959 . . . . 0.0 110.592 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -66.39 -47.52 73.06 Favored 'General case' 0 CA--C 1.528 0.12 0 O-C-N 121.86 -0.525 . . . . 0.0 111.457 176.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 61.7 mt -64.82 -40.25 88.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 119.369 0.986 . . . . 0.0 109.128 -177.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 92.8 mttt . . . . . 0 N--CA 1.469 0.475 0 CA-C-N 119.449 1.022 . . . . 0.0 109.551 174.852 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.5 t . . . . . 0 N--CA 1.454 -0.275 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.3 p -134.53 171.59 14.1 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.481 1.112 . . . . 0.0 109.4 176.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 27.6 p-90 . . . . . 0 C--O 1.234 0.276 0 O-C-N 121.674 -0.641 . . . . 0.0 110.709 173.984 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.442 0 CA-C-O 121.499 0.666 . . . . 0.0 110.785 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -152.93 152.12 31.11 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 170.235 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 57.0 mt -53.54 -36.88 62.29 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 118.627 0.649 . . . . 0.0 112.12 -178.165 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.56 -25.21 68.13 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.871 0.759 . . . . 0.0 112.509 -179.09 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.4 mt -83.57 -20.81 33.11 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.316 0.646 . . . . 0.0 111.561 -176.961 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 24.0 mt -68.07 128.94 93.26 Favored Pre-proline 0 CA--C 1.539 0.527 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -177.085 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -50.81 117.94 3.76 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 123.337 2.691 . . . . 0.0 110.705 169.705 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -73.01 -34.37 66.34 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 122.65 0.38 . . . . 0.0 111.532 -171.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.7 t -141.64 123.06 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 177.847 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -143.58 107.68 4.74 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 106.86 -1.534 . . . . 0.0 106.86 171.35 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.6 pt . . . . . 0 CA--C 1.532 0.256 0 C-N-CA 123.599 0.76 . . . . 0.0 110.49 -169.794 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 . . . . . 0 C--O 1.238 0.465 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -73.76 162.91 28.64 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.219 1.008 . . . . 0.0 112.548 -170.277 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -151.3 163.41 38.97 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.514 1.926 . . . . 0.0 108.006 169.813 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.3 m -131.07 155.9 42.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 124.756 1.222 . . . . 0.0 109.816 172.125 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.1 117.67 34.75 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 178.233 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 69.1 mt -121.49 113.85 40.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -171.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.5 ttm-85 -69.88 142.41 53.01 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 168.699 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.8 p -140.86 147.81 22.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -122.13 151.77 40.6 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.929 1.292 . . . . 0.0 109.347 -174.61 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 56.0 m -62.51 93.28 0.05 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.094 0.958 . . . . 0.0 110.955 172.376 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.404 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -138.87 24.3 0.07 OUTLIER Pre-proline 0 CA--C 1.552 1.027 0 CA-C-O 116.767 -1.587 . . . . 0.0 114.015 169.442 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.404 ' CD ' ' N ' ' A' ' 30' ' ' ALA . 83.5 Cg_exo . . . . . 0 C--N 1.359 1.091 0 CA-C-N 123.774 2.383 . . . . 0.0 113.606 172.409 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 . . . . . 0 CA--C 1.541 0.633 0 CA-C-O 121.455 0.645 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.4 m -141.89 160.98 39.09 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.097 1.359 . . . . 0.0 109.004 176.659 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.8 tttt -148.24 165.77 29.96 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 126.963 2.105 . . . . 0.0 107.117 -174.462 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -125.64 131.38 52.65 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 169.782 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 44.2 pt -112.85 159.59 12.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 125.414 1.486 . . . . 0.0 110.569 174.068 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 25.0 t -126.24 121.77 59.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 -173.63 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 26.4 mmt85 -139.34 147.02 40.98 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.382 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.53 135.71 2.49 Favored Glycine 0 C--N 1.331 0.305 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 -179.656 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -153.57 155.71 36.65 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -171.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -59.36 -29.98 68.07 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -179.049 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 8.9 p-90 -68.46 -23.75 64.62 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.78 0.718 . . . . 0.0 112.4 -179.481 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.03 78.61 8.7 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 119.346 0.975 . . . . 0.0 110.085 177.064 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -62.3 -18.39 61.2 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.943 0.897 . . . . 0.0 111.468 172.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -128.1 143.15 51.05 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.771 1.629 . . . . 0.0 106.888 178.829 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -65.08 -30.92 71.92 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 118.478 0.581 . . . . 0.0 109.828 176.623 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.54 -29.35 58.78 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 118.484 -0.77 . . . . 0.0 112.788 171.445 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -68.71 -49.5 58.4 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.559 1.072 . . . . 0.0 110.476 -175.255 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.444 HG12 ' H ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -66.93 -38.08 80.68 Favored 'Isoleucine or valine' 0 C--N 1.34 0.18 0 CA-C-O 117.859 -1.067 . . . . 0.0 110.157 175.8 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -61.95 -47.67 83.82 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 119.776 1.171 . . . . 0.0 110.275 179.036 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -61.96 -46.71 88.09 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.319 0.509 . . . . 0.0 111.362 179.163 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 32.6 tttt -62.92 -54.8 32.9 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 123.027 0.531 . . . . 0.0 111.078 -179.451 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 86.2 t -72.3 -49.3 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-O 118.183 -0.913 . . . . 0.0 109.161 -170.549 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.8 m -65.45 -28.27 69.11 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 120.048 1.294 . . . . 0.0 110.992 178.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.13 -49.29 76.4 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 170.219 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -62.45 -44.3 96.73 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 118.734 1.267 . . . . 0.0 111.304 177.458 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 39.2 mmt -55.99 -49.34 73.88 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-O 119.133 -0.461 . . . . 0.0 110.032 175.183 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -66.75 -29.11 69.0 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.965 0.802 . . . . 0.0 112.281 179.598 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -67.59 -37.33 82.43 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.718 1.144 . . . . 0.0 110.511 171.014 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -69.1 -27.5 65.65 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 119.546 1.066 . . . . 0.0 110.479 169.549 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 122.37 -25.72 6.55 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 127.914 2.673 . . . . 0.0 111.215 177.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 95.9 m -54.16 142.92 24.14 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 126.732 2.013 . . . . 0.0 110.792 -175.538 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -108.84 142.0 40.06 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -176.219 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 85.7 m -137.57 165.55 26.05 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 -167.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -153.03 125.74 8.31 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.864 2.066 . . . . 0.0 107.124 173.748 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.8 p -73.55 124.71 26.42 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 169.435 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 35.1 mt -71.41 -25.74 62.46 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.796 -0.565 . . . . 0.0 110.257 172.38 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 162.69 -165.34 36.22 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 108.477 -1.849 . . . . 0.0 108.477 177.89 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -148.04 173.35 28.11 Favored Glycine 0 CA--C 1.519 0.329 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 173.624 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -168.36 -160.23 15.7 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 108.501 -1.84 . . . . 0.0 108.501 -178.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 35.6 ptt-85 -136.4 160.16 39.58 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 121.084 -1.245 . . . . 0.0 108.057 177.357 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 86.5 mt . . . . . 0 C--N 1.325 -0.487 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 -170.803 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 23.7 t60 . . . . . 0 C--O 1.232 0.132 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.1 t -145.45 133.94 16.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 176.274 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -169.74 -176.97 2.54 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.07 0.948 . . . . 0.0 109.302 -179.416 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 102.71 -170.06 19.77 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.407 -0.677 . . . . 0.0 111.407 173.824 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -157.92 151.51 23.67 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.858 0.863 . . . . 0.0 109.833 179.48 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.8 t -84.36 148.24 26.73 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 168.678 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 4.5 ptt? -76.27 -41.06 50.15 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 169.795 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.26 -25.14 54.66 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 118.881 -0.581 . . . . 0.0 112.246 -173.19 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -135.05 -1.83 2.62 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -169.619 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.04 -178.08 49.46 Favored Glycine 0 CA--C 1.535 1.297 0 CA-C-N 119.141 0.882 . . . . 0.0 113.089 176.415 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.86 139.57 33.59 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.999 2.466 . . . . 0.0 110.129 175.181 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.49 170.49 16.46 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.045 0.538 . . . . 0.0 110.58 169.758 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -78.4 84.0 4.59 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 168.605 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 48.5 m80 -57.95 -14.14 5.82 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -175.933 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.78 -41.1 85.86 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.429 1.492 . . . . 0.0 111.937 169.914 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 67.7 mt -65.8 -45.07 92.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.856 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.61 -49.38 76.62 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.354 1.061 . . . . 0.0 110.917 -179.006 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.4 p -63.19 -48.58 77.77 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 118.295 -0.86 . . . . 0.0 110.763 -176.438 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -60.08 -39.3 85.59 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.248 0.931 . . . . 0.0 110.764 -177.33 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 52.9 mttm -71.24 -45.05 64.11 Favored 'General case' 0 CA--C 1.528 0.112 0 O-C-N 121.839 -0.538 . . . . 0.0 111.817 178.652 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 73.9 mt -65.73 -38.29 81.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-N 119.363 0.983 . . . . 0.0 108.943 -179.444 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 92.7 mttt . . . . . 0 N--CA 1.468 0.431 0 CA-C-N 119.471 1.032 . . . . 0.0 109.115 171.905 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 C--O 1.235 0.293 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.7 p -133.01 169.9 16.16 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.353 1.061 . . . . 0.0 109.76 177.606 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 41.6 p-90 . . . . . 0 C--O 1.235 0.339 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 171.231 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.3 mmt . . . . . 0 N--CA 1.482 1.164 0 CA-C-O 121.74 0.781 . . . . 0.0 111.037 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.52 164.57 31.21 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 126.665 1.986 . . . . 0.0 105.958 169.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.6 p -138.69 120.46 17.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 175.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.54 174.57 4.06 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.98 0.895 . . . . 0.0 110.281 175.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -148.74 149.94 32.26 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 105.053 -2.202 . . . . 0.0 105.053 169.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 17.0 mt -60.23 -26.93 66.78 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -171.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.58 -28.06 65.64 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.888 0.767 . . . . 0.0 112.434 175.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.8 mt -79.3 -28.08 42.19 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 123.334 0.654 . . . . 0.0 111.149 -177.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 39.9 mt -64.85 128.0 93.22 Favored Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -47.16 130.31 16.56 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.41 2.74 . . . . 0.0 110.944 171.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -81.74 -37.63 26.97 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.357 0.599 . . . . 0.0 110.922 -173.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 43.8 t -134.73 135.13 53.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 170.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -152.93 123.54 7.27 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 169.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 20.2 pt -148.57 159.33 6.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 125.601 1.56 . . . . 0.0 107.334 -171.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -126.42 102.13 7.01 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 170.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.6 m -116.83 131.94 56.82 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.499 1.12 . . . . 0.0 111.354 -168.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -159.05 40.15 0.22 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.02 0.928 . . . . 0.0 110.775 171.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 155.48 -119.53 0.93 Allowed Glycine 0 C--N 1.339 0.746 0 O-C-N 120.91 -1.119 . . . . 0.0 111.333 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 91.1 t -123.98 122.77 65.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 126.836 2.054 . . . . 0.0 106.275 -177.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -161.1 156.17 24.11 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.281 1.032 . . . . 0.0 108.786 -175.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -81.8 155.83 25.22 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 123.213 0.605 . . . . 0.0 110.772 -172.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -144.54 160.42 41.14 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.73 1.212 . . . . 0.0 108.174 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.1 m -132.85 152.34 35.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 C-N-CA 124.299 1.04 . . . . 0.0 109.169 173.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.36 123.65 47.22 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 103.654 -2.721 . . . . 0.0 103.654 173.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.7 mt -125.55 121.16 59.53 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 -177.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 23.1 ttp180 -76.64 143.47 40.12 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 169.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.2 t -133.66 142.45 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 C-N-CA 128.568 2.747 . . . . 0.0 104.593 -172.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -127.77 151.95 48.37 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.164 0.985 . . . . 0.0 108.806 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 39.1 m -63.7 90.74 0.06 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.997 0.919 . . . . 0.0 111.48 175.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.42 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -136.32 19.21 0.05 OUTLIER Pre-proline 0 CA--C 1.552 1.025 0 CA-C-O 116.473 -1.727 . . . . 0.0 113.201 168.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.42 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 77.0 Cg_exo -46.67 147.26 4.63 Favored 'Trans proline' 0 C--N 1.362 1.284 0 CA-C-N 123.915 2.434 . . . . 0.0 113.064 172.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.9 mmm180 52.1 10.26 0.12 Allowed 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -173.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.8 m 52.1 29.09 5.99 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.291 1.036 . . . . 0.0 110.957 -169.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -164.17 3.03 0.06 OUTLIER Glycine 0 C--N 1.344 0.973 0 CA-C-O 118.445 -1.197 . . . . 0.0 114.984 -169.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.08 137.4 73.63 Favored Pre-proline 0 CA--C 1.544 0.731 0 CA-C-N 119.617 1.708 . . . . 0.0 109.586 169.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.23 -19.91 14.97 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.708 2.272 . . . . 0.0 112.967 -175.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.44 159.41 18.44 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.725 0.81 . . . . 0.0 110.762 176.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -142.88 35.39 1.4 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.338 1.455 . . . . 0.0 109.295 177.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -79.65 177.16 9.08 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.672 0.789 . . . . 0.0 109.437 176.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 12.5 m -140.28 158.55 43.85 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.503 1.121 . . . . 0.0 108.66 170.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -150.95 165.4 33.83 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 127.284 2.233 . . . . 0.0 105.822 -173.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.9 mp0 -128.72 147.87 50.8 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 176.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.3 pt -127.11 154.38 37.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 124.623 1.169 . . . . 0.0 109.456 176.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.0 t -117.66 119.28 61.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 178.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.414 ' HG3' HG21 ' A' ' 60' ' ' VAL . 9.9 mmp_? -129.49 145.28 51.46 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.007 1.323 . . . . 0.0 107.454 176.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.98 134.43 2.32 Favored Glycine 0 N--CA 1.452 -0.282 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 177.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -151.92 150.2 29.78 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -170.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -60.69 -27.57 67.96 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 118.88 -0.581 . . . . 0.0 112.407 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 11.3 p-90 -69.72 -26.16 64.2 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.259 0.936 . . . . 0.0 113.02 176.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.02 82.27 7.68 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 119.926 1.239 . . . . 0.0 109.667 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -66.34 -12.45 56.79 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.029 0.932 . . . . 0.0 111.884 176.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -142.06 152.01 42.92 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.522 1.929 . . . . 0.0 107.946 178.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -73.9 -32.88 63.78 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 121.692 -0.63 . . . . 0.0 110.308 -170.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.09 -28.39 52.13 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-O 118.561 -0.733 . . . . 0.0 112.265 172.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -66.43 -48.72 69.1 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 119.269 0.941 . . . . 0.0 110.731 -176.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.427 HG12 ' H ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -67.89 -42.85 86.12 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.675 177.568 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -61.51 -44.63 96.73 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 119.896 1.225 . . . . 0.0 110.098 -177.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -63.03 -48.55 78.25 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.888 0.767 . . . . 0.0 111.936 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 36.1 tttt -62.41 -52.89 61.77 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.387 0.675 . . . . 0.0 110.951 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.414 HG21 ' HG3' ' A' ' 45' ' ' ARG . 78.4 t -70.86 -49.61 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-O 118.231 -0.89 . . . . 0.0 109.125 -170.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 66.7 m -68.25 -23.4 64.78 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 119.721 1.146 . . . . 0.0 111.186 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.6 -48.82 78.77 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 169.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.419 ' HA ' ' HE3' ' A' ' 66' ' ' LYS . 18.4 t70 -62.27 -45.79 91.68 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 118.448 1.124 . . . . 0.0 111.816 176.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 39.0 mmt -55.99 -48.2 76.32 Favored 'General case' 0 C--O 1.227 -0.083 0 CA-C-N 118.17 0.441 . . . . 0.0 110.463 176.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -69.82 -27.56 64.97 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 118.779 0.718 . . . . 0.0 112.037 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.419 ' HE3' ' HA ' ' A' ' 63' ' ' ASP . 52.1 mtmt -66.58 -36.48 82.73 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.37 0.986 . . . . 0.0 110.25 169.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -70.36 -30.91 67.97 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 120.0 1.273 . . . . 0.0 110.44 169.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 129.62 -26.63 4.29 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 127.618 2.532 . . . . 0.0 111.365 174.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 85.6 m -51.15 142.36 12.72 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 126.306 1.842 . . . . 0.0 111.861 -175.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -101.96 146.73 27.46 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 176.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 79.2 m -143.1 163.28 33.29 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -168.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -150.65 128.88 11.97 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 169.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 9.2 p -66.95 131.58 46.18 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 169.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 38.8 mt -74.83 -21.52 59.23 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 120.974 -1.079 . . . . 0.0 110.176 170.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 162.53 -168.35 37.42 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 108.66 -1.776 . . . . 0.0 108.66 175.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -133.34 172.83 21.36 Favored Glycine 0 CA--C 1.521 0.421 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 173.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -171.59 -163.99 26.47 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 108.084 -2.006 . . . . 0.0 108.084 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 29.2 ptt180 -135.47 154.81 51.3 Favored 'General case' 0 CA--C 1.512 -0.511 0 O-C-N 120.639 -1.506 . . . . 0.0 109.294 172.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.9 mt -110.41 134.96 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 104.331 -2.47 . . . . 0.0 104.331 178.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 18.9 m -139.58 158.87 43.39 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 173.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -148.54 26.43 0.94 Allowed 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.702 -0.624 . . . . 0.0 111.125 176.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -73.1 -96.67 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.42 1.488 . . . . 0.0 108.698 -176.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.2 m 42.44 -150.99 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.202 1.801 . . . . 0.0 112.675 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 -127.07 21.14 6.84 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.621 1.568 . . . . 0.0 108.232 169.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -143.23 118.44 10.16 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 102.792 -3.04 . . . . 0.0 102.792 -177.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.45 ' H ' ' HD2' ' A' ' 86' ' ' LYS . 2.5 mptt -74.28 -0.3 16.55 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 123.887 0.875 . . . . 0.0 113.052 -169.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.1 ttmt -50.55 121.53 5.88 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.409 1.084 . . . . 0.0 108.315 171.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 93.3 mt -66.22 149.29 11.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 175.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 22.3 t60 -136.18 144.88 45.2 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 121.162 -0.961 . . . . 0.0 109.811 -173.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.6 t -133.82 130.43 55.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -173.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -171.26 -175.48 1.68 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.474 0.579 . . . . 0.0 110.235 -169.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.47 -166.47 39.94 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 174.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -157.67 161.09 38.57 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.391 0.676 . . . . 0.0 111.629 175.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.9 t -87.74 154.46 20.55 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 168.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.4 ptm -92.34 -32.37 15.01 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 119.024 0.829 . . . . 0.0 110.422 173.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.19 -24.35 59.34 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.048 0.84 . . . . 0.0 111.836 175.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -133.92 -4.9 2.79 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -169.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.4 -177.21 52.92 Favored Glycine 0 CA--C 1.535 1.317 0 CA-C-N 119.412 1.006 . . . . 0.0 113.124 175.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.58 138.55 38.66 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.232 2.621 . . . . 0.0 110.41 176.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.45 169.56 18.01 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.694 0.798 . . . . 0.0 111.192 169.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -79.5 80.85 5.83 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 169.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 41.9 m80 -56.1 -20.13 16.03 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.843 0.857 . . . . 0.0 113.244 -178.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.23 -44.3 71.6 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.428 1.491 . . . . 0.0 112.352 169.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 70.7 mt -66.25 -44.7 91.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.43 -49.38 76.42 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.921 0.888 . . . . 0.0 110.78 -178.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.46 HG22 HG12 ' A' ' 118' ' ' VAL . 13.1 p -64.55 -46.71 81.68 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 118.362 -0.827 . . . . 0.0 110.708 -175.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -60.87 -40.1 91.69 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 119.295 0.952 . . . . 0.0 110.705 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 45.1 mttm -68.36 -46.97 68.68 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.807 -0.558 . . . . 0.0 111.509 177.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 68.8 mt -66.63 -38.51 81.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 119.469 1.031 . . . . 0.0 109.198 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -57.68 -47.82 81.25 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 119.696 1.134 . . . . 0.0 109.56 173.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.56 -35.79 81.66 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.051 0.387 . . . . 0.0 111.54 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 21.3 tptt -69.97 -36.27 75.08 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.277 0.631 . . . . 0.0 111.287 178.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -128.37 70.0 78.99 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 124.867 1.267 . . . . 0.0 110.026 -175.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -68.32 -14.77 41.07 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.835 2.357 . . . . 0.0 112.859 -176.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -67.69 -20.93 65.34 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.895 0.878 . . . . 0.0 112.017 172.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -116.18 -175.65 2.79 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.729 2.011 . . . . 0.0 108.331 -178.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -136.68 161.81 34.91 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 171.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.46 HG12 HG22 ' A' ' 106' ' ' THR . 3.1 t -140.75 144.78 26.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 -172.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.6 p -136.83 170.18 16.52 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.496 1.119 . . . . 0.0 109.507 177.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 41.8 p-90 -143.75 155.63 44.24 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 172.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.39 120.4 4.41 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 171.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -77.61 1.01 20.98 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 120.341 -0.544 . . . . 0.0 112.277 -171.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -61.32 -33.05 72.95 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.68 1.592 . . . . 0.0 113.007 -176.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -82.86 -171.03 46.7 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 123.561 0.6 . . . . 0.0 112.815 -173.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 2.1 t80 . . . . . 0 C--O 1.236 0.369 0 C-N-CA 124.513 1.125 . . . . 0.0 110.545 -169.582 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptp . . . . . 0 N--CA 1.484 1.23 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.14 165.61 33.35 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.988 1.315 . . . . 0.0 108.914 174.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.9 m -67.67 169.28 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 C-N-CA 123.979 0.912 . . . . 0.0 110.665 173.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -74.15 173.87 9.5 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.776 0.798 . . . . 0.0 111.631 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -146.29 143.72 29.35 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 105.558 -2.016 . . . . 0.0 105.558 169.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 76.6 mt -55.69 -33.03 63.8 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -171.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.82 -25.44 66.44 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.911 0.778 . . . . 0.0 112.318 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.1 mt -81.23 -24.39 37.43 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.481 0.712 . . . . 0.0 111.397 -176.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 52.3 mt -70.9 131.02 87.74 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-O 118.145 -0.931 . . . . 0.0 108.783 -169.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -47.27 120.38 4.32 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 124.26 3.307 . . . . 0.0 112.894 172.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -66.13 -35.76 81.35 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.475 1.51 . . . . 0.0 111.739 -178.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.9 t -143.41 138.23 26.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 176.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -153.19 113.82 4.06 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 169.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.2 pt -141.64 158.48 21.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 123.145 0.578 . . . . 0.0 110.878 -169.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -147.41 43.1 1.1 Allowed 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.427 1.491 . . . . 0.0 109.336 169.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.6 m -72.92 70.24 1.0 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.433 1.093 . . . . 0.0 108.753 170.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -74.96 36.27 0.11 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.352 1.861 . . . . 0.0 112.151 -177.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 159.69 -174.38 36.53 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 127.237 2.351 . . . . 0.0 107.858 -170.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.0 t -70.25 98.95 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 174.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -142.58 158.01 44.12 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.676 1.19 . . . . 0.0 109.782 -177.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.4 mttm -70.48 156.2 39.69 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.63 1.172 . . . . 0.0 111.785 -172.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -144.54 161.59 38.72 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.614 1.966 . . . . 0.0 107.639 169.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.1 m -129.15 151.76 36.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 124.971 1.309 . . . . 0.0 109.537 173.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.97 120.34 39.66 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 104.202 -2.518 . . . . 0.0 104.202 171.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 46.1 mt -122.06 127.34 75.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 -177.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -81.36 148.0 29.56 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 169.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.1 t -133.03 144.25 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 -177.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -125.65 154.19 42.7 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.534 1.134 . . . . 0.0 109.396 -176.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 44.3 m -69.54 47.45 0.08 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.996 1.718 . . . . 0.0 114.157 177.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.13 -5.4 0.09 OUTLIER Pre-proline 0 CA--C 1.556 1.192 0 CA-C-O 114.775 -2.536 . . . . 0.0 117.334 169.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -43.43 153.65 0.22 Allowed 'Trans proline' 0 C--N 1.363 1.292 0 C-N-CA 123.599 2.866 . . . . 0.0 115.543 178.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 42.6 ttt180 55.15 14.51 1.02 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.232 1.413 . . . . 0.0 112.707 -169.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.1 m 51.36 25.59 2.66 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.212 1.405 . . . . 0.0 112.099 -169.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 170.69 25.72 0.02 OUTLIER Glycine 0 C--N 1.343 0.96 0 CA-C-O 118.569 -1.128 . . . . 0.0 115.29 -172.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.84 149.41 23.05 Favored Pre-proline 0 CA--C 1.544 0.741 0 CA-C-N 119.446 1.623 . . . . 0.0 110.245 170.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.41 -24.47 19.27 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 122.536 2.158 . . . . 0.0 113.152 -174.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.92 155.03 39.56 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.45 0.7 . . . . 0.0 110.376 175.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -141.11 30.59 1.79 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.827 1.251 . . . . 0.0 110.109 176.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 -74.15 173.77 9.65 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-O 121.647 0.737 . . . . 0.0 109.903 174.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.5 m -140.71 160.38 40.17 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.862 1.265 . . . . 0.0 108.778 172.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -148.28 170.19 18.45 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 127.43 2.292 . . . . 0.0 106.291 -173.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.3 mp0 -133.15 154.08 50.94 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 121.084 -1.01 . . . . 0.0 108.294 178.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 34.2 pt -137.69 156.58 32.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 C-N-CA 125.712 1.605 . . . . 0.0 109.337 178.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 85.4 t -118.7 119.42 61.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.0 mmt85 -134.84 143.46 47.03 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -179.99 136.24 2.69 Favored Glycine 0 CA--C 1.509 -0.287 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -178.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -154.74 153.3 31.03 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -169.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -55.05 -29.67 57.96 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 178.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 8.7 p-90 -73.53 -22.54 60.07 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.969 0.804 . . . . 0.0 113.124 -179.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.86 83.5 7.17 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-N 120.056 1.298 . . . . 0.0 110.047 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -64.18 -18.41 64.46 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.976 0.91 . . . . 0.0 112.003 176.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -138.08 146.85 43.43 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.746 1.619 . . . . 0.0 108.398 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 29.2 m80 -65.03 -33.77 76.83 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.133 0.573 . . . . 0.0 110.832 -175.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.93 -25.82 45.03 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 118.382 -0.818 . . . . 0.0 112.987 173.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -67.75 -50.83 55.12 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 119.705 1.139 . . . . 0.0 110.569 -176.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.414 HG12 ' H ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -67.65 -37.17 78.2 Favored 'Isoleucine or valine' 0 C--N 1.339 0.147 0 CA-C-O 117.913 -1.041 . . . . 0.0 109.976 176.333 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -60.3 -49.47 77.46 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.651 1.114 . . . . 0.0 110.45 178.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -63.2 -47.1 84.01 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.345 0.52 . . . . 0.0 111.3 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.2 tttt -61.1 -53.7 53.76 Favored 'General case' 0 CA--C 1.522 -0.124 0 C-N-CA 123.126 0.571 . . . . 0.0 111.091 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 95.4 t -71.94 -44.91 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 117.937 -1.03 . . . . 0.0 109.294 -171.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.0 m -62.73 -33.77 75.82 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 120.292 1.406 . . . . 0.0 110.703 177.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.33 -47.6 89.93 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-N 118.946 0.794 . . . . 0.0 111.273 171.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -63.04 -46.29 88.23 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 118.625 1.213 . . . . 0.0 111.363 178.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 38.2 mmt -57.27 -45.93 83.57 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 123.488 0.715 . . . . 0.0 110.727 175.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -63.79 -36.42 83.82 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.786 0.835 . . . . 0.0 111.696 177.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -66.89 -37.21 83.96 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 119.232 0.923 . . . . 0.0 110.917 172.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -68.78 -23.65 64.33 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 119.283 0.947 . . . . 0.0 111.965 171.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 118.1 -12.93 12.76 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 126.248 1.88 . . . . 0.0 112.626 174.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 91.0 m -67.27 168.45 10.49 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.022 1.329 . . . . 0.0 111.55 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -125.44 152.11 45.33 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 170.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 65.4 m -143.44 163.69 32.41 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -168.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -148.71 137.59 21.49 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.042 1.737 . . . . 0.0 106.843 170.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.9 p -78.7 118.49 20.83 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 169.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 44.3 mt -70.85 -22.59 62.29 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 122.023 -0.423 . . . . 0.0 110.381 174.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 163.42 -166.76 37.34 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 172.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -151.68 175.66 30.39 Favored Glycine 0 CA--C 1.52 0.344 0 N-CA-C 111.807 -0.517 . . . . 0.0 111.807 171.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -166.6 -162.07 17.25 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 108.366 -1.894 . . . . 0.0 108.366 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.95 164.94 25.84 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 120.893 -1.357 . . . . 0.0 108.515 174.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 68.8 mt -114.53 144.1 22.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 -171.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 39.0 p -155.88 -152.55 0.39 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.855 1.662 . . . . 0.0 108.345 -175.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.41 160.01 41.78 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.139 1.376 . . . . 0.0 109.009 173.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -124.89 77.79 1.64 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.13 0.972 . . . . 0.0 109.765 -170.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.5 m 58.66 12.93 2.38 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 169.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -142.13 138.55 31.7 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 174.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -58.77 -26.99 64.56 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -169.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 35.9 mtmt -118.91 11.39 12.55 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 118.103 -0.951 . . . . 0.0 113.032 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -95.68 86.04 4.31 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 169.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 78.8 mt -60.72 158.75 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 172.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -141.1 160.09 40.83 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 120.611 -1.305 . . . . 0.0 110.124 -177.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.0 t -141.84 137.11 31.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -163.03 -179.58 6.83 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.953 0.901 . . . . 0.0 109.247 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.9 -166.5 19.22 Favored Glycine 0 CA--C 1.523 0.553 0 O-C-N 121.695 -0.628 . . . . 0.0 112.592 169.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -159.07 157.85 31.87 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.903 1.281 . . . . 0.0 109.527 178.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.4 t -89.96 147.33 23.77 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 168.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.42 -42.46 62.02 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 171.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -80.72 -24.6 38.67 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 118.912 -0.566 . . . . 0.0 112.205 -171.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -132.49 -1.07 3.53 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -169.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.11 -179.72 49.81 Favored Glycine 0 CA--C 1.534 1.249 0 CA-C-N 118.964 0.802 . . . . 0.0 113.288 173.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.38 138.63 33.19 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.935 2.423 . . . . 0.0 109.981 175.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.07 168.1 20.65 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.254 0.55 . . . . 0.0 111.094 170.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -79.26 81.82 5.48 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 168.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 45.7 m80 -57.04 -18.38 13.85 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -174.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.82 -40.36 69.49 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.018 1.327 . . . . 0.0 112.151 170.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 61.2 mt -66.06 -47.28 85.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 178.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.42 -49.29 78.37 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.315 1.046 . . . . 0.0 110.798 -176.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 31.0 p -63.32 -49.12 75.2 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 118.642 -0.694 . . . . 0.0 109.568 -175.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -59.35 -40.72 87.34 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.11 0.868 . . . . 0.0 111.31 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 44.4 mttm -65.72 -47.15 76.31 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 118.507 0.594 . . . . 0.0 111.338 177.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 67.7 mt -64.01 -39.26 84.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 CA-C-N 119.202 0.91 . . . . 0.0 109.235 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.0 mtpt -61.91 -44.23 97.22 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.351 0.978 . . . . 0.0 109.999 177.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.13 -40.19 96.87 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.156 0.434 . . . . 0.0 111.15 176.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.457 ' HA ' ' HE2' ' A' ' 112' ' ' LYS . 0.7 OUTLIER -66.16 -32.27 73.62 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 118.056 -0.973 . . . . 0.0 111.835 178.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -133.36 73.28 73.94 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 119.208 0.913 . . . . 0.0 110.213 -173.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.31 -26.08 50.62 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 123.446 2.764 . . . . 0.0 115.141 -176.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -72.63 -11.82 60.8 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.493 0.717 . . . . 0.0 112.642 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -112.87 174.85 5.7 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.865 1.666 . . . . 0.0 109.039 -178.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -133.62 160.57 37.1 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 169.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.2 t -144.14 142.73 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 -174.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 9.7 p -135.08 171.25 14.69 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.694 1.198 . . . . 0.0 108.764 176.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 55.7 p-90 -142.81 156.54 44.98 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 172.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -154.57 102.76 2.42 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 174.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.07 -0.6 22.39 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -169.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -58.1 -30.12 66.02 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.373 1.069 . . . . 0.0 112.201 178.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -73.84 131.8 14.65 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 170.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 . . . . . 0 C--O 1.239 0.535 0 C-N-CA 125.614 1.566 . . . . 0.0 108.747 178.302 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.7 mmm . . . . . 0 N--CA 1.483 1.215 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.52 -174.07 3.94 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.456 1.502 . . . . 0.0 108.827 175.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.0 p -145.55 153.91 13.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 124.848 1.259 . . . . 0.0 107.861 177.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -162.95 -162.85 0.8 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.798 2.039 . . . . 0.0 107.463 -175.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -146.21 153.06 40.18 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.675 1.99 . . . . 0.0 105.887 169.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 54.4 mt -53.15 -36.2 60.58 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.036 0.835 . . . . 0.0 112.077 -177.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.24 -25.72 68.19 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 118.801 0.728 . . . . 0.0 112.571 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.9 mt -83.73 -22.24 32.04 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.465 0.706 . . . . 0.0 111.489 -177.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 15.9 mt -66.48 131.71 94.2 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -50.39 128.9 24.49 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.842 2.361 . . . . 0.0 110.786 171.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -74.66 -41.69 59.86 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.378 0.671 . . . . 0.0 110.794 -176.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 53.5 t -136.29 129.18 46.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 177.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -152.12 111.94 4.0 Favored 'General case' 0 CA--C 1.521 -0.173 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 171.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 9.5 pt -147.86 157.97 8.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 125.077 1.351 . . . . 0.0 109.067 -169.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -59.23 -51.12 71.33 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.837 0.855 . . . . 0.0 112.697 -176.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.8 m 41.97 43.77 2.77 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.977 1.711 . . . . 0.0 114.65 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -132.02 11.25 4.66 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.289 1.035 . . . . 0.0 111.187 173.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.33 -161.84 35.41 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 94.5 t -71.48 140.69 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 123.679 0.792 . . . . 0.0 108.946 169.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -163.85 167.42 20.78 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.844 1.257 . . . . 0.0 109.787 169.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.5 mttt -99.62 151.7 20.89 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.603 1.161 . . . . 0.0 108.83 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -142.91 162.8 34.5 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.232 1.013 . . . . 0.0 108.984 -174.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.0 m -133.6 155.25 40.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 C-N-CA 124.542 1.137 . . . . 0.0 109.718 173.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -106.96 116.73 32.44 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 178.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 80.3 mt -120.71 115.11 45.98 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -173.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -72.76 142.83 48.13 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 168.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.6 p -138.75 146.9 25.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -127.85 146.83 50.49 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.884 1.274 . . . . 0.0 108.484 -171.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 61.2 m -61.95 100.21 0.15 Allowed 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.598 0.759 . . . . 0.0 111.077 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.499 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -144.98 22.75 0.04 OUTLIER Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 126.029 1.732 . . . . 0.0 112.976 168.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.499 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 72.0 Cg_exo -46.36 150.77 2.02 Favored 'Trans proline' 0 C--N 1.361 1.235 0 CA-C-N 123.872 2.419 . . . . 0.0 114.991 178.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.9 14.19 0.3 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.562 1.545 . . . . 0.0 113.282 -171.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.6 m 53.68 31.34 12.57 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.664 1.185 . . . . 0.0 111.69 -169.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -163.99 0.85 0.05 OUTLIER Glycine 0 CA--C 1.533 1.169 0 CA-C-O 118.326 -1.263 . . . . 0.0 115.982 -174.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.28 142.07 76.37 Favored Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 119.842 1.821 . . . . 0.0 110.911 176.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -79.22 -20.36 9.9 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.015 2.477 . . . . 0.0 113.743 -174.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.96 159.53 22.72 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.612 0.765 . . . . 0.0 110.838 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -143.43 30.05 1.4 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.563 1.145 . . . . 0.0 111.214 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -76.36 176.25 8.36 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.234 0.54 . . . . 0.0 109.891 171.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.9 m -143.27 159.94 41.4 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.964 1.306 . . . . 0.0 108.936 176.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.8 tttt -149.6 165.54 31.96 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 126.768 2.027 . . . . 0.0 107.246 -174.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -124.95 128.4 48.54 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 169.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 39.5 pt -108.89 155.07 10.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 124.84 1.256 . . . . 0.0 110.257 173.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 33.1 t -119.32 114.92 46.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 -175.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 12.7 mmp_? -128.38 146.84 50.66 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.084 1.353 . . . . 0.0 108.404 -177.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 174.98 137.55 2.52 Favored Glycine 0 C--N 1.332 0.306 0 CA-C-N 118.849 0.75 . . . . 0.0 111.303 176.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -153.33 154.16 34.02 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -169.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -56.92 -34.47 68.0 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 118.591 -0.719 . . . . 0.0 112.556 175.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 10.1 p-90 -65.5 -27.31 68.39 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.1 0.864 . . . . 0.0 112.294 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -87.29 73.22 9.72 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 119.033 0.833 . . . . 0.0 109.585 175.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -67.9 -5.05 14.89 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.458 0.703 . . . . 0.0 111.648 175.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -138.66 147.96 43.45 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 126.197 1.799 . . . . 0.0 107.142 173.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 59.9 m80 -73.89 -31.49 63.14 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 121.812 -0.555 . . . . 0.0 110.185 -169.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.76 -28.72 50.69 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 118.333 -0.842 . . . . 0.0 112.586 171.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -67.49 -49.31 64.06 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 119.624 1.102 . . . . 0.0 110.729 -177.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.401 ' H ' HG12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -67.35 -38.5 80.95 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 CA-C-O 117.732 -1.127 . . . . 0.0 110.045 177.058 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -64.43 -41.88 96.34 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 120.19 1.359 . . . . 0.0 110.669 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -63.43 -48.83 76.14 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.315 0.961 . . . . 0.0 111.304 176.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -56.79 -55.7 30.89 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.372 1.069 . . . . 0.0 110.628 178.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 81.1 t -77.08 -44.43 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-O 117.79 -1.1 . . . . 0.0 109.791 -169.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.1 t -62.73 -36.85 84.36 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 120.555 1.525 . . . . 0.0 109.266 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.51 -50.74 64.51 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 172.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -62.71 -45.95 90.36 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 118.728 1.264 . . . . 0.0 111.755 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 38.7 mmt -57.31 -47.86 80.42 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.377 0.671 . . . . 0.0 110.145 176.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -66.54 -30.92 71.33 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 118.698 -0.668 . . . . 0.0 111.805 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -67.48 -35.13 78.56 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.757 1.162 . . . . 0.0 110.724 170.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -72.8 -15.05 61.64 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 119.525 1.057 . . . . 0.0 111.208 169.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 110.04 -25.5 16.2 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 127.431 2.443 . . . . 0.0 112.247 177.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 93.3 m -55.8 149.28 14.95 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.957 1.703 . . . . 0.0 111.936 -175.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -108.87 143.36 38.18 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 177.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 96.1 m -141.3 164.91 28.98 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -168.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -151.41 128.37 11.04 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.794 1.637 . . . . 0.0 106.932 171.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.1 p -73.48 117.3 15.07 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 169.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 39.4 mt -70.76 -23.42 62.41 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.904 -0.497 . . . . 0.0 110.563 174.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.42 -170.97 42.46 Favored Glycine 0 C--N 1.337 0.626 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 171.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -132.23 169.91 22.02 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 174.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -174.34 -161.57 24.49 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -177.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 50.0 ttt180 -141.65 152.22 43.75 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 125.082 1.353 . . . . 0.0 107.816 -172.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 40.6 mt -123.79 139.89 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 173.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 18.6 m -140.47 151.5 44.9 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 172.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 72.0 m-70 -76.27 -17.09 59.63 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 118.737 -0.649 . . . . 0.0 112.173 178.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 38.1 mm-40 -145.61 143.52 29.92 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.5 1.92 . . . . 0.0 106.949 171.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 65.1 m -148.36 -149.71 0.31 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.326 1.45 . . . . 0.0 108.222 174.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -60.25 -8.38 2.51 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.839 1.256 . . . . 0.0 113.415 171.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -127.4 150.74 49.49 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.429 1.492 . . . . 0.0 107.919 169.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -84.05 -2.36 56.55 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -169.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.43 174.74 9.3 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 120.503 1.502 . . . . 0.0 109.097 169.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 77.3 mt -60.5 130.45 24.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 102.478 -3.156 . . . . 0.0 102.478 167.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 22.9 t60 -121.86 150.44 41.93 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 118.868 0.758 . . . . 0.0 110.378 -169.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.9 t -129.11 125.02 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -164.77 -167.98 1.36 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.694 0.798 . . . . 0.0 109.076 -171.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.71 -176.09 53.95 Favored Glycine 0 CA--C 1.527 0.793 0 O-C-N 121.633 -0.667 . . . . 0.0 111.473 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -158.97 149.84 20.01 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.01 0.924 . . . . 0.0 110.804 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.0 t -75.37 162.48 28.35 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 168.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.2 ptm -103.72 -31.27 9.93 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 118.629 -0.7 . . . . 0.0 110.783 170.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -73.71 -25.74 60.36 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 119.351 0.978 . . . . 0.0 111.6 174.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -132.49 -6.17 3.3 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.941 0.896 . . . . 0.0 113.351 -169.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.94 -176.1 54.1 Favored Glycine 0 CA--C 1.534 1.277 0 CA-C-N 118.945 0.793 . . . . 0.0 113.39 173.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -67.67 135.23 35.18 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.267 2.645 . . . . 0.0 110.471 175.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.69 168.23 20.44 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.11 0.564 . . . . 0.0 110.891 169.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -81.56 80.07 8.01 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 169.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -55.46 -20.5 12.77 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.09 -44.29 67.47 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.925 1.29 . . . . 0.0 112.196 170.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 71.7 mt -64.59 -48.35 85.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.46 -50.94 71.41 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.508 1.123 . . . . 0.0 110.443 -176.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.2 p -64.69 -46.25 83.19 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 119.347 0.976 . . . . 0.0 111.048 -175.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -60.7 -39.92 90.28 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.564 1.074 . . . . 0.0 110.625 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.3 mttt -72.55 -41.34 65.87 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 121.676 -0.64 . . . . 0.0 111.965 178.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 76.8 mt -65.76 -41.75 90.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 119.289 0.95 . . . . 0.0 108.662 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -55.88 -47.42 77.41 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.54 1.063 . . . . 0.0 109.882 173.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.43 -41.82 98.99 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 119.2 -0.428 . . . . 0.0 111.646 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -72.19 -33.6 67.78 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.787 0.721 . . . . 0.0 111.591 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -126.1 63.89 50.98 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 124.092 0.957 . . . . 0.0 110.502 -170.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.68 -10.64 29.13 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.154 2.569 . . . . 0.0 113.309 -174.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -67.77 -10.24 50.99 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.981 0.912 . . . . 0.0 112.231 170.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -129.2 179.64 5.65 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.288 1.835 . . . . 0.0 109.099 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -135.56 155.88 49.76 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 172.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.1 t -137.99 146.74 26.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 -169.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 21.6 p -136.18 168.17 19.89 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.778 1.231 . . . . 0.0 109.247 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 36.5 p-90 -146.1 162.41 38.0 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.838 -0.539 . . . . 0.0 110.321 172.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -152.27 139.05 18.88 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 169.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -81.12 78.58 7.91 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 172.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -141.23 -175.09 4.21 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.043 1.737 . . . . 0.0 106.334 170.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 103.53 -153.41 17.95 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-N 119.526 1.057 . . . . 0.0 111.038 -175.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 87.4 t80 . . . . . 0 C--O 1.238 0.47 0 C-N-CA 125.167 1.387 . . . . 0.0 109.558 176.18 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.7 ttp . . . . . 0 N--CA 1.482 1.139 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.34 -173.3 3.61 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.627 0.771 . . . . 0.0 110.184 172.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 49.9 t -132.83 148.55 31.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 169.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -153.31 -174.35 4.91 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.174 1.79 . . . . 0.0 107.916 -177.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -139.28 149.11 43.89 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 170.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.0 mt -54.75 -33.72 61.62 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.684 0.794 . . . . 0.0 112.343 -174.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.0 -25.22 68.03 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.077 0.853 . . . . 0.0 112.561 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 79.6 mt -78.28 -25.68 46.8 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.205 0.602 . . . . 0.0 111.369 -177.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.0 mt -69.63 130.43 90.48 Favored Pre-proline 0 CA--C 1.538 0.502 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -173.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -50.67 127.6 21.42 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.856 2.371 . . . . 0.0 109.884 169.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -82.39 -34.07 28.48 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 121.88 -0.512 . . . . 0.0 111.481 -171.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 52.5 t -133.92 131.86 56.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 171.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -152.99 126.86 8.93 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 174.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.3 pt -147.93 167.18 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.097 0.959 . . . . 0.0 110.349 -169.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -144.08 89.66 2.05 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.553 1.141 . . . . 0.0 108.588 169.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.1 m -65.11 170.87 4.08 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.901 1.68 . . . . 0.0 113.125 -173.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -146.65 -43.85 0.19 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.669 1.188 . . . . 0.0 110.572 169.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.98 -40.28 0.25 Allowed Glycine 0 CA--C 1.525 0.693 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 177.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 96.6 t -143.26 120.83 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 103.874 -2.639 . . . . 0.0 103.874 169.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -153.9 148.3 26.05 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.055 0.843 . . . . 0.0 110.382 -175.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -72.61 156.19 39.25 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 122.952 0.501 . . . . 0.0 110.464 -176.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -147.64 164.86 32.2 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.472 1.109 . . . . 0.0 108.302 172.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.4 m -133.92 153.08 35.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 C-N-CA 124.725 1.21 . . . . 0.0 108.963 173.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.1 114.71 28.82 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 54.0 mt -119.38 117.92 55.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -170.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.7 ttp180 -73.63 147.13 44.06 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 169.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.0 t -135.2 150.3 29.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 127.097 2.159 . . . . 0.0 105.517 -176.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -131.8 153.86 49.69 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.691 1.196 . . . . 0.0 108.245 176.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.2 m -68.87 44.71 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.946 1.698 . . . . 0.0 114.111 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -73.96 -5.56 0.09 OUTLIER Pre-proline 0 CA--C 1.551 1.004 0 CA-C-O 115.159 -2.353 . . . . 0.0 116.824 172.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -50.18 158.0 2.66 Favored 'Trans proline' 0 C--N 1.359 1.118 0 CA-C-N 125.263 2.915 . . . . 0.0 112.068 169.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 21.8 ttp180 54.32 26.58 7.04 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 121.518 -0.739 . . . . 0.0 110.606 -169.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.6 m 49.87 24.21 1.24 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.169 1.788 . . . . 0.0 113.672 -170.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 143.39 77.88 0.04 OUTLIER Glycine 0 C--N 1.34 0.79 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -176.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -72.43 148.93 91.02 Favored Pre-proline 0 CA--C 1.541 0.618 0 CA-C-N 117.997 0.898 . . . . 0.0 108.932 178.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -54.9 -27.63 54.61 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.418 2.745 . . . . 0.0 115.797 -172.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.15 -40.92 97.58 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.758 0.823 . . . . 0.0 112.339 -175.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 44.82 35.03 1.33 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.631 1.572 . . . . 0.0 113.267 -170.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -83.35 -179.86 7.49 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.278 1.031 . . . . 0.0 109.635 175.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.1 m -141.58 161.18 38.56 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.288 1.435 . . . . 0.0 108.969 174.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.5 tttt -149.63 162.19 40.69 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 126.203 1.801 . . . . 0.0 107.772 -172.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.5 mp0 -130.22 119.75 23.4 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 172.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 43.9 pt -104.99 159.24 5.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 C-N-CA 125.137 1.375 . . . . 0.0 110.705 178.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.4 t -118.14 120.59 64.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.447 ' HG3' HG21 ' A' ' 60' ' ' VAL . 9.4 mmp_? -126.55 141.09 51.98 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 176.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.04 131.81 1.83 Allowed Glycine 0 C--N 1.331 0.256 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 174.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -148.81 147.47 28.8 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -169.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -57.5 -27.31 62.43 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 177.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 12.2 p-90 -68.09 -27.97 66.94 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.221 0.918 . . . . 0.0 112.438 176.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.44 83.39 7.95 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 119.411 1.005 . . . . 0.0 109.054 175.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -66.85 -16.97 64.65 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 122.859 0.464 . . . . 0.0 111.65 176.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -134.3 152.69 51.95 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.028 1.731 . . . . 0.0 108.441 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 76.8 m-70 -73.3 -33.27 65.09 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -169.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.39 -28.75 56.02 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 118.408 -0.806 . . . . 0.0 112.71 173.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -67.63 -49.61 62.12 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 119.443 1.02 . . . . 0.0 110.46 -177.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.21 -42.79 91.7 Favored 'Isoleucine or valine' 0 C--N 1.341 0.209 0 CA-C-O 117.933 -1.032 . . . . 0.0 109.659 175.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -61.05 -45.13 96.03 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.687 1.131 . . . . 0.0 110.68 -177.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -63.32 -49.09 75.34 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.2 0.909 . . . . 0.0 111.655 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 31.5 tttt -59.13 -50.41 74.14 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.599 0.76 . . . . 0.0 110.883 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.447 HG21 ' HG3' ' A' ' 45' ' ' ARG . 91.9 t -72.73 -42.33 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-O 117.832 -1.08 . . . . 0.0 109.012 -172.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 63.0 m -60.15 -33.27 71.94 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-N 120.65 1.568 . . . . 0.0 111.087 173.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.03 -53.92 39.04 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-N 119.468 1.031 . . . . 0.0 110.54 172.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.449 ' HA ' ' HE3' ' A' ' 66' ' ' LYS . 19.0 t70 -60.32 -46.1 91.06 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.442 1.121 . . . . 0.0 111.828 -178.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 35.3 mmt -59.45 -50.21 74.83 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.963 0.905 . . . . 0.0 110.119 178.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -67.07 -29.73 69.59 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 118.461 0.573 . . . . 0.0 111.605 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.449 ' HE3' ' HA ' ' A' ' 63' ' ' ASP . 52.3 mtmt -66.06 -36.55 83.52 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.343 0.974 . . . . 0.0 110.861 170.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -72.44 -13.14 61.37 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.817 1.189 . . . . 0.0 112.069 169.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.76 -10.85 66.49 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 126.267 1.889 . . . . 0.0 112.346 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 85.1 m -56.38 153.0 10.4 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.815 1.308 . . . . 0.0 111.233 175.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -114.3 139.36 49.5 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 170.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 35.4 m -141.56 161.24 38.41 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -168.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -153.35 126.84 8.68 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 176.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.7 p -70.59 121.27 17.55 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 169.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 36.6 mt -66.9 -24.5 66.11 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.864 -0.523 . . . . 0.0 109.82 170.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.91 -170.21 42.66 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 125.3 1.429 . . . . 0.0 109.612 169.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -124.15 169.29 16.23 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 173.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -175.83 -166.29 33.06 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -175.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -143.88 160.38 40.89 Favored 'General case' 0 CA--C 1.516 -0.344 0 O-C-N 120.906 -1.349 . . . . 0.0 109.561 178.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 95.2 mt -123.26 141.48 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 -176.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 18.8 m -139.4 146.4 40.11 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 123.579 0.549 . . . . 0.0 111.237 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.85 171.02 9.95 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.369 1.868 . . . . 0.0 112.988 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -63.8 6.56 0.15 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 127.6 2.36 . . . . 0.0 114.51 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.0 m -113.27 11.61 18.72 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.852 1.261 . . . . 0.0 111.11 174.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 19.9 tp60 -124.19 -19.09 5.66 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.491 1.516 . . . . 0.0 110.358 172.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -150.26 163.48 38.18 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.66 1.984 . . . . 0.0 106.707 171.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -57.19 -28.04 62.49 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.938 0.79 . . . . 0.0 112.831 178.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -127.34 176.45 7.42 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.3 1.44 . . . . 0.0 108.617 179.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 77.9 mt -64.41 132.15 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 N-CA-C 104.255 -2.498 . . . . 0.0 104.255 169.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 21.6 t60 -129.4 150.84 50.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 118.73 0.695 . . . . 0.0 110.308 -169.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.3 t -133.36 135.22 56.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 -178.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -170.56 -171.18 1.02 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -170.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 109.65 -172.74 16.24 Favored Glycine 0 CA--C 1.523 0.55 0 CA-C-N 119.3 0.955 . . . . 0.0 113.32 169.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -157.4 154.02 28.17 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.923 1.689 . . . . 0.0 107.668 -169.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.5 t -126.27 140.25 52.68 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 169.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 21.7 ptp -80.62 -34.98 34.63 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 118.71 -0.662 . . . . 0.0 110.11 173.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.65 -25.03 49.32 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.068 0.849 . . . . 0.0 112.182 -177.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -133.13 -5.29 3.06 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -169.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.87 171.83 42.96 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-N 118.964 0.802 . . . . 0.0 112.044 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.78 137.24 34.92 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.299 2.0 . . . . 0.0 109.312 177.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.18 170.75 6.56 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.16 0.505 . . . . 0.0 111.114 171.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 21.6 mm100 -64.99 -32.82 74.73 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 119.255 -0.402 . . . . 0.0 111.955 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 35.8 m80 61.7 -30.99 0.07 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 128.316 2.646 . . . . 0.0 115.526 -174.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.56 -45.94 88.21 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.649 1.18 . . . . 0.0 111.179 173.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 73.5 mt -61.21 -46.16 97.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.43 -52.04 66.98 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.891 1.276 . . . . 0.0 110.522 -174.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.2 p -64.57 -44.13 91.7 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.418 -177.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -60.63 -41.53 95.08 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.811 1.187 . . . . 0.0 110.736 -179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 25.7 mmtp -65.93 -47.9 73.16 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 118.735 0.698 . . . . 0.0 111.102 176.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 56.6 mt -64.67 -41.87 93.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 119.194 0.906 . . . . 0.0 109.237 -176.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -56.59 -49.48 74.77 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 119.776 1.171 . . . . 0.0 109.619 175.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.76 -36.5 83.28 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 122.478 0.311 . . . . 0.0 111.765 -176.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -90.18 -15.29 31.78 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 118.674 -0.679 . . . . 0.0 112.452 -175.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -132.91 63.94 69.07 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 124.883 1.273 . . . . 0.0 109.369 176.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -71.05 -7.07 20.6 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.133 2.555 . . . . 0.0 112.835 -175.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -61.9 -20.27 63.57 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.382 1.073 . . . . 0.0 112.255 174.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -143.6 -165.97 2.22 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.48 1.112 . . . . 0.0 109.508 176.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -131.76 158.77 40.35 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.116 1.367 . . . . 0.0 108.988 -174.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.2 t -137.25 146.46 27.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 -172.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 17.2 p -136.15 168.21 19.81 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.809 1.244 . . . . 0.0 109.501 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 31.6 p-90 -146.62 156.07 42.94 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 121.762 -0.586 . . . . 0.0 110.411 171.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -159.27 117.96 2.89 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 169.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.76 -1.36 21.67 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 118.458 0.572 . . . . 0.0 112.297 -171.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -58.68 -31.36 68.14 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.441 1.096 . . . . 0.0 112.248 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -78.51 135.3 15.52 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 175.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 52.1 p90 . . . . . 0 C--O 1.239 0.519 0 C-N-CA 125.593 1.557 . . . . 0.0 109.397 171.625 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.9 tpp . . . . . 0 N--CA 1.482 1.135 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.08 168.3 20.63 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.427 1.091 . . . . 0.0 109.661 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.7 t -136.39 119.92 23.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 -178.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.67 -177.63 3.8 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.783 0.833 . . . . 0.0 111.111 177.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -152.93 146.5 25.04 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 169.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 61.3 mt -55.18 -34.3 63.73 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -173.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.22 -26.24 65.61 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.845 0.748 . . . . 0.0 112.159 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.2 mt -81.47 -23.46 37.4 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.513 0.725 . . . . 0.0 111.22 -177.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.8 mt -66.31 129.29 94.17 Favored Pre-proline 0 CA--C 1.538 0.514 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 -175.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -46.65 116.22 1.53 Allowed 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 124.195 3.263 . . . . 0.0 111.777 170.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -72.63 -31.73 65.36 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.603 0.761 . . . . 0.0 111.577 -172.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 64.2 t -141.72 137.24 31.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 171.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -151.18 110.84 4.02 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 169.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 40.5 pt -141.37 158.05 22.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 C-N-CA 124.211 1.005 . . . . 0.0 109.195 -170.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -75.21 -178.54 3.96 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.507 0.723 . . . . 0.0 110.308 172.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.2 m -147.91 0.09 0.63 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.963 1.305 . . . . 0.0 113.114 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -67.15 -25.36 66.13 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 120.159 1.345 . . . . 0.0 113.39 -171.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 176.79 -160.8 28.31 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -174.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.4 t -64.17 143.3 15.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 123.618 0.767 . . . . 0.0 109.243 172.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -156.58 157.84 36.03 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.179 0.991 . . . . 0.0 111.145 173.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.1 mmtm -72.46 152.65 41.81 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 173.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -142.1 160.05 41.0 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 175.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.4 m -130.15 152.98 38.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 124.615 1.166 . . . . 0.0 109.433 173.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.2 114.92 29.17 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 104.201 -2.518 . . . . 0.0 104.201 177.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 54.5 mt -118.88 124.88 73.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -172.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -78.24 148.09 34.1 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 169.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.3 t -132.12 145.53 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -127.55 148.51 50.34 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.762 1.225 . . . . 0.0 108.218 178.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.4 m -62.35 99.13 0.13 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.759 0.824 . . . . 0.0 110.92 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.488 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -142.44 20.15 0.04 OUTLIER Pre-proline 0 CA--C 1.552 1.028 0 CA-C-O 116.491 -1.719 . . . . 0.0 113.502 169.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.488 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 76.3 Cg_exo -45.29 140.53 7.97 Favored 'Trans proline' 0 C--N 1.363 1.301 0 CA-C-N 123.817 2.399 . . . . 0.0 114.174 177.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.3 tpp180 43.23 24.65 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.509 2.323 . . . . 0.0 114.325 -172.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.9 m 50.85 30.33 5.06 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.2 1.4 . . . . 0.0 112.353 -173.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -155.52 -2.04 0.12 Allowed Glycine 0 CA--C 1.53 0.998 0 CA-C-O 118.504 -1.164 . . . . 0.0 114.895 -171.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.09 137.86 80.08 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-N 119.517 1.658 . . . . 0.0 110.283 172.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -77.62 -20.86 11.84 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.866 2.377 . . . . 0.0 113.089 -178.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.93 159.63 22.43 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.598 0.759 . . . . 0.0 110.823 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -143.55 35.48 1.3 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.247 1.419 . . . . 0.0 109.624 178.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -84.29 -179.67 7.25 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.027 0.931 . . . . 0.0 109.448 177.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.5 m -141.84 160.5 40.06 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.628 1.171 . . . . 0.0 109.403 174.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -152.0 171.56 17.64 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 127.393 2.277 . . . . 0.0 106.509 -172.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.8 mp0 -133.24 157.66 44.86 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 172.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 30.3 pt -137.13 156.03 33.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 C-N-CA 125.717 1.607 . . . . 0.0 109.114 177.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 52.9 t -118.54 120.87 65.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 178.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 25.6 mmt85 -135.63 144.89 46.34 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 176.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 178.44 134.72 2.15 Favored Glycine 0 N--CA 1.453 -0.202 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -178.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.405 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 9.7 m-85 -154.79 155.53 34.64 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -169.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -58.02 -34.13 69.71 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.714 0.806 . . . . 0.0 112.07 -178.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.405 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 13.9 p-90 -67.32 -27.55 67.24 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 118.707 -0.663 . . . . 0.0 112.613 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.36 80.5 9.19 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 119.635 1.107 . . . . 0.0 109.104 175.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -64.23 -18.13 64.23 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.062 0.545 . . . . 0.0 112.0 175.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -134.07 151.05 51.24 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 126.601 1.961 . . . . 0.0 108.023 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -74.1 -31.92 63.0 Favored 'General case' 0 C--O 1.234 0.254 0 O-C-N 121.847 -0.533 . . . . 0.0 110.064 -169.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.32 -29.76 48.96 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 118.564 -0.731 . . . . 0.0 112.48 172.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -67.75 -50.65 56.12 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 119.289 0.95 . . . . 0.0 110.796 -175.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.442 HG12 ' H ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -67.36 -38.26 80.5 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.157 0 CA-C-O 117.846 -1.073 . . . . 0.0 110.036 176.009 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -59.92 -48.35 82.06 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.76 1.163 . . . . 0.0 110.317 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -63.54 -47.68 80.61 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.347 0.521 . . . . 0.0 111.495 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 31.6 tttt -61.2 -52.81 63.24 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 123.198 0.599 . . . . 0.0 111.144 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 92.6 t -70.94 -46.1 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-O 118.024 -0.989 . . . . 0.0 108.975 -172.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.8 m -62.32 -31.95 72.64 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 120.283 1.402 . . . . 0.0 111.055 176.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.16 -49.78 74.39 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-N 119.038 0.835 . . . . 0.0 111.077 171.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -61.68 -44.19 97.41 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 118.654 1.227 . . . . 0.0 111.61 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.6 mmt -59.39 -47.82 84.0 Favored 'General case' 0 C--O 1.226 -0.159 0 C-N-CA 123.06 0.544 . . . . 0.0 110.053 176.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -67.49 -28.61 67.99 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.85 0.75 . . . . 0.0 112.025 179.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -68.05 -36.98 80.79 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 119.585 1.084 . . . . 0.0 110.418 170.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -68.04 -29.74 68.79 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 119.625 1.102 . . . . 0.0 110.122 169.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 122.37 -23.17 7.26 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 128.13 2.776 . . . . 0.0 111.297 177.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 84.6 m -53.82 146.5 13.74 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 126.682 1.993 . . . . 0.0 111.321 -175.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -107.87 142.01 38.6 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 72.7 m -142.44 163.86 31.71 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -168.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -151.81 133.79 15.0 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.552 1.541 . . . . 0.0 107.668 170.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.6 p -72.22 115.76 11.84 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 169.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 45.6 mt -67.04 -24.98 66.05 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.986 -0.446 . . . . 0.0 110.002 172.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.92 -164.32 37.74 Favored Glycine 0 C--N 1.336 0.536 0 N-CA-C 108.374 -1.89 . . . . 0.0 108.374 172.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -155.13 -176.41 27.31 Favored Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 111.004 -0.838 . . . . 0.0 111.004 171.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -171.44 -156.4 11.82 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 -175.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.1 ttp180 -135.66 147.0 48.41 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 -177.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.3 mt -121.79 141.2 43.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 106.484 -1.672 . . . . 0.0 106.484 -174.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.2 m -141.43 170.06 16.44 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.018 1.327 . . . . 0.0 110.657 -171.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 7.0 m170 65.17 179.9 0.19 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.948 2.099 . . . . 0.0 111.546 -170.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -142.62 152.92 42.99 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.558 1.143 . . . . 0.0 108.799 -172.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.7 m -66.66 7.99 0.3 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.144 2.178 . . . . 0.0 115.163 -171.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -139.04 18.03 2.63 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.75 1.62 . . . . 0.0 110.04 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -137.05 -52.56 0.68 Allowed 'General case' 0 N--CA 1.467 0.384 0 O-C-N 121.581 -0.699 . . . . 0.0 112.291 -170.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -159.39 159.63 33.98 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.709 1.204 . . . . 0.0 107.768 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 42.0 pttt -48.34 137.01 11.7 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 172.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 41.7 mm -59.21 149.04 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 176.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 19.4 t60 -131.15 152.32 50.56 Favored 'General case' 0 CA--C 1.515 -0.367 0 O-C-N 121.554 -0.716 . . . . 0.0 109.699 176.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.6 t -133.22 132.57 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 -176.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -160.15 -167.93 2.07 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.937 1.295 . . . . 0.0 108.886 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.15 -171.34 42.96 Favored Glycine 0 CA--C 1.525 0.703 0 O-C-N 121.612 -0.68 . . . . 0.0 113.632 176.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -161.87 152.89 18.01 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.523 1.129 . . . . 0.0 110.123 -169.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.5 t -81.59 168.45 18.17 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 167.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 20.8 ptp -111.44 -29.68 7.69 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 121.215 -0.928 . . . . 0.0 111.39 170.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.19 -25.76 59.88 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.716 1.144 . . . . 0.0 111.434 171.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -131.76 -7.14 3.6 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.886 0.874 . . . . 0.0 113.015 -169.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.39 -179.11 48.94 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 123.735 0.683 . . . . 0.0 113.638 172.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -68.4 142.08 53.33 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.83 2.354 . . . . 0.0 110.743 173.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.68 178.19 6.26 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 168.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -63.61 -28.4 69.9 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 119.045 -0.503 . . . . 0.0 111.868 170.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 42.4 m80 59.08 -23.16 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 128.283 2.633 . . . . 0.0 116.63 -173.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.72 -39.04 93.31 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.688 1.195 . . . . 0.0 110.794 172.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 75.3 mt -63.33 -44.44 99.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 175.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.1 -44.62 94.71 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.135 0.974 . . . . 0.0 111.252 -177.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.54 -51.0 67.3 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 119.275 0.943 . . . . 0.0 110.611 176.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -57.6 -43.98 85.1 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.027 0.83 . . . . 0.0 110.62 -177.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -71.41 -40.27 70.57 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 118.102 -0.951 . . . . 0.0 111.832 -178.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 83.8 mt -69.3 -34.89 64.96 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-N 120.78 1.627 . . . . 0.0 108.957 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -61.84 -43.72 98.29 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 120.404 1.457 . . . . 0.0 110.385 171.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.86 -37.67 87.78 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.922 0.783 . . . . 0.0 111.615 178.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 41.6 tptt -66.61 -38.2 86.49 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.804 0.842 . . . . 0.0 111.142 176.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -130.7 68.97 82.24 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 124.208 1.003 . . . . 0.0 110.048 -171.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -68.47 -19.4 42.99 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.536 2.158 . . . . 0.0 112.519 -175.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -73.53 -5.37 39.71 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.706 1.202 . . . . 0.0 112.258 172.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -136.64 -168.43 2.26 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.824 1.65 . . . . 0.0 109.396 -173.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -147.62 164.01 34.83 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.774 0.797 . . . . 0.0 110.138 -178.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.7 p -145.99 154.26 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 126.163 1.785 . . . . 0.0 106.755 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 21.2 p -139.05 171.48 14.25 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.923 0.889 . . . . 0.0 109.399 171.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 19.6 p-90 -141.56 151.95 43.65 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 169.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.46 137.05 12.13 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 103.933 -2.617 . . . . 0.0 103.933 169.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -80.7 46.49 0.88 Allowed 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 119.395 0.998 . . . . 0.0 109.708 178.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -67.28 -28.47 68.04 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 125.584 1.554 . . . . 0.0 112.442 -169.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -170.49 -175.37 39.19 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 125.194 1.378 . . . . 0.0 109.737 -178.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 73.8 t80 . . . . . 0 C--O 1.234 0.272 0 CA-C-O 121.267 0.556 . . . . 0.0 109.926 -178.719 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtt . . . . . 0 N--CA 1.482 1.163 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.09 169.5 22.23 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.223 1.409 . . . . 0.0 108.693 176.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.52 140.6 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 177.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -76.65 179.91 5.72 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.472 0.709 . . . . 0.0 110.895 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -149.68 153.22 36.63 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 125.963 1.705 . . . . 0.0 106.486 171.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 44.2 mt -56.39 -33.18 65.5 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 118.697 0.681 . . . . 0.0 112.666 -176.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.52 -25.49 65.87 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.919 0.781 . . . . 0.0 112.167 177.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.1 mt -86.64 -21.91 26.47 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.87 0.868 . . . . 0.0 111.372 -176.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 56.7 mt -64.54 128.56 93.55 Favored Pre-proline 0 CA--C 1.54 0.559 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 178.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -46.3 114.94 0.97 Allowed 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 124.232 3.288 . . . . 0.0 111.58 172.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -72.08 -30.81 65.49 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.369 0.668 . . . . 0.0 112.071 -169.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 42.3 t -143.12 142.47 25.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 171.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -151.38 127.8 10.67 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 169.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 40.9 pt -147.53 163.98 6.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 127.622 2.369 . . . . 0.0 106.219 -176.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -143.82 -37.55 0.33 Allowed 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.01 165.69 12.87 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.27 0.628 . . . . 0.0 111.069 172.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -143.97 84.78 1.79 Allowed 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.844 1.258 . . . . 0.0 108.089 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.3 -166.05 39.38 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 -173.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 66.6 t -66.45 126.75 26.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 169.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -160.05 158.37 30.34 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.782 0.833 . . . . 0.0 110.815 169.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -77.86 154.12 32.07 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.019 0.928 . . . . 0.0 110.495 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -142.28 164.91 28.88 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.313 1.045 . . . . 0.0 108.891 175.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.9 m -132.14 152.91 37.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 C-N-CA 124.589 1.156 . . . . 0.0 109.287 172.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.2 tp -108.11 117.95 35.49 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 177.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 95.4 mt -122.7 123.04 67.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -171.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -79.57 147.8 31.98 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 169.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.5 p -138.38 146.99 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 175.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 -120.01 156.96 29.85 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.852 1.261 . . . . 0.0 108.78 -176.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.4 m -63.15 87.64 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.698 1.199 . . . . 0.0 111.922 177.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.415 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -138.55 19.39 0.05 OUTLIER Pre-proline 0 CA--C 1.551 1.019 0 CA-C-O 116.405 -1.759 . . . . 0.0 114.449 169.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 30' ' ' ALA . 80.1 Cg_exo -43.96 137.33 6.98 Favored 'Trans proline' 0 C--N 1.36 1.157 0 CA-C-N 123.976 2.456 . . . . 0.0 113.681 172.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.4 mmp_? 42.38 25.45 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 127.497 2.319 . . . . 0.0 114.339 -172.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.2 m 50.4 30.57 4.66 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.028 1.331 . . . . 0.0 112.236 -173.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -153.47 -1.61 0.17 Allowed Glycine 0 CA--C 1.53 0.992 0 CA-C-O 118.508 -1.162 . . . . 0.0 114.684 -169.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.29 135.25 75.66 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 119.462 1.631 . . . . 0.0 109.846 170.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -77.99 -21.31 10.96 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.764 2.309 . . . . 0.0 113.201 -176.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.16 162.95 18.69 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.696 0.799 . . . . 0.0 110.851 177.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.24 66.9 0.96 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.996 1.319 . . . . 0.0 108.42 177.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -133.38 -172.26 2.91 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.739 1.616 . . . . 0.0 108.514 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.8 m -142.26 158.17 44.02 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.958 0.903 . . . . 0.0 110.334 -174.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -149.21 166.01 30.16 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 127.56 2.344 . . . . 0.0 105.947 -175.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.8 mp0 -125.33 151.6 45.83 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 174.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 21.2 pt -127.27 155.04 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 125.997 1.719 . . . . 0.0 108.594 173.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 85.1 t -127.87 115.96 41.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 -173.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 26.7 mmt85 -135.33 139.82 44.6 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -176.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -170.92 141.61 6.6 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 178.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -156.1 149.02 24.15 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -171.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -58.77 -32.83 69.65 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 118.839 -0.6 . . . . 0.0 111.61 174.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 9.7 p-90 -65.32 -26.83 68.22 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.018 0.826 . . . . 0.0 112.489 177.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.41 73.44 10.5 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 119.337 0.971 . . . . 0.0 109.524 175.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -65.67 -8.56 21.27 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.35 0.66 . . . . 0.0 112.104 176.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -138.17 144.91 40.94 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 126.896 2.079 . . . . 0.0 106.836 177.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 60.9 m80 -71.44 -31.13 66.84 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 121.885 -0.509 . . . . 0.0 109.979 -171.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.47 -27.27 47.31 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 118.258 -0.877 . . . . 0.0 112.676 171.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -68.33 -48.93 63.58 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 119.818 1.19 . . . . 0.0 110.763 -176.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.438 HG12 ' H ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -67.32 -40.26 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 CA-C-O 117.732 -1.127 . . . . 0.0 109.782 175.78 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -62.49 -44.66 95.85 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 120.047 1.294 . . . . 0.0 110.599 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -62.49 -47.34 84.42 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.818 0.735 . . . . 0.0 111.369 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 31.7 tttt -62.29 -53.59 52.92 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.245 0.618 . . . . 0.0 110.999 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 92.0 t -73.52 -48.35 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-O 118.539 -0.743 . . . . 0.0 109.179 -171.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.0 t -63.32 -34.74 78.35 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 119.568 1.076 . . . . 0.0 109.759 178.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.28 -48.59 85.24 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-N 118.978 0.808 . . . . 0.0 111.182 172.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -63.02 -43.6 98.29 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 118.69 1.245 . . . . 0.0 111.596 178.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 39.2 mmt -59.27 -47.31 85.85 Favored 'General case' 0 CA--C 1.527 0.077 0 C-N-CA 122.769 0.428 . . . . 0.0 110.111 176.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -64.92 -32.69 74.53 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.423 0.689 . . . . 0.0 111.274 179.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -67.4 -35.65 79.71 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.443 1.019 . . . . 0.0 111.052 170.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -69.03 -15.8 63.55 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 119.838 1.199 . . . . 0.0 111.286 169.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 109.17 -18.82 30.46 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 126.838 2.161 . . . . 0.0 111.94 177.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 73.1 m -57.05 162.91 2.27 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.654 1.982 . . . . 0.0 112.874 -175.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -123.25 137.35 54.89 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 176.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 80.4 m -142.69 166.17 25.4 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -168.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -151.09 131.65 13.88 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.797 1.239 . . . . 0.0 108.32 170.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.3 p -69.74 115.77 9.36 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 169.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 64.3 mt -66.97 -26.93 67.06 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.984 0.514 . . . . 0.0 109.95 173.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.08 -172.97 42.92 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 169.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -123.13 165.52 15.76 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 110.951 -0.859 . . . . 0.0 110.951 175.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -168.54 -163.56 22.74 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -178.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.7 ttp180 -146.45 158.37 43.88 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 121.141 -1.211 . . . . 0.0 107.763 -175.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 56.7 mt -120.98 130.79 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 104.851 -2.278 . . . . 0.0 104.851 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 30.1 m -152.33 176.49 11.56 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.478 1.911 . . . . 0.0 108.237 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -81.24 150.57 28.53 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 168.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -62.29 -35.46 79.1 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.888 0.767 . . . . 0.0 112.876 -174.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 77.7 p -170.73 -147.9 0.06 Allowed 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 -172.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -64.54 -20.36 66.18 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.486 0.585 . . . . 0.0 110.52 168.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -76.24 136.16 39.68 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 123.538 0.735 . . . . 0.0 109.161 169.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -80.92 -6.59 58.87 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 117.405 -1.283 . . . . 0.0 113.909 -169.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -50.37 129.25 21.45 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 120.052 1.296 . . . . 0.0 108.587 177.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 49.6 mm -69.12 146.0 12.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -176.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 12.4 t60 -130.29 143.11 50.58 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 54.5 t -131.82 106.0 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 -169.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -164.16 162.86 23.02 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.311 0.644 . . . . 0.0 109.517 -175.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 143.08 -169.08 25.85 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -155.85 151.66 27.41 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.101 0.56 . . . . 0.0 110.64 171.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.4 t -90.41 161.34 15.61 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 168.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 27.6 ptm -94.04 -33.91 13.22 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 118.995 0.816 . . . . 0.0 110.018 169.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.6 -25.38 56.94 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.905 0.775 . . . . 0.0 112.006 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -133.46 -4.13 2.98 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -169.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.83 -175.39 52.03 Favored Glycine 0 CA--C 1.535 1.326 0 CA-C-N 119.031 0.832 . . . . 0.0 113.344 173.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.99 138.8 37.93 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.385 2.724 . . . . 0.0 111.206 175.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.24 168.44 17.29 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 168.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 23.0 mm100 -68.55 -27.07 65.76 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.856 -0.528 . . . . 0.0 111.864 172.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 37.6 m80 60.48 -29.24 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 128.962 2.905 . . . . 0.0 115.895 -175.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.8 -40.66 93.5 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.536 1.134 . . . . 0.0 112.467 -179.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.3 mp -62.55 -46.33 96.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 177.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.3 m -59.47 -47.22 86.34 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 123.892 0.877 . . . . 0.0 110.621 -176.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.5 p -64.77 -41.12 96.1 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 118.097 -0.954 . . . . 0.0 111.065 -176.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -58.91 -45.51 90.13 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.951 1.25 . . . . 0.0 110.649 177.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 44.3 mttm -67.41 -46.24 73.79 Favored 'General case' 0 N--CA 1.462 0.158 0 O-C-N 122.128 -0.358 . . . . 0.0 111.037 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 55.7 mt -68.57 -38.05 78.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -176.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -58.62 -42.15 87.56 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 120.523 1.511 . . . . 0.0 110.031 174.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.0 -40.41 96.3 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.646 0.657 . . . . 0.0 111.369 177.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -66.89 -23.06 65.95 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.197 0.599 . . . . 0.0 112.205 174.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 9.9 t80 50.19 53.19 13.78 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 126.327 1.851 . . . . 0.0 113.244 174.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -71.19 -16.08 31.76 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 122.193 1.928 . . . . 0.0 111.78 173.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -148.5 166.66 27.53 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 127.481 2.312 . . . . 0.0 106.861 177.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -49.58 -40.73 39.7 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.938 1.295 . . . . 0.0 112.695 178.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -157.64 165.87 34.35 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 119.197 0.908 . . . . 0.0 110.757 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.4 t -140.12 143.94 28.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 126.389 1.876 . . . . 0.0 106.04 -175.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 6.3 p -139.66 170.23 16.28 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.335 1.054 . . . . 0.0 109.879 177.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 39.5 p-90 -140.96 161.28 38.21 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 169.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -158.47 141.92 15.11 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 103.915 -2.624 . . . . 0.0 103.915 169.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -80.84 48.83 1.13 Allowed 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 119.216 0.917 . . . . 0.0 109.269 176.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -66.7 -33.68 76.17 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 125.018 1.327 . . . . 0.0 113.476 -169.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 162.75 -159.94 32.31 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -171.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 86.1 t80 . . . . . 0 C--O 1.237 0.443 0 CA-C-O 121.46 0.647 . . . . 0.0 109.899 173.911 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 N--CA 1.484 1.261 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.25 168.73 23.17 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.329 1.452 . . . . 0.0 108.627 176.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.2 p -147.35 143.33 19.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 178.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -81.0 -176.42 5.92 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.205 0.602 . . . . 0.0 110.526 178.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -152.39 151.25 30.59 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 169.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 78.1 mt -56.08 -34.62 66.14 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.273 0.629 . . . . 0.0 112.549 -176.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.1 -25.21 65.21 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.691 0.678 . . . . 0.0 112.08 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.5 mt -83.41 -21.74 32.91 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.539 0.736 . . . . 0.0 111.328 -177.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.4 mt -65.34 127.48 92.96 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 177.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -47.76 125.38 11.15 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 123.649 2.899 . . . . 0.0 111.193 171.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -76.48 -36.44 57.84 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.097 0.475 . . . . 0.0 111.008 -173.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.6 t -140.67 133.07 31.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 177.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -154.56 119.76 5.02 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 105.072 -2.196 . . . . 0.0 105.072 169.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.7 pp -145.6 158.9 12.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 C-N-CA 124.477 1.111 . . . . 0.0 109.53 -171.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -74.11 -179.61 3.91 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.963 1.705 . . . . 0.0 110.455 171.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.9 m -142.92 22.3 1.93 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.978 1.311 . . . . 0.0 111.227 -177.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -57.48 -39.99 77.63 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -169.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 152.95 -50.35 0.51 Allowed Glycine 0 C--N 1.336 0.534 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 177.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.3 t -146.32 130.62 10.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 105.642 -1.985 . . . . 0.0 105.642 170.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -159.34 152.85 22.64 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.931 0.787 . . . . 0.0 110.385 178.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -72.94 151.32 41.91 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.702 0.801 . . . . 0.0 110.758 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -144.12 161.85 37.78 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.848 1.259 . . . . 0.0 107.845 177.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.5 m -130.34 151.45 35.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 C-N-CA 124.24 1.016 . . . . 0.0 109.349 174.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.74 114.58 28.88 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 103.643 -2.725 . . . . 0.0 103.643 176.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.8 mt -120.31 124.79 73.28 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -172.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.2 ttm180 -78.93 143.69 35.57 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 168.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.5 p -137.39 136.88 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 178.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -107.18 148.91 28.29 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.889 1.275 . . . . 0.0 109.006 -172.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.1 p -72.43 85.25 1.12 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.56 0.695 . . . . 0.0 111.138 178.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -131.52 33.07 0.23 Allowed Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 124.602 1.161 . . . . 0.0 112.368 169.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -60.61 141.94 96.54 Favored 'Trans proline' 0 C--N 1.354 0.824 0 CA-C-N 122.133 1.798 . . . . 0.0 109.961 -178.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.0 mmp_? 44.37 21.86 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.86 2.064 . . . . 0.0 113.953 -169.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.5 m 48.2 30.89 2.34 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.362 1.465 . . . . 0.0 112.428 -171.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -125.03 -18.81 2.53 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-O 118.751 -1.027 . . . . 0.0 114.068 -169.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.29 133.37 95.44 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 119.124 1.462 . . . . 0.0 110.013 176.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -79.36 -14.94 12.86 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.087 2.524 . . . . 0.0 112.599 176.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.4 164.57 8.94 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.117 0.967 . . . . 0.0 111.089 176.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -148.86 48.91 1.0 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.968 1.307 . . . . 0.0 108.573 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -102.4 175.89 5.36 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 125.963 1.705 . . . . 0.0 108.692 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.6 m -139.85 158.85 43.41 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.639 0.776 . . . . 0.0 110.256 175.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -142.07 166.41 24.78 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 127.973 2.509 . . . . 0.0 105.417 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 30.7 mp0 -126.69 149.75 49.38 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.1 pt -132.94 155.62 41.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 C-N-CA 125.059 1.344 . . . . 0.0 109.86 178.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 85.3 t -117.66 114.93 46.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.9 mmp_? -126.6 147.14 49.93 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 173.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 178.72 139.27 3.46 Favored Glycine 0 C--N 1.331 0.259 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 176.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.404 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 20.6 m-85 -154.59 150.22 27.49 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 123.397 0.679 . . . . 0.0 109.344 -171.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.4 tptt -62.31 -26.55 68.49 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 118.578 -0.725 . . . . 0.0 112.055 177.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.404 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 9.9 p-90 -63.86 -27.93 69.5 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.677 1.126 . . . . 0.0 112.28 176.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.63 76.05 10.04 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 119.242 0.928 . . . . 0.0 109.491 174.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -66.77 -5.79 13.49 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.219 0.607 . . . . 0.0 112.135 175.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -139.43 144.39 38.05 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 126.471 1.908 . . . . 0.0 107.026 175.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -70.62 -30.98 67.77 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 121.979 -0.451 . . . . 0.0 110.036 -171.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.55 -30.15 40.5 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 118.759 -0.639 . . . . 0.0 112.627 172.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -68.09 -50.52 54.4 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 119.134 0.879 . . . . 0.0 110.804 -175.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.431 HG12 ' H ' ' A' ' 56' ' ' ILE . 0.1 OUTLIER -67.08 -38.42 81.2 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.19 0 CA-C-O 117.761 -1.114 . . . . 0.0 109.935 174.85 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -60.16 -46.11 90.79 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 120.191 1.36 . . . . 0.0 110.91 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -65.35 -48.47 72.87 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 122.644 0.377 . . . . 0.0 111.275 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 44.3 tttt -62.29 -49.12 76.91 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 123.304 0.642 . . . . 0.0 111.479 -176.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 86.7 t -75.15 -45.5 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-O 118.423 -0.799 . . . . 0.0 109.33 -172.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.9 m -61.85 -35.82 79.42 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 119.423 1.01 . . . . 0.0 110.103 175.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.7 -48.02 87.15 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 173.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -63.35 -45.27 91.99 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 118.96 1.38 . . . . 0.0 111.429 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 39.1 mmt -59.57 -43.9 93.47 Favored 'General case' 0 C--O 1.227 -0.091 0 CA-C-N 118.202 0.456 . . . . 0.0 109.933 177.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -68.58 -27.92 66.48 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.716 0.807 . . . . 0.0 111.752 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -69.39 -36.86 77.18 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 119.455 1.025 . . . . 0.0 109.749 169.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -68.09 -25.79 65.5 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 119.928 1.24 . . . . 0.0 110.266 169.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 122.25 -27.63 6.04 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 128.237 2.827 . . . . 0.0 111.313 174.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 97.2 m -58.58 145.23 40.2 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 126.07 1.748 . . . . 0.0 110.691 -177.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -108.43 156.28 19.62 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 177.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 86.1 m -141.48 165.42 27.56 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 -168.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -150.92 132.7 14.98 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.546 1.538 . . . . 0.0 107.085 169.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.6 p -70.82 121.05 17.32 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 169.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 38.1 mt -70.34 -23.2 62.77 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.99 -0.444 . . . . 0.0 109.902 171.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.94 -166.27 39.04 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 170.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -146.86 173.12 27.17 Favored Glycine 0 CA--C 1.52 0.387 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 172.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -172.35 -156.13 12.07 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 107.356 -2.298 . . . . 0.0 107.356 -178.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 26.9 ptt-85 -142.31 160.25 40.62 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 120.614 -1.521 . . . . 0.0 109.403 176.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 93.7 mt -118.09 145.03 24.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 104.404 -2.443 . . . . 0.0 104.404 -174.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.8 p -144.5 163.07 34.94 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 123.424 0.69 . . . . 0.0 110.393 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -112.08 31.36 6.3 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.089 1.356 . . . . 0.0 109.723 176.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 51.74 -164.8 0.06 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 127.368 2.267 . . . . 0.0 112.677 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.4 p -67.01 -46.92 73.03 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.875 1.27 . . . . 0.0 111.043 176.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -158.36 -39.47 0.06 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.829 0.851 . . . . 0.0 111.522 -177.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -60.09 140.28 56.96 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 118.422 0.556 . . . . 0.0 110.696 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -70.78 -12.94 61.85 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -169.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -58.68 127.53 32.66 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 120.783 1.628 . . . . 0.0 108.167 177.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 71.6 mt -75.18 154.34 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 105.642 -1.984 . . . . 0.0 105.642 174.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 23.1 t60 -138.36 159.08 42.97 Favored 'General case' 0 C--N 1.331 -0.221 0 O-C-N 120.836 -1.165 . . . . 0.0 109.98 177.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.0 t -137.49 130.89 43.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -162.28 -173.99 3.86 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.047 0.939 . . . . 0.0 109.869 -172.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.38 -172.33 50.4 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 123.659 0.647 . . . . 0.0 112.285 178.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -160.79 151.55 18.47 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.716 0.806 . . . . 0.0 111.05 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.0 t -72.43 164.86 25.67 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 168.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 23.0 ptp -111.69 -28.92 7.91 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 118.359 -0.829 . . . . 0.0 111.174 171.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.14 -26.5 60.36 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.737 1.153 . . . . 0.0 111.428 171.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -131.13 -6.04 3.88 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.777 0.831 . . . . 0.0 113.139 -169.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.18 -179.21 42.79 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 123.603 0.62 . . . . 0.0 113.504 173.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.17 135.62 40.99 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.067 2.512 . . . . 0.0 110.633 176.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.74 169.36 18.43 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 169.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -77.98 81.93 4.36 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 168.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -57.45 -14.94 5.57 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -175.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.58 -39.91 89.79 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.019 1.328 . . . . 0.0 111.47 170.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 63.0 mt -64.5 -47.18 90.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 176.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.9 -50.12 74.42 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.142 0.977 . . . . 0.0 110.526 -176.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 10.1 p -64.56 -47.48 78.58 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 119.243 0.929 . . . . 0.0 111.276 -176.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -60.21 -40.3 89.63 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.397 0.999 . . . . 0.0 110.475 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 49.2 mttm -65.45 -49.08 70.46 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 119.187 -0.435 . . . . 0.0 111.356 176.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 62.9 mt -64.54 -40.14 88.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-N 119.067 0.849 . . . . 0.0 109.16 -176.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -58.62 -48.13 82.04 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.605 1.093 . . . . 0.0 109.633 174.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.86 -39.06 93.27 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.56 0.344 . . . . 0.0 111.328 -178.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 21.7 tptm -67.19 -38.99 86.32 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 118.758 -0.639 . . . . 0.0 110.987 177.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -128.32 69.13 78.08 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 123.808 0.843 . . . . 0.0 110.605 -169.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.34 -12.63 35.5 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 122.857 2.372 . . . . 0.0 112.991 -177.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.45 -9.73 54.93 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.209 1.003 . . . . 0.0 112.274 170.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -126.84 -178.37 4.37 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.613 1.965 . . . . 0.0 108.647 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -136.91 159.17 42.66 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 171.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.4 t -141.01 140.19 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 -171.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.3 p -134.55 173.67 11.39 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 169.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 37.6 p-90 -142.27 156.17 45.27 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.242 0.544 . . . . 0.0 109.905 174.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.71 123.89 5.28 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 103.161 -2.903 . . . . 0.0 103.161 173.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -80.28 27.5 0.33 Allowed 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.484 1.038 . . . . 0.0 113.171 -169.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -67.24 -178.0 0.76 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.783 0.833 . . . . 0.0 109.486 169.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 91.53 -143.2 16.45 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.044 -1.223 . . . . 0.0 110.044 -176.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 86.5 t80 . . . . . 0 C--O 1.239 0.523 0 C-N-CA 124.827 1.251 . . . . 0.0 109.523 -176.628 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 N--CA 1.483 1.178 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.79 172.09 14.18 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 125.23 1.412 . . . . 0.0 108.421 174.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.2 p -152.36 166.17 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 174.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.56 176.03 3.14 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 118.454 0.57 . . . . 0.0 110.933 178.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -155.04 153.22 30.61 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.226 1.011 . . . . 0.0 108.399 177.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.0 mt -54.36 -32.83 57.82 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.771 0.828 . . . . 0.0 112.401 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.79 -23.61 67.43 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.76 0.709 . . . . 0.0 112.527 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 76.0 mt -74.83 -26.72 59.91 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 118.512 0.596 . . . . 0.0 110.944 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.2 mt -72.42 133.03 83.33 Favored Pre-proline 0 C--O 1.239 0.503 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 -177.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.23 135.0 48.21 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 121.067 1.178 . . . . 0.0 109.229 169.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -72.61 -33.48 66.7 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.325 0.583 . . . . 0.0 111.404 -175.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 51.0 t -135.25 138.89 47.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 105.221 -2.14 . . . . 0.0 105.221 172.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -149.92 129.4 13.03 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 169.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.5 pt -146.3 158.9 11.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 126.676 1.99 . . . . 0.0 106.305 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -151.39 44.89 0.79 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 122.004 0.907 . . . . 0.0 110.047 177.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.5 m -145.71 172.39 13.36 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.549 1.54 . . . . 0.0 110.045 -177.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -155.48 167.09 31.52 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.515 1.526 . . . . 0.0 108.232 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.15 -72.14 2.89 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 124.781 1.181 . . . . 0.0 111.194 175.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 70.7 t -154.39 130.4 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 126.511 1.924 . . . . 0.0 106.871 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -163.88 158.31 19.74 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.097 0.959 . . . . 0.0 110.594 169.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -79.53 158.11 27.26 Favored 'General case' 0 C--O 1.233 0.231 0 O-C-N 121.697 -0.627 . . . . 0.0 109.653 176.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.3 163.35 35.79 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.365 1.066 . . . . 0.0 108.805 176.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.2 m -136.65 157.0 36.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 124.655 1.182 . . . . 0.0 110.127 172.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.34 119.59 39.94 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 104.732 -2.322 . . . . 0.0 104.732 177.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 57.2 mt -121.29 114.51 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 CA-C-N 119.488 1.04 . . . . 0.0 108.48 -172.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 24.0 ttm-85 -71.54 138.12 48.61 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 104.967 -2.235 . . . . 0.0 104.967 168.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.4 p -136.31 116.49 17.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 178.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -81.7 142.83 32.33 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 169.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.1 t -67.72 117.01 9.06 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 169.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.444 ' N ' ' HD3' ' A' ' 31' ' ' PRO . . . -143.57 43.11 0.42 Allowed Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 123.781 0.833 . . . . 0.0 108.921 168.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.444 ' HD3' ' N ' ' A' ' 30' ' ' ALA . 31.9 Cg_exo -56.56 131.98 48.99 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.063 1.842 . . . . 0.0 111.731 -169.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.2 ttp180 39.44 30.96 0.06 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 127.281 2.232 . . . . 0.0 113.849 -171.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.3 m 52.53 22.18 2.07 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.449 1.5 . . . . 0.0 113.661 -174.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -97.07 -15.39 39.04 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 124.507 1.051 . . . . 0.0 112.584 -176.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -140.81 60.75 13.7 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 125.229 1.412 . . . . 0.0 108.985 177.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -65.17 135.22 42.52 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 123.083 2.522 . . . . 0.0 112.204 -170.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 38.94 45.69 1.0 Allowed 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 127.494 2.318 . . . . 0.0 113.382 -176.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.29 -37.33 87.11 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.616 -1.174 . . . . 0.0 110.506 176.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -157.38 174.64 15.11 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.591 1.956 . . . . 0.0 107.415 -170.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.0 m -141.86 157.49 44.93 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.941 0.896 . . . . 0.0 110.435 173.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -148.98 165.28 32.1 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 127.767 2.427 . . . . 0.0 106.651 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -125.93 126.89 45.12 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.341 -1.725 . . . . 0.0 106.341 170.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 30.4 pt -110.01 155.51 11.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 125.044 1.338 . . . . 0.0 110.267 175.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 24.5 t -120.43 125.89 74.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 -175.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.4 mmp_? -129.65 146.59 51.43 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.965 1.306 . . . . 0.0 107.739 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -172.98 133.99 2.81 Favored Glycine 0 N--CA 1.453 -0.208 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 169.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.405 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 10.7 m-85 -152.21 159.72 43.51 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -177.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -78.73 -26.13 44.7 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 121.793 -0.567 . . . . 0.0 109.894 -176.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.405 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 12.9 p-90 -61.33 -31.99 71.87 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 119.183 -0.437 . . . . 0.0 111.671 174.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -86.79 71.66 10.29 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 118.735 0.698 . . . . 0.0 109.524 173.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -63.42 -15.39 57.48 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 122.893 0.477 . . . . 0.0 111.775 177.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.41 144.24 51.09 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 126.548 1.939 . . . . 0.0 107.891 177.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 43.6 m80 -68.45 -34.6 76.25 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 119.148 -0.453 . . . . 0.0 112.134 -169.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.08 -28.89 55.85 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 118.311 -0.852 . . . . 0.0 112.645 174.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -68.29 -48.58 64.59 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 119.633 1.106 . . . . 0.0 111.323 -174.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.418 HG12 ' H ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -65.92 -41.28 89.61 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 CA-C-O 118.438 -0.791 . . . . 0.0 109.772 176.152 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -61.72 -53.34 57.42 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 118.317 -0.849 . . . . 0.0 109.722 -178.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -60.1 -42.85 95.56 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.16 0.891 . . . . 0.0 111.841 -176.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 31.6 tttt -60.52 -51.14 70.72 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 123.226 0.61 . . . . 0.0 110.796 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 63.9 t -84.74 -36.98 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-O 117.949 -1.024 . . . . 0.0 111.28 -169.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 71.7 p -64.43 -31.89 73.29 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 120.871 1.669 . . . . 0.0 109.684 171.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.66 -50.03 72.11 Favored Glycine 0 C--N 1.337 0.638 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 171.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -62.07 -43.34 99.04 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 118.68 1.24 . . . . 0.0 111.726 178.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 34.6 mmt -60.05 -46.08 90.71 Favored 'General case' 0 C--O 1.225 -0.191 0 N-CA-C 109.776 -0.454 . . . . 0.0 109.776 178.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -68.47 -27.91 66.57 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.606 0.762 . . . . 0.0 112.127 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -68.34 -37.22 80.32 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.34 0.973 . . . . 0.0 109.953 169.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -69.42 -25.37 64.09 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 119.631 1.105 . . . . 0.0 110.494 169.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 120.17 -26.35 7.1 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 127.996 2.713 . . . . 0.0 111.543 177.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 89.7 m -56.06 153.26 9.22 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 126.377 1.871 . . . . 0.0 111.51 -177.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -120.07 140.02 51.66 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -169.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 77.2 m -131.54 165.83 22.74 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 -167.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -153.13 122.48 6.67 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.72 2.008 . . . . 0.0 106.486 172.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.8 p -71.47 120.69 17.41 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 169.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 42.1 mt -68.53 -27.23 65.92 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.996 -0.44 . . . . 0.0 110.109 175.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 171.05 -171.38 43.87 Favored Glycine 0 C--N 1.337 0.592 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 175.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -138.09 164.37 25.56 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 176.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -168.54 -162.16 20.06 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -176.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 57.4 ttt180 -138.78 144.71 39.51 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 121.034 -1.274 . . . . 0.0 107.582 -172.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 99.6 mt -112.28 134.74 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 104.309 -2.478 . . . . 0.0 104.309 172.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.1 m -135.64 164.17 28.47 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 123.753 0.821 . . . . 0.0 108.986 172.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -128.64 21.54 5.99 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.624 1.569 . . . . 0.0 110.65 -175.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -134.04 31.7 3.54 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.964 1.706 . . . . 0.0 108.894 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 90.3 p -67.36 167.72 11.99 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.524 1.129 . . . . 0.0 110.596 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -64.19 -26.14 68.38 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.888 -0.508 . . . . 0.0 110.252 169.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.414 ' O ' ' HE3' ' A' ' 87' ' ' LYS . 34.8 t70 -83.08 -9.85 59.01 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.455 1.102 . . . . 0.0 112.228 178.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 81.8 tttt 65.92 -33.88 0.19 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 128.452 2.701 . . . . 0.0 114.321 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.414 ' HE3' ' O ' ' A' ' 85' ' ' ASP . 0.0 OUTLIER -57.95 157.99 7.15 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 119.495 1.043 . . . . 0.0 109.159 169.625 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.9 pt -58.73 134.97 23.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 168.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 40.9 t60 -132.81 146.62 51.98 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -169.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.9 t -125.08 129.56 73.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 -171.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -161.58 -169.1 2.16 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.673 1.189 . . . . 0.0 107.836 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 103.06 176.11 26.58 Favored Glycine 0 CA--C 1.522 0.53 0 CA-C-N 119.423 1.01 . . . . 0.0 112.113 169.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -151.85 143.85 23.82 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 122.953 0.501 . . . . 0.0 109.965 169.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.8 t -72.79 165.58 24.57 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 168.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 27.7 ptm -103.53 -30.5 10.48 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 118.558 -0.735 . . . . 0.0 110.486 169.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.42 -24.19 53.98 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.403 1.001 . . . . 0.0 111.874 174.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -134.76 -6.98 2.44 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -169.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.24 -173.5 54.91 Favored Glycine 0 CA--C 1.537 1.436 0 CA-C-N 119.325 0.966 . . . . 0.0 113.712 174.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -67.33 156.33 66.66 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.425 2.75 . . . . 0.0 111.116 176.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -104.88 166.16 10.57 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.68 1.192 . . . . 0.0 109.774 171.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -78.99 85.72 4.91 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 169.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -58.43 -16.47 15.06 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -178.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.82 -42.04 78.87 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.595 1.158 . . . . 0.0 111.473 170.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 59.1 mt -65.58 -46.95 88.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.98 -50.51 73.13 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.795 0.838 . . . . 0.0 110.802 -177.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.6 p -66.54 -44.26 82.88 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.891 -174.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -58.09 -43.63 87.18 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.754 1.161 . . . . 0.0 110.34 178.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -69.58 -44.58 70.51 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-O 118.976 -0.535 . . . . 0.0 111.407 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 62.9 mt -66.64 -38.35 81.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 119.674 1.124 . . . . 0.0 109.095 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -59.09 -46.35 88.51 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.805 1.184 . . . . 0.0 109.646 173.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.66 -38.31 90.63 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.398 0.545 . . . . 0.0 111.77 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 39.0 tptt -65.11 -37.61 88.02 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.86 0.864 . . . . 0.0 111.043 176.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -129.27 67.96 79.39 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 124.282 1.033 . . . . 0.0 110.132 -170.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.09 -15.7 39.8 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.754 2.303 . . . . 0.0 113.052 -173.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -71.86 -6.55 42.51 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.996 0.918 . . . . 0.0 112.242 172.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -130.51 -176.02 3.84 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.691 1.996 . . . . 0.0 108.844 -177.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -142.52 160.52 40.13 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 106.671 -1.604 . . . . 0.0 106.671 177.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.1 t -142.55 148.79 19.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 -172.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 17.6 p -137.19 171.35 14.62 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.69 0.796 . . . . 0.0 109.534 177.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 24.8 p-90 -145.16 165.83 27.19 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 121.558 -0.713 . . . . 0.0 111.919 178.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -145.82 164.43 31.94 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.757 2.023 . . . . 0.0 106.622 170.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -107.12 9.25 30.43 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 122.865 0.466 . . . . 0.0 110.783 -174.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -71.97 178.54 3.68 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 121.29 -0.881 . . . . 0.0 108.986 169.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -178.19 -173.05 43.26 Favored Glycine 0 CA--C 1.522 0.492 0 O-C-N 121.334 -0.854 . . . . 0.0 113.99 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 82.8 t80 . . . . . 0 C--O 1.238 0.496 0 C-N-CA 126.402 1.881 . . . . 0.0 112.052 -169.79 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.482 1.148 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.2 153.52 37.68 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 122.061 -0.399 . . . . 0.0 110.02 170.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.9 m -138.46 172.94 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 126.155 1.782 . . . . 0.0 109.026 -176.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.59 172.11 1.74 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.653 0.74 . . . . 0.0 111.056 171.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -150.37 150.17 31.06 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 169.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 68.5 mt -56.83 -32.35 65.66 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -174.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.58 -25.87 66.0 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.039 0.836 . . . . 0.0 112.222 178.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.3 mt -85.24 -23.84 28.06 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 123.786 0.834 . . . . 0.0 111.389 -176.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 61.7 mt -64.64 129.05 94.11 Favored Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 -178.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -44.34 117.11 1.24 Allowed 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 124.494 3.463 . . . . 0.0 111.81 172.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -76.85 -34.93 57.81 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.17 0.51 . . . . 0.0 111.31 -169.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.9 t -137.83 135.78 45.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 174.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -154.16 107.99 2.97 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 169.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 15.6 pt -140.35 164.88 21.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 124.46 1.104 . . . . 0.0 108.419 -172.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.0 -35.29 76.45 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.04 0.936 . . . . 0.0 113.218 -175.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.6 m 55.23 19.28 2.85 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 174.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -132.15 -25.11 2.04 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.93 1.241 . . . . 0.0 112.81 -170.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -146.27 -166.38 12.07 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 123.923 0.773 . . . . 0.0 111.544 176.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 90.4 t -79.18 141.07 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 170.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -159.6 159.74 33.55 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.954 0.902 . . . . 0.0 110.271 177.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -79.76 151.73 30.2 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 169.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -142.14 158.84 43.29 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.619 1.168 . . . . 0.0 108.466 -178.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.9 m -128.37 154.11 38.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 124.662 1.185 . . . . 0.0 109.984 173.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -110.53 114.46 27.88 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 104.546 -2.39 . . . . 0.0 104.546 178.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.2 mt -117.98 121.76 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -172.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -73.47 147.99 43.61 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 169.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.4 t -132.49 146.82 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 178.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -124.95 154.27 41.43 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.604 1.161 . . . . 0.0 108.568 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.3 m -64.26 88.36 0.05 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.034 0.934 . . . . 0.0 111.798 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -136.66 35.39 0.26 Allowed Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 125.295 1.438 . . . . 0.0 112.422 169.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -45.98 141.82 8.78 Favored 'Trans proline' 0 C--N 1.359 1.087 0 CA-C-N 123.009 2.11 . . . . 0.0 111.981 170.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? 37.6 43.84 0.47 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.26 1.824 . . . . 0.0 112.904 -169.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 m 67.35 9.42 6.98 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.932 1.693 . . . . 0.0 113.75 173.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.35 133.91 1.75 Allowed Glycine 0 C--N 1.338 0.683 0 CA-C-N 119.461 1.028 . . . . 0.0 110.675 174.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -147.63 159.69 40.53 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 125.921 1.688 . . . . 0.0 108.301 -177.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.16 -26.2 21.47 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.3 2.0 . . . . 0.0 112.696 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.05 155.71 37.96 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.645 0.778 . . . . 0.0 110.214 173.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.62 34.88 1.16 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.895 1.278 . . . . 0.0 109.87 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.0 mm-40 -82.34 178.24 8.34 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.73 0.812 . . . . 0.0 109.56 177.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.3 m -140.57 159.26 42.6 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.653 1.181 . . . . 0.0 109.051 172.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -149.87 171.28 17.03 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 127.565 2.346 . . . . 0.0 106.185 -173.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.9 mp0 -134.77 152.58 51.87 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 174.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 38.4 pt -130.08 155.06 41.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 125.474 1.51 . . . . 0.0 109.37 176.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 45.4 t -118.42 120.14 63.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.2 mmp_? -128.66 145.01 51.28 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.312 1.445 . . . . 0.0 107.622 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.93 132.92 1.72 Allowed Glycine 0 C--N 1.331 0.282 0 CA-C-N 119.632 1.105 . . . . 0.0 111.142 174.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -154.46 157.87 39.09 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -172.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.3 mttp -58.78 -34.85 71.92 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 119.186 -0.435 . . . . 0.0 111.852 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 15.6 p-90 -65.4 -30.75 71.6 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 118.964 -0.541 . . . . 0.0 112.326 -177.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.53 74.57 10.38 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 119.161 0.891 . . . . 0.0 109.465 175.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.93 -17.36 63.16 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.221 0.608 . . . . 0.0 111.572 175.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.81 144.25 51.09 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 126.147 1.779 . . . . 0.0 108.025 178.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -67.95 -34.93 77.52 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 119.27 -0.395 . . . . 0.0 111.862 -169.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.77 -29.1 53.16 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 118.411 -0.804 . . . . 0.0 112.664 174.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -66.55 -49.88 65.0 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 119.437 1.017 . . . . 0.0 111.394 -172.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.45 HG12 ' H ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -66.08 -41.4 89.48 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 CA-C-O 118.987 -0.53 . . . . 0.0 110.271 176.293 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -62.3 -49.05 77.19 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 119.26 -0.4 . . . . 0.0 110.217 -177.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -63.94 -45.3 89.8 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 118.608 0.64 . . . . 0.0 111.149 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 28.7 tttt -57.36 -54.36 47.73 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.523 0.729 . . . . 0.0 110.826 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 91.7 t -80.91 -40.8 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-O 117.799 -1.096 . . . . 0.0 110.827 -169.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 58.2 m -62.94 -25.8 68.51 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 120.77 1.623 . . . . 0.0 110.911 173.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.06 -55.43 29.62 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 169.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -61.26 -39.03 88.84 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 118.645 1.222 . . . . 0.0 112.689 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 38.7 mmt -57.26 -47.38 81.56 Favored 'General case' 0 N--CA 1.461 0.077 0 CA-C-N 118.624 0.647 . . . . 0.0 109.515 174.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -67.79 -28.77 67.88 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.15 0.58 . . . . 0.0 112.542 178.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.9 mttm -63.24 -44.34 95.49 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.56 1.073 . . . . 0.0 109.445 169.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -65.93 -25.87 67.33 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 119.183 0.901 . . . . 0.0 110.89 171.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 122.82 -26.25 6.25 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 127.432 2.444 . . . . 0.0 111.64 175.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 97.2 m -53.9 148.46 10.41 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.649 1.98 . . . . 0.0 112.252 -173.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -108.79 138.78 44.56 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -177.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 91.7 m -141.74 162.16 36.16 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 -168.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -153.01 131.58 12.24 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.595 1.558 . . . . 0.0 107.872 171.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.0 p -69.74 118.5 12.68 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 169.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 43.7 mt -68.49 -25.4 64.95 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.882 -0.511 . . . . 0.0 109.903 172.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.38 -164.29 37.51 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 108.317 -1.913 . . . . 0.0 108.317 173.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -150.88 -179.32 26.53 Favored Glycine 0 N--CA 1.451 -0.303 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 171.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -169.83 -157.19 11.81 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 -175.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -143.45 147.24 34.27 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 -173.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 12.2 mt -121.52 138.93 50.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 -172.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 58.3 p -158.73 -150.75 0.25 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.288 1.835 . . . . 0.0 107.704 -172.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -129.68 164.72 23.33 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.004 1.322 . . . . 0.0 107.596 172.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -59.61 154.51 17.5 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.403 0.621 . . . . 0.0 110.038 175.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.8 m -60.99 -23.23 65.22 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -170.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -139.81 13.64 2.49 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.825 1.25 . . . . 0.0 111.4 -175.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -151.35 147.37 26.84 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.555 1.07 . . . . 0.0 110.477 -176.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -67.5 -12.08 59.48 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -176.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -53.03 131.96 37.09 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 120.153 1.342 . . . . 0.0 108.981 177.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 55.7 mt -66.3 152.02 9.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 -177.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 20.7 t60 -138.87 152.47 47.82 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 121.609 -0.682 . . . . 0.0 109.541 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.6 t -135.01 131.37 52.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 -178.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -160.19 -164.37 1.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 O-C-N 121.486 -0.759 . . . . 0.0 109.388 -177.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.04 -172.23 55.11 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 118.812 0.733 . . . . 0.0 112.457 173.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -162.45 150.07 13.96 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.989 0.915 . . . . 0.0 110.151 -174.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.0 t -78.74 165.59 23.43 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 167.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 21.8 ptp -108.45 -28.99 9.04 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 118.52 -0.752 . . . . 0.0 111.025 171.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.2 -25.16 57.99 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 119.49 1.041 . . . . 0.0 111.602 171.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -133.78 -5.95 2.82 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -169.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.77 -178.07 51.11 Favored Glycine 0 CA--C 1.535 1.335 0 CA-C-N 119.025 0.83 . . . . 0.0 113.575 173.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -68.13 142.31 55.52 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.806 2.337 . . . . 0.0 110.815 174.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.51 177.31 5.4 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 169.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 21.4 mm100 -62.91 -28.59 70.16 Favored 'General case' 0 CA--C 1.535 0.404 0 O-C-N 121.85 -0.532 . . . . 0.0 111.66 172.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . 0.263 38.3 m80 59.45 -27.64 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 128.556 2.742 . . . . 0.0 116.481 -174.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.26 -42.41 99.15 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 119.547 1.067 . . . . 0.0 110.251 173.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 62.2 mt -61.06 -47.26 94.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 176.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.4 -52.35 64.95 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.399 1.079 . . . . 0.0 110.599 -173.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 33.0 p -64.63 -48.47 74.74 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 118.781 -0.628 . . . . 0.0 109.636 -176.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -60.58 -40.24 91.01 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.958 0.799 . . . . 0.0 111.096 -177.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 48.9 mttm -64.78 -46.94 79.97 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 118.877 0.762 . . . . 0.0 111.19 176.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 63.2 mt -62.14 -44.39 98.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -60.19 -44.06 95.38 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.782 0.719 . . . . 0.0 110.336 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.67 -42.07 98.09 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.839 0.456 . . . . 0.0 111.321 178.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -76.66 -25.57 53.87 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 118.475 -0.774 . . . . 0.0 112.553 -178.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -134.61 64.04 61.98 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 124.394 1.078 . . . . 0.0 110.029 -172.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.95 -9.79 27.33 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.169 2.579 . . . . 0.0 113.348 -174.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -66.99 -10.93 54.87 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.97 0.908 . . . . 0.0 112.267 170.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -127.37 175.86 7.88 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.225 1.81 . . . . 0.0 109.103 178.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -136.04 155.32 50.4 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 171.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.3 t -138.09 146.37 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 -169.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.0 p -135.71 170.97 15.13 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.55 1.14 . . . . 0.0 109.283 176.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 34.9 p-90 -147.24 156.81 43.27 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 121.817 -0.552 . . . . 0.0 111.034 172.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -159.23 106.13 1.75 Allowed 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 173.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.63 -13.32 61.98 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -169.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -61.89 -31.79 72.11 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.749 0.82 . . . . 0.0 112.136 176.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -80.46 169.55 52.62 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 111.66 -0.576 . . . . 0.0 111.66 178.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 51.4 p90 . . . . . 0 C--O 1.237 0.397 0 C-N-CA 124.702 1.201 . . . . 0.0 108.303 177.537 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.483 1.178 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.62 163.86 15.45 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.444 0.698 . . . . 0.0 110.521 173.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.9 p -150.49 149.65 14.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 177.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.26 176.3 5.36 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.705 0.802 . . . . 0.0 111.55 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -153.36 149.6 28.0 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 126.488 1.915 . . . . 0.0 106.309 169.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 68.9 mt -54.79 -34.61 62.9 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 123.395 0.678 . . . . 0.0 112.539 -175.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.29 -25.05 65.85 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.861 0.755 . . . . 0.0 112.42 -178.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.8 mt -78.72 -25.05 44.58 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.023 0.529 . . . . 0.0 111.195 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 21.1 mt -70.87 129.39 89.71 Favored Pre-proline 0 CA--C 1.538 0.504 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -176.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -52.87 128.14 27.54 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.703 2.269 . . . . 0.0 110.644 169.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -80.47 -23.71 40.0 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 121.909 -0.495 . . . . 0.0 111.854 176.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.1 t -136.22 131.55 48.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 173.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -163.38 116.04 1.51 Allowed 'General case' 0 C--O 1.233 0.205 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 169.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -142.42 164.41 17.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.379 1.072 . . . . 0.0 109.127 -173.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -132.38 13.84 4.58 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.694 1.598 . . . . 0.0 110.752 175.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.3 m -71.84 66.84 0.57 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.788 1.635 . . . . 0.0 110.534 174.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -72.01 -6.72 44.24 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.784 1.634 . . . . 0.0 112.443 175.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -147.83 -173.58 18.96 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 126.946 2.212 . . . . 0.0 107.665 173.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.4 t -60.65 96.21 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.452 1.101 . . . . 0.0 109.547 -178.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -147.56 157.24 43.48 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 125.156 1.382 . . . . 0.0 109.423 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -71.17 157.1 38.74 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 124.082 0.953 . . . . 0.0 112.073 -171.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -145.31 164.74 30.5 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.066 1.747 . . . . 0.0 107.657 170.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.5 m -131.21 150.92 34.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 C-N-CA 124.28 1.032 . . . . 0.0 109.199 171.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.73 118.67 36.74 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 104.234 -2.506 . . . . 0.0 104.234 173.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 53.6 mt -120.31 124.84 73.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 -177.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -81.18 148.7 29.42 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 169.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.5 t -133.02 147.09 31.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 -175.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -132.49 147.33 52.36 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.815 1.246 . . . . 0.0 107.96 -178.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.8 m -62.25 103.18 0.36 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.524 0.73 . . . . 0.0 111.117 -178.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.515 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -144.45 19.18 0.04 OUTLIER Pre-proline 0 CA--C 1.555 1.146 0 CA-C-O 116.265 -1.826 . . . . 0.0 113.654 169.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.515 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 87.2 Cg_exo -40.81 131.65 2.75 Favored 'Trans proline' 0 C--N 1.365 1.428 0 CA-C-N 123.538 2.299 . . . . 0.0 114.349 178.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . 0.305 1.0 OUTLIER 23.46 47.82 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 130.145 3.378 . . . . 0.0 114.937 -168.723 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.1 m 55.46 24.54 6.87 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.892 1.277 . . . . 0.0 113.419 176.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -147.56 -7.59 0.25 Allowed Glycine 0 CA--C 1.528 0.895 0 CA-C-O 118.413 -1.215 . . . . 0.0 114.974 -169.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.73 133.26 86.31 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 119.553 1.676 . . . . 0.0 110.373 174.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -78.51 -19.87 11.24 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.842 2.362 . . . . 0.0 112.661 178.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.49 160.76 18.64 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.809 0.844 . . . . 0.0 110.859 177.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.08 36.71 1.13 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.428 1.491 . . . . 0.0 109.462 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -87.72 -177.45 5.84 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.327 1.051 . . . . 0.0 109.455 178.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.3 m -141.52 159.24 42.63 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.616 1.166 . . . . 0.0 109.547 175.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -153.41 166.33 33.01 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 127.107 2.163 . . . . 0.0 106.727 -173.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -127.61 154.28 45.42 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 119.577 1.08 . . . . 0.0 108.968 177.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.6 pt -134.73 153.05 34.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 C-N-CA 125.185 1.394 . . . . 0.0 109.37 175.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 43.2 t -118.98 114.22 44.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.4 mmp_? -126.63 147.11 49.95 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 175.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -176.97 141.29 5.32 Favored Glycine 0 C--N 1.331 0.253 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 175.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -152.9 153.83 33.82 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -172.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -59.51 -28.8 67.38 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 8.0 p-90 -70.91 -24.56 62.49 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.115 0.871 . . . . 0.0 112.596 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.42 75.74 9.97 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.586 1.085 . . . . 0.0 110.587 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -63.81 -14.49 53.34 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.288 0.635 . . . . 0.0 112.142 173.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -131.04 136.98 48.96 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.723 1.609 . . . . 0.0 107.317 177.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 34.6 m80 -60.72 -32.5 71.75 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 123.102 0.561 . . . . 0.0 110.594 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.69 -27.85 52.42 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 118.326 -0.845 . . . . 0.0 112.986 172.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -68.43 -49.78 57.5 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 119.619 1.1 . . . . 0.0 110.395 -176.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.42 HG12 ' H ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -67.36 -40.38 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-O 117.63 -1.176 . . . . 0.0 109.839 175.636 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -59.88 -47.8 84.28 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 120.301 1.41 . . . . 0.0 110.628 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -64.67 -47.62 77.78 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.569 0.622 . . . . 0.0 111.576 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 46.8 tttt -62.81 -50.75 69.74 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.11 0.564 . . . . 0.0 111.151 -178.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 93.2 t -71.96 -48.41 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-O 118.255 -0.879 . . . . 0.0 108.808 -172.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.9 m -64.21 -26.76 68.65 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 120.098 1.317 . . . . 0.0 111.251 177.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.91 -51.19 57.4 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 170.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -61.01 -43.03 99.48 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 118.495 1.147 . . . . 0.0 111.667 177.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.3 mmt -59.72 -47.18 86.66 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 118.974 -0.536 . . . . 0.0 109.859 177.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -69.82 -27.54 64.96 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.959 0.8 . . . . 0.0 112.096 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -67.28 -38.29 84.83 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.309 0.959 . . . . 0.0 109.988 169.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -69.02 -26.7 65.13 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 119.655 1.116 . . . . 0.0 110.293 169.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 119.7 -22.73 8.61 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 128.059 2.742 . . . . 0.0 112.219 175.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 92.9 m -52.64 147.98 7.83 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 126.067 1.747 . . . . 0.0 111.791 -178.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -108.11 140.18 41.69 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 66.7 m -140.71 163.04 33.96 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -168.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -151.78 128.23 10.68 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.515 1.526 . . . . 0.0 107.489 175.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.8 p -70.9 121.46 18.14 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 169.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 51.4 mt -70.17 -27.14 64.28 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.968 -0.457 . . . . 0.0 109.851 171.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.62 -170.34 41.09 Favored Glycine 0 C--N 1.337 0.63 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 173.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -131.98 165.05 23.6 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.399 -0.68 . . . . 0.0 111.399 176.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -166.05 -162.99 18.69 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 125.284 1.421 . . . . 0.0 109.666 177.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 33.8 ptt180 -138.22 159.72 41.31 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 121.067 -1.255 . . . . 0.0 109.2 176.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 84.6 mt -116.91 124.31 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 103.843 -2.651 . . . . 0.0 103.843 -174.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 21.4 m -137.21 176.25 8.88 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 125.392 1.477 . . . . 0.0 109.873 -169.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 62.03 -7.64 0.11 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 128.586 2.754 . . . . 0.0 115.747 172.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -50.51 -31.17 14.74 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.187 1.795 . . . . 0.0 112.381 169.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.8 p -130.31 13.22 5.57 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.96 1.304 . . . . 0.0 111.934 -175.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -125.25 -7.7 7.04 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.879 0.872 . . . . 0.0 111.888 177.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -146.83 -51.52 0.21 Allowed 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.762 1.225 . . . . 0.0 109.58 173.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? 126.26 -40.19 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.482 1 C-N-CA 131.935 4.094 . . . . 0.0 108.8 176.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.1 ttmm -62.42 119.19 8.65 Favored 'General case' 0 C--N 1.343 0.302 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 169.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.468 ' HB ' HG13 ' A' ' 118' ' ' VAL . 21.4 mt -68.25 146.58 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 177.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 20.0 t60 -133.17 146.18 51.31 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 174.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.7 t -137.37 134.84 47.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -171.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -174.42 172.39 3.18 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.253 1.421 . . . . 0.0 107.858 -178.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 144.1 -169.89 26.1 Favored Glycine 0 C--N 1.334 0.441 0 CA-C-N 119.017 0.826 . . . . 0.0 112.249 169.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -160.46 114.11 2.12 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.582 1.553 . . . . 0.0 107.737 -176.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.3 t -72.62 142.65 48.35 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 168.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.0 ppp? -71.64 -39.91 70.07 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 171.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.79 -25.06 35.57 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 118.711 -0.662 . . . . 0.0 112.408 -172.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -134.58 0.47 3.01 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -169.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.94 -175.27 53.95 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-N 119.197 0.908 . . . . 0.0 112.881 176.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -76.16 138.57 20.47 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.975 2.45 . . . . 0.0 109.847 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.48 171.76 9.59 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.094 0.473 . . . . 0.0 110.625 169.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 58.2 mm-40 -64.25 -35.77 81.91 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 119.116 -0.469 . . . . 0.0 111.828 175.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 33.9 m80 59.96 -31.2 0.05 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 128.767 2.827 . . . . 0.0 115.479 -173.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.57 -37.96 85.76 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.132 1.373 . . . . 0.0 112.115 174.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 90.4 mt -63.41 -46.51 95.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 176.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.67 -47.37 84.72 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.193 0.997 . . . . 0.0 110.939 -177.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.513 HG22 HG12 ' A' ' 118' ' ' VAL . 5.9 p -64.23 -51.98 61.01 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 119.137 0.881 . . . . 0.0 110.694 -177.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -60.28 -39.82 88.26 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 118.726 0.694 . . . . 0.0 110.574 -175.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -64.59 -56.05 16.46 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-O 118.462 -0.78 . . . . 0.0 111.187 174.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 66.9 mt -63.36 -41.4 92.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.215 -172.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -54.29 -46.2 72.68 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 120.121 1.328 . . . . 0.0 110.194 175.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -69.28 -28.85 66.65 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -176.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.42 ' HE3' ' HA ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -65.9 -51.01 62.35 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 119.087 0.858 . . . . 0.0 111.583 -170.002 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.518 ' H ' ' CD ' ' A' ' 114' ' ' PRO . 37.2 p90 -161.77 -32.6 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.703 0 N-CA-C 117.637 2.458 . . . . 0.0 117.637 -173.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.518 ' CD ' ' H ' ' A' ' 113' ' ' TYR . 88.9 Cg_exo -54.9 130.55 41.23 Favored 'Trans proline' 0 C--N 1.353 0.801 0 CA-C-N 123.196 2.177 . . . . 0.0 114.545 -169.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -76.11 -30.36 58.2 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 168.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -79.56 -158.1 0.15 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 127.643 2.377 . . . . 0.0 108.962 169.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -134.02 169.05 17.71 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.013 -1.054 . . . . 0.0 111.288 -169.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.513 HG12 HG22 ' A' ' 106' ' ' THR . 5.2 t -134.86 136.69 51.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 16.8 p -137.0 170.79 15.52 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.664 1.12 . . . . 0.0 109.926 176.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 38.5 p-90 -141.49 152.31 44.08 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 172.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -158.53 113.4 2.56 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 103.643 -2.725 . . . . 0.0 103.643 169.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.42 22.34 0.13 Allowed 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 118.808 0.731 . . . . 0.0 112.694 -169.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -61.84 -29.79 70.41 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.949 1.3 . . . . 0.0 111.863 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -88.24 147.09 19.97 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 169.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 . . . . . 0 C--O 1.238 0.463 0 C-N-CA 125.246 1.418 . . . . 0.0 108.855 -174.348 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 N--CA 1.483 1.22 0 CA-C-O 120.557 0.217 . . . . 0.0 110.564 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.78 165.87 26.85 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.278 1.431 . . . . 0.0 107.953 172.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.3 p -150.51 156.83 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 177.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -159.89 -172.82 3.8 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.165 1.786 . . . . 0.0 108.077 -177.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -146.97 147.96 31.24 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 169.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 71.5 mt -57.94 -30.02 65.62 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -173.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.22 -26.71 63.99 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.979 0.809 . . . . 0.0 111.981 177.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.2 mt -83.88 -25.52 30.17 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.772 0.829 . . . . 0.0 111.215 -177.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 51.9 mt -63.34 127.83 91.66 Favored Pre-proline 0 CA--C 1.538 0.506 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -45.9 122.8 5.48 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.968 3.112 . . . . 0.0 111.409 172.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -79.45 -36.24 39.18 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 121.209 0.528 . . . . 0.0 110.768 -172.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 77.9 t -136.69 129.97 45.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 N-CA-C 105.658 -1.978 . . . . 0.0 105.658 175.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -154.69 125.7 7.19 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 170.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.9 pt -144.65 164.16 13.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 124.835 1.254 . . . . 0.0 108.451 -173.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -60.6 144.86 50.79 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.849 0.357 . . . . 0.0 110.152 173.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.0 m -62.25 -35.86 80.24 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.222 1.409 . . . . 0.0 114.45 -169.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -157.61 129.9 7.23 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.366 0.666 . . . . 0.0 109.484 -173.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 149.61 -164.56 29.47 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-O 121.646 0.581 . . . . 0.0 112.503 172.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 93.1 t -125.57 126.55 70.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 169.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -160.47 161.32 32.83 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 122.829 0.452 . . . . 0.0 111.317 -169.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -71.95 156.55 39.13 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 175.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.1 163.74 32.02 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 172.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.2 m -133.29 149.59 31.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 C-N-CA 124.385 1.074 . . . . 0.0 109.15 172.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.53 121.59 41.39 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 104.055 -2.572 . . . . 0.0 104.055 173.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 85.5 mt -122.57 126.47 74.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -177.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -82.14 148.31 28.57 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 169.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.5 t -137.26 147.02 27.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 126.857 2.063 . . . . 0.0 105.606 -173.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -128.11 152.0 48.53 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.684 1.194 . . . . 0.0 108.889 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.8 m -62.86 93.26 0.06 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.31 1.044 . . . . 0.0 111.028 175.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.51 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -141.1 16.39 0.04 OUTLIER Pre-proline 0 CA--C 1.551 0.992 0 CA-C-O 116.245 -1.836 . . . . 0.0 114.115 169.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.51 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 76.8 Cg_exo -46.77 152.58 1.61 Allowed 'Trans proline' 0 C--N 1.363 1.298 0 CA-C-N 124.104 2.501 . . . . 0.0 114.226 175.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.74 12.53 0.41 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.122 1.369 . . . . 0.0 113.359 -173.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.5 m 52.43 29.84 7.47 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.699 1.2 . . . . 0.0 111.511 -169.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -167.25 8.29 0.05 OUTLIER Glycine 0 CA--C 1.531 1.065 0 CA-C-O 118.369 -1.239 . . . . 0.0 115.294 -172.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.33 138.64 67.26 Favored Pre-proline 0 CA--C 1.544 0.747 0 CA-C-N 119.616 1.708 . . . . 0.0 110.294 173.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -77.91 -21.95 10.56 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 122.855 2.37 . . . . 0.0 113.304 -174.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.82 163.01 17.65 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.488 0.715 . . . . 0.0 110.597 176.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.65 35.53 1.16 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.031 1.332 . . . . 0.0 109.824 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -86.61 -178.35 6.37 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.006 0.922 . . . . 0.0 109.587 177.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.9 m -142.17 157.19 45.16 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.711 1.205 . . . . 0.0 109.088 176.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -151.64 167.51 27.9 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 127.146 2.178 . . . . 0.0 106.427 -173.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 -131.88 154.12 49.53 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 175.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 35.8 pt -132.38 155.68 41.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 125.168 1.387 . . . . 0.0 109.852 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 98.6 t -118.16 115.11 47.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 177.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 12.1 mmp_? -125.78 141.93 51.76 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.239 1.416 . . . . 0.0 107.518 176.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -177.9 137.32 3.33 Favored Glycine 0 C--N 1.333 0.363 0 CA-C-N 119.31 0.959 . . . . 0.0 111.113 174.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -153.19 153.3 32.47 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 117.097 0.449 . . . . 0.0 110.54 -169.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -57.26 -32.47 66.62 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.086 0.954 . . . . 0.0 112.274 177.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 13.0 p-90 -67.83 -27.64 66.88 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.853 0.752 . . . . 0.0 112.529 177.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.98 81.63 8.7 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 119.724 1.147 . . . . 0.0 109.438 174.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -64.11 -19.1 65.03 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.266 0.626 . . . . 0.0 112.017 174.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -135.22 152.56 51.67 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 126.327 1.851 . . . . 0.0 108.001 -179.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 44.8 m-70 -73.72 -32.85 64.08 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 121.84 -0.537 . . . . 0.0 109.575 -169.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.0 -28.9 55.64 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 118.481 -0.771 . . . . 0.0 112.597 172.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -66.73 -50.51 62.55 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 119.356 0.98 . . . . 0.0 110.637 -175.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.4 ' H ' HG12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -66.67 -40.21 85.61 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 CA-C-O 117.257 -1.354 . . . . 0.0 109.826 175.533 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -60.86 -47.83 84.6 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-N 120.214 1.37 . . . . 0.0 110.243 -178.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -61.73 -46.17 90.78 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.001 0.819 . . . . 0.0 111.886 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 34.4 tttt -61.21 -50.0 74.88 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 123.082 0.553 . . . . 0.0 110.671 178.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 86.6 t -77.54 -39.98 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-O 117.751 -1.119 . . . . 0.0 109.757 -170.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 80.8 p -63.08 -34.16 76.99 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 120.888 1.676 . . . . 0.0 109.617 175.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.65 -53.32 46.34 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 171.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -60.22 -46.26 90.36 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 118.547 1.174 . . . . 0.0 111.813 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 38.0 mmt -57.92 -48.96 78.36 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.366 0.666 . . . . 0.0 110.369 177.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -68.21 -28.48 67.28 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.66 0.664 . . . . 0.0 111.996 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -67.95 -38.0 82.28 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 119.243 0.928 . . . . 0.0 110.594 171.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -67.56 -29.86 69.34 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 119.67 1.123 . . . . 0.0 110.437 169.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 126.96 -21.87 5.79 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 127.458 2.456 . . . . 0.0 111.692 174.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 68.1 m -52.45 150.14 5.12 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 125.947 1.699 . . . . 0.0 112.438 -176.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -108.51 136.24 48.45 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 173.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 99.5 m -144.13 164.96 29.17 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -168.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -149.83 136.17 19.0 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.007 1.723 . . . . 0.0 107.847 171.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.3 p -73.22 125.0 26.75 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 169.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 44.4 mt -75.26 -23.29 57.44 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.812 -0.555 . . . . 0.0 110.398 173.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.01 -174.02 43.52 Favored Glycine 0 C--N 1.337 0.604 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 171.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -123.48 168.07 15.7 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 175.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -172.32 -165.25 29.13 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -173.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -149.38 150.49 32.51 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -169.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 58.7 mt -129.97 147.46 33.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 -172.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.5 p -151.66 168.73 24.07 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.701 1.2 . . . . 0.0 110.744 177.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 4.4 p-80 -170.62 160.67 7.28 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 128.463 2.705 . . . . 0.0 106.194 174.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -154.07 161.42 41.93 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.9 m -55.88 -33.0 64.2 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.163 -0.961 . . . . 0.0 112.104 172.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -92.33 -0.38 57.39 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.199 1.399 . . . . 0.0 111.742 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -150.01 65.47 0.97 Allowed 'General case' 0 C--O 1.233 0.219 0 C-N-CA 125.809 1.644 . . . . 0.0 106.978 -172.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -68.93 -25.85 64.78 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.018 -0.992 . . . . 0.0 113.504 -169.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -60.42 135.84 57.86 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 169.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.6 mt -65.99 150.57 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 170.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 36.2 t60 -131.85 150.74 52.06 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 121.109 -0.995 . . . . 0.0 108.605 177.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.2 t -131.83 136.62 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -178.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -161.0 -161.09 0.79 Allowed 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 125.145 1.378 . . . . 0.0 107.424 -172.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.73 -177.81 45.21 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-O 122.539 1.077 . . . . 0.0 113.451 169.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -164.07 150.64 11.45 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 126.032 1.733 . . . . 0.0 106.793 -169.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.3 t -116.96 145.9 43.35 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.66 1.584 . . . . 0.0 106.813 171.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.0 ptm -87.35 -34.46 18.81 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 118.79 -0.624 . . . . 0.0 110.193 174.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.81 -26.09 56.94 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.117 0.871 . . . . 0.0 111.949 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -131.13 -5.09 3.89 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -169.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.44 173.8 40.27 Favored Glycine 0 CA--C 1.533 1.197 0 CA-C-N 118.858 0.754 . . . . 0.0 112.312 178.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.23 134.37 24.76 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.71 2.273 . . . . 0.0 109.527 177.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.28 166.57 19.86 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.674 0.75 . . . . 0.0 112.433 176.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -77.64 74.87 4.19 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.897 1.279 . . . . 0.0 108.973 169.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -54.15 -22.33 10.93 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -176.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.81 -40.64 89.07 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.955 0.902 . . . . 0.0 111.761 173.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 65.0 mt -63.28 -46.36 95.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.55 -50.86 72.25 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.451 1.1 . . . . 0.0 110.129 -176.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 20.9 p -65.39 -42.61 92.47 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 118.049 -0.977 . . . . 0.0 111.378 -174.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -61.35 -40.86 95.82 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.821 1.191 . . . . 0.0 110.742 178.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 43.4 mttm -66.51 -46.28 76.77 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 121.793 -0.567 . . . . 0.0 111.277 176.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 67.2 mt -64.8 -40.71 89.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -177.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -58.37 -44.37 88.85 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 119.88 1.218 . . . . 0.0 109.862 174.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.52 -38.92 91.83 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 119.11 -0.471 . . . . 0.0 111.63 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 57.4 tttt -72.29 -32.93 67.04 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.99 0.814 . . . . 0.0 111.802 176.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -125.92 63.2 47.05 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 123.784 0.834 . . . . 0.0 111.129 -170.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.44 -14.33 36.91 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.871 2.381 . . . . 0.0 112.984 -176.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -70.92 -7.83 48.67 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.143 0.977 . . . . 0.0 112.175 171.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -129.15 -170.81 2.34 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.818 2.047 . . . . 0.0 108.373 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -134.87 168.69 18.62 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 171.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.7 t -142.55 143.45 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 26.0 p -136.21 172.0 13.65 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.075 0.95 . . . . 0.0 108.912 173.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 45.7 p-90 -145.45 155.62 43.23 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.076 0.465 . . . . 0.0 110.752 172.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -154.85 130.45 9.9 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 104.304 -2.48 . . . . 0.0 104.304 172.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -81.66 35.98 0.42 Allowed 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 119.442 1.019 . . . . 0.0 113.201 -169.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -73.91 -178.29 3.2 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.324 -0.86 . . . . 0.0 109.819 173.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 70.88 -167.5 51.03 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.254 0.93 . . . . 0.0 113.638 175.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 38.5 t80 . . . . . 0 C--O 1.241 0.615 0 C-N-CA 125.633 1.573 . . . . 0.0 109.163 -174.754 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 mpp? . . . . . 0 N--CA 1.483 1.221 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.3 165.39 34.16 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.015 1.326 . . . . 0.0 108.693 175.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.0 t -139.9 137.34 38.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.09 -176.28 3.96 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.287 0.565 . . . . 0.0 110.743 178.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -151.87 152.14 32.2 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.544 1.538 . . . . 0.0 106.864 170.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.2 mt -57.03 -31.66 65.38 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.568 0.622 . . . . 0.0 112.553 -176.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.84 -24.7 65.3 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 118.825 0.739 . . . . 0.0 112.376 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.2 mt -85.31 -18.68 33.15 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.549 0.74 . . . . 0.0 111.499 -176.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 50.1 mt -65.01 131.84 95.32 Favored Pre-proline 0 CA--C 1.54 0.577 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -50.4 115.79 2.13 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 123.503 2.802 . . . . 0.0 110.104 169.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -70.73 -39.18 73.5 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -169.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 45.5 t -140.83 138.5 34.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 176.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -152.51 112.49 3.99 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 169.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 40.0 pt -138.2 36.33 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 124.693 1.197 . . . . 0.0 109.88 -169.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -62.66 92.48 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.052 1.341 . . . . 0.0 111.837 -177.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.6 m -165.06 178.27 7.17 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 127.84 2.456 . . . . 0.0 107.803 176.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -139.9 159.31 42.47 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.344 1.458 . . . . 0.0 108.495 -178.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.93 -165.79 44.74 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -169.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.6 t -72.61 141.43 16.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 171.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -153.42 158.79 41.95 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.58 1.152 . . . . 0.0 108.807 171.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.4 mmtp -74.68 154.57 38.4 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.045 0.938 . . . . 0.0 109.174 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.99 161.58 39.78 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.75 0.82 . . . . 0.0 108.985 176.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.6 m -133.79 152.09 34.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 C-N-CA 124.897 1.279 . . . . 0.0 109.331 173.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 28.2 tp -108.83 116.12 31.38 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 105.226 -2.138 . . . . 0.0 105.226 177.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 86.0 mt -120.15 119.12 59.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -169.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.3 ttp180 -78.13 145.36 35.75 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 168.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.3 p -139.25 148.85 23.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -130.71 145.95 52.06 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.084 1.353 . . . . 0.0 108.29 -169.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.0 m -61.38 108.23 0.9 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.644 0.778 . . . . 0.0 111.266 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.411 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -150.35 22.25 0.03 OUTLIER Pre-proline 0 CA--C 1.552 1.03 0 C-N-CA 125.185 1.394 . . . . 0.0 112.441 168.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 30' ' ' ALA . 45.5 Cg_endo -60.7 134.07 51.94 Favored 'Trans proline' 0 C--N 1.359 1.087 0 CA-C-N 122.669 1.989 . . . . 0.0 110.998 -171.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 38.16 27.21 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 129.263 3.025 . . . . 0.0 114.21 -169.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.0 m 46.1 33.23 1.64 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.418 1.487 . . . . 0.0 112.371 -171.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -128.41 -28.84 0.81 Allowed Glycine 0 C--N 1.341 0.82 0 CA-C-O 118.688 -1.062 . . . . 0.0 113.766 -169.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.28 140.65 96.9 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 119.241 1.52 . . . . 0.0 109.919 175.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -78.09 -14.74 14.97 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.106 2.537 . . . . 0.0 112.958 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.45 155.83 20.78 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.934 0.894 . . . . 0.0 111.251 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -143.5 36.22 1.32 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.75 1.62 . . . . 0.0 109.007 177.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -85.95 -178.52 6.59 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.393 1.077 . . . . 0.0 109.585 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.4 m -140.71 157.85 44.83 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.393 1.077 . . . . 0.0 109.29 173.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -152.87 168.26 26.35 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 127.354 2.261 . . . . 0.0 106.23 -173.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -130.88 147.39 52.52 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.03 -1.044 . . . . 0.0 108.614 177.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 29.8 pt -130.75 156.0 42.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 125.881 1.672 . . . . 0.0 109.315 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.2 t -131.23 116.53 33.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 -169.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.5 mmt85 -137.22 148.9 46.82 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -176.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 177.69 137.43 2.75 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -154.85 154.09 32.18 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -170.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -59.71 -29.22 67.97 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.274 0.629 . . . . 0.0 112.651 178.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 11.2 p-90 -69.4 -28.21 65.96 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.014 0.825 . . . . 0.0 112.258 178.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.86 77.67 9.67 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 119.41 1.005 . . . . 0.0 109.022 175.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -63.13 -18.59 63.6 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 122.937 0.495 . . . . 0.0 111.303 173.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.65 146.3 51.44 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.64 1.576 . . . . 0.0 107.724 178.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -72.67 -30.22 64.08 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.131 0.572 . . . . 0.0 110.262 -169.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.41 -30.8 42.05 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 118.636 -0.697 . . . . 0.0 112.549 170.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -69.37 -47.61 63.75 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 119.34 0.973 . . . . 0.0 110.902 -175.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.446 ' H ' HG12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -67.73 -40.8 84.52 Favored 'Isoleucine or valine' 0 C--N 1.34 0.178 0 CA-C-O 117.891 -1.052 . . . . 0.0 110.117 175.635 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -61.21 -45.65 93.7 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.747 1.158 . . . . 0.0 110.288 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -62.53 -47.16 85.13 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.318 0.508 . . . . 0.0 111.583 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 26.1 tttp -63.62 -54.08 41.5 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 122.814 0.446 . . . . 0.0 110.995 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 97.3 t -71.07 -52.36 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -170.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 33.4 m -67.2 -27.96 67.69 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 119.206 0.912 . . . . 0.0 111.249 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.56 -46.92 93.3 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 170.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -63.23 -42.22 99.22 Favored 'General case' 0 CA--C 1.526 0.053 0 CA-C-N 118.568 1.184 . . . . 0.0 111.245 176.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.5 mmt -59.72 -45.1 93.18 Favored 'General case' 0 C--O 1.226 -0.18 0 CA-C-N 118.242 0.473 . . . . 0.0 110.14 176.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.7 mm-40 -66.72 -30.49 70.74 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.817 0.847 . . . . 0.0 111.912 178.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -68.61 -39.19 80.96 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.718 1.145 . . . . 0.0 110.301 170.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -65.4 -26.25 67.9 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.178 0.899 . . . . 0.0 110.431 169.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 119.09 -22.07 9.19 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 128.152 2.786 . . . . 0.0 111.82 175.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 91.3 m -58.69 150.58 23.04 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 126.452 1.901 . . . . 0.0 111.414 -176.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -108.78 146.03 34.24 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.481 1.113 . . . . 0.0 108.174 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 82.4 m -140.01 162.88 34.14 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -168.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -150.81 122.5 8.03 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 125.417 1.487 . . . . 0.0 107.66 173.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.5 p -69.88 120.0 14.95 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 169.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 45.1 mt -68.1 -25.64 65.41 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.987 -0.445 . . . . 0.0 109.893 172.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 165.55 -167.27 38.9 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 125.434 1.492 . . . . 0.0 109.432 170.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -132.76 170.89 21.88 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 123.977 0.799 . . . . 0.0 111.489 176.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -171.16 -161.31 21.59 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 125.471 1.51 . . . . 0.0 109.719 -177.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -142.29 165.95 26.04 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 121.372 -1.075 . . . . 0.0 108.909 174.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 60.1 mt -119.26 136.66 55.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 123.12 0.568 . . . . 0.0 109.544 -169.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 40.1 m 52.02 -162.0 0.09 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.92 2.488 . . . . 0.0 115.48 169.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -127.07 171.78 11.08 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.839 2.056 . . . . 0.0 106.833 175.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -58.43 -30.32 66.81 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.986 -0.446 . . . . 0.0 111.673 -178.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.9 m -71.93 63.53 0.48 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.824 1.65 . . . . 0.0 110.398 169.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -58.3 -17.04 16.76 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.01 1.324 . . . . 0.0 114.011 -175.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -63.87 -24.87 67.91 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.226 1.01 . . . . 0.0 112.557 173.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -63.16 160.93 14.44 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.202 1.001 . . . . 0.0 110.065 175.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -48.53 134.09 15.87 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 169.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 37.6 mm -63.67 148.33 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 -176.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 24.3 t60 -137.06 158.35 44.65 Favored 'General case' 0 C--N 1.332 -0.193 0 O-C-N 121.508 -0.745 . . . . 0.0 109.506 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.5 t -140.16 132.27 32.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -166.88 -173.69 2.47 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.18 0.992 . . . . 0.0 108.809 -172.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.92 -166.33 21.31 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-N 119.059 0.845 . . . . 0.0 112.263 171.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -155.64 178.22 10.5 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.424 1.09 . . . . 0.0 110.145 178.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.8 t -129.91 151.15 50.79 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 104.824 -2.288 . . . . 0.0 104.824 169.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.3 ptm -88.88 -34.05 17.11 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 118.787 -0.625 . . . . 0.0 110.281 175.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.34 -25.85 55.13 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.08 0.855 . . . . 0.0 111.981 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -130.84 -4.63 4.04 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -169.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.94 175.61 42.19 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-N 118.854 0.752 . . . . 0.0 112.353 177.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -66.7 138.43 49.18 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.428 2.085 . . . . 0.0 110.035 173.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.31 169.31 7.44 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.033 0.533 . . . . 0.0 110.953 171.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 21.2 mm100 -63.25 -30.26 71.43 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 118.975 -0.536 . . . . 0.0 111.428 170.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 40.2 m80 60.8 -31.56 0.07 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 129.017 2.927 . . . . 0.0 115.496 -175.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.09 -41.94 93.57 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.202 1.401 . . . . 0.0 112.318 178.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.8 mt -62.38 -49.15 85.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 177.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.4 m -54.68 -45.16 73.89 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.54 1.136 . . . . 0.0 112.172 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.527 HG22 HG12 ' A' ' 118' ' ' VAL . 1.0 OUTLIER -61.3 -50.0 74.76 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 119.747 1.158 . . . . 0.0 110.315 178.442 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -61.26 -41.42 96.89 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.972 0.805 . . . . 0.0 110.889 -177.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 24.5 mmtp -68.23 -43.82 77.09 Favored 'General case' 0 C--N 1.338 0.086 0 CA-C-O 118.699 -0.667 . . . . 0.0 111.629 178.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 79.9 mt -67.23 -38.15 80.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 119.958 1.254 . . . . 0.0 109.01 -178.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -58.31 -45.25 88.38 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 119.64 1.109 . . . . 0.0 109.49 173.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.05 -37.88 89.03 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.351 0.523 . . . . 0.0 111.787 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 41.7 tptt -62.34 -44.12 97.23 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 123.943 0.897 . . . . 0.0 110.811 178.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -141.59 73.54 24.21 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 118.401 0.546 . . . . 0.0 110.491 -170.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.89 -6.22 18.66 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.307 2.672 . . . . 0.0 113.602 -173.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -68.21 -19.83 64.79 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.84 0.745 . . . . 0.0 111.515 169.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 22.8 m-30 -109.37 178.37 4.46 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.042 1.337 . . . . 0.0 108.822 169.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -131.85 161.14 33.69 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 171.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.527 HG12 HG22 ' A' ' 106' ' ' THR . 2.6 t -139.97 141.0 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 -169.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 16.9 p -135.06 171.09 14.92 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.137 0.975 . . . . 0.0 109.241 173.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 35.6 p-90 -143.28 152.24 41.45 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 121.597 -0.69 . . . . 0.0 109.436 172.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.42 119.56 3.8 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.182 -2.155 . . . . 0.0 105.182 170.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.42 -3.72 32.21 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 120.309 -0.557 . . . . 0.0 112.345 -171.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -58.34 -30.74 66.96 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.754 1.221 . . . . 0.0 112.692 -178.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -72.7 134.61 20.79 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 173.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 . . . . . 0 C--O 1.239 0.514 0 C-N-CA 125.606 1.562 . . . . 0.0 108.942 177.014 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.9 tpt . . . . . 0 N--CA 1.482 1.157 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.18 153.77 40.25 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.212 1.405 . . . . 0.0 107.383 169.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.1 t -68.33 126.14 27.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -178.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -76.37 -176.46 3.66 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.363 0.665 . . . . 0.0 110.43 172.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -149.21 147.64 28.65 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 169.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 95.1 mt -55.51 -34.21 64.44 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.537 0.735 . . . . 0.0 112.407 -175.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.05 -25.54 66.31 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.834 0.743 . . . . 0.0 112.249 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.6 mt -79.25 -24.01 43.28 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.178 0.591 . . . . 0.0 111.183 -178.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 39.5 mt -68.31 128.78 93.1 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -176.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -47.42 123.05 7.41 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.939 3.093 . . . . 0.0 111.925 172.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -71.87 -37.52 70.19 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.499 0.72 . . . . 0.0 111.294 -177.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 63.9 t -137.52 134.32 46.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 176.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -152.66 119.96 5.92 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 171.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.5 pt -147.96 168.95 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 124.28 1.032 . . . . 0.0 109.299 -169.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -126.05 97.68 5.2 Favored 'General case' 0 N--CA 1.461 0.123 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 169.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.2 m -70.69 51.22 0.14 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 127.928 2.491 . . . . 0.0 113.054 -171.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -60.2 -37.05 79.08 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.515 1.126 . . . . 0.0 113.004 -169.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 160.12 -56.78 0.32 Allowed Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 174.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 46.9 t -142.14 122.98 11.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 173.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -160.15 151.21 19.18 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.309 1.044 . . . . 0.0 108.771 -174.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -75.66 156.3 34.94 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.491 0.717 . . . . 0.0 110.003 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.44 163.34 35.97 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.004 1.322 . . . . 0.0 107.869 -178.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.3 m -135.95 156.04 36.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 C-N-CA 124.304 1.041 . . . . 0.0 109.7 172.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.81 122.23 45.97 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 104.225 -2.509 . . . . 0.0 104.225 173.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 73.9 mt -121.53 122.5 67.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 -176.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 37.6 ttp180 -80.74 146.82 30.84 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 169.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.6 t -132.13 143.77 39.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 -175.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -128.96 138.36 51.93 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 176.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.5 p -67.31 115.87 7.44 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.777 0.799 . . . . 0.0 110.641 -175.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.405 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -148.43 27.49 0.05 OUTLIER Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 125.833 1.653 . . . . 0.0 111.609 169.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.405 ' CD ' ' N ' ' A' ' 30' ' ' ALA . 35.2 Cg_endo -59.73 156.06 39.68 Favored 'Trans proline' 0 C--N 1.358 1.064 0 CA-C-N 122.569 1.953 . . . . 0.0 111.985 -173.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.5 ttp180 50.56 19.06 0.52 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.446 1.898 . . . . 0.0 112.664 -169.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.7 m 50.19 31.46 5.11 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.385 1.474 . . . . 0.0 112.282 -173.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -166.59 1.66 0.04 OUTLIER Glycine 0 C--N 1.343 0.917 0 CA-C-O 118.28 -1.289 . . . . 0.0 115.837 -173.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.76 142.05 78.97 Favored Pre-proline 0 CA--C 1.543 0.702 0 CA-C-N 119.858 1.829 . . . . 0.0 110.493 173.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -78.47 -15.77 13.79 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 123.053 2.502 . . . . 0.0 113.495 -175.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.71 157.92 22.94 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.574 0.75 . . . . 0.0 111.333 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.16 76.62 1.28 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.197 1.399 . . . . 0.0 107.531 176.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -138.22 175.69 9.35 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 126.982 2.113 . . . . 0.0 107.416 -177.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.2 m -140.89 157.86 44.77 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.299 0.64 . . . . 0.0 110.589 -175.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -152.22 167.5 28.38 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 127.586 2.355 . . . . 0.0 106.008 -175.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.9 mp0 -133.21 156.49 47.42 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 120.713 -1.242 . . . . 0.0 108.443 176.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 32.2 pt -136.31 155.35 34.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 125.255 1.422 . . . . 0.0 109.807 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 48.1 t -118.14 122.36 69.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 -179.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.1 mmp_? -129.29 146.18 51.23 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.083 1.353 . . . . 0.0 107.832 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 177.32 131.36 1.5 Allowed Glycine 0 C--N 1.331 0.283 0 CA-C-N 119.173 0.897 . . . . 0.0 111.045 173.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -153.95 152.3 30.42 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -173.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.9 pttm -58.89 -29.4 66.99 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 11.1 p-90 -65.4 -27.52 68.6 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.231 0.923 . . . . 0.0 111.854 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.56 75.67 10.01 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 118.871 0.76 . . . . 0.0 109.052 172.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -67.22 -6.59 18.75 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.685 0.794 . . . . 0.0 111.574 175.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -137.28 146.14 44.34 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 126.63 1.972 . . . . 0.0 107.224 173.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 61.1 m-70 -68.97 -34.29 75.08 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -171.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.97 -26.49 48.47 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 118.355 -0.831 . . . . 0.0 112.766 174.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -69.11 -48.06 63.53 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 119.749 1.159 . . . . 0.0 111.111 -175.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.416 ' H ' HG12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -66.08 -38.02 81.09 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.024 176.284 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -62.23 -50.32 72.2 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.612 177.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -60.99 -44.12 97.85 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.798 1.181 . . . . 0.0 112.02 -178.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.6 tppt? -57.08 -54.64 44.45 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.169 0.988 . . . . 0.0 110.527 177.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.2 t -85.26 -34.41 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-O 117.619 -1.182 . . . . 0.0 111.974 -168.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 57.2 p -63.26 -33.18 74.94 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 121.345 1.884 . . . . 0.0 109.485 170.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.74 -52.85 50.5 Favored Glycine 0 C--N 1.338 0.64 0 N-CA-C 110.354 -1.099 . . . . 0.0 110.354 171.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.403 ' HA ' ' HE3' ' A' ' 66' ' ' LYS . 19.8 t70 -59.86 -44.6 94.04 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.717 1.258 . . . . 0.0 111.993 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 35.4 mmt -60.35 -47.98 83.72 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 123.238 0.615 . . . . 0.0 109.903 178.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -68.57 -28.62 67.11 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 118.501 0.591 . . . . 0.0 111.827 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.403 ' HE3' ' HA ' ' A' ' 63' ' ' ASP . 53.1 mtmt -67.3 -37.7 83.8 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 118.119 -0.943 . . . . 0.0 110.393 170.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -68.82 -30.04 68.51 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.871 1.214 . . . . 0.0 110.31 169.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 126.2 -22.36 5.98 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 127.625 2.536 . . . . 0.0 111.872 175.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 82.5 m -55.52 152.09 9.49 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 126.188 1.795 . . . . 0.0 112.339 -177.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -110.68 140.86 44.66 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 96.8 m -143.32 165.03 28.61 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -168.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -151.43 127.24 10.27 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.545 1.538 . . . . 0.0 107.542 175.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.2 p -70.56 120.15 15.77 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 169.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 58.3 mt -71.29 -22.96 61.88 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.932 -0.48 . . . . 0.0 110.424 174.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 165.96 -169.27 40.16 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 172.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -135.76 174.96 21.09 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 174.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -178.53 -168.16 37.4 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 -176.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -137.84 163.05 32.38 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 119.029 1.414 . . . . 0.0 109.73 173.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 75.0 mt -116.76 131.5 69.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 -169.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.4 m 57.05 167.2 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 129.69 3.196 . . . . 0.0 116.011 174.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -156.47 156.69 34.18 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.201 1.401 . . . . 0.0 107.498 174.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -57.62 -30.25 65.19 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.046 0.384 . . . . 0.0 111.298 178.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 m -62.99 -18.04 62.83 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.552 1.541 . . . . 0.0 113.876 177.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.1 mm-40 -137.75 -2.66 1.91 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.287 1.035 . . . . 0.0 112.568 -171.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -44.45 -26.75 0.38 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 127.602 2.361 . . . . 0.0 116.847 -169.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -56.04 -17.68 7.55 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 172.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -140.86 143.21 34.61 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 172.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.419 HD12 ' H ' ' A' ' 88' ' ' ILE . 5.3 mp -68.21 147.54 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 178.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 28.1 t60 -135.55 159.18 42.41 Favored 'General case' 0 C--N 1.334 -0.091 0 O-C-N 121.297 -0.877 . . . . 0.0 109.427 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.4 t -141.01 135.65 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -166.26 -174.28 2.86 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.623 0.769 . . . . 0.0 109.664 -172.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.35 -170.48 39.05 Favored Glycine 0 CA--C 1.523 0.581 0 O-C-N 121.77 -0.581 . . . . 0.0 112.101 171.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -159.95 152.88 21.59 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.061 0.944 . . . . 0.0 109.845 -178.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.7 t -82.79 154.77 24.56 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 168.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.8 ppp? -82.29 -39.24 23.2 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 171.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.6 -25.59 45.22 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 119.152 -0.451 . . . . 0.0 111.971 -175.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -132.0 -2.32 3.64 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -169.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.88 -174.79 51.0 Favored Glycine 0 CA--C 1.534 1.281 0 CA-C-N 118.903 0.774 . . . . 0.0 113.101 174.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.98 138.34 43.82 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.963 2.442 . . . . 0.0 110.091 173.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.75 170.93 15.24 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.614 0.721 . . . . 0.0 111.488 170.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -78.86 76.02 5.36 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 169.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -57.62 -18.63 21.16 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -174.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.15 -35.77 76.05 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.194 0.998 . . . . 0.0 112.35 171.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 69.4 mt -65.81 -45.53 91.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 176.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.3 m -58.68 -46.85 86.33 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.998 0.919 . . . . 0.0 111.52 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 21.0 p -60.56 -53.26 59.63 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 119.184 0.902 . . . . 0.0 109.325 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -61.81 -40.96 97.07 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.795 0.725 . . . . 0.0 111.437 -175.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -66.53 -48.13 70.69 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 118.708 0.685 . . . . 0.0 111.481 178.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 73.4 mt -66.36 -37.45 79.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 119.229 0.922 . . . . 0.0 109.003 -178.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 46.7 mtpt -61.75 -43.98 97.79 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.615 1.098 . . . . 0.0 110.118 175.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.44 -38.48 91.31 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.687 0.676 . . . . 0.0 111.37 176.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -65.79 -38.47 89.08 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.597 0.759 . . . . 0.0 111.195 177.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -133.05 69.15 78.78 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 124.448 1.099 . . . . 0.0 110.221 -170.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -69.48 -12.51 33.59 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 123.069 2.513 . . . . 0.0 113.429 -172.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -70.37 -8.09 47.99 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.895 0.878 . . . . 0.0 112.266 171.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -131.21 -178.69 4.95 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.272 1.829 . . . . 0.0 109.086 -179.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -141.44 158.51 43.77 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.602 1.161 . . . . 0.0 108.158 177.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.4 t -139.65 141.48 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 -169.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.3 p -132.51 172.0 13.05 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.084 0.953 . . . . 0.0 109.498 176.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 33.5 p-90 -144.34 153.07 41.6 Favored 'General case' 0 C--O 1.235 0.299 0 O-C-N 121.603 -0.686 . . . . 0.0 109.967 173.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.5 118.41 3.56 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 170.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.71 -2.48 26.54 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 -169.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -63.03 -32.82 74.27 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.39 1.076 . . . . 0.0 112.667 -177.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -69.31 158.01 53.35 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 111.076 -0.809 . . . . 0.0 111.076 178.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 52.1 p90 . . . . . 0 C--O 1.238 0.455 0 C-N-CA 124.968 1.307 . . . . 0.0 110.031 175.588 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.1 tpt . . . . . 0 N--CA 1.481 1.123 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.19 164.91 29.86 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.839 1.256 . . . . 0.0 108.672 175.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.9 t -67.37 124.12 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 178.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -76.25 -174.42 2.79 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.703 0.801 . . . . 0.0 110.816 174.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -152.73 153.98 34.32 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.85 1.66 . . . . 0.0 106.635 170.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.4 mt -53.28 -36.58 61.33 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.038 0.835 . . . . 0.0 112.0 -179.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.02 -25.66 68.22 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.875 0.761 . . . . 0.0 112.506 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.1 mt -83.66 -20.27 33.89 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.38 0.672 . . . . 0.0 111.44 -178.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 32.0 mt -67.38 131.61 93.25 Favored Pre-proline 0 CA--C 1.539 0.52 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -49.76 119.54 4.88 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 123.066 2.511 . . . . 0.0 110.63 169.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -71.15 -39.65 71.82 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.791 0.836 . . . . 0.0 111.155 -175.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.9 t -134.89 139.45 47.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 172.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -152.02 122.87 7.5 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 170.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 45.1 pt -145.29 167.91 9.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 127.366 2.266 . . . . 0.0 105.703 177.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -148.27 -37.56 0.18 Allowed 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.807 -0.558 . . . . 0.0 111.988 178.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.1 m -65.9 162.3 19.37 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.177 0.991 . . . . 0.0 112.194 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -144.49 127.13 16.12 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 172.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 148.84 -126.09 2.19 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 108.382 -1.887 . . . . 0.0 108.382 -169.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.2 t -135.39 119.42 25.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 104.91 -2.256 . . . . 0.0 104.91 173.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -156.6 151.21 25.69 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 118.887 0.767 . . . . 0.0 110.767 -174.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -66.35 155.31 37.68 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.331 0.586 . . . . 0.0 110.523 -178.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -141.48 163.56 32.6 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.309 1.444 . . . . 0.0 107.376 173.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.4 m -138.34 156.56 30.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 C-N-CA 123.905 0.882 . . . . 0.0 109.467 172.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.21 118.86 37.85 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 104.392 -2.448 . . . . 0.0 104.392 176.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 62.8 mt -121.72 115.71 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 119.809 1.186 . . . . 0.0 108.402 -173.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -74.54 140.88 44.77 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 168.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.9 p -134.85 148.01 29.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 178.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -127.52 143.47 51.18 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.184 1.393 . . . . 0.0 108.623 -169.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.8 m -62.49 105.08 0.58 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.574 0.75 . . . . 0.0 111.308 177.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.401 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -149.02 25.27 0.04 OUTLIER Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 125.568 1.547 . . . . 0.0 111.872 168.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 30' ' ' ALA . 43.6 Cg_endo -61.0 133.97 50.38 Favored 'Trans proline' 0 C--N 1.356 0.964 0 CA-C-N 122.263 1.844 . . . . 0.0 111.115 -169.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 37.49 28.29 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 129.063 2.945 . . . . 0.0 114.222 -170.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.6 m 45.17 38.61 3.41 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.191 1.396 . . . . 0.0 112.021 -172.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -149.84 41.0 0.84 Allowed Glycine 0 C--N 1.34 0.772 0 C-N-CA 123.741 0.686 . . . . 0.0 112.453 -169.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -137.36 143.18 40.32 Favored Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 124.251 1.02 . . . . 0.0 108.42 171.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -78.13 -18.37 12.84 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.917 2.411 . . . . 0.0 113.188 -175.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.78 152.36 36.1 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.654 0.781 . . . . 0.0 111.02 -178.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -140.16 28.85 2.06 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.423 1.489 . . . . 0.0 110.013 176.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -76.5 178.36 6.68 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.839 0.855 . . . . 0.0 109.986 176.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.6 m -140.59 161.26 38.17 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.841 1.256 . . . . 0.0 109.186 174.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 58.9 tttt -145.56 165.13 29.54 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 126.947 2.099 . . . . 0.0 107.074 -176.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.7 mp0 -125.31 119.49 28.53 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 173.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 35.5 pt -104.34 154.45 6.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 124.286 1.034 . . . . 0.0 110.078 174.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 45.9 t -121.33 124.28 71.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 -172.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.6 mmp_? -132.36 148.61 52.43 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.185 1.394 . . . . 0.0 108.585 -176.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.97 134.93 2.33 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 169.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -156.69 152.51 27.16 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 124.09 0.956 . . . . 0.0 108.471 -176.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -63.52 -26.83 68.89 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 8.1 p-90 -65.63 -25.52 67.41 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.021 0.828 . . . . 0.0 111.701 178.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.09 83.99 5.88 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 170.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -65.58 -16.21 63.47 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.346 0.658 . . . . 0.0 111.473 174.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -138.74 153.41 48.48 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 126.768 2.027 . . . . 0.0 107.896 178.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 37.8 m-70 -70.99 -34.06 71.02 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -171.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.44 -26.81 44.21 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 118.319 -0.848 . . . . 0.0 112.829 174.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -68.77 -49.75 56.05 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 119.653 1.115 . . . . 0.0 110.892 -175.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.436 HG12 ' H ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -65.42 -39.44 85.22 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.105 175.892 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -61.51 -52.52 64.15 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 118.106 -0.95 . . . . 0.0 109.503 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -60.34 -43.49 96.4 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 119.465 1.03 . . . . 0.0 112.002 -177.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.1 tppt? -57.37 -53.66 55.6 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 124.02 0.928 . . . . 0.0 110.596 176.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.2 t -85.42 -36.86 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-O 117.566 -1.207 . . . . 0.0 112.042 -168.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 83.4 p -63.19 -36.65 84.34 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 121.237 1.835 . . . . 0.0 109.432 171.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.45 -48.83 81.88 Favored Glycine 0 C--N 1.34 0.755 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 171.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -62.86 -43.7 98.09 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 118.848 1.324 . . . . 0.0 111.668 178.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 35.7 mmt -60.85 -44.0 97.59 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-N 118.225 0.466 . . . . 0.0 110.065 177.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -66.93 -29.9 69.89 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.048 0.939 . . . . 0.0 111.968 177.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -68.68 -38.71 80.55 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.67 1.123 . . . . 0.0 109.938 169.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -66.93 -24.71 66.11 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 119.269 0.941 . . . . 0.0 110.495 169.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.73 -21.97 12.11 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 128.412 2.911 . . . . 0.0 112.094 176.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 89.5 m -59.37 150.48 26.15 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 126.0 1.72 . . . . 0.0 110.832 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -108.82 153.07 24.03 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 89.9 m -144.59 162.99 35.25 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 -168.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -149.69 125.91 10.72 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 169.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.7 p -68.32 115.19 7.48 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 169.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 53.3 mt -67.45 -23.63 65.54 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 122.072 -0.393 . . . . 0.0 110.206 174.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 172.64 -174.6 45.71 Favored Glycine 0 C--N 1.338 0.674 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 170.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -133.08 166.81 23.59 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 172.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -173.86 -156.74 13.93 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 -176.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -141.01 159.39 42.31 Favored 'General case' 0 CA--C 1.518 -0.288 0 O-C-N 120.93 -1.335 . . . . 0.0 110.416 175.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 78.3 mt -111.05 136.46 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 104.299 -2.482 . . . . 0.0 104.299 174.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.5 m -144.97 -175.44 4.69 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.478 1.511 . . . . 0.0 108.58 -177.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -138.78 22.66 2.66 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.003 0.921 . . . . 0.0 111.446 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -66.9 -31.4 71.97 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.586 -0.696 . . . . 0.0 112.096 -170.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 43.7 m -62.19 118.3 7.2 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.118 0.967 . . . . 0.0 110.067 -178.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 90.6 mm-40 50.33 23.94 1.37 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.901 1.281 . . . . 0.0 112.663 -171.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.8 t70 50.54 19.7 0.61 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 127.041 2.136 . . . . 0.0 114.101 -171.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -147.36 -46.47 0.17 Allowed 'General case' 0 N--CA 1.467 0.418 0 O-C-N 121.143 -0.973 . . . . 0.0 112.341 -170.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -68.2 132.85 47.89 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 66.6 mt -67.61 147.48 12.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 106.239 -1.764 . . . . 0.0 106.239 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 30.0 t60 -135.67 151.45 50.22 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 121.493 -0.754 . . . . 0.0 109.119 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.1 t -142.03 118.63 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -173.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -168.05 165.81 13.34 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.942 0.897 . . . . 0.0 108.994 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 136.52 -178.59 18.72 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-N 118.685 0.675 . . . . 0.0 111.511 170.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -141.99 146.38 35.52 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.226 0.61 . . . . 0.0 111.253 169.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.5 t -84.21 153.08 23.84 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 168.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 27.6 ptm -84.39 -35.4 23.16 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 119.128 0.876 . . . . 0.0 109.753 171.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.73 -26.21 57.28 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.68 0.673 . . . . 0.0 112.144 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -132.97 -3.58 3.17 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -169.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 78.42 -176.07 54.45 Favored Glycine 0 CA--C 1.535 1.29 0 CA-C-N 119.114 0.87 . . . . 0.0 113.121 174.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -70.47 167.61 24.87 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 123.765 2.977 . . . . 0.0 111.412 174.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -124.57 166.18 16.53 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.941 1.296 . . . . 0.0 111.003 -173.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 24.6 mm100 -78.85 74.57 5.38 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.81 0.844 . . . . 0.0 109.164 171.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -53.78 -23.63 12.63 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.15 0.98 . . . . 0.0 112.697 176.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -51.71 -42.37 62.18 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.168 1.387 . . . . 0.0 112.688 171.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 78.3 mt -65.42 -48.48 82.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 179.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.4 m -57.39 -48.05 80.1 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.468 1.107 . . . . 0.0 110.845 -177.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.7 p -66.44 -48.62 69.38 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 119.17 0.896 . . . . 0.0 110.713 -177.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -57.47 -42.98 83.67 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 119.332 0.969 . . . . 0.0 110.547 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -70.0 -50.52 40.69 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 118.522 -0.751 . . . . 0.0 111.074 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 76.6 mt -63.55 -38.48 82.33 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 120.097 1.317 . . . . 0.0 109.591 -175.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -56.1 -48.32 76.36 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.651 1.114 . . . . 0.0 109.99 174.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.95 -38.77 89.48 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 122.585 0.354 . . . . 0.0 111.628 -179.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -72.35 -33.03 66.98 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 118.817 -0.611 . . . . 0.0 112.028 -177.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -138.1 64.72 41.62 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 123.695 0.798 . . . . 0.0 110.566 -169.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -70.58 -5.64 17.19 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 123.526 2.818 . . . . 0.0 113.322 -176.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -64.54 -17.17 63.67 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.833 0.853 . . . . 0.0 111.942 170.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -127.65 179.61 5.43 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.589 1.955 . . . . 0.0 108.201 172.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -129.24 159.89 34.67 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 172.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.1 t -136.59 143.75 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 -169.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.4 p -136.5 167.85 20.59 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 123.828 0.851 . . . . 0.0 109.683 175.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 13.4 p-90 -139.15 165.82 26.15 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 170.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -146.97 115.9 6.86 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 176.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.44 -13.52 62.1 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 119.201 -0.428 . . . . 0.0 111.985 174.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -61.44 -29.28 69.85 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.222 1.009 . . . . 0.0 111.718 -175.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -80.11 -167.25 35.37 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 124.094 0.854 . . . . 0.0 112.102 174.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 46.7 p90 . . . . . 0 C--O 1.238 0.458 0 C-N-CA 125.626 1.57 . . . . 0.0 113.392 177.623 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.6 mtt . . . . . 0 N--CA 1.483 1.192 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.7 166.38 13.12 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 169.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.7 t -138.49 152.66 25.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 175.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -157.41 -172.62 4.06 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.754 1.622 . . . . 0.0 108.189 -177.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -145.21 147.67 32.68 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 169.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.2 mt -56.18 -34.41 66.18 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -172.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.16 -22.71 63.91 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.748 0.703 . . . . 0.0 112.54 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.4 mt -81.85 -20.0 39.85 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.376 0.67 . . . . 0.0 111.287 -178.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 46.9 mt -66.52 133.01 94.25 Favored Pre-proline 0 CA--C 1.542 0.643 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -49.48 130.29 25.19 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.304 2.669 . . . . 0.0 111.259 170.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -80.46 -37.87 31.06 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.005 0.431 . . . . 0.0 111.508 -175.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.2 t -136.27 130.44 47.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 176.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -151.93 123.36 7.8 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 169.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.9 pt -147.8 168.83 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.901 1.28 . . . . 0.0 109.732 -169.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -142.55 108.03 5.05 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.719 0.808 . . . . 0.0 110.04 171.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 53.0 m -67.65 162.94 22.49 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.958 0.903 . . . . 0.0 112.212 177.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -151.5 -41.31 0.12 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.251 1.42 . . . . 0.0 109.368 169.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -178.1 -55.63 0.07 OUTLIER Glycine 0 CA--C 1.523 0.58 0 N-CA-C 107.51 -2.236 . . . . 0.0 107.51 169.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 25.4 t -139.16 136.27 41.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 169.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -153.54 148.77 26.94 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 123.841 0.857 . . . . 0.0 109.861 -176.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -76.22 153.08 36.35 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.015 0.526 . . . . 0.0 110.298 -178.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -145.56 162.2 38.01 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.574 1.15 . . . . 0.0 108.125 176.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.0 m -130.31 153.58 39.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 C-N-CA 124.361 1.064 . . . . 0.0 109.493 173.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -108.09 114.79 28.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 103.864 -2.643 . . . . 0.0 103.864 178.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 49.7 mt -118.27 125.84 74.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -171.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 -81.75 149.38 28.45 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 169.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.7 t -132.93 147.77 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 127.325 2.25 . . . . 0.0 105.031 -176.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -132.15 147.93 52.45 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 177.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.3 m -61.0 101.53 0.15 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.649 0.78 . . . . 0.0 110.852 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.5 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -144.45 19.96 0.04 OUTLIER Pre-proline 0 CA--C 1.55 0.971 0 CA-C-O 116.319 -1.8 . . . . 0.0 113.872 169.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.5 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 75.3 Cg_exo -45.97 153.45 0.92 Allowed 'Trans proline' 0 C--N 1.362 1.288 0 CA-C-N 124.015 2.47 . . . . 0.0 113.316 172.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 46.14 18.31 0.05 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.732 1.613 . . . . 0.0 114.862 -170.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.3 m 49.96 30.91 4.3 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.961 1.304 . . . . 0.0 111.826 -169.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 179.95 34.82 0.07 OUTLIER Glycine 0 C--N 1.342 0.862 0 CA-C-O 119.425 -0.653 . . . . 0.0 113.076 -170.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.25 149.29 95.96 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 118.492 1.146 . . . . 0.0 109.071 169.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.96 -24.06 11.71 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.627 2.218 . . . . 0.0 113.068 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.48 160.51 27.41 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.649 0.78 . . . . 0.0 110.738 177.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.35 37.22 1.11 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.351 1.46 . . . . 0.0 109.519 177.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -85.22 -179.94 7.09 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.211 1.004 . . . . 0.0 109.655 178.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.9 m -140.85 157.87 44.77 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.703 1.201 . . . . 0.0 109.068 173.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.7 tmtm? -156.1 165.92 34.99 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.275 1.83 . . . . 0.0 107.408 -169.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.5 mp0 -131.56 155.89 46.69 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.95 1.25 . . . . 0.0 109.334 175.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 41.7 pt -139.66 158.17 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 126.046 1.738 . . . . 0.0 110.084 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.2 t -118.44 118.83 59.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 12.2 mmp_? -127.43 141.36 51.69 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 175.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.87 137.25 2.96 Favored Glycine 0 C--N 1.332 0.329 0 CA-C-N 119.09 0.859 . . . . 0.0 111.493 174.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.405 ' CD1' ' CZ2' ' A' ' 49' ' ' TRP . 12.9 m-85 -154.02 150.8 28.64 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -170.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -60.13 -29.08 68.4 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 118.681 -0.676 . . . . 0.0 112.197 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.405 ' CZ2' ' CD1' ' A' ' 47' ' ' TYR . 11.8 p-90 -63.48 -29.18 70.5 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.257 0.935 . . . . 0.0 112.391 177.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.8 73.24 10.65 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 119.204 0.911 . . . . 0.0 109.349 174.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -68.87 -2.42 9.59 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.421 0.688 . . . . 0.0 111.869 177.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -138.93 145.19 39.52 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 126.588 1.955 . . . . 0.0 107.008 172.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -71.27 -32.0 68.17 Favored 'General case' 0 C--O 1.234 0.273 0 O-C-N 121.879 -0.513 . . . . 0.0 110.058 -171.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.61 -27.83 42.19 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 118.438 -0.791 . . . . 0.0 112.629 172.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -68.51 -49.64 58.15 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 119.647 1.112 . . . . 0.0 110.809 -176.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.43 -40.75 87.37 Favored 'Isoleucine or valine' 0 C--N 1.342 0.239 0 CA-C-O 117.837 -1.078 . . . . 0.0 109.619 175.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -61.13 -45.55 94.21 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.781 1.173 . . . . 0.0 110.446 -178.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -63.78 -49.01 74.63 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.864 0.756 . . . . 0.0 111.606 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.4 tttp -59.58 -49.0 79.47 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.422 0.689 . . . . 0.0 111.014 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 88.8 t -75.08 -42.86 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-O 117.686 -1.15 . . . . 0.0 109.244 -172.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 65.4 m -59.11 -36.28 74.89 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 120.572 1.533 . . . . 0.0 110.541 173.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.14 -53.94 41.6 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 172.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.421 ' HA ' ' HE3' ' A' ' 66' ' ' LYS . 18.4 t70 -61.61 -46.19 90.88 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 118.718 1.259 . . . . 0.0 111.679 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 35.5 mmt -57.62 -51.14 70.7 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.509 0.724 . . . . 0.0 109.793 178.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.9 mm-40 -67.79 -27.19 66.53 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.717 0.69 . . . . 0.0 111.957 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.421 ' HE3' ' HA ' ' A' ' 63' ' ' ASP . 51.1 mtmt -67.78 -38.14 82.98 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 119.518 1.054 . . . . 0.0 110.576 170.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -68.01 -30.92 70.28 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.808 1.186 . . . . 0.0 109.779 169.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 126.75 -26.24 5.16 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 128.253 2.835 . . . . 0.0 110.875 177.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 89.5 m -49.72 142.01 9.14 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 127.214 2.206 . . . . 0.0 111.799 -174.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -104.67 138.32 41.17 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 178.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 59.3 m -142.06 160.36 40.37 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -168.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -146.49 134.76 21.77 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.419 1.488 . . . . 0.0 107.998 172.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.3 p -74.0 119.42 18.19 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 169.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 35.0 mt -71.58 -22.04 61.79 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 121.85 -0.531 . . . . 0.0 110.024 172.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.29 -163.78 37.12 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 170.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -149.67 -175.57 22.05 Favored Glycine 0 N--CA 1.451 -0.326 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 170.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -174.17 -161.41 24.1 Favored Glycine 0 CA--C 1.52 0.394 0 N-CA-C 107.598 -2.201 . . . . 0.0 107.598 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.2 ptt180 -134.22 154.27 51.36 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.102 -1.234 . . . . 0.0 108.612 172.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 66.8 mt -113.27 142.01 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 104.429 -2.434 . . . . 0.0 104.429 -177.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.0 m -118.23 134.07 55.34 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 172.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 35.5 t60 -66.05 168.11 8.84 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.021 0.928 . . . . 0.0 110.317 -178.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -59.82 157.81 11.63 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.262 0.625 . . . . 0.0 110.063 173.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.9 m -128.87 -178.82 4.77 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.89 1.276 . . . . 0.0 108.262 169.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -66.06 -8.82 25.62 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.499 0.72 . . . . 0.0 112.67 178.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -142.3 -54.05 0.42 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.933 1.293 . . . . 0.0 110.251 176.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -65.9 139.71 58.29 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.072 0.463 . . . . 0.0 111.264 -175.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -68.92 164.48 22.06 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.079 0.952 . . . . 0.0 111.156 176.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 71.1 mt -63.67 135.95 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 103.609 -2.737 . . . . 0.0 103.609 168.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 27.2 t60 -134.71 156.76 48.24 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 119.322 0.964 . . . . 0.0 110.566 -170.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 22.0 t -138.31 130.46 38.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -168.97 -165.45 0.55 Allowed 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.796 0.839 . . . . 0.0 110.051 -176.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.33 -165.53 54.21 Favored Glycine 0 CA--C 1.524 0.595 0 O-C-N 121.755 -0.591 . . . . 0.0 112.434 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -164.85 157.12 15.98 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.015 0.926 . . . . 0.0 111.015 -173.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.6 t -81.94 159.86 23.5 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 167.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.0 ptm -95.84 -33.63 12.16 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 118.961 0.801 . . . . 0.0 110.424 169.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.95 -25.42 58.86 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.188 0.904 . . . . 0.0 112.039 176.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -131.91 -5.31 3.56 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -169.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.56 -177.49 49.21 Favored Glycine 0 CA--C 1.535 1.339 0 CA-C-N 119.022 0.828 . . . . 0.0 113.506 172.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -69.39 138.22 38.46 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.173 2.582 . . . . 0.0 110.363 173.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -78.42 171.8 14.56 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.035 0.445 . . . . 0.0 109.933 169.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 92.3 mm-40 -77.61 83.95 3.99 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 168.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -57.55 -13.92 4.47 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -176.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.0 -44.45 87.24 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.93 1.292 . . . . 0.0 110.788 169.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 61.1 mt -64.76 -47.21 89.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 179.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.76 -51.31 70.51 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.044 0.938 . . . . 0.0 110.43 -175.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.6 p -65.91 -46.12 79.43 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 117.862 -1.066 . . . . 0.0 110.313 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -58.71 -42.28 88.32 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 120.239 1.381 . . . . 0.0 110.938 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -65.48 -46.32 80.2 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 118.765 -0.636 . . . . 0.0 111.265 177.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 57.4 mt -64.93 -44.26 96.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 -178.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 26.9 mtpt -62.48 -39.02 92.12 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 119.396 0.998 . . . . 0.0 110.935 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.31 -39.83 91.95 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.676 0.671 . . . . 0.0 111.267 177.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -90.46 -24.68 20.64 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 118.275 0.488 . . . . 0.0 112.052 -175.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -142.74 69.84 19.76 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 126.416 1.886 . . . . 0.0 108.312 -171.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.97 -19.05 30.81 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 122.453 2.102 . . . . 0.0 112.729 -176.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -52.88 127.04 22.23 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.575 1.15 . . . . 0.0 111.504 -175.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 6.9 t80 61.34 0.47 0.44 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.336 2.255 . . . . 0.0 115.239 -177.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 65.03 164.84 0.16 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.501 1.92 . . . . 0.0 113.241 -178.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.4 t -132.21 148.44 32.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 C-N-CA 126.53 1.932 . . . . 0.0 106.491 178.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 20.7 p -134.13 169.07 17.7 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.577 1.151 . . . . 0.0 110.293 -178.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 27.3 p-90 -146.48 155.67 42.71 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.143 0.577 . . . . 0.0 109.923 169.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -160.55 101.95 1.35 Allowed 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 172.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.32 -13.45 62.28 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -169.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -61.65 -33.36 73.83 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.355 1.062 . . . . 0.0 112.393 -178.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -85.17 146.55 21.96 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 173.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 65.3 t80 . . . . . 0 C--O 1.235 0.323 0 CA-C-N 117.937 0.868 . . . . 0.0 108.771 176.368 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.0 mmt . . . . . 0 N--CA 1.483 1.184 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.83 147.95 48.52 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 170.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.2 p -155.84 151.55 9.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -176.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.95 -178.71 5.64 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.164 0.507 . . . . 0.0 110.394 176.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -151.78 150.19 29.88 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 171.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 53.9 mt -57.87 -31.14 66.42 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.268 0.627 . . . . 0.0 112.617 -175.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.44 -25.09 65.73 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.674 0.67 . . . . 0.0 112.278 178.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.1 mt -79.82 -24.79 41.12 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.04 0.536 . . . . 0.0 111.024 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 7.3 mt -68.97 131.99 90.63 Favored Pre-proline 0 C--O 1.237 0.421 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 176.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.66 135.61 31.15 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 121.526 1.484 . . . . 0.0 110.571 176.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.67 -27.27 66.7 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.673 0.789 . . . . 0.0 111.578 -178.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.2 t -139.6 134.87 39.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -178.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -152.41 121.17 6.5 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 169.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.5 pt -146.58 172.17 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 124.497 1.119 . . . . 0.0 110.192 -169.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -129.65 95.28 3.95 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.745 1.218 . . . . 0.0 108.667 171.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.2 m -54.42 148.28 12.23 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.904 1.681 . . . . 0.0 111.634 177.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -161.05 -51.22 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.797 0.839 . . . . 0.0 111.524 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 167.57 -59.21 0.22 Allowed Glycine 0 C--N 1.335 0.527 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 -174.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 60.8 t -144.39 132.25 17.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 126.767 2.027 . . . . 0.0 105.708 172.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -155.52 150.18 26.25 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 123.689 0.795 . . . . 0.0 109.474 175.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.95 152.87 41.2 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -178.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.16 162.14 38.65 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.477 1.111 . . . . 0.0 108.787 -177.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.6 m -134.95 155.38 38.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 C-N-CA 124.492 1.117 . . . . 0.0 110.178 171.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -108.28 117.8 35.1 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 176.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 53.9 mt -119.0 114.77 45.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -173.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -74.22 145.23 44.29 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 168.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.9 p -139.26 148.62 23.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -178.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -130.94 144.98 51.87 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.017 1.327 . . . . 0.0 108.074 -170.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.7 m -62.58 103.85 0.46 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.646 0.778 . . . . 0.0 111.653 -177.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.42 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -146.53 24.02 0.04 OUTLIER Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 125.487 1.515 . . . . 0.0 112.252 168.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.42 ' CD ' ' N ' ' A' ' 30' ' ' ALA . 56.8 Cg_endo -60.93 141.37 94.36 Favored 'Trans proline' 0 C--N 1.357 0.985 0 CA-C-N 122.575 1.955 . . . . 0.0 110.93 -173.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 44.2 19.86 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.706 2.403 . . . . 0.0 114.131 -170.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.7 m 45.72 36.71 2.85 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.833 1.253 . . . . 0.0 111.415 -169.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -161.47 55.81 0.31 Allowed Glycine 0 C--N 1.34 0.802 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 -169.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -135.79 143.69 45.63 Favored Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 169.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -76.51 -19.93 14.39 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.758 2.305 . . . . 0.0 112.998 -175.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.57 152.73 37.92 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.559 0.744 . . . . 0.0 110.737 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -139.29 31.81 2.13 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.623 1.569 . . . . 0.0 109.227 174.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -78.34 178.62 7.53 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.925 0.89 . . . . 0.0 109.745 178.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.7 m -138.95 158.22 44.59 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.464 1.106 . . . . 0.0 108.99 172.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -152.75 175.11 13.21 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 127.629 2.372 . . . . 0.0 105.894 -173.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -140.78 156.35 46.19 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 120.735 -1.228 . . . . 0.0 108.424 177.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 34.7 pt -136.47 155.15 33.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 124.92 1.288 . . . . 0.0 109.255 179.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.7 t -116.14 122.13 68.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 -178.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -126.05 145.28 50.39 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 177.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -179.69 129.77 1.4 Allowed Glycine 0 C--N 1.329 0.177 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 173.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -151.56 153.89 35.4 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -173.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.1 tptt -60.35 -32.93 71.73 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 119.175 -0.441 . . . . 0.0 111.761 -178.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 15.7 p-90 -64.35 -31.03 72.07 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.413 0.551 . . . . 0.0 112.395 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.48 74.86 10.26 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 119.15 0.886 . . . . 0.0 109.187 175.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -63.19 -18.75 63.83 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.195 0.598 . . . . 0.0 111.378 176.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -123.65 146.4 48.23 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.929 1.692 . . . . 0.0 107.99 176.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 39.8 m-70 -71.9 -33.9 68.69 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.327 0.651 . . . . 0.0 109.68 -169.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.73 -28.68 57.07 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 118.379 -0.819 . . . . 0.0 112.545 173.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -68.58 -48.58 63.82 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 119.626 1.103 . . . . 0.0 111.072 -174.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.437 HG12 ' H ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -65.72 -40.46 87.87 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-O 118.268 -0.873 . . . . 0.0 109.963 176.174 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -61.94 -50.96 70.05 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 119.401 -0.919 . . . . 0.0 109.74 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -60.76 -44.2 97.02 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 119.31 0.959 . . . . 0.0 111.807 -178.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 22.2 tttp -60.08 -51.56 69.12 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 123.159 0.584 . . . . 0.0 110.71 178.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.7 t -84.56 -33.53 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-O 117.923 -1.037 . . . . 0.0 111.506 -169.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 61.1 p -63.64 -34.69 78.39 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 121.071 1.759 . . . . 0.0 109.403 170.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.15 -51.06 60.7 Favored Glycine 0 C--N 1.338 0.667 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 171.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -60.71 -42.93 98.21 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 118.579 1.189 . . . . 0.0 112.137 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 38.0 mmt -62.67 -45.68 91.7 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 122.814 0.446 . . . . 0.0 110.249 176.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -68.19 -29.06 67.83 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 118.768 0.713 . . . . 0.0 111.843 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -67.57 -37.47 82.67 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 119.163 0.892 . . . . 0.0 110.365 170.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -68.71 -27.73 66.21 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.581 1.082 . . . . 0.0 110.77 169.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 125.69 -25.84 5.53 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 127.441 2.448 . . . . 0.0 111.788 175.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 88.4 m -57.35 151.56 15.92 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 126.389 1.876 . . . . 0.0 112.192 -175.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -109.77 145.31 36.87 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 86.9 m -140.63 165.16 28.22 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -168.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -153.11 126.29 8.54 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.448 1.499 . . . . 0.0 107.735 170.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.7 p -69.69 119.55 14.1 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 169.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 42.5 mt -70.9 -25.47 62.79 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.858 -0.526 . . . . 0.0 110.263 173.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.9 -172.01 43.09 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 109.769 -1.333 . . . . 0.0 109.769 172.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -132.26 177.17 18.94 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 176.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 179.15 -163.71 31.45 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 108.341 -1.904 . . . . 0.0 108.341 -176.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -136.55 152.85 50.95 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 121.005 -1.291 . . . . 0.0 108.506 171.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.7 mt -108.54 139.42 31.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 103.897 -2.631 . . . . 0.0 103.897 178.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.9 m -134.42 136.92 43.62 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 177.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 52.9 m-70 -72.12 -15.7 61.99 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 118.962 -0.542 . . . . 0.0 112.396 -177.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -147.87 146.1 28.93 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.659 1.584 . . . . 0.0 107.892 169.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 75.2 m -146.56 79.09 1.52 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.448 1.499 . . . . 0.0 107.807 171.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 52.87 32.03 11.73 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.279 1.432 . . . . 0.0 111.884 -172.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -155.3 164.08 39.26 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 126.757 2.023 . . . . 0.0 106.293 177.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -79.68 -27.94 40.74 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.387 -0.821 . . . . 0.0 111.217 174.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -72.25 155.29 40.36 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 119.002 0.819 . . . . 0.0 110.812 -178.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 64.8 mt -61.74 148.26 10.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 169.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 35.7 t60 -134.57 156.43 48.69 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.248 1.019 . . . . 0.0 109.349 -178.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.7 t -135.27 129.1 49.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 179.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -165.85 -164.99 0.76 Allowed 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.171 0.988 . . . . 0.0 108.512 -176.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.96 -172.26 55.18 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -160.38 154.33 22.9 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.326 0.65 . . . . 0.0 110.722 -176.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.4 t -82.26 163.54 21.77 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 168.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 20.3 ptp -102.06 -30.97 10.86 Favored 'General case' 0 C--O 1.232 0.156 0 O-C-N 121.524 -0.735 . . . . 0.0 110.444 169.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.92 -26.7 61.49 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.179 0.9 . . . . 0.0 111.737 173.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -133.25 -2.96 3.1 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -169.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.15 -174.68 46.7 Favored Glycine 0 CA--C 1.535 1.33 0 CA-C-N 119.088 0.858 . . . . 0.0 113.051 175.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.97 143.29 54.14 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.814 2.343 . . . . 0.0 110.424 172.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.51 176.94 5.65 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.138 0.575 . . . . 0.0 109.927 169.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 20.8 mm100 -63.34 -28.83 70.27 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.841 -0.537 . . . . 0.0 111.68 171.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 39.2 m80 60.54 -29.72 0.05 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 128.767 2.827 . . . . 0.0 116.311 -175.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.38 -43.08 99.67 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.21 1.004 . . . . 0.0 110.681 173.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 69.1 mt -60.79 -44.41 97.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 177.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.95 -53.46 56.99 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.328 1.051 . . . . 0.0 110.105 -177.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.3 p -63.86 -44.73 92.25 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 117.7 -1.143 . . . . 0.0 110.123 -173.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -58.1 -40.73 81.92 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 120.215 1.37 . . . . 0.0 111.163 -179.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 36.3 mttm -69.82 -44.47 69.92 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 121.782 -0.574 . . . . 0.0 111.061 178.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 58.7 mt -64.65 -43.23 96.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 118.79 0.723 . . . . 0.0 109.115 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -55.85 -43.57 77.21 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 119.605 1.093 . . . . 0.0 109.976 175.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.79 -48.84 70.42 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 119.273 -0.394 . . . . 0.0 111.38 -177.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -93.17 -39.05 11.24 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -169.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -74.26 147.22 85.25 Favored Pre-proline 0 CA--C 1.541 0.629 0 CA-C-N 119.421 1.01 . . . . 0.0 110.146 -170.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -52.08 -36.06 64.28 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.629 2.886 . . . . 0.0 114.759 178.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -79.89 101.22 8.44 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 169.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -73.68 6.98 2.72 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.779 0.832 . . . . 0.0 113.171 -172.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -133.16 146.82 51.9 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.768 1.167 . . . . 0.0 109.588 174.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.2 t -153.77 154.24 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 -172.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 19.8 p -129.3 168.51 16.13 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.784 0.834 . . . . 0.0 110.219 175.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 43.9 p-90 -146.06 162.18 38.48 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 121.742 -0.599 . . . . 0.0 109.728 169.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.16 142.04 21.15 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 169.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -82.42 77.13 9.24 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 174.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -139.84 -157.68 0.79 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.992 2.117 . . . . 0.0 105.363 170.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 92.42 -168.88 31.17 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-N 120.78 1.627 . . . . 0.0 113.244 170.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 57.7 t80 . . . . . 0 C--O 1.238 0.452 0 C-N-CA 125.917 1.687 . . . . 0.0 112.034 -172.344 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.3 tpt . . . . . 0 N--CA 1.481 1.107 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.83 167.05 30.98 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.09 1.356 . . . . 0.0 108.73 177.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.5 t -141.95 133.33 26.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 177.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -76.93 -179.41 5.47 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.156 0.582 . . . . 0.0 110.389 172.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -149.84 146.16 26.97 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 169.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 80.9 mt -55.11 -33.32 62.74 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.83 0.852 . . . . 0.0 112.657 -175.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.74 -25.69 67.4 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.087 0.858 . . . . 0.0 112.341 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.2 mt -78.54 -25.51 45.51 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.189 0.596 . . . . 0.0 111.094 -178.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.8 mt -70.6 131.38 88.02 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -172.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -49.57 119.93 5.24 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 123.525 2.817 . . . . 0.0 111.359 169.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -74.04 -29.88 62.14 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.15 0.5 . . . . 0.0 111.49 -176.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.9 t -141.84 131.54 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 174.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -149.39 111.35 4.59 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 169.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.9 pt -139.01 162.28 28.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 124.01 0.924 . . . . 0.0 109.7 -169.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -128.07 62.05 1.43 Allowed 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 125.099 1.36 . . . . 0.0 108.383 174.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.5 p -67.69 18.73 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.486 2.314 . . . . 0.0 113.284 176.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -59.85 -17.77 39.09 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.66 1.984 . . . . 0.0 112.112 172.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -141.83 165.83 26.42 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 169.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.8 t -76.92 91.39 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 -178.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -138.07 165.52 26.39 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.134 0.974 . . . . 0.0 111.892 -169.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -65.55 156.18 33.42 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 124.834 1.254 . . . . 0.0 111.684 -169.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -147.17 161.17 41.44 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.082 1.353 . . . . 0.0 108.257 171.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.5 m -130.0 154.62 40.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 C-N-CA 124.782 1.233 . . . . 0.0 109.803 174.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.05 115.65 30.52 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 104.212 -2.514 . . . . 0.0 104.212 176.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 73.3 mt -119.65 124.51 73.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -173.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -81.41 145.08 30.98 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 169.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.2 t -129.68 143.44 41.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 -175.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -130.96 132.97 45.39 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 -178.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.0 t -66.43 118.66 10.38 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -175.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.401 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -151.05 32.06 0.06 OUTLIER Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 126.163 1.785 . . . . 0.0 109.77 168.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 30' ' ' ALA . 44.8 Cg_endo -61.3 156.24 47.06 Favored 'Trans proline' 0 C--N 1.357 1.012 0 CA-C-N 121.913 1.719 . . . . 0.0 111.458 -171.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 41.8 tpt85 54.44 9.91 0.29 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.091 1.756 . . . . 0.0 112.891 -169.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.0 m 51.98 32.31 9.93 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.023 1.329 . . . . 0.0 111.412 -170.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -163.95 -3.91 0.04 OUTLIER Glycine 0 CA--C 1.531 1.043 0 CA-C-O 118.382 -1.232 . . . . 0.0 115.264 -173.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.7 144.79 84.72 Favored Pre-proline 0 CA--C 1.542 0.65 0 CA-C-N 119.768 1.784 . . . . 0.0 110.799 174.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -76.22 -19.11 15.66 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.934 2.423 . . . . 0.0 112.88 179.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.46 152.33 34.76 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.017 0.927 . . . . 0.0 111.071 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.45 28.52 1.19 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.99 1.316 . . . . 0.0 110.943 178.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -70.45 174.01 6.27 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.352 0.661 . . . . 0.0 110.0 172.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.4 m -137.55 161.88 35.23 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.303 1.041 . . . . 0.0 110.112 177.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.6 tttp -148.85 165.45 31.46 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.533 2.333 . . . . 0.0 106.137 -174.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -137.52 140.15 40.93 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 106.09 -1.818 . . . . 0.0 106.09 175.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 41.2 pt -134.3 156.83 41.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 124.218 1.007 . . . . 0.0 110.724 -172.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 95.7 t -121.55 118.75 56.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 -177.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 27.2 mmt85 -136.02 144.23 45.17 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 177.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.22 135.57 2.42 Favored Glycine 0 C--N 1.331 0.284 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 -178.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -153.58 160.94 42.59 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 117.356 0.578 . . . . 0.0 110.122 -169.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.5 mtmm -59.88 -33.86 72.39 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -179.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.446 ' CH2' ' HE2' ' A' ' 59' ' ' LYS . 9.5 p-90 -68.66 -24.23 64.5 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.835 0.743 . . . . 0.0 112.634 -179.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.47 82.13 8.54 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 119.588 1.085 . . . . 0.0 109.297 176.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -65.45 -19.38 65.91 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.44 171.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -133.89 148.68 51.27 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 126.048 1.739 . . . . 0.0 108.137 -178.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -72.56 -30.97 64.89 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 121.925 -0.485 . . . . 0.0 109.897 -171.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.01 -28.64 53.66 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 118.082 -0.961 . . . . 0.0 112.776 172.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -65.53 -55.85 15.53 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.669 1.122 . . . . 0.0 109.583 -179.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.423 HG12 ' H ' ' A' ' 56' ' ' ILE . 0.1 OUTLIER -66.07 -34.62 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-O 117.355 -1.307 . . . . 0.0 110.687 -179.502 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -60.98 -53.59 55.38 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 120.104 1.32 . . . . 0.0 109.506 175.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -60.37 -42.91 96.77 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.983 0.81 . . . . 0.0 111.896 -178.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.446 ' HE2' ' CH2' ' A' ' 49' ' ' TRP . 0.0 OUTLIER -59.28 -55.54 33.51 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.221 1.008 . . . . 0.0 110.209 178.589 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 89.9 t -77.62 -43.77 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-O 117.801 -1.095 . . . . 0.0 109.881 -169.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.7 p -63.81 -31.26 72.39 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 120.709 1.595 . . . . 0.0 109.937 175.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.29 -51.31 59.57 Favored Glycine 0 C--N 1.337 0.636 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 171.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -61.71 -44.53 96.74 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 118.835 1.318 . . . . 0.0 111.68 178.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 38.4 mmt -59.12 -46.96 86.98 Favored 'General case' 0 C--O 1.227 -0.081 0 CA-C-O 119.231 -0.414 . . . . 0.0 110.045 177.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -69.27 -28.27 66.15 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.654 0.661 . . . . 0.0 112.152 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -67.59 -37.41 82.53 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.342 0.974 . . . . 0.0 110.255 170.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -68.25 -31.01 70.2 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.772 1.169 . . . . 0.0 110.106 169.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 127.5 -23.43 5.41 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 127.93 2.681 . . . . 0.0 111.662 174.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 95.8 m -55.92 154.42 7.36 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 126.404 1.882 . . . . 0.0 112.602 -177.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -112.49 145.47 40.18 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.909 1.284 . . . . 0.0 108.066 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 74.9 m -144.64 164.33 31.29 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -168.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -149.02 130.57 14.88 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.289 1.435 . . . . 0.0 107.713 171.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.6 p -75.06 114.73 13.89 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 169.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 39.7 mt -68.65 -25.33 64.77 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.823 -0.548 . . . . 0.0 110.374 176.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.14 -164.88 37.83 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 175.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -154.32 -175.5 25.58 Favored Glycine 0 N--CA 1.452 -0.268 0 N-CA-C 111.509 -0.636 . . . . 0.0 111.509 171.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -171.49 -153.71 9.26 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 108.488 -1.845 . . . . 0.0 108.488 -176.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -143.25 142.96 31.55 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 -174.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 61.7 mt -108.17 151.31 10.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -171.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.3 m 62.19 -175.39 0.14 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.574 1.949 . . . . 0.0 110.887 -170.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -153.78 169.51 23.18 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.98 1.312 . . . . 0.0 108.555 177.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 20.9 tp60 -66.42 -25.52 66.79 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.246 0.619 . . . . 0.0 112.055 -178.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.3 m -57.85 148.8 24.22 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.367 1.067 . . . . 0.0 111.531 -178.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -76.33 -9.56 58.73 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.644 0.778 . . . . 0.0 112.87 -174.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -56.53 127.07 29.41 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.246 1.018 . . . . 0.0 109.957 177.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -67.73 -23.41 65.26 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.446 0.698 . . . . 0.0 111.869 179.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -55.88 129.61 40.26 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 177.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 50.0 mt -68.99 159.93 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 31.5 t60 -143.94 166.29 25.35 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 120.677 -1.264 . . . . 0.0 109.698 -178.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.9 t -141.41 133.62 28.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 173.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -157.17 -170.04 3.14 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.221 1.008 . . . . 0.0 108.726 -178.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.28 -175.46 45.89 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-N 118.619 0.645 . . . . 0.0 112.145 176.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -162.33 149.4 13.64 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.532 1.133 . . . . 0.0 110.546 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.6 t -71.63 166.2 22.38 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 168.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.5 ptm -111.5 -29.86 7.6 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 118.485 -0.769 . . . . 0.0 111.051 170.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -73.59 -25.55 60.4 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.574 1.079 . . . . 0.0 111.407 172.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -132.65 -9.47 3.18 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.05 0.94 . . . . 0.0 113.037 -169.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 78.68 -176.66 54.37 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-N 118.773 0.715 . . . . 0.0 113.71 171.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.43 137.2 42.31 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.059 2.506 . . . . 0.0 110.482 175.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -78.01 168.8 19.32 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 169.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -77.76 84.69 4.08 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 168.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -57.86 -13.86 5.09 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -175.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.03 -41.46 96.61 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.651 1.18 . . . . 0.0 110.978 170.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 56.2 mt -65.46 -47.43 86.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 177.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.97 -49.68 76.94 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.066 0.946 . . . . 0.0 110.703 -176.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.4 p -64.4 -47.53 78.82 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 118.182 -0.913 . . . . 0.0 110.989 -176.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -60.01 -40.38 89.07 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.52 1.055 . . . . 0.0 110.537 -178.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 52.9 mttm -67.29 -46.22 74.26 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-O 118.935 -0.555 . . . . 0.0 111.476 177.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 63.8 mt -64.61 -39.87 87.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-N 119.432 1.015 . . . . 0.0 109.006 -179.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -58.98 -47.33 85.55 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 119.855 1.207 . . . . 0.0 109.514 175.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.73 -38.2 89.54 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.033 0.379 . . . . 0.0 111.55 -179.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -69.95 -36.53 75.34 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 118.718 -0.658 . . . . 0.0 111.326 177.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -127.78 63.59 61.22 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 124.087 0.955 . . . . 0.0 110.408 -171.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -70.7 -11.41 29.56 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.158 2.572 . . . . 0.0 113.159 -172.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -67.54 -12.78 61.15 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.731 0.813 . . . . 0.0 112.05 170.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -129.5 -173.57 3.05 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.289 1.836 . . . . 0.0 108.988 178.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -135.78 162.35 33.03 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.409 1.484 . . . . 0.0 107.016 176.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.4 t -139.89 143.64 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 -173.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 16.6 p -134.69 174.42 10.59 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.478 1.111 . . . . 0.0 108.914 174.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 47.5 p-90 -143.16 161.53 37.99 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.669 -0.644 . . . . 0.0 110.657 171.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.05 136.22 20.01 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 171.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -80.62 79.66 7.21 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 172.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -136.29 -175.73 4.09 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.675 1.59 . . . . 0.0 106.736 169.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.22 -157.31 31.71 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 119.544 1.065 . . . . 0.0 111.436 -174.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 86.2 t80 . . . . . 0 C--O 1.238 0.465 0 C-N-CA 125.03 1.332 . . . . 0.0 109.945 177.941 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.3 mtm . . . . . 0 N--CA 1.483 1.191 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.51 106.67 3.3 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 170.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.1 t -63.02 132.86 29.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -171.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -145.08 -169.52 3.21 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.223 1.809 . . . . 0.0 108.126 -175.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -146.73 146.59 30.37 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 169.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 51.0 mt -58.99 -29.22 67.06 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -173.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.61 -26.41 66.24 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.113 0.87 . . . . 0.0 111.883 177.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.7 mt -82.69 -24.18 33.79 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.654 0.782 . . . . 0.0 111.191 -177.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 51.3 mt -65.46 129.01 94.27 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -178.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -44.82 120.72 3.0 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 124.141 3.227 . . . . 0.0 111.599 172.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -78.75 -32.94 46.86 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.283 0.563 . . . . 0.0 111.139 -170.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.2 t -136.85 140.26 43.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 105.091 -2.188 . . . . 0.0 105.091 172.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -151.77 130.15 12.1 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 170.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.9 pt -147.9 160.85 7.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 126.873 2.069 . . . . 0.0 106.9 -178.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -152.08 42.61 0.68 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.701 0.8 . . . . 0.0 110.445 178.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.4 m -144.35 172.02 13.51 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.323 1.049 . . . . 0.0 110.621 -172.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -149.04 165.93 30.2 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 126.798 2.039 . . . . 0.0 107.12 174.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.47 -160.78 54.18 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -169.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.6 t -75.29 131.26 35.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 175.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -154.65 150.86 28.11 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 124.341 1.056 . . . . 0.0 108.955 169.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -77.1 154.98 32.74 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.521 0.728 . . . . 0.0 110.377 -177.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.31 162.51 37.97 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.0 1.32 . . . . 0.0 108.164 179.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.8 m -132.7 154.31 39.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 124.418 1.087 . . . . 0.0 109.488 172.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.35 119.22 38.88 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 104.293 -2.484 . . . . 0.0 104.293 176.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.2 mt -122.26 123.79 69.57 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -173.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.453 ' HE ' ' CE1' ' A' ' 28' ' ' HIS . 36.9 ttp-105 -77.36 147.59 36.03 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 169.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.8 t -133.29 143.72 38.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 -178.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.453 ' CE1' ' HE ' ' A' ' 26' ' ' ARG . 99.9 m-70 -123.68 145.06 49.25 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 125.021 1.329 . . . . 0.0 107.913 174.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.0 m -62.07 107.93 0.96 Allowed 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.439 0.696 . . . . 0.0 110.635 177.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -148.9 29.1 0.05 OUTLIER Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 124.823 1.249 . . . . 0.0 112.404 169.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -70.8 21.26 0.21 Allowed 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 123.489 2.792 . . . . 0.0 115.84 -169.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.83 12.58 0.88 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.877 1.671 . . . . 0.0 110.672 175.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.6 m 50.27 28.11 3.01 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.717 1.207 . . . . 0.0 112.749 -170.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 163.75 32.41 0.02 OUTLIER Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.96 1.267 . . . . 0.0 111.198 -173.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -68.89 153.59 95.86 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 117.813 0.807 . . . . 0.0 109.504 177.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.89 -27.2 17.98 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 122.33 2.02 . . . . 0.0 112.647 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.62 148.83 49.89 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.675 0.79 . . . . 0.0 110.112 176.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -142.77 30.97 1.46 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.039 1.336 . . . . 0.0 110.109 177.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -75.71 177.03 7.16 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.527 0.68 . . . . 0.0 109.812 174.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.6 m -140.92 158.54 43.79 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.822 1.249 . . . . 0.0 108.463 173.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -153.06 170.75 19.7 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 126.894 2.078 . . . . 0.0 106.296 -171.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.408 ' HB2' ' HE3' ' A' ' 108' ' ' LYS . 17.7 mp0 -134.08 157.16 46.85 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 169.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 32.6 pt -132.46 155.39 41.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 125.344 1.458 . . . . 0.0 109.508 178.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 56.7 t -116.9 121.35 67.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 177.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.8 mmp_? -127.52 141.1 51.74 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 177.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -171.64 136.6 3.94 Favored Glycine 0 C--N 1.329 0.192 0 CA-C-N 119.538 1.063 . . . . 0.0 110.609 170.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -153.85 148.55 26.39 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -173.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.5 pttm -54.99 -31.08 60.66 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.355 1.462 . . . . 0.0 113.236 173.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 11.8 p-90 -68.92 -28.71 66.91 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.29 0.95 . . . . 0.0 112.044 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.79 73.6 10.28 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 119.278 0.944 . . . . 0.0 109.235 174.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -65.94 -6.82 13.7 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.861 0.864 . . . . 0.0 111.457 174.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -137.14 144.09 42.8 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.621 1.968 . . . . 0.0 106.809 173.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 44.1 m-70 -70.34 -31.37 68.63 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -171.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.29 -29.84 35.45 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 118.529 -0.748 . . . . 0.0 112.652 172.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -68.85 -48.57 63.14 Favored 'General case' 0 C--N 1.341 0.199 0 CA-C-N 119.39 0.995 . . . . 0.0 111.097 -174.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.434 HG12 ' H ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -65.36 -41.68 91.82 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.018 176.168 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -61.83 -50.72 71.15 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 119.296 -0.962 . . . . 0.0 109.668 -178.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -61.13 -44.43 97.34 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.125 0.875 . . . . 0.0 111.91 -178.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 30.5 tttt -59.9 -50.32 74.23 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.315 0.646 . . . . 0.0 110.895 178.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.4 t -85.71 -33.6 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-O 117.572 -1.204 . . . . 0.0 111.401 -169.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 84.6 p -61.57 -36.71 81.41 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 121.306 1.866 . . . . 0.0 109.179 169.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -56.63 -52.47 50.27 Favored Glycine 0 C--N 1.34 0.753 0 C-N-CA 124.218 0.913 . . . . 0.0 111.141 170.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -60.73 -45.16 95.32 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 119.14 1.47 . . . . 0.0 111.854 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 35.2 mmt -59.46 -47.03 87.04 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.998 0.519 . . . . 0.0 109.787 178.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -68.17 -30.08 69.11 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.536 0.734 . . . . 0.0 111.937 178.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -66.59 -37.94 85.97 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 119.511 1.051 . . . . 0.0 110.278 171.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -64.62 -46.15 83.83 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.746 1.157 . . . . 0.0 108.486 169.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 142.17 -21.49 2.45 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 127.872 2.653 . . . . 0.0 111.204 174.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 80.8 m -54.65 148.36 12.75 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 126.891 2.076 . . . . 0.0 111.608 -176.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -108.56 141.47 40.42 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 94.5 m -141.6 165.51 27.29 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -168.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -154.33 130.03 10.02 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.869 1.667 . . . . 0.0 107.431 171.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.1 p -69.82 123.77 22.3 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 169.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 33.9 mt -69.31 -28.3 66.14 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.933 -0.479 . . . . 0.0 109.969 172.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.98 -171.29 43.34 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 174.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -124.78 173.6 17.1 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 174.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -178.2 -164.96 32.2 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 108.254 -1.938 . . . . 0.0 108.254 -176.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 12.0 ptp180 -148.06 161.76 40.74 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 120.741 -1.447 . . . . 0.0 109.208 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 81.9 mt -123.52 149.69 27.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 -171.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.0 p -145.43 158.2 43.88 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.067 1.347 . . . . 0.0 109.137 176.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -155.78 37.27 0.36 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.605 0.762 . . . . 0.0 110.406 173.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -73.47 1.61 9.47 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 121.149 -0.969 . . . . 0.0 111.52 171.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 m -50.23 152.64 1.7 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 128.661 2.784 . . . . 0.0 112.944 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -90.83 12.63 18.74 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.508 1.123 . . . . 0.0 111.185 175.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -150.07 166.59 29.29 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.787 2.035 . . . . 0.0 107.369 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -73.07 35.21 0.08 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.92 1.688 . . . . 0.0 112.756 -175.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.2 ttmm -105.22 107.97 19.24 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 125.248 1.419 . . . . 0.0 107.525 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 82.7 mt -72.29 160.29 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 169.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 21.1 t60 -139.65 155.49 47.37 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 120.519 -1.363 . . . . 0.0 110.359 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.5 t -136.58 137.48 47.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 -177.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -164.96 -171.01 2.1 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.084 -1.01 . . . . 0.0 109.854 -174.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.69 -167.71 54.76 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-O 121.402 0.446 . . . . 0.0 112.278 169.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -158.36 173.2 17.02 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.315 1.046 . . . . 0.0 110.218 -172.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.0 t -107.17 164.0 12.53 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 127.033 2.133 . . . . 0.0 106.2 168.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 21.4 ptp -105.96 -29.89 9.67 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 118.547 -0.739 . . . . 0.0 110.881 172.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -73.12 -26.32 61.18 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.39 0.995 . . . . 0.0 111.563 172.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -132.0 -3.74 3.57 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -169.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 72.52 -177.14 41.01 Favored Glycine 0 CA--C 1.535 1.297 0 CA-C-N 118.908 0.776 . . . . 0.0 112.73 177.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.49 138.13 37.92 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.889 2.393 . . . . 0.0 110.916 175.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.96 176.47 5.69 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.297 0.639 . . . . 0.0 110.026 169.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 21.5 mm100 -65.7 -31.83 73.05 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 121.901 -0.499 . . . . 0.0 112.292 178.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 39.1 m80 61.63 -30.83 0.07 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 128.438 2.695 . . . . 0.0 115.972 -174.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.7 -44.46 96.18 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.224 1.01 . . . . 0.0 110.787 174.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 72.9 mt -60.47 -45.35 97.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 176.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.46 -52.24 66.07 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 124.61 1.164 . . . . 0.0 109.747 -174.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 22.6 p -67.09 -43.07 83.49 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 117.982 -1.009 . . . . 0.0 111.151 -174.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -59.38 -41.9 90.43 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.756 1.162 . . . . 0.0 110.386 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.408 ' HE3' ' HB2' ' A' ' 42' ' ' GLU . 42.1 mttm -66.77 -45.4 78.62 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 119.009 -0.519 . . . . 0.0 111.263 176.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 55.8 mt -63.44 -42.81 97.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 119.111 0.868 . . . . 0.0 108.992 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -58.22 -47.41 83.61 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 120.216 1.371 . . . . 0.0 109.455 176.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.45 -40.28 96.08 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.753 0.421 . . . . 0.0 111.634 -177.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -80.9 -19.89 43.36 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 118.269 -0.872 . . . . 0.0 112.735 -178.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -131.93 64.36 72.19 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 124.524 1.13 . . . . 0.0 109.517 -178.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.8 -14.24 38.6 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.944 2.429 . . . . 0.0 112.922 -175.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -67.22 -11.86 58.54 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.283 1.033 . . . . 0.0 112.068 169.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -125.65 177.54 6.19 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.516 1.927 . . . . 0.0 108.639 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -125.65 165.31 18.79 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 170.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.2 t -144.43 143.51 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 -178.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 22.1 p -137.3 173.96 11.12 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.079 0.952 . . . . 0.0 108.848 172.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 52.1 p-90 -143.79 157.4 44.41 Favored 'General case' 0 C--O 1.235 0.297 0 O-C-N 121.988 -0.445 . . . . 0.0 110.6 173.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -154.13 97.95 2.1 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 176.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -69.16 -8.67 47.69 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -173.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -58.0 -29.98 65.7 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.46 1.104 . . . . 0.0 112.465 170.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -61.89 152.79 42.41 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 111.754 -0.538 . . . . 0.0 111.754 176.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 53.1 p90 . . . . . 0 C--O 1.238 0.464 0 C-N-CA 124.902 1.281 . . . . 0.0 110.011 -179.424 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.484 1.266 0 N-CA-C 110.482 -0.192 . . . . 0.0 110.482 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.84 157.55 27.48 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.956 -0.465 . . . . 0.0 109.758 169.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.5 p -59.46 139.5 19.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 174.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -71.86 177.65 4.13 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.715 0.769 . . . . 0.0 111.454 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -151.27 151.59 32.04 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 126.677 1.991 . . . . 0.0 105.924 170.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 52.4 mt -55.44 -34.49 64.52 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.732 0.696 . . . . 0.0 112.656 -175.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.15 -25.86 64.59 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.744 0.702 . . . . 0.0 112.21 179.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.0 mt -81.83 -23.23 36.57 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.468 0.707 . . . . 0.0 111.178 -178.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.2 mt -64.84 128.03 93.23 Favored Pre-proline 0 CA--C 1.54 0.577 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 178.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -47.41 140.21 15.96 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.588 2.859 . . . . 0.0 111.249 170.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -89.78 -36.06 15.36 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 121.987 -0.446 . . . . 0.0 111.627 -170.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.4 t -140.99 138.96 34.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 124.866 1.266 . . . . 0.0 107.702 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 68.5 t0 -152.93 111.34 3.69 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 169.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 36.6 pt -138.07 40.47 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.913 1.285 . . . . 0.0 109.439 -173.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -63.95 83.07 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.204 1.402 . . . . 0.0 111.97 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.9 m -162.32 177.38 9.64 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 128.193 2.597 . . . . 0.0 107.783 174.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -144.89 161.98 37.97 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.648 1.179 . . . . 0.0 108.976 -176.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.88 -160.26 50.36 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 -170.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.7 t -69.35 136.96 25.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 173.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -157.31 153.76 27.93 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.934 0.894 . . . . 0.0 108.737 168.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -80.05 155.88 27.36 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.91 163.61 32.92 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.997 1.319 . . . . 0.0 108.27 176.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.5 m -133.23 150.83 32.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 124.36 1.064 . . . . 0.0 109.589 172.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.05 117.0 33.6 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 104.139 -2.541 . . . . 0.0 104.139 175.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 76.5 mt -118.93 122.82 70.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 -175.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 36.2 ttp180 -79.46 147.49 32.25 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 169.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.8 t -133.73 145.01 34.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 104.762 -2.31 . . . . 0.0 104.762 -175.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -130.42 150.14 51.77 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.596 1.158 . . . . 0.0 108.129 -179.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.9 m -60.81 100.73 0.12 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.122 0.969 . . . . 0.0 111.773 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.518 ' H ' ' HD3' ' A' ' 31' ' ' PRO . . . -144.59 17.78 0.04 OUTLIER Pre-proline 0 CA--C 1.554 1.111 0 CA-C-O 116.188 -1.863 . . . . 0.0 113.898 169.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.518 ' HD3' ' H ' ' A' ' 30' ' ' ALA . 66.9 Cg_exo -40.12 130.6 2.23 Favored 'Trans proline' 0 C--N 1.365 1.444 0 CA-C-N 123.702 2.358 . . . . 0.0 114.41 177.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . 0.302 1.2 tpm_? 23.59 47.74 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 130.331 3.452 . . . . 0.0 114.933 -168.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.1 m 55.8 24.4 7.34 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.901 1.28 . . . . 0.0 113.323 176.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -146.95 -7.05 0.29 Allowed Glycine 0 CA--C 1.529 0.931 0 CA-C-O 118.469 -1.184 . . . . 0.0 114.92 -169.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.53 132.63 85.5 Favored Pre-proline 0 CA--C 1.543 0.705 0 CA-C-N 119.522 1.661 . . . . 0.0 110.295 173.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -78.47 -20.09 11.15 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.829 2.353 . . . . 0.0 112.702 178.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.9 160.87 19.58 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.051 0.94 . . . . 0.0 111.12 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.2 60.91 0.97 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.248 1.419 . . . . 0.0 108.487 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -124.22 -173.21 2.71 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.545 1.538 . . . . 0.0 108.75 177.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.1 m -142.76 159.23 42.64 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.786 0.834 . . . . 0.0 110.596 -173.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -151.07 165.95 32.24 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 127.625 2.37 . . . . 0.0 106.168 -174.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.5 mp0 -131.26 154.23 48.69 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 121.039 -1.038 . . . . 0.0 108.494 177.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 39.3 pt -135.26 156.18 38.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 125.277 1.431 . . . . 0.0 109.686 178.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 54.2 t -118.65 120.34 63.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 105.434 -2.062 . . . . 0.0 105.434 177.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.0 mmp_? -130.28 146.23 51.86 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 172.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -179.55 140.51 4.33 Favored Glycine 0 N--CA 1.454 -0.139 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 174.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -154.88 156.06 35.46 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -170.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.5 mmtm -53.05 -39.45 63.26 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.407 1.083 . . . . 0.0 112.026 174.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 12.8 p-90 -67.2 -27.72 67.49 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.519 0.6 . . . . 0.0 112.503 -176.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.96 80.32 9.05 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 119.295 0.952 . . . . 0.0 108.964 173.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -63.73 -18.52 64.11 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.254 0.621 . . . . 0.0 111.488 174.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -132.1 148.87 52.51 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 126.47 1.908 . . . . 0.0 108.043 178.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 37.3 m-70 -72.52 -32.26 65.99 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -170.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.85 -29.08 54.29 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 118.561 -0.733 . . . . 0.0 112.663 172.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -67.14 -49.66 64.04 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 119.338 0.972 . . . . 0.0 110.84 -175.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.421 ' H ' HG12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -66.8 -38.88 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 CA-C-O 117.557 -1.211 . . . . 0.0 109.995 174.977 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -60.36 -47.33 86.52 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 120.191 1.36 . . . . 0.0 110.404 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -63.67 -47.91 79.31 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.265 0.484 . . . . 0.0 111.507 179.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 40.9 tttt -62.63 -51.19 68.24 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 123.239 0.616 . . . . 0.0 111.315 -178.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 94.6 t -72.56 -46.33 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-O 118.189 -0.91 . . . . 0.0 108.967 -172.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 56.6 m -64.11 -27.26 68.97 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 120.157 1.344 . . . . 0.0 111.162 175.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.84 -51.28 56.88 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 170.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -60.73 -43.37 98.0 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.418 1.109 . . . . 0.0 111.638 178.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.5 mmt -59.62 -47.25 86.32 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 123.131 0.573 . . . . 0.0 110.011 177.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -69.48 -28.26 65.92 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.892 0.769 . . . . 0.0 112.066 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -66.92 -38.24 85.84 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 119.179 0.9 . . . . 0.0 110.112 169.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -69.48 -25.66 64.18 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 119.668 1.122 . . . . 0.0 110.496 169.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 118.84 -21.42 9.62 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 127.919 2.676 . . . . 0.0 112.456 175.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 92.2 m -53.08 149.59 6.61 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 126.112 1.765 . . . . 0.0 112.1 -178.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -108.48 138.65 44.43 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 177.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 97.3 m -141.41 164.18 30.92 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -168.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -153.79 130.26 10.61 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.499 1.52 . . . . 0.0 107.49 174.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 5.9 p -70.92 122.1 19.34 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 169.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 41.9 mt -70.12 -25.67 63.6 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.861 -0.525 . . . . 0.0 109.941 170.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.93 -171.78 43.03 Favored Glycine 0 C--N 1.337 0.608 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 170.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -128.84 171.87 19.68 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 175.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -176.81 -162.71 27.84 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 108.6 -1.8 . . . . 0.0 108.6 -176.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -146.0 163.67 34.47 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 121.055 -1.262 . . . . 0.0 108.547 -178.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 81.4 mt -133.28 143.87 37.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 -170.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 69.6 m -144.17 170.58 15.69 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.546 1.538 . . . . 0.0 108.765 170.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -145.79 140.11 26.9 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.002 1.321 . . . . 0.0 107.693 176.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -137.65 51.15 1.92 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.107 1.363 . . . . 0.0 108.821 -177.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.8 m 60.33 -173.77 0.12 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.596 1.559 . . . . 0.0 112.458 175.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -62.48 -20.13 64.25 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 120.723 -1.236 . . . . 0.0 111.868 174.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -67.86 -39.48 83.77 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.171 0.988 . . . . 0.0 112.668 -178.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 26.4 mtmm -132.46 8.36 4.25 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -176.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.2 mptt 63.2 -178.17 0.15 Allowed 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 126.277 1.831 . . . . 0.0 113.545 169.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 59.4 mt -81.71 149.06 4.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 169.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 54.2 t60 -143.93 149.41 36.78 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 121.193 -0.942 . . . . 0.0 109.69 -179.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 18.7 t -127.81 128.95 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.114 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -160.81 -172.4 3.48 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.236 -0.915 . . . . 0.0 111.132 -169.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 66.29 -166.21 38.14 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-O 121.425 0.459 . . . . 0.0 112.616 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -162.08 157.2 23.04 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.083 0.953 . . . . 0.0 110.502 -170.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.9 t -85.24 164.38 18.09 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 168.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.0 ptm -104.83 -31.8 9.12 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 118.625 -0.702 . . . . 0.0 110.646 169.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.8 -26.41 61.5 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.324 0.965 . . . . 0.0 111.556 174.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -132.46 -3.56 3.39 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.925 0.89 . . . . 0.0 113.089 -169.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.46 -177.3 43.74 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-N 118.779 0.718 . . . . 0.0 112.997 175.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -67.89 142.07 55.92 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.652 2.234 . . . . 0.0 110.41 172.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.19 173.89 9.5 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 122.369 1.08 . . . . 0.0 110.322 169.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -81.47 79.48 8.06 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 103.828 -2.656 . . . . 0.0 103.828 167.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 51.6 m80 -60.95 -13.74 18.04 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -169.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.86 -35.91 77.8 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.554 0.742 . . . . 0.0 111.622 172.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 83.8 mt -65.15 -44.16 95.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 177.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.87 -48.44 81.37 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.158 0.983 . . . . 0.0 110.684 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.4 p -66.38 -42.46 87.91 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 117.813 -1.089 . . . . 0.0 110.661 -177.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -58.22 -44.11 88.02 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 120.226 1.376 . . . . 0.0 110.772 177.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -69.13 -44.21 72.84 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.873 -0.517 . . . . 0.0 111.635 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 81.5 mt -71.55 -34.19 51.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 O-C-N 121.257 -0.902 . . . . 0.0 109.478 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -57.73 -46.62 84.18 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.684 1.129 . . . . 0.0 109.483 170.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.27 -35.77 80.01 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.163 0.438 . . . . 0.0 111.499 177.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 56.0 tttm -65.6 -34.29 77.89 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.774 0.715 . . . . 0.0 111.496 176.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -131.16 73.49 80.52 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 123.83 0.852 . . . . 0.0 111.285 -173.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -55.08 -26.58 51.04 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.143 2.562 . . . . 0.0 114.25 176.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -72.73 -7.52 50.92 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.29 1.036 . . . . 0.0 112.738 178.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -127.63 -175.69 3.54 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.27 1.828 . . . . 0.0 108.948 -177.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -138.8 165.86 25.91 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 170.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.6 t -141.82 143.76 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 -173.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 19.3 p -133.05 168.8 17.83 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.198 0.999 . . . . 0.0 108.676 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 57.9 p-90 -139.99 157.61 45.39 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.178 0.513 . . . . 0.0 111.802 173.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -148.94 140.35 23.31 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 170.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.02 -18.86 59.09 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.937 -0.477 . . . . 0.0 111.222 -174.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.24 153.97 24.81 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.427 -0.796 . . . . 0.0 110.989 176.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 151.38 -163.08 29.78 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.486 -1.045 . . . . 0.0 110.486 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 36.7 p90 . . . . . 0 C--O 1.239 0.535 0 C-N-CA 125.282 1.433 . . . . 0.0 109.115 174.375 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ttt . . . . . 0 N--CA 1.483 1.219 0 CA-C-O 119.5 -0.286 . . . . 0.0 110.519 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.89 176.93 10.95 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.229 1.412 . . . . 0.0 108.874 -179.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.7 p -142.37 156.83 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 123.522 0.729 . . . . 0.0 109.305 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -157.11 -177.05 6.32 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.866 2.467 . . . . 0.0 106.484 175.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -141.95 142.41 33.0 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 169.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 81.5 mt -57.46 -32.36 66.87 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.734 0.814 . . . . 0.0 112.713 -171.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.84 -25.52 64.69 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.895 0.77 . . . . 0.0 112.1 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.5 mt -80.53 -24.92 38.99 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.37 0.668 . . . . 0.0 111.186 -177.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 41.0 mt -67.24 128.49 93.75 Favored Pre-proline 0 C--O 1.24 0.558 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -175.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -46.9 127.05 11.8 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.885 3.057 . . . . 0.0 111.341 171.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -81.4 -34.1 31.83 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 121.051 0.453 . . . . 0.0 111.311 -170.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.0 t -138.77 133.7 41.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 174.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -147.95 133.49 18.73 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 170.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 38.6 pt -147.42 156.82 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 127.113 2.165 . . . . 0.0 106.102 -177.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -150.01 46.02 0.92 Allowed 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 122.113 0.958 . . . . 0.0 109.973 178.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.9 m -145.8 173.73 11.85 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.795 1.638 . . . . 0.0 109.623 -176.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -150.68 168.98 22.73 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 125.288 1.435 . . . . 0.0 108.306 174.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.66 -92.5 1.72 Allowed Glycine 0 C--N 1.331 0.304 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 178.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.5 t -145.73 141.09 22.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 C-N-CA 128.034 2.534 . . . . 0.0 105.076 174.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -160.35 152.13 19.95 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 119.034 0.834 . . . . 0.0 110.444 172.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.25 152.03 39.79 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.62 0.768 . . . . 0.0 109.35 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.98 161.15 41.94 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.296 1.038 . . . . 0.0 109.082 -178.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.4 m -131.21 153.69 39.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 C-N-CA 124.4 1.08 . . . . 0.0 110.097 173.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -108.39 115.02 29.34 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 104.345 -2.465 . . . . 0.0 104.345 177.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 54.4 mt -119.37 124.53 73.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 -172.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -78.55 148.97 33.16 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 169.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.5 t -133.56 148.17 30.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 105.55 -2.019 . . . . 0.0 105.55 -179.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -129.59 156.2 44.58 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.806 1.243 . . . . 0.0 109.357 -178.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.1 m -68.75 44.41 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.1 1.76 . . . . 0.0 114.626 178.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -72.7 -9.41 0.15 Allowed Pre-proline 0 CA--C 1.557 1.234 0 N-CA-C 117.846 2.535 . . . . 0.0 117.846 170.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -46.29 159.22 0.28 Allowed 'Trans proline' 0 C--N 1.362 1.262 0 C-N-CA 123.82 3.013 . . . . 0.0 116.67 -177.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . 0.25 8.2 ptp180 46.63 22.1 0.16 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 126.222 1.809 . . . . 0.0 113.313 -169.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.7 m 49.69 27.14 2.08 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.971 1.708 . . . . 0.0 112.811 -172.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 169.28 30.29 0.02 OUTLIER Glycine 0 CA--C 1.528 0.858 0 CA-C-O 118.7 -1.055 . . . . 0.0 114.796 -173.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.22 148.78 29.23 Favored Pre-proline 0 CA--C 1.544 0.739 0 CA-C-N 119.168 1.484 . . . . 0.0 110.213 171.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.1 -25.5 19.17 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 122.494 2.13 . . . . 0.0 112.768 -176.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.44 157.52 33.99 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.711 0.804 . . . . 0.0 110.472 174.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -142.78 36.38 1.43 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.227 1.411 . . . . 0.0 109.044 174.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -81.67 176.18 9.85 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.862 0.865 . . . . 0.0 109.34 178.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.5 m -141.16 160.36 40.26 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.61 1.164 . . . . 0.0 108.984 171.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -149.59 169.83 20.07 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 127.338 2.255 . . . . 0.0 106.457 -173.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.1 mp0 -133.27 152.79 51.94 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 176.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 38.9 pt -133.96 155.73 40.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 125.551 1.54 . . . . 0.0 109.589 178.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 89.1 t -117.08 120.09 63.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 105.696 -1.965 . . . . 0.0 105.696 177.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.426 ' HG3' HG21 ' A' ' 60' ' ' VAL . 10.4 mmp_? -127.69 142.17 51.41 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 174.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -172.63 139.84 5.42 Favored Glycine 0 C--N 1.332 0.321 0 CA-C-N 119.429 1.013 . . . . 0.0 111.412 172.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.423 ' CD2' ' CZ2' ' A' ' 49' ' ' TRP . 30.1 m-85 -154.81 156.61 36.54 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.673 0.789 . . . . 0.0 109.893 -171.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.3 mttp -67.68 -32.02 72.39 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 118.793 -0.622 . . . . 0.0 111.007 175.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.423 ' CZ2' ' CD2' ' A' ' 47' ' ' TYR . 14.5 p-90 -62.57 -30.86 71.63 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.723 0.692 . . . . 0.0 111.575 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.73 71.04 6.68 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.357 0.663 . . . . 0.0 109.47 171.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -61.33 -18.3 57.94 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.502 0.721 . . . . 0.0 111.454 176.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -125.02 146.97 49.18 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 126.466 1.906 . . . . 0.0 107.764 176.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 60.9 m80 -73.12 -31.35 64.26 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 122.887 0.475 . . . . 0.0 110.441 -169.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.02 -30.83 49.21 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 118.612 -0.709 . . . . 0.0 112.4 172.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -69.67 -49.13 56.49 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 119.321 0.964 . . . . 0.0 111.084 -176.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.429 HG12 ' H ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -65.79 -40.18 86.94 Favored 'Isoleucine or valine' 0 C--N 1.342 0.274 0 CA-C-O 117.518 -1.23 . . . . 0.0 109.699 175.391 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -59.98 -50.55 73.29 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 119.726 1.148 . . . . 0.0 109.96 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -61.14 -45.35 95.02 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 119.059 0.845 . . . . 0.0 112.028 -178.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 30.7 tttt -61.4 -49.09 78.28 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 122.912 0.485 . . . . 0.0 110.574 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.426 HG21 ' HG3' ' A' ' 45' ' ' ARG . 85.0 t -78.91 -39.42 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 117.692 -1.146 . . . . 0.0 109.954 -170.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 91.5 p -61.42 -39.23 90.02 Favored 'General case' 0 C--N 1.339 0.122 0 CA-C-N 120.757 1.617 . . . . 0.0 109.13 174.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -57.28 -51.66 56.23 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 123.948 0.785 . . . . 0.0 111.363 172.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -61.73 -46.31 90.19 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 118.943 1.372 . . . . 0.0 111.68 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 36.0 mmt -59.41 -47.52 85.14 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.349 0.66 . . . . 0.0 110.456 177.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -62.84 -35.82 81.21 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.788 0.835 . . . . 0.0 111.279 177.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -66.38 -35.5 80.5 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 118.043 -0.98 . . . . 0.0 111.302 172.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -71.73 -17.51 62.2 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 119.972 1.26 . . . . 0.0 112.159 170.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.37 -8.57 41.19 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.696 1.617 . . . . 0.0 112.543 178.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 90.4 m -65.96 165.44 13.2 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.636 1.218 . . . . 0.0 110.863 176.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -125.33 148.3 48.79 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 170.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 65.9 m -145.31 165.34 28.73 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -168.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -149.22 137.64 20.9 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.811 1.645 . . . . 0.0 106.921 169.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.4 p -77.69 115.48 17.47 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 169.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 36.9 mt -67.99 -24.43 65.13 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 121.981 -0.449 . . . . 0.0 110.149 174.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.92 -165.73 38.69 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 170.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -147.7 178.84 25.04 Favored Glycine 0 CA--C 1.519 0.318 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 172.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -176.29 -157.84 18.41 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 107.546 -2.221 . . . . 0.0 107.546 -176.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 31.0 ptt-85 -137.02 157.78 45.95 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 120.616 -1.52 . . . . 0.0 108.811 173.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 97.4 mt -114.71 142.55 27.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 -177.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.0 m -135.86 148.53 48.68 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.123 0.969 . . . . 0.0 108.71 178.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -138.83 -34.45 0.61 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.525 1.13 . . . . 0.0 110.779 -177.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -83.17 34.06 0.46 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 119.075 0.852 . . . . 0.0 109.93 169.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.8 m -66.99 -176.52 0.53 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.901 2.08 . . . . 0.0 111.295 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 20.6 tp60 -57.98 -21.54 45.09 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.317 1.047 . . . . 0.0 112.459 177.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -139.27 155.13 47.96 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.902 1.681 . . . . 0.0 107.189 169.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 59.2 mtmt -64.97 -18.07 64.95 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -176.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -54.91 127.94 31.02 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 120.13 1.332 . . . . 0.0 108.366 174.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 69.3 mt -65.63 150.69 10.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 -178.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 24.5 t60 -136.87 155.61 49.54 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 121.171 -0.956 . . . . 0.0 109.652 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.6 t -137.37 124.89 30.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -164.48 -178.3 5.33 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 121.468 -0.77 . . . . 0.0 109.909 -172.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.49 -174.04 55.19 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -178.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -157.3 155.79 31.31 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.05 0.54 . . . . 0.0 111.958 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.1 t -75.81 164.67 26.0 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 168.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.3 ptm -108.53 -30.5 8.22 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 118.492 -0.766 . . . . 0.0 111.122 170.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.06 -26.06 60.18 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.551 1.069 . . . . 0.0 111.431 173.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -131.91 -7.42 3.53 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.915 0.886 . . . . 0.0 113.015 -169.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.92 -177.13 52.49 Favored Glycine 0 CA--C 1.535 1.293 0 CA-C-N 118.673 0.669 . . . . 0.0 113.607 171.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.08 135.65 38.16 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.092 2.528 . . . . 0.0 110.404 176.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.04 167.94 20.95 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.131 0.491 . . . . 0.0 110.128 169.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 -78.92 82.63 5.1 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 168.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -57.57 -15.09 6.34 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -176.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.55 -43.96 80.42 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.22 1.408 . . . . 0.0 111.215 169.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 64.1 mt -64.58 -47.12 90.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.91 -50.94 71.63 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.777 0.831 . . . . 0.0 110.923 -176.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.6 p -65.05 -46.95 79.13 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.593 -174.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -60.04 -40.2 88.56 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.311 0.959 . . . . 0.0 110.592 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -66.39 -47.52 73.06 Favored 'General case' 0 CA--C 1.528 0.12 0 O-C-N 121.86 -0.525 . . . . 0.0 111.457 176.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 61.7 mt -64.82 -40.25 88.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 119.369 0.986 . . . . 0.0 109.128 -177.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -58.53 -47.51 83.93 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 119.449 1.022 . . . . 0.0 109.551 174.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.28 -39.42 94.55 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.57 0.348 . . . . 0.0 111.489 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -66.34 -36.28 82.5 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 118.674 -0.679 . . . . 0.0 111.108 177.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -130.23 69.55 81.98 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 123.569 0.748 . . . . 0.0 111.198 -171.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -56.94 -21.96 43.84 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 123.39 2.727 . . . . 0.0 114.615 179.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -69.16 -8.15 42.91 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.234 1.013 . . . . 0.0 112.683 176.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -128.36 178.32 6.35 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.425 1.89 . . . . 0.0 108.935 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -135.26 158.54 44.09 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 170.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.5 t -139.37 142.16 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 -169.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.3 p -134.53 171.59 14.1 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.481 1.112 . . . . 0.0 109.4 176.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 27.6 p-90 -143.83 163.28 33.81 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 121.674 -0.641 . . . . 0.0 110.709 173.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.19 131.76 14.84 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 172.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.76 -8.13 57.54 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 122.731 0.412 . . . . 0.0 111.117 178.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -63.15 -27.97 69.74 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.136 1.374 . . . . 0.0 113.001 -178.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -60.09 159.6 23.3 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 123.744 0.688 . . . . 0.0 112.73 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 52.4 p90 . . . . . 0 C--O 1.239 0.525 0 C-N-CA 124.95 1.3 . . . . 0.0 110.542 -176.625 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 mtt . . . . . 0 N--CA 1.482 1.147 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.15 162.66 40.46 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.039 1.335 . . . . 0.0 108.623 176.098 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.4 p -148.32 148.04 16.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 179.759 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.15 174.76 6.72 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.499 0.666 . . . . 0.0 110.785 179.209 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -152.93 152.12 31.11 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 170.235 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 57.0 mt -53.54 -36.88 62.29 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 118.627 0.649 . . . . 0.0 112.12 -178.165 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.56 -25.21 68.13 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.871 0.759 . . . . 0.0 112.509 -179.09 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.4 mt -83.57 -20.81 33.11 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.316 0.646 . . . . 0.0 111.561 -176.961 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 24.0 mt -68.07 128.94 93.26 Favored Pre-proline 0 CA--C 1.539 0.527 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -177.085 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -50.81 117.94 3.76 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 123.337 2.691 . . . . 0.0 110.705 169.705 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -73.01 -34.37 66.34 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 122.65 0.38 . . . . 0.0 111.532 -171.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.7 t -141.64 123.06 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 177.847 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -143.58 107.68 4.74 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 106.86 -1.534 . . . . 0.0 106.86 171.35 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.6 pt -136.92 157.21 35.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 123.599 0.76 . . . . 0.0 110.49 -169.794 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -128.4 -13.2 4.94 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.536 2.334 . . . . 0.0 110.362 176.072 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.6 m -68.49 47.4 0.06 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.857 2.063 . . . . 0.0 113.247 172.751 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -65.6 -36.91 85.11 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 120.985 -1.072 . . . . 0.0 108.915 169.093 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -89.36 171.78 38.8 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 108.53 -1.828 . . . . 0.0 108.53 168.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.2 t -68.69 92.6 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 123.223 0.609 . . . . 0.0 110.38 -171.701 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -146.06 167.02 24.4 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 126.33 1.852 . . . . 0.0 108.771 176.282 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -73.76 162.91 28.64 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.219 1.008 . . . . 0.0 112.548 -170.277 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -151.3 163.41 38.97 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.514 1.926 . . . . 0.0 108.006 169.813 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.3 m -131.07 155.9 42.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 124.756 1.222 . . . . 0.0 109.816 172.125 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.1 117.67 34.75 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 178.233 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 69.1 mt -121.49 113.85 40.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -171.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.5 ttm-85 -69.88 142.41 53.01 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 168.699 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.8 p -140.86 147.81 22.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -122.13 151.77 40.6 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.929 1.292 . . . . 0.0 109.347 -174.61 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 56.0 m -62.51 93.28 0.05 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.094 0.958 . . . . 0.0 110.955 172.376 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.404 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -138.87 24.3 0.07 OUTLIER Pre-proline 0 CA--C 1.552 1.027 0 CA-C-O 116.767 -1.587 . . . . 0.0 114.015 169.442 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.404 ' CD ' ' N ' ' A' ' 30' ' ' ALA . 83.5 Cg_exo -44.39 137.71 7.85 Favored 'Trans proline' 0 C--N 1.359 1.091 0 CA-C-N 123.774 2.383 . . . . 0.0 113.606 172.409 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 43.69 22.98 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.779 2.031 . . . . 0.0 114.495 -171.856 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.7 m 50.05 30.4 4.12 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.133 1.373 . . . . 0.0 112.402 -171.357 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -154.19 2.25 0.23 Allowed Glycine 0 CA--C 1.53 1.019 0 CA-C-O 118.6 -1.111 . . . . 0.0 114.892 -170.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.07 141.06 77.11 Favored Pre-proline 0 CA--C 1.544 0.719 0 CA-C-N 119.427 1.613 . . . . 0.0 110.42 172.281 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.77 -23.47 10.94 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.733 2.289 . . . . 0.0 112.927 -178.851 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.37 157.8 30.9 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.795 0.838 . . . . 0.0 110.583 177.729 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -141.52 27.63 1.87 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.815 1.246 . . . . 0.0 110.825 177.714 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -76.72 177.99 7.14 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.734 0.814 . . . . 0.0 110.05 173.891 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.4 m -141.89 160.98 39.09 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.097 1.359 . . . . 0.0 109.004 176.659 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.8 tttt -148.24 165.77 29.96 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 126.963 2.105 . . . . 0.0 107.117 -174.462 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -125.64 131.38 52.65 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 169.782 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 44.2 pt -112.85 159.59 12.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 125.414 1.486 . . . . 0.0 110.569 174.068 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 25.0 t -126.24 121.77 59.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 -173.63 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 26.4 mmt85 -139.34 147.02 40.98 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.382 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.53 135.71 2.49 Favored Glycine 0 C--N 1.331 0.305 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 -179.656 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -153.57 155.71 36.65 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -171.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -59.36 -29.98 68.07 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -179.049 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 8.9 p-90 -68.46 -23.75 64.62 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.78 0.718 . . . . 0.0 112.4 -179.481 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.03 78.61 8.7 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 119.346 0.975 . . . . 0.0 110.085 177.064 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -62.3 -18.39 61.2 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.943 0.897 . . . . 0.0 111.468 172.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -128.1 143.15 51.05 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.771 1.629 . . . . 0.0 106.888 178.829 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -65.08 -30.92 71.92 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 118.478 0.581 . . . . 0.0 109.828 176.623 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.54 -29.35 58.78 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 118.484 -0.77 . . . . 0.0 112.788 171.445 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -68.71 -49.5 58.4 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.559 1.072 . . . . 0.0 110.476 -175.255 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.444 HG12 ' H ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -66.93 -38.08 80.68 Favored 'Isoleucine or valine' 0 C--N 1.34 0.18 0 CA-C-O 117.859 -1.067 . . . . 0.0 110.157 175.8 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -61.95 -47.67 83.82 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 119.776 1.171 . . . . 0.0 110.275 179.036 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -61.96 -46.71 88.09 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.319 0.509 . . . . 0.0 111.362 179.163 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 32.6 tttt -62.92 -54.8 32.9 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 123.027 0.531 . . . . 0.0 111.078 -179.451 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 86.2 t -72.3 -49.3 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-O 118.183 -0.913 . . . . 0.0 109.161 -170.549 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.8 m -65.45 -28.27 69.11 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 120.048 1.294 . . . . 0.0 110.992 178.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.13 -49.29 76.4 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 170.219 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -62.45 -44.3 96.73 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 118.734 1.267 . . . . 0.0 111.304 177.458 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 39.2 mmt -55.99 -49.34 73.88 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-O 119.133 -0.461 . . . . 0.0 110.032 175.183 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -66.75 -29.11 69.0 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.965 0.802 . . . . 0.0 112.281 179.598 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -67.59 -37.33 82.43 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.718 1.144 . . . . 0.0 110.511 171.014 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -69.1 -27.5 65.65 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 119.546 1.066 . . . . 0.0 110.479 169.549 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 122.37 -25.72 6.55 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 127.914 2.673 . . . . 0.0 111.215 177.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 95.9 m -54.16 142.92 24.14 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 126.732 2.013 . . . . 0.0 110.792 -175.538 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -108.84 142.0 40.06 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -176.219 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 85.7 m -137.57 165.55 26.05 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 -167.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -153.03 125.74 8.31 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.864 2.066 . . . . 0.0 107.124 173.748 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.8 p -73.55 124.71 26.42 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 169.435 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 35.1 mt -71.41 -25.74 62.46 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.796 -0.565 . . . . 0.0 110.257 172.38 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 162.69 -165.34 36.22 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 108.477 -1.849 . . . . 0.0 108.477 177.89 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -148.04 173.35 28.11 Favored Glycine 0 CA--C 1.519 0.329 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 173.624 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -168.36 -160.23 15.7 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 108.501 -1.84 . . . . 0.0 108.501 -178.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 35.6 ptt-85 -136.4 160.16 39.58 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 121.084 -1.245 . . . . 0.0 108.057 177.357 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 86.5 mt -115.49 148.63 18.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 -170.803 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 38.9 m 62.08 174.23 0.13 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.678 1.991 . . . . 0.0 112.433 -172.066 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -153.68 -168.44 2.98 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.257 1.823 . . . . 0.0 107.768 -179.918 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -54.65 156.24 3.66 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.567 0.747 . . . . 0.0 111.236 176.731 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.5 m -67.65 19.8 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.662 1.985 . . . . 0.0 114.424 -179.009 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -63.19 -21.97 66.56 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.256 1.022 . . . . 0.0 111.092 174.238 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -146.97 173.78 12.12 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.64 1.576 . . . . 0.0 107.733 172.9 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -114.08 -18.79 11.6 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.641 1.576 . . . . 0.0 110.887 178.422 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -55.83 135.35 51.96 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 169.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.412 HD12 ' H ' ' A' ' 88' ' ' ILE . 5.4 mp -68.71 156.07 7.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 -179.171 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 23.7 t60 -136.38 164.26 28.55 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 121.435 -0.791 . . . . 0.0 109.399 -179.404 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.1 t -145.45 133.94 16.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 176.274 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -169.74 -176.97 2.54 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.07 0.948 . . . . 0.0 109.302 -179.416 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 102.71 -170.06 19.77 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.407 -0.677 . . . . 0.0 111.407 173.824 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -157.92 151.51 23.67 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.858 0.863 . . . . 0.0 109.833 179.48 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.8 t -84.36 148.24 26.73 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 168.678 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 4.5 ptt? -76.27 -41.06 50.15 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 169.795 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.26 -25.14 54.66 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 118.881 -0.581 . . . . 0.0 112.246 -173.19 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -135.05 -1.83 2.62 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -169.619 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.04 -178.08 49.46 Favored Glycine 0 CA--C 1.535 1.297 0 CA-C-N 119.141 0.882 . . . . 0.0 113.089 176.415 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.86 139.57 33.59 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.999 2.466 . . . . 0.0 110.129 175.181 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.49 170.49 16.46 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.045 0.538 . . . . 0.0 110.58 169.758 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -78.4 84.0 4.59 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 168.605 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 48.5 m80 -57.95 -14.14 5.82 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -175.933 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.78 -41.1 85.86 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.429 1.492 . . . . 0.0 111.937 169.914 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 67.7 mt -65.8 -45.07 92.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.856 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.61 -49.38 76.62 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.354 1.061 . . . . 0.0 110.917 -179.006 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.4 p -63.19 -48.58 77.77 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 118.295 -0.86 . . . . 0.0 110.763 -176.438 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -60.08 -39.3 85.59 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.248 0.931 . . . . 0.0 110.764 -177.33 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 52.9 mttm -71.24 -45.05 64.11 Favored 'General case' 0 CA--C 1.528 0.112 0 O-C-N 121.839 -0.538 . . . . 0.0 111.817 178.652 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 73.9 mt -65.73 -38.29 81.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-N 119.363 0.983 . . . . 0.0 108.943 -179.444 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -57.93 -50.85 71.95 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.471 1.032 . . . . 0.0 109.115 171.905 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.5 -30.06 69.48 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -177.205 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -61.03 -40.58 94.14 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.998 0.817 . . . . 0.0 110.809 177.172 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -150.63 78.2 7.66 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 123.331 0.653 . . . . 0.0 109.285 -173.446 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -70.86 -4.75 15.4 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.215 2.61 . . . . 0.0 114.053 -169.868 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -68.92 -21.6 64.2 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 118.958 0.799 . . . . 0.0 111.399 169.794 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 22.8 m-30 -104.26 175.85 5.35 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.686 1.194 . . . . 0.0 109.037 169.891 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -138.35 158.3 44.55 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.434 1.094 . . . . 0.0 108.461 179.412 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.7 t -140.51 143.96 28.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -169.762 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.7 p -133.01 169.9 16.16 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.353 1.061 . . . . 0.0 109.76 177.606 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 41.6 p-90 -143.57 150.95 39.59 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 171.231 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.09 101.78 1.94 Allowed 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 104.665 -2.346 . . . . 0.0 104.665 172.361 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.05 -22.96 66.45 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -169.258 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -53.39 -27.23 22.99 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 126.934 2.093 . . . . 0.0 114.879 -169.905 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -63.84 -22.24 66.22 Favored Glycine 0 CA--C 1.537 1.442 0 CA-C-O 118.553 -1.137 . . . . 0.0 113.243 177.266 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 . . . . . 0 N--CA 1.47 0.558 0 C-N-CA 127.613 2.365 . . . . 0.0 113.469 177.683 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' PO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_